{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 132,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import os\n",
    "from matplotlib import pyplot as plt\n",
    "import plotly.express as px\n",
    "import plotly.io as pio\n",
    "import plotly.graph_objects as go"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "pio.renderers.default = 'notebook'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.set_option(\"display.min_rows\", 100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.set_option(\"display.max_rows\", 400)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.set_option(\"display.max_columns\", 100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "pd.set_option('display.max_colwidth', None)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "filepath = \"C:\\\\Users\\\\edidd\\\\Documents\\\\Ubiqum\\\\Data Analytics Course\\\\covid19\\\\resources\\\\COVID-19 Science Report Diagnostics V14.pdf\""
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##  Reading PDF into df with camelot"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "import camelot"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "tables_camelot = camelot.read_pdf(\n",
    "    filepath, \n",
    "    pages= \"all\", \n",
    "    strip_text='\\n', \n",
    "    layout_kwargs={'detect_vertical': False}, \n",
    "    flag_size=True, \n",
    "    line_scale=60\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "tables1 = camelot.read_pdf(\n",
    "    filepath, \n",
    "    pages= \"33\", \n",
    "    strip_text='\\n', \n",
    "    layout_kwargs={'detect_vertical': False}, \n",
    "    flag_size=True, \n",
    "    line_scale=60\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>0</th>\n",
       "      <th>1</th>\n",
       "      <th>2</th>\n",
       "      <th>3</th>\n",
       "      <th>4</th>\n",
       "      <th>5</th>\n",
       "      <th>6</th>\n",
       "      <th>7</th>\n",
       "      <th>8</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Tests for two gene targets: E and RdRp.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Obtained EUA approval from Korean CDC 27 Feb 2020.&lt;s&gt;151,152&lt;/s&gt; FDA EUA issued on 23/04/2020</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Integrated DNA Technologies (IDT)&lt;s&gt;24,242&lt;/s&gt; USA</td>\n",
       "      <td>3 Mar 2020</td>\n",
       "      <td>2019-nCoV CDC EUA Kit Follows US CDC protocol to test for 3 N gene targets, and 1 human RNase P gene as control.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.  Obtained EUA approval from US FDA 3 Mar 2020 for lot number #0000500383.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>USD $125&lt;s&gt;24&lt;/s&gt;for 500 rxn</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Luminex&lt;s&gt;164,165,253,25&lt;/s&gt;&lt;s&gt;4&lt;/s&gt; USA</td>\n",
       "      <td>4 Mar 2020</td>\n",
       "      <td>ARIES SARS-CoV-2 Assay Tests for two gene targets: ORF1ab &amp; N</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs spiked with purified SARS-CoV-2 viral genomic RNA (2x to 5x LoD) serving as contrived positive samples.&lt;s&gt;254&lt;/s&gt;</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs serving as negative controls.&lt;s&gt;254&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 3 Apr 2020.</td>\n",
       "      <td>2 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Genomica&lt;s&gt;255,256&lt;/s&gt; Spain</td>\n",
       "      <td>6 Mar 2020</td>\n",
       "      <td>qCOVID-19 Real-time RT-PCR</td>\n",
       "      <td>Reported 100%.&lt;s&gt;255&lt;/s&gt; Tested at the Carlos III Health Institute with 80 samples (unclear of sample types).</td>\n",
       "      <td>Reported 100%.&lt;s&gt;255&lt;/s&gt; Tested at the Carlos III Health Institute with 80 samples (unclear of sample types).</td>\n",
       "      <td>Available.  Received CE Mark 6 Mar 2020.&lt;s&gt;256&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Avellino Lab&lt;s&gt;257-259&lt;/s&gt; USA</td>\n",
       "      <td>9 Mar 2020</td>\n",
       "      <td>AvellinoCoV2 test Tests for two gene targets from US CDC protocol: N1 &amp; N3</td>\n",
       "      <td>100% (30/30)  30 oropharyngeal and nasopharyngeal swab specimens spiked with whole SARS-CoV-2 viral RNA (1x to 100x LoD) serving as contrived positive samples.&lt;s&gt;259&lt;/s&gt;</td>\n",
       "      <td>100% (30/30)  30 oropharyngeal and nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;259&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 25 Mar 2020.&lt;s&gt;257&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Wadsworth Center, New York State Department of Public Health&lt;s&gt;194,260&lt;/s&gt; USA</td>\n",
       "      <td>10 Mar 2020</td>\n",
       "      <td>New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel Tests for two gene targets: N1 &amp; N2.</td>\n",
       "      <td>(42/43)  For the easyMAG extraction, 43 individual sputum samples were spiked with the extracted whole SARS-CoV-2 virus genomic RNA (2x</td>\n",
       "      <td>(29/29)  For the easyMAG extraction, 30 individual sputum samples were used but 1 was invalidated, leaving 29 samples. Testing was</td>\n",
       "      <td>Available.   Obtained EUA approval from US FDA  for use in Wadsworth Center, New York State Public</td>\n",
       "      <td>42 min 45 s cycle time per gene target</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                  0  \\\n",
       "0   Molecular Tests   \n",
       "1              Type   \n",
       "2                     \n",
       "3  Real-time RT-PCR   \n",
       "4  Real-time RT-PCR   \n",
       "5  Real-time RT-PCR   \n",
       "6  Real-time RT-PCR   \n",
       "7  Real-time RT-PCR   \n",
       "\n",
       "                                                                                1  \\\n",
       "0                                                                                   \n",
       "1                                                                    Organisation   \n",
       "2                                                                                   \n",
       "3                              Integrated DNA Technologies (IDT)<s>24,242</s> USA   \n",
       "4                                        Luminex<s>164,165,253,25</s><s>4</s> USA   \n",
       "5                                                    Genomica<s>255,256</s> Spain   \n",
       "6                                                  Avellino Lab<s>257-259</s> USA   \n",
       "7  Wadsworth Center, New York State Department of Public Health<s>194,260</s> USA   \n",
       "\n",
       "             2  \\\n",
       "0                \n",
       "1     Reported   \n",
       "2                \n",
       "3   3 Mar 2020   \n",
       "4   4 Mar 2020   \n",
       "5   6 Mar 2020   \n",
       "6   9 Mar 2020   \n",
       "7  10 Mar 2020   \n",
       "\n",
       "                                                                                                                  3  \\\n",
       "0                                                                                                                     \n",
       "1                                                                                                              Test   \n",
       "2                                                                           Tests for two gene targets: E and RdRp.   \n",
       "3  2019-nCoV CDC EUA Kit Follows US CDC protocol to test for 3 N gene targets, and 1 human RNase P gene as control.   \n",
       "4                                                     ARIES SARS-CoV-2 Assay Tests for two gene targets: ORF1ab & N   \n",
       "5                                                                                        qCOVID-19 Real-time RT-PCR   \n",
       "6                                        AvellinoCoV2 test Tests for two gene targets from US CDC protocol: N1 & N3   \n",
       "7                        New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel Tests for two gene targets: N1 & N2.   \n",
       "\n",
       "                                                                                                                                                                           4  \\\n",
       "0                                                                                                                                                                              \n",
       "1                                                                                                                                                                Sensitivity   \n",
       "2                                                                                                                                                                              \n",
       "3                                                                                                                                                                  (no info)   \n",
       "4                    100% (30/30)  30 nasopharyngeal swabs spiked with purified SARS-CoV-2 viral genomic RNA (2x to 5x LoD) serving as contrived positive samples.<s>254</s>   \n",
       "5                                                              Reported 100%.<s>255</s> Tested at the Carlos III Health Institute with 80 samples (unclear of sample types).   \n",
       "6  100% (30/30)  30 oropharyngeal and nasopharyngeal swab specimens spiked with whole SARS-CoV-2 viral RNA (1x to 100x LoD) serving as contrived positive samples.<s>259</s>   \n",
       "7                                    (42/43)  For the easyMAG extraction, 43 individual sputum samples were spiked with the extracted whole SARS-CoV-2 virus genomic RNA (2x   \n",
       "\n",
       "                                                                                                                                    5  \\\n",
       "0                                                                                                                                       \n",
       "1                                                                                                                         Specificity   \n",
       "2                                                                                                                                       \n",
       "3                                                                                                                           (no info)   \n",
       "4                                                       100% (30/30)  30 nasopharyngeal swabs serving as negative controls.<s>254</s>   \n",
       "5                       Reported 100%.<s>255</s> Tested at the Carlos III Health Institute with 80 samples (unclear of sample types).   \n",
       "6                            100% (30/30)  30 oropharyngeal and nasopharyngeal swab specimens serving as negative controls.<s>259</s>   \n",
       "7  (29/29)  For the easyMAG extraction, 30 individual sputum samples were used but 1 was invalidated, leaving 29 samples. Testing was   \n",
       "\n",
       "                                                                                                    6  \\\n",
       "0                                                                                                       \n",
       "1                                                                                        Availability   \n",
       "2       Obtained EUA approval from Korean CDC 27 Feb 2020.<s>151,152</s> FDA EUA issued on 23/04/2020   \n",
       "3   Commercially available.  Obtained EUA approval from US FDA 3 Mar 2020 for lot number #0000500383.   \n",
       "4                             Commercially available.   Obtained EUA approval from US FDA 3 Apr 2020.   \n",
       "5                                                  Available.  Received CE Mark 6 Mar 2020.<s>256</s>   \n",
       "6                  Commercially available.   Obtained EUA approval from US FDA 25 Mar 2020.<s>257</s>   \n",
       "7  Available.   Obtained EUA approval from US FDA  for use in Wadsworth Center, New York State Public   \n",
       "\n",
       "                                        7                             8  \n",
       "0                                                                        \n",
       "1                              Turnaround                         Costs  \n",
       "2                                                                        \n",
       "3                               (no info)  USD $125<s>24</s>for 500 rxn  \n",
       "4                                    2 hr                     (no info)  \n",
       "5                               (no info)                     (no info)  \n",
       "6                                                             (no info)  \n",
       "7  42 min 45 s cycle time per gene target                     (no info)  "
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tables1[0].df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "camelot.plot(tables1[0], kind='grid')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "57"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(tables_camelot)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>0</th>\n",
       "      <th>1</th>\n",
       "      <th>2</th>\n",
       "      <th>3</th>\n",
       "      <th>4</th>\n",
       "      <th>5</th>\n",
       "      <th>6</th>\n",
       "      <th>7</th>\n",
       "      <th>8</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular tests (rRT-PCR)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Date</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>Charité Institute of Virology, Berlin, Germany &lt;s&gt;1,99&lt;/s&gt;</td>\n",
       "      <td>13 Jan 2020</td>\n",
       "      <td>Primer and Probe   First line screening assay: E gene assay  Confirmatory assay: RdRp gene assay  Additional confirmatory assay: N gene assay</td>\n",
       "      <td>First line screening assay  Technical LOD: 5.2 RNA copies/reaction, at 95% hit rate  95% CI: 3.7-9.6 RNA copies/reaction.  Confirmatory assay Technical LOD: 3.8 RNA copies/reaction, at 95% hit rate 95% CI: 2.7-7.6 RNA copies/reaction.  Additional confirmatory assay Technical LOD: 8.3 RNA copies/reaction, at 95% hit rate;  95% CI: 6.1-16.3 RNA copies/reaction.</td>\n",
       "      <td>Chemical stability No positive signal detected for non-specific reactivity of oligonucleotides.  Cross-reactivity with other coronaviruses No reactivity with any of three assays for five coronaviruses: (HCoV) -229E, -NL63, -OC43,  -HKU1, and MERS-CoV  Tests of human clinical samples previously tested to contain respiratory viruses All tests returned negative results for all 75 samples.</td>\n",
       "      <td>Available • SARS-CoV genomic RNA as positive control.</td>\n",
       "      <td>47 min 15 sec of cycle time (plus probe) for each assay</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>Charité Institute of Virology, Berlin, Germany &lt;s&gt;1,12&lt;/s&gt;</td>\n",
       "      <td>17 Jan 2020</td>\n",
       "      <td>Primer and Probe   First line screening assay: E gene assay  Confirmatory assay: RdRp gene assay</td>\n",
       "      <td>First line screening assay  Technical LOD: 5.2 RNA copies/reaction, at 95% hit rate  95% CI: 3.7-9.6 RNA copies/reaction.  Confirmatory assay Technical LOD: 3.8 RNA copies/reaction, at 95% hit rate 95% CI: 2.7-7.6 RNA copies/reaction.  (Preliminary experiment compared single probe assay for SARS-CoV with single probe assay for SARS-CoV-2.)</td>\n",
       "      <td>Chemical stability No positive signal detected for non-specific reactivity of oligonucleotides.  Cross-reactivity with other coronaviruses No reactivity with any of three assays for five coronaviruses: (HCoV) -229E, -NL63, -OC43,  -HKU1, and MERS-CoV  Tests of human clinical samples previously tested to contain respiratory viruses All tests returned negative results for all 75 samples.</td>\n",
       "      <td>Available • SARS-CoV genomic RNA as positive control.  • Synthetic control RNA for SARS-CoV-2 E gene assay is available via EVAg.  • Synthetic control for SARS-CoV-2 RdRp is expected to be available via EVAg from Jan 21st onward.</td>\n",
       "      <td>47 min 15 sec of cycle time (plus probe) for each assay</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>School of Public Health, The University</td>\n",
       "      <td>16 Jan 2020</td>\n",
       "      <td>Primer and Probe</td>\n",
       "      <td>Positive control using SARS-CoV RNA Wide dynamic range of 2&lt;s&gt;-4&lt;/s&gt; to 2000 TCID&lt;s&gt;50&lt;/s&gt;/reaction.</td>\n",
       "      <td>Exclusivity  Negative results against all of these preparations:</td>\n",
       "      <td>Available • Positive control (Available from HKU)</td>\n",
       "      <td>28 min 40 sec of cycle time for each assay</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                           0  \\\n",
       "0  Molecular tests (rRT-PCR)   \n",
       "1                       Type   \n",
       "2                    rRT-PCR   \n",
       "3                    rRT-PCR   \n",
       "4                    rRT-PCR   \n",
       "\n",
       "                                                            1            2  \\\n",
       "0                                                                            \n",
       "1                                                Organisation         Date   \n",
       "2  Charité Institute of Virology, Berlin, Germany <s>1,99</s>  13 Jan 2020   \n",
       "3  Charité Institute of Virology, Berlin, Germany <s>1,12</s>  17 Jan 2020   \n",
       "4                     School of Public Health, The University  16 Jan 2020   \n",
       "\n",
       "                                                                                                                                               3  \\\n",
       "0                                                                                                                                                  \n",
       "1                                                                                                                                           Test   \n",
       "2  Primer and Probe   First line screening assay: E gene assay  Confirmatory assay: RdRp gene assay  Additional confirmatory assay: N gene assay   \n",
       "3                                               Primer and Probe   First line screening assay: E gene assay  Confirmatory assay: RdRp gene assay   \n",
       "4                                                                                                                               Primer and Probe   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                           4  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                              \n",
       "1                                                                                                                                                                                                                                                                                                                                                                Sensitivity   \n",
       "2  First line screening assay  Technical LOD: 5.2 RNA copies/reaction, at 95% hit rate  95% CI: 3.7-9.6 RNA copies/reaction.  Confirmatory assay Technical LOD: 3.8 RNA copies/reaction, at 95% hit rate 95% CI: 2.7-7.6 RNA copies/reaction.  Additional confirmatory assay Technical LOD: 8.3 RNA copies/reaction, at 95% hit rate;  95% CI: 6.1-16.3 RNA copies/reaction.   \n",
       "3                      First line screening assay  Technical LOD: 5.2 RNA copies/reaction, at 95% hit rate  95% CI: 3.7-9.6 RNA copies/reaction.  Confirmatory assay Technical LOD: 3.8 RNA copies/reaction, at 95% hit rate 95% CI: 2.7-7.6 RNA copies/reaction.  (Preliminary experiment compared single probe assay for SARS-CoV with single probe assay for SARS-CoV-2.)   \n",
       "4                                                                                                                                                                                                                                                                       Positive control using SARS-CoV RNA Wide dynamic range of 2<s>-4</s> to 2000 TCID<s>50</s>/reaction.   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                      5  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                           Specificity   \n",
       "2  Chemical stability No positive signal detected for non-specific reactivity of oligonucleotides.  Cross-reactivity with other coronaviruses No reactivity with any of three assays for five coronaviruses: (HCoV) -229E, -NL63, -OC43,  -HKU1, and MERS-CoV  Tests of human clinical samples previously tested to contain respiratory viruses All tests returned negative results for all 75 samples.   \n",
       "3  Chemical stability No positive signal detected for non-specific reactivity of oligonucleotides.  Cross-reactivity with other coronaviruses No reactivity with any of three assays for five coronaviruses: (HCoV) -229E, -NL63, -OC43,  -HKU1, and MERS-CoV  Tests of human clinical samples previously tested to contain respiratory viruses All tests returned negative results for all 75 samples.   \n",
       "4                                                                                                                                                                                                                                                                                                                                      Exclusivity  Negative results against all of these preparations:   \n",
       "\n",
       "                                                                                                                                                                                                                                       6  \\\n",
       "0                                                                                                                                                                                                                                          \n",
       "1                                                                                                                                                                                                                           Availability   \n",
       "2                                                                                                                                                                                  Available • SARS-CoV genomic RNA as positive control.   \n",
       "3  Available • SARS-CoV genomic RNA as positive control.  • Synthetic control RNA for SARS-CoV-2 E gene assay is available via EVAg.  • Synthetic control for SARS-CoV-2 RdRp is expected to be available via EVAg from Jan 21st onward.   \n",
       "4                                                                                                                                                                                      Available • Positive control (Available from HKU)   \n",
       "\n",
       "                                                         7          8  \n",
       "0                                                                      \n",
       "1                                               Turnaround      Costs  \n",
       "2  47 min 15 sec of cycle time (plus probe) for each assay  (no info)  \n",
       "3  47 min 15 sec of cycle time (plus probe) for each assay  (no info)  \n",
       "4               28 min 40 sec of cycle time for each assay  (no info)  "
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tables_camelot[2].df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tables_camelot[0].df.shape[1] "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'accuracy': 99.79, 'whitespace': 20.63, 'order': 1, 'page': 14}"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tables_camelot[3].parsing_report"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "# tests_df = pd.DataFrame()\n",
    "# for i in range(0, 43):\n",
    "#     tests_df = pd.concat([tests_df, tables_camelot[i].df])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df = pd.DataFrame()\n",
    "for i in tables_camelot:\n",
    "    if i.df.shape[1] == 9:\n",
    "        tests_df = pd.concat([tests_df, i.df])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>0</th>\n",
       "      <th>1</th>\n",
       "      <th>2</th>\n",
       "      <th>3</th>\n",
       "      <th>4</th>\n",
       "      <th>5</th>\n",
       "      <th>6</th>\n",
       "      <th>7</th>\n",
       "      <th>8</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular tests (rRT-PCR)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Date</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>Charité Institute of Virology, Berlin, Germany &lt;s&gt;1,99&lt;/s&gt;</td>\n",
       "      <td>13 Jan 2020</td>\n",
       "      <td>Primer and Probe   First line screening assay: E gene assay  Confirmatory assay: RdRp gene assay  Additional confirmatory assay: N gene assay</td>\n",
       "      <td>First line screening assay  Technical LOD: 5.2 RNA copies/reaction, at 95% hit rate  95% CI: 3.7-9.6 RNA copies/reaction.  Confirmatory assay Technical LOD: 3.8 RNA copies/reaction, at 95% hit rate 95% CI: 2.7-7.6 RNA copies/reaction.  Additional confirmatory assay Technical LOD: 8.3 RNA copies/reaction, at 95% hit rate;  95% CI: 6.1-16.3 RNA copies/reaction.</td>\n",
       "      <td>Chemical stability No positive signal detected for non-specific reactivity of oligonucleotides.  Cross-reactivity with other coronaviruses No reactivity with any of three assays for five coronaviruses: (HCoV) -229E, -NL63, -OC43,  -HKU1, and MERS-CoV  Tests of human clinical samples previously tested to contain respiratory viruses All tests returned negative results for all 75 samples.</td>\n",
       "      <td>Available • SARS-CoV genomic RNA as positive control.</td>\n",
       "      <td>47 min 15 sec of cycle time (plus probe) for each assay</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>Charité Institute of Virology, Berlin, Germany &lt;s&gt;1,12&lt;/s&gt;</td>\n",
       "      <td>17 Jan 2020</td>\n",
       "      <td>Primer and Probe   First line screening assay: E gene assay  Confirmatory assay: RdRp gene assay</td>\n",
       "      <td>First line screening assay  Technical LOD: 5.2 RNA copies/reaction, at 95% hit rate  95% CI: 3.7-9.6 RNA copies/reaction.  Confirmatory assay Technical LOD: 3.8 RNA copies/reaction, at 95% hit rate 95% CI: 2.7-7.6 RNA copies/reaction.  (Preliminary experiment compared single probe assay for SARS-CoV with single probe assay for SARS-CoV-2.)</td>\n",
       "      <td>Chemical stability No positive signal detected for non-specific reactivity of oligonucleotides.  Cross-reactivity with other coronaviruses No reactivity with any of three assays for five coronaviruses: (HCoV) -229E, -NL63, -OC43,  -HKU1, and MERS-CoV  Tests of human clinical samples previously tested to contain respiratory viruses All tests returned negative results for all 75 samples.</td>\n",
       "      <td>Available • SARS-CoV genomic RNA as positive control.  • Synthetic control RNA for SARS-CoV-2 E gene assay is available via EVAg.  • Synthetic control for SARS-CoV-2 RdRp is expected to be available via EVAg from Jan 21st onward.</td>\n",
       "      <td>47 min 15 sec of cycle time (plus probe) for each assay</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>School of Public Health, The University</td>\n",
       "      <td>16 Jan 2020</td>\n",
       "      <td>Primer and Probe</td>\n",
       "      <td>Positive control using SARS-CoV RNA Wide dynamic range of 2&lt;s&gt;-4&lt;/s&gt; to 2000 TCID&lt;s&gt;50&lt;/s&gt;/reaction.</td>\n",
       "      <td>Exclusivity  Negative results against all of these preparations:</td>\n",
       "      <td>Available • Positive control (Available from HKU)</td>\n",
       "      <td>28 min 40 sec of cycle time for each assay</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular tests (rRT-PCR)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Date</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td>of Hong Kong (HKU)&lt;s&gt;13,14&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Assay 1 (Target: ORF1b-nsp14 gene)  Assay 2 (Target: N gene)</td>\n",
       "      <td></td>\n",
       "      <td>• RNA extracted from cultured viruses • RNA from retrospective human clinical specimens previously tested positive for other infections • RNA from control human clinical specimens</td>\n",
       "      <td>Primers and probes: • HKU-ORF1b-nsp14F • HKU- ORF1b-nsp14R • HKU-ORF1b-nsp141P • HKU-NF • HKU-NR • HKU-NP</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>Chinese Center for Disease Control and Prevention, Beijing, China&lt;s&gt;100&lt;/s&gt;</td>\n",
       "      <td>21 Jan 2020</td>\n",
       "      <td>Primer and Probe   Target 1 (ORF1ab gene)  Target 2 (N gene)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Department of Medical Sciences, Ministry of Public Health, Thailand&lt;s&gt;101&lt;/s&gt;</td>\n",
       "      <td>Jan 2020</td>\n",
       "      <td>With gel electrophoresis</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available Primers: • NbatCoV_F1  • NbatCoV_R1</td>\n",
       "      <td>107 min of cycle time</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>National Institute of Infectious Diseases, Japan&lt;s&gt;102&lt;/s&gt;</td>\n",
       "      <td>23 Jan 2020</td>\n",
       "      <td>With gel electrophoresis (Nested RT-PCR)  Primer and Probe (Real-time RT-PCR)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available Primers and probes: • NIID_2019-nCOV_N_F2 • NIID_2019-nCOV_N_R2 • NIID_2019-nCOV_N_P2</td>\n",
       "      <td>81 min for Nested RT-PCR  95 min for Real-time RT-PCR</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>Centers for Disease Control and Prevention, Atlanta, USA&lt;s&gt;15,16&lt;/s&gt;</td>\n",
       "      <td>24 Jan 2020</td>\n",
       "      <td>Primer and Probe   3 N gene targets  1 human RNase P gene control</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available Primers and probes: • 2019-nCOV_N1_F • 2019-nCOV_N1_R • 2019-nCOV_N1_P • 2019-nCOV_N2_F • 2019-nCOV_N2_R • 2019-nCOV_N2_P • 2019-nCOV_N3_F • 2019-nCOV_N3_R • 2019-nCOV_N3_P • RP_F • RP_R • RP_P</td>\n",
       "      <td>43 min 45 sec of cycle time for each assay</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular tests (rRT-PCR)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Date</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>Institut Pasteur, Paris, France&lt;s&gt;10&lt;/s&gt;</td>\n",
       "      <td>2 Mar 2020</td>\n",
       "      <td>Primer and Probe   2 RdRp gene targets with Charité’s E gene target as confirmatory</td>\n",
       "      <td>100 or more copies of RNA genome equivalent per reaction always detected.  Samples containing 10 copies of RNA genome could be detected with multiplex assay.</td>\n",
       "      <td>Cross-reactivity with other respiratory viruses was tested and were all negative in reactivity with the two RdRp gene targets.</td>\n",
       "      <td>Available Primers and probes: • nCoV_IP2-12669Fw • nCoV_IP2-12759Rv • nCoV_IP2-12696bProbe(+) • nCoV_IP4-14059Fw • nCoV_IP4-14146Rv • nCoV_IP4-14084Probe(+) • E_Sarbeco_F1 • E_Sarbeco_R2 • E_Sarbeco_P1</td>\n",
       "      <td>61 min of cycle time for each assay</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2.1.1 PCR Kits</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>Genosensor, LLC &lt;s&gt;103&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>&lt;s&gt;GS COVID-19 RT-PCR Kit&lt;/s&gt; Real-time reverse transcription polymerase chain reaction test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal/oropharyngeal swabs, nasal swabs, mid-turbinate swabs from individuals suspected of COVID-19. Positive results are indicative of the presence of SARS-CoV-2 RNA.</td>\n",
       "      <td>&lt;s&gt;100% (32/32)&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;100% (32/32)&lt;/s&gt;</td>\n",
       "      <td>Available.  EUA issued on 16th April 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>KorvaLabs Inc. &lt;s&gt;104&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Curative-Korva SARS-CoV-2 Assay  Real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in oropharyngeal (throat) swab, nasopharyngeal swab, nasal swab, and oral fluid specimens from individuals suspected of COVID-19. Results are for the detection of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA.</td>\n",
       "      <td>100% (5/5)</td>\n",
       "      <td>100% (5/5)</td>\n",
       "      <td>Available.  EUA issued on 16th April 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>Genosensor, LLC &lt;s&gt;103&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>&lt;s&gt;GS COVID-19 RT-PCR Kit&lt;/s&gt; Real-time reverse transcription polymerase chain reaction test intended</td>\n",
       "      <td>&lt;s&gt;100% (32/32)&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;100% (32/32)&lt;/s&gt;</td>\n",
       "      <td>Available.  EUA issued on 16th April 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal/oropharyngeal swabs, nasal swabs, mid-turbinate swabs from individuals suspected of COVID-19. Positive results are indicative of the presence of SARS-CoV-2 RNA.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>KorvaLabs Inc. &lt;s&gt;104&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Curative-Korva SARS-CoV-2 Assay  Real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in oropharyngeal (throat) swab, nasopharyngeal swab, nasal swab, and oral fluid specimens from individuals suspected of COVID-19. Results are for the detection of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA.</td>\n",
       "      <td>100% (5/5)</td>\n",
       "      <td>100% (5/5)</td>\n",
       "      <td>Available.  EUA issued on 16th April 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>Shanghai Fosun Long March Medical Science Co. Ltd&lt;s&gt;105&lt;/s&gt; Manufactured for: Fosun Pharma USA Inc.</td>\n",
       "      <td></td>\n",
       "      <td>COVID-19 RT-PCR &lt;s&gt;Detection Kit&lt;/s&gt; Real-time RT-PCR for qualitative detection of SARS-CoV-2 ORF1ab, N and E gene targets  Real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper and lower respiratory specimens (such as anterior</td>\n",
       "      <td>99.51% (203/204)&lt;s&gt;106&lt;/s&gt;</td>\n",
       "      <td>96.44% (379/393)&lt;s&gt;106&lt;/s&gt;</td>\n",
       "      <td>Available.  EUA issued on 17th April 2020   Received CE mark on 17 March 2020.   Received emergency approval from the National Medical Products Administration</td>\n",
       "      <td>Within 2 Hours</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>nasal swabs, mid-turbinate nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) from individuals suspected of COVID-19. Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper and lower respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>(NMPA) on 27 March 2020.   Approved for inclusion in the Australian Register of Therapeutic Goods on 8 May 2020&lt;s&gt;107&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR assay</td>\n",
       "      <td>Rhoenix, Inc. &lt;s&gt;108&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Rheonix COVID-19 MDx Assay&lt;s&gt;109&lt;/s&gt; Qualitative detection of total nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal washes, nasal aspirates and bronchoalveolar lavage (BAL) fluid.</td>\n",
       "      <td>100%&lt;s&gt;109&lt;/s&gt;</td>\n",
       "      <td>100%</td>\n",
       "      <td>FDA EUA issued on 29/04/2020&lt;s&gt;109&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR assay</td>\n",
       "      <td>LabGenomics Co., Ltd &lt;s&gt;110&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>LabGun COVID-10 RT-PCR Kit &lt;s&gt;111&lt;/s&gt; Qualitative detection of total nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasopharyngeal washes, &lt;s&gt;nasal aspirates and sputum&lt;/s&gt;</td>\n",
       "      <td>100% (50/50)&lt;s&gt;111&lt;/s&gt;</td>\n",
       "      <td>100% (100/100) &lt;s&gt;111&lt;/s&gt;</td>\n",
       "      <td>FDA EUA issued on 29/04/2020 &lt;s&gt;111&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Bioperfectus Technologies&lt;s&gt;112&lt;/s&gt; China</td>\n",
       "      <td>14 Jan 2020</td>\n",
       "      <td>RT-PCR test kit</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available as scientific research product – does not require registration&lt;s&gt;112&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Co-Diagnostics&lt;s&gt;113-&lt;/s&gt;&lt;s&gt;115&lt;/s&gt; USA</td>\n",
       "      <td>23 Jan 2020</td>\n",
       "      <td>Logix Smart Coronavirus COVID-19 test RT-PCR kit with lower false positive</td>\n",
       "      <td>100% (21/21)&lt;s&gt;116&lt;/s&gt;</td>\n",
       "      <td>No specific statistics but claims to have ability to reliably and accurately differentiate between similar genetic sequences, in order to reduce the likelihood of a false-positive diagnosis.   Company shared that it achieves this by creating reactions that are far more specific than competing PCR technologies and 2.5 million times more effective in reducing amplification errors.&lt;s&gt;113,117&lt;/s&gt; 100%&lt;s&gt;116&lt;/s&gt;</td>\n",
       "      <td>Commercially available for sale on 10 Feb 2020.&lt;s&gt;114&lt;/s&gt; Received CE Mark 24 Feb 2020.&lt;s&gt;118&lt;/s&gt; Obtained EUA approval from US FDA 3 Apr 2020.&lt;s&gt;115&lt;/s&gt;</td>\n",
       "      <td>Within 2 hours&lt;s&gt;116&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Altona Diagnostics&lt;s&gt;119,120&lt;/s&gt;Germany</td>\n",
       "      <td>23 Jan 2020</td>\n",
       "      <td>RealStar SARS-CoV-2 RT- &lt;s&gt;PCR Kit 1.0&lt;/s&gt;Real time RT-PCR for qualitative detection of SARS-CoV-2 RNA (target genes E gene and S gene).</td>\n",
       "      <td>95% (24/25) detection for S gene;   100% (25/25) detection for E gene.</td>\n",
       "      <td>35/35 for both S and E gene.</td>\n",
       "      <td>Available FDA EUA issued on 22 April 2020  Received CE mark for IVD  HSA provisional authorisation approved on 15 May 2020 &lt;s&gt;121&lt;/s&gt;</td>\n",
       "      <td>2:15 hours&lt;s&gt;122&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Roche&lt;s&gt;123-126&lt;/s&gt; Switzerland</td>\n",
       "      <td>31 Jan 2020</td>\n",
       "      <td>Cobas SARS-CoV-2 Test Runs on the Cobas 6800/8800 systems. Tests for two gene targets: ORF1ab &amp; E.</td>\n",
       "      <td>100% (50/50)  50 nasopharyngeal swab clinical samples spiked with cultured SARS-CoV-2 virus Low (1.5x LoD) and moderate (4x LoD)</td>\n",
       "      <td>100% (100/100)  100 nasopharyngeal swab clinical samples serve as negative controls.&lt;s&gt;126&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 13 Mar 2020.&lt;s&gt;125&lt;/s&gt; CE Mark for IVD.</td>\n",
       "      <td>3 hr 30 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>contrived positive samples &lt;s&gt;126&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Approved for inclusion on the Australia’s ARTG on 20 March 2020.  Date of HSA Provisional Authorisation: 19/03/2020&lt;s&gt;127&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>A*STAR&lt;s&gt;4,128&lt;/s&gt;(Manufactured by Singapore’s MiRxes which has a nonexclusive license)&lt;s&gt;129&lt;/s&gt; Singapore</td>\n",
       "      <td>1 Feb 2020</td>\n",
       "      <td>A*STAR Fortitude 2.0 Test is based on rRT-PCR, for the qualitative detection of SARS- CoV-2 specific RNA in nasopharyngeal swab specimens.  Supports 188 tests per kit</td>\n",
       "      <td>100%&lt;s&gt;130&lt;/s&gt;</td>\n",
       "      <td>100%</td>\n",
       "      <td>Available but not for commercial sale yet.   Provisional authorization for clinical use from Singapore's HSA.&lt;s&gt;4,129&lt;/s&gt; Date of Provisional Authorisation from HSA: 30 April 2020</td>\n",
       "      <td>90 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>PCL&lt;s&gt;131&lt;/s&gt; South Korea</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>Multiplex diagnostic kit  PCLMD-nCoV one step RT-PCR kit Organisation: PCL&lt;s&gt;132&lt;/s&gt; Qualitative detection of SARS-Co-V-2 by sputum samples</td>\n",
       "      <td>Sensitivity: 100% (35/35) &lt;s&gt;132&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Developed as of 3 Feb 2020.   CE approved &lt;s&gt;132&lt;/s&gt;</td>\n",
       "      <td>1 hr 45 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Biomeme&lt;s&gt;133,134&lt;/s&gt; USA</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>Shelf-stable strip with 3 reaction wells, each reaction contains lyophilized master mix, multiplexed primers, and probes for the following triplex: - 2019-nCoV-Orf1ab - 2019-nCoV-S - MS2 bacteriophage as an RNA extraction and RT-PCR control</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>$300 for 10 strips +  $5,950 for PCR Thermocycler + $450 for sample prep kit</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Livzon&lt;s&gt;135&lt;/s&gt;</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>Novel coronavirus (2019-nCoV) nucleic acid diagnostic kit (PCR-fluorescence method) Detection of ORF1ab and N genes.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Developed.  Undergoing testing. Emergency use approval submitted to China’s NMPA on 27 Jan 2020</td>\n",
       "      <td>30 minutes&lt;s&gt;136&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Acumen Research Laboratories&lt;s&gt;137&lt;/s&gt; Singapore</td>\n",
       "      <td>7 Feb 2020</td>\n",
       "      <td>&lt;s&gt;Acu-Corona™ 2.0/3.0&lt;/s&gt;With specific gene targets.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Prototype developed.  Acu-Corona 2.0 obtained Provisional Authorisation from Singapore Health Sciences Authority on 31 March 2020. Acu-Corona 3.0 obtained Provisional Authorisation from HSA on 14 April 2020. (HSA authorisation for Acu-Corona 2.0: &lt;s&gt;138&lt;/s&gt;HSA authorisation for Acu-Corona 3.0:&lt;s&gt;139&lt;/s&gt; Currently CE-IVD pending and approved for research only, seeking approval from US Food and Drug Authorisation</td>\n",
       "      <td>Allows up to 94 patient samples &lt;s&gt;per 1.5h&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR  [Point-of-Care]</td>\n",
       "      <td>Cepheid&lt;s&gt;27,140,141&lt;/s&gt; (Plus collaboration with Sherlock Biosciences)&lt;s&gt;142&lt;/s&gt; USA</td>\n",
       "      <td>10 Feb 2020</td>\n",
       "      <td>SAR-CoV-2 Xpert Xpress Cartridge-based nucleic acid amplification test. Tests for two gene targets: N2 &amp; E.</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swab specimens were spiked with SARS-CoV- (2x to 5x LoD) serving as contrived positive samples.&lt;s&gt;141&lt;/s&gt;</td>\n",
       "      <td>100% (35/35)  35 nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;141&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 21 Mar 2020.&lt;s&gt;27&lt;/s&gt; Approved for inclusion on the Australian Register of Therapeutic Goods on 22 March 2020. &lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>45 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>TIB-Molbiol&lt;s&gt;124,144&lt;/s&gt;(distributed by Roche)  Germany</td>\n",
       "      <td>12 Feb 2020</td>\n",
       "      <td>2019-nCoV Real-Time Reverse Transcription PCR Kit Tests for three gene targets: E, RdRp, and N.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available. Orders for the kit have been placed from World Health Organisation, national health authorities and laboratories in about 60 countries. &lt;s&gt;144&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>About €160&lt;s&gt;144&lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>AusDiagnostics&lt;s&gt;145-&lt;/s&gt;&lt;s&gt;147&lt;/s&gt; Australia</td>\n",
       "      <td>16 Feb 2020</td>\n",
       "      <td>AusDiagnostics respiratory virus panel (including SARS-CoV-2) test Multiplex panel. Tests for two gene targets: ORF1a &amp; ORF8</td>\n",
       "      <td>100%&lt;s&gt;147&lt;/s&gt;</td>\n",
       "      <td>100%&lt;s&gt;147&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Received CE Mark Mar 2020.&lt;s&gt;147&lt;/s&gt; Approved for inclusion in Australia’s ARTG.&lt;s&gt;81&lt;/s&gt;</td>\n",
       "      <td>3 hr&lt;s&gt;146&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Seegene&lt;s&gt;148,149&lt;/s&gt; South Korea</td>\n",
       "      <td>18 Feb 2020</td>\n",
       "      <td>Allplex 2019-nCoV Assay Single-tube assay that tests for three gene targets: E, RdRp, and N.</td>\n",
       "      <td>100% (49/49) from upper respiratory specimens (nasopharyngeal/ oropharyngeal swabs)  100% (49/49) from lower respiratory specimens (sputum)&lt;s&gt;150&lt;/s&gt;</td>\n",
       "      <td>94% (94/100) from upper respiratory specimens (nasopharyngeal/ oropharyngeal swabs)  97.87% (92/94) from lower respiratory specimens (sputum)  &lt;s&gt;150&lt;/s&gt;</td>\n",
       "      <td>Commercially available.  Obtained EUA approval from Korean FDA 12 Feb 2020.&lt;s&gt;151,152&lt;/s&gt; Product already has CE Mark for IVD.    Obtained HSA provisional approval on 2 April 2020, supplied through All Eights (Singapore) Pte Ltd. &lt;s&gt;153&lt;/s&gt; Approved for inclusion on the Australian Register of Therapeutic Goods on 27 March 2020 &lt;s&gt;143&lt;/s&gt; FDA EUA issued 21/04/2020</td>\n",
       "      <td>1 hour 50 minutes after extraction &lt;s&gt;150&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR  [Point-of-Care]</td>\n",
       "      <td>Credo Diagnostics Biomedical&lt;s&gt;154,155&lt;/s&gt; Singapore</td>\n",
       "      <td>21 Feb 2020</td>\n",
       "      <td>VitaPCR SARS-CoV-2 Assay Runs on Credo’s VitaPCR automated point-of-care molecular testing platform.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.   Received CE Mark 17 Mar 2020.   Submitted to US FDA for EUA approval.  Has provisional authorisation from Singapore’s HSA.</td>\n",
       "      <td>20 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Osang Healthcare&lt;s&gt;156,157&lt;/s&gt;(partnership with Italy’s ELITech Group)  South Korea</td>\n",
       "      <td>3 Mar 2020</td>\n",
       "      <td>GeneFinder COVID-19 Plus RealAmp Kit Tests for three gene targets: RdRp, E, and N.  Runs on all major PCR cyclers as well as on the Sample-to-Result Platform ELITe InGenius.</td>\n",
       "      <td>100% for both upper and lower respiratory tract samples   Evaluated using 30 nasopharyngeal swabs (upper respiratory tract) and sputum (lower respiratory tract) specimens spiked with SARS-CoV-2 virus (1x to 4x LoD) serving as contrived positive samples &lt;s&gt;158&lt;/s&gt;</td>\n",
       "      <td>100% for both upper and lower respiratory tract samples   Evaluated using 30 nasopharyngeal swabs and sputum specimens serving as negative controls&lt;s&gt;158&lt;/s&gt;</td>\n",
       "      <td>Available.   Received CE Mark for IVD.  Obtained EUA approval from US FDA on 18 April 2020. &lt;s&gt;158&lt;/s&gt; Date of Provisional Authorisation from HSA: 14 May 2020, supplied through SPD Scientific Pte Ltd&lt;s&gt;159&lt;/s&gt;</td>\n",
       "      <td>About 120 minutes &lt;s&gt;158&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR  [Point-of-Care]</td>\n",
       "      <td>Mesa Biotech&lt;s&gt;28,30,160-162&lt;/s&gt; USA</td>\n",
       "      <td>4 Mar 2020</td>\n",
       "      <td>Accula SARS-Cov-2 Test Automated PCR test for the qualitative visual detection of nucleic acid from the SARS-CoV-2 virus that runs on the Accula system machines.</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs spiked with SARS-CoV-2 RNA (2x to 50x LoD) serving as contrived positive samples.&lt;s&gt;162&lt;/s&gt;</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs serving as negative controls.&lt;s&gt;162&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 23 Mar 2020.</td>\n",
       "      <td>30 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Luminex&lt;s&gt;163-165&lt;/s&gt; USA</td>\n",
       "      <td>4 Mar 2020</td>\n",
       "      <td>NxTAG CoV Extended Panel Assay Multiplex panel that can be run on Luminex’s MAGPIX System together with optional NxTag Respiratory Pathogen Panel.  Tests for three gene targets: ORF1ab, E, &amp; N</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs spiked with purified SARS-CoV-2 viral genomic RNA (2x to 5x LoD) serving as contrived positive samples.</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs serving as negative controls.</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 27 Mar 2020.  Date of Provisional Authorisation from HSA: 8 May 2020&lt;s&gt;166&lt;/s&gt;</td>\n",
       "      <td>4 hr  (2 hr 15 min to  2 hr 25 min cycle time)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>LGC Biosearch Technologies&lt;s&gt;25,167&lt;/s&gt;</td>\n",
       "      <td>10 Mar 2020</td>\n",
       "      <td>2019-nCoV CDC Probe and Primer Kits for SARS-CoV-2 Lot numbers #143503 and #143764</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.  Obtained EUA approval from US FDA 10 Mar 2020 for lot number #143503 and #143764.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>USD $230 for 1000 rxn&lt;s&gt;167&lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Fulgent Therapeutics, LLC&lt;s&gt;168&lt;/s&gt; USA</td>\n",
       "      <td>11 Mar 2020</td>\n",
       "      <td>COVID-19 Virus Testing by RT-PCR  Real-time RT-PCR for the qualitative detection of SARS-CoV-2 N1 and N2</td>\n",
       "      <td>&lt;s&gt;100% (30/30)&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;100% (64/64)&lt;/s&gt;</td>\n",
       "      <td>Submitted to US FDA for EUA Approval.  Commercially Available&lt;s&gt;169&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>genes in upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal direct swab specimens)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>FDA EUA issued on 15/5/2020&lt;s&gt;170&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>bioMérieux&lt;s&gt;171-173&lt;/s&gt;(subsidiary BioFire Defense)  France</td>\n",
       "      <td>11 Mar 2020</td>\n",
       "      <td>BioFire COVID-19 test Fully automated and designed to run on FILMARRAY® 2.0 and FILMARRAY® TORCH platforms. Tests for two gene targets: ORF1ab &amp; ORF8</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swab specimens were spiked with live SARS-CoV-2 virus (1x to 100x LoD) serving as contrived positive samples.&lt;s&gt;174&lt;/s&gt;</td>\n",
       "      <td>100% (66/66)  66 clinical nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;174&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 24 Mar 2020.&lt;s&gt;173&lt;/s&gt;</td>\n",
       "      <td>45 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Hologic&lt;s&gt;175-177&lt;/s&gt; USA</td>\n",
       "      <td>16 Mar 2020</td>\n",
       "      <td>Panther Fusion SARS-CoV-2 Assay Test for two conserved regions of the ORF1ab gene</td>\n",
       "      <td>100% (69/69)  69 remnant clinical nasopharyngeal specimens were spiked with inactivated cultured SARS-CoV-2 virus (1x to 5x LoD) serving as contrived positive samples.&lt;s&gt;177&lt;/s&gt;</td>\n",
       "      <td>100 (109/109)  109 remnant clinical nasopharyngeal specimens serving as negative controls.&lt;s&gt;177&lt;/s&gt;</td>\n",
       "      <td>Commercially available.  Obtained EUA approval from US FDA 16 Mar 2020.   Approved for inclusion into the Australian Register of Therapeutic Goods on 20 March 2020.&lt;s&gt;81&lt;/s&gt;</td>\n",
       "      <td>Can generate results in 3 hours&lt;s&gt;178&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>LabCorp (Laboratory Corporation of America)&lt;s&gt;176,179&lt;/s&gt; USA</td>\n",
       "      <td>16 Mar 2020</td>\n",
       "      <td>COVID-19 RT-PCR Test Test for three gene targets: N1, N2, &amp; N3</td>\n",
       "      <td>100% (80/80)  40 nasopharyngeal swab specimens and 40 bronchoalveolar lavage specimens were spiked with quantitated live SARS-CoV-2 (1x to 8x LoD) to form 80 contrived positive samples.&lt;s&gt;179&lt;/s&gt;</td>\n",
       "      <td>100% (100/100)   50 nasopharyngeal swab specimens and 50 bronchoalveolar lavage specimens serving as negative controls.&lt;s&gt;179&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 16 Mar 2020.</td>\n",
       "      <td>Approximately 2-4 days from the date of pickup of a specimen for testing to the release of the test result to the health care provider &lt;s&gt;180&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Quidel&lt;s&gt;181,182&lt;/s&gt; USA</td>\n",
       "      <td>17 Mar 2020</td>\n",
       "      <td>Lyra SARS-CoV-2 Assay Identification of the SARS-CoV-2 virus occurs by the use of target specific primers and fluorescent-labeled 102 probes that hybridize to a conserved region of the non-structural Polyprotein</td>\n",
       "      <td>100% (92/92)  92 nasopharyngeal swab specimens were spiked with SARS-CoV-2 RNA (1x to 5x LoD) serving as contrived positive samples.&lt;s&gt;182&lt;/s&gt;</td>\n",
       "      <td>(100% (92/92)  92 nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;182&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 17 Mar 2020.</td>\n",
       "      <td>45 min cycle time per gene</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>(pp1ab) of the SARS-CoV-2 virus.&lt;s&gt;183&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Quests Diagnostics&lt;s&gt;184,185&lt;/s&gt; USA</td>\n",
       "      <td>17 Mar 2020</td>\n",
       "      <td>Quest SARS-CoV-2 rRT-PCR Tests on two gene targets: N1 &amp; N3</td>\n",
       "      <td>100% (30/30)  12 pairs of nasopharyngeal swab and sputum specimens from actual COVID-19 patient formed 24 samples, together wiith 6 additional randomly selected to be duplicated, serving as total 30 positive samples.&lt;s&gt;185&lt;/s&gt;</td>\n",
       "      <td>100% (72/72)  72 presumed-negative nasopharyngeal/throat swab specimens from before Oct 2019 servings as negative controls.&lt;s&gt;185&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 17 Mar 2020.</td>\n",
       "      <td>58 min 40 s cycle time per gene</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Abbott Molecular&lt;s&gt;27,186,187&lt;/s&gt; USA</td>\n",
       "      <td>18 Mar 2020</td>\n",
       "      <td>Abbott RealTime SARS-CoV-2 assay Will run on the Abbott m2000 RealTime system. Tests for two gene targets: RdRp &amp; N.</td>\n",
       "      <td>100% (60/60)  61 nasopharyngeal swabs spiked with  recombinant virus containing SARS-CoV-2 RNA sequences (1x to 20x LoD) serving as contrived positive samples. 1 sample was invalidated and excluded.&lt;s&gt;187&lt;/s&gt;</td>\n",
       "      <td>100% (31/31)  34 nasopharyngeal swabs serving as negative controls. 3 samples were invalidated and excluded.&lt;s&gt;187&lt;/s&gt;</td>\n",
       "      <td>Commercially available.    Obtained EUA approval from US FDA 18 Mar 2020.  Approved for inclusion on the Australian Register of Therapeutic Goods on 17 April 2020.&lt;s&gt;143&lt;/s&gt;Date of HAS Provisional Authorisation: 01/04/2020 &lt;s&gt;188&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>DiaSorin Molecular&lt;s&gt;189-191&lt;/s&gt; Italy</td>\n",
       "      <td>19 Mar 2020</td>\n",
       "      <td>Simplexa COVID-19 Direct Will run on the DiaSorin’s LIAISOn MDX thermocycler.  Tests for two gene targets: S &amp; ORF1ab.</td>\n",
       "      <td>100% (52/52)  108 fresh nasopharyngeal swab specimens from 3 clinical site2s were compared with one of two brands of established comparator assay.&lt;s&gt;191&lt;/s&gt;</td>\n",
       "      <td>100% (56/56)  108 fresh nasopharyngeal swab specimens from 3 clinical sites were compared with one of two brands of established comparator assay.&lt;s&gt;191&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 19 Mar 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>DiaCarta&lt;s&gt;192,193&lt;/s&gt; USA</td>\n",
       "      <td>23 Mar 2020</td>\n",
       "      <td>QuantiVirus SARS-CoV-2 Tests for two gene targets: N, ORF1ab, &amp; E</td>\n",
       "      <td>96.7%</td>\n",
       "      <td>100%</td>\n",
       "      <td>Commercially available.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Clinically validated in the company's CLIA-certified lab in Richmond, California.</td>\n",
       "      <td>Clinically validated in the company's CLIA-certified lab in Richmond, California.</td>\n",
       "      <td>Received CE Mark for IVD Mar 2020.   Obtained EUA approval from US FDA 8 Apr 2020.&lt;s&gt;194&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>PerkinElmer&lt;s&gt;28,195,19&lt;/s&gt;&lt;s&gt;6&lt;/s&gt; USA</td>\n",
       "      <td>24 Mar 2020</td>\n",
       "      <td>PerkinElmer New Coronavirus Nucleic Acid Detection Kit Tests for two gene targets: N &amp; ORF1ab.</td>\n",
       "      <td>100% (47/47)  47 oropharyngeal and nasopharyngeal swab specimens spiked with inactivated SARS-CoV-2 virus (1x to 5x LoD) serving as contrived positive samples.&lt;s&gt;196&lt;/s&gt;</td>\n",
       "      <td>100% (94/94)  94 oropharyngeal and nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;196&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 24 Mar 2020.  EUA amendment on April 1st to add an additional nucleic acid extraction method which utilizes the chemagic Viral DNA/RNA 300 Kit H96 on a new extraction platform, the chemagic 360 equipped with the chemagic Rod Head Set 96; and (2) make other minor changes and edits to the IFU labeling was granted on 01/04/2020 &lt;s&gt;197&lt;/s&gt;</td>\n",
       "      <td>104 min 30s cycle time per gene target.</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Genetron Health&lt;s&gt;198&lt;/s&gt; China</td>\n",
       "      <td>7 Aor 2020</td>\n",
       "      <td>Detection Kit for Novel Coronavirus (SARS-CoV-2) RNA</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.   Received CE Mark 7 Apr 2020.  Submitted to US FDA for EUA approval.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Mobidiag&lt;s&gt;199&lt;/s&gt;&lt;s&gt;Finland&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>&lt;s&gt;Amplidiag COVID-19&lt;/s&gt; Real-time RT-PCR test with two molecular targets (orf1ab and N) including at least one conserved region and one specific region to mitigate effects of genetic drift and avoid cross-</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available as an emergency use test in Finland and France, set up for routine use in main clinical laboratories in Finland with capacity to test up to 4000 samples a day.&lt;s&gt;200&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;48 samples in &lt;3h&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>reaction with other endemic coronaviruses.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>In the process for obtaining emergency use authorisation in Sweden and the UK. In the process for &lt;s&gt;obtaining CE-IVD.&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Genetic &lt;s&gt;Signatures Ltd&lt;/s&gt; Australia</td>\n",
       "      <td></td>\n",
       "      <td>EasyScreen™ SARS-CoV-2 Detection Kit  Real time PCR which enables qualitative detection of SARS-CoV-2 via two targets (SARS-CoV-2 N and &lt;s&gt;E genes)&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available.  CE-IVD marked.&lt;s&gt;201&lt;/s&gt; Approved for inclusion into the Australian Register of Therapeutic Goods on 13 April 2020.&lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Shanghai ZJ Bio-Tech Co Ltd (also called Liferiver)&lt;s&gt;202&lt;/s&gt; China</td>\n",
       "      <td></td>\n",
       "      <td>Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR Kit (Detection for 3 genes) Qualitative detection of SARS-CoV-2 by real time &lt;s&gt;PCR&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available.  Approved for inclusion into the Australian Register of Therapeutic Goods on 22 March 2020.&lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>AITbiotech Pte Ltd&lt;s&gt;203&lt;/s&gt; Singapore</td>\n",
       "      <td></td>\n",
       "      <td>abTES™ COVID-19 qPCR I Kit Qualitative RT-PCR which detects two COVID-19 specific regions from its non-structure polypeptide</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HSA: 05/03/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>DSO National Laboratories&lt;s&gt;204&lt;/s&gt; &lt;s&gt;Singapore&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Real-Time PCR Assay for the Detection of SARSCoV-2 Virus  RT-PCR based on specific detection of the polymerase gene region in SARS-CoV-2 virus.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HSA: &lt;s&gt;10/03/2020&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Biowalker Pte Ltd&lt;s&gt;205&lt;/s&gt; Singapore</td>\n",
       "      <td></td>\n",
       "      <td>Kit for Novel-Coronavirus (2019-nCoV) RNA (Isothermal Amplification-Real Time Fluorescence Assay) Detection of 2019-nCoV RNA in swab and sputum samples</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HSA: 24/03/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>JN Medsys Pte Ltd&lt;s&gt;206&lt;/s&gt; Singapore</td>\n",
       "      <td></td>\n",
       "      <td>ProTect™ COVID-19 RT-qPCR Kit In-vitro qualitative detection of SARS-CoV-2 from samples. The test targets SARS-CoV-2 N1, N2 and N3 genes and the human RNase P control gene.</td>\n",
       "      <td>High sensitivity and specificity, no statistics given</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HSA: 19/03/2020</td>\n",
       "      <td>Within 2 hours&lt;s&gt;207&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Veredus Laboratories Pte Ltd&lt;s&gt;127&lt;/s&gt; Singapore</td>\n",
       "      <td></td>\n",
       "      <td>VereCoV™ Detection Kit  Multiplex RT-PCR/microarray-based in-vitro diagnostic test.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Date of Provisional Authorisation by HSA: 18/02/2020</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Vela Operations Singapore Pte Ltd&lt;s&gt;208&lt;/s&gt; Singapore</td>\n",
       "      <td></td>\n",
       "      <td>ViroKey SARS-CoV-2 RT-PCR Test</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HSA: 15/04/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>SPD Scientific Pte Ltd&lt;s&gt;209&lt;/s&gt; Singapore</td>\n",
       "      <td></td>\n",
       "      <td>Cepheid® Xpert® Xpress SARS-CoV-2</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HAS: 26/03/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>PerkinElmer Singapore Pte Ltd &lt;s&gt;210&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>PerkinElmer® SARS-CoV-2 Real-time RT-PCR Assay</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Provisional Authorisation from HSA: 20/04/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>&lt;s&gt;BioWalker Pte Ltd&lt;/s&gt;&lt;s&gt;211&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>BioWalker SARS-CoV-2 Assay 2.0&lt;s&gt;212&lt;/s&gt;The test  uses rRT-PCR for qualitative detection of SARS-CoV-2 nucleic acids in human nasopharyngeal or oropharyngeal swab samples.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 30 April 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Medicell Pharmaceutical (S) Pte Ltd&lt;s&gt;213&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Sansure Biotech Novel Coronavirus (2019- nCoV) Nucleic Acid Diagnostic Kit</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 23/04/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Trax management Services Inc.&lt;s&gt;214&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>PhoenixDx 2019-CoV</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>100% (10/10)</td>\n",
       "      <td>FDA EUA issued on 20/4/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Ustar Biotechnologies (Hangzhou) Co Ltd (China)&lt;s&gt;215&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>EasyNat Diagnostic Kit for Novel-Coronavirus (2019-nCoV) RNA (Isothermal Amplification-Real Time Fluorescence Assay)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Approved for inclusion on the Australian Register of Therapeutic Goods on 23 April 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>CTK Biotech Inc (United States of America)&lt;s&gt;216&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Aridia COVID-19 Real-Time PCR Test</td>\n",
       "      <td>95.1%</td>\n",
       "      <td>95.9%</td>\n",
       "      <td>Approved for inclusion on the Australian Register of Therapeutic Goods on 24 April 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>PCL&lt;s&gt;132&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>PCL COVID19 Ag Rapid FIA &lt;s&gt;132&lt;/s&gt; Qualitative detection of SARS-CoV-2 antigens from human oropharyngeal and &lt;s&gt;deep sputum samples&lt;/s&gt;</td>\n",
       "      <td>Sensitivity: 100%</td>\n",
       "      <td></td>\n",
       "      <td>CE approved</td>\n",
       "      <td>10 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Seasun Biomaterials &lt;s&gt;217&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>&lt;s&gt;RT-PCR Test&lt;/s&gt;U-TOP COVID-19 Detection Kit &lt;s&gt;218&lt;/s&gt; Qualitative detection of SARS-CoV-2 antigens from oropharyngeal and nasopharyngeal swab specimens, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens and &lt;s&gt;sputum samples&lt;/s&gt;</td>\n",
       "      <td>100% (for both nasopharyngeal and sputum)&lt;s&gt;218&lt;/s&gt;</td>\n",
       "      <td>No cross-reactivity with 33 microorganisms</td>\n",
       "      <td>FDA EUA issued on 27/04/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>bioMérieux SA &lt;s&gt;219&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>BioFire Respiratory Panel 2.1 &lt;s&gt;220&lt;/s&gt; Multiplex RT-PCR test detecting SARS-CoV-2 spike (S) and membrane (M) gene.</td>\n",
       "      <td>98% (48/49)</td>\n",
       "      <td>100% (279/279)</td>\n",
       "      <td>FDA EUA issued on 1 May 2020&lt;s&gt;220&lt;/s&gt; Date of Provisional Authorisation from HSA: 14 May 2020&lt;s&gt;221&lt;/s&gt;</td>\n",
       "      <td>Around 45 mins</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Bio-Rad Laboratories, Inc. &lt;s&gt;222&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Bio-Rad SARS-CoV-2 &lt;s&gt;ddPCR Test&lt;/s&gt;&lt;s&gt;223&lt;/s&gt; Multiplex RT-PCR test detecting SARS-CoV-2 spike (S) and membrane (M) &lt;s&gt;gene&lt;/s&gt;</td>\n",
       "      <td>94.87% (37/39, analysis done after Thermo MagMAX extraction); 94.59% (35/37, analysis done after QIAamp viral RNA extraction)</td>\n",
       "      <td>94.87% (37/39, analysis done after Thermo MagMAX extraction); 95.00% (38/40, analysis done after QIAamp viral RNA extraction)</td>\n",
       "      <td>FDA EUA issued on 1 May 2020 &lt;s&gt;223&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Public Health England&lt;s&gt;224&lt;/s&gt; UK</td>\n",
       "      <td>10 Feb 2020</td>\n",
       "      <td>Real time RT-PCR (RdRp gene) assay which employs the use of two probes; one which detects 2019-nCoV, SARS-CoV and bat-SARS-related-CoVs, and the other 2019-nCoV only. The assay will be evaluated on the ABI 7500 Fast real-time PCR system.&lt;s&gt;225&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available (non-commercially) to 9 labs across the UK.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Real-time RT-RAA</td>\n",
       "      <td>Beijing Ditan Hospital&lt;s&gt;226&lt;/s&gt; China</td>\n",
       "      <td>29 Jan 2020</td>\n",
       "      <td>Real time Reverse-Transcription Recombinase Aided Amplification (RT-RAA) assay  Novel isothermal nucleic acid amplification technique  for detection of SARS-CoV-2.   Assay was performed at 42°C within 30min using a portable real-time fluorescence detector,</td>\n",
       "      <td>(Recombinant plasmids containing conserved ORF1ab genes was used to analyse the specificity and sensitivity.)</td>\n",
       "      <td>(Recombinant plasmids containing conserved ORF1ab genes was used to analyse the specificity and sensitivity.)</td>\n",
       "      <td>Clinical trials phase.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>ScienCell Research Laboratories&lt;s&gt;227-229&lt;/s&gt; USA</td>\n",
       "      <td>24 Jan 2020</td>\n",
       "      <td>ScienCell SARS-CoV-2 Coronavirus Real-time RT-PCR (RT-qPCR) Detection Kit Tests for two gene targets: N1 &amp; N2</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs spiked with SARS-CoV-2 RNA (not actual clinical sample) serving as contrived positive samples.&lt;s&gt;228&lt;/s&gt;</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs serving as negative controls.&lt;s&gt;228&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 3 Apr 2020.</td>\n",
       "      <td>43 min 45 s cycle time for each gene</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Liferiver Biotech&lt;s&gt;230,231&lt;/s&gt; China</td>\n",
       "      <td>29 Jan 2020</td>\n",
       "      <td>Fluorescent PCR&lt;s&gt;231&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>€ 991&lt;s&gt;232&lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Liferiver Biotech&lt;s&gt;230,233&lt;/s&gt; China</td>\n",
       "      <td>29 Jan 2020</td>\n",
       "      <td>Multiplex RT-PCR&lt;s&gt;233&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.  Date of Provisional Authorisation from HSA: 4 May 2020&lt;s&gt;234&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>€ 1347&lt;s&gt;235&lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>GenScript&lt;s&gt;230,236,237&lt;/s&gt; USA</td>\n",
       "      <td>29 Jan 2020</td>\n",
       "      <td>qRT-PCR Targets RdRp gene, N gene and E gene in Wuhan-Hu-1</td>\n",
       "      <td>“This assay is RUO and has not been tested on clinical samples. We</td>\n",
       "      <td>“This assay may have cross-reactivity with other coronavirus family</td>\n",
       "      <td>Commercially available for RUO.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>genome (GenBank &lt;s&gt;sequences NC_045512.2)&lt;/s&gt;[same as Charite’s first protocol]</td>\n",
       "      <td>make no claims on the performance of this assay.” &lt;s&gt;236&lt;/s&gt;</td>\n",
       "      <td>members such as causative agents of the Middle East Respiratory Syndrome (MERS) or Severe Acute Respiratory Syndrome (SARS).”&lt;s&gt;236&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>CerTest Biotec&lt;s&gt;238&lt;/s&gt; Spain</td>\n",
       "      <td>30 Jan 2020</td>\n",
       "      <td>VIASURE 2019-nCoV Real Time PCR Kit Amplification of a fragment of the S gene.&lt;s&gt;239&lt;/s&gt;</td>\n",
       "      <td>97.5%&lt;s&gt;240&lt;/s&gt;</td>\n",
       "      <td>&gt;99.9%&lt;s&gt;240&lt;/s&gt;</td>\n",
       "      <td>Available.   Received CE Mark for IVD for the version adapted for the BD MAX™ System.&lt;s&gt;239&lt;/s&gt; Approved for inclusion on Australia’s ARTG on 21 March 2020.</td>\n",
       "      <td>120 minutes&lt;s&gt;240&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>GeneFirst&lt;s&gt;241&lt;/s&gt; UK</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>Capable of detecting only the SARS-CoV-2</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available</td>\n",
       "      <td>&lt; 3 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>GeneFirst&lt;s&gt;241&lt;/s&gt; UK</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>Multiplex assay which simultaneously detects SARS-CoV-2 as well as 17 other common viruses and bacteria</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available.</td>\n",
       "      <td>&lt; 3 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Kogene Biotech&lt;s&gt;131,151&lt;/s&gt; South Korea</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>Powerchek 2019-nCoV Real-time PCR kit Tests for two gene targets: E and RdRp.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from Korean CDC 4 Feb 2020.&lt;s&gt;151,242&lt;/s&gt; Approved for inclusion on the Australian Register of Therapeutic Goods.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Thermo Fisher Scientific&lt;s&gt;133,243-245&lt;/s&gt; USA</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>TaqPath COVID-19 Combo Kit (previously TaqMan 2019-nCoV Assay Kit) Real-time RT-PCR kit assays specifically target all 44 complete genomes currently available at GISAID, and do not target any of the 2,116 complete</td>\n",
       "      <td>100% (60/60)  30 nasopharyngeal swab specimens and 30 bronchoalveolar lavage specimens were spiked with extracted SARS-CoV-2 viral genomic RNA (2x to 5x LoD) to</td>\n",
       "      <td>100% (60/60)  30 nasopharyngeal swab specimens and 30 bronchoalveolar lavage specimens were used as negative controls.&lt;s&gt;245&lt;/s&gt;</td>\n",
       "      <td>Commercially available.  Received CE Mark for IVD 26 Mar 2020.&lt;s&gt;246&lt;/s&gt; Obtained EUA approval from US FDA 13 Mar 2020.&lt;s&gt;244&lt;/s&gt;</td>\n",
       "      <td>36 min cycle time per gene target</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>genomes of other coronaviruses currently available at NCBIm.  Tests for three gene targets: ORF1ab, N, &amp; S.</td>\n",
       "      <td>form 60 contrived positive samples.&lt;s&gt;245&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Obtained HSA provisional approval on 20 March 2020. Approved for inclusion on the Australian Register of Therapeutic Goods on &lt;s&gt;24 March 2020&lt;/s&gt;.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>US CDC&lt;s&gt;17,247,248&lt;/s&gt; USA</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>Centers for Disease Control and Prevention (CDC) 2019-Novel Coronavirus (2019-nCoV) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel Tests for three gene targets: N1, N2, and N3 (subsequently removed&lt;s&gt;248&lt;/s&gt;) plus 1 human RNase P gene control.</td>\n",
       "      <td>100% (!3/13)  117 respiratory specimens collected from 46 subjects tested with two analytically validated real-time RT-PCR assays for N4 and N5 gene targets.&lt;s&gt;247&lt;/s&gt;</td>\n",
       "      <td>100% (104/104)  117 respiratory specimens collected from 46 subjects tested with two analytically validated real-time RT-PCR assays for N4 and N5 gene targets.&lt;s&gt;247&lt;/s&gt;</td>\n",
       "      <td>Available to laboratories designated by CDC as qualified, and in the US, certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity tests. Available to qualified international laboratories.  Not available to U.S. hospitals or other primary care settings.   Obtained EUA approval from US FDA 4 Feb 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>SolGent&lt;s&gt;151,152,249&lt;/s&gt; South Korea</td>\n",
       "      <td>28 Feb 2020</td>\n",
       "      <td>DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit  Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 N, ORF1a and PCRC genes in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes, bronchoalveolar lavage (BAL) fluid and sputum.</td>\n",
       "      <td>100%</td>\n",
       "      <td>100%</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from Korean CDC 27 Feb 2020.&lt;s&gt;151,152&lt;/s&gt; Received CE Mark for IVD.   FDA EUA issued on 21 May 2020 &lt;s&gt;250&lt;/s&gt;</td>\n",
       "      <td>2 hr PCR</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>SD Biosensor&lt;s&gt;151,152&lt;/s&gt; South Korea</td>\n",
       "      <td>28 Feb 2020</td>\n",
       "      <td>STANDARD M n-CoV Real-Time Detection Kit</td>\n",
       "      <td>Sensitivity: 100% (30/30)&lt;s&gt;251&lt;/s&gt;</td>\n",
       "      <td>Specificity: 100% (30/30)&lt;s&gt;251&lt;/s&gt;</td>\n",
       "      <td>Available.</td>\n",
       "      <td>90 min &lt;s&gt;252&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Tests for two gene targets: E and RdRp.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Obtained EUA approval from Korean CDC 27 Feb 2020.&lt;s&gt;151,152&lt;/s&gt; FDA EUA issued on 23/04/2020</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Integrated DNA Technologies (IDT)&lt;s&gt;24,242&lt;/s&gt; USA</td>\n",
       "      <td>3 Mar 2020</td>\n",
       "      <td>2019-nCoV CDC EUA Kit Follows US CDC protocol to test for 3 N gene targets, and 1 human RNase P gene as control.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.  Obtained EUA approval from US FDA 3 Mar 2020 for lot number #0000500383.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>USD $125&lt;s&gt;24&lt;/s&gt;for 500 rxn</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Luminex&lt;s&gt;164,165,253,25&lt;/s&gt;&lt;s&gt;4&lt;/s&gt; USA</td>\n",
       "      <td>4 Mar 2020</td>\n",
       "      <td>ARIES SARS-CoV-2 Assay Tests for two gene targets: ORF1ab &amp; N</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs spiked with purified SARS-CoV-2 viral genomic RNA (2x to 5x LoD) serving as contrived positive samples.&lt;s&gt;254&lt;/s&gt;</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs serving as negative controls.&lt;s&gt;254&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 3 Apr 2020.</td>\n",
       "      <td>2 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Genomica&lt;s&gt;255,256&lt;/s&gt; Spain</td>\n",
       "      <td>6 Mar 2020</td>\n",
       "      <td>qCOVID-19 Real-time RT-PCR</td>\n",
       "      <td>Reported 100%.&lt;s&gt;255&lt;/s&gt; Tested at the Carlos III Health Institute with 80 samples (unclear of sample types).</td>\n",
       "      <td>Reported 100%.&lt;s&gt;255&lt;/s&gt; Tested at the Carlos III Health Institute with 80 samples (unclear of sample types).</td>\n",
       "      <td>Available.  Received CE Mark 6 Mar 2020.&lt;s&gt;256&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Avellino Lab&lt;s&gt;257-259&lt;/s&gt; USA</td>\n",
       "      <td>9 Mar 2020</td>\n",
       "      <td>AvellinoCoV2 test Tests for two gene targets from US CDC protocol: N1 &amp; N3</td>\n",
       "      <td>100% (30/30)  30 oropharyngeal and nasopharyngeal swab specimens spiked with whole SARS-CoV-2 viral RNA (1x to 100x LoD) serving as contrived positive samples.&lt;s&gt;259&lt;/s&gt;</td>\n",
       "      <td>100% (30/30)  30 oropharyngeal and nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;259&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 25 Mar 2020.&lt;s&gt;257&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Wadsworth Center, New York State Department of Public Health&lt;s&gt;194,260&lt;/s&gt; USA</td>\n",
       "      <td>10 Mar 2020</td>\n",
       "      <td>New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel Tests for two gene targets: N1 &amp; N2.</td>\n",
       "      <td>(42/43)  For the easyMAG extraction, 43 individual sputum samples were spiked with the extracted whole SARS-CoV-2 virus genomic RNA (2x</td>\n",
       "      <td>(29/29)  For the easyMAG extraction, 30 individual sputum samples were used but 1 was invalidated, leaving 29 samples. Testing was</td>\n",
       "      <td>Available.   Obtained EUA approval from US FDA  for use in Wadsworth Center, New York State Public</td>\n",
       "      <td>42 min 45 s cycle time per gene target</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>to 200x LoD) to serve as contrived positive samples. Testing was also done with eMAG and EZ1 extraction.&lt;s&gt;260&lt;/s&gt;</td>\n",
       "      <td>also done with eMAG and EZ1 extraction.&lt;s&gt;260&lt;/s&gt;</td>\n",
       "      <td>Department of Health, and the New York City Department of Health and Mental Hygiene, Public Health Laboratories.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>NeuMoDx&lt;s&gt;261-263&lt;/s&gt;</td>\n",
       "      <td>12 Mar 2020</td>\n",
       "      <td>NeuMoDx™ SARS-CoV-2 Assay Real-time RT-PCR for use on fully automated NeuMoDx™ 288 and 96 Molecular Systems. Tests for two gene targets: Nsp2 &amp; N.</td>\n",
       "      <td>100% (87/87)  87 clinical nasopharyngeal swab specimens were spiked with SARS-CoV-2 genomic RNA (1x to 8x LoD) serving as contrived positive samples.&lt;s&gt;263&lt;/s&gt;</td>\n",
       "      <td>100% (82/82  82 clinical nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;263&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 30 Mar 2020.&lt;s&gt;261&lt;/s&gt;</td>\n",
       "      <td>80 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Becton Dickinson (BD)&lt;s&gt;264-266&lt;/s&gt; USA</td>\n",
       "      <td>17 Mar 2020</td>\n",
       "      <td>BioGX SARS-CoV-2 Reagents for BD MAX System Tests for two gene targets: N1 &amp; N2</td>\n",
       "      <td>100% (29/29)  30 retrospective collected clinical nasopharyngeal swab specimens spiked with quantified genomic RNA of SARS- CoV-2 (1x to 5x LoD) serving as contrived positive samples. 1 sample removed from data analysis.&lt;s&gt;264&lt;/s&gt;</td>\n",
       "      <td>100% (30/30)  30 retrospective collected clinical nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;264&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 2 Apr 2020.  Approved for inclusion on the Australian Register of Therapeutic Goods on 17 April 2020.&lt;s&gt;81&lt;/s&gt;</td>\n",
       "      <td>2 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Maccura Biotechnology&lt;s&gt;257,26&lt;/s&gt;&lt;s&gt;7,268&lt;/s&gt; China</td>\n",
       "      <td>22 Mar 2020</td>\n",
       "      <td>SARS-CoV-2 Fluorescent PCR Kit Tests for three gene targets: ORF1ab, N, &amp; E.</td>\n",
       "      <td>100% (30/30)  15 nasopharyngeal and 15 oropharyngeal swab samples from suspected cases that tested negative had additional aliquot spiked with SARS-CoV-2 whole genomic RNA (2x to 5x LoD) serving as 30 contrived positive samples.&lt;s&gt;268&lt;/s&gt;</td>\n",
       "      <td>100% (30/30)  15 nasopharyngeal and 15 oropharyngeal swab samples from suspected cases that tested negative had additional aliquot serving as 30 negative controls.&lt;s&gt;268&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Received CE Mark in Mar 2020.&lt;s&gt;267&lt;/s&gt; Obtained EUA approval from US FDA 15 Apr 2020.</td>\n",
       "      <td>37 min 10 s cycle time per gene target</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Ipsum Diagnostics&lt;s&gt;269,270&lt;/s&gt;</td>\n",
       "      <td>1 Apr 2020</td>\n",
       "      <td>COV-19 IDx assay N1 gene target</td>\n",
       "      <td>100% (36/36)  36 nasopharyngeal swabs spiked with BEI</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>Commercially available.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>ATCC Genomic RNA from SARS Related Coronavirus 2 (not actual clinical sample) serving as contrived positive samples.&lt;s&gt;270&lt;/s&gt;</td>\n",
       "      <td>30 nasopharyngeal swabs serving as negative controls.&lt;s&gt;270&lt;/s&gt;</td>\n",
       "      <td>Obtained EUA approval from US FDA 1 Apr 2020.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Gnomegen&lt;s&gt;271,272&lt;/s&gt;(Subsidiary of QuestGenomics)  USA (China)</td>\n",
       "      <td>6 Apr 2020</td>\n",
       "      <td>Gnomegen COVID-19 RT-Digital PCR Detection Kit Tests for two gene targets: N1 &amp; N2</td>\n",
       "      <td>100% (30/30)  30 oropharyngeal swabs spiked with quantified SARS-CoV-2 whole viral RNA (1x to 5x LoD) serving as contrived positive samples.&lt;s&gt;272&lt;/s&gt;</td>\n",
       "      <td>100% (30/30)  30 oropharyngeal swabs serving as negative controls.&lt;s&gt;272&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 6 Apr 2020.</td>\n",
       "      <td>129 min 30 s cycle time</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>InBios International&lt;s&gt;248,273,2&lt;/s&gt;&lt;s&gt;74&lt;/s&gt; USA</td>\n",
       "      <td>7 Apr 2020</td>\n",
       "      <td>Smart Detect SARS-CoV-2 rRT-PCR Kit multiplex one-step rRT-PCR that can run on CFX96 Touch Real-Time PCR.  Tests for three gene targets: N, E, &amp; ORF1b</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs spiked with SARS-CoV-2 viral genomic RNA (1x to 5x LoD) serving as contrived positive samples.&lt;s&gt;273&lt;/s&gt;</td>\n",
       "      <td>96.7% (29/30)  30 nasopharyngeal swabs serving as negative controls.&lt;s&gt;273&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 7 Apr 2020.</td>\n",
       "      <td>4 hr&lt;s&gt;274&lt;/s&gt; (43 min 45 s cycle time for each gene)&lt;s&gt;273&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Becton Dickinson (BD)&lt;s&gt;275,276&lt;/s&gt; USA</td>\n",
       "      <td>8 Apr 2020</td>\n",
       "      <td>BD SARS-CoV-2 Reagents for BD MAX System Test is a rRT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasal, nasopharyngeal and oropharyngeal swab samples from individuals suspected of COVID-19 by their healthcare provider.  Tests for two gene targets: N1 &amp; N2</td>\n",
       "      <td>96% (48/50)  50 retrospective collected clinical nasopharyngeal swabs spiked with quantified genomic RNA of SARS- CoV-2 (1x to 5x LoD) serving as contrived positive samples.&lt;s&gt;276&lt;/s&gt;</td>\n",
       "      <td>100% (29/29)  29 retrospective collected clinical nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;276&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 8 Apr 2020.  Date of Provisional Authorisation from HSA: 6 May 2020&lt;s&gt;277&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Real-time PCR and microarray technologies  [Point-of-Care]</td>\n",
       "      <td>Mobidiag&lt;s&gt;278&lt;/s&gt;(collaboration with Autobio Diagnostics, China)    Finland</td>\n",
       "      <td>10 Feb 2020</td>\n",
       "      <td>Novodiag Cartridge-based qPCR system, fully automated, allowing the rapid detection of both novel coronavirus and influenzas in around 30 minutes.  Two gene targets for SARS-CoV-2 (orf1ab and N)&lt;s&gt;199&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>In development.</td>\n",
       "      <td>Less than an hour</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Real Time RT-PCR</td>\n",
       "      <td>BGI&lt;s&gt;279-281&lt;/s&gt; (Pathomics Health as distributor)   China</td>\n",
       "      <td>23 Jan 2020</td>\n",
       "      <td>Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV In vitro RT-PCR combining fluorescent probing.&lt;s&gt;282&lt;/s&gt; Real-time RT-PCR assay for qualitative detection of SARS-CoV-2 in throat swabs and bronchoalveolar lavage fluid (BALF).</td>\n",
       "      <td>BALF: 81% Throat Swab: 91.2% RNA: 97.1% Combined: 88.1%&lt;s&gt;283&lt;/s&gt;</td>\n",
       "      <td>BALF: 100% Throat Swab: 100% RNA: 96.2% Combined: 99.6%&lt;s&gt;283&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Received CE Mark for IVD 2 Mar 2020.&lt;s&gt;284&lt;/s&gt; BGI is also engaged with relevant organizations in Hong Kong, Taiwan, Brunei, Thailand, Nigeria, South Africa, to supply the test kits.&lt;s&gt;279&lt;/s&gt; Passed emergency approval procedure of China’s NMPA.  Obtained EUA approval from US FDA 27 Mar 2020.&lt;s&gt;280,281&lt;/s&gt; Approved for inclusion on Australia’s ARTG on 10 April 2020.  Date of Provisional Authorisation from HSA:  24 April 2020 &lt;s&gt;285&lt;/s&gt;</td>\n",
       "      <td>3 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>CapitalBio&lt;s&gt;45&lt;/s&gt;(collaboration with Tsinghua University and West China Hospital of Sichuan University)  China</td>\n",
       "      <td>24 Feb 2020</td>\n",
       "      <td>Detection of six common respiratory viruses including SARS-CoV-2 within 1.5 hours using samples of patients' oral and pharyngeal Secretions.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available.  Approved by China’s NMPA.</td>\n",
       "      <td>1 hr 30 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>qPCR</td>\n",
       "      <td>Primerdesign&lt;s&gt;286-291&lt;/s&gt;(molecular diagnostics division of Novacyt)</td>\n",
       "      <td>31 Jan 2020</td>\n",
       "      <td>Genesig Real-Time PCR COVID-19 (CE) [Previously Coronavirus (Strain 2019-nCoV) Easy/Standard Kit]&lt;s&gt;287&lt;/s&gt;</td>\n",
       "      <td>96%&lt;s&gt;292&lt;/s&gt;</td>\n",
       "      <td>100%</td>\n",
       "      <td>Commercially available.   Received CE Mark for IVD 17 Feb 2020.&lt;s&gt;293,294&lt;/s&gt;</td>\n",
       "      <td>&lt; 2 hr  64 min 30 s cycle time per gene&lt;s&gt;291&lt;/s&gt;</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td>France/UK</td>\n",
       "      <td></td>\n",
       "      <td>Can run on multiple molecular testing platforms, including Primerdesign’s own genesig® q16 and q32 instrument</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Obtained EUA approval from US FDA 20 Mar 2020.&lt;s&gt;290&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>qPCR</td>\n",
       "      <td>Coyote Bioscience&lt;s&gt;133,295&lt;/s&gt; China</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>2019-nCoV Prep Free QPCR Assay Runs on the Mini8 Portable Molecular Diagnostic QPCR Station (CFDA approved)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available. Reportedly being used in China in over 30 hospitals, 16 local CDC offices, and 8 airports.</td>\n",
       "      <td>1 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>qPCR  [Point-of-Care]</td>\n",
       "      <td>Molbio Diagnostics&lt;s&gt;295&lt;/s&gt; India</td>\n",
       "      <td>12 Feb 2020</td>\n",
       "      <td>qPCR Truenat Beta CoV &lt;s&gt;296&lt;/s&gt;Potentially real-time PCR then detection of wavelengths of fluorescent signal.</td>\n",
       "      <td>100% &lt;s&gt;297&lt;/s&gt;</td>\n",
       "      <td>100% &lt;s&gt;297&lt;/s&gt;</td>\n",
       "      <td>Available.   Approved by the Indian Council of Medical Research for coronavirus testing in India on 4 April 2020.&lt;s&gt;298&lt;/s&gt;</td>\n",
       "      <td>55 min</td>\n",
       "      <td>Rs 1,000 – Rs 1,500) &lt;s&gt;298&lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>qPCR  [Point-of-Care]</td>\n",
       "      <td>OnSiteGene&lt;s&gt;295&lt;/s&gt;(San Diego-based subsidiary of Singapore's Star Array)  USA</td>\n",
       "      <td>12 Feb 2020</td>\n",
       "      <td>Star Array 2019 Novel Coronavirus (SARS-CoV-2) Nucleic Acid Detection &lt;s&gt;Kit 1.0 &lt;/s&gt; 2019-nCoV rRT-PCR kit for use on existing Peak V, that performs spatial thermal cycling using a heated liquid metal for direct amplification without the need for sample prep. Genes detected are the SARS-CoV-2 N gene and ORF1ab gene. &lt;s&gt;299&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Developed. Currently seeking collaborators to perform clinical tests in China and the US.&lt;s&gt;299&lt;/s&gt;</td>\n",
       "      <td>10 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>PCR-based genotyping</td>\n",
       "      <td>Genomica&lt;s&gt;300,301&lt;/s&gt; Spain</td>\n",
       "      <td>30 Jan 2020</td>\n",
       "      <td>CLART COVID-19 Based on Genomica’s CLART technology of PCR-based genotyping with low-density microarray.</td>\n",
       "      <td>&gt;96%&lt;s&gt;302&lt;/s&gt;</td>\n",
       "      <td>98%</td>\n",
       "      <td>Available.  Received CE Mark 6 Mar 2020.&lt;s&gt;256&lt;/s&gt;</td>\n",
       "      <td>&lt; 5 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>ddPCR</td>\n",
       "      <td>Bio-Rad Laboratories&lt;s&gt;303-305&lt;/s&gt; USA</td>\n",
       "      <td>19 Mar 2020</td>\n",
       "      <td>COVID-19 Droplet Digital PCR (ddPCR) Assay Quantitative assay for use on Bio-Rad’s QX200 and QXDx Droplet Digital PCR Systems.</td>\n",
       "      <td>Reported enhanced sensitivity.&lt;s&gt;304&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.   EUA Submission Pending&lt;s&gt;306&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Conventional and Real Time RT-PCR</td>\n",
       "      <td>Genekam&lt;s&gt;307,308&lt;/s&gt; Germany</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>5 options: 1. Conventional PCR 2. Real Time PCR for nCoV only&lt;s&gt;309&lt;/s&gt;3. Multiplex Real Time PCR for nCoV + other Bat CoV&lt;s&gt;310&lt;/s&gt;4. Multiplex Real Time PCR for nCoV + other Bat CoV + MERS&lt;s&gt;311&lt;/s&gt;5. Multiplex Real Time PCR for nCoV + Influenza A&lt;s&gt;312&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>In development as of 6 Feb 2020</td>\n",
       "      <td>126 min 15 s&lt;s&gt;309,311&lt;/s&gt;or 120 min&lt;s&gt;310,312&lt;/s&gt; of cycle time</td>\n",
       "      <td>€ 599&lt;s&gt;308&lt;/s&gt;€ 699&lt;s&gt;308&lt;/s&gt;€ 799&lt;s&gt;308&lt;/s&gt;€ 999&lt;s&gt;308&lt;/s&gt;€ 899&lt;s&gt;308&lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Combination of RT-PCR and meta-genomics detection</td>\n",
       "      <td>BGI&lt;s&gt;279&lt;/s&gt; (Pathomics Health as distributor)&lt;s&gt;313&lt;/s&gt; China</td>\n",
       "      <td>23 Jan 2020</td>\n",
       "      <td>2019-nCoV PMseq Kit   A metagenomics sequencing kit based on combinatorial Probe Anchor Synthesis.  Faster SARS-CoV-2 virus detection, and able to detect both known and novel microorganisms, enabling monitoring of evolution during transmission.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Has been providing technical support for the scientific clinical prevention and control of the epidemic in Wuhan.  Passed emergency approval procedure of China’s NMPA.</td>\n",
       "      <td>SARS-CoV-2 detection stated to be faster than Fluorescent RT-PCR kit.  For detection of unknown pathogens, Within 5 hours, 128 samples can be simultaneously screened and sequenced by SE50, and 128 samples can be simultaneously tested and sequenced by PE100 in 22 hours, as well as possible mutation and evolution monitoring</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Jiangsu Bioperfectus Technologies Co Ltd &lt;s&gt;314&lt;/s&gt;</td>\n",
       "      <td>11 May 2020</td>\n",
       "      <td>COVID-19 Coronavirus Real &lt;s&gt;Time PCR Kit &lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Approved for inclusion in the Australian Register of Therapeutic Goods on 5 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>TCM Biosciences&lt;s&gt;131,315&lt;/s&gt; South Korea</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>TCM-Q Corona Ⅲ RT-PCR using SARS-CoV-2 RdRP gene and E-Sarbeco &lt;s&gt;gene&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;100%&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;100%&lt;/s&gt;</td>\n",
       "      <td>Developed as of 3 Feb 2020.  Submitted to Korean CDC for EUA.</td>\n",
       "      <td>&lt;s&gt;70 min&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Bioneer&lt;s&gt;131&lt;/s&gt; South Korea</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>AccuPower COVID-19 Real-Time RT-PCR kit&lt;s&gt;316&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Assumed developed as of 3 Feb 2020. Submitted to Korean CDC for EUA.  Received CE mark. Distributed to 20 &lt;s&gt;hospitals in Romania&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>CEVI&lt;s&gt;131,317&lt;/s&gt; (Partnership with Wells Bio)  South Korea</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>CareGENE N-CoV RT-PCR &lt;s&gt;Kit&lt;/s&gt;Real time RT-PCR kit to detect SARS-CoV-2 RdRP and E genes in human nasopharyngeal swab, oropharyngeal swab and &lt;s&gt;sputum&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>In development as of 6 Feb 2020.  &lt;s&gt;CE mark on March 3&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;83 minutes&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>QuantuMDx&lt;s&gt;295,318&lt;/s&gt;UK</td>\n",
       "      <td>12 Feb 2020</td>\n",
       "      <td>(SARS-CoV-2 Detection RT-PCR Testing kit. Detect SARS-CoV-2 in human oropharyngeal and nasopharyngeal swab</td>\n",
       "      <td>100%</td>\n",
       "      <td>100%</td>\n",
       "      <td>EUA application submitted to DFA, CE-IVD mark by mid may</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Liferiver Bio-Tech &lt;s&gt;319&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR Kit Test  is used for the in vitro qualitative detection of 2019-nCoV RNA in upper respiratory tract specimens and lower respiratory tract specimens.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 4 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Fast Track Diagnostics Luxembourg Sárl. (a Siemens Healthineers Company)</td>\n",
       "      <td></td>\n",
       "      <td>FTD SARS-CoV-2. Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal swabs, nasopharyngeal swabs, nasopharyngeal wash and bronchoalveolar lavage.</td>\n",
       "      <td>100% (44/44)</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>FDA EUA issued on 5 May 2020&lt;s&gt;320&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>bioMérieux SA&lt;s&gt;321&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>ARGENE®  SARS-CoV-2 R-gene test Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal</td>\n",
       "      <td>100% (76/76)</td>\n",
       "      <td>100% (50/50)</td>\n",
       "      <td>FDA EUA issued on 6 May 2020&lt;s&gt;322&lt;/s&gt; CE marked on 10 April 2020, validated in France since 11 March 2020.</td>\n",
       "      <td>4-5 Hours</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes and bronchoalveolar lavage (BAL) fluid.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>OPTI Medical Systems, Inc</td>\n",
       "      <td></td>\n",
       "      <td>OPTI SARS-CoV-2 RT-PCR Test Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in upper and lower respiratory specimens (such as nasal, nasopharyngeal, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate).</td>\n",
       "      <td>100% in both sputum and NP swab</td>\n",
       "      <td>100% in both sputum and NP swab</td>\n",
       "      <td>FDA EUA issued on 6 May 2020&lt;s&gt;323&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Zymo Research Corporation</td>\n",
       "      <td></td>\n",
       "      <td>Quick SARS-CoV-2 rRT-PCR Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in upper and lower respiratory specimens (such as nasal, nasopharyngeal, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate).</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>FDA EUA issued on 7 May 2020&lt;s&gt;324&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Rutgers Clinical Genomics Laboratory at RUCDR Infinite Biologics - Rutgers University</td>\n",
       "      <td></td>\n",
       "      <td>Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal swab, mid-turbinate nasal swab, and</td>\n",
       "      <td>100% for nasopharyngeal and oropharyngeal swabs (30/30) as well as saliva</td>\n",
       "      <td>100% for nasopharyngeal and oropharyngeal swabs (30/30) as well as saliva</td>\n",
       "      <td>FDA EUA issued on 7 May 2020&lt;s&gt;325&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>bronchoalveolar lavage &lt;s&gt;(BAL) fluid.&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Abbott Molecular Inc.&lt;s&gt;326&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Alinity m SARS-CoV-2 assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, nasal swabs, and bronchoalveolar lavage (BAL) fluid</td>\n",
       "      <td>100% (31/31)</td>\n",
       "      <td>100% (40/40)</td>\n",
       "      <td>FDA EUA issued on 11 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>1drop Inc &lt;s&gt;327&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>1 copy™ covid-19 qPCR multi kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 E and &lt;s&gt;326&lt;/s&gt;RdRp gene in nasopharyngeal, oropharyngeal, anterior nasal, mid-turbinate nasal swab specimens as well as nasopharyngeal wash/aspirate and nasal aspirate specimens.</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>(No info)</td>\n",
       "      <td>FDA EUA issued on 11 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Applied DNA Sciences, Inc.&lt;s&gt;328&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Linea™ COVID-19 Real Time PCR Assay Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal, oropharyngeal and nasal swab specimens as well as nasopharyngeal wash/aspirate and nasal aspirate specimens.</td>\n",
       "      <td>98% (62/63)</td>\n",
       "      <td>93% (63/67)</td>\n",
       "      <td>FDA EUA issued on 13 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>GeneMatrix, Inc.&lt;s&gt;329&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>NeoPlexTM COVID-19 Detection Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal, oropharyngeal and nasal swab specimens as well as nasopharyngeal</td>\n",
       "      <td>100% for nasopharyngeal, oropharyngeal and sputum samples (40/40)</td>\n",
       "      <td>100% for nasopharyngeal, oropharyngeal and sputum samples (40/40)</td>\n",
       "      <td>FDA EUA issued on 14 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>wash/aspirate and nasal aspirate specimens.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Assurance Scientific Laboratories&lt;s&gt;330&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Assurance SARS-CoV-2 Panel Real-time RT-PCR for the qualitative detection of SARS-CoV-2 E, N1 and N2 genes in upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal swabs).</td>\n",
       "      <td>100% (38/38 using samples extracted with Abnova Precipitor; 34/34 using samples extracted with Zymo Research Kit &lt;s&gt;on the IndiMag)&lt;/s&gt;</td>\n",
       "      <td>100% (30/30 using samples extracted with Abnova Precipitor; 48/48 using samples extracted with Zymo Research Kit on the IndiMag)</td>\n",
       "      <td>FDA EUA issued on 15 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Real Time RT-PCR</td>\n",
       "      <td>Quidel Corporation&lt;s&gt;331&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Lyra® Direct SARS-CoV-2 Assay Real-time RT-PCR for the qualitative detection of SARS-CoV-2 RNA in upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal swabs).</td>\n",
       "      <td>97% (29/30)</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>FDA EUA issued on 18 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Wuhan EasyDiagnosis Biomedicine Co Ltd (China) &lt;s&gt;332&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>COVID-19 (SARS-CoV-2) Nucleic Acid Test kit Real-time RT-PCR test kit, intended for the qualitative detection of nucleic acid from the SARS-CoV-2, in upper and lower respiratory tract specimens. Gene targets are the SARS-CoV-2 N and ORF1ab gene.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Approved for inclusion on the Australian Register of Therapeutic Goods on 19 May 2020.&lt;s&gt;333&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>AMT Pte Ltd</td>\n",
       "      <td></td>\n",
       "      <td>AMT RESOLUTE 1.0 Real-time RT-PCR for the qualitative detection of SARS-CoV-2 RNA. RNA extraction is not required as this kit is intended for direct amplification of SARS-CoV-2 RNA from nasopharyngeal swabs in universal transport medium.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>HSA provisional authorisation approved on 20 May 2020&lt;s&gt;334&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>P23 Labs &lt;s&gt;335&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>P23 Labs TaqPath SARS-CoV-2 Assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab,</td>\n",
       "      <td>100% (31/31)</td>\n",
       "      <td>100% (11/11)</td>\n",
       "      <td>FDA EUA issued on 21 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens as well as bronchoalveolar lavage (BAL) specimens.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>BioCore</td>\n",
       "      <td></td>\n",
       "      <td>BioCore 2019-nCoV Real Time PCR Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 N and RdRp genes in upper respiratory specimens (such as nasal, mid-turbinate, oropharyngeal, and nasopharyngeal swabs) and lower respiratory specimens (such as sputum, bronchoalveolar lavage (BAL), and tracheal aspirates).</td>\n",
       "      <td>100% (20/20) for both nasopharyngeal and sputum specimens</td>\n",
       "      <td>100% (40/40) for both nasopharyngeal and sputum specimens</td>\n",
       "      <td>FDA EUA issued on 21 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2.1.2 Genome Sequencing</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NGS</td>\n",
       "      <td>IDbyDNA&lt;s&gt;336,337&lt;/s&gt; USA</td>\n",
       "      <td>29 Jan 2020</td>\n",
       "      <td>Next-generation sequencing-based metagenomics, allows enhanced pathogen detection and profiling in comparison to conventional PCR testing.&lt;s&gt;337&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>NGS</td>\n",
       "      <td>Fulgent Genetics&lt;s&gt;168&lt;/s&gt; USA</td>\n",
       "      <td>11 Mar 2020</td>\n",
       "      <td>Kiloplex PCR Plus NGS Next-generation sequencing using thousands of PCR primers to amplify sample viral genetic material before sequencing on the Illumina platform.</td>\n",
       "      <td>Undergoing validation by joint venture Fujian Fujun Gene Biotech.</td>\n",
       "      <td>Undergoing validation by joint venture Fujian Fujun Gene Biotech.</td>\n",
       "      <td>Available.  Soon to be submitted to US FDA for EUA Approval.</td>\n",
       "      <td>4 hr</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Genome sequencing</td>\n",
       "      <td>Oxford Nanopore&lt;s&gt;338,339&lt;/s&gt; UK</td>\n",
       "      <td>22 Jan 2020</td>\n",
       "      <td>Works with public health labs globally to support rapid sequencing of SARS-CoV-2 through sharing of methods / workflows.   Nanopore sequencing workflows can provide a</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available. 28 January: US Centers for Disease Control and Prevention (CDC) releases nCoV genomes sequenced with nanopore sequencing</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>consensus viral genome from sample within a day.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>29 January: A paper in the Lancet characterised full-length genomes of 2019-nCoV patients using Nanopore sequencing, providing important information on possible virus origins and cell-binding receptors that is crucial for determining viral transmission capacity.  30 March: Singapore sequences its genome in less than 7 hours  14 April: In the UK, more than 600 genomes have been uploaded onto GISAID, using nanopore sequencing&lt;s&gt;340&lt;/s&gt;.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>End-to-end solution of sample processing to epidemiological info generation</td>\n",
       "      <td>Oxford Nanopore&lt;s&gt;338,341&lt;/s&gt; UK</td>\n",
       "      <td>22 Jan 2020</td>\n",
       "      <td>ARTIC project  A ‘lab-in-a-suitcase’ solution for processing samples from viral outbreaks, to generating real-time epidemiological information interpretable and actionable by public health bodies.  Deployable to remote/resource-limited locations.  Based on viral genome data generated prospectively during similar outbreaks (eg. MERS, SARS etc).</td>\n",
       "      <td>Not stated but described to have high sensitivity compared to metagenomic approaches.&lt;s&gt;342&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available  3 February: First Belgian nCoV sample arrives in a lab at 5pm and using the ARTIC protocol, the sequence is completed by 9am.  3 March: The SARS-CoV2 virus from Scotland’s first case is sequenced in under 24 hours using nanopore sequencing and the ARTIC protocol&lt;s&gt;340&lt;/s&gt;.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Relies on direct amplification of the virus using tiled, multiplexed primers.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>2.1.3 Microfluidics</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Microfluidics   [Point-of-Care]</td>\n",
       "      <td>Abbott Diagnostics&lt;s&gt;29,343&lt;/s&gt; USA</td>\n",
       "      <td>27 Mar 2020</td>\n",
       "      <td>ID Now COVID-19 test Automated assay that runs on Abbott’s ID Now platform.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 27 Mar 2020.</td>\n",
       "      <td>5-13 min  (5 min for positive results, 13 min for negative results)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Microfluidic</td>\n",
       "      <td>Veredus Laboratories&lt;s&gt;344-346&lt;/s&gt; Singapore</td>\n",
       "      <td>24 Jan 2020</td>\n",
       "      <td>VereCoV  Lab-on-Chip platform integrating PCR and microarray  Claims to detect MERS-CoV, SARS-CoV and SARS-CoV-2 in a single test</td>\n",
       "      <td>Stated to be high but with no accompanying statistics.&lt;s&gt;347&lt;/s&gt;</td>\n",
       "      <td>Stated to be high but with no accompanying statistics.&lt;s&gt;347&lt;/s&gt;</td>\n",
       "      <td>Available for RUO since Jan 2020.   Provisional approval for IVD by Singapore’s HSA since Mar 2020.&lt;s&gt;346&lt;/s&gt; Used for testing of swab samples from Singapore’s land, sea and air checkpoints since Mar 2020.&lt;s&gt;348&lt;/s&gt;</td>\n",
       "      <td>2 hours&lt;s&gt;349&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Microfluidic</td>\n",
       "      <td>Lexagene&lt;s&gt;350&lt;/s&gt; USA</td>\n",
       "      <td>27 Jan 2020</td>\n",
       "      <td>Genetic analyser using microfluidic technology</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Expected to be commercially available in Q3 2020.</td>\n",
       "      <td>1 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Microfluidic</td>\n",
       "      <td>Shenzhen Shineway Technology&lt;s&gt;351,352&lt;/s&gt;(collaboration with HKUST)  Hong Kong</td>\n",
       "      <td>6 Feb 2020</td>\n",
       "      <td>Novel silicon-based micro-heater, which has lower thermal mass and a better thermal conductivity, could speed up temperature rises to around 30&lt;s&gt;o&lt;/s&gt;C per second, greatly reducing the detection time compared to conventional PCR devices which has an average of 4-5&lt;s&gt;o&lt;/s&gt;C per second.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available. In use by the Centers for Disease Control and Prevention (CDCP) in Shenzhen and Guangzhou with two more sets being delivered to the CDCP in Hubei and Nansha.&lt;s&gt;352&lt;/s&gt; Device already has CE Mark and is qualified for export to all European Union (EU) countries as well as Hong Kong.&lt;s&gt;351&lt;/s&gt;</td>\n",
       "      <td>40 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Microfluidic</td>\n",
       "      <td>QIAGEN&lt;s&gt;353-355&lt;/s&gt; The Netherlands</td>\n",
       "      <td>10 Feb 2020</td>\n",
       "      <td>QIAStat-Dx Respiratory SARS-CoV-2 Panel [Plus]</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>Commercially available.</td>\n",
       "      <td>About an hour (Press release:&lt;s&gt;356&lt;/s&gt;)</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Tests for two gene targets: ORF1b recommended by the Chinese CDC and N recommended by the US CDC.</td>\n",
       "      <td>Evaluated using 10 positive clinical samples and 20 low positive contrived samples (1x–2x LOD) from retrospective nasopharyngeal swab clinical specimens in transport medium.&lt;s&gt;355&lt;/s&gt;</td>\n",
       "      <td>Evaluated using 30 negative samples from retrospective nasopharyngeal swab clinical specimens in transport medium.&lt;s&gt;355&lt;/s&gt;</td>\n",
       "      <td>Obtained EUA approval from US FDA 30 Mar 2020.&lt;s&gt;354&lt;/s&gt; Approved for inclusion in the Australian Register of Therapeutic Goods on 8 May 2020</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Microfluidic</td>\n",
       "      <td>GenMark Diagnostics&lt;s&gt;291,357,35&lt;/s&gt;&lt;s&gt;8&lt;/s&gt; USA</td>\n",
       "      <td>11 Mar 2020</td>\n",
       "      <td>ePlex SARS-CoV-2 Automated single cartridge using digital microfluidics.</td>\n",
       "      <td>100% (17/17)  65 fresh nasopharyngeal swab specimens from 3 clinical site2s were compared with one of two brands of established comparator assay.&lt;s&gt;291&lt;/s&gt;</td>\n",
       "      <td>97.9% (47/48)  65 fresh nasopharyngeal swab specimens from 3 clinical site2s were compared with one of two brands of established comparator assay.&lt;s&gt;291&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA Approval 19 Mar 2020.&lt;s&gt;358&lt;/s&gt;</td>\n",
       "      <td>Less than 2 hours&lt;s&gt;359&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Microfluidic</td>\n",
       "      <td>Fluidigm&lt;s&gt;360&lt;/s&gt; USA</td>\n",
       "      <td>16 Mar 2020</td>\n",
       "      <td>Aimed at using Fluidigm's Biomark HD system and microfluidics technology, to develop integrated fluidic circuits for parallel assays.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>In development.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>2.1.4 LAMP</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>LAMP  [Point-of-Care]</td>\n",
       "      <td>HiberGene Diagnostics&lt;s&gt;361,362&lt;/s&gt;(collaboration with distribution partner in Shenzhen, China, Medcaptain Medical Technologies)  Ireland</td>\n",
       "      <td>11 Feb 2020</td>\n",
       "      <td>Loop-mediated isothermal amplification (LAMP)-based Coronavirus test Allows for rapid near-patient testing</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>In development using the template of existing CE-marked Flu and RSV respiratory tests.</td>\n",
       "      <td>60-70 min (including patient sample preparation time)&lt;s&gt;362&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>LAMP</td>\n",
       "      <td>Atila BioSystems&lt;s&gt;176,363,3&lt;/s&gt;&lt;s&gt;64&lt;/s&gt; USA</td>\n",
       "      <td>10 Apr 2020</td>\n",
       "      <td>iAMP COVID-19 Detection Kit Real-time fluorescent reverse transcription isothermal amplification without requiring RNA extraction and can run up to 94 samples simultaneously.&lt;s&gt;363,364&lt;/s&gt;Tests for two gene targets: N &amp; ORF1ab.</td>\n",
       "      <td>100% (35/35)  35 oropharyngeal swabs from healthy individuals spiked with iAMP COVID-19 Sample Buffer Mix (2x to 10x LoD) serving as contrived positive samples.&lt;s&gt;363&lt;/s&gt;</td>\n",
       "      <td>100% (40/40)  40 oropharyngeal swabs from healthy individuals serving as negative controls.&lt;s&gt;363&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 10 Apr 2020.</td>\n",
       "      <td>51 min</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>RT-LAMP</td>\n",
       "      <td>Seasun Biomaterials&lt;s&gt;365&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>AQ-TOP™ COVID-19 Rapid Detection Kit RT-LAMP test designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens, bronchoalveolar lavage (BAL) specimens as well as sputum.</td>\n",
       "      <td>100% (20/20) for both nasopharyngeal and sputum specimens</td>\n",
       "      <td>100% (25/25) for both nasopharyngeal and sputum specimens</td>\n",
       "      <td>FDA EUA issued on 21 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>2.1.5 Enzyme-assisted nanocomplex</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Enzyme-assisted nanocomplex</td>\n",
       "      <td>iHealthtech&lt;s&gt;345,366&lt;/s&gt;(Asst Prof Shao Huilin)   Singapore</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>enVision (enzyme-assisted nanocomplexes for visual identification of nucleic acids) Uses enzyme-assisted nanocomplexes</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>In development.</td>\n",
       "      <td>30 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>2.1.6 CRISPR-based diagnostics</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>CRISPR-based diagnostics</td>\n",
       "      <td>Sherlock Biosciences&lt;s&gt;34,142,29&lt;/s&gt;&lt;s&gt;5,367&lt;/s&gt; (Plus collaboration with Cepheid)&lt;s&gt;142&lt;/s&gt; USA</td>\n",
       "      <td>24 Jan 2020</td>\n",
       "      <td>SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing)  SHERLOCK platform uses various CRISPR proteins (Cas13, Cas12a, and Csm6) to allow for simultaneous detection of multiple nucleic acids.&lt;s&gt;142&lt;/s&gt; Designed to detect RNA from upper respiratory specimens (such as nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, nasopharyngeal wash/aspirate or nasal aspirate) and bronchoalveolar lavage specimens. Step one is a reverse transcriptase loop-mediated amplification (RT-LAMP) where targeted</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>100%</td>\n",
       "      <td>Protocol published 14 Feb 2020.&lt;s&gt;368,369&lt;/s&gt; FDA EUA issued on 6/5/2020&lt;s&gt;370&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>SARS-CoV-2 genomic RNA is reverse transcribed to DNA, and this DNA is amplified by a strand-displacing DNA polymerase. Step two is the transcription of the amplified DNA to activate the collateral cleavage activity of a CRISPR complex programmed to the target RNA sequence.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>CRISPR-based diagnostics</td>\n",
       "      <td>Mammoth Biosciences&lt;s&gt;32-35&lt;/s&gt; (Partnering with UCSF Researchers)  USA</td>\n",
       "      <td>30 Jan 2020</td>\n",
       "      <td>SARS-CoV-2 DNA Endonuclease-Targeted CRISPR Trans Reporter (DETECTR) Using the CRISPR Cas12 that cleaves a FAM-Biotin reporter molecule. Tests for two gene targets:  E &amp; N2.</td>\n",
       "      <td>95% (Using contrived reference samples and clinical samples from US patients, including 36 patients with COVID-19 infection and 42 patients with other viral respiratory infections)  (Press release:&lt;s&gt;371&lt;/s&gt; Study:&lt;s&gt;35&lt;/s&gt;</td>\n",
       "      <td>Specificity: 100% (Using contrived reference samples and clinical samples from US patients, including 36 patients with COVID-19 infection and 42 patients with other viral respiratory infections)   (Press release:&lt;s&gt;371&lt;/s&gt;Study:&lt;s&gt;35&lt;/s&gt;</td>\n",
       "      <td>Developed.   Awaiting EUA from US FDA (pending clinical validation)   (Press release:&lt;s&gt;371&lt;/s&gt;Study:&lt;s&gt;35&lt;/s&gt;</td>\n",
       "      <td>45 minutes (with manual RNA extraction)   (Press release:&lt;s&gt;371&lt;/s&gt;Study:&lt;s&gt;35&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2.1.7 Immunoassay for SARS-CoV-2 antigens</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Immunoassay for SARS-CoV-2 viral nucleoprotein antigens</td>\n",
       "      <td>SD Biosensor &lt;s&gt;372&lt;/s&gt;&lt;s&gt;South Korea&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>STANDARD F COVID-19 Ag FIA Fluorescent immunoassay to detect SARS-CoV-2 infection in human nasopharyngeal swab specimen by identifying the existence of SARS-CoV-2 &lt;s&gt;viral nucleoprotein antigens&lt;/s&gt;</td>\n",
       "      <td>Higher sensitivity than &lt;s&gt;rapid test&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available. Obtained &lt;s&gt;CE certification&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;30 minutes&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Immunoassay for SARS-CoV-2 antigens</td>\n",
       "      <td>SD Biosensor &lt;s&gt;53&lt;/s&gt; &lt;s&gt;South Korea&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>STANDARD Q COVID-19 Ag  Rapid chromatographic immunoassay for the qualitative detection of specific antigens to SARS-CoV-2 present in the human &lt;s&gt;nasopharynx&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available. Obtained &lt;s&gt;CE certification&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;30 minutes&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Molecular Tests</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Immunoassay for SARS-CoV-2 antigens  [Point-of-Care]</td>\n",
       "      <td>Sona Nanotech&lt;s&gt;373&lt;/s&gt;(collaboration with GE Healthcare Life Sciences, The Native Antigen Company, Bond)&lt;s&gt;374&lt;/s&gt;&lt;s&gt;375&lt;/s&gt; Canada</td>\n",
       "      <td>10 Feb 2020</td>\n",
       "      <td>Proprietary nanotechnology  lateral flow test using antigens specific to SARS-CoV-2 produced at Native's Oxford facility using proprietary mammalian VirtuE expression system.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>In development.</td>\n",
       "      <td>5-15 min</td>\n",
       "      <td>&lt;$50</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Immunoassay for SARS-CoV-2 antigens</td>\n",
       "      <td>Quidel Corporation&lt;s&gt;376&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Sofia 2 SARS Antigen FIA Lateral flow immunofluorescent sandwich assay that is used with the Sofia 2 instrument intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal (NP) and nasal (NS) swab specimens.</td>\n",
       "      <td>100% (47/47)</td>\n",
       "      <td>80% (84/96)</td>\n",
       "      <td>FDA EUA issued on 8 May 2020</td>\n",
       "      <td>(No info)</td>\n",
       "      <td>(No info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>2.1.8 Others</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Carbohydrate-based glycation pattern detection</td>\n",
       "      <td>Iceni Diagnostics&lt;s&gt;377&lt;/s&gt; UK</td>\n",
       "      <td>20 Mar 2020</td>\n",
       "      <td>Carbohydrate-based, lateral flow assay for detection of glycation patterns of SARS-CoV-2</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>In development.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>(no info)</td>\n",
       "      <td>Lab Geneomics&lt;s&gt;131&lt;/s&gt; South Korea</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Undergoing commercialisation as of 6 Feb 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Target amplification assay</td>\n",
       "      <td>Hologic, Inc.&lt;s&gt;378&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Aptima® SARS-CoV-2 Assay (Panther® System) Nucleic acid amplification in vitro diagnostic test designed to qualitatively detect RNA from SARS-CoV-2 isolated and purified from nasopharyngeal (NP), nasal, mid-turbinate and oropharyngeal (OP) swab specimens, nasopharyngeal wash/ aspirate or nasal aspirates.</td>\n",
       "      <td>98.2% (54/55)</td>\n",
       "      <td>100% (50/50)</td>\n",
       "      <td>FDA EUA issued on 14 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Serological tests (Antibody immunoassay test)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2.2.1 Total Antibody Immunoassays</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Total Antibody Immunoassay (ELISA)</td>\n",
       "      <td>Bio-Rad Laboratories&lt;s&gt;222&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>&lt;s&gt;ELISA Total Antibodies&lt;/s&gt;Platelia SARS-CoV-2 Total Antibody Assay&lt;s&gt;379&lt;/s&gt; Qualitative detection of total antibodies to SARS-CoV-2 in human serum and plasma &lt;s&gt;EDTA&lt;/s&gt;</td>\n",
       "      <td>100% in Serum, 83.33% in Plasma</td>\n",
       "      <td>99.51% in Serum, 100% in Plasma</td>\n",
       "      <td>FDA EUA issued on 29/04/2020&lt;s&gt;379&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Total antibody immunoassay</td>\n",
       "      <td>Beijing Wantai Biologicalpharmacy Enterprise Co Ltd&lt;s&gt;380&lt;/s&gt; China</td>\n",
       "      <td></td>\n",
       "      <td>Wantai SARS-CoV-2 Ab Rapid Test Kit  Rapid qualitative detection of total antibodies against SARS-CoV-2 in human serum, plasma or whole blood specimens, employing chromatographic lateral flow device in a cassette format &lt;s&gt;(colloidal gold)&lt;/s&gt;</td>\n",
       "      <td>96.6% (131/137)  Evaluated using 137 specimens from confirmed COVID-19 patients and 209 specimens from healthy &lt;s&gt;individuals&lt;/s&gt;</td>\n",
       "      <td>95.2% (199/209)  Evaluated using 137 specimens from confirmed COVID-19 patients and 209 specimens from healthy individuals</td>\n",
       "      <td>Available.  CE-IVD marked. Approved for inclusion into the Australian Register of Therapeutic Goods on 27 March 2020.&lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Total Antibody Immunoassay</td>\n",
       "      <td>Wadsworth Center&lt;s&gt;381&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>New York SARS-CoV Microsphere Immunoassay for Antibody Detection &lt;s&gt;382&lt;/s&gt; Qualitative detection of total antibodies to SARS-CoV-2 in human serum.</td>\n",
       "      <td>88.0% (95/108)</td>\n",
       "      <td>99.6% (Blood donors), 98.7% (Diverse group of viral pathogens), 96.7% (Respiratory infections), 97.1% (Other study with &lt;s&gt;respiratory infections)&lt;/s&gt;</td>\n",
       "      <td>FDA EUA issued on 30/04/2020 &lt;s&gt;382&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Total antibody Immunoassay</td>\n",
       "      <td>Roche Diagnostics</td>\n",
       "      <td></td>\n",
       "      <td>Elecsys Anti-SARS-CoV-2&lt;s&gt;383&lt;/s&gt; Immunoassay for qualitative detection of antibodies to SARS-CoV-2</td>\n",
       "      <td>65.5% (76/116, Day 0-6 post-PCR confirmation); 88.1% (52/59, Day 7-13 post-PCR confirmation); 100% (29/29, &gt;/= 14 days post-PCR confirmation)</td>\n",
       "      <td>99.81% (5262/5272)</td>\n",
       "      <td>FDA EUA issued on 2 May 2020&lt;s&gt;383&lt;/s&gt; Date of Provisional Authorisation from HSA: 5 May 2020 &lt;s&gt;384&lt;/s&gt; Approved for inclusion on the Australian Register of Therapeutic Goods on 20 May 2020.&lt;s&gt;385&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Serological tests (Antibody immunoassay test)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Total Antibody immunoassay  [Point-of-Care]</td>\n",
       "      <td>Mologic (partnership with the Institut Pasteur de Dakar)&lt;s&gt;386,387&lt;/s&gt; UK</td>\n",
       "      <td>25 Feb 2020</td>\n",
       "      <td>Lateral flow immunoassay for detection of antibodies for SARS-CoV-2.</td>\n",
       "      <td>98% at days 14-21 &lt;s&gt;388&lt;/s&gt;&lt;s&gt;389&lt;/s&gt;</td>\n",
       "      <td>98%&lt;s&gt;388&lt;/s&gt;</td>\n",
       "      <td>Developed. Ready for manufacture with CE mark.&lt;s&gt;388&lt;/s&gt;</td>\n",
       "      <td>10 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Total Antibody immunoassay</td>\n",
       "      <td>Ortho Clinical Diagnostics&lt;s&gt;390-392&lt;/s&gt; USA</td>\n",
       "      <td>6 Apr 2020</td>\n",
       "      <td>VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack Runs on VITROS ECi/ECiQ/3600 Immunodiagnostic System and the VITROS 5600/XT 7600 Integrated Systems.  Can run up to 150 samples per hour.&lt;s&gt;392&lt;/s&gt;</td>\n",
       "      <td>83.3% (30/36)  Tested with 36 samples from patients confirmed to be SARS-CoV-2 positive with PCR.&lt;s&gt;391&lt;/s&gt;</td>\n",
       "      <td>100% (400/400)  400 presumed SARS-CoV-2 negative samples from healthy blood donors serving as negative controls.&lt;s&gt;391&lt;/s&gt;</td>\n",
       "      <td>Available.   Obtained EUA approval from US FDA 14 Apr 2020.  Date of Provisional Authorisation from HSA: 8 May 2020&lt;s&gt;393&lt;/s&gt;</td>\n",
       "      <td>48 min  (Up to 150 samples per hour)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2.2.2 IgG/IgM antibody immunoassay</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>IgG/IgM antibody immunoassay (ELISA)</td>\n",
       "      <td>Livzon&lt;s&gt;135&lt;/s&gt;(collaboration with Wuhan Institute of Virology, Chinese Academy of Science)</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>Diagnostics kit for IgM/IgG antibody to novel coronavirus (ELISA) Indirect method for ELISA for in vitro qualitative detection of antibodies to SARS-CoV-2 in human serum or plasma.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Developed.  Undergoing testing. Emergency use approval submitted to China’s NMPA on 28 Jan 2020.   Approved on 14 March for commercial use. &lt;s&gt;394&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>IgG/IgM antibody immunoassay (colloidal gold)  [Point-of-Care]</td>\n",
       "      <td>Mobidiag (in collaboration with Autobio &lt;s&gt;Diagnostics)&lt;/s&gt;&lt;s&gt;199&lt;/s&gt;Finland</td>\n",
       "      <td></td>\n",
       "      <td>Anti-SARS-CoV-2 Rapid &lt;s&gt;Test&lt;/s&gt; Immunoassay Anti-SARS-CoV-2 Rapid Test is based on a colloidal gold method for the rapid, qualitative determination of SARS-CoV-2 IgG/IgM antibodies in human serum, plasma or whole blood.</td>\n",
       "      <td>&lt;s&gt;97.4%&lt;/s&gt;</td>\n",
       "      <td>96.2%</td>\n",
       "      <td>CE-IVD marked. For in vitro diagnostic use.  FDA EUA issued on 24/04/2020</td>\n",
       "      <td>&lt;15 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Serological tests (Antibody immunoassay test)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>IgG/IgM antibody immunoassay (colloidal gold)</td>\n",
       "      <td>Livzon&lt;s&gt;135&lt;/s&gt;(collaboration with Wuhan Institute of Virology, Chinese Academy of Science)</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>Diagnostics kit for IgM/IgG antibody to novel coronavirus (colloidal gold) Immunochromatography assay for in vitro qualitative detection of antibodies to SARS-CoV-2 in human serum or plasma.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Developed.  Undergoing testing. Emergency use approval submitted to China’s NMPA on 2 Feb 2020.  Approved for inclusion on the Australian Register of Therapeutic Goods on 23 April 2020.</td>\n",
       "      <td>15 mi</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Camtech Diagnostics Pte Ltd&lt;s&gt;395&lt;/s&gt;Singapore</td>\n",
       "      <td></td>\n",
       "      <td>Camtech COVID-19 IgM/IgG Immunoassay kit for the rapid and differential detection of IgG and IgM against COVID-19 using serum, plasma and whole &lt;s&gt;blood.&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HSA: 09/04/2020</td>\n",
       "      <td>10 Minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>IgG/IgM antibody immunoassay  (CLIA)</td>\n",
       "      <td>Shenzhen Tisenc Medical Device&lt;s&gt;55&lt;/s&gt;(collaboration with Shenzhen University and Shenzhen No.3 People’s Hospital)  China</td>\n",
       "      <td>12 Feb 2020</td>\n",
       "      <td>2019 Novel Coronavirus &lt;s&gt;IgM kit (CLIA)&lt;/s&gt;2019 Novel Coronavirus &lt;s&gt;IgG kit (CLIA)&lt;/s&gt;Chemiluminescence antibody test kit using serum or plasma.</td>\n",
       "      <td>IgM kit - 96.6% (29/30) IgG kit - 96.6% (29/30)&lt;s&gt;396&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available. Received CE certification on 6 March 2020&lt;s&gt;396&lt;/s&gt;</td>\n",
       "      <td>22 min (unclear if serum/plasma extraction time included or not)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>IgG/IgM antibody immunoassay (CLIA)</td>\n",
       "      <td>Snibe Diagnostic&lt;s&gt;397,398&lt;/s&gt; China</td>\n",
       "      <td>28 Feb 2020</td>\n",
       "      <td>Maglumi 2019-nCoV (SARS-CoV-2) IgM/IgG kits Fully automated CLIA using 10μL sample volume of serum or plasma.</td>\n",
       "      <td>Differs across different durations from symptom onset &lt;5 days: IgA – 3.3% (1/30); IgG – 10% (3/30)  5-10 days: IgA – 15.4% (2/13); IgG – 53.8% (7/13)  10-21 days: IgA – 60% (3/5); IgG – 100% (5/5)&lt;s&gt;399&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available.   Have been distributed in China and will soon be in Italy.   Received CE Mark 19 Feb 2020.&lt;s&gt;398&lt;/s&gt;</td>\n",
       "      <td>30 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Serological tests (Antibody immunoassay test)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>GenBody Inc (South Korea)&lt;s&gt;214&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>GenBody COVID-19 &lt;s&gt;IgM/IgG&lt;/s&gt; Point-of-care chromatographic immunoassay kit for the rapid and differential detection of anti-SARS-CoV-2 IgM and IgG using serum, plasma and whole blood from capillary blood samples.&lt;s&gt;214&lt;/s&gt;</td>\n",
       "      <td>Sensitivity : 50% at Day 1-6, 91.7% at after Day 7&lt;s&gt;214&lt;/s&gt;</td>\n",
       "      <td>Specificity : 97.5%&lt;s&gt;214&lt;/s&gt;</td>\n",
       "      <td>Availability: Approved for inclusion on the Australian Register of Therapeutic Goods on &lt;s&gt;28 April 2020.&lt;/s&gt;</td>\n",
       "      <td>10 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Healgen Scientific Limited Liability Company (USA)&lt;s&gt;400&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>COVID-19 Antibody Rapid Detection Kit&lt;s&gt;400&lt;/s&gt; Rapid test for the qualitative, differential detection of both anti-SARS-CoV-2 IgM and IgG antibodies from whole blood, serum and plasma, using lateral flow method</td>\n",
       "      <td>Sensitivity: IgG 97.2%; IgM 87.9%</td>\n",
       "      <td>Specificity: IgG 100%; IgM 100%</td>\n",
       "      <td>Approved for inclusion on the Australian Register of Therapeutic Goods on 29 April 2020. Pending &lt;s&gt;FDA approval &lt;/s&gt;</td>\n",
       "      <td>10 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>PCL</td>\n",
       "      <td></td>\n",
       "      <td>PCL COVID19 IgG/IgM Rapid Gold&lt;s&gt;132&lt;/s&gt; Qualitative detection of COVID-19 IgG/IgM antibodies using lateral flow technique</td>\n",
       "      <td>100%</td>\n",
       "      <td></td>\n",
       "      <td>Approved for inclusion on the Australian Register of Therapeutic Goods on 1 May 2020. &lt;s&gt;132&lt;/s&gt;</td>\n",
       "      <td>10 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>IgG/IgM antibody immunoassay  [Point-of-Care]</td>\n",
       "      <td>BioMedomics /  Jiangsu Medomics Medical Technology&lt;s&gt;54,57,58&lt;/s&gt; USA / China</td>\n",
       "      <td>21 Feb 2020</td>\n",
       "      <td>COVID-19 IgM/IgG Rapid Test   Lateral flow immunoassay with both IgM and IgG antibodies adhered using colloidal gold.  Can be used with fingerstick whole blood.</td>\n",
       "      <td>88.66%   352 positives out of 397 positive cases: - 256 both IgG and IgM - 72 IgG - 24 IgM</td>\n",
       "      <td>90.63%  12 positives out of 128 negative controls: - 1 both IgG and IgM - 1 IgG - 10 IgM</td>\n",
       "      <td>Commercially available. More than half a million sold in China.  Received CE Mark for IVD 8 Mar 2020. Already sold in Italy.&lt;s&gt;58&lt;/s&gt; Submitted to US FDA for EUA approval.&lt;s&gt;59,60&lt;/s&gt;</td>\n",
       "      <td>15 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Shenzen YHLO Biotech Co. Ltd (China)&lt;s&gt;401&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>iFlash 8000 CLIA analyser&lt;s&gt;402&lt;/s&gt; Fully Automated chemiluminescent immunoassay for anti-</td>\n",
       "      <td>Sensitivity: 81.5% for IgM, 100% for IgG&lt;s&gt;402&lt;/s&gt;</td>\n",
       "      <td>Specificity: 88.1% for IgM, 92.8% for IgG&lt;s&gt;402&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Serological tests (Antibody immunoassay test)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>SARS-CoV-2 IgM and IgG &lt;s&gt;antibodies.&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Biolidics Limited&lt;s&gt;403&lt;/s&gt; Singapore</td>\n",
       "      <td></td>\n",
       "      <td>Nanjing Vazyme 2019-nCoV IgG/IgM Detection &lt;s&gt;Kit&lt;/s&gt;&lt;s&gt;Also marketed as&lt;/s&gt;Biolidics 2019-nCoV IgG/IgM Detection Kit Detection of 2019-nCoV IgG and IgM in human serum, &lt;s&gt;plasma and whole blood&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HSA: 20/03/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Everest Links Pte Ltd&lt;s&gt;404&lt;/s&gt; Singapore</td>\n",
       "      <td></td>\n",
       "      <td>VivaDiag™ COVID-19 IgM/IgG Rapid Test In vitro diagnostic test for the qualitative determination of COVID-19’s igM and IgG antibodies in human blood, serum and plasma.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HSA: 20/03/2020  Date of approval for inclusion into ARTG: &lt;s&gt;26/03/2020&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Grit Overseas Pte Ltd &lt;s&gt;405&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>DiagnoSure COVID-19 IgG/ IgM Rapid Test Cassette</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 24/04/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>CTK Biotech Inc&lt;s&gt;406&lt;/s&gt; USA</td>\n",
       "      <td></td>\n",
       "      <td>OnSite COVID-19 IgG/IgM Rapid Test  Designed for initial screening by detecting anti-SAR-CoV-2 IgG and IgM antibodies in human serum, &lt;s&gt;plasma or whole blood&lt;/s&gt;</td>\n",
       "      <td>96.9%</td>\n",
       "      <td>99.4%</td>\n",
       "      <td>Available commercially.  Approved for inclusion into the Australian Register of Therapeutic Goods on 19 March 2020. &lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>10 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Qingdao Hightop Biotech Co Ltd&lt;s&gt;407&lt;/s&gt; China</td>\n",
       "      <td></td>\n",
       "      <td>SARS-CoV-2 IgM/lgG Antibody Rapid Test  Qualitative detection of SARS-CoV-2 IgG and IgM antibodies in human serum, plasma or whole blood &lt;s&gt;samples&lt;/s&gt;</td>\n",
       "      <td>IgM – 82% &lt;s&gt;IgG – 93%&lt;/s&gt;</td>\n",
       "      <td>IgM – 97% IgG – 97.5%</td>\n",
       "      <td>Available.   Approved for inclusion into the Australian Register of Therapeutic Goods on 31 March 2020. &lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>15 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Hangzhou Realy Tech Co Ltd   China</td>\n",
       "      <td></td>\n",
       "      <td>2019-nCOV/COVID-19 &lt;s&gt;IgG/IgM Rapid Test Device&lt;/s&gt; &lt;s&gt;Lateral flow IgG/IgM&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Approved for inclusion on the Australian Register of Therapeutic Goods on 16 April 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Serological tests (Antibody immunoassay test)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>&lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Hangzhou Clongene Biotech &lt;s&gt;Co Ltd&lt;/s&gt; China</td>\n",
       "      <td></td>\n",
       "      <td>COVID-19 IgG/IgM Rapid &lt;s&gt;Test Cassette&lt;/s&gt; Rapid point-of-care lateral flow chromatographic immunoassay for the qualitative detective of IgG and IgM antibodies to &lt;s&gt;SARS-CoV-2&lt;/s&gt;</td>\n",
       "      <td>IgM – 87.01% (67/77)  IgG – 99.42% (75/77) &lt;s&gt;408&lt;/s&gt;</td>\n",
       "      <td>IgM – 98.89% (89/90) &lt;s&gt;408&lt;/s&gt;</td>\n",
       "      <td>Available.   Received CE mark.&lt;s&gt;408&lt;/s&gt;Approved for inclusion into the Australian Register of Therapeutic Goods on &lt;s&gt;26 March 2020&lt;/s&gt;&lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Hangzhou Biotest &lt;s&gt;Biotech Co Ltd&lt;/s&gt; China</td>\n",
       "      <td></td>\n",
       "      <td>COVID-19 IgG/IgM Rapid &lt;s&gt;Test Cassette&lt;/s&gt; Rapid chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2 in human whole blood, serum or &lt;s&gt;plasma&lt;/s&gt;</td>\n",
       "      <td>IgG – 100% (75/75) IgM – 91.8% (78/85)&lt;s&gt;409&lt;/s&gt;</td>\n",
       "      <td>IgG – 99.5% (369/371); IgM – 99.2% (368/371)&lt;s&gt;409&lt;/s&gt;</td>\n",
       "      <td>Available.   Received CE mark. Approved for inclusion into the Australian Register of Therapeutic Goods on 4 April 2020.&lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Guangzhou Wondfo Biotech&lt;s&gt;44-&lt;/s&gt;&lt;s&gt;48&lt;/s&gt; China</td>\n",
       "      <td>20 Feb 2020</td>\n",
       "      <td>Wondfo SARS-CoV-2 Antibody Test (Lateral Flow Method)  Colloidal gold method for IgM and IgG antibody detection.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available.   Approved by China’s NMPA.  Received CE Mark Mar 2020.&lt;s&gt;48,49&lt;/s&gt; Obtained HSA provisional approval on 9 April 2020, supplied through SkyQuest Pte Ltd.&lt;s&gt;410&lt;/s&gt; Approved for inclusion on the Australian Register of Therapeutic Goods on 25 March 2020.&lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>15 min (unclear if serum/plasma extraction time included or not)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Serological tests (Antibody immunoassay test)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 27 April 2020&lt;s&gt;411&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Hangzhou AllTest Biotech&lt;s&gt;81,412,413&lt;/s&gt; China</td>\n",
       "      <td>2 Mar 2020</td>\n",
       "      <td>2019-nCoV IgG/IgM Rapid Test Cassette Lateral flow chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2 in human whole blood, serum or plasma specimen.</td>\n",
       "      <td>IgM test 85.0% (17/20) IgG test 100.0% (20/20)  Tested with the results compared to leading commercial PCR.</td>\n",
       "      <td>IgM test 96.0% (48/50) IgG test 98.0% (49/50)  Tested with the results compared to leading commercial PCR.</td>\n",
       "      <td>Commercially available.   Received CE Mark for IVD.  Approved for inclusion in Australia’s ARTG.&lt;s&gt;81&lt;/s&gt; Used in study by Lee et al (2020).&lt;s&gt;414&lt;/s&gt;</td>\n",
       "      <td>10 min</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Pharmact AG&lt;s&gt;50&lt;/s&gt; Germany</td>\n",
       "      <td>10 Mar 2020</td>\n",
       "      <td>CoV-2 Rapid Test Using drops of blood from fingerstick onto test cassette, with two drops of buffer solution.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available.</td>\n",
       "      <td>20 min</td>\n",
       "      <td>€39.95</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Zhejiang Orient Gene Biotech&lt;s&gt;51,52&lt;/s&gt; China</td>\n",
       "      <td>10 Mar 2020</td>\n",
       "      <td>COVID-19 IgG/IgM Rapid Test Solid phase immunochromatography assay for rapid qualitative detection of IgG and IgM antibodies to SARS-CoV-2 using human whole blood, serum or plasma.</td>\n",
       "      <td>IgM test 87.9% (87/99) IgG test 97.2% (35/36)  Tested with 113 blood samples, and the results compared to RT-PCR or clinical diagnosis.</td>\n",
       "      <td>IgM test 100% (14/14) IgG test 100% (14/14)  Tested with 113 blood samples, and the results compared to RT-PCR or clinical diagnosis.</td>\n",
       "      <td>Available.   Received CE Mark. Currently one of only a few tests used for coronavirus screening in China.  Commercialisation and distribution licensing deal with Aytu Bioscience for USA.   Approved for inclusion on Australia’s ARTG on 1 April 2020.&lt;s&gt;81&lt;/s&gt;</td>\n",
       "      <td>2-10 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>SD Biosensor&lt;s&gt;53&lt;/s&gt; South Korea</td>\n",
       "      <td>(Webpage found as of 12 Mar 2020)</td>\n",
       "      <td>STANDARD Q COVID-19 IgM/IgG Duo Immunochromatography assay for rapid qualitative detection of IgG and IgM antibodies to SARS-CoV-2 using human whole blood, serum or plasma.</td>\n",
       "      <td>Sensitivity at 81.8% (27/33)&lt;s&gt;53&lt;/s&gt;</td>\n",
       "      <td>Specificity at 96.7% (29/30)</td>\n",
       "      <td>Available.</td>\n",
       "      <td>10 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Serological tests (Antibody immunoassay test)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Chembio Diagnostic Systems&lt;s&gt;415-417&lt;/s&gt; USA</td>\n",
       "      <td>20 Mar 2020</td>\n",
       "      <td>DPP COVID-19 IgM/IgG System Lateral flow assay testing for IgM and IgG, to be read using the DPP Micro Reader or DPP Micro Reader 2 (not visually).</td>\n",
       "      <td>IgM: 50% (3/6) IgG: 100% (6/6)  Tested with fresh, fingerstick blood samples prospectively-collected from 11 hospital workers in the United States (New York), 6 of whom were confirmed positive cases with results from FDA-authorised RT-PCR test.&lt;s&gt;416&lt;/s&gt;</td>\n",
       "      <td>IgM: 100% (6/6) IgG: 100% (6/6)  Tested with fresh, fingerstick blood samples prospectively-collected from 11 hospital workers in the United States (New York), 5 of whom were confirmed negative with results from FDA-authorised RT-PCR test.&lt;s&gt;416&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 14 Apr 2020.</td>\n",
       "      <td>10-15 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Cellex&lt;s&gt;61,358&lt;/s&gt; USA</td>\n",
       "      <td>1 Apr 2020</td>\n",
       "      <td>qSARS-CoV-2 IgG/IgM Rapid Test For “aid in the diagnosis of patients with suspected SARS-CoV-2 infection in conjunction with clinical presentation and the results of other laboratory tests.”&lt;s&gt;61&lt;/s&gt;Can be used with serum, plasmas, or whole blood from venepuncture (not fingerstick).</td>\n",
       "      <td>93.8% (120/128)  Tested with 98 positive serum or plasma samples collected from individuals who tested positive with RT- PCR and 30 samples from hospitalised individuals who were clinically confirmed positive and exhibited severe symptoms.&lt;s&gt;61&lt;/s&gt;</td>\n",
       "      <td>96.0% (240/250)  Tested with negative serum or plasma samples collected prior to September 2019.&lt;s&gt;61&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 1 Apr 2020.  Approved for inclusion in Australia’s ARTG 31 Mar 2020.&lt;s&gt;81&lt;/s&gt;</td>\n",
       "      <td>15-20min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Nankai University&lt;s&gt;56&lt;/s&gt; (in collaboration with KingFocus Biomedical)  China</td>\n",
       "      <td>17 Feb 2020</td>\n",
       "      <td>Novel Coronavirus (2019-nCoV) IgM/IgG antibody detection kit</td>\n",
       "      <td>75% (30/40) in first clinical trial, but suboptimal in the second trial&lt;s&gt;418&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available non-commercially in China. &lt;s&gt;418&lt;/s&gt;</td>\n",
       "      <td>15 min  (unclear if serum/plasma extraction time included or not)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Hangzhou Laihe Biotech Co Ltd&lt;s&gt;419&lt;/s&gt; &lt;s&gt;China&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold)  POCT rapid SARS-CoV-2 &lt;s&gt;IgM/IgG antibody test&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.   Approved for inclusion into the Australian Register of Therapeutic Goods on 6 April 2020.&lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>Within 10 min</td>\n",
       "      <td>$20 per test kit</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Shanghai LiangRun &lt;s&gt;420&lt;/s&gt; China</td>\n",
       "      <td>27 April 2020</td>\n",
       "      <td>LionRun Diagnostic Kit for Antibody IgM-IgG of Novel Coronavirus COVID-19</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 27 April 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Serological tests (Antibody immunoassay test)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>An in vitro diagnostic test for the qualitative and differential detection of IgM and IgG antibodies against SARS-CoV-2</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Grey Solutions Pte Ltd &lt;s&gt;421&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>i-Test COVID -19 IgM/IgG Antibody Rapid Test (Colloidal Gold)  The test is an in-vitro qualitative determination of Novel coronavirus (COVID2019) Antibody in human serum or plasma or whole blood.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 30 April 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Innovation Scientific Pty Ltd (Australia) &lt;s&gt;314&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>InnoScreen COVID-19 IgG/IgM Rapid Test Lateral Flow IgG/IgM [Point-of-care]</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Approved for inclusion in the Australian Register of Therapeutic Goods on 11 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>MP Biomedicals Asia Pacific Pte Ltd&lt;s&gt;422&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>MP Diagnostics ASSURE® SARS-CoV-2 IgG/IgM Rapid Test Qualitative in vitro immunochromatographic test to detect and differentiate IgG/IgM antibodies against SARS- CoV-2 in human plasma, serum or whole blood with anti-coagulants</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 8 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Xiamen Boson Biotech Co.&lt;s&gt;423&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Xiamen Boson Rapid 2019-nCOV IgG/IgM Combo Test Card Immunochromatography for the rapid qualitative determination of IgG and IgM antibodies to 2019 novel coronavirus (2019- nCoV, SARS-CoV- 2) in human serum, plasma, or whole blood</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 14 May 2020, supplied by Trans Sahara Corporation Pte Ltd &lt;s&gt;424&lt;/s&gt;</td>\n",
       "      <td>15 mins</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Atlaslink Beijing Technology Co Ltd (China) &lt;s&gt;425&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>NOVA Test® COVID-19 IgG/IgM Antibody Test (Colloidal Gold) Qualitative detection of IgG/IgM antibodies to</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Approved for inclusion into the Australian Register of Therapeutic Goods on 18 May 2020</td>\n",
       "      <td>10 mins</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Serological tests (Antibody immunoassay test)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>SARS-CoV-2 in human serum, plasma or whole blood.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Healthgroup Medical Pte Ltd (Singapore)</td>\n",
       "      <td></td>\n",
       "      <td>HealthGroup Medical V-CODE Sars-CoV-2 (COVID-19) IgG/IgM Rapid Test Lateral flow immunoassay for the qualitative detection and differentiation of IgG and IgM of Novel Coronavirus (SARS-CoV-2) in human whole blood, serum or plasma.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>HSA provisional authorisation approved on 18 May 2020&lt;s&gt;426&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2.2.3 IgM Antibody Immunoassay</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>IgM antibody immunoassay  [Point-of-Care]</td>\n",
       "      <td>Guangzhou Medical University&lt;s&gt;11,43&lt;/s&gt;(Dr Zhong Nanshan) In collaboration with Jiangsu Medomics Medical Technologies and many other institutes  China</td>\n",
       "      <td>15 Feb 2020</td>\n",
       "      <td>SARS-CoV-2 rapid IgG-IgM combined antibody kit &lt;s&gt;(colloidal gold)&lt;/s&gt; In-vitro detection of IgG/IgM antibodies using lateral flow &lt;s&gt;immunoassay techniques&lt;/s&gt;&lt;s&gt;427&lt;/s&gt;,&lt;s&gt;57&lt;/s&gt;</td>\n",
       "      <td>88.66% (352/397)   Evaluated using blood samples from 397 clinically confirmed (including PCR test) SARS-CoV-2-infected patients.&lt;s&gt;57&lt;/s&gt;</td>\n",
       "      <td>90.63% (116/128)   Evaluated using blood samples from 128 non-SARS-CoV-2-infected patients.&lt;s&gt;57&lt;/s&gt;</td>\n",
       "      <td>Available for use in China but not commercially</td>\n",
       "      <td>15 min (unclear if serum/plasma extraction time included or not)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>IgM antibody immunoassay</td>\n",
       "      <td>Innovita Biological Technology&lt;s&gt;44&lt;/s&gt; China</td>\n",
       "      <td>23 Feb 2020</td>\n",
       "      <td>2019-nCoV Antibody Test &lt;s&gt;(colloidal gold)&lt;/s&gt; IgG and IgM antibody detection from venous whole blood/ plasma/ serum samples</td>\n",
       "      <td>87.3% &lt;s&gt;428&lt;/s&gt;</td>\n",
       "      <td>100% &lt;s&gt;428&lt;/s&gt;</td>\n",
       "      <td>Available commercially.  Approved by China’s NMPA.  Approved for inclusion on the Australian Register of Therapeutic Goods.&lt;s&gt;81&lt;/s&gt; CE-IVD approved. &lt;s&gt;3&lt;/s&gt; Partnered with Scanwell Health to be distributed in US, together with an accompanying smartphone app,</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Projected to be $70 as distributed by Scanwell Health &lt;s&gt;428&lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Serological tests (Antibody immunoassay test)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>pending US FDA EUA approval. &lt;s&gt;428&lt;/s&gt; Date of Provisional Authorisation from HSA: 27 April 2020</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>IgM antibody immunoassay</td>\n",
       "      <td>Epitope Diagnostics</td>\n",
       "      <td></td>\n",
       "      <td>EDI Novel Coronavirus COVID-19 IgM ELISA Kit Qualitative detection of human anti-COVID- 19 IgG antibody in human serum using ELISA.</td>\n",
       "      <td>73.8% (34/42)</td>\n",
       "      <td>100% (153/153)</td>\n",
       "      <td>HSA provisional authorisation approved on 15 May 2020.&lt;s&gt;429&lt;/s&gt; CE marked.&lt;s&gt;430&lt;/s&gt; Pending EUA approval from US FDA.</td>\n",
       "      <td>90 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>2.2.4 IgG Antibody Immunoassay</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>IgG antibody immunoassay</td>\n",
       "      <td>Abbott Laboratories Inc.&lt;s&gt;431,432&lt;/s&gt; USA</td>\n",
       "      <td>15 Apr 2020</td>\n",
       "      <td>SARS-CoV-2 IgG test Lab-based serology test for the detection of IgG. Can run on ARCHITECT® i1000SR and i2000SR laboratory instruments.</td>\n",
       "      <td>Sensitivity: 0% (Less than 3 days post symptom onset), 25% (3-7 days post symptoms onset), 86.36% (8-13 days post symptoms onset), 100% (more than 14 days post symptoms onset)&lt;s&gt;433&lt;/s&gt;</td>\n",
       "      <td>Specificity: 100% (73/73)&lt;s&gt;433&lt;/s&gt;</td>\n",
       "      <td>Commercially available.  FDA EUA issued on 23/04/2020  Date of Provisional Authorisation from HSA: 30 April 2020 &lt;s&gt;434&lt;/s&gt;</td>\n",
       "      <td>(100-200 tests per hour)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>IgG Antibody immunoassay</td>\n",
       "      <td>Mount Sinai Laboratory&lt;s&gt;435&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>COVID-19 ELISA IgG &lt;s&gt;Antibody test&lt;/s&gt; ELISA performed for the qualitative detection of human IgG antibodies in serum and plasma specimens collected from individuals suspected of prior infection with the virus that causes COVID-19. Detection of IgG SARS-CoV-2 antibodies. The presence of IgG antibodies defines IgG antibody seroconversion and generally becomes detectable beginning 10-14 &lt;s&gt;days following infection.&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;92% (37/40)&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;100% (74/74)&lt;/s&gt;</td>\n",
       "      <td>Available.  EUA issued on 15th &lt;s&gt;April 2020.&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Serological tests (Antibody immunoassay test)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>IgG Antibody detection</td>\n",
       "      <td>Ortho-Clinical &lt;s&gt;Diagnostics, Inc.&lt;/s&gt;&lt;s&gt;436&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack</td>\n",
       "      <td>87.5% (42/48)</td>\n",
       "      <td>100% (407/407)</td>\n",
       "      <td>FDA EUA issued on 24/4/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>IgG Antibody detection</td>\n",
       "      <td>Diasorin Inc.&lt;s&gt;437&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>LIAISON SARS-CoV-2 S1/S2 IgG</td>\n",
       "      <td>25% (Less than 5 days from diagnosis),  89.8% (6-14 days from diagnosis),  97.56% (More than 15 days from diagnosis)</td>\n",
       "      <td>99.3% (1082/1090)</td>\n",
       "      <td>FDA EUA issued on 24/4/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>IgG Antibody detection</td>\n",
       "      <td>Epitope Diagnostics</td>\n",
       "      <td></td>\n",
       "      <td>EDI Novel Coronavirus COVID-19 IgG ELISA Kit Qualitative detection of human anti-COVID- 19 IgG antibody in human serum using ELISA.</td>\n",
       "      <td>98.4% (184/187)</td>\n",
       "      <td>99.8% (623/624)</td>\n",
       "      <td>HSA provisional authorisation approved on 15 May 2020.&lt;s&gt;438&lt;/s&gt; CE marked.&lt;s&gt;430&lt;/s&gt; Pending EUA approval from US FDA.</td>\n",
       "      <td>90 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>2.2.5 IgA/IgG antibody immunoassay</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>IgA/IgG antibody immunoassay</td>\n",
       "      <td>EUROIMMUN AG&lt;s&gt;439-441&lt;/s&gt; Germany</td>\n",
       "      <td>21 Feb 2020</td>\n",
       "      <td>&lt;s&gt;Anti-SARS-CoV-2 ELISA&lt;/s&gt; ELISA for IgG and IgA antibody detection.  S1 domain of the spike protein is used as the substrate in the ELISAs as it is considered immunogenic and is evolutionarily less conserved, leading to high specificity. &lt;s&gt;442&lt;/s&gt;</td>\n",
       "      <td>Sensitivity: 90% (27/30) Specificity: 100% (80/80)&lt;s&gt;443&lt;/s&gt;</td>\n",
       "      <td>IgG – 99% IgA – approximately 90%, not recommended for screening &lt;s&gt;444&lt;/s&gt;</td>\n",
       "      <td>Commercially available. CE-marked since 25 March 2020 &lt;s&gt;262&lt;/s&gt;</td>\n",
       "      <td>2 hours &lt;s&gt;445&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>2.2.6 Neutralising Antibodies Test</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Neutralising Antibodies test</td>\n",
       "      <td>Genscript Biotech (Singapore) Pte Ltd, in collaboration with Duke-NUS Medical School &lt;s&gt;40,41&lt;/s&gt; (Professor Wang Linfa) and A*Star DxD Hub&lt;s&gt;446&lt;/s&gt;</td>\n",
       "      <td>26 Feb 2020</td>\n",
       "      <td>SARS-CoV-2 Neutralization Antibody Detection Kit  Blocking assay intended for the qualitative detection of neutralization antibodies against SARS-CoV-2 in human serum</td>\n",
       "      <td>At a cutoff inhibition of 20%: 100% (evaluated using 77 COVID-19 patients in Singapore), 98% (evaluated using 50 COVID-19 patients in Nanjing, China)   At a cutoff inhibition of 40%: 95.6% (evaluated using 77 COVID-19 patients in Singapore), 96% (evaluated using 50</td>\n",
       "      <td>100% (75/75 in cohort done in Singapore; 50/50 in cohort done in Nanjing, China)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 8 May 2020&lt;s&gt;447&lt;/s&gt;</td>\n",
       "      <td>1-2 hours</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Serological tests (Antibody immunoassay test)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Type</td>\n",
       "      <td>Organisation</td>\n",
       "      <td>Reported</td>\n",
       "      <td>Test</td>\n",
       "      <td>Sensitivity</td>\n",
       "      <td>Specificity</td>\n",
       "      <td>Availability</td>\n",
       "      <td>Turnaround</td>\n",
       "      <td>Costs</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>COVID-19 patients in Nanjing, China)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                                              0  \\\n",
       "0                                                     Molecular tests (rRT-PCR)   \n",
       "1                                                                          Type   \n",
       "2                                                                       rRT-PCR   \n",
       "3                                                                       rRT-PCR   \n",
       "4                                                                       rRT-PCR   \n",
       "0                                                     Molecular tests (rRT-PCR)   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                                       rRT-PCR   \n",
       "4                                                                        RT-PCR   \n",
       "5                                                                        RT-PCR   \n",
       "6                                                                       rRT-PCR   \n",
       "0                                                     Molecular tests (rRT-PCR)   \n",
       "1                                                                          Type   \n",
       "2                                                                       rRT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                2.1.1 PCR Kits   \n",
       "3                                                                    RT-PCR Kit   \n",
       "4                                                                    RT-PCR Kit   \n",
       "5                                                                    RT-PCR Kit   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                                    RT-PCR Kit   \n",
       "4                                                                    RT-PCR Kit   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                                  RT-PCR assay   \n",
       "4                                                                  RT-PCR assay   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                                        RT-PCR   \n",
       "4                                                                        RT-PCR   \n",
       "5                                                                        RT-PCR   \n",
       "6                                                                        RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                                        RT-PCR   \n",
       "4                                                                        RT-PCR   \n",
       "5                                                                        RT-PCR   \n",
       "6                                                                        RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                        RT-PCR   \n",
       "3                                                       RT-PCR  [Point-of-Care]   \n",
       "4                                                                        RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                        RT-PCR   \n",
       "3                                                                        RT-PCR   \n",
       "4                                                       RT-PCR  [Point-of-Care]   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                        RT-PCR   \n",
       "3                                                       RT-PCR  [Point-of-Care]   \n",
       "4                                                                        RT-PCR   \n",
       "5                                                                        RT-PCR   \n",
       "6                                                                        RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                                        RT-PCR   \n",
       "4                                                                        RT-PCR   \n",
       "5                                                                        RT-PCR   \n",
       "6                                                                        RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                                        RT-PCR   \n",
       "4                                                                        RT-PCR   \n",
       "5                                                                        RT-PCR   \n",
       "6                                                                        RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                                        RT-PCR   \n",
       "4                                                                        RT-PCR   \n",
       "5                                                                        RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                                        RT-PCR   \n",
       "4                                                                        RT-PCR   \n",
       "5                                                                        RT-PCR   \n",
       "6                                                                        RT-PCR   \n",
       "7                                                                        RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                        RT-PCR   \n",
       "3                                                                        RT-PCR   \n",
       "4                                                                        RT-PCR   \n",
       "5                                                                        RT-PCR   \n",
       "6                                                                        RT-PCR   \n",
       "7                                                                        RT-PCR   \n",
       "8                                                                        RT-PCR   \n",
       "9                                                                        RT-PCR   \n",
       "10                                                                       RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                        RT-PCR   \n",
       "3                                                                        RT-PCR   \n",
       "4                                                                        RT-PCR   \n",
       "5                                                                        RT-PCR   \n",
       "6                                                                        RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                        RT-PCR   \n",
       "3                                                              Real-time RT-RAA   \n",
       "4                                                              Real-time RT-PCR   \n",
       "5                                                              Real-time RT-PCR   \n",
       "6                                                              Real-time RT-PCR   \n",
       "7                                                              Real-time RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                              Real-time RT-PCR   \n",
       "4                                                              Real-time RT-PCR   \n",
       "5                                                              Real-time RT-PCR   \n",
       "6                                                              Real-time RT-PCR   \n",
       "7                                                              Real-time RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                              Real-time RT-PCR   \n",
       "4                                                              Real-time RT-PCR   \n",
       "5                                                              Real-time RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                              Real-time RT-PCR   \n",
       "4                                                              Real-time RT-PCR   \n",
       "5                                                              Real-time RT-PCR   \n",
       "6                                                              Real-time RT-PCR   \n",
       "7                                                              Real-time RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                              Real-time RT-PCR   \n",
       "4                                                              Real-time RT-PCR   \n",
       "5                                                              Real-time RT-PCR   \n",
       "6                                                              Real-time RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                              Real-time RT-PCR   \n",
       "4                                                              Real-time RT-PCR   \n",
       "5                                                              Real-time RT-PCR   \n",
       "6                    Real-time PCR and microarray technologies  [Point-of-Care]   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                              Real Time RT-PCR   \n",
       "3                                                                        RT-PCR   \n",
       "4                                                                          qPCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                                          qPCR   \n",
       "4                                                         qPCR  [Point-of-Care]   \n",
       "5                                                         qPCR  [Point-of-Care]   \n",
       "6                                                          PCR-based genotyping   \n",
       "7                                                                         ddPCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                             Conventional and Real Time RT-PCR   \n",
       "3                             Combination of RT-PCR and meta-genomics detection   \n",
       "4                                                                        RT-PCR   \n",
       "5                                                                        RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                        RT-PCR   \n",
       "3                                                                        RT-PCR   \n",
       "4                                                                        RT-PCR   \n",
       "5                                                                        RT-PCR   \n",
       "6                                                                        RT-PCR   \n",
       "7                                                                        RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                                        RT-PCR   \n",
       "4                                                                        RT-PCR   \n",
       "5                                                                        RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                                        RT-PCR   \n",
       "4                                                                        RT-PCR   \n",
       "5                                                                        RT-PCR   \n",
       "6                                                                        RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                                        RT-PCR   \n",
       "4                                                              Real Time RT-PCR   \n",
       "5                                                                        RT-PCR   \n",
       "6                                                                        RT-PCR   \n",
       "7                                                                        RT-PCR   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                                        RT-PCR   \n",
       "4                                                       2.1.2 Genome Sequencing   \n",
       "5                                                                           NGS   \n",
       "6                                                                           NGS   \n",
       "7                                                             Genome sequencing   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3   End-to-end solution of sample processing to epidemiological info generation   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                           2.1.3 Microfluidics   \n",
       "4                                               Microfluidics   [Point-of-Care]   \n",
       "5                                                                  Microfluidic   \n",
       "6                                                                  Microfluidic   \n",
       "7                                                                  Microfluidic   \n",
       "8                                                                  Microfluidic   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                                  Microfluidic   \n",
       "4                                                                  Microfluidic   \n",
       "5                                                                    2.1.4 LAMP   \n",
       "6                                                         LAMP  [Point-of-Care]   \n",
       "7                                                                          LAMP   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                       RT-LAMP   \n",
       "3                                             2.1.5 Enzyme-assisted nanocomplex   \n",
       "4                                                   Enzyme-assisted nanocomplex   \n",
       "5                                                2.1.6 CRISPR-based diagnostics   \n",
       "6                                                      CRISPR-based diagnostics   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                      CRISPR-based diagnostics   \n",
       "4                                     2.1.7 Immunoassay for SARS-CoV-2 antigens   \n",
       "5                       Immunoassay for SARS-CoV-2 viral nucleoprotein antigens   \n",
       "6                                           Immunoassay for SARS-CoV-2 antigens   \n",
       "0                                                               Molecular Tests   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                          Immunoassay for SARS-CoV-2 antigens  [Point-of-Care]   \n",
       "4                                           Immunoassay for SARS-CoV-2 antigens   \n",
       "5                                                                  2.1.8 Others   \n",
       "6                                Carbohydrate-based glycation pattern detection   \n",
       "7                                                                     (no info)   \n",
       "8                                                    Target amplification assay   \n",
       "0                                 Serological tests (Antibody immunoassay test)   \n",
       "1                                                                          Type   \n",
       "2                                             2.2.1 Total Antibody Immunoassays   \n",
       "3                                            Total Antibody Immunoassay (ELISA)   \n",
       "4                                                    Total antibody immunoassay   \n",
       "5                                                    Total Antibody Immunoassay   \n",
       "6                                                    Total antibody Immunoassay   \n",
       "0                                 Serological tests (Antibody immunoassay test)   \n",
       "1                                                                          Type   \n",
       "2                                   Total Antibody immunoassay  [Point-of-Care]   \n",
       "3                                                    Total Antibody immunoassay   \n",
       "4                                            2.2.2 IgG/IgM antibody immunoassay   \n",
       "5                                          IgG/IgM antibody immunoassay (ELISA)   \n",
       "6                IgG/IgM antibody immunoassay (colloidal gold)  [Point-of-Care]   \n",
       "0                                 Serological tests (Antibody immunoassay test)   \n",
       "1                                                                          Type   \n",
       "2                                 IgG/IgM antibody immunoassay (colloidal gold)   \n",
       "3                                                  IgG/IgM antibody immunoassay   \n",
       "4                                          IgG/IgM antibody immunoassay  (CLIA)   \n",
       "5                                           IgG/IgM antibody immunoassay (CLIA)   \n",
       "0                                 Serological tests (Antibody immunoassay test)   \n",
       "1                                                                          Type   \n",
       "2                                                  IgG/IgM antibody immunoassay   \n",
       "3                                                  IgG/IgM antibody immunoassay   \n",
       "4                                                  IgG/IgM antibody immunoassay   \n",
       "5                                 IgG/IgM antibody immunoassay  [Point-of-Care]   \n",
       "6                                                  IgG/IgM antibody immunoassay   \n",
       "0                                 Serological tests (Antibody immunoassay test)   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                  IgG/IgM antibody immunoassay   \n",
       "4                                                  IgG/IgM antibody immunoassay   \n",
       "5                                                  IgG/IgM antibody immunoassay   \n",
       "6                                                  IgG/IgM antibody immunoassay   \n",
       "7                                                  IgG/IgM antibody immunoassay   \n",
       "8                                                  IgG/IgM antibody immunoassay   \n",
       "0                                 Serological tests (Antibody immunoassay test)   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                  IgG/IgM antibody immunoassay   \n",
       "4                                                  IgG/IgM antibody immunoassay   \n",
       "5                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "0                                 Serological tests (Antibody immunoassay test)   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "4                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "5                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "6                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "0                                 Serological tests (Antibody immunoassay test)   \n",
       "1                                                                          Type   \n",
       "2                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "3                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "4                                                  IgG/IgM antibody immunoassay   \n",
       "5                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "6                                                  IgG/IgM antibody immunoassay   \n",
       "0                                 Serological tests (Antibody immunoassay test)   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                  IgG/IgM antibody immunoassay   \n",
       "4                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "5                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "6                                                  IgG/IgM antibody immunoassay   \n",
       "7                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "0                                 Serological tests (Antibody immunoassay test)   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "4                                                2.2.3 IgM Antibody Immunoassay   \n",
       "5                                     IgM antibody immunoassay  [Point-of-Care]   \n",
       "6                                                      IgM antibody immunoassay   \n",
       "0                                 Serological tests (Antibody immunoassay test)   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "3                                                      IgM antibody immunoassay   \n",
       "4                                                2.2.4 IgG Antibody Immunoassay   \n",
       "5                                                      IgG antibody immunoassay   \n",
       "6                                                      IgG Antibody immunoassay   \n",
       "0                                 Serological tests (Antibody immunoassay test)   \n",
       "1                                                                          Type   \n",
       "2                                                        IgG Antibody detection   \n",
       "3                                                        IgG Antibody detection   \n",
       "4                                                        IgG Antibody detection   \n",
       "5                                            2.2.5 IgA/IgG antibody immunoassay   \n",
       "6                                                  IgA/IgG antibody immunoassay   \n",
       "7                                            2.2.6 Neutralising Antibodies Test   \n",
       "8                                                  Neutralising Antibodies test   \n",
       "0                                 Serological tests (Antibody immunoassay test)   \n",
       "1                                                                          Type   \n",
       "2                                                                                 \n",
       "\n",
       "                                                                                                                                                          1  \\\n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                Charité Institute of Virology, Berlin, Germany <s>1,99</s>   \n",
       "3                                                                                                Charité Institute of Virology, Berlin, Germany <s>1,12</s>   \n",
       "4                                                                                                                   School of Public Health, The University   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                            of Hong Kong (HKU)<s>13,14</s>   \n",
       "3                                                                               Chinese Center for Disease Control and Prevention, Beijing, China<s>100</s>   \n",
       "4                                                                             Department of Medical Sciences, Ministry of Public Health, Thailand<s>101</s>   \n",
       "5                                                                                                National Institute of Infectious Diseases, Japan<s>102</s>   \n",
       "6                                                                                      Centers for Disease Control and Prevention, Atlanta, USA<s>15,16</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                  Institut Pasteur, Paris, France<s>10</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                                Genosensor, LLC <s>103</s>   \n",
       "4                                                                                                                                 KorvaLabs Inc. <s>104</s>   \n",
       "5                                                                                                                                Genosensor, LLC <s>103</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                                 KorvaLabs Inc. <s>104</s>   \n",
       "4                                                       Shanghai Fosun Long March Medical Science Co. Ltd<s>105</s> Manufactured for: Fosun Pharma USA Inc.   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                                  Rhoenix, Inc. <s>108</s>   \n",
       "4                                                                                                                           LabGenomics Co., Ltd <s>110</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                 Bioperfectus Technologies<s>112</s> China   \n",
       "4                                                                                                                   Co-Diagnostics<s>113-</s><s>115</s> USA   \n",
       "5                                                                                                                   Altona Diagnostics<s>119,120</s>Germany   \n",
       "6                                                                                                                           Roche<s>123-126</s> Switzerland   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                               A*STAR<s>4,128</s>(Manufactured by Singapore’s MiRxes which has a nonexclusive license)<s>129</s> Singapore   \n",
       "4                                                                                                                                 PCL<s>131</s> South Korea   \n",
       "5                                                                                                                                 Biomeme<s>133,134</s> USA   \n",
       "6                                                                                                                                          Livzon<s>135</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                          Acumen Research Laboratories<s>137</s> Singapore   \n",
       "3                                                                     Cepheid<s>27,140,141</s> (Plus collaboration with Sherlock Biosciences)<s>142</s> USA   \n",
       "4                                                                                                  TIB-Molbiol<s>124,144</s>(distributed by Roche)  Germany   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                             AusDiagnostics<s>145-</s><s>147</s> Australia   \n",
       "3                                                                                                                         Seegene<s>148,149</s> South Korea   \n",
       "4                                                                                                      Credo Diagnostics Biomedical<s>154,155</s> Singapore   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                       Osang Healthcare<s>156,157</s>(partnership with Italy’s ELITech Group)  South Korea   \n",
       "3                                                                                                                      Mesa Biotech<s>28,30,160-162</s> USA   \n",
       "4                                                                                                                                 Luminex<s>163-165</s> USA   \n",
       "5                                                                                                                   LGC Biosearch Technologies<s>25,167</s>   \n",
       "6                                                                                                                   Fulgent Therapeutics, LLC<s>168</s> USA   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                              bioMérieux<s>171-173</s>(subsidiary BioFire Defense)  France   \n",
       "4                                                                                                                                 Hologic<s>175-177</s> USA   \n",
       "5                                                                                             LabCorp (Laboratory Corporation of America)<s>176,179</s> USA   \n",
       "6                                                                                                                                  Quidel<s>181,182</s> USA   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                      Quests Diagnostics<s>184,185</s> USA   \n",
       "4                                                                                                                     Abbott Molecular<s>27,186,187</s> USA   \n",
       "5                                                                                                                    DiaSorin Molecular<s>189-191</s> Italy   \n",
       "6                                                                                                                                DiaCarta<s>192,193</s> USA   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                   PerkinElmer<s>28,195,19</s><s>6</s> USA   \n",
       "4                                                                                                                           Genetron Health<s>198</s> China   \n",
       "5                                                                                                                          Mobidiag<s>199</s><s>Finland</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                   Genetic <s>Signatures Ltd</s> Australia   \n",
       "4                                                                                       Shanghai ZJ Bio-Tech Co Ltd (also called Liferiver)<s>202</s> China   \n",
       "5                                                                                                                    AITbiotech Pte Ltd<s>203</s> Singapore   \n",
       "6                                                                                                      DSO National Laboratories<s>204</s> <s>Singapore</s>   \n",
       "7                                                                                                                     Biowalker Pte Ltd<s>205</s> Singapore   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                     JN Medsys Pte Ltd<s>206</s> Singapore   \n",
       "3                                                                                                          Veredus Laboratories Pte Ltd<s>127</s> Singapore   \n",
       "4                                                                                                     Vela Operations Singapore Pte Ltd<s>208</s> Singapore   \n",
       "5                                                                                                                SPD Scientific Pte Ltd<s>209</s> Singapore   \n",
       "6                                                                                                                  PerkinElmer Singapore Pte Ltd <s>210</s>   \n",
       "7                                                                                                                        <s>BioWalker Pte Ltd</s><s>211</s>   \n",
       "8                                                                                                             Medicell Pharmaceutical (S) Pte Ltd<s>213</s>   \n",
       "9                                                                                                                   Trax management Services Inc.<s>214</s>   \n",
       "10                                                                                                Ustar Biotechnologies (Hangzhou) Co Ltd (China)<s>215</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                      CTK Biotech Inc (United States of America)<s>216</s>   \n",
       "3                                                                                                                                             PCL<s>132</s>   \n",
       "4                                                                                                                            Seasun Biomaterials <s>217</s>   \n",
       "5                                                                                                                                  bioMérieux SA <s>219</s>   \n",
       "6                                                                                                                     Bio-Rad Laboratories, Inc. <s>222</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                        Public Health England<s>224</s> UK   \n",
       "3                                                                                                                    Beijing Ditan Hospital<s>226</s> China   \n",
       "4                                                                                                         ScienCell Research Laboratories<s>227-229</s> USA   \n",
       "5                                                                                                                     Liferiver Biotech<s>230,231</s> China   \n",
       "6                                                                                                                     Liferiver Biotech<s>230,233</s> China   \n",
       "7                                                                                                                           GenScript<s>230,236,237</s> USA   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                            CerTest Biotec<s>238</s> Spain   \n",
       "4                                                                                                                                    GeneFirst<s>241</s> UK   \n",
       "5                                                                                                                                    GeneFirst<s>241</s> UK   \n",
       "6                                                                                                                  Kogene Biotech<s>131,151</s> South Korea   \n",
       "7                                                                                                            Thermo Fisher Scientific<s>133,243-245</s> USA   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                               US CDC<s>17,247,248</s> USA   \n",
       "4                                                                                                                     SolGent<s>151,152,249</s> South Korea   \n",
       "5                                                                                                                    SD Biosensor<s>151,152</s> South Korea   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                        Integrated DNA Technologies (IDT)<s>24,242</s> USA   \n",
       "4                                                                                                                  Luminex<s>164,165,253,25</s><s>4</s> USA   \n",
       "5                                                                                                                              Genomica<s>255,256</s> Spain   \n",
       "6                                                                                                                            Avellino Lab<s>257-259</s> USA   \n",
       "7                                                                            Wadsworth Center, New York State Department of Public Health<s>194,260</s> USA   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                                     NeuMoDx<s>261-263</s>   \n",
       "4                                                                                                                   Becton Dickinson (BD)<s>264-266</s> USA   \n",
       "5                                                                                                      Maccura Biotechnology<s>257,26</s><s>7,268</s> China   \n",
       "6                                                                                                                           Ipsum Diagnostics<s>269,270</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                          Gnomegen<s>271,272</s>(Subsidiary of QuestGenomics)  USA (China)   \n",
       "4                                                                                                         InBios International<s>248,273,2</s><s>74</s> USA   \n",
       "5                                                                                                                   Becton Dickinson (BD)<s>275,276</s> USA   \n",
       "6                                                                              Mobidiag<s>278</s>(collaboration with Autobio Diagnostics, China)    Finland   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                               BGI<s>279-281</s> (Pathomics Health as distributor)   China   \n",
       "3                                          CapitalBio<s>45</s>(collaboration with Tsinghua University and West China Hospital of Sichuan University)  China   \n",
       "4                                                                                     Primerdesign<s>286-291</s>(molecular diagnostics division of Novacyt)   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                 France/UK   \n",
       "3                                                                                                                     Coyote Bioscience<s>133,295</s> China   \n",
       "4                                                                                                                        Molbio Diagnostics<s>295</s> India   \n",
       "5                                                                           OnSiteGene<s>295</s>(San Diego-based subsidiary of Singapore's Star Array)  USA   \n",
       "6                                                                                                                              Genomica<s>300,301</s> Spain   \n",
       "7                                                                                                                    Bio-Rad Laboratories<s>303-305</s> USA   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                             Genekam<s>307,308</s> Germany   \n",
       "3                                                                                           BGI<s>279</s> (Pathomics Health as distributor)<s>313</s> China   \n",
       "4                                                                                                       Jiangsu Bioperfectus Technologies Co Ltd <s>314</s>   \n",
       "5                                                                                                                 TCM Biosciences<s>131,315</s> South Korea   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                             Bioneer<s>131</s> South Korea   \n",
       "3                                                                                              CEVI<s>131,317</s> (Partnership with Wells Bio)  South Korea   \n",
       "4                                                                                                                                 QuantuMDx<s>295,318</s>UK   \n",
       "5                                                                                                                             Liferiver Bio-Tech <s>319</s>   \n",
       "6                                                                                  Fast Track Diagnostics Luxembourg Sárl. (a Siemens Healthineers Company)   \n",
       "7                                                                                                                                   bioMérieux SA<s>321</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                                 OPTI Medical Systems, Inc   \n",
       "4                                                                                                                                 Zymo Research Corporation   \n",
       "5                                                                     Rutgers Clinical Genomics Laboratory at RUCDR Infinite Biologics - Rutgers University   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                           Abbott Molecular Inc.<s>326</s>   \n",
       "4                                                                                                                                      1drop Inc <s>327</s>   \n",
       "5                                                                                                                      Applied DNA Sciences, Inc.<s>328</s>   \n",
       "6                                                                                                                                GeneMatrix, Inc.<s>329</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                               Assurance Scientific Laboratories<s>330</s>   \n",
       "4                                                                                                                              Quidel Corporation<s>331</s>   \n",
       "5                                                                                                 Wuhan EasyDiagnosis Biomedicine Co Ltd (China) <s>332</s>   \n",
       "6                                                                                                                                               AMT Pte Ltd   \n",
       "7                                                                                                                                       P23 Labs <s>335</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                                                   BioCore   \n",
       "4                                                                                                                                                             \n",
       "5                                                                                                                                 IDbyDNA<s>336,337</s> USA   \n",
       "6                                                                                                                            Fulgent Genetics<s>168</s> USA   \n",
       "7                                                                                                                          Oxford Nanopore<s>338,339</s> UK   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                          Oxford Nanopore<s>338,341</s> UK   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                                                             \n",
       "4                                                                                                                       Abbott Diagnostics<s>29,343</s> USA   \n",
       "5                                                                                                              Veredus Laboratories<s>344-346</s> Singapore   \n",
       "6                                                                                                                                    Lexagene<s>350</s> USA   \n",
       "7                                                                           Shenzhen Shineway Technology<s>351,352</s>(collaboration with HKUST)  Hong Kong   \n",
       "8                                                                                                                      QIAGEN<s>353-355</s> The Netherlands   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                          GenMark Diagnostics<s>291,357,35</s><s>8</s> USA   \n",
       "4                                                                                                                                    Fluidigm<s>360</s> USA   \n",
       "5                                                                                                                                                             \n",
       "6                 HiberGene Diagnostics<s>361,362</s>(collaboration with distribution partner in Shenzhen, China, Medcaptain Medical Technologies)  Ireland   \n",
       "7                                                                                                             Atila BioSystems<s>176,363,3</s><s>64</s> USA   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                             Seasun Biomaterials<s>365</s>   \n",
       "3                                                                                                                                                             \n",
       "4                                                                                              iHealthtech<s>345,366</s>(Asst Prof Shao Huilin)   Singapore   \n",
       "5                                                                                                                                                             \n",
       "6                                                          Sherlock Biosciences<s>34,142,29</s><s>5,367</s> (Plus collaboration with Cepheid)<s>142</s> USA   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                   Mammoth Biosciences<s>32-35</s> (Partnering with UCSF Researchers)  USA   \n",
       "4                                                                                                                                                             \n",
       "5                                                                                                                 SD Biosensor <s>372</s><s>South Korea</s>   \n",
       "6                                                                                                                 SD Biosensor <s>53</s> <s>South Korea</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                      Sona Nanotech<s>373</s>(collaboration with GE Healthcare Life Sciences, The Native Antigen Company, Bond)<s>374</s><s>375</s> Canada   \n",
       "4                                                                                                                              Quidel Corporation<s>376</s>   \n",
       "5                                                                                                                                                             \n",
       "6                                                                                                                            Iceni Diagnostics<s>377</s> UK   \n",
       "7                                                                                                                       Lab Geneomics<s>131</s> South Korea   \n",
       "8                                                                                                                                   Hologic, Inc.<s>378</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                            Bio-Rad Laboratories<s>222</s>   \n",
       "4                                                                                       Beijing Wantai Biologicalpharmacy Enterprise Co Ltd<s>380</s> China   \n",
       "5                                                                                                                                Wadsworth Center<s>381</s>   \n",
       "6                                                                                                                                         Roche Diagnostics   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                 Mologic (partnership with the Institut Pasteur de Dakar)<s>386,387</s> UK   \n",
       "3                                                                                                              Ortho Clinical Diagnostics<s>390-392</s> USA   \n",
       "4                                                                                                                                                             \n",
       "5                                                              Livzon<s>135</s>(collaboration with Wuhan Institute of Virology, Chinese Academy of Science)   \n",
       "6                                                                              Mobidiag (in collaboration with Autobio <s>Diagnostics)</s><s>199</s>Finland   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                              Livzon<s>135</s>(collaboration with Wuhan Institute of Virology, Chinese Academy of Science)   \n",
       "3                                                                                                            Camtech Diagnostics Pte Ltd<s>395</s>Singapore   \n",
       "4                                Shenzhen Tisenc Medical Device<s>55</s>(collaboration with Shenzhen University and Shenzhen No.3 People’s Hospital)  China   \n",
       "5                                                                                                                      Snibe Diagnostic<s>397,398</s> China   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                       GenBody Inc (South Korea)<s>214</s>   \n",
       "3                                                                                              Healgen Scientific Limited Liability Company (USA)<s>400</s>   \n",
       "4                                                                                                                                                       PCL   \n",
       "5                                                                             BioMedomics /  Jiangsu Medomics Medical Technology<s>54,57,58</s> USA / China   \n",
       "6                                                                                                            Shenzen YHLO Biotech Co. Ltd (China)<s>401</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                     Biolidics Limited<s>403</s> Singapore   \n",
       "4                                                                                                                 Everest Links Pte Ltd<s>404</s> Singapore   \n",
       "5                                                                                                                          Grit Overseas Pte Ltd <s>405</s>   \n",
       "6                                                                                                                             CTK Biotech Inc<s>406</s> USA   \n",
       "7                                                                                                            Qingdao Hightop Biotech Co Ltd<s>407</s> China   \n",
       "8                                                                                                                        Hangzhou Realy Tech Co Ltd   China   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                             Hangzhou Clongene Biotech <s>Co Ltd</s> China   \n",
       "4                                                                                                              Hangzhou Biotest <s>Biotech Co Ltd</s> China   \n",
       "5                                                                                                         Guangzhou Wondfo Biotech<s>44-</s><s>48</s> China   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                           Hangzhou AllTest Biotech<s>81,412,413</s> China   \n",
       "4                                                                                                                              Pharmact AG<s>50</s> Germany   \n",
       "5                                                                                                            Zhejiang Orient Gene Biotech<s>51,52</s> China   \n",
       "6                                                                                                                         SD Biosensor<s>53</s> South Korea   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                              Chembio Diagnostic Systems<s>415-417</s> USA   \n",
       "3                                                                                                                                   Cellex<s>61,358</s> USA   \n",
       "4                                                                            Nankai University<s>56</s> (in collaboration with KingFocus Biomedical)  China   \n",
       "5                                                                                                      Hangzhou Laihe Biotech Co Ltd<s>419</s> <s>China</s>   \n",
       "6                                                                                                                        Shanghai LiangRun <s>420</s> China   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                         Grey Solutions Pte Ltd <s>421</s>   \n",
       "4                                                                                                      Innovation Scientific Pty Ltd (Australia) <s>314</s>   \n",
       "5                                                                                                             MP Biomedicals Asia Pacific Pte Ltd<s>422</s>   \n",
       "6                                                                                                                        Xiamen Boson Biotech Co.<s>423</s>   \n",
       "7                                                                                                    Atlaslink Beijing Technology Co Ltd (China) <s>425</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                   Healthgroup Medical Pte Ltd (Singapore)   \n",
       "4                                                                                                                                                             \n",
       "5   Guangzhou Medical University<s>11,43</s>(Dr Zhong Nanshan) In collaboration with Jiangsu Medomics Medical Technologies and many other institutes  China   \n",
       "6                                                                                                             Innovita Biological Technology<s>44</s> China   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "3                                                                                                                                       Epitope Diagnostics   \n",
       "4                                                                                                                                                             \n",
       "5                                                                                                                Abbott Laboratories Inc.<s>431,432</s> USA   \n",
       "6                                                                                                                          Mount Sinai Laboratory<s>435</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                         Ortho-Clinical <s>Diagnostics, Inc.</s><s>436</s>   \n",
       "3                                                                                                                                   Diasorin Inc.<s>437</s>   \n",
       "4                                                                                                                                       Epitope Diagnostics   \n",
       "5                                                                                                                                                             \n",
       "6                                                                                                                        EUROIMMUN AG<s>439-441</s> Germany   \n",
       "7                                                                                                                                                             \n",
       "8     Genscript Biotech (Singapore) Pte Ltd, in collaboration with Duke-NUS Medical School <s>40,41</s> (Professor Wang Linfa) and A*Star DxD Hub<s>446</s>   \n",
       "0                                                                                                                                                             \n",
       "1                                                                                                                                              Organisation   \n",
       "2                                                                                                                                                             \n",
       "\n",
       "                                    2  \\\n",
       "0                                       \n",
       "1                                Date   \n",
       "2                         13 Jan 2020   \n",
       "3                         17 Jan 2020   \n",
       "4                         16 Jan 2020   \n",
       "0                                       \n",
       "1                                Date   \n",
       "2                                       \n",
       "3                         21 Jan 2020   \n",
       "4                            Jan 2020   \n",
       "5                         23 Jan 2020   \n",
       "6                         24 Jan 2020   \n",
       "0                                       \n",
       "1                                Date   \n",
       "2                          2 Mar 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "5                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                         14 Jan 2020   \n",
       "4                         23 Jan 2020   \n",
       "5                         23 Jan 2020   \n",
       "6                         31 Jan 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                          1 Feb 2020   \n",
       "4                          3 Feb 2020   \n",
       "5                          4 Feb 2020   \n",
       "6                          4 Feb 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                          7 Feb 2020   \n",
       "3                         10 Feb 2020   \n",
       "4                         12 Feb 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                         16 Feb 2020   \n",
       "3                         18 Feb 2020   \n",
       "4                         21 Feb 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                          3 Mar 2020   \n",
       "3                          4 Mar 2020   \n",
       "4                          4 Mar 2020   \n",
       "5                         10 Mar 2020   \n",
       "6                         11 Mar 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                         11 Mar 2020   \n",
       "4                         16 Mar 2020   \n",
       "5                         16 Mar 2020   \n",
       "6                         17 Mar 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                         17 Mar 2020   \n",
       "4                         18 Mar 2020   \n",
       "5                         19 Mar 2020   \n",
       "6                         23 Mar 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                         24 Mar 2020   \n",
       "4                          7 Aor 2020   \n",
       "5                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "5                                       \n",
       "6                                       \n",
       "7                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "5                                       \n",
       "6                                       \n",
       "7                                       \n",
       "8                                       \n",
       "9                                       \n",
       "10                                      \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "5                                       \n",
       "6                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                         10 Feb 2020   \n",
       "3                         29 Jan 2020   \n",
       "4                         24 Jan 2020   \n",
       "5                         29 Jan 2020   \n",
       "6                         29 Jan 2020   \n",
       "7                         29 Jan 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                         30 Jan 2020   \n",
       "4                          3 Feb 2020   \n",
       "5                          3 Feb 2020   \n",
       "6                          3 Feb 2020   \n",
       "7                          4 Feb 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                          4 Feb 2020   \n",
       "4                         28 Feb 2020   \n",
       "5                         28 Feb 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                          3 Mar 2020   \n",
       "4                          4 Mar 2020   \n",
       "5                          6 Mar 2020   \n",
       "6                          9 Mar 2020   \n",
       "7                         10 Mar 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                         12 Mar 2020   \n",
       "4                         17 Mar 2020   \n",
       "5                         22 Mar 2020   \n",
       "6                          1 Apr 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                          6 Apr 2020   \n",
       "4                          7 Apr 2020   \n",
       "5                          8 Apr 2020   \n",
       "6                         10 Feb 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                         23 Jan 2020   \n",
       "3                         24 Feb 2020   \n",
       "4                         31 Jan 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                          4 Feb 2020   \n",
       "4                         12 Feb 2020   \n",
       "5                         12 Feb 2020   \n",
       "6                         30 Jan 2020   \n",
       "7                         19 Mar 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                          4 Feb 2020   \n",
       "3                         23 Jan 2020   \n",
       "4                         11 May 2020   \n",
       "5                          3 Feb 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                          3 Feb 2020   \n",
       "3                          3 Feb 2020   \n",
       "4                         12 Feb 2020   \n",
       "5                                       \n",
       "6                                       \n",
       "7                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "5                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "5                                       \n",
       "6                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "5                                       \n",
       "6                                       \n",
       "7                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "5                         29 Jan 2020   \n",
       "6                         11 Mar 2020   \n",
       "7                         22 Jan 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                         22 Jan 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                         27 Mar 2020   \n",
       "5                         24 Jan 2020   \n",
       "6                         27 Jan 2020   \n",
       "7                          6 Feb 2020   \n",
       "8                         10 Feb 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                         11 Mar 2020   \n",
       "4                         16 Mar 2020   \n",
       "5                                       \n",
       "6                         11 Feb 2020   \n",
       "7                         10 Apr 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                          3 Feb 2020   \n",
       "5                                       \n",
       "6                         24 Jan 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                         30 Jan 2020   \n",
       "4                                       \n",
       "5                                       \n",
       "6                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                         10 Feb 2020   \n",
       "4                                       \n",
       "5                                       \n",
       "6                         20 Mar 2020   \n",
       "7                          3 Feb 2020   \n",
       "8                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "5                                       \n",
       "6                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                         25 Feb 2020   \n",
       "3                          6 Apr 2020   \n",
       "4                                       \n",
       "5                          4 Feb 2020   \n",
       "6                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                          4 Feb 2020   \n",
       "3                                       \n",
       "4                         12 Feb 2020   \n",
       "5                         28 Feb 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "5                         21 Feb 2020   \n",
       "6                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "5                                       \n",
       "6                                       \n",
       "7                                       \n",
       "8                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "5                         20 Feb 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                          2 Mar 2020   \n",
       "4                         10 Mar 2020   \n",
       "5                         10 Mar 2020   \n",
       "6   (Webpage found as of 12 Mar 2020)   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                         20 Mar 2020   \n",
       "3                          1 Apr 2020   \n",
       "4                         17 Feb 2020   \n",
       "5                                       \n",
       "6                       27 April 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "5                                       \n",
       "6                                       \n",
       "7                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "5                         15 Feb 2020   \n",
       "6                         23 Feb 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "5                         15 Apr 2020   \n",
       "6                                       \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "3                                       \n",
       "4                                       \n",
       "5                                       \n",
       "6                         21 Feb 2020   \n",
       "7                                       \n",
       "8                         26 Feb 2020   \n",
       "0                                       \n",
       "1                            Reported   \n",
       "2                                       \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               3  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                  Primer and Probe   First line screening assay: E gene assay  Confirmatory assay: RdRp gene assay  Additional confirmatory assay: N gene assay   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                               Primer and Probe   First line screening assay: E gene assay  Confirmatory assay: RdRp gene assay   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Primer and Probe   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Assay 1 (Target: ORF1b-nsp14 gene)  Assay 2 (Target: N gene)   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Primer and Probe   Target 1 (ORF1ab gene)  Target 2 (N gene)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       With gel electrophoresis   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                  With gel electrophoresis (Nested RT-PCR)  Primer and Probe (Real-time RT-PCR)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                              Primer and Probe   3 N gene targets  1 human RNase P gene control   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                            Primer and Probe   2 RdRp gene targets with Charité’s E gene target as confirmatory   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "3                                                                                                                                                                     <s>GS COVID-19 RT-PCR Kit</s> Real-time reverse transcription polymerase chain reaction test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal/oropharyngeal swabs, nasal swabs, mid-turbinate swabs from individuals suspected of COVID-19. Positive results are indicative of the presence of SARS-CoV-2 RNA.   \n",
       "4                               Curative-Korva SARS-CoV-2 Assay  Real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in oropharyngeal (throat) swab, nasopharyngeal swab, nasal swab, and oral fluid specimens from individuals suspected of COVID-19. Results are for the detection of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                          <s>GS COVID-19 RT-PCR Kit</s> Real-time reverse transcription polymerase chain reaction test intended   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                           for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal/oropharyngeal swabs, nasal swabs, mid-turbinate swabs from individuals suspected of COVID-19. Positive results are indicative of the presence of SARS-CoV-2 RNA.   \n",
       "3                               Curative-Korva SARS-CoV-2 Assay  Real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in oropharyngeal (throat) swab, nasopharyngeal swab, nasal swab, and oral fluid specimens from individuals suspected of COVID-19. Results are for the detection of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA.   \n",
       "4                                                                                                                                                                                                                                        COVID-19 RT-PCR <s>Detection Kit</s> Real-time RT-PCR for qualitative detection of SARS-CoV-2 ORF1ab, N and E gene targets  Real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper and lower respiratory specimens (such as anterior   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                            nasal swabs, mid-turbinate nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) from individuals suspected of COVID-19. Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper and lower respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA.   \n",
       "3                                                                                                                                                                                                                                                 Rheonix COVID-19 MDx Assay<s>109</s> Qualitative detection of total nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal washes, nasal aspirates and bronchoalveolar lavage (BAL) fluid.   \n",
       "4                                                                                                                                                                                                                                                             LabGun COVID-10 RT-PCR Kit <s>111</s> Qualitative detection of total nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasopharyngeal washes, <s>nasal aspirates and sputum</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                RT-PCR test kit   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                     Logix Smart Coronavirus COVID-19 test RT-PCR kit with lower false positive   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                       RealStar SARS-CoV-2 RT- <s>PCR Kit 1.0</s>Real time RT-PCR for qualitative detection of SARS-CoV-2 RNA (target genes E gene and S gene).   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                             Cobas SARS-CoV-2 Test Runs on the Cobas 6800/8800 systems. Tests for two gene targets: ORF1ab & E.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "3                                                                                                                                                                                                                                                                                                                                                         A*STAR Fortitude 2.0 Test is based on rRT-PCR, for the qualitative detection of SARS- CoV-2 specific RNA in nasopharyngeal swab specimens.  Supports 188 tests per kit   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                    Multiplex diagnostic kit  PCLMD-nCoV one step RT-PCR kit Organisation: PCL<s>132</s> Qualitative detection of SARS-Co-V-2 by sputum samples   \n",
       "5                                                                                                                                                                                                                                                                               Shelf-stable strip with 3 reaction wells, each reaction contains lyophilized master mix, multiplexed primers, and probes for the following triplex: - 2019-nCoV-Orf1ab - 2019-nCoV-S - MS2 bacteriophage as an RNA extraction and RT-PCR control   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                           Novel coronavirus (2019-nCoV) nucleic acid diagnostic kit (PCR-fluorescence method) Detection of ORF1ab and N genes.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                          <s>Acu-Corona™ 2.0/3.0</s>With specific gene targets.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                    SAR-CoV-2 Xpert Xpress Cartridge-based nucleic acid amplification test. Tests for two gene targets: N2 & E.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                2019-nCoV Real-Time Reverse Transcription PCR Kit Tests for three gene targets: E, RdRp, and N.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                   AusDiagnostics respiratory virus panel (including SARS-CoV-2) test Multiplex panel. Tests for two gene targets: ORF1a & ORF8   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                   Allplex 2019-nCoV Assay Single-tube assay that tests for three gene targets: E, RdRp, and N.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                           VitaPCR SARS-CoV-2 Assay Runs on Credo’s VitaPCR automated point-of-care molecular testing platform.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                  GeneFinder COVID-19 Plus RealAmp Kit Tests for three gene targets: RdRp, E, and N.  Runs on all major PCR cyclers as well as on the Sample-to-Result Platform ELITe InGenius.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                              Accula SARS-Cov-2 Test Automated PCR test for the qualitative visual detection of nucleic acid from the SARS-CoV-2 virus that runs on the Accula system machines.   \n",
       "4                                                                                                                                                                                                                                                                                                                               NxTAG CoV Extended Panel Assay Multiplex panel that can be run on Luminex’s MAGPIX System together with optional NxTag Respiratory Pathogen Panel.  Tests for three gene targets: ORF1ab, E, & N   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                             2019-nCoV CDC Probe and Primer Kits for SARS-CoV-2 Lot numbers #143503 and #143764   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                       COVID-19 Virus Testing by RT-PCR  Real-time RT-PCR for the qualitative detection of SARS-CoV-2 N1 and N2   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                          genes in upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal direct swab specimens)   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                          BioFire COVID-19 test Fully automated and designed to run on FILMARRAY® 2.0 and FILMARRAY® TORCH platforms. Tests for two gene targets: ORF1ab & ORF8   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                              Panther Fusion SARS-CoV-2 Assay Test for two conserved regions of the ORF1ab gene   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                 COVID-19 RT-PCR Test Test for three gene targets: N1, N2, & N3   \n",
       "6                                                                                                                                                                                                                                                                                                            Lyra SARS-CoV-2 Assay Identification of the SARS-CoV-2 virus occurs by the use of target specific primers and fluorescent-labeled 102 probes that hybridize to a conserved region of the non-structural Polyprotein   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     (pp1ab) of the SARS-CoV-2 virus.<s>183</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Quest SARS-CoV-2 rRT-PCR Tests on two gene targets: N1 & N3   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                           Abbott RealTime SARS-CoV-2 assay Will run on the Abbott m2000 RealTime system. Tests for two gene targets: RdRp & N.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                         Simplexa COVID-19 Direct Will run on the DiaSorin’s LIAISOn MDX thermocycler.  Tests for two gene targets: S & ORF1ab.   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                              QuantiVirus SARS-CoV-2 Tests for two gene targets: N, ORF1ab, & E   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                 PerkinElmer New Coronavirus Nucleic Acid Detection Kit Tests for two gene targets: N & ORF1ab.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Detection Kit for Novel Coronavirus (SARS-CoV-2) RNA   \n",
       "5                                                                                                                                                                                                                                                                                                                <s>Amplidiag COVID-19</s> Real-time RT-PCR test with two molecular targets (orf1ab and N) including at least one conserved region and one specific region to mitigate effects of genetic drift and avoid cross-   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     reaction with other endemic coronaviruses.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                        EasyScreen™ SARS-CoV-2 Detection Kit  Real time PCR which enables qualitative detection of SARS-CoV-2 via two targets (SARS-CoV-2 N and <s>E genes)</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                               Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR Kit (Detection for 3 genes) Qualitative detection of SARS-CoV-2 by real time <s>PCR</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                   abTES™ COVID-19 qPCR I Kit Qualitative RT-PCR which detects two COVID-19 specific regions from its non-structure polypeptide   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                Real-Time PCR Assay for the Detection of SARSCoV-2 Virus  RT-PCR based on specific detection of the polymerase gene region in SARS-CoV-2 virus.   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                        Kit for Novel-Coronavirus (2019-nCoV) RNA (Isothermal Amplification-Real Time Fluorescence Assay) Detection of 2019-nCoV RNA in swab and sputum samples   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                   ProTect™ COVID-19 RT-qPCR Kit In-vitro qualitative detection of SARS-CoV-2 from samples. The test targets SARS-CoV-2 N1, N2 and N3 genes and the human RNase P control gene.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                            VereCoV™ Detection Kit  Multiplex RT-PCR/microarray-based in-vitro diagnostic test.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 ViroKey SARS-CoV-2 RT-PCR Test   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Cepheid® Xpert® Xpress SARS-CoV-2   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 PerkinElmer® SARS-CoV-2 Real-time RT-PCR Assay   \n",
       "7                                                                                                                                                                                                                                                                                                                                                    BioWalker SARS-CoV-2 Assay 2.0<s>212</s>The test  uses rRT-PCR for qualitative detection of SARS-CoV-2 nucleic acids in human nasopharyngeal or oropharyngeal swab samples.   \n",
       "8                                                                                                                                                                                                                                                                                                                                                                                                                                                     Sansure Biotech Novel Coronavirus (2019- nCoV) Nucleic Acid Diagnostic Kit   \n",
       "9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             PhoenixDx 2019-CoV   \n",
       "10                                                                                                                                                                                                                                                                                                                                                                                                          EasyNat Diagnostic Kit for Novel-Coronavirus (2019-nCoV) RNA (Isothermal Amplification-Real Time Fluorescence Assay)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Aridia COVID-19 Real-Time PCR Test   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                       PCL COVID19 Ag Rapid FIA <s>132</s> Qualitative detection of SARS-CoV-2 antigens from human oropharyngeal and <s>deep sputum samples</s>   \n",
       "4                                                                                                                                                                                                                                  <s>RT-PCR Test</s>U-TOP COVID-19 Detection Kit <s>218</s> Qualitative detection of SARS-CoV-2 antigens from oropharyngeal and nasopharyngeal swab specimens, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens and <s>sputum samples</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                           BioFire Respiratory Panel 2.1 <s>220</s> Multiplex RT-PCR test detecting SARS-CoV-2 spike (S) and membrane (M) gene.   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                               Bio-Rad SARS-CoV-2 <s>ddPCR Test</s><s>223</s> Multiplex RT-PCR test detecting SARS-CoV-2 spike (S) and membrane (M) <s>gene</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                        Real time RT-PCR (RdRp gene) assay which employs the use of two probes; one which detects 2019-nCoV, SARS-CoV and bat-SARS-related-CoVs, and the other 2019-nCoV only. The assay will be evaluated on the ABI 7500 Fast real-time PCR system.<s>225</s>   \n",
       "3                                                                                                                                                                                                                                                               Real time Reverse-Transcription Recombinase Aided Amplification (RT-RAA) assay  Novel isothermal nucleic acid amplification technique  for detection of SARS-CoV-2.   Assay was performed at 42°C within 30min using a portable real-time fluorescence detector,   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                  ScienCell SARS-CoV-2 Coronavirus Real-time RT-PCR (RT-qPCR) Detection Kit Tests for two gene targets: N1 & N2   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Fluorescent PCR<s>231</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Multiplex RT-PCR<s>233</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                                                                     qRT-PCR Targets RdRp gene, N gene and E gene in Wuhan-Hu-1   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                genome (GenBank <s>sequences NC_045512.2)</s>[same as Charite’s first protocol]   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                       VIASURE 2019-nCoV Real Time PCR Kit Amplification of a fragment of the S gene.<s>239</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Capable of detecting only the SARS-CoV-2   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                        Multiplex assay which simultaneously detects SARS-CoV-2 as well as 17 other common viruses and bacteria   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                  Powerchek 2019-nCoV Real-time PCR kit Tests for two gene targets: E and RdRp.   \n",
       "7                                                                                                                                                                                                                                                                                                          TaqPath COVID-19 Combo Kit (previously TaqMan 2019-nCoV Assay Kit) Real-time RT-PCR kit assays specifically target all 44 complete genomes currently available at GISAID, and do not target any of the 2,116 complete   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                    genomes of other coronaviruses currently available at NCBIm.  Tests for three gene targets: ORF1ab, N, & S.   \n",
       "3                                                                                                                                                                                                                                                                 Centers for Disease Control and Prevention (CDC) 2019-Novel Coronavirus (2019-nCoV) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel Tests for three gene targets: N1, N2, and N3 (subsequently removed<s>248</s>) plus 1 human RNase P gene control.   \n",
       "4                                                                                                                                                                                          DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit  Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 N, ORF1a and PCRC genes in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes, bronchoalveolar lavage (BAL) fluid and sputum.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       STANDARD M n-CoV Real-Time Detection Kit   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Tests for two gene targets: E and RdRp.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                               2019-nCoV CDC EUA Kit Follows US CDC protocol to test for 3 N gene targets, and 1 human RNase P gene as control.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                  ARIES SARS-CoV-2 Assay Tests for two gene targets: ORF1ab & N   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     qCOVID-19 Real-time RT-PCR   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                     AvellinoCoV2 test Tests for two gene targets from US CDC protocol: N1 & N3   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                                     New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel Tests for two gene targets: N1 & N2.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "3                                                                                                                                                                                                                                                                                                                                                                             NeuMoDx™ SARS-CoV-2 Assay Real-time RT-PCR for use on fully automated NeuMoDx™ 288 and 96 Molecular Systems. Tests for two gene targets: Nsp2 & N.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                BioGX SARS-CoV-2 Reagents for BD MAX System Tests for two gene targets: N1 & N2   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                   SARS-CoV-2 Fluorescent PCR Kit Tests for three gene targets: ORF1ab, N, & E.   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                COV-19 IDx assay N1 gene target   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                             Gnomegen COVID-19 RT-Digital PCR Detection Kit Tests for two gene targets: N1 & N2   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                         Smart Detect SARS-CoV-2 rRT-PCR Kit multiplex one-step rRT-PCR that can run on CFX96 Touch Real-Time PCR.  Tests for three gene targets: N, E, & ORF1b   \n",
       "5                                                                                                                                                                                                                   BD SARS-CoV-2 Reagents for BD MAX System Test is a rRT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasal, nasopharyngeal and oropharyngeal swab samples from individuals suspected of COVID-19 by their healthcare provider.  Tests for two gene targets: N1 & N2   \n",
       "6                                                                                                                                                                                                                                                                                                                   Novodiag Cartridge-based qPCR system, fully automated, allowing the rapid detection of both novel coronavirus and influenzas in around 30 minutes.  Two gene targets for SARS-CoV-2 (orf1ab and N)<s>199</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                 Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV In vitro RT-PCR combining fluorescent probing.<s>282</s> Real-time RT-PCR assay for qualitative detection of SARS-CoV-2 in throat swabs and bronchoalveolar lavage fluid (BALF).   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                   Detection of six common respiratory viruses including SARS-CoV-2 within 1.5 hours using samples of patients' oral and pharyngeal Secretions.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    Genesig Real-Time PCR COVID-19 (CE) [Previously Coronavirus (Strain 2019-nCoV) Easy/Standard Kit]<s>287</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                  Can run on multiple molecular testing platforms, including Primerdesign’s own genesig® q16 and q32 instrument   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                    2019-nCoV Prep Free QPCR Assay Runs on the Mini8 Portable Molecular Diagnostic QPCR Station (CFDA approved)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                 qPCR Truenat Beta CoV <s>296</s>Potentially real-time PCR then detection of wavelengths of fluorescent signal.   \n",
       "5                                                                                                                                                                                      Star Array 2019 Novel Coronavirus (SARS-CoV-2) Nucleic Acid Detection <s>Kit 1.0 </s> 2019-nCoV rRT-PCR kit for use on existing Peak V, that performs spatial thermal cycling using a heated liquid metal for direct amplification without the need for sample prep. Genes detected are the SARS-CoV-2 N gene and ORF1ab gene. <s>299</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                       CLART COVID-19 Based on Genomica’s CLART technology of PCR-based genotyping with low-density microarray.   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                 COVID-19 Droplet Digital PCR (ddPCR) Assay Quantitative assay for use on Bio-Rad’s QX200 and QXDx Droplet Digital PCR Systems.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                            5 options: 1. Conventional PCR 2. Real Time PCR for nCoV only<s>309</s>3. Multiplex Real Time PCR for nCoV + other Bat CoV<s>310</s>4. Multiplex Real Time PCR for nCoV + other Bat CoV + MERS<s>311</s>5. Multiplex Real Time PCR for nCoV + Influenza A<s>312</s>   \n",
       "3                                                                                                                                                                                                                                                                           2019-nCoV PMseq Kit   A metagenomics sequencing kit based on combinatorial Probe Anchor Synthesis.  Faster SARS-CoV-2 virus detection, and able to detect both known and novel microorganisms, enabling monitoring of evolution during transmission.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 COVID-19 Coronavirus Real <s>Time PCR Kit </s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                     TCM-Q Corona Ⅲ RT-PCR using SARS-CoV-2 RdRP gene and E-Sarbeco <s>gene</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                              AccuPower COVID-19 Real-Time RT-PCR kit<s>316</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                  CareGENE N-CoV RT-PCR <s>Kit</s>Real time RT-PCR kit to detect SARS-CoV-2 RdRP and E genes in human nasopharyngeal swab, oropharyngeal swab and <s>sputum</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                     (SARS-CoV-2 Detection RT-PCR Testing kit. Detect SARS-CoV-2 in human oropharyngeal and nasopharyngeal swab   \n",
       "5                                                                                                                                                                                                                                                                                                                 Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR Kit Test  is used for the in vitro qualitative detection of 2019-nCoV RNA in upper respiratory tract specimens and lower respiratory tract specimens.   \n",
       "6                                                                                                                                                                                                                                                                                                                                             FTD SARS-CoV-2. Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal swabs, nasopharyngeal swabs, nasopharyngeal wash and bronchoalveolar lavage.   \n",
       "7                                                                                                                                                                                                                                                                                                                                                     ARGENE®  SARS-CoV-2 R-gene test Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                        swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes and bronchoalveolar lavage (BAL) fluid.   \n",
       "3                                                                                                                                                                                                         OPTI SARS-CoV-2 RT-PCR Test Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in upper and lower respiratory specimens (such as nasal, nasopharyngeal, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate).   \n",
       "4                                                                                                                                                                                                        Quick SARS-CoV-2 rRT-PCR Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in upper and lower respiratory specimens (such as nasal, nasopharyngeal, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate).   \n",
       "5                                                                                                                                                                                                                                                                                     Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal swab, mid-turbinate nasal swab, and   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     bronchoalveolar lavage <s>(BAL) fluid.</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                       Alinity m SARS-CoV-2 assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, nasal swabs, and bronchoalveolar lavage (BAL) fluid   \n",
       "4                                                                                                                                                                                                                                          1 copy™ covid-19 qPCR multi kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 E and <s>326</s>RdRp gene in nasopharyngeal, oropharyngeal, anterior nasal, mid-turbinate nasal swab specimens as well as nasopharyngeal wash/aspirate and nasal aspirate specimens.   \n",
       "5                                                                                                                                                                                                                                                                                   Linea™ COVID-19 Real Time PCR Assay Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal, oropharyngeal and nasal swab specimens as well as nasopharyngeal wash/aspirate and nasal aspirate specimens.   \n",
       "6                                                                                                                                                                                                                                                                                                                                      NeoPlexTM COVID-19 Detection Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal, oropharyngeal and nasal swab specimens as well as nasopharyngeal   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    wash/aspirate and nasal aspirate specimens.   \n",
       "3                                                                                                                                                                                                                                                                                                                                    Assurance SARS-CoV-2 Panel Real-time RT-PCR for the qualitative detection of SARS-CoV-2 E, N1 and N2 genes in upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal swabs).   \n",
       "4                                                                                                                                                                                                                                                                                                                                                Lyra® Direct SARS-CoV-2 Assay Real-time RT-PCR for the qualitative detection of SARS-CoV-2 RNA in upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal swabs).   \n",
       "5                                                                                                                                                                                                                                                                          COVID-19 (SARS-CoV-2) Nucleic Acid Test kit Real-time RT-PCR test kit, intended for the qualitative detection of nucleic acid from the SARS-CoV-2, in upper and lower respiratory tract specimens. Gene targets are the SARS-CoV-2 N and ORF1ab gene.   \n",
       "6                                                                                                                                                                                                                                                                                  AMT RESOLUTE 1.0 Real-time RT-PCR for the qualitative detection of SARS-CoV-2 RNA. RNA extraction is not required as this kit is intended for direct amplification of SARS-CoV-2 RNA from nasopharyngeal swabs in universal transport medium.   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                    P23 Labs TaqPath SARS-CoV-2 Assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab,   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                      anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens as well as bronchoalveolar lavage (BAL) specimens.   \n",
       "3                                                                                                                                                                                           BioCore 2019-nCoV Real Time PCR Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 N and RdRp genes in upper respiratory specimens (such as nasal, mid-turbinate, oropharyngeal, and nasopharyngeal swabs) and lower respiratory specimens (such as sputum, bronchoalveolar lavage (BAL), and tracheal aspirates).   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "5                                                                                                                                                                                                                                                                                                                                                                           Next-generation sequencing-based metagenomics, allows enhanced pathogen detection and profiling in comparison to conventional PCR testing.<s>337</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                           Kiloplex PCR Plus NGS Next-generation sequencing using thousands of PCR primers to amplify sample viral genetic material before sequencing on the Illumina platform.   \n",
       "7                                                                                                                                                                                                                                                                                                                                                         Works with public health labs globally to support rapid sequencing of SARS-CoV-2 through sharing of methods / workflows.   Nanopore sequencing workflows can provide a   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                               consensus viral genome from sample within a day.   \n",
       "3                                                                                                                                                                      ARTIC project  A ‘lab-in-a-suitcase’ solution for processing samples from viral outbreaks, to generating real-time epidemiological information interpretable and actionable by public health bodies.  Deployable to remote/resource-limited locations.  Based on viral genome data generated prospectively during similar outbreaks (eg. MERS, SARS etc).   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                  Relies on direct amplification of the virus using tiled, multiplexed primers.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                    ID Now COVID-19 test Automated assay that runs on Abbott’s ID Now platform.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                              VereCoV  Lab-on-Chip platform integrating PCR and microarray  Claims to detect MERS-CoV, SARS-CoV and SARS-CoV-2 in a single test   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Genetic analyser using microfluidic technology   \n",
       "7                                                                                                                                                                                                                                 Novel silicon-based micro-heater, which has lower thermal mass and a better thermal conductivity, could speed up temperature rises to around 30<s>o</s>C per second, greatly reducing the detection time compared to conventional PCR devices which has an average of 4-5<s>o</s>C per second.   \n",
       "8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 QIAStat-Dx Respiratory SARS-CoV-2 Panel [Plus]   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                              Tests for two gene targets: ORF1b recommended by the Chinese CDC and N recommended by the US CDC.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                       ePlex SARS-CoV-2 Automated single cartridge using digital microfluidics.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                          Aimed at using Fluidigm's Biomark HD system and microfluidics technology, to develop integrated fluidic circuits for parallel assays.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                     Loop-mediated isothermal amplification (LAMP)-based Coronavirus test Allows for rapid near-patient testing   \n",
       "7                                                                                                                                                                                                                                                                                            iAMP COVID-19 Detection Kit Real-time fluorescent reverse transcription isothermal amplification without requiring RNA extraction and can run up to 94 samples simultaneously.<s>363,364</s>Tests for two gene targets: N & ORF1ab.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                       AQ-TOP™ COVID-19 Rapid Detection Kit RT-LAMP test designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens, bronchoalveolar lavage (BAL) specimens as well as sputum.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                         enVision (enzyme-assisted nanocomplexes for visual identification of nucleic acids) Uses enzyme-assisted nanocomplexes   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "6   SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing)  SHERLOCK platform uses various CRISPR proteins (Cas13, Cas12a, and Csm6) to allow for simultaneous detection of multiple nucleic acids.<s>142</s> Designed to detect RNA from upper respiratory specimens (such as nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, nasopharyngeal wash/aspirate or nasal aspirate) and bronchoalveolar lavage specimens. Step one is a reverse transcriptase loop-mediated amplification (RT-LAMP) where targeted   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                              SARS-CoV-2 genomic RNA is reverse transcribed to DNA, and this DNA is amplified by a strand-displacing DNA polymerase. Step two is the transcription of the amplified DNA to activate the collateral cleavage activity of a CRISPR complex programmed to the target RNA sequence.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                  SARS-CoV-2 DNA Endonuclease-Targeted CRISPR Trans Reporter (DETECTR) Using the CRISPR Cas12 that cleaves a FAM-Biotin reporter molecule. Tests for two gene targets:  E & N2.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "5                                                                                                                                                                                                                                                                                                                         STANDARD F COVID-19 Ag FIA Fluorescent immunoassay to detect SARS-CoV-2 infection in human nasopharyngeal swab specimen by identifying the existence of SARS-CoV-2 <s>viral nucleoprotein antigens</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                             STANDARD Q COVID-19 Ag  Rapid chromatographic immunoassay for the qualitative detection of specific antigens to SARS-CoV-2 present in the human <s>nasopharynx</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "3                                                                                                                                                                                                                                                                                                                                                 Proprietary nanotechnology  lateral flow test using antigens specific to SARS-CoV-2 produced at Native's Oxford facility using proprietary mammalian VirtuE expression system.   \n",
       "4                                                                                                                                                                                                                                                               Sofia 2 SARS Antigen FIA Lateral flow immunofluorescent sandwich assay that is used with the Sofia 2 instrument intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal (NP) and nasal (NS) swab specimens.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                       Carbohydrate-based, lateral flow assay for detection of glycation patterns of SARS-CoV-2   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      (no info)   \n",
       "8                                                                                                                                                                                                              Aptima® SARS-CoV-2 Assay (Panther® System) Nucleic acid amplification in vitro diagnostic test designed to qualitatively detect RNA from SARS-CoV-2 isolated and purified from nasopharyngeal (NP), nasal, mid-turbinate and oropharyngeal (OP) swab specimens, nasopharyngeal wash/ aspirate or nasal aspirates.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "3                                                                                                                                                                                                                                                                                                                                                  <s>ELISA Total Antibodies</s>Platelia SARS-CoV-2 Total Antibody Assay<s>379</s> Qualitative detection of total antibodies to SARS-CoV-2 in human serum and plasma <s>EDTA</s>   \n",
       "4                                                                                                                                                                                                                                                                            Wantai SARS-CoV-2 Ab Rapid Test Kit  Rapid qualitative detection of total antibodies against SARS-CoV-2 in human serum, plasma or whole blood specimens, employing chromatographic lateral flow device in a cassette format <s>(colloidal gold)</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                            New York SARS-CoV Microsphere Immunoassay for Antibody Detection <s>382</s> Qualitative detection of total antibodies to SARS-CoV-2 in human serum.   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                            Elecsys Anti-SARS-CoV-2<s>383</s> Immunoassay for qualitative detection of antibodies to SARS-CoV-2   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                           Lateral flow immunoassay for detection of antibodies for SARS-CoV-2.   \n",
       "3                                                                                                                                                                                                                                                                                                        VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack Runs on VITROS ECi/ECiQ/3600 Immunodiagnostic System and the VITROS 5600/XT 7600 Integrated Systems.  Can run up to 150 samples per hour.<s>392</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "5                                                                                                                                                                                                                                                                                                                                           Diagnostics kit for IgM/IgG antibody to novel coronavirus (ELISA) Indirect method for ELISA for in vitro qualitative detection of antibodies to SARS-CoV-2 in human serum or plasma.   \n",
       "6                                                                                                                                                                                                                                                                                                  Anti-SARS-CoV-2 Rapid <s>Test</s> Immunoassay Anti-SARS-CoV-2 Rapid Test is based on a colloidal gold method for the rapid, qualitative determination of SARS-CoV-2 IgG/IgM antibodies in human serum, plasma or whole blood.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                 Diagnostics kit for IgM/IgG antibody to novel coronavirus (colloidal gold) Immunochromatography assay for in vitro qualitative detection of antibodies to SARS-CoV-2 in human serum or plasma.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                  Camtech COVID-19 IgM/IgG Immunoassay kit for the rapid and differential detection of IgG and IgM against COVID-19 using serum, plasma and whole <s>blood.</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                             2019 Novel Coronavirus <s>IgM kit (CLIA)</s>2019 Novel Coronavirus <s>IgG kit (CLIA)</s>Chemiluminescence antibody test kit using serum or plasma.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                  Maglumi 2019-nCoV (SARS-CoV-2) IgM/IgG kits Fully automated CLIA using 10μL sample volume of serum or plasma.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                              GenBody COVID-19 <s>IgM/IgG</s> Point-of-care chromatographic immunoassay kit for the rapid and differential detection of anti-SARS-CoV-2 IgM and IgG using serum, plasma and whole blood from capillary blood samples.<s>214</s>   \n",
       "3                                                                                                                                                                                                                                                                                                            COVID-19 Antibody Rapid Detection Kit<s>400</s> Rapid test for the qualitative, differential detection of both anti-SARS-CoV-2 IgM and IgG antibodies from whole blood, serum and plasma, using lateral flow method   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                     PCL COVID19 IgG/IgM Rapid Gold<s>132</s> Qualitative detection of COVID-19 IgG/IgM antibodies using lateral flow technique   \n",
       "5                                                                                                                                                                                                                                                                                                                                                               COVID-19 IgM/IgG Rapid Test   Lateral flow immunoassay with both IgM and IgG antibodies adhered using colloidal gold.  Can be used with fingerstick whole blood.   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                     iFlash 8000 CLIA analyser<s>402</s> Fully Automated chemiluminescent immunoassay for anti-   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      SARS-CoV-2 IgM and IgG <s>antibodies.</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                         Nanjing Vazyme 2019-nCoV IgG/IgM Detection <s>Kit</s><s>Also marketed as</s>Biolidics 2019-nCoV IgG/IgM Detection Kit Detection of 2019-nCoV IgG and IgM in human serum, <s>plasma and whole blood</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                        VivaDiag™ COVID-19 IgM/IgG Rapid Test In vitro diagnostic test for the qualitative determination of COVID-19’s igM and IgG antibodies in human blood, serum and plasma.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                               DiagnoSure COVID-19 IgG/ IgM Rapid Test Cassette   \n",
       "6                                                                                                                                                                                                                                                                                                                                                             OnSite COVID-19 IgG/IgM Rapid Test  Designed for initial screening by detecting anti-SAR-CoV-2 IgG and IgM antibodies in human serum, <s>plasma or whole blood</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                        SARS-CoV-2 IgM/lgG Antibody Rapid Test  Qualitative detection of SARS-CoV-2 IgG and IgM antibodies in human serum, plasma or whole blood <s>samples</s>   \n",
       "8                                                                                                                                                                                                                                                                                                                                                                                                                                                2019-nCOV/COVID-19 <s>IgG/IgM Rapid Test Device</s> <s>Lateral flow IgG/IgM</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "3                                                                                                                                                                                                                                                                                                                                          COVID-19 IgG/IgM Rapid <s>Test Cassette</s> Rapid point-of-care lateral flow chromatographic immunoassay for the qualitative detective of IgG and IgM antibodies to <s>SARS-CoV-2</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                               COVID-19 IgG/IgM Rapid <s>Test Cassette</s> Rapid chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2 in human whole blood, serum or <s>plasma</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                               Wondfo SARS-CoV-2 Antibody Test (Lateral Flow Method)  Colloidal gold method for IgM and IgG antibody detection.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "3                                                                                                                                                                                                                                                                                                                           2019-nCoV IgG/IgM Rapid Test Cassette Lateral flow chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2 in human whole blood, serum or plasma specimen.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                  CoV-2 Rapid Test Using drops of blood from fingerstick onto test cassette, with two drops of buffer solution.   \n",
       "5                                                                                                                                                                                                                                                                                                                                           COVID-19 IgG/IgM Rapid Test Solid phase immunochromatography assay for rapid qualitative detection of IgG and IgM antibodies to SARS-CoV-2 using human whole blood, serum or plasma.   \n",
       "6                                                                                                                                                                                                                                                                                                                                                   STANDARD Q COVID-19 IgM/IgG Duo Immunochromatography assay for rapid qualitative detection of IgG and IgM antibodies to SARS-CoV-2 using human whole blood, serum or plasma.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                            DPP COVID-19 IgM/IgG System Lateral flow assay testing for IgM and IgG, to be read using the DPP Micro Reader or DPP Micro Reader 2 (not visually).   \n",
       "3                                                                                                                                                                                                                                    qSARS-CoV-2 IgG/IgM Rapid Test For “aid in the diagnosis of patients with suspected SARS-CoV-2 infection in conjunction with clinical presentation and the results of other laboratory tests.”<s>61</s>Can be used with serum, plasmas, or whole blood from venepuncture (not fingerstick).   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Novel Coronavirus (2019-nCoV) IgM/IgG antibody detection kit   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                             Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold)  POCT rapid SARS-CoV-2 <s>IgM/IgG antibody test</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                      LionRun Diagnostic Kit for Antibody IgM-IgG of Novel Coronavirus COVID-19   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                        An in vitro diagnostic test for the qualitative and differential detection of IgM and IgG antibodies against SARS-CoV-2   \n",
       "3                                                                                                                                                                                                                                                                                                                            i-Test COVID -19 IgM/IgG Antibody Rapid Test (Colloidal Gold)  The test is an in-vitro qualitative determination of Novel coronavirus (COVID2019) Antibody in human serum or plasma or whole blood.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                    InnoScreen COVID-19 IgG/IgM Rapid Test Lateral Flow IgG/IgM [Point-of-care]   \n",
       "5                                                                                                                                                                                                                                                                                             MP Diagnostics ASSURE® SARS-CoV-2 IgG/IgM Rapid Test Qualitative in vitro immunochromatographic test to detect and differentiate IgG/IgM antibodies against SARS- CoV-2 in human plasma, serum or whole blood with anti-coagulants   \n",
       "6                                                                                                                                                                                                                                                                                         Xiamen Boson Rapid 2019-nCOV IgG/IgM Combo Test Card Immunochromatography for the rapid qualitative determination of IgG and IgM antibodies to 2019 novel coronavirus (2019- nCoV, SARS-CoV- 2) in human serum, plasma, or whole blood   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                      NOVA Test® COVID-19 IgG/IgM Antibody Test (Colloidal Gold) Qualitative detection of IgG/IgM antibodies to   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                              SARS-CoV-2 in human serum, plasma or whole blood.   \n",
       "3                                                                                                                                                                                                                                                                                         HealthGroup Medical V-CODE Sars-CoV-2 (COVID-19) IgG/IgM Rapid Test Lateral flow immunoassay for the qualitative detection and differentiation of IgG and IgM of Novel Coronavirus (SARS-CoV-2) in human whole blood, serum or plasma.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "5                                                                                                                                                                                                                                                                                                                                           SARS-CoV-2 rapid IgG-IgM combined antibody kit <s>(colloidal gold)</s> In-vitro detection of IgG/IgM antibodies using lateral flow <s>immunoassay techniques</s><s>427</s>,<s>57</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                  2019-nCoV Antibody Test <s>(colloidal gold)</s> IgG and IgM antibody detection from venous whole blood/ plasma/ serum samples   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                            EDI Novel Coronavirus COVID-19 IgM ELISA Kit Qualitative detection of human anti-COVID- 19 IgG antibody in human serum using ELISA.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                        SARS-CoV-2 IgG test Lab-based serology test for the detection of IgG. Can run on ARCHITECT® i1000SR and i2000SR laboratory instruments.   \n",
       "6                                                                                          COVID-19 ELISA IgG <s>Antibody test</s> ELISA performed for the qualitative detection of human IgG antibodies in serum and plasma specimens collected from individuals suspected of prior infection with the virus that causes COVID-19. Detection of IgG SARS-CoV-2 antibodies. The presence of IgG antibodies defines IgG antibody seroconversion and generally becomes detectable beginning 10-14 <s>days following infection.</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                              VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   LIAISON SARS-CoV-2 S1/S2 IgG   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                            EDI Novel Coronavirus COVID-19 IgG ELISA Kit Qualitative detection of human anti-COVID- 19 IgG antibody in human serum using ELISA.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "6                                                                                                                                                                                                                                                                    <s>Anti-SARS-CoV-2 ELISA</s> ELISA for IgG and IgA antibody detection.  S1 domain of the spike protein is used as the substrate in the ELISAs as it is considered immunogenic and is evolutionarily less conserved, leading to high specificity. <s>442</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "8                                                                                                                                                                                                                                                                                                                                                         SARS-CoV-2 Neutralization Antibody Detection Kit  Blocking assay intended for the qualitative detection of neutralization antibodies against SARS-CoV-2 in human serum   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Test   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                            4  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2   First line screening assay  Technical LOD: 5.2 RNA copies/reaction, at 95% hit rate  95% CI: 3.7-9.6 RNA copies/reaction.  Confirmatory assay Technical LOD: 3.8 RNA copies/reaction, at 95% hit rate 95% CI: 2.7-7.6 RNA copies/reaction.  Additional confirmatory assay Technical LOD: 8.3 RNA copies/reaction, at 95% hit rate;  95% CI: 6.1-16.3 RNA copies/reaction.   \n",
       "3                       First line screening assay  Technical LOD: 5.2 RNA copies/reaction, at 95% hit rate  95% CI: 3.7-9.6 RNA copies/reaction.  Confirmatory assay Technical LOD: 3.8 RNA copies/reaction, at 95% hit rate 95% CI: 2.7-7.6 RNA copies/reaction.  (Preliminary experiment compared single probe assay for SARS-CoV with single probe assay for SARS-CoV-2.)   \n",
       "4                                                                                                                                                                                                                                                                        Positive control using SARS-CoV RNA Wide dynamic range of 2<s>-4</s> to 2000 TCID<s>50</s>/reaction.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                               100 or more copies of RNA genome equivalent per reaction always detected.  Samples containing 10 copies of RNA genome could be detected with multiplex assay.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                                         <s>100% (32/32)</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                  100% (5/5)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                         <s>100% (32/32)</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                                                  100% (5/5)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                  99.51% (203/204)<s>106</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                                              100%<s>109</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                      100% (50/50)<s>111</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                      100% (21/21)<s>116</s>   \n",
       "5                                                                                                                                                                                                                                                                                                      95% (24/25) detection for S gene;   100% (25/25) detection for E gene.   \n",
       "6                                                                                                                                                                                                                                            100% (50/50)  50 nasopharyngeal swab clinical samples spiked with cultured SARS-CoV-2 virus Low (1.5x LoD) and moderate (4x LoD)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                       contrived positive samples <s>126</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                              100%<s>130</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                        Sensitivity: 100% (35/35) <s>132</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "3                                                                                                                                                                                                                                   100% (30/30)  30 nasopharyngeal swab specimens were spiked with SARS-CoV- (2x to 5x LoD) serving as contrived positive samples.<s>141</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                              100%<s>147</s>   \n",
       "3                                                                                                                                                                                                                       100% (49/49) from upper respiratory specimens (nasopharyngeal/ oropharyngeal swabs)  100% (49/49) from lower respiratory specimens (sputum)<s>150</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                     100% for both upper and lower respiratory tract samples   Evaluated using 30 nasopharyngeal swabs (upper respiratory tract) and sputum (lower respiratory tract) specimens spiked with SARS-CoV-2 virus (1x to 4x LoD) serving as contrived positive samples <s>158</s>   \n",
       "3                                                                                                                                                                                                                                           100% (30/30)  30 nasopharyngeal swabs spiked with SARS-CoV-2 RNA (2x to 50x LoD) serving as contrived positive samples.<s>162</s>   \n",
       "4                                                                                                                                                                                                                               100% (30/30)  30 nasopharyngeal swabs spiked with purified SARS-CoV-2 viral genomic RNA (2x to 5x LoD) serving as contrived positive samples.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                         <s>100% (30/30)</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                     100% (30/30)  30 nasopharyngeal swab specimens were spiked with live SARS-CoV-2 virus (1x to 100x LoD) serving as contrived positive samples.<s>174</s>   \n",
       "4                                                                                                                                                                                           100% (69/69)  69 remnant clinical nasopharyngeal specimens were spiked with inactivated cultured SARS-CoV-2 virus (1x to 5x LoD) serving as contrived positive samples.<s>177</s>   \n",
       "5                                                                                                                                                                         100% (80/80)  40 nasopharyngeal swab specimens and 40 bronchoalveolar lavage specimens were spiked with quantitated live SARS-CoV-2 (1x to 8x LoD) to form 80 contrived positive samples.<s>179</s>   \n",
       "6                                                                                                                                                                                                                              100% (92/92)  92 nasopharyngeal swab specimens were spiked with SARS-CoV-2 RNA (1x to 5x LoD) serving as contrived positive samples.<s>182</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                          100% (30/30)  12 pairs of nasopharyngeal swab and sputum specimens from actual COVID-19 patient formed 24 samples, together wiith 6 additional randomly selected to be duplicated, serving as total 30 positive samples.<s>185</s>   \n",
       "4                                                                                                                                                            100% (60/60)  61 nasopharyngeal swabs spiked with  recombinant virus containing SARS-CoV-2 RNA sequences (1x to 20x LoD) serving as contrived positive samples. 1 sample was invalidated and excluded.<s>187</s>   \n",
       "5                                                                                                                                                                                                                100% (52/52)  108 fresh nasopharyngeal swab specimens from 3 clinical site2s were compared with one of two brands of established comparator assay.<s>191</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                       96.7%   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                           Clinically validated in the company's CLIA-certified lab in Richmond, California.   \n",
       "3                                                                                                                                                                                                   100% (47/47)  47 oropharyngeal and nasopharyngeal swab specimens spiked with inactivated SARS-CoV-2 virus (1x to 5x LoD) serving as contrived positive samples.<s>196</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                       High sensitivity and specificity, no statistics given   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                               \n",
       "4                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "8                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "9                                                                                                                                                                                                                                                                                                                                                                100% (30/30)   \n",
       "10                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                       95.1%   \n",
       "3                                                                                                                                                                                                                                                                                                                                                           Sensitivity: 100%   \n",
       "4                                                                                                                                                                                                                                                                                                                         100% (for both nasopharyngeal and sputum)<s>218</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                 98% (48/49)   \n",
       "6                                                                                                                                                                                                                                               94.87% (37/39, analysis done after Thermo MagMAX extraction); 94.59% (35/37, analysis done after QIAamp viral RNA extraction)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "3                                                                                                                                                                                                                                                               (Recombinant plasmids containing conserved ORF1ab genes was used to analyse the specificity and sensitivity.)   \n",
       "4                                                                                                                                                                                                                              100% (30/30)  30 nasopharyngeal swabs spiked with SARS-CoV-2 RNA (not actual clinical sample) serving as contrived positive samples.<s>228</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                          “This assay is RUO and has not been tested on clinical samples. We   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                make no claims on the performance of this assay.” <s>236</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                             97.5%<s>240</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "7                                                                                                                                                                                                            100% (60/60)  30 nasopharyngeal swab specimens and 30 bronchoalveolar lavage specimens were spiked with extracted SARS-CoV-2 viral genomic RNA (2x to 5x LoD) to   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                               form 60 contrived positive samples.<s>245</s>   \n",
       "3                                                                                                                                                                                                     100% (!3/13)  117 respiratory specimens collected from 46 subjects tested with two analytically validated real-time RT-PCR assays for N4 and N5 gene targets.<s>247</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                        100%   \n",
       "5                                                                                                                                                                                                                                                                                                                                         Sensitivity: 100% (30/30)<s>251</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "4                                                                                                                                                                                                                     100% (30/30)  30 nasopharyngeal swabs spiked with purified SARS-CoV-2 viral genomic RNA (2x to 5x LoD) serving as contrived positive samples.<s>254</s>   \n",
       "5                                                                                                                                                                                                                                                               Reported 100%.<s>255</s> Tested at the Carlos III Health Institute with 80 samples (unclear of sample types).   \n",
       "6                                                                                                                                                                                                   100% (30/30)  30 oropharyngeal and nasopharyngeal swab specimens spiked with whole SARS-CoV-2 viral RNA (1x to 100x LoD) serving as contrived positive samples.<s>259</s>   \n",
       "7                                                                                                                                                                                                                                     (42/43)  For the easyMAG extraction, 43 individual sputum samples were spiked with the extracted whole SARS-CoV-2 virus genomic RNA (2x   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                          to 200x LoD) to serve as contrived positive samples. Testing was also done with eMAG and EZ1 extraction.<s>260</s>   \n",
       "3                                                                                                                                                                                                             100% (87/87)  87 clinical nasopharyngeal swab specimens were spiked with SARS-CoV-2 genomic RNA (1x to 8x LoD) serving as contrived positive samples.<s>263</s>   \n",
       "4                                                                                                                                      100% (29/29)  30 retrospective collected clinical nasopharyngeal swab specimens spiked with quantified genomic RNA of SARS- CoV-2 (1x to 5x LoD) serving as contrived positive samples. 1 sample removed from data analysis.<s>264</s>   \n",
       "5                                                                                                                              100% (30/30)  15 nasopharyngeal and 15 oropharyngeal swab samples from suspected cases that tested negative had additional aliquot spiked with SARS-CoV-2 whole genomic RNA (2x to 5x LoD) serving as 30 contrived positive samples.<s>268</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                       100% (36/36)  36 nasopharyngeal swabs spiked with BEI   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                              ATCC Genomic RNA from SARS Related Coronavirus 2 (not actual clinical sample) serving as contrived positive samples.<s>270</s>   \n",
       "3                                                                                                                                                                                                                      100% (30/30)  30 oropharyngeal swabs spiked with quantified SARS-CoV-2 whole viral RNA (1x to 5x LoD) serving as contrived positive samples.<s>272</s>   \n",
       "4                                                                                                                                                                                                                              100% (30/30)  30 nasopharyngeal swabs spiked with SARS-CoV-2 viral genomic RNA (1x to 5x LoD) serving as contrived positive samples.<s>273</s>   \n",
       "5                                                                                                                                                                                     96% (48/50)  50 retrospective collected clinical nasopharyngeal swabs spiked with quantified genomic RNA of SARS- CoV-2 (1x to 5x LoD) serving as contrived positive samples.<s>276</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                           BALF: 81% Throat Swab: 91.2% RNA: 97.1% Combined: 88.1%<s>283</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                               96%<s>292</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                             100% <s>297</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                              >96%<s>302</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                    Reported enhanced sensitivity.<s>304</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                 <s>100%</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                        100%   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                100% (44/44)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                100% (76/76)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                             100% in both sputum and NP swab   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                100% (30/30)   \n",
       "5                                                                                                                                                                                                                                                                                                   100% for nasopharyngeal and oropharyngeal swabs (30/30) as well as saliva   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                                                100% (31/31)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                100% (30/30)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                 98% (62/63)   \n",
       "6                                                                                                                                                                                                                                                                                                           100% for nasopharyngeal, oropharyngeal and sputum samples (40/40)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                     100% (38/38 using samples extracted with Abnova Precipitor; 34/34 using samples extracted with Zymo Research Kit <s>on the IndiMag)</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                 97% (29/30)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                100% (31/31)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                   100% (20/20) for both nasopharyngeal and sputum specimens   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                               \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                           Undergoing validation by joint venture Fujian Fujun Gene Biotech.   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                             Not stated but described to have high sensitivity compared to metagenomic approaches.<s>342</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                                                               \n",
       "4                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                            Stated to be high but with no accompanying statistics.<s>347</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "8                                                                                                                                                                                                                                                                                                                                                                100% (30/30)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                     Evaluated using 10 positive clinical samples and 20 low positive contrived samples (1x–2x LOD) from retrospective nasopharyngeal swab clinical specimens in transport medium.<s>355</s>   \n",
       "3                                                                                                                                                                                                                 100% (17/17)  65 fresh nasopharyngeal swab specimens from 3 clinical site2s were compared with one of two brands of established comparator assay.<s>291</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                               \n",
       "6                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "7                                                                                                                                                                                                  100% (35/35)  35 oropharyngeal swabs from healthy individuals spiked with iAMP COVID-19 Sample Buffer Mix (2x to 10x LoD) serving as contrived positive samples.<s>363</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                   100% (20/20) for both nasopharyngeal and sputum specimens   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                               \n",
       "4                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                               \n",
       "6                                                                                                                                                                                                                                                                                                                                                                100% (30/30)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                             95% (Using contrived reference samples and clinical samples from US patients, including 36 patients with COVID-19 infection and 42 patients with other viral respiratory infections)  (Press release:<s>371</s> Study:<s>35</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                               \n",
       "5                                                                                                                                                                                                                                                                                                                                   Higher sensitivity than <s>rapid test</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                100% (47/47)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                               \n",
       "6                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "8                                                                                                                                                                                                                                                                                                                                                               98.2% (54/55)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                             100% in Serum, 83.33% in Plasma   \n",
       "4                                                                                                                                                                                                                                           96.6% (131/137)  Evaluated using 137 specimens from confirmed COVID-19 patients and 209 specimens from healthy <s>individuals</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                              88.0% (95/108)   \n",
       "6                                                                                                                                                                                                                               65.5% (76/116, Day 0-6 post-PCR confirmation); 88.1% (52/59, Day 7-13 post-PCR confirmation); 100% (29/29, >/= 14 days post-PCR confirmation)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                      98% at days 14-21 <s>388</s><s>389</s>   \n",
       "3                                                                                                                                                                                                                                                                 83.3% (30/36)  Tested with 36 samples from patients confirmed to be SARS-CoV-2 positive with PCR.<s>391</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                               \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                <s>97.4%</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                   IgM kit - 96.6% (29/30) IgG kit - 96.6% (29/30)<s>396</s>   \n",
       "5                                                                                                                                                              Differs across different durations from symptom onset <5 days: IgA – 3.3% (1/30); IgG – 10% (3/30)  5-10 days: IgA – 15.4% (2/13); IgG – 53.8% (7/13)  10-21 days: IgA – 60% (3/5); IgG – 100% (5/5)<s>399</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                Sensitivity : 50% at Day 1-6, 91.7% at after Day 7<s>214</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                           Sensitivity: IgG 97.2%; IgM 87.9%   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                        100%   \n",
       "5                                                                                                                                                                                                                                                                                  88.66%   352 positives out of 397 positive cases: - 256 both IgG and IgM - 72 IgG - 24 IgM   \n",
       "6                                                                                                                                                                                                                                                                                                                          Sensitivity: 81.5% for IgM, 100% for IgG<s>402</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                       96.9%   \n",
       "7                                                                                                                                                                                                                                                                                                                                                  IgM – 82% <s>IgG – 93%</s>   \n",
       "8                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                       IgM – 87.01% (67/77)  IgG – 99.42% (75/77) <s>408</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                            IgG – 100% (75/75) IgM – 91.8% (78/85)<s>409</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                 IgM test 85.0% (17/20) IgG test 100.0% (20/20)  Tested with the results compared to leading commercial PCR.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "5                                                                                                                                                                                                                                     IgM test 87.9% (87/99) IgG test 97.2% (35/36)  Tested with 113 blood samples, and the results compared to RT-PCR or clinical diagnosis.   \n",
       "6                                                                                                                                                                                                                                                                                                                                       Sensitivity at 81.8% (27/33)<s>53</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                              IgM: 50% (3/6) IgG: 100% (6/6)  Tested with fresh, fingerstick blood samples prospectively-collected from 11 hospital workers in the United States (New York), 6 of whom were confirmed positive cases with results from FDA-authorised RT-PCR test.<s>416</s>   \n",
       "3                                                                                                                    93.8% (120/128)  Tested with 98 positive serum or plasma samples collected from individuals who tested positive with RT- PCR and 30 samples from hospitalised individuals who were clinically confirmed positive and exhibited severe symptoms.<s>61</s>   \n",
       "4                                                                                                                                                                                                                                                                                           75% (30/40) in first clinical trial, but suboptimal in the second trial<s>418</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                               \n",
       "5                                                                                                                                                                                                                                  88.66% (352/397)   Evaluated using blood samples from 397 clinically confirmed (including PCR test) SARS-CoV-2-infected patients.<s>57</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                            87.3% <s>428</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                               \n",
       "3                                                                                                                                                                                                                                                                                                                                                               73.8% (34/42)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                               \n",
       "5                                                                                                                                                                                   Sensitivity: 0% (Less than 3 days post symptom onset), 25% (3-7 days post symptoms onset), 86.36% (8-13 days post symptoms onset), 100% (more than 14 days post symptoms onset)<s>433</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                          <s>92% (37/40)</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                               87.5% (42/48)   \n",
       "3                                                                                                                                                                                                                                                        25% (Less than 5 days from diagnosis),  89.8% (6-14 days from diagnosis),  97.56% (More than 15 days from diagnosis)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                             98.4% (184/187)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                               \n",
       "6                                                                                                                                                                                                                                                                                                                Sensitivity: 90% (27/30) Specificity: 100% (80/80)<s>443</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                               \n",
       "8                                                                                                   At a cutoff inhibition of 20%: 100% (evaluated using 77 COVID-19 patients in Singapore), 98% (evaluated using 50 COVID-19 patients in Nanjing, China)   At a cutoff inhibition of 40%: 95.6% (evaluated using 77 COVID-19 patients in Singapore), 96% (evaluated using 50   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                               \n",
       "1                                                                                                                                                                                                                                                                                                                                                                 Sensitivity   \n",
       "2                                                                                                                                                                                                                                                                                                                                        COVID-19 patients in Nanjing, China)   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                             5  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                         Chemical stability No positive signal detected for non-specific reactivity of oligonucleotides.  Cross-reactivity with other coronaviruses No reactivity with any of three assays for five coronaviruses: (HCoV) -229E, -NL63, -OC43,  -HKU1, and MERS-CoV  Tests of human clinical samples previously tested to contain respiratory viruses All tests returned negative results for all 75 samples.   \n",
       "3                         Chemical stability No positive signal detected for non-specific reactivity of oligonucleotides.  Cross-reactivity with other coronaviruses No reactivity with any of three assays for five coronaviruses: (HCoV) -229E, -NL63, -OC43,  -HKU1, and MERS-CoV  Tests of human clinical samples previously tested to contain respiratory viruses All tests returned negative results for all 75 samples.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                             Exclusivity  Negative results against all of these preparations:   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                          • RNA extracted from cultured viruses • RNA from retrospective human clinical specimens previously tested positive for other infections • RNA from control human clinical specimens   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                               Cross-reactivity with other respiratory viruses was tested and were all negative in reactivity with the two RdRp gene targets.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                          <s>100% (32/32)</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                   100% (5/5)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                          <s>100% (32/32)</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                   100% (5/5)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                   96.44% (379/393)<s>106</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                         100%   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                    100% (100/100) <s>111</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "4   No specific statistics but claims to have ability to reliably and accurately differentiate between similar genetic sequences, in order to reduce the likelihood of a false-positive diagnosis.   Company shared that it achieves this by creating reactions that are far more specific than competing PCR technologies and 2.5 million times more effective in reducing amplification errors.<s>113,117</s> 100%<s>116</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                 35/35 for both S and E gene.   \n",
       "6                                                                                                                                                                                                                                                                                                                               100% (100/100)  100 nasopharyngeal swab clinical samples serve as negative controls.<s>126</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                         100%   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "3                                                                                                                                                                                                                                                                                                                                       100% (35/35)  35 nasopharyngeal swab specimens serving as negative controls.<s>141</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                               100%<s>147</s>   \n",
       "3                                                                                                                                                                                                                                                                    94% (94/100) from upper respiratory specimens (nasopharyngeal/ oropharyngeal swabs)  97.87% (92/94) from lower respiratory specimens (sputum)  <s>150</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                100% for both upper and lower respiratory tract samples   Evaluated using 30 nasopharyngeal swabs and sputum specimens serving as negative controls<s>158</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                100% (30/30)  30 nasopharyngeal swabs serving as negative controls.<s>162</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                          100% (30/30)  30 nasopharyngeal swabs serving as negative controls.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                          <s>100% (64/64)</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                              100% (66/66)  66 clinical nasopharyngeal swab specimens serving as negative controls.<s>174</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                         100 (109/109)  109 remnant clinical nasopharyngeal specimens serving as negative controls.<s>177</s>   \n",
       "5                                                                                                                                                                                                                                                                                            100% (100/100)   50 nasopharyngeal swab specimens and 50 bronchoalveolar lavage specimens serving as negative controls.<s>179</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                      (100% (92/92)  92 nasopharyngeal swab specimens serving as negative controls.<s>182</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                        100% (72/72)  72 presumed-negative nasopharyngeal/throat swab specimens from before Oct 2019 servings as negative controls.<s>185</s>   \n",
       "4                                                                                                                                                                                                                                                                                                       100% (31/31)  34 nasopharyngeal swabs serving as negative controls. 3 samples were invalidated and excluded.<s>187</s>   \n",
       "5                                                                                                                                                                                                                                                                  100% (56/56)  108 fresh nasopharyngeal swab specimens from 3 clinical sites were compared with one of two brands of established comparator assay.<s>191</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                         100%   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                            Clinically validated in the company's CLIA-certified lab in Richmond, California.   \n",
       "3                                                                                                                                                                                                                                                                                                                     100% (94/94)  94 oropharyngeal and nasopharyngeal swab specimens serving as negative controls.<s>196</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "8                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "9                                                                                                                                                                                                                                                                                                                                                                                                                 100% (10/10)   \n",
       "10                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                        95.9%   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                   No cross-reactivity with 33 microorganisms   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                               100% (279/279)   \n",
       "6                                                                                                                                                                                                                                                                                                94.87% (37/39, analysis done after Thermo MagMAX extraction); 95.00% (38/40, analysis done after QIAamp viral RNA extraction)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "3                                                                                                                                                                                                                                                                                                                (Recombinant plasmids containing conserved ORF1ab genes was used to analyse the specificity and sensitivity.)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                100% (30/30)  30 nasopharyngeal swabs serving as negative controls.<s>228</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                          “This assay may have cross-reactivity with other coronavirus family   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                      members such as causative agents of the Middle East Respiratory Syndrome (MERS) or Severe Acute Respiratory Syndrome (SARS).”<s>236</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                             >99.9%<s>240</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "7                                                                                                                                                                                                                                                                                             100% (60/60)  30 nasopharyngeal swab specimens and 30 bronchoalveolar lavage specimens were used as negative controls.<s>245</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                    100% (104/104)  117 respiratory specimens collected from 46 subjects tested with two analytically validated real-time RT-PCR assays for N4 and N5 gene targets.<s>247</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                         100%   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                          Specificity: 100% (30/30)<s>251</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                100% (30/30)  30 nasopharyngeal swabs serving as negative controls.<s>254</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                Reported 100%.<s>255</s> Tested at the Carlos III Health Institute with 80 samples (unclear of sample types).   \n",
       "6                                                                                                                                                                                                                                                                                                                     100% (30/30)  30 oropharyngeal and nasopharyngeal swab specimens serving as negative controls.<s>259</s>   \n",
       "7                                                                                                                                                                                                                                                                                           (29/29)  For the easyMAG extraction, 30 individual sputum samples were used but 1 was invalidated, leaving 29 samples. Testing was   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                            also done with eMAG and EZ1 extraction.<s>260</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                               100% (82/82  82 clinical nasopharyngeal swab specimens serving as negative controls.<s>263</s>   \n",
       "4                                                                                                                                                                                                                                                                                                      100% (30/30)  30 retrospective collected clinical nasopharyngeal swab specimens serving as negative controls.<s>264</s>   \n",
       "5                                                                                                                                                                                                                                                100% (30/30)  15 nasopharyngeal and 15 oropharyngeal swab samples from suspected cases that tested negative had additional aliquot serving as 30 negative controls.<s>268</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                 100% (30/30)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                              30 nasopharyngeal swabs serving as negative controls.<s>270</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                 100% (30/30)  30 oropharyngeal swabs serving as negative controls.<s>272</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                               96.7% (29/30)  30 nasopharyngeal swabs serving as negative controls.<s>273</s>   \n",
       "5                                                                                                                                                                                                                                                                                                      100% (29/29)  29 retrospective collected clinical nasopharyngeal swab specimens serving as negative controls.<s>276</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                            BALF: 100% Throat Swab: 100% RNA: 96.2% Combined: 99.6%<s>283</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                         100%   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                              100% <s>297</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                          98%   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                  <s>100%</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                         100%   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                 100% (30/30)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                 100% (50/50)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                              100% in both sputum and NP swab   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                 100% (30/30)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                    100% for nasopharyngeal and oropharyngeal swabs (30/30) as well as saliva   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                 100% (40/40)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (No info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                  93% (63/67)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                            100% for nasopharyngeal, oropharyngeal and sputum samples (40/40)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                             100% (30/30 using samples extracted with Abnova Precipitor; 48/48 using samples extracted with Zymo Research Kit on the IndiMag)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                 100% (30/30)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                 100% (11/11)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                    100% (40/40) for both nasopharyngeal and sputum specimens   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                            Undergoing validation by joint venture Fujian Fujun Gene Biotech.   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                             Stated to be high but with no accompanying statistics.<s>347</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "8                                                                                                                                                                                                                                                                                                                                                                                                                 100% (30/30)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                 Evaluated using 30 negative samples from retrospective nasopharyngeal swab clinical specimens in transport medium.<s>355</s>   \n",
       "3                                                                                                                                                                                                                                                                 97.9% (47/48)  65 fresh nasopharyngeal swab specimens from 3 clinical site2s were compared with one of two brands of established comparator assay.<s>291</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                        100% (40/40)  40 oropharyngeal swabs from healthy individuals serving as negative controls.<s>363</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                    100% (25/25) for both nasopharyngeal and sputum specimens   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                         100%   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                Specificity: 100% (Using contrived reference samples and clinical samples from US patients, including 36 patients with COVID-19 infection and 42 patients with other viral respiratory infections)   (Press release:<s>371</s>Study:<s>35</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                  80% (84/96)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "8                                                                                                                                                                                                                                                                                                                                                                                                                 100% (50/50)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                              99.51% in Serum, 100% in Plasma   \n",
       "4                                                                                                                                                                                                                                                                                                   95.2% (199/209)  Evaluated using 137 specimens from confirmed COVID-19 patients and 209 specimens from healthy individuals   \n",
       "5                                                                                                                                                                                                                                                                       99.6% (Blood donors), 98.7% (Diverse group of viral pathogens), 96.7% (Respiratory infections), 97.1% (Other study with <s>respiratory infections)</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                           99.81% (5262/5272)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                98%<s>388</s>   \n",
       "3                                                                                                                                                                                                                                                                                                   100% (400/400)  400 presumed SARS-CoV-2 negative samples from healthy blood donors serving as negative controls.<s>391</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                        96.2%   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                Specificity : 97.5%<s>214</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                              Specificity: IgG 100%; IgM 100%   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "5                                                                                                                                                                                                                                                                                                                                     90.63%  12 positives out of 128 negative controls: - 1 both IgG and IgM - 1 IgG - 10 IgM   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                          Specificity: 88.1% for IgM, 92.8% for IgG<s>402</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                        99.4%   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                        IgM – 97% IgG – 97.5%   \n",
       "8                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                              IgM – 98.89% (89/90) <s>408</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                       IgG – 99.5% (369/371); IgM – 99.2% (368/371)<s>409</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                   IgM test 96.0% (48/50) IgG test 98.0% (49/50)  Tested with the results compared to leading commercial PCR.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "5                                                                                                                                                                                                                                                                                        IgM test 100% (14/14) IgG test 100% (14/14)  Tested with 113 blood samples, and the results compared to RT-PCR or clinical diagnosis.   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                 Specificity at 96.7% (29/30)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                    IgM: 100% (6/6) IgG: 100% (6/6)  Tested with fresh, fingerstick blood samples prospectively-collected from 11 hospital workers in the United States (New York), 5 of whom were confirmed negative with results from FDA-authorised RT-PCR test.<s>416</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                    96.0% (240/250)  Tested with negative serum or plasma samples collected prior to September 2019.<s>61</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "5                                                                                                                                                                                                                                                                                                                         90.63% (116/128)   Evaluated using blood samples from 128 non-SARS-CoV-2-infected patients.<s>57</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                              100% <s>428</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                               100% (153/153)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                          Specificity: 100% (73/73)<s>433</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                          <s>100% (74/74)</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                               100% (407/407)   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                            99.3% (1082/1090)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                              99.8% (623/624)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "6                                                                                                                                                                                                                                                                                                                                                  IgG – 99% IgA – approximately 90%, not recommended for screening <s>444</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "8                                                                                                                                                                                                                                                                                                                                             100% (75/75 in cohort done in Singapore; 50/50 in cohort done in Nanjing, China)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                  Specificity   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    6  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                               Available • SARS-CoV genomic RNA as positive control.   \n",
       "3                                                                                                                                                                                                                                               Available • SARS-CoV genomic RNA as positive control.  • Synthetic control RNA for SARS-CoV-2 E gene assay is available via EVAg.  • Synthetic control for SARS-CoV-2 RdRp is expected to be available via EVAg from Jan 21st onward.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                   Available • Positive control (Available from HKU)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                           Primers and probes: • HKU-ORF1b-nsp14F • HKU- ORF1b-nsp14R • HKU-ORF1b-nsp141P • HKU-NF • HKU-NR • HKU-NP   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Available   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                       Available Primers: • NbatCoV_F1  • NbatCoV_R1   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                     Available Primers and probes: • NIID_2019-nCOV_N_F2 • NIID_2019-nCOV_N_R2 • NIID_2019-nCOV_N_P2   \n",
       "6                                                                                                                                                                                                                                                                         Available Primers and probes: • 2019-nCOV_N1_F • 2019-nCOV_N1_R • 2019-nCOV_N1_P • 2019-nCOV_N2_F • 2019-nCOV_N2_R • 2019-nCOV_N2_P • 2019-nCOV_N3_F • 2019-nCOV_N3_R • 2019-nCOV_N3_P • RP_F • RP_R • RP_P   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                           Available Primers and probes: • nCoV_IP2-12669Fw • nCoV_IP2-12759Rv • nCoV_IP2-12696bProbe(+) • nCoV_IP4-14059Fw • nCoV_IP4-14146Rv • nCoV_IP4-14084Probe(+) • E_Sarbeco_F1 • E_Sarbeco_R2 • E_Sarbeco_P1   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                          Available.  EUA issued on 16th April 2020.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                          Available.  EUA issued on 16th April 2020.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                          Available.  EUA issued on 16th April 2020.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                          Available.  EUA issued on 16th April 2020.   \n",
       "4                                                                                                                                                                                                                                                                                                                      Available.  EUA issued on 17th April 2020   Received CE mark on 17 March 2020.   Received emergency approval from the National Medical Products Administration   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                           (NMPA) on 27 March 2020.   Approved for inclusion in the Australian Register of Therapeutic Goods on 8 May 2020<s>107</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                              FDA EUA issued on 29/04/2020<s>109</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                             FDA EUA issued on 29/04/2020 <s>111</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                  Available as scientific research product – does not require registration<s>112</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                           Commercially available for sale on 10 Feb 2020.<s>114</s> Received CE Mark 24 Feb 2020.<s>118</s> Obtained EUA approval from US FDA 3 Apr 2020.<s>115</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                               Available FDA EUA issued on 22 April 2020  Received CE mark for IVD  HSA provisional authorisation approved on 15 May 2020 <s>121</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                 Commercially available.   Obtained EUA approval from US FDA 13 Mar 2020.<s>125</s> CE Mark for IVD.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                       Approved for inclusion on the Australia’s ARTG on 20 March 2020.  Date of HSA Provisional Authorisation: 19/03/2020<s>127</s>   \n",
       "3                                                                                                                                                                                                                                                                                                 Available but not for commercial sale yet.   Provisional authorization for clinical use from Singapore's HSA.<s>4,129</s> Date of Provisional Authorisation from HSA: 30 April 2020   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                Developed as of 3 Feb 2020.   CE approved <s>132</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                             Commercially available.   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                     Developed.  Undergoing testing. Emergency use approval submitted to China’s NMPA on 27 Jan 2020   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                      Prototype developed.  Acu-Corona 2.0 obtained Provisional Authorisation from Singapore Health Sciences Authority on 31 March 2020. Acu-Corona 3.0 obtained Provisional Authorisation from HSA on 14 April 2020. (HSA authorisation for Acu-Corona 2.0: <s>138</s>HSA authorisation for Acu-Corona 3.0:<s>139</s> Currently CE-IVD pending and approved for research only, seeking approval from US Food and Drug Authorisation   \n",
       "3                                                                                                                                                                                                                                                                                               Commercially available.   Obtained EUA approval from US FDA 21 Mar 2020.<s>27</s> Approved for inclusion on the Australian Register of Therapeutic Goods on 22 March 2020. <s>143</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                       Available. Orders for the kit have been placed from World Health Organisation, national health authorities and laboratories in about 60 countries. <s>144</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                 Commercially available.   Received CE Mark Mar 2020.<s>147</s> Approved for inclusion in Australia’s ARTG.<s>81</s>   \n",
       "3                                                                                                       Commercially available.  Obtained EUA approval from Korean FDA 12 Feb 2020.<s>151,152</s> Product already has CE Mark for IVD.    Obtained HSA provisional approval on 2 April 2020, supplied through All Eights (Singapore) Pte Ltd. <s>153</s> Approved for inclusion on the Australian Register of Therapeutic Goods on 27 March 2020 <s>143</s> FDA EUA issued 21/04/2020   \n",
       "4                                                                                                                                                                                                                                                                                                                                Commercially available.   Received CE Mark 17 Mar 2020.   Submitted to US FDA for EUA approval.  Has provisional authorisation from Singapore’s HSA.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                   Available.   Received CE Mark for IVD.  Obtained EUA approval from US FDA on 18 April 2020. <s>158</s> Date of Provisional Authorisation from HSA: 14 May 2020, supplied through SPD Scientific Pte Ltd<s>159</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                            Commercially available.   Obtained EUA approval from US FDA 23 Mar 2020.   \n",
       "4                                                                                                                                                                                                                                                                                                                                          Commercially available.   Obtained EUA approval from US FDA 27 Mar 2020.  Date of Provisional Authorisation from HSA: 8 May 2020<s>166</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                          Commercially available.  Obtained EUA approval from US FDA 10 Mar 2020 for lot number #143503 and #143764.   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                             Submitted to US FDA for EUA Approval.  Commercially Available<s>169</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                               FDA EUA issued on 15/5/2020<s>170</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                  Commercially available.   Obtained EUA approval from US FDA 24 Mar 2020.<s>173</s>   \n",
       "4                                                                                                                                                                                                                                                                                                       Commercially available.  Obtained EUA approval from US FDA 16 Mar 2020.   Approved for inclusion into the Australian Register of Therapeutic Goods on 20 March 2020.<s>81</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                            Commercially available.   Obtained EUA approval from US FDA 16 Mar 2020.   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                            Commercially available.   Obtained EUA approval from US FDA 17 Mar 2020.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                            Commercially available.   Obtained EUA approval from US FDA 17 Mar 2020.   \n",
       "4                                                                                                                                                                                                                                           Commercially available.    Obtained EUA approval from US FDA 18 Mar 2020.  Approved for inclusion on the Australian Register of Therapeutic Goods on 17 April 2020.<s>143</s>Date of HAS Provisional Authorisation: 01/04/2020 <s>188</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                            Commercially available.   Obtained EUA approval from US FDA 19 Mar 2020.   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                             Commercially available.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                        Received CE Mark for IVD Mar 2020.   Obtained EUA approval from US FDA 8 Apr 2020.<s>194</s>   \n",
       "3                                                                       Commercially available.   Obtained EUA approval from US FDA 24 Mar 2020.  EUA amendment on April 1st to add an additional nucleic acid extraction method which utilizes the chemagic Viral DNA/RNA 300 Kit H96 on a new extraction platform, the chemagic 360 equipped with the chemagic Rod Head Set 96; and (2) make other minor changes and edits to the IFU labeling was granted on 01/04/2020 <s>197</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                       Commercially available.   Received CE Mark 7 Apr 2020.  Submitted to US FDA for EUA approval.   \n",
       "5                                                                                                                                                                                                                                                                                                 Available as an emergency use test in Finland and France, set up for routine use in main clinical laboratories in Finland with capacity to test up to 4000 samples a day.<s>200</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                          In the process for obtaining emergency use authorisation in Sweden and the UK. In the process for <s>obtaining CE-IVD.</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                           Available.  CE-IVD marked.<s>201</s> Approved for inclusion into the Australian Register of Therapeutic Goods on 13 April 2020.<s>143</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                    Available.  Approved for inclusion into the Australian Register of Therapeutic Goods on 22 March 2020.<s>143</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                Date of Provisional Authorisation by HSA: 05/03/2020   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                         Date of Provisional Authorisation by HSA: <s>10/03/2020</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                                Date of Provisional Authorisation by HSA: 24/03/2020   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                Date of Provisional Authorisation by HSA: 19/03/2020   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                Date of Provisional Authorisation by HSA: 18/02/2020   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                Date of Provisional Authorisation by HSA: 15/04/2020   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                Date of Provisional Authorisation by HAS: 26/03/2020   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                      Provisional Authorisation from HSA: 20/04/2020   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                           Date of Provisional Authorisation from HSA: 30 April 2020   \n",
       "8                                                                                                                                                                                                                                                                                                                                                                                                                              Date of Provisional Authorisation from HSA: 23/04/2020   \n",
       "9                                                                                                                                                                                                                                                                                                                                                                                                                                                         FDA EUA issued on 20/4/2020   \n",
       "10                                                                                                                                                                                                                                                                                                                                                                                           Approved for inclusion on the Australian Register of Therapeutic Goods on 23 April 2020.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                            Approved for inclusion on the Australian Register of Therapeutic Goods on 24 April 2020.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                         CE approved   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                        FDA EUA issued on 27/04/2020   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                            FDA EUA issued on 1 May 2020<s>220</s> Date of Provisional Authorisation from HSA: 14 May 2020<s>221</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                             FDA EUA issued on 1 May 2020 <s>223</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                               Available (non-commercially) to 9 labs across the UK.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                              Clinical trials phase.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                             Commercially available.   Obtained EUA approval from US FDA 3 Apr 2020.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                             Commercially available.   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                           Commercially available.  Date of Provisional Authorisation from HSA: 4 May 2020<s>234</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                                                     Commercially available for RUO.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "3                                                                                                                                                                                                                                                                                                                        Available.   Received CE Mark for IVD for the version adapted for the BD MAX™ System.<s>239</s> Approved for inclusion on Australia’s ARTG on 21 March 2020.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Available   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Available.   \n",
       "6                                                                                                                                                                                                                                                                                                                   Commercially available.   Obtained EUA approval from Korean CDC 4 Feb 2020.<s>151,242</s> Approved for inclusion on the Australian Register of Therapeutic Goods.   \n",
       "7                                                                                                                                                                                                                                                                                                                                                   Commercially available.  Received CE Mark for IVD 26 Mar 2020.<s>246</s> Obtained EUA approval from US FDA 13 Mar 2020.<s>244</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                 Obtained HSA provisional approval on 20 March 2020. Approved for inclusion on the Australian Register of Therapeutic Goods on <s>24 March 2020</s>.   \n",
       "3                                                                                                                                Available to laboratories designated by CDC as qualified, and in the US, certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity tests. Available to qualified international laboratories.  Not available to U.S. hospitals or other primary care settings.   Obtained EUA approval from US FDA 4 Feb 2020.   \n",
       "4                                                                                                                                                                                                                                                                                                                     Commercially available.   Obtained EUA approval from Korean CDC 27 Feb 2020.<s>151,152</s> Received CE Mark for IVD.   FDA EUA issued on 21 May 2020 <s>250</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Available.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                       Obtained EUA approval from Korean CDC 27 Feb 2020.<s>151,152</s> FDA EUA issued on 23/04/2020   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                   Commercially available.  Obtained EUA approval from US FDA 3 Mar 2020 for lot number #0000500383.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                             Commercially available.   Obtained EUA approval from US FDA 3 Apr 2020.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                  Available.  Received CE Mark 6 Mar 2020.<s>256</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                  Commercially available.   Obtained EUA approval from US FDA 25 Mar 2020.<s>257</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                  Available.   Obtained EUA approval from US FDA  for use in Wadsworth Center, New York State Public   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                    Department of Health, and the New York City Department of Health and Mental Hygiene, Public Health Laboratories.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                  Commercially available.   Obtained EUA approval from US FDA 30 Mar 2020.<s>261</s>   \n",
       "4                                                                                                                                                                                                                                                                                                          Commercially available.   Obtained EUA approval from US FDA 2 Apr 2020.  Approved for inclusion on the Australian Register of Therapeutic Goods on 17 April 2020.<s>81</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                    Commercially available.   Received CE Mark in Mar 2020.<s>267</s> Obtained EUA approval from US FDA 15 Apr 2020.   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                             Commercially available.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                       Obtained EUA approval from US FDA 1 Apr 2020.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                             Commercially available.   Obtained EUA approval from US FDA 6 Apr 2020.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                             Commercially available.   Obtained EUA approval from US FDA 7 Apr 2020.   \n",
       "5                                                                                                                                                                                                                                                                                                                                           Commercially available.   Obtained EUA approval from US FDA 8 Apr 2020.  Date of Provisional Authorisation from HSA: 6 May 2020<s>277</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                                     In development.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2   Commercially available.   Received CE Mark for IVD 2 Mar 2020.<s>284</s> BGI is also engaged with relevant organizations in Hong Kong, Taiwan, Brunei, Thailand, Nigeria, South Africa, to supply the test kits.<s>279</s> Passed emergency approval procedure of China’s NMPA.  Obtained EUA approval from US FDA 27 Mar 2020.<s>280,281</s> Approved for inclusion on Australia’s ARTG on 10 April 2020.  Date of Provisional Authorisation from HSA:  24 April 2020 <s>285</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                               Available.  Approved by China’s NMPA.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                       Commercially available.   Received CE Mark for IVD 17 Feb 2020.<s>293,294</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                            Obtained EUA approval from US FDA 20 Mar 2020.<s>290</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                               Available. Reportedly being used in China in over 30 hospitals, 16 local CDC offices, and 8 airports.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                         Available.   Approved by the Indian Council of Medical Research for coronavirus testing in India on 4 April 2020.<s>298</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                 Developed. Currently seeking collaborators to perform clinical tests in China and the US.<s>299</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                  Available.  Received CE Mark 6 Mar 2020.<s>256</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                          Commercially available.   EUA Submission Pending<s>306</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                     In development as of 6 Feb 2020   \n",
       "3                                                                                                                                                                                                                                                                                                             Has been providing technical support for the scientific clinical prevention and control of the epidemic in Wuhan.  Passed emergency approval procedure of China’s NMPA.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                Approved for inclusion in the Australian Register of Therapeutic Goods on 5 May 2020   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                       Developed as of 3 Feb 2020.  Submitted to Korean CDC for EUA.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                               Assumed developed as of 3 Feb 2020. Submitted to Korean CDC for EUA.  Received CE mark. Distributed to 20 <s>hospitals in Romania</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                         In development as of 6 Feb 2020.  <s>CE mark on March 3</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                            EUA application submitted to DFA, CE-IVD mark by mid may   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                              Date of Provisional Authorisation from HSA: 4 May 2020   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                              FDA EUA issued on 5 May 2020<s>320</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                         FDA EUA issued on 6 May 2020<s>322</s> CE marked on 10 April 2020, validated in France since 11 March 2020.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                              FDA EUA issued on 6 May 2020<s>323</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                              FDA EUA issued on 7 May 2020<s>324</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                              FDA EUA issued on 7 May 2020<s>325</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                       FDA EUA issued on 11 May 2020   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                       FDA EUA issued on 11 May 2020   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                       FDA EUA issued on 13 May 2020   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                       FDA EUA issued on 14 May 2020   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                       FDA EUA issued on 15 May 2020   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                       FDA EUA issued on 18 May 2020   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                    Approved for inclusion on the Australian Register of Therapeutic Goods on 19 May 2020.<s>333</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                     HSA provisional authorisation approved on 20 May 2020<s>334</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                                                       FDA EUA issued on 21 May 2020   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                       FDA EUA issued on 21 May 2020   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                             Commercially available.   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                        Available.  Soon to be submitted to US FDA for EUA Approval.   \n",
       "7                                                                                                                                                                                                                                                                                                                                                 Available. 28 January: US Centers for Disease Control and Prevention (CDC) releases nCoV genomes sequenced with nanopore sequencing   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                              29 January: A paper in the Lancet characterised full-length genomes of 2019-nCoV patients using Nanopore sequencing, providing important information on possible virus origins and cell-binding receptors that is crucial for determining viral transmission capacity.  30 March: Singapore sequences its genome in less than 7 hours  14 April: In the UK, more than 600 genomes have been uploaded onto GISAID, using nanopore sequencing<s>340</s>.   \n",
       "3                                                                                                                                                                                        Available  3 February: First Belgian nCoV sample arrives in a lab at 5pm and using the ARTIC protocol, the sequence is completed by 9am.  3 March: The SARS-CoV2 virus from Scotland’s first case is sequenced in under 24 hours using nanopore sequencing and the ARTIC protocol<s>340</s>.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                            Commercially available.   Obtained EUA approval from US FDA 27 Mar 2020.   \n",
       "5                                                                                                                                                                                                                                                             Available for RUO since Jan 2020.   Provisional approval for IVD by Singapore’s HSA since Mar 2020.<s>346</s> Used for testing of swab samples from Singapore’s land, sea and air checkpoints since Mar 2020.<s>348</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                   Expected to be commercially available in Q3 2020.   \n",
       "7                                                                                                                                                                      Available. In use by the Centers for Disease Control and Prevention (CDCP) in Shenzhen and Guangzhou with two more sets being delivered to the CDCP in Hubei and Nansha.<s>352</s> Device already has CE Mark and is qualified for export to all European Union (EU) countries as well as Hong Kong.<s>351</s>   \n",
       "8                                                                                                                                                                                                                                                                                                                                                                                                                                                             Commercially available.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                       Obtained EUA approval from US FDA 30 Mar 2020.<s>354</s> Approved for inclusion in the Australian Register of Therapeutic Goods on 8 May 2020   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                              Commercially available.   Obtained EUA Approval 19 Mar 2020.<s>358</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                     In development.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                              In development using the template of existing CE-marked Flu and RSV respiratory tests.   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                            Commercially available.   Obtained EUA approval from US FDA 10 Apr 2020.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                       FDA EUA issued on 21 May 2020   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                     In development.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                  Protocol published 14 Feb 2020.<s>368,369</s> FDA EUA issued on 6/5/2020<s>370</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "3                                                                                                                                                                                                                                                                                                                                                                      Developed.   Awaiting EUA from US FDA (pending clinical validation)   (Press release:<s>371</s>Study:<s>35</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                         Available. Obtained <s>CE certification</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                         Available. Obtained <s>CE certification</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                     In development.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                        FDA EUA issued on 8 May 2020   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                                     In development.   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                                       Undergoing commercialisation as of 6 Feb 2020   \n",
       "8                                                                                                                                                                                                                                                                                                                                                                                                                                                       FDA EUA issued on 14 May 2020   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                              FDA EUA issued on 29/04/2020<s>379</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                     Available.  CE-IVD marked. Approved for inclusion into the Australian Register of Therapeutic Goods on 27 March 2020.<s>143</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                             FDA EUA issued on 30/04/2020 <s>382</s>   \n",
       "6                                                                                                                                                                                                                                                                           FDA EUA issued on 2 May 2020<s>383</s> Date of Provisional Authorisation from HSA: 5 May 2020 <s>384</s> Approved for inclusion on the Australian Register of Therapeutic Goods on 20 May 2020.<s>385</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                            Developed. Ready for manufacture with CE mark.<s>388</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                       Available.   Obtained EUA approval from US FDA 14 Apr 2020.  Date of Provisional Authorisation from HSA: 8 May 2020<s>393</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "5                                                                                                                                                                                                                                                                                                                              Developed.  Undergoing testing. Emergency use approval submitted to China’s NMPA on 28 Jan 2020.   Approved on 14 March for commercial use. <s>394</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                           CE-IVD marked. For in vitro diagnostic use.  FDA EUA issued on 24/04/2020   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                           Developed.  Undergoing testing. Emergency use approval submitted to China’s NMPA on 2 Feb 2020.  Approved for inclusion on the Australian Register of Therapeutic Goods on 23 April 2020.   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                Date of Provisional Authorisation by HSA: 09/04/2020   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                      Available. Received CE certification on 6 March 2020<s>396</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                    Available.   Have been distributed in China and will soon be in Italy.   Received CE Mark 19 Feb 2020.<s>398</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                       Availability: Approved for inclusion on the Australian Register of Therapeutic Goods on <s>28 April 2020.</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                                               Approved for inclusion on the Australian Register of Therapeutic Goods on 29 April 2020. Pending <s>FDA approval </s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                    Approved for inclusion on the Australian Register of Therapeutic Goods on 1 May 2020. <s>132</s>   \n",
       "5                                                                                                                                                                                                                                                                                             Commercially available. More than half a million sold in China.  Received CE Mark for IVD 8 Mar 2020. Already sold in Italy.<s>58</s> Submitted to US FDA for EUA approval.<s>59,60</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                                           (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                Date of Provisional Authorisation by HSA: 20/03/2020   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                   Date of Provisional Authorisation by HSA: 20/03/2020  Date of approval for inclusion into ARTG: <s>26/03/2020</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                              Date of Provisional Authorisation from HSA: 24/04/2020   \n",
       "6                                                                                                                                                                                                                                                                                                                                                      Available commercially.  Approved for inclusion into the Australian Register of Therapeutic Goods on 19 March 2020. <s>143</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                  Available.   Approved for inclusion into the Australian Register of Therapeutic Goods on 31 March 2020. <s>143</s>   \n",
       "8                                                                                                                                                                                                                                                                                                                                                                                             Approved for inclusion on the Australian Register of Therapeutic Goods on 16 April 2020   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                          <s>143</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                  Available.   Received CE mark.<s>408</s>Approved for inclusion into the Australian Register of Therapeutic Goods on <s>26 March 2020</s><s>143</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                  Available.   Received CE mark. Approved for inclusion into the Australian Register of Therapeutic Goods on 4 April 2020.<s>143</s>   \n",
       "5                                                                                                                                                                                                   Available.   Approved by China’s NMPA.  Received CE Mark Mar 2020.<s>48,49</s> Obtained HSA provisional approval on 9 April 2020, supplied through SkyQuest Pte Ltd.<s>410</s> Approved for inclusion on the Australian Register of Therapeutic Goods on 25 March 2020.<s>143</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                 Date of Provisional Authorisation from HSA: 27 April 2020<s>411</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                              Commercially available.   Received CE Mark for IVD.  Approved for inclusion in Australia’s ARTG.<s>81</s> Used in study by Lee et al (2020).<s>414</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Available.   \n",
       "5                                                                                                                                                                                                                   Available.   Received CE Mark. Currently one of only a few tests used for coronavirus screening in China.  Commercialisation and distribution licensing deal with Aytu Bioscience for USA.   Approved for inclusion on Australia’s ARTG on 1 April 2020.<s>81</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Available.   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                            Commercially available.   Obtained EUA approval from US FDA 14 Apr 2020.   \n",
       "3                                                                                                                                                                                                                                                                                                                                           Commercially available.   Obtained EUA approval from US FDA 1 Apr 2020.  Approved for inclusion in Australia’s ARTG 31 Mar 2020.<s>81</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                     Available non-commercially in China. <s>418</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                                                       Commercially available.   Approved for inclusion into the Australian Register of Therapeutic Goods on 6 April 2020.<s>143</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                           Date of Provisional Authorisation from HSA: 27 April 2020   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                           Date of Provisional Authorisation from HSA: 30 April 2020   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                               Approved for inclusion in the Australian Register of Therapeutic Goods on 11 May 2020   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                              Date of Provisional Authorisation from HSA: 8 May 2020   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                    Date of Provisional Authorisation from HSA: 14 May 2020, supplied by Trans Sahara Corporation Pte Ltd <s>424</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                             Approved for inclusion into the Australian Register of Therapeutic Goods on 18 May 2020   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                     HSA provisional authorisation approved on 18 May 2020<s>426</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                     Available for use in China but not commercially   \n",
       "6                                                                                                                                                                                                                Available commercially.  Approved by China’s NMPA.  Approved for inclusion on the Australian Register of Therapeutic Goods.<s>81</s> CE-IVD approved. <s>3</s> Partnered with Scanwell Health to be distributed in US, together with an accompanying smartphone app,   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                   pending US FDA EUA approval. <s>428</s> Date of Provisional Authorisation from HSA: 27 April 2020   \n",
       "3                                                                                                                                                                                                                                                                                                                                                             HSA provisional authorisation approved on 15 May 2020.<s>429</s> CE marked.<s>430</s> Pending EUA approval from US FDA.   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "5                                                                                                                                                                                                                                                                                                                                                         Commercially available.  FDA EUA issued on 23/04/2020  Date of Provisional Authorisation from HSA: 30 April 2020 <s>434</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                   Available.  EUA issued on 15th <s>April 2020.</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                         FDA EUA issued on 24/4/2020   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                         FDA EUA issued on 24/4/2020   \n",
       "4                                                                                                                                                                                                                                                                                                                                                             HSA provisional authorisation approved on 15 May 2020.<s>438</s> CE marked.<s>430</s> Pending EUA approval from US FDA.   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                    Commercially available. CE-marked since 25 March 2020 <s>262</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "8                                                                                                                                                                                                                                                                                                                                                                                                                    Date of Provisional Authorisation from HSA: 8 May 2020<s>447</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Availability   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                      7  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                               47 min 15 sec of cycle time (plus probe) for each assay   \n",
       "3                                                                                                                                                                                                                                                                               47 min 15 sec of cycle time (plus probe) for each assay   \n",
       "4                                                                                                                                                                                                                                                                                            28 min 40 sec of cycle time for each assay   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                 107 min of cycle time   \n",
       "5                                                                                                                                                                                                                                                                                 81 min for Nested RT-PCR  95 min for Real-time RT-PCR   \n",
       "6                                                                                                                                                                                                                                                                                            43 min 45 sec of cycle time for each assay   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                   61 min of cycle time for each assay   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                        Within 2 Hours   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                              Within 2 hours<s>116</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                  2:15 hours<s>122</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                           3 hr 30 min   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                            90 minutes   \n",
       "4                                                                                                                                                                                                                                                                                                                           1 hr 45 min   \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                  30 minutes<s>136</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                       Allows up to 94 patient samples <s>per 1.5h</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                45 min   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                        3 hr<s>146</s>   \n",
       "3                                                                                                                                                                                                                                                                                         1 hour 50 minutes after extraction <s>150</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                20 min   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                          About 120 minutes <s>158</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                30 min   \n",
       "4                                                                                                                                                                                                                                                                                        4 hr  (2 hr 15 min to  2 hr 25 min cycle time)   \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                                45 min   \n",
       "4                                                                                                                                                                                                                                                                                             Can generate results in 3 hours<s>178</s>   \n",
       "5                                                                                                                                                                                     Approximately 2-4 days from the date of pickup of a specimen for testing to the release of the test result to the health care provider <s>180</s>   \n",
       "6                                                                                                                                                                                                                                                                                                            45 min cycle time per gene   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                       58 min 40 s cycle time per gene   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                               104 min 30s cycle time per gene target.   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                              <s>48 samples in <3h</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                              Within 2 hours<s>207</s>   \n",
       "3                                                                                                                                                                                                                                                                                                                                         \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "8                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "9                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "10                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "3                                                                                                                                                                                                                                                                                                                            10 minutes   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                        Around 45 mins   \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                  43 min 45 s cycle time for each gene   \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                 120 minutes<s>240</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                < 3 hr   \n",
       "5                                                                                                                                                                                                                                                                                                                                < 3 hr   \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                     36 min cycle time per gene target   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                              2 hr PCR   \n",
       "5                                                                                                                                                                                                                                                                                                                     90 min <s>252</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                  2 hr   \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                         \n",
       "7                                                                                                                                                                                                                                                                                                42 min 45 s cycle time per gene target   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                                80 min   \n",
       "4                                                                                                                                                                                                                                                                                                                                  2 hr   \n",
       "5                                                                                                                                                                                                                                                                                                37 min 10 s cycle time per gene target   \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                               129 min 30 s cycle time   \n",
       "4                                                                                                                                                                                                                                                                       4 hr<s>274</s> (43 min 45 s cycle time for each gene)<s>273</s>   \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                     Less than an hour   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                  3 hr   \n",
       "3                                                                                                                                                                                                                                                                                                                           1 hr 30 min   \n",
       "4                                                                                                                                                                                                                                                                                     < 2 hr  64 min 30 s cycle time per gene<s>291</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                                  1 hr   \n",
       "4                                                                                                                                                                                                                                                                                                                                55 min   \n",
       "5                                                                                                                                                                                                                                                                                                                                10 min   \n",
       "6                                                                                                                                                                                                                                                                                                                                < 5 hr   \n",
       "7                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                      126 min 15 s<s>309,311</s>or 120 min<s>310,312</s> of cycle time   \n",
       "3   SARS-CoV-2 detection stated to be faster than Fluorescent RT-PCR kit.  For detection of unknown pathogens, Within 5 hours, 128 samples can be simultaneously screened and sequenced by SE50, and 128 samples can be simultaneously tested and sequenced by PE100 in 22 hours, as well as possible mutation and evolution monitoring   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                         <s>70 min</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "3                                                                                                                                                                                                                                                                                                                     <s>83 minutes</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                             4-5 Hours   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                         \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                  4 hr   \n",
       "7                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                                         \n",
       "4                                                                                                                                                                                                                                                                   5-13 min  (5 min for positive results, 13 min for negative results)   \n",
       "5                                                                                                                                                                                                                                                                                                                     2 hours<s>349</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                                  1 hr   \n",
       "7                                                                                                                                                                                                                                                                                                                                40 min   \n",
       "8                                                                                                                                                                                                                                                                                              About an hour (Press release:<s>356</s>)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                           Less than 2 hours<s>359</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                         \n",
       "6                                                                                                                                                                                                                                                                       60-70 min (including patient sample preparation time)<s>362</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                51 min   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "3                                                                                                                                                                                                                                                                                                                                         \n",
       "4                                                                                                                                                                                                                                                                                                                                30 min   \n",
       "5                                                                                                                                                                                                                                                                                                                                         \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                    45 minutes (with manual RNA extraction)   (Press release:<s>371</s>Study:<s>35</s>   \n",
       "4                                                                                                                                                                                                                                                                                                                                         \n",
       "5                                                                                                                                                                                                                                                                                                                     <s>30 minutes</s>   \n",
       "6                                                                                                                                                                                                                                                                                                                     <s>30 minutes</s>   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                              5-15 min   \n",
       "4                                                                                                                                                                                                                                                                                                                             (No info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                         \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "8                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                10 min   \n",
       "3                                                                                                                                                                                                                                                                                                  48 min  (Up to 150 samples per hour)   \n",
       "4                                                                                                                                                                                                                                                                                                                                         \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                               <15 min   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                 15 mi   \n",
       "3                                                                                                                                                                                                                                                                                                                            10 Minutes   \n",
       "4                                                                                                                                                                                                                                                                      22 min (unclear if serum/plasma extraction time included or not)   \n",
       "5                                                                                                                                                                                                                                                                                                                                30 min   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                            10 minutes   \n",
       "3                                                                                                                                                                                                                                                                                                                            10 minutes   \n",
       "4                                                                                                                                                                                                                                                                                                                            10 minutes   \n",
       "5                                                                                                                                                                                                                                                                                                                                15 min   \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                            10 minutes   \n",
       "7                                                                                                                                                                                                                                                                                                                            15 minutes   \n",
       "8                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "5                                                                                                                                                                                                                                                                      15 min (unclear if serum/plasma extraction time included or not)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                                10 min   \n",
       "4                                                                                                                                                                                                                                                                                                                                20 min   \n",
       "5                                                                                                                                                                                                                                                                                                                              2-10 min   \n",
       "6                                                                                                                                                                                                                                                                                                                                10 min   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                             10-15 min   \n",
       "3                                                                                                                                                                                                                                                                                                                              15-20min   \n",
       "4                                                                                                                                                                                                                                                                     15 min  (unclear if serum/plasma extraction time included or not)   \n",
       "5                                                                                                                                                                                                                                                                                                                         Within 10 min   \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                               15 mins   \n",
       "7                                                                                                                                                                                                                                                                                                                               10 mins   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                                         \n",
       "5                                                                                                                                                                                                                                                                      15 min (unclear if serum/plasma extraction time included or not)   \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "3                                                                                                                                                                                                                                                                                                                            90 minutes   \n",
       "4                                                                                                                                                                                                                                                                                                                                         \n",
       "5                                                                                                                                                                                                                                                                                                              (100-200 tests per hour)   \n",
       "6                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "3                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "4                                                                                                                                                                                                                                                                                                                            90 minutes   \n",
       "5                                                                                                                                                                                                                                                                                                                                         \n",
       "6                                                                                                                                                                                                                                                                                                                    2 hours <s>445</s>   \n",
       "7                                                                                                                                                                                                                                                                                                                                         \n",
       "8                                                                                                                                                                                                                                                                                                                             1-2 hours   \n",
       "0                                                                                                                                                                                                                                                                                                                                         \n",
       "1                                                                                                                                                                                                                                                                                                                            Turnaround   \n",
       "2                                                                                                                                                                                                                                                                                                                                         \n",
       "\n",
       "                                                                               8  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                      (no info)  \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5   $300 for 10 strips +  $5,950 for PCR Thermocycler + $450 for sample prep kit  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                      (no info)  \n",
       "3                                                                      (no info)  \n",
       "4                                                           About €160<s>144</s>  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                      (no info)  \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                      (no info)  \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                USD $230 for 1000 rxn<s>167</s>  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                                 \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "7                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                      (no info)  \n",
       "3                                                                                 \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "7                                                                      (no info)  \n",
       "8                                                                      (no info)  \n",
       "9                                                                      (no info)  \n",
       "10                                                                     (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                      (no info)  \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                      (no info)  \n",
       "3                                                                      (no info)  \n",
       "4                                                                     (by quote)  \n",
       "5                                                                € 991<s>232</s>  \n",
       "6                                                               € 1347<s>235</s>  \n",
       "7                                                                     (by quote)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "7                                                                     (by quote)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                   USD $125<s>24</s>for 500 rxn  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "7                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                      (no info)  \n",
       "3                                                                      (no info)  \n",
       "4                                                                     (by quote)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                Rs 1,000 – Rs 1,500) <s>298</s>  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "7                                                                     (by quote)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2    € 599<s>308</s>€ 699<s>308</s>€ 799<s>308</s>€ 999<s>308</s>€ 899<s>308</s>  \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                      (no info)  \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "7                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "7                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                                 \n",
       "5                                                                     (by quote)  \n",
       "6                                                                     (by quote)  \n",
       "7                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                                 \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "7                                                                      (no info)  \n",
       "8                                                                     (by quote)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                                 \n",
       "6                                                                      (no info)  \n",
       "7                                                                     (by quote)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                      (no info)  \n",
       "3                                                                                 \n",
       "4                                                                      (no info)  \n",
       "5                                                                                 \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                                 \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                           <$50  \n",
       "4                                                                      (No info)  \n",
       "5                                                                                 \n",
       "6                                                                      (no info)  \n",
       "7                                                                      (no info)  \n",
       "8                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                      (no info)  \n",
       "3                                                                      (no info)  \n",
       "4                                                                                 \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                      (no info)  \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                      (no info)  \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "7                                                                      (no info)  \n",
       "8                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                     (by quote)  \n",
       "4                                                                         €39.95  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                      (no info)  \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                               $20 per test kit  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "7                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                                 \n",
       "5                                                                      (no info)  \n",
       "6               Projected to be $70 as distributed by Scanwell Health <s>428</s>  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 \n",
       "3                                                                      (no info)  \n",
       "4                                                                                 \n",
       "5                                                                      (no info)  \n",
       "6                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                      (no info)  \n",
       "3                                                                      (no info)  \n",
       "4                                                                      (no info)  \n",
       "5                                                                                 \n",
       "6                                                                      (no info)  \n",
       "7                                                                                 \n",
       "8                                                                      (no info)  \n",
       "0                                                                                 \n",
       "1                                                                          Costs  \n",
       "2                                                                                 "
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tests_df"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Set columns names the same as 2nd row"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df.columns = tests_df.iloc[1]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Drop first two rows, which have titles and column names, repectively"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df.drop([0,1], inplace = True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Reset index, in order to have a continuous index starting with 0"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df.reset_index(inplace = True, drop = True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Dropping rows containing sub-titles and rows with only white spaces"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['Type', 'Organisation', 'Date', 'Test', 'Sensitivity', 'Specificity',\n",
       "       'Availability', 'Turnaround', 'Costs'],\n",
       "      dtype='object', name=1)"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tests_df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df = tests_df.loc[~((tests_df.Organisation == \"\") & \n",
    "                          (tests_df.Date == \"\") & \n",
    "                          (tests_df.Test == \"\") & \n",
    "                          (tests_df.Sensitivity == \"\") & \n",
    "                          (tests_df.Specificity == \"\") & \n",
    "                          (tests_df.Availability == \"\") & \n",
    "                          (tests_df.Turnaround == \"\") & \n",
    "                          (tests_df.Costs == \"\")\n",
    "                         ) ,:]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Reseting index"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df.reset_index(inplace = True, drop = True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Concatenating rows previously splitted on the original PDF due to page break"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Index of broken rows"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "index_merge = tests_df.loc[(tests_df.Type.shift(-1) == \"\"), :].index"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Dataframe containing only splitted rows"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>1</th>\n",
       "      <th>Type</th>\n",
       "      <th>Organisation</th>\n",
       "      <th>Date</th>\n",
       "      <th>Test</th>\n",
       "      <th>Sensitivity</th>\n",
       "      <th>Specificity</th>\n",
       "      <th>Availability</th>\n",
       "      <th>Turnaround</th>\n",
       "      <th>Costs</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>School of Public Health, The University</td>\n",
       "      <td>16 Jan 2020</td>\n",
       "      <td>Primer and Probe</td>\n",
       "      <td>Positive control using SARS-CoV RNA Wide dynamic range of 2&lt;s&gt;-4&lt;/s&gt; to 2000 TCID&lt;s&gt;50&lt;/s&gt;/reaction.</td>\n",
       "      <td>Exclusivity  Negative results against all of these preparations:</td>\n",
       "      <td>Available • Positive control (Available from HKU)</td>\n",
       "      <td>28 min 40 sec of cycle time for each assay</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td></td>\n",
       "      <td>of Hong Kong (HKU)&lt;s&gt;13,14&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Assay 1 (Target: ORF1b-nsp14 gene)  Assay 2 (Target: N gene)</td>\n",
       "      <td></td>\n",
       "      <td>• RNA extracted from cultured viruses • RNA from retrospective human clinical specimens previously tested positive for other infections • RNA from control human clinical specimens</td>\n",
       "      <td>Primers and probes: • HKU-ORF1b-nsp14F • HKU- ORF1b-nsp14R • HKU-ORF1b-nsp141P • HKU-NF • HKU-NR • HKU-NP</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>Genosensor, LLC &lt;s&gt;103&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>&lt;s&gt;GS COVID-19 RT-PCR Kit&lt;/s&gt; Real-time reverse transcription polymerase chain reaction test intended</td>\n",
       "      <td>&lt;s&gt;100% (32/32)&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;100% (32/32)&lt;/s&gt;</td>\n",
       "      <td>Available.  EUA issued on 16th April 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal/oropharyngeal swabs, nasal swabs, mid-turbinate swabs from individuals suspected of COVID-19. Positive results are indicative of the presence of SARS-CoV-2 RNA.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>Shanghai Fosun Long March Medical Science Co. Ltd&lt;s&gt;105&lt;/s&gt; Manufactured for: Fosun Pharma USA Inc.</td>\n",
       "      <td></td>\n",
       "      <td>COVID-19 RT-PCR &lt;s&gt;Detection Kit&lt;/s&gt; Real-time RT-PCR for qualitative detection of SARS-CoV-2 ORF1ab, N and E gene targets  Real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper and lower respiratory specimens (such as anterior</td>\n",
       "      <td>99.51% (203/204)&lt;s&gt;106&lt;/s&gt;</td>\n",
       "      <td>96.44% (379/393)&lt;s&gt;106&lt;/s&gt;</td>\n",
       "      <td>Available.  EUA issued on 17th April 2020   Received CE mark on 17 March 2020.   Received emergency approval from the National Medical Products Administration</td>\n",
       "      <td>Within 2 Hours</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>nasal swabs, mid-turbinate nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) from individuals suspected of COVID-19. Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper and lower respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>(NMPA) on 27 March 2020.   Approved for inclusion in the Australian Register of Therapeutic Goods on 8 May 2020&lt;s&gt;107&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Roche&lt;s&gt;123-126&lt;/s&gt; Switzerland</td>\n",
       "      <td>31 Jan 2020</td>\n",
       "      <td>Cobas SARS-CoV-2 Test Runs on the Cobas 6800/8800 systems. Tests for two gene targets: ORF1ab &amp; E.</td>\n",
       "      <td>100% (50/50)  50 nasopharyngeal swab clinical samples spiked with cultured SARS-CoV-2 virus Low (1.5x LoD) and moderate (4x LoD)</td>\n",
       "      <td>100% (100/100)  100 nasopharyngeal swab clinical samples serve as negative controls.&lt;s&gt;126&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 13 Mar 2020.&lt;s&gt;125&lt;/s&gt; CE Mark for IVD.</td>\n",
       "      <td>3 hr 30 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>contrived positive samples &lt;s&gt;126&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Approved for inclusion on the Australia’s ARTG on 20 March 2020.  Date of HSA Provisional Authorisation: 19/03/2020&lt;s&gt;127&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Fulgent Therapeutics, LLC&lt;s&gt;168&lt;/s&gt; USA</td>\n",
       "      <td>11 Mar 2020</td>\n",
       "      <td>COVID-19 Virus Testing by RT-PCR  Real-time RT-PCR for the qualitative detection of SARS-CoV-2 N1 and N2</td>\n",
       "      <td>&lt;s&gt;100% (30/30)&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;100% (64/64)&lt;/s&gt;</td>\n",
       "      <td>Submitted to US FDA for EUA Approval.  Commercially Available&lt;s&gt;169&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>genes in upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal direct swab specimens)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>FDA EUA issued on 15/5/2020&lt;s&gt;170&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Quidel&lt;s&gt;181,182&lt;/s&gt; USA</td>\n",
       "      <td>17 Mar 2020</td>\n",
       "      <td>Lyra SARS-CoV-2 Assay Identification of the SARS-CoV-2 virus occurs by the use of target specific primers and fluorescent-labeled 102 probes that hybridize to a conserved region of the non-structural Polyprotein</td>\n",
       "      <td>100% (92/92)  92 nasopharyngeal swab specimens were spiked with SARS-CoV-2 RNA (1x to 5x LoD) serving as contrived positive samples.&lt;s&gt;182&lt;/s&gt;</td>\n",
       "      <td>(100% (92/92)  92 nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;182&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 17 Mar 2020.</td>\n",
       "      <td>45 min cycle time per gene</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>(pp1ab) of the SARS-CoV-2 virus.&lt;s&gt;183&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>DiaCarta&lt;s&gt;192,193&lt;/s&gt; USA</td>\n",
       "      <td>23 Mar 2020</td>\n",
       "      <td>QuantiVirus SARS-CoV-2 Tests for two gene targets: N, ORF1ab, &amp; E</td>\n",
       "      <td>96.7%</td>\n",
       "      <td>100%</td>\n",
       "      <td>Commercially available.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Clinically validated in the company's CLIA-certified lab in Richmond, California.</td>\n",
       "      <td>Clinically validated in the company's CLIA-certified lab in Richmond, California.</td>\n",
       "      <td>Received CE Mark for IVD Mar 2020.   Obtained EUA approval from US FDA 8 Apr 2020.&lt;s&gt;194&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Mobidiag&lt;s&gt;199&lt;/s&gt;&lt;s&gt;Finland&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>&lt;s&gt;Amplidiag COVID-19&lt;/s&gt; Real-time RT-PCR test with two molecular targets (orf1ab and N) including at least one conserved region and one specific region to mitigate effects of genetic drift and avoid cross-</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available as an emergency use test in Finland and France, set up for routine use in main clinical laboratories in Finland with capacity to test up to 4000 samples a day.&lt;s&gt;200&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;48 samples in &lt;3h&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>reaction with other endemic coronaviruses.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>In the process for obtaining emergency use authorisation in Sweden and the UK. In the process for &lt;s&gt;obtaining CE-IVD.&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>GenScript&lt;s&gt;230,236,237&lt;/s&gt; USA</td>\n",
       "      <td>29 Jan 2020</td>\n",
       "      <td>qRT-PCR Targets RdRp gene, N gene and E gene in Wuhan-Hu-1</td>\n",
       "      <td>“This assay is RUO and has not been tested on clinical samples. We</td>\n",
       "      <td>“This assay may have cross-reactivity with other coronavirus family</td>\n",
       "      <td>Commercially available for RUO.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>genome (GenBank &lt;s&gt;sequences NC_045512.2)&lt;/s&gt;[same as Charite’s first protocol]</td>\n",
       "      <td>make no claims on the performance of this assay.” &lt;s&gt;236&lt;/s&gt;</td>\n",
       "      <td>members such as causative agents of the Middle East Respiratory Syndrome (MERS) or Severe Acute Respiratory Syndrome (SARS).”&lt;s&gt;236&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Thermo Fisher Scientific&lt;s&gt;133,243-245&lt;/s&gt; USA</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>TaqPath COVID-19 Combo Kit (previously TaqMan 2019-nCoV Assay Kit) Real-time RT-PCR kit assays specifically target all 44 complete genomes currently available at GISAID, and do not target any of the 2,116 complete</td>\n",
       "      <td>100% (60/60)  30 nasopharyngeal swab specimens and 30 bronchoalveolar lavage specimens were spiked with extracted SARS-CoV-2 viral genomic RNA (2x to 5x LoD) to</td>\n",
       "      <td>100% (60/60)  30 nasopharyngeal swab specimens and 30 bronchoalveolar lavage specimens were used as negative controls.&lt;s&gt;245&lt;/s&gt;</td>\n",
       "      <td>Commercially available.  Received CE Mark for IVD 26 Mar 2020.&lt;s&gt;246&lt;/s&gt; Obtained EUA approval from US FDA 13 Mar 2020.&lt;s&gt;244&lt;/s&gt;</td>\n",
       "      <td>36 min cycle time per gene target</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>84</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>genomes of other coronaviruses currently available at NCBIm.  Tests for three gene targets: ORF1ab, N, &amp; S.</td>\n",
       "      <td>form 60 contrived positive samples.&lt;s&gt;245&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Obtained HSA provisional approval on 20 March 2020. Approved for inclusion on the Australian Register of Therapeutic Goods on &lt;s&gt;24 March 2020&lt;/s&gt;.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>SD Biosensor&lt;s&gt;151,152&lt;/s&gt; South Korea</td>\n",
       "      <td>28 Feb 2020</td>\n",
       "      <td>STANDARD M n-CoV Real-Time Detection Kit</td>\n",
       "      <td>Sensitivity: 100% (30/30)&lt;s&gt;251&lt;/s&gt;</td>\n",
       "      <td>Specificity: 100% (30/30)&lt;s&gt;251&lt;/s&gt;</td>\n",
       "      <td>Available.</td>\n",
       "      <td>90 min &lt;s&gt;252&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>88</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Tests for two gene targets: E and RdRp.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Obtained EUA approval from Korean CDC 27 Feb 2020.&lt;s&gt;151,152&lt;/s&gt; FDA EUA issued on 23/04/2020</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Wadsworth Center, New York State Department of Public Health&lt;s&gt;194,260&lt;/s&gt; USA</td>\n",
       "      <td>10 Mar 2020</td>\n",
       "      <td>New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel Tests for two gene targets: N1 &amp; N2.</td>\n",
       "      <td>(42/43)  For the easyMAG extraction, 43 individual sputum samples were spiked with the extracted whole SARS-CoV-2 virus genomic RNA (2x</td>\n",
       "      <td>(29/29)  For the easyMAG extraction, 30 individual sputum samples were used but 1 was invalidated, leaving 29 samples. Testing was</td>\n",
       "      <td>Available.   Obtained EUA approval from US FDA  for use in Wadsworth Center, New York State Public</td>\n",
       "      <td>42 min 45 s cycle time per gene target</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>to 200x LoD) to serve as contrived positive samples. Testing was also done with eMAG and EZ1 extraction.&lt;s&gt;260&lt;/s&gt;</td>\n",
       "      <td>also done with eMAG and EZ1 extraction.&lt;s&gt;260&lt;/s&gt;</td>\n",
       "      <td>Department of Health, and the New York City Department of Health and Mental Hygiene, Public Health Laboratories.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Ipsum Diagnostics&lt;s&gt;269,270&lt;/s&gt;</td>\n",
       "      <td>1 Apr 2020</td>\n",
       "      <td>COV-19 IDx assay N1 gene target</td>\n",
       "      <td>100% (36/36)  36 nasopharyngeal swabs spiked with BEI</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>Commercially available.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>ATCC Genomic RNA from SARS Related Coronavirus 2 (not actual clinical sample) serving as contrived positive samples.&lt;s&gt;270&lt;/s&gt;</td>\n",
       "      <td>30 nasopharyngeal swabs serving as negative controls.&lt;s&gt;270&lt;/s&gt;</td>\n",
       "      <td>Obtained EUA approval from US FDA 1 Apr 2020.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>qPCR</td>\n",
       "      <td>Primerdesign&lt;s&gt;286-291&lt;/s&gt;(molecular diagnostics division of Novacyt)</td>\n",
       "      <td>31 Jan 2020</td>\n",
       "      <td>Genesig Real-Time PCR COVID-19 (CE) [Previously Coronavirus (Strain 2019-nCoV) Easy/Standard Kit]&lt;s&gt;287&lt;/s&gt;</td>\n",
       "      <td>96%&lt;s&gt;292&lt;/s&gt;</td>\n",
       "      <td>100%</td>\n",
       "      <td>Commercially available.   Received CE Mark for IVD 17 Feb 2020.&lt;s&gt;293,294&lt;/s&gt;</td>\n",
       "      <td>&lt; 2 hr  64 min 30 s cycle time per gene&lt;s&gt;291&lt;/s&gt;</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td></td>\n",
       "      <td>France/UK</td>\n",
       "      <td></td>\n",
       "      <td>Can run on multiple molecular testing platforms, including Primerdesign’s own genesig® q16 and q32 instrument</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Obtained EUA approval from US FDA 20 Mar 2020.&lt;s&gt;290&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>bioMérieux SA&lt;s&gt;321&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>ARGENE®  SARS-CoV-2 R-gene test Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal</td>\n",
       "      <td>100% (76/76)</td>\n",
       "      <td>100% (50/50)</td>\n",
       "      <td>FDA EUA issued on 6 May 2020&lt;s&gt;322&lt;/s&gt; CE marked on 10 April 2020, validated in France since 11 March 2020.</td>\n",
       "      <td>4-5 Hours</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes and bronchoalveolar lavage (BAL) fluid.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Rutgers Clinical Genomics Laboratory at RUCDR Infinite Biologics - Rutgers University</td>\n",
       "      <td></td>\n",
       "      <td>Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal swab, mid-turbinate nasal swab, and</td>\n",
       "      <td>100% for nasopharyngeal and oropharyngeal swabs (30/30) as well as saliva</td>\n",
       "      <td>100% for nasopharyngeal and oropharyngeal swabs (30/30) as well as saliva</td>\n",
       "      <td>FDA EUA issued on 7 May 2020&lt;s&gt;325&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>127</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>bronchoalveolar lavage &lt;s&gt;(BAL) fluid.&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>131</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>GeneMatrix, Inc.&lt;s&gt;329&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>NeoPlexTM COVID-19 Detection Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal, oropharyngeal and nasal swab specimens as well as nasopharyngeal</td>\n",
       "      <td>100% for nasopharyngeal, oropharyngeal and sputum samples (40/40)</td>\n",
       "      <td>100% for nasopharyngeal, oropharyngeal and sputum samples (40/40)</td>\n",
       "      <td>FDA EUA issued on 14 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>132</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>wash/aspirate and nasal aspirate specimens.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>P23 Labs &lt;s&gt;335&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>P23 Labs TaqPath SARS-CoV-2 Assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab,</td>\n",
       "      <td>100% (31/31)</td>\n",
       "      <td>100% (11/11)</td>\n",
       "      <td>FDA EUA issued on 21 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>138</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens as well as bronchoalveolar lavage (BAL) specimens.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>142</th>\n",
       "      <td>Genome sequencing</td>\n",
       "      <td>Oxford Nanopore&lt;s&gt;338,339&lt;/s&gt; UK</td>\n",
       "      <td>22 Jan 2020</td>\n",
       "      <td>Works with public health labs globally to support rapid sequencing of SARS-CoV-2 through sharing of methods / workflows.   Nanopore sequencing workflows can provide a</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available. 28 January: US Centers for Disease Control and Prevention (CDC) releases nCoV genomes sequenced with nanopore sequencing</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>143</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>consensus viral genome from sample within a day.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>29 January: A paper in the Lancet characterised full-length genomes of 2019-nCoV patients using Nanopore sequencing, providing important information on possible virus origins and cell-binding receptors that is crucial for determining viral transmission capacity.  30 March: Singapore sequences its genome in less than 7 hours  14 April: In the UK, more than 600 genomes have been uploaded onto GISAID, using nanopore sequencing&lt;s&gt;340&lt;/s&gt;.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>144</th>\n",
       "      <td>End-to-end solution of sample processing to epidemiological info generation</td>\n",
       "      <td>Oxford Nanopore&lt;s&gt;338,341&lt;/s&gt; UK</td>\n",
       "      <td>22 Jan 2020</td>\n",
       "      <td>ARTIC project  A ‘lab-in-a-suitcase’ solution for processing samples from viral outbreaks, to generating real-time epidemiological information interpretable and actionable by public health bodies.  Deployable to remote/resource-limited locations.  Based on viral genome data generated prospectively during similar outbreaks (eg. MERS, SARS etc).</td>\n",
       "      <td>Not stated but described to have high sensitivity compared to metagenomic approaches.&lt;s&gt;342&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available  3 February: First Belgian nCoV sample arrives in a lab at 5pm and using the ARTIC protocol, the sequence is completed by 9am.  3 March: The SARS-CoV2 virus from Scotland’s first case is sequenced in under 24 hours using nanopore sequencing and the ARTIC protocol&lt;s&gt;340&lt;/s&gt;.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>145</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Relies on direct amplification of the virus using tiled, multiplexed primers.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>Microfluidic</td>\n",
       "      <td>QIAGEN&lt;s&gt;353-355&lt;/s&gt; The Netherlands</td>\n",
       "      <td>10 Feb 2020</td>\n",
       "      <td>QIAStat-Dx Respiratory SARS-CoV-2 Panel [Plus]</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>Commercially available.</td>\n",
       "      <td>About an hour (Press release:&lt;s&gt;356&lt;/s&gt;)</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>151</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Tests for two gene targets: ORF1b recommended by the Chinese CDC and N recommended by the US CDC.</td>\n",
       "      <td>Evaluated using 10 positive clinical samples and 20 low positive contrived samples (1x–2x LOD) from retrospective nasopharyngeal swab clinical specimens in transport medium.&lt;s&gt;355&lt;/s&gt;</td>\n",
       "      <td>Evaluated using 30 negative samples from retrospective nasopharyngeal swab clinical specimens in transport medium.&lt;s&gt;355&lt;/s&gt;</td>\n",
       "      <td>Obtained EUA approval from US FDA 30 Mar 2020.&lt;s&gt;354&lt;/s&gt; Approved for inclusion in the Australian Register of Therapeutic Goods on 8 May 2020</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>CRISPR-based diagnostics</td>\n",
       "      <td>Sherlock Biosciences&lt;s&gt;34,142,29&lt;/s&gt;&lt;s&gt;5,367&lt;/s&gt; (Plus collaboration with Cepheid)&lt;s&gt;142&lt;/s&gt; USA</td>\n",
       "      <td>24 Jan 2020</td>\n",
       "      <td>SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing)  SHERLOCK platform uses various CRISPR proteins (Cas13, Cas12a, and Csm6) to allow for simultaneous detection of multiple nucleic acids.&lt;s&gt;142&lt;/s&gt; Designed to detect RNA from upper respiratory specimens (such as nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, nasopharyngeal wash/aspirate or nasal aspirate) and bronchoalveolar lavage specimens. Step one is a reverse transcriptase loop-mediated amplification (RT-LAMP) where targeted</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>100%</td>\n",
       "      <td>Protocol published 14 Feb 2020.&lt;s&gt;368,369&lt;/s&gt; FDA EUA issued on 6/5/2020&lt;s&gt;370&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>159</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>SARS-CoV-2 genomic RNA is reverse transcribed to DNA, and this DNA is amplified by a strand-displacing DNA polymerase. Step two is the transcription of the amplified DNA to activate the collateral cleavage activity of a CRISPR complex programmed to the target RNA sequence.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Shenzen YHLO Biotech Co. Ltd (China)&lt;s&gt;401&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>iFlash 8000 CLIA analyser&lt;s&gt;402&lt;/s&gt; Fully Automated chemiluminescent immunoassay for anti-</td>\n",
       "      <td>Sensitivity: 81.5% for IgM, 100% for IgG&lt;s&gt;402&lt;/s&gt;</td>\n",
       "      <td>Specificity: 88.1% for IgM, 92.8% for IgG&lt;s&gt;402&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>185</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>SARS-CoV-2 IgM and IgG &lt;s&gt;antibodies.&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>191</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Hangzhou Realy Tech Co Ltd   China</td>\n",
       "      <td></td>\n",
       "      <td>2019-nCOV/COVID-19 &lt;s&gt;IgG/IgM Rapid Test Device&lt;/s&gt; &lt;s&gt;Lateral flow IgG/IgM&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Approved for inclusion on the Australian Register of Therapeutic Goods on 16 April 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>192</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>&lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Guangzhou Wondfo Biotech&lt;s&gt;44-&lt;/s&gt;&lt;s&gt;48&lt;/s&gt; China</td>\n",
       "      <td>20 Feb 2020</td>\n",
       "      <td>Wondfo SARS-CoV-2 Antibody Test (Lateral Flow Method)  Colloidal gold method for IgM and IgG antibody detection.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available.   Approved by China’s NMPA.  Received CE Mark Mar 2020.&lt;s&gt;48,49&lt;/s&gt; Obtained HSA provisional approval on 9 April 2020, supplied through SkyQuest Pte Ltd.&lt;s&gt;410&lt;/s&gt; Approved for inclusion on the Australian Register of Therapeutic Goods on 25 March 2020.&lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>15 min (unclear if serum/plasma extraction time included or not)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>196</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 27 April 2020&lt;s&gt;411&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>205</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Shanghai LiangRun &lt;s&gt;420&lt;/s&gt; China</td>\n",
       "      <td>27 April 2020</td>\n",
       "      <td>LionRun Diagnostic Kit for Antibody IgM-IgG of Novel Coronavirus COVID-19</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 27 April 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>206</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>An in vitro diagnostic test for the qualitative and differential detection of IgM and IgG antibodies against SARS-CoV-2</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>211</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Atlaslink Beijing Technology Co Ltd (China) &lt;s&gt;425&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>NOVA Test® COVID-19 IgG/IgM Antibody Test (Colloidal Gold) Qualitative detection of IgG/IgM antibodies to</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Approved for inclusion into the Australian Register of Therapeutic Goods on 18 May 2020</td>\n",
       "      <td>10 mins</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>212</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>SARS-CoV-2 in human serum, plasma or whole blood.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>215</th>\n",
       "      <td>IgM antibody immunoassay</td>\n",
       "      <td>Innovita Biological Technology&lt;s&gt;44&lt;/s&gt; China</td>\n",
       "      <td>23 Feb 2020</td>\n",
       "      <td>2019-nCoV Antibody Test &lt;s&gt;(colloidal gold)&lt;/s&gt; IgG and IgM antibody detection from venous whole blood/ plasma/ serum samples</td>\n",
       "      <td>87.3% &lt;s&gt;428&lt;/s&gt;</td>\n",
       "      <td>100% &lt;s&gt;428&lt;/s&gt;</td>\n",
       "      <td>Available commercially.  Approved by China’s NMPA.  Approved for inclusion on the Australian Register of Therapeutic Goods.&lt;s&gt;81&lt;/s&gt; CE-IVD approved. &lt;s&gt;3&lt;/s&gt; Partnered with Scanwell Health to be distributed in US, together with an accompanying smartphone app,</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Projected to be $70 as distributed by Scanwell Health &lt;s&gt;428&lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>216</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>pending US FDA EUA approval. &lt;s&gt;428&lt;/s&gt; Date of Provisional Authorisation from HSA: 27 April 2020</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>224</th>\n",
       "      <td>Neutralising Antibodies test</td>\n",
       "      <td>Genscript Biotech (Singapore) Pte Ltd, in collaboration with Duke-NUS Medical School &lt;s&gt;40,41&lt;/s&gt; (Professor Wang Linfa) and A*Star DxD Hub&lt;s&gt;446&lt;/s&gt;</td>\n",
       "      <td>26 Feb 2020</td>\n",
       "      <td>SARS-CoV-2 Neutralization Antibody Detection Kit  Blocking assay intended for the qualitative detection of neutralization antibodies against SARS-CoV-2 in human serum</td>\n",
       "      <td>At a cutoff inhibition of 20%: 100% (evaluated using 77 COVID-19 patients in Singapore), 98% (evaluated using 50 COVID-19 patients in Nanjing, China)   At a cutoff inhibition of 40%: 95.6% (evaluated using 77 COVID-19 patients in Singapore), 96% (evaluated using 50</td>\n",
       "      <td>100% (75/75 in cohort done in Singapore; 50/50 in cohort done in Nanjing, China)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 8 May 2020&lt;s&gt;447&lt;/s&gt;</td>\n",
       "      <td>1-2 hours</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>225</th>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>COVID-19 patients in Nanjing, China)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "1                                                                           Type  \\\n",
       "2                                                                        rRT-PCR   \n",
       "3                                                                                  \n",
       "11                                                                    RT-PCR Kit   \n",
       "12                                                                                 \n",
       "14                                                                    RT-PCR Kit   \n",
       "15                                                                                 \n",
       "21                                                                        RT-PCR   \n",
       "22                                                                                 \n",
       "37                                                                        RT-PCR   \n",
       "38                                                                                 \n",
       "42                                                                        RT-PCR   \n",
       "43                                                                                 \n",
       "47                                                                        RT-PCR   \n",
       "48                                                                                 \n",
       "51                                                                        RT-PCR   \n",
       "52                                                                                 \n",
       "77                                                              Real-time RT-PCR   \n",
       "78                                                                                 \n",
       "83                                                              Real-time RT-PCR   \n",
       "84                                                                                 \n",
       "87                                                              Real-time RT-PCR   \n",
       "88                                                                                 \n",
       "93                                                              Real-time RT-PCR   \n",
       "94                                                                                 \n",
       "98                                                              Real-time RT-PCR   \n",
       "99                                                                                 \n",
       "106                                                                         qPCR   \n",
       "107                                                                                \n",
       "122                                                                       RT-PCR   \n",
       "123                                                                                \n",
       "126                                                                       RT-PCR   \n",
       "127                                                                                \n",
       "131                                                                       RT-PCR   \n",
       "132                                                                                \n",
       "137                                                                       RT-PCR   \n",
       "138                                                                                \n",
       "142                                                            Genome sequencing   \n",
       "143                                                                                \n",
       "144  End-to-end solution of sample processing to epidemiological info generation   \n",
       "145                                                                                \n",
       "150                                                                 Microfluidic   \n",
       "151                                                                                \n",
       "158                                                     CRISPR-based diagnostics   \n",
       "159                                                                                \n",
       "184                                                 IgG/IgM antibody immunoassay   \n",
       "185                                                                                \n",
       "191                                                 IgG/IgM antibody immunoassay   \n",
       "192                                                                                \n",
       "195                                 IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "196                                                                                \n",
       "205                                                 IgG/IgM antibody immunoassay   \n",
       "206                                                                                \n",
       "211                                 IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "212                                                                                \n",
       "215                                                     IgM antibody immunoassay   \n",
       "216                                                                                \n",
       "224                                                 Neutralising Antibodies test   \n",
       "225                                                                                \n",
       "\n",
       "1                                                                                                                                             Organisation  \\\n",
       "2                                                                                                                  School of Public Health, The University   \n",
       "3                                                                                                                           of Hong Kong (HKU)<s>13,14</s>   \n",
       "11                                                                                                                              Genosensor, LLC <s>103</s>   \n",
       "12                                                                                                                                                           \n",
       "14                                                     Shanghai Fosun Long March Medical Science Co. Ltd<s>105</s> Manufactured for: Fosun Pharma USA Inc.   \n",
       "15                                                                                                                                                           \n",
       "21                                                                                                                         Roche<s>123-126</s> Switzerland   \n",
       "22                                                                                                                                                           \n",
       "37                                                                                                                 Fulgent Therapeutics, LLC<s>168</s> USA   \n",
       "38                                                                                                                                                           \n",
       "42                                                                                                                                Quidel<s>181,182</s> USA   \n",
       "43                                                                                                                                                           \n",
       "47                                                                                                                              DiaCarta<s>192,193</s> USA   \n",
       "48                                                                                                                                                           \n",
       "51                                                                                                                        Mobidiag<s>199</s><s>Finland</s>   \n",
       "52                                                                                                                                                           \n",
       "77                                                                                                                         GenScript<s>230,236,237</s> USA   \n",
       "78                                                                                                                                                           \n",
       "83                                                                                                          Thermo Fisher Scientific<s>133,243-245</s> USA   \n",
       "84                                                                                                                                                           \n",
       "87                                                                                                                  SD Biosensor<s>151,152</s> South Korea   \n",
       "88                                                                                                                                                           \n",
       "93                                                                          Wadsworth Center, New York State Department of Public Health<s>194,260</s> USA   \n",
       "94                                                                                                                                                           \n",
       "98                                                                                                                         Ipsum Diagnostics<s>269,270</s>   \n",
       "99                                                                                                                                                           \n",
       "106                                                                                  Primerdesign<s>286-291</s>(molecular diagnostics division of Novacyt)   \n",
       "107                                                                                                                                              France/UK   \n",
       "122                                                                                                                                bioMérieux SA<s>321</s>   \n",
       "123                                                                                                                                                          \n",
       "126                                                                  Rutgers Clinical Genomics Laboratory at RUCDR Infinite Biologics - Rutgers University   \n",
       "127                                                                                                                                                          \n",
       "131                                                                                                                             GeneMatrix, Inc.<s>329</s>   \n",
       "132                                                                                                                                                          \n",
       "137                                                                                                                                    P23 Labs <s>335</s>   \n",
       "138                                                                                                                                                          \n",
       "142                                                                                                                       Oxford Nanopore<s>338,339</s> UK   \n",
       "143                                                                                                                                                          \n",
       "144                                                                                                                       Oxford Nanopore<s>338,341</s> UK   \n",
       "145                                                                                                                                                          \n",
       "150                                                                                                                   QIAGEN<s>353-355</s> The Netherlands   \n",
       "151                                                                                                                                                          \n",
       "158                                                       Sherlock Biosciences<s>34,142,29</s><s>5,367</s> (Plus collaboration with Cepheid)<s>142</s> USA   \n",
       "159                                                                                                                                                          \n",
       "184                                                                                                         Shenzen YHLO Biotech Co. Ltd (China)<s>401</s>   \n",
       "185                                                                                                                                                          \n",
       "191                                                                                                                     Hangzhou Realy Tech Co Ltd   China   \n",
       "192                                                                                                                                                          \n",
       "195                                                                                                      Guangzhou Wondfo Biotech<s>44-</s><s>48</s> China   \n",
       "196                                                                                                                                                          \n",
       "205                                                                                                                     Shanghai LiangRun <s>420</s> China   \n",
       "206                                                                                                                                                          \n",
       "211                                                                                                 Atlaslink Beijing Technology Co Ltd (China) <s>425</s>   \n",
       "212                                                                                                                                                          \n",
       "215                                                                                                          Innovita Biological Technology<s>44</s> China   \n",
       "216                                                                                                                                                          \n",
       "224  Genscript Biotech (Singapore) Pte Ltd, in collaboration with Duke-NUS Medical School <s>40,41</s> (Professor Wang Linfa) and A*Star DxD Hub<s>446</s>   \n",
       "225                                                                                                                                                          \n",
       "\n",
       "1             Date  \\\n",
       "2      16 Jan 2020   \n",
       "3                    \n",
       "11                   \n",
       "12                   \n",
       "14                   \n",
       "15                   \n",
       "21     31 Jan 2020   \n",
       "22                   \n",
       "37     11 Mar 2020   \n",
       "38                   \n",
       "42     17 Mar 2020   \n",
       "43                   \n",
       "47     23 Mar 2020   \n",
       "48                   \n",
       "51                   \n",
       "52                   \n",
       "77     29 Jan 2020   \n",
       "78                   \n",
       "83      4 Feb 2020   \n",
       "84                   \n",
       "87     28 Feb 2020   \n",
       "88                   \n",
       "93     10 Mar 2020   \n",
       "94                   \n",
       "98      1 Apr 2020   \n",
       "99                   \n",
       "106    31 Jan 2020   \n",
       "107                  \n",
       "122                  \n",
       "123                  \n",
       "126                  \n",
       "127                  \n",
       "131                  \n",
       "132                  \n",
       "137                  \n",
       "138                  \n",
       "142    22 Jan 2020   \n",
       "143                  \n",
       "144    22 Jan 2020   \n",
       "145                  \n",
       "150    10 Feb 2020   \n",
       "151                  \n",
       "158    24 Jan 2020   \n",
       "159                  \n",
       "184                  \n",
       "185                  \n",
       "191                  \n",
       "192                  \n",
       "195    20 Feb 2020   \n",
       "196                  \n",
       "205  27 April 2020   \n",
       "206                  \n",
       "211                  \n",
       "212                  \n",
       "215    23 Feb 2020   \n",
       "216                  \n",
       "224    26 Feb 2020   \n",
       "225                  \n",
       "\n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Test  \\\n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Primer and Probe   \n",
       "3                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Assay 1 (Target: ORF1b-nsp14 gene)  Assay 2 (Target: N gene)   \n",
       "11                                                                                                                                                                                                                                                                                                                                                                                                                          <s>GS COVID-19 RT-PCR Kit</s> Real-time reverse transcription polymerase chain reaction test intended   \n",
       "12                                                                                                                                                                                                                                                                           for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal/oropharyngeal swabs, nasal swabs, mid-turbinate swabs from individuals suspected of COVID-19. Positive results are indicative of the presence of SARS-CoV-2 RNA.   \n",
       "14                                                                                                                                                                                                                                        COVID-19 RT-PCR <s>Detection Kit</s> Real-time RT-PCR for qualitative detection of SARS-CoV-2 ORF1ab, N and E gene targets  Real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper and lower respiratory specimens (such as anterior   \n",
       "15                            nasal swabs, mid-turbinate nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) from individuals suspected of COVID-19. Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper and lower respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA.   \n",
       "21                                                                                                                                                                                                                                                                                                                                                                                                                             Cobas SARS-CoV-2 Test Runs on the Cobas 6800/8800 systems. Tests for two gene targets: ORF1ab & E.   \n",
       "22                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "37                                                                                                                                                                                                                                                                                                                                                                                                                       COVID-19 Virus Testing by RT-PCR  Real-time RT-PCR for the qualitative detection of SARS-CoV-2 N1 and N2   \n",
       "38                                                                                                                                                                                                                                                                                                                                                                                                                          genes in upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal direct swab specimens)   \n",
       "42                                                                                                                                                                                                                                                                                                            Lyra SARS-CoV-2 Assay Identification of the SARS-CoV-2 virus occurs by the use of target specific primers and fluorescent-labeled 102 probes that hybridize to a conserved region of the non-structural Polyprotein   \n",
       "43                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     (pp1ab) of the SARS-CoV-2 virus.<s>183</s>   \n",
       "47                                                                                                                                                                                                                                                                                                                                                                                                                                                              QuantiVirus SARS-CoV-2 Tests for two gene targets: N, ORF1ab, & E   \n",
       "48                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "51                                                                                                                                                                                                                                                                                                                <s>Amplidiag COVID-19</s> Real-time RT-PCR test with two molecular targets (orf1ab and N) including at least one conserved region and one specific region to mitigate effects of genetic drift and avoid cross-   \n",
       "52                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     reaction with other endemic coronaviruses.   \n",
       "77                                                                                                                                                                                                                                                                                                                                                                                                                                                                     qRT-PCR Targets RdRp gene, N gene and E gene in Wuhan-Hu-1   \n",
       "78                                                                                                                                                                                                                                                                                                                                                                                                                                                genome (GenBank <s>sequences NC_045512.2)</s>[same as Charite’s first protocol]   \n",
       "83                                                                                                                                                                                                                                                                                                          TaqPath COVID-19 Combo Kit (previously TaqMan 2019-nCoV Assay Kit) Real-time RT-PCR kit assays specifically target all 44 complete genomes currently available at GISAID, and do not target any of the 2,116 complete   \n",
       "84                                                                                                                                                                                                                                                                                                                                                                                                                    genomes of other coronaviruses currently available at NCBIm.  Tests for three gene targets: ORF1ab, N, & S.   \n",
       "87                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       STANDARD M n-CoV Real-Time Detection Kit   \n",
       "88                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Tests for two gene targets: E and RdRp.   \n",
       "93                                                                                                                                                                                                                                                                                                                                                                                                                                     New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel Tests for two gene targets: N1 & N2.   \n",
       "94                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "98                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                COV-19 IDx assay N1 gene target   \n",
       "99                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  \n",
       "106                                                                                                                                                                                                                                                                                                                                                                                                                   Genesig Real-Time PCR COVID-19 (CE) [Previously Coronavirus (Strain 2019-nCoV) Easy/Standard Kit]<s>287</s>   \n",
       "107                                                                                                                                                                                                                                                                                                                                                                                                                 Can run on multiple molecular testing platforms, including Primerdesign’s own genesig® q16 and q32 instrument   \n",
       "122                                                                                                                                                                                                                                                                                                                                                    ARGENE®  SARS-CoV-2 R-gene test Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal   \n",
       "123                                                                                                                                                                                                                                                                                                                                                                                                                       swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes and bronchoalveolar lavage (BAL) fluid.   \n",
       "126                                                                                                                                                                                                                                                                                    Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal swab, mid-turbinate nasal swab, and   \n",
       "127                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    bronchoalveolar lavage <s>(BAL) fluid.</s>   \n",
       "131                                                                                                                                                                                                                                                                                                                                     NeoPlexTM COVID-19 Detection Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal, oropharyngeal and nasal swab specimens as well as nasopharyngeal   \n",
       "132                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   wash/aspirate and nasal aspirate specimens.   \n",
       "137                                                                                                                                                                                                                                                                                                                                                                   P23 Labs TaqPath SARS-CoV-2 Assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab,   \n",
       "138                                                                                                                                                                                                                                                                                                                                                                     anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens as well as bronchoalveolar lavage (BAL) specimens.   \n",
       "142                                                                                                                                                                                                                                                                                                                                                        Works with public health labs globally to support rapid sequencing of SARS-CoV-2 through sharing of methods / workflows.   Nanopore sequencing workflows can provide a   \n",
       "143                                                                                                                                                                                                                                                                                                                                                                                                                                                                              consensus viral genome from sample within a day.   \n",
       "144                                                                                                                                                                     ARTIC project  A ‘lab-in-a-suitcase’ solution for processing samples from viral outbreaks, to generating real-time epidemiological information interpretable and actionable by public health bodies.  Deployable to remote/resource-limited locations.  Based on viral genome data generated prospectively during similar outbreaks (eg. MERS, SARS etc).   \n",
       "145                                                                                                                                                                                                                                                                                                                                                                                                                                                 Relies on direct amplification of the virus using tiled, multiplexed primers.   \n",
       "150                                                                                                                                                                                                                                                                                                                                                                                                                                                                                QIAStat-Dx Respiratory SARS-CoV-2 Panel [Plus]   \n",
       "151                                                                                                                                                                                                                                                                                                                                                                                                                             Tests for two gene targets: ORF1b recommended by the Chinese CDC and N recommended by the US CDC.   \n",
       "158  SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing)  SHERLOCK platform uses various CRISPR proteins (Cas13, Cas12a, and Csm6) to allow for simultaneous detection of multiple nucleic acids.<s>142</s> Designed to detect RNA from upper respiratory specimens (such as nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, nasopharyngeal wash/aspirate or nasal aspirate) and bronchoalveolar lavage specimens. Step one is a reverse transcriptase loop-mediated amplification (RT-LAMP) where targeted   \n",
       "159                                                                                                                                                                                                                                             SARS-CoV-2 genomic RNA is reverse transcribed to DNA, and this DNA is amplified by a strand-displacing DNA polymerase. Step two is the transcription of the amplified DNA to activate the collateral cleavage activity of a CRISPR complex programmed to the target RNA sequence.   \n",
       "184                                                                                                                                                                                                                                                                                                                                                                                                                                    iFlash 8000 CLIA analyser<s>402</s> Fully Automated chemiluminescent immunoassay for anti-   \n",
       "185                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     SARS-CoV-2 IgM and IgG <s>antibodies.</s>   \n",
       "191                                                                                                                                                                                                                                                                                                                                                                                                                                               2019-nCOV/COVID-19 <s>IgG/IgM Rapid Test Device</s> <s>Lateral flow IgG/IgM</s>   \n",
       "192                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "195                                                                                                                                                                                                                                                                                                                                                                                                              Wondfo SARS-CoV-2 Antibody Test (Lateral Flow Method)  Colloidal gold method for IgM and IgG antibody detection.   \n",
       "196                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "205                                                                                                                                                                                                                                                                                                                                                                                                                                                     LionRun Diagnostic Kit for Antibody IgM-IgG of Novel Coronavirus COVID-19   \n",
       "206                                                                                                                                                                                                                                                                                                                                                                                                       An in vitro diagnostic test for the qualitative and differential detection of IgM and IgG antibodies against SARS-CoV-2   \n",
       "211                                                                                                                                                                                                                                                                                                                                                                                                                     NOVA Test® COVID-19 IgG/IgM Antibody Test (Colloidal Gold) Qualitative detection of IgG/IgM antibodies to   \n",
       "212                                                                                                                                                                                                                                                                                                                                                                                                                                                                             SARS-CoV-2 in human serum, plasma or whole blood.   \n",
       "215                                                                                                                                                                                                                                                                                                                                                                                                 2019-nCoV Antibody Test <s>(colloidal gold)</s> IgG and IgM antibody detection from venous whole blood/ plasma/ serum samples   \n",
       "216                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "224                                                                                                                                                                                                                                                                                                                                                        SARS-CoV-2 Neutralization Antibody Detection Kit  Blocking assay intended for the qualitative detection of neutralization antibodies against SARS-CoV-2 in human serum   \n",
       "225                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 \n",
       "\n",
       "1                                                                                                                                                                                                                                                                  Sensitivity  \\\n",
       "2                                                                                                                                                                         Positive control using SARS-CoV RNA Wide dynamic range of 2<s>-4</s> to 2000 TCID<s>50</s>/reaction.   \n",
       "3                                                                                                                                                                                                                                                                                \n",
       "11                                                                                                                                                                                                                                                         <s>100% (32/32)</s>   \n",
       "12                                                                                                                                                                                                                                                                               \n",
       "14                                                                                                                                                                                                                                                  99.51% (203/204)<s>106</s>   \n",
       "15                                                                                                                                                                                                                                                                               \n",
       "21                                                                                                                                            100% (50/50)  50 nasopharyngeal swab clinical samples spiked with cultured SARS-CoV-2 virus Low (1.5x LoD) and moderate (4x LoD)   \n",
       "22                                                                                                                                                                                                                                       contrived positive samples <s>126</s>   \n",
       "37                                                                                                                                                                                                                                                         <s>100% (30/30)</s>   \n",
       "38                                                                                                                                                                                                                                                                               \n",
       "42                                                                                                                              100% (92/92)  92 nasopharyngeal swab specimens were spiked with SARS-CoV-2 RNA (1x to 5x LoD) serving as contrived positive samples.<s>182</s>   \n",
       "43                                                                                                                                                                                                                                                                               \n",
       "47                                                                                                                                                                                                                                                                       96.7%   \n",
       "48                                                                                                                                                                                           Clinically validated in the company's CLIA-certified lab in Richmond, California.   \n",
       "51                                                                                                                                                                                                                                                                   (no info)   \n",
       "52                                                                                                                                                                                                                                                                               \n",
       "77                                                                                                                                                                                                          “This assay is RUO and has not been tested on clinical samples. We   \n",
       "78                                                                                                                                                                                                                make no claims on the performance of this assay.” <s>236</s>   \n",
       "83                                                                                                            100% (60/60)  30 nasopharyngeal swab specimens and 30 bronchoalveolar lavage specimens were spiked with extracted SARS-CoV-2 viral genomic RNA (2x to 5x LoD) to   \n",
       "84                                                                                                                                                                                                                               form 60 contrived positive samples.<s>245</s>   \n",
       "87                                                                                                                                                                                                                                         Sensitivity: 100% (30/30)<s>251</s>   \n",
       "88                                                                                                                                                                                                                                                                               \n",
       "93                                                                                                                                     (42/43)  For the easyMAG extraction, 43 individual sputum samples were spiked with the extracted whole SARS-CoV-2 virus genomic RNA (2x   \n",
       "94                                                                                                                                                          to 200x LoD) to serve as contrived positive samples. Testing was also done with eMAG and EZ1 extraction.<s>260</s>   \n",
       "98                                                                                                                                                                                                                       100% (36/36)  36 nasopharyngeal swabs spiked with BEI   \n",
       "99                                                                                                                                              ATCC Genomic RNA from SARS Related Coronavirus 2 (not actual clinical sample) serving as contrived positive samples.<s>270</s>   \n",
       "106                                                                                                                                                                                                                                                              96%<s>292</s>   \n",
       "107                                                                                                                                                                                                                                                                              \n",
       "122                                                                                                                                                                                                                                                               100% (76/76)   \n",
       "123                                                                                                                                                                                                                                                                              \n",
       "126                                                                                                                                                                                                  100% for nasopharyngeal and oropharyngeal swabs (30/30) as well as saliva   \n",
       "127                                                                                                                                                                                                                                                                              \n",
       "131                                                                                                                                                                                                          100% for nasopharyngeal, oropharyngeal and sputum samples (40/40)   \n",
       "132                                                                                                                                                                                                                                                                              \n",
       "137                                                                                                                                                                                                                                                               100% (31/31)   \n",
       "138                                                                                                                                                                                                                                                                              \n",
       "142                                                                                                                                                                                                                                                                  (no info)   \n",
       "143                                                                                                                                                                                                                                                                              \n",
       "144                                                                                                                                                                            Not stated but described to have high sensitivity compared to metagenomic approaches.<s>342</s>   \n",
       "145                                                                                                                                                                                                                                                                              \n",
       "150                                                                                                                                                                                                                                                               100% (30/30)   \n",
       "151                                                                                    Evaluated using 10 positive clinical samples and 20 low positive contrived samples (1x–2x LOD) from retrospective nasopharyngeal swab clinical specimens in transport medium.<s>355</s>   \n",
       "158                                                                                                                                                                                                                                                               100% (30/30)   \n",
       "159                                                                                                                                                                                                                                                                              \n",
       "184                                                                                                                                                                                                                         Sensitivity: 81.5% for IgM, 100% for IgG<s>402</s>   \n",
       "185                                                                                                                                                                                                                                                                              \n",
       "191                                                                                                                                                                                                                                                                  (no info)   \n",
       "192                                                                                                                                                                                                                                                                              \n",
       "195                                                                                                                                                                                                                                                                  (no info)   \n",
       "196                                                                                                                                                                                                                                                                              \n",
       "205                                                                                                                                                                                                                                                                  (no info)   \n",
       "206                                                                                                                                                                                                                                                                              \n",
       "211                                                                                                                                                                                                                                                                  (no info)   \n",
       "212                                                                                                                                                                                                                                                                              \n",
       "215                                                                                                                                                                                                                                                           87.3% <s>428</s>   \n",
       "216                                                                                                                                                                                                                                                                              \n",
       "224  At a cutoff inhibition of 20%: 100% (evaluated using 77 COVID-19 patients in Singapore), 98% (evaluated using 50 COVID-19 patients in Nanjing, China)   At a cutoff inhibition of 40%: 95.6% (evaluated using 77 COVID-19 patients in Singapore), 96% (evaluated using 50   \n",
       "225                                                                                                                                                                                                                                       COVID-19 patients in Nanjing, China)   \n",
       "\n",
       "1                                                                                                                                                                            Specificity  \\\n",
       "2                                                                                                                       Exclusivity  Negative results against all of these preparations:   \n",
       "3    • RNA extracted from cultured viruses • RNA from retrospective human clinical specimens previously tested positive for other infections • RNA from control human clinical specimens   \n",
       "11                                                                                                                                                                   <s>100% (32/32)</s>   \n",
       "12                                                                                                                                                                                         \n",
       "14                                                                                                                                                            96.44% (379/393)<s>106</s>   \n",
       "15                                                                                                                                                                                         \n",
       "21                                                                                        100% (100/100)  100 nasopharyngeal swab clinical samples serve as negative controls.<s>126</s>   \n",
       "22                                                                                                                                                                                         \n",
       "37                                                                                                                                                                   <s>100% (64/64)</s>   \n",
       "38                                                                                                                                                                                         \n",
       "42                                                                                               (100% (92/92)  92 nasopharyngeal swab specimens serving as negative controls.<s>182</s>   \n",
       "43                                                                                                                                                                                         \n",
       "47                                                                                                                                                                                  100%   \n",
       "48                                                                                                     Clinically validated in the company's CLIA-certified lab in Richmond, California.   \n",
       "51                                                                                                                                                                             (no info)   \n",
       "52                                                                                                                                                                                         \n",
       "77                                                                                                                   “This assay may have cross-reactivity with other coronavirus family   \n",
       "78                                               members such as causative agents of the Middle East Respiratory Syndrome (MERS) or Severe Acute Respiratory Syndrome (SARS).”<s>236</s>   \n",
       "83                                                      100% (60/60)  30 nasopharyngeal swab specimens and 30 bronchoalveolar lavage specimens were used as negative controls.<s>245</s>   \n",
       "84                                                                                                                                                                                         \n",
       "87                                                                                                                                                   Specificity: 100% (30/30)<s>251</s>   \n",
       "88                                                                                                                                                                                         \n",
       "93                                                    (29/29)  For the easyMAG extraction, 30 individual sputum samples were used but 1 was invalidated, leaving 29 samples. Testing was   \n",
       "94                                                                                                                                     also done with eMAG and EZ1 extraction.<s>260</s>   \n",
       "98                                                                                                                                                                          100% (30/30)   \n",
       "99                                                                                                                       30 nasopharyngeal swabs serving as negative controls.<s>270</s>   \n",
       "106                                                                                                                                                                                 100%   \n",
       "107                                                                                                                                                                                        \n",
       "122                                                                                                                                                                         100% (50/50)   \n",
       "123                                                                                                                                                                                        \n",
       "126                                                                                                            100% for nasopharyngeal and oropharyngeal swabs (30/30) as well as saliva   \n",
       "127                                                                                                                                                                                        \n",
       "131                                                                                                                    100% for nasopharyngeal, oropharyngeal and sputum samples (40/40)   \n",
       "132                                                                                                                                                                                        \n",
       "137                                                                                                                                                                         100% (11/11)   \n",
       "138                                                                                                                                                                                        \n",
       "142                                                                                                                                                                            (no info)   \n",
       "143                                                                                                                                                                                        \n",
       "144                                                                                                                                                                            (no info)   \n",
       "145                                                                                                                                                                                        \n",
       "150                                                                                                                                                                         100% (30/30)   \n",
       "151                                                         Evaluated using 30 negative samples from retrospective nasopharyngeal swab clinical specimens in transport medium.<s>355</s>   \n",
       "158                                                                                                                                                                                 100%   \n",
       "159                                                                                                                                                                                        \n",
       "184                                                                                                                                  Specificity: 88.1% for IgM, 92.8% for IgG<s>402</s>   \n",
       "185                                                                                                                                                                                        \n",
       "191                                                                                                                                                                            (no info)   \n",
       "192                                                                                                                                                                                        \n",
       "195                                                                                                                                                                            (no info)   \n",
       "196                                                                                                                                                                                        \n",
       "205                                                                                                                                                                            (no info)   \n",
       "206                                                                                                                                                                                        \n",
       "211                                                                                                                                                                            (no info)   \n",
       "212                                                                                                                                                                                        \n",
       "215                                                                                                                                                                      100% <s>428</s>   \n",
       "216                                                                                                                                                                                        \n",
       "224                                                                                                     100% (75/75 in cohort done in Singapore; 50/50 in cohort done in Nanjing, China)   \n",
       "225                                                                                                                                                                                        \n",
       "\n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                              Availability  \\\n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                         Available • Positive control (Available from HKU)   \n",
       "3                                                                                                                                                                                                                                                                                                                                                 Primers and probes: • HKU-ORF1b-nsp14F • HKU- ORF1b-nsp14R • HKU-ORF1b-nsp141P • HKU-NF • HKU-NR • HKU-NP   \n",
       "11                                                                                                                                                                                                                                                                                                                                                                                                               Available.  EUA issued on 16th April 2020.   \n",
       "12                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "14                                                                                                                                                                                                                                                                                           Available.  EUA issued on 17th April 2020   Received CE mark on 17 March 2020.   Received emergency approval from the National Medical Products Administration   \n",
       "15                                                                                                                                                                                                                                                                                                                                (NMPA) on 27 March 2020.   Approved for inclusion in the Australian Register of Therapeutic Goods on 8 May 2020<s>107</s>   \n",
       "21                                                                                                                                                                                                                                                                                                                                                      Commercially available.   Obtained EUA approval from US FDA 13 Mar 2020.<s>125</s> CE Mark for IVD.   \n",
       "22                                                                                                                                                                                                                                                                                                                            Approved for inclusion on the Australia’s ARTG on 20 March 2020.  Date of HSA Provisional Authorisation: 19/03/2020<s>127</s>   \n",
       "37                                                                                                                                                                                                                                                                                                                                                                                  Submitted to US FDA for EUA Approval.  Commercially Available<s>169</s>   \n",
       "38                                                                                                                                                                                                                                                                                                                                                                                                                    FDA EUA issued on 15/5/2020<s>170</s>   \n",
       "42                                                                                                                                                                                                                                                                                                                                                                                 Commercially available.   Obtained EUA approval from US FDA 17 Mar 2020.   \n",
       "43                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "47                                                                                                                                                                                                                                                                                                                                                                                                                                  Commercially available.   \n",
       "48                                                                                                                                                                                                                                                                                                                                                             Received CE Mark for IVD Mar 2020.   Obtained EUA approval from US FDA 8 Apr 2020.<s>194</s>   \n",
       "51                                                                                                                                                                                                                                                                      Available as an emergency use test in Finland and France, set up for routine use in main clinical laboratories in Finland with capacity to test up to 4000 samples a day.<s>200</s>   \n",
       "52                                                                                                                                                                                                                                                                                                                               In the process for obtaining emergency use authorisation in Sweden and the UK. In the process for <s>obtaining CE-IVD.</s>   \n",
       "77                                                                                                                                                                                                                                                                                                                                                                                                                          Commercially available for RUO.   \n",
       "78                                                                                                                                                                                                                                                                                                                                                                                                                                                            \n",
       "83                                                                                                                                                                                                                                                                                                                        Commercially available.  Received CE Mark for IVD 26 Mar 2020.<s>246</s> Obtained EUA approval from US FDA 13 Mar 2020.<s>244</s>   \n",
       "84                                                                                                                                                                                                                                                                                                      Obtained HSA provisional approval on 20 March 2020. Approved for inclusion on the Australian Register of Therapeutic Goods on <s>24 March 2020</s>.   \n",
       "87                                                                                                                                                                                                                                                                                                                                                                                                                                               Available.   \n",
       "88                                                                                                                                                                                                                                                                                                                                                            Obtained EUA approval from Korean CDC 27 Feb 2020.<s>151,152</s> FDA EUA issued on 23/04/2020   \n",
       "93                                                                                                                                                                                                                                                                                                                                                       Available.   Obtained EUA approval from US FDA  for use in Wadsworth Center, New York State Public   \n",
       "94                                                                                                                                                                                                                                                                                                                                         Department of Health, and the New York City Department of Health and Mental Hygiene, Public Health Laboratories.   \n",
       "98                                                                                                                                                                                                                                                                                                                                                                                                                                  Commercially available.   \n",
       "99                                                                                                                                                                                                                                                                                                                                                                                                            Obtained EUA approval from US FDA 1 Apr 2020.   \n",
       "106                                                                                                                                                                                                                                                                                                                                                                           Commercially available.   Received CE Mark for IVD 17 Feb 2020.<s>293,294</s>   \n",
       "107                                                                                                                                                                                                                                                                                                                                                                                                Obtained EUA approval from US FDA 20 Mar 2020.<s>290</s>   \n",
       "122                                                                                                                                                                                                                                                                                                                                             FDA EUA issued on 6 May 2020<s>322</s> CE marked on 10 April 2020, validated in France since 11 March 2020.   \n",
       "123                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "126                                                                                                                                                                                                                                                                                                                                                                                                                  FDA EUA issued on 7 May 2020<s>325</s>   \n",
       "127                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "131                                                                                                                                                                                                                                                                                                                                                                                                                           FDA EUA issued on 14 May 2020   \n",
       "132                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "137                                                                                                                                                                                                                                                                                                                                                                                                                           FDA EUA issued on 21 May 2020   \n",
       "138                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "142                                                                                                                                                                                                                                                                                                                     Available. 28 January: US Centers for Disease Control and Prevention (CDC) releases nCoV genomes sequenced with nanopore sequencing   \n",
       "143  29 January: A paper in the Lancet characterised full-length genomes of 2019-nCoV patients using Nanopore sequencing, providing important information on possible virus origins and cell-binding receptors that is crucial for determining viral transmission capacity.  30 March: Singapore sequences its genome in less than 7 hours  14 April: In the UK, more than 600 genomes have been uploaded onto GISAID, using nanopore sequencing<s>340</s>.   \n",
       "144                                                                                                                                                            Available  3 February: First Belgian nCoV sample arrives in a lab at 5pm and using the ARTIC protocol, the sequence is completed by 9am.  3 March: The SARS-CoV2 virus from Scotland’s first case is sequenced in under 24 hours using nanopore sequencing and the ARTIC protocol<s>340</s>.   \n",
       "145                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "150                                                                                                                                                                                                                                                                                                                                                                                                                                 Commercially available.   \n",
       "151                                                                                                                                                                                                                                                                                                           Obtained EUA approval from US FDA 30 Mar 2020.<s>354</s> Approved for inclusion in the Australian Register of Therapeutic Goods on 8 May 2020   \n",
       "158                                                                                                                                                                                                                                                                                                                                                                      Protocol published 14 Feb 2020.<s>368,369</s> FDA EUA issued on 6/5/2020<s>370</s>   \n",
       "159                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "184                                                                                                                                                                                                                                                                                                                                                                                                                                               (no info)   \n",
       "185                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "191                                                                                                                                                                                                                                                                                                                                                                 Approved for inclusion on the Australian Register of Therapeutic Goods on 16 April 2020   \n",
       "192                                                                                                                                                                                                                                                                                                                                                                                                                                              <s>143</s>   \n",
       "195                                                                                                                                                                       Available.   Approved by China’s NMPA.  Received CE Mark Mar 2020.<s>48,49</s> Obtained HSA provisional approval on 9 April 2020, supplied through SkyQuest Pte Ltd.<s>410</s> Approved for inclusion on the Australian Register of Therapeutic Goods on 25 March 2020.<s>143</s>   \n",
       "196                                                                                                                                                                                                                                                                                                                                                                                     Date of Provisional Authorisation from HSA: 27 April 2020<s>411</s>   \n",
       "205                                                                                                                                                                                                                                                                                                                                                                                               Date of Provisional Authorisation from HSA: 27 April 2020   \n",
       "206                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "211                                                                                                                                                                                                                                                                                                                                                                 Approved for inclusion into the Australian Register of Therapeutic Goods on 18 May 2020   \n",
       "212                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "215                                                                                                                                                                                    Available commercially.  Approved by China’s NMPA.  Approved for inclusion on the Australian Register of Therapeutic Goods.<s>81</s> CE-IVD approved. <s>3</s> Partnered with Scanwell Health to be distributed in US, together with an accompanying smartphone app,   \n",
       "216                                                                                                                                                                                                                                                                                                                                                       pending US FDA EUA approval. <s>428</s> Date of Provisional Authorisation from HSA: 27 April 2020   \n",
       "224                                                                                                                                                                                                                                                                                                                                                                                        Date of Provisional Authorisation from HSA: 8 May 2020<s>447</s>   \n",
       "225                                                                                                                                                                                                                                                                                                                                                                                                                                                           \n",
       "\n",
       "1                                                          Turnaround  \\\n",
       "2                          28 min 40 sec of cycle time for each assay   \n",
       "3                                                                       \n",
       "11                                                          (no info)   \n",
       "12                                                                      \n",
       "14                                                     Within 2 Hours   \n",
       "15                                                                      \n",
       "21                                                        3 hr 30 min   \n",
       "22                                                                      \n",
       "37                                                          (no info)   \n",
       "38                                                                      \n",
       "42                                         45 min cycle time per gene   \n",
       "43                                                                      \n",
       "47                                                          (no info)   \n",
       "48                                                                      \n",
       "51                                           <s>48 samples in <3h</s>   \n",
       "52                                                                      \n",
       "77                                                          (no info)   \n",
       "78                                                                      \n",
       "83                                  36 min cycle time per gene target   \n",
       "84                                                                      \n",
       "87                                                  90 min <s>252</s>   \n",
       "88                                                                      \n",
       "93                             42 min 45 s cycle time per gene target   \n",
       "94                                                                      \n",
       "98                                                          (no info)   \n",
       "99                                                                      \n",
       "106                 < 2 hr  64 min 30 s cycle time per gene<s>291</s>   \n",
       "107                                                                     \n",
       "122                                                         4-5 Hours   \n",
       "123                                                                     \n",
       "126                                                         (no info)   \n",
       "127                                                                     \n",
       "131                                                         (no info)   \n",
       "132                                                                     \n",
       "137                                                         (no info)   \n",
       "138                                                                     \n",
       "142                                                         (no info)   \n",
       "143                                                                     \n",
       "144                                                         (no info)   \n",
       "145                                                                     \n",
       "150                          About an hour (Press release:<s>356</s>)   \n",
       "151                                                                     \n",
       "158                                                         (no info)   \n",
       "159                                                                     \n",
       "184                                                         (no info)   \n",
       "185                                                                     \n",
       "191                                                         (no info)   \n",
       "192                                                                     \n",
       "195  15 min (unclear if serum/plasma extraction time included or not)   \n",
       "196                                                                     \n",
       "205                                                         (no info)   \n",
       "206                                                                     \n",
       "211                                                           10 mins   \n",
       "212                                                                     \n",
       "215                                                         (no info)   \n",
       "216                                                                     \n",
       "224                                                         1-2 hours   \n",
       "225                                                                     \n",
       "\n",
       "1                                                               Costs  \n",
       "2                                                           (no info)  \n",
       "3                                                                      \n",
       "11                                                          (no info)  \n",
       "12                                                                     \n",
       "14                                                          (no info)  \n",
       "15                                                                     \n",
       "21                                                          (no info)  \n",
       "22                                                                     \n",
       "37                                                          (no info)  \n",
       "38                                                                     \n",
       "42                                                          (no info)  \n",
       "43                                                                     \n",
       "47                                                          (no info)  \n",
       "48                                                                     \n",
       "51                                                          (no info)  \n",
       "52                                                                     \n",
       "77                                                         (by quote)  \n",
       "78                                                                     \n",
       "83                                                         (by quote)  \n",
       "84                                                                     \n",
       "87                                                          (no info)  \n",
       "88                                                                     \n",
       "93                                                          (no info)  \n",
       "94                                                                     \n",
       "98                                                          (no info)  \n",
       "99                                                                     \n",
       "106                                                        (by quote)  \n",
       "107                                                                    \n",
       "122                                                         (no info)  \n",
       "123                                                                    \n",
       "126                                                         (no info)  \n",
       "127                                                                    \n",
       "131                                                         (no info)  \n",
       "132                                                                    \n",
       "137                                                         (no info)  \n",
       "138                                                                    \n",
       "142                                                         (no info)  \n",
       "143                                                                    \n",
       "144                                                         (no info)  \n",
       "145                                                                    \n",
       "150                                                        (by quote)  \n",
       "151                                                                    \n",
       "158                                                         (no info)  \n",
       "159                                                                    \n",
       "184                                                         (no info)  \n",
       "185                                                                    \n",
       "191                                                         (no info)  \n",
       "192                                                                    \n",
       "195                                                         (no info)  \n",
       "196                                                                    \n",
       "205                                                         (no info)  \n",
       "206                                                                    \n",
       "211                                                         (no info)  \n",
       "212                                                                    \n",
       "215  Projected to be $70 as distributed by Scanwell Health <s>428</s>  \n",
       "216                                                                    \n",
       "224                                                         (no info)  \n",
       "225                                                                    "
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "to_merge = tests_df.loc[(tests_df.Type.shift(-1) == \"\") | (tests_df.Type == \"\"), :]\n",
    "to_merge"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Dataframe containing merged rows"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>1</th>\n",
       "      <th>Type</th>\n",
       "      <th>Organisation</th>\n",
       "      <th>Date</th>\n",
       "      <th>Test</th>\n",
       "      <th>Sensitivity</th>\n",
       "      <th>Specificity</th>\n",
       "      <th>Availability</th>\n",
       "      <th>Turnaround</th>\n",
       "      <th>Costs</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>School of Public Health, The University of Hong Kong (HKU)&lt;s&gt;13,14&lt;/s&gt;</td>\n",
       "      <td>16 Jan 2020</td>\n",
       "      <td>Primer and Probe Assay 1 (Target: ORF1b-nsp14 gene)  Assay 2 (Target: N gene)</td>\n",
       "      <td>Positive control using SARS-CoV RNA Wide dynamic range of 2&lt;s&gt;-4&lt;/s&gt; to 2000 TCID&lt;s&gt;50&lt;/s&gt;/reaction.</td>\n",
       "      <td>Exclusivity  Negative results against all of these preparations: • RNA extracted from cultured viruses • RNA from retrospective human clinical specimens previously tested positive for other infections • RNA from control human clinical specimens</td>\n",
       "      <td>Available • Positive control (Available from HKU) Primers and probes: • HKU-ORF1b-nsp14F • HKU- ORF1b-nsp14R • HKU-ORF1b-nsp141P • HKU-NF • HKU-NR • HKU-NP</td>\n",
       "      <td>28 min 40 sec of cycle time for each assay</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>Genosensor, LLC &lt;s&gt;103&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>&lt;s&gt;GS COVID-19 RT-PCR Kit&lt;/s&gt; Real-time reverse transcription polymerase chain reaction test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal/oropharyngeal swabs, nasal swabs, mid-turbinate swabs from individuals suspected of COVID-19. Positive results are indicative of the presence of SARS-CoV-2 RNA.</td>\n",
       "      <td>&lt;s&gt;100% (32/32)&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;100% (32/32)&lt;/s&gt;</td>\n",
       "      <td>Available.  EUA issued on 16th April 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>Shanghai Fosun Long March Medical Science Co. Ltd&lt;s&gt;105&lt;/s&gt; Manufactured for: Fosun Pharma USA Inc.</td>\n",
       "      <td></td>\n",
       "      <td>COVID-19 RT-PCR &lt;s&gt;Detection Kit&lt;/s&gt; Real-time RT-PCR for qualitative detection of SARS-CoV-2 ORF1ab, N and E gene targets  Real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper and lower respiratory specimens (such as anterior nasal swabs, mid-turbinate nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) from individuals suspected of COVID-19. Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper and lower respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA.</td>\n",
       "      <td>99.51% (203/204)&lt;s&gt;106&lt;/s&gt;</td>\n",
       "      <td>96.44% (379/393)&lt;s&gt;106&lt;/s&gt;</td>\n",
       "      <td>Available.  EUA issued on 17th April 2020   Received CE mark on 17 March 2020.   Received emergency approval from the National Medical Products Administration (NMPA) on 27 March 2020.   Approved for inclusion in the Australian Register of Therapeutic Goods on 8 May 2020&lt;s&gt;107&lt;/s&gt;</td>\n",
       "      <td>Within 2 Hours</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Roche&lt;s&gt;123-126&lt;/s&gt; Switzerland</td>\n",
       "      <td>31 Jan 2020</td>\n",
       "      <td>Cobas SARS-CoV-2 Test Runs on the Cobas 6800/8800 systems. Tests for two gene targets: ORF1ab &amp; E.</td>\n",
       "      <td>100% (50/50)  50 nasopharyngeal swab clinical samples spiked with cultured SARS-CoV-2 virus Low (1.5x LoD) and moderate (4x LoD) contrived positive samples &lt;s&gt;126&lt;/s&gt;</td>\n",
       "      <td>100% (100/100)  100 nasopharyngeal swab clinical samples serve as negative controls.&lt;s&gt;126&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 13 Mar 2020.&lt;s&gt;125&lt;/s&gt; CE Mark for IVD. Approved for inclusion on the Australia’s ARTG on 20 March 2020.  Date of HSA Provisional Authorisation: 19/03/2020&lt;s&gt;127&lt;/s&gt;</td>\n",
       "      <td>3 hr 30 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Fulgent Therapeutics, LLC&lt;s&gt;168&lt;/s&gt; USA</td>\n",
       "      <td>11 Mar 2020</td>\n",
       "      <td>COVID-19 Virus Testing by RT-PCR  Real-time RT-PCR for the qualitative detection of SARS-CoV-2 N1 and N2 genes in upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal direct swab specimens)</td>\n",
       "      <td>&lt;s&gt;100% (30/30)&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;100% (64/64)&lt;/s&gt;</td>\n",
       "      <td>Submitted to US FDA for EUA Approval.  Commercially Available&lt;s&gt;169&lt;/s&gt; FDA EUA issued on 15/5/2020&lt;s&gt;170&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Quidel&lt;s&gt;181,182&lt;/s&gt; USA</td>\n",
       "      <td>17 Mar 2020</td>\n",
       "      <td>Lyra SARS-CoV-2 Assay Identification of the SARS-CoV-2 virus occurs by the use of target specific primers and fluorescent-labeled 102 probes that hybridize to a conserved region of the non-structural Polyprotein (pp1ab) of the SARS-CoV-2 virus.&lt;s&gt;183&lt;/s&gt;</td>\n",
       "      <td>100% (92/92)  92 nasopharyngeal swab specimens were spiked with SARS-CoV-2 RNA (1x to 5x LoD) serving as contrived positive samples.&lt;s&gt;182&lt;/s&gt;</td>\n",
       "      <td>(100% (92/92)  92 nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;182&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 17 Mar 2020.</td>\n",
       "      <td>45 min cycle time per gene</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>DiaCarta&lt;s&gt;192,193&lt;/s&gt; USA</td>\n",
       "      <td>23 Mar 2020</td>\n",
       "      <td>QuantiVirus SARS-CoV-2 Tests for two gene targets: N, ORF1ab, &amp; E</td>\n",
       "      <td>96.7% Clinically validated in the company's CLIA-certified lab in Richmond, California.</td>\n",
       "      <td>100% Clinically validated in the company's CLIA-certified lab in Richmond, California.</td>\n",
       "      <td>Commercially available. Received CE Mark for IVD Mar 2020.   Obtained EUA approval from US FDA 8 Apr 2020.&lt;s&gt;194&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Mobidiag&lt;s&gt;199&lt;/s&gt;&lt;s&gt;Finland&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>&lt;s&gt;Amplidiag COVID-19&lt;/s&gt; Real-time RT-PCR test with two molecular targets (orf1ab and N) including at least one conserved region and one specific region to mitigate effects of genetic drift and avoid cross- reaction with other endemic coronaviruses.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available as an emergency use test in Finland and France, set up for routine use in main clinical laboratories in Finland with capacity to test up to 4000 samples a day.&lt;s&gt;200&lt;/s&gt; In the process for obtaining emergency use authorisation in Sweden and the UK. In the process for &lt;s&gt;obtaining CE-IVD.&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;48 samples in &lt;3h&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>GenScript&lt;s&gt;230,236,237&lt;/s&gt; USA</td>\n",
       "      <td>29 Jan 2020</td>\n",
       "      <td>qRT-PCR Targets RdRp gene, N gene and E gene in Wuhan-Hu-1 genome (GenBank &lt;s&gt;sequences NC_045512.2)&lt;/s&gt;[same as Charite’s first protocol]</td>\n",
       "      <td>“This assay is RUO and has not been tested on clinical samples. We make no claims on the performance of this assay.” &lt;s&gt;236&lt;/s&gt;</td>\n",
       "      <td>“This assay may have cross-reactivity with other coronavirus family members such as causative agents of the Middle East Respiratory Syndrome (MERS) or Severe Acute Respiratory Syndrome (SARS).”&lt;s&gt;236&lt;/s&gt;</td>\n",
       "      <td>Commercially available for RUO.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Thermo Fisher Scientific&lt;s&gt;133,243-245&lt;/s&gt; USA</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>TaqPath COVID-19 Combo Kit (previously TaqMan 2019-nCoV Assay Kit) Real-time RT-PCR kit assays specifically target all 44 complete genomes currently available at GISAID, and do not target any of the 2,116 complete genomes of other coronaviruses currently available at NCBIm.  Tests for three gene targets: ORF1ab, N, &amp; S.</td>\n",
       "      <td>100% (60/60)  30 nasopharyngeal swab specimens and 30 bronchoalveolar lavage specimens were spiked with extracted SARS-CoV-2 viral genomic RNA (2x to 5x LoD) to form 60 contrived positive samples.&lt;s&gt;245&lt;/s&gt;</td>\n",
       "      <td>100% (60/60)  30 nasopharyngeal swab specimens and 30 bronchoalveolar lavage specimens were used as negative controls.&lt;s&gt;245&lt;/s&gt;</td>\n",
       "      <td>Commercially available.  Received CE Mark for IVD 26 Mar 2020.&lt;s&gt;246&lt;/s&gt; Obtained EUA approval from US FDA 13 Mar 2020.&lt;s&gt;244&lt;/s&gt; Obtained HSA provisional approval on 20 March 2020. Approved for inclusion on the Australian Register of Therapeutic Goods on &lt;s&gt;24 March 2020&lt;/s&gt;.</td>\n",
       "      <td>36 min cycle time per gene target</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>SD Biosensor&lt;s&gt;151,152&lt;/s&gt; South Korea</td>\n",
       "      <td>28 Feb 2020</td>\n",
       "      <td>STANDARD M n-CoV Real-Time Detection Kit Tests for two gene targets: E and RdRp.</td>\n",
       "      <td>Sensitivity: 100% (30/30)&lt;s&gt;251&lt;/s&gt;</td>\n",
       "      <td>Specificity: 100% (30/30)&lt;s&gt;251&lt;/s&gt;</td>\n",
       "      <td>Available. Obtained EUA approval from Korean CDC 27 Feb 2020.&lt;s&gt;151,152&lt;/s&gt; FDA EUA issued on 23/04/2020</td>\n",
       "      <td>90 min &lt;s&gt;252&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Wadsworth Center, New York State Department of Public Health&lt;s&gt;194,260&lt;/s&gt; USA</td>\n",
       "      <td>10 Mar 2020</td>\n",
       "      <td>New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel Tests for two gene targets: N1 &amp; N2.</td>\n",
       "      <td>(42/43)  For the easyMAG extraction, 43 individual sputum samples were spiked with the extracted whole SARS-CoV-2 virus genomic RNA (2x to 200x LoD) to serve as contrived positive samples. Testing was also done with eMAG and EZ1 extraction.&lt;s&gt;260&lt;/s&gt;</td>\n",
       "      <td>(29/29)  For the easyMAG extraction, 30 individual sputum samples were used but 1 was invalidated, leaving 29 samples. Testing was also done with eMAG and EZ1 extraction.&lt;s&gt;260&lt;/s&gt;</td>\n",
       "      <td>Available.   Obtained EUA approval from US FDA  for use in Wadsworth Center, New York State Public Department of Health, and the New York City Department of Health and Mental Hygiene, Public Health Laboratories.</td>\n",
       "      <td>42 min 45 s cycle time per gene target</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Ipsum Diagnostics&lt;s&gt;269,270&lt;/s&gt;</td>\n",
       "      <td>1 Apr 2020</td>\n",
       "      <td>COV-19 IDx assay N1 gene target</td>\n",
       "      <td>100% (36/36)  36 nasopharyngeal swabs spiked with BEI ATCC Genomic RNA from SARS Related Coronavirus 2 (not actual clinical sample) serving as contrived positive samples.&lt;s&gt;270&lt;/s&gt;</td>\n",
       "      <td>100% (30/30) 30 nasopharyngeal swabs serving as negative controls.&lt;s&gt;270&lt;/s&gt;</td>\n",
       "      <td>Commercially available. Obtained EUA approval from US FDA 1 Apr 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>qPCR</td>\n",
       "      <td>Primerdesign&lt;s&gt;286-291&lt;/s&gt;(molecular diagnostics division of Novacyt) France/UK</td>\n",
       "      <td>31 Jan 2020</td>\n",
       "      <td>Genesig Real-Time PCR COVID-19 (CE) [Previously Coronavirus (Strain 2019-nCoV) Easy/Standard Kit]&lt;s&gt;287&lt;/s&gt; Can run on multiple molecular testing platforms, including Primerdesign’s own genesig® q16 and q32 instrument</td>\n",
       "      <td>96%&lt;s&gt;292&lt;/s&gt;</td>\n",
       "      <td>100%</td>\n",
       "      <td>Commercially available.   Received CE Mark for IVD 17 Feb 2020.&lt;s&gt;293,294&lt;/s&gt; Obtained EUA approval from US FDA 20 Mar 2020.&lt;s&gt;290&lt;/s&gt;</td>\n",
       "      <td>&lt; 2 hr  64 min 30 s cycle time per gene&lt;s&gt;291&lt;/s&gt;</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>bioMérieux SA&lt;s&gt;321&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>ARGENE®  SARS-CoV-2 R-gene test Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes and bronchoalveolar lavage (BAL) fluid.</td>\n",
       "      <td>100% (76/76)</td>\n",
       "      <td>100% (50/50)</td>\n",
       "      <td>FDA EUA issued on 6 May 2020&lt;s&gt;322&lt;/s&gt; CE marked on 10 April 2020, validated in France since 11 March 2020.</td>\n",
       "      <td>4-5 Hours</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Rutgers Clinical Genomics Laboratory at RUCDR Infinite Biologics - Rutgers University</td>\n",
       "      <td></td>\n",
       "      <td>Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal swab, mid-turbinate nasal swab, and bronchoalveolar lavage &lt;s&gt;(BAL) fluid.&lt;/s&gt;</td>\n",
       "      <td>100% for nasopharyngeal and oropharyngeal swabs (30/30) as well as saliva</td>\n",
       "      <td>100% for nasopharyngeal and oropharyngeal swabs (30/30) as well as saliva</td>\n",
       "      <td>FDA EUA issued on 7 May 2020&lt;s&gt;325&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>131</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>GeneMatrix, Inc.&lt;s&gt;329&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>NeoPlexTM COVID-19 Detection Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal, oropharyngeal and nasal swab specimens as well as nasopharyngeal wash/aspirate and nasal aspirate specimens.</td>\n",
       "      <td>100% for nasopharyngeal, oropharyngeal and sputum samples (40/40)</td>\n",
       "      <td>100% for nasopharyngeal, oropharyngeal and sputum samples (40/40)</td>\n",
       "      <td>FDA EUA issued on 14 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>P23 Labs &lt;s&gt;335&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>P23 Labs TaqPath SARS-CoV-2 Assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens as well as bronchoalveolar lavage (BAL) specimens.</td>\n",
       "      <td>100% (31/31)</td>\n",
       "      <td>100% (11/11)</td>\n",
       "      <td>FDA EUA issued on 21 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>142</th>\n",
       "      <td>Genome sequencing</td>\n",
       "      <td>Oxford Nanopore&lt;s&gt;338,339&lt;/s&gt; UK</td>\n",
       "      <td>22 Jan 2020</td>\n",
       "      <td>Works with public health labs globally to support rapid sequencing of SARS-CoV-2 through sharing of methods / workflows.   Nanopore sequencing workflows can provide a consensus viral genome from sample within a day.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available. 28 January: US Centers for Disease Control and Prevention (CDC) releases nCoV genomes sequenced with nanopore sequencing 29 January: A paper in the Lancet characterised full-length genomes of 2019-nCoV patients using Nanopore sequencing, providing important information on possible virus origins and cell-binding receptors that is crucial for determining viral transmission capacity.  30 March: Singapore sequences its genome in less than 7 hours  14 April: In the UK, more than 600 genomes have been uploaded onto GISAID, using nanopore sequencing&lt;s&gt;340&lt;/s&gt;.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>144</th>\n",
       "      <td>End-to-end solution of sample processing to epidemiological info generation</td>\n",
       "      <td>Oxford Nanopore&lt;s&gt;338,341&lt;/s&gt; UK</td>\n",
       "      <td>22 Jan 2020</td>\n",
       "      <td>ARTIC project  A ‘lab-in-a-suitcase’ solution for processing samples from viral outbreaks, to generating real-time epidemiological information interpretable and actionable by public health bodies.  Deployable to remote/resource-limited locations.  Based on viral genome data generated prospectively during similar outbreaks (eg. MERS, SARS etc). Relies on direct amplification of the virus using tiled, multiplexed primers.</td>\n",
       "      <td>Not stated but described to have high sensitivity compared to metagenomic approaches.&lt;s&gt;342&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available  3 February: First Belgian nCoV sample arrives in a lab at 5pm and using the ARTIC protocol, the sequence is completed by 9am.  3 March: The SARS-CoV2 virus from Scotland’s first case is sequenced in under 24 hours using nanopore sequencing and the ARTIC protocol&lt;s&gt;340&lt;/s&gt;.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>Microfluidic</td>\n",
       "      <td>QIAGEN&lt;s&gt;353-355&lt;/s&gt; The Netherlands</td>\n",
       "      <td>10 Feb 2020</td>\n",
       "      <td>QIAStat-Dx Respiratory SARS-CoV-2 Panel [Plus] Tests for two gene targets: ORF1b recommended by the Chinese CDC and N recommended by the US CDC.</td>\n",
       "      <td>100% (30/30) Evaluated using 10 positive clinical samples and 20 low positive contrived samples (1x–2x LOD) from retrospective nasopharyngeal swab clinical specimens in transport medium.&lt;s&gt;355&lt;/s&gt;</td>\n",
       "      <td>100% (30/30) Evaluated using 30 negative samples from retrospective nasopharyngeal swab clinical specimens in transport medium.&lt;s&gt;355&lt;/s&gt;</td>\n",
       "      <td>Commercially available. Obtained EUA approval from US FDA 30 Mar 2020.&lt;s&gt;354&lt;/s&gt; Approved for inclusion in the Australian Register of Therapeutic Goods on 8 May 2020</td>\n",
       "      <td>About an hour (Press release:&lt;s&gt;356&lt;/s&gt;)</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>CRISPR-based diagnostics</td>\n",
       "      <td>Sherlock Biosciences&lt;s&gt;34,142,29&lt;/s&gt;&lt;s&gt;5,367&lt;/s&gt; (Plus collaboration with Cepheid)&lt;s&gt;142&lt;/s&gt; USA</td>\n",
       "      <td>24 Jan 2020</td>\n",
       "      <td>SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing)  SHERLOCK platform uses various CRISPR proteins (Cas13, Cas12a, and Csm6) to allow for simultaneous detection of multiple nucleic acids.&lt;s&gt;142&lt;/s&gt; Designed to detect RNA from upper respiratory specimens (such as nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, nasopharyngeal wash/aspirate or nasal aspirate) and bronchoalveolar lavage specimens. Step one is a reverse transcriptase loop-mediated amplification (RT-LAMP) where targeted SARS-CoV-2 genomic RNA is reverse transcribed to DNA, and this DNA is amplified by a strand-displacing DNA polymerase. Step two is the transcription of the amplified DNA to activate the collateral cleavage activity of a CRISPR complex programmed to the target RNA sequence.</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>100%</td>\n",
       "      <td>Protocol published 14 Feb 2020.&lt;s&gt;368,369&lt;/s&gt; FDA EUA issued on 6/5/2020&lt;s&gt;370&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Shenzen YHLO Biotech Co. Ltd (China)&lt;s&gt;401&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>iFlash 8000 CLIA analyser&lt;s&gt;402&lt;/s&gt; Fully Automated chemiluminescent immunoassay for anti- SARS-CoV-2 IgM and IgG &lt;s&gt;antibodies.&lt;/s&gt;</td>\n",
       "      <td>Sensitivity: 81.5% for IgM, 100% for IgG&lt;s&gt;402&lt;/s&gt;</td>\n",
       "      <td>Specificity: 88.1% for IgM, 92.8% for IgG&lt;s&gt;402&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>191</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Hangzhou Realy Tech Co Ltd   China</td>\n",
       "      <td></td>\n",
       "      <td>2019-nCOV/COVID-19 &lt;s&gt;IgG/IgM Rapid Test Device&lt;/s&gt; &lt;s&gt;Lateral flow IgG/IgM&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Approved for inclusion on the Australian Register of Therapeutic Goods on 16 April 2020 &lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Guangzhou Wondfo Biotech&lt;s&gt;44-&lt;/s&gt;&lt;s&gt;48&lt;/s&gt; China</td>\n",
       "      <td>20 Feb 2020</td>\n",
       "      <td>Wondfo SARS-CoV-2 Antibody Test (Lateral Flow Method)  Colloidal gold method for IgM and IgG antibody detection.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available.   Approved by China’s NMPA.  Received CE Mark Mar 2020.&lt;s&gt;48,49&lt;/s&gt; Obtained HSA provisional approval on 9 April 2020, supplied through SkyQuest Pte Ltd.&lt;s&gt;410&lt;/s&gt; Approved for inclusion on the Australian Register of Therapeutic Goods on 25 March 2020.&lt;s&gt;143&lt;/s&gt; Date of Provisional Authorisation from HSA: 27 April 2020&lt;s&gt;411&lt;/s&gt;</td>\n",
       "      <td>15 min (unclear if serum/plasma extraction time included or not)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>205</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Shanghai LiangRun &lt;s&gt;420&lt;/s&gt; China</td>\n",
       "      <td>27 April 2020</td>\n",
       "      <td>LionRun Diagnostic Kit for Antibody IgM-IgG of Novel Coronavirus COVID-19 An in vitro diagnostic test for the qualitative and differential detection of IgM and IgG antibodies against SARS-CoV-2</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 27 April 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>211</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Atlaslink Beijing Technology Co Ltd (China) &lt;s&gt;425&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>NOVA Test® COVID-19 IgG/IgM Antibody Test (Colloidal Gold) Qualitative detection of IgG/IgM antibodies to SARS-CoV-2 in human serum, plasma or whole blood.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Approved for inclusion into the Australian Register of Therapeutic Goods on 18 May 2020</td>\n",
       "      <td>10 mins</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>215</th>\n",
       "      <td>IgM antibody immunoassay</td>\n",
       "      <td>Innovita Biological Technology&lt;s&gt;44&lt;/s&gt; China</td>\n",
       "      <td>23 Feb 2020</td>\n",
       "      <td>2019-nCoV Antibody Test &lt;s&gt;(colloidal gold)&lt;/s&gt; IgG and IgM antibody detection from venous whole blood/ plasma/ serum samples</td>\n",
       "      <td>87.3% &lt;s&gt;428&lt;/s&gt;</td>\n",
       "      <td>100% &lt;s&gt;428&lt;/s&gt;</td>\n",
       "      <td>Available commercially.  Approved by China’s NMPA.  Approved for inclusion on the Australian Register of Therapeutic Goods.&lt;s&gt;81&lt;/s&gt; CE-IVD approved. &lt;s&gt;3&lt;/s&gt; Partnered with Scanwell Health to be distributed in US, together with an accompanying smartphone app, pending US FDA EUA approval. &lt;s&gt;428&lt;/s&gt; Date of Provisional Authorisation from HSA: 27 April 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Projected to be $70 as distributed by Scanwell Health &lt;s&gt;428&lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>224</th>\n",
       "      <td>Neutralising Antibodies test</td>\n",
       "      <td>Genscript Biotech (Singapore) Pte Ltd, in collaboration with Duke-NUS Medical School &lt;s&gt;40,41&lt;/s&gt; (Professor Wang Linfa) and A*Star DxD Hub&lt;s&gt;446&lt;/s&gt;</td>\n",
       "      <td>26 Feb 2020</td>\n",
       "      <td>SARS-CoV-2 Neutralization Antibody Detection Kit  Blocking assay intended for the qualitative detection of neutralization antibodies against SARS-CoV-2 in human serum</td>\n",
       "      <td>At a cutoff inhibition of 20%: 100% (evaluated using 77 COVID-19 patients in Singapore), 98% (evaluated using 50 COVID-19 patients in Nanjing, China)   At a cutoff inhibition of 40%: 95.6% (evaluated using 77 COVID-19 patients in Singapore), 96% (evaluated using 50 COVID-19 patients in Nanjing, China)</td>\n",
       "      <td>100% (75/75 in cohort done in Singapore; 50/50 in cohort done in Nanjing, China)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 8 May 2020&lt;s&gt;447&lt;/s&gt;</td>\n",
       "      <td>1-2 hours</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "1                                                                            Type  \\\n",
       "2                                                                        rRT-PCR    \n",
       "11                                                                    RT-PCR Kit    \n",
       "14                                                                    RT-PCR Kit    \n",
       "21                                                                        RT-PCR    \n",
       "37                                                                        RT-PCR    \n",
       "42                                                                        RT-PCR    \n",
       "47                                                                        RT-PCR    \n",
       "51                                                                        RT-PCR    \n",
       "77                                                              Real-time RT-PCR    \n",
       "83                                                              Real-time RT-PCR    \n",
       "87                                                              Real-time RT-PCR    \n",
       "93                                                              Real-time RT-PCR    \n",
       "98                                                              Real-time RT-PCR    \n",
       "106                                                                         qPCR    \n",
       "122                                                                       RT-PCR    \n",
       "126                                                                       RT-PCR    \n",
       "131                                                                       RT-PCR    \n",
       "137                                                                       RT-PCR    \n",
       "142                                                            Genome sequencing    \n",
       "144  End-to-end solution of sample processing to epidemiological info generation    \n",
       "150                                                                 Microfluidic    \n",
       "158                                                     CRISPR-based diagnostics    \n",
       "184                                                 IgG/IgM antibody immunoassay    \n",
       "191                                                 IgG/IgM antibody immunoassay    \n",
       "195                                 IgG/IgM antibody immunoassay [Point-of-Care]    \n",
       "205                                                 IgG/IgM antibody immunoassay    \n",
       "211                                 IgG/IgM antibody immunoassay [Point-of-Care]    \n",
       "215                                                     IgM antibody immunoassay    \n",
       "224                                                 Neutralising Antibodies test    \n",
       "\n",
       "1                                                                                                                                              Organisation  \\\n",
       "2                                                                                    School of Public Health, The University of Hong Kong (HKU)<s>13,14</s>   \n",
       "11                                                                                                                              Genosensor, LLC <s>103</s>    \n",
       "14                                                     Shanghai Fosun Long March Medical Science Co. Ltd<s>105</s> Manufactured for: Fosun Pharma USA Inc.    \n",
       "21                                                                                                                         Roche<s>123-126</s> Switzerland    \n",
       "37                                                                                                                 Fulgent Therapeutics, LLC<s>168</s> USA    \n",
       "42                                                                                                                                Quidel<s>181,182</s> USA    \n",
       "47                                                                                                                              DiaCarta<s>192,193</s> USA    \n",
       "51                                                                                                                        Mobidiag<s>199</s><s>Finland</s>    \n",
       "77                                                                                                                         GenScript<s>230,236,237</s> USA    \n",
       "83                                                                                                          Thermo Fisher Scientific<s>133,243-245</s> USA    \n",
       "87                                                                                                                  SD Biosensor<s>151,152</s> South Korea    \n",
       "93                                                                          Wadsworth Center, New York State Department of Public Health<s>194,260</s> USA    \n",
       "98                                                                                                                         Ipsum Diagnostics<s>269,270</s>    \n",
       "106                                                                         Primerdesign<s>286-291</s>(molecular diagnostics division of Novacyt) France/UK   \n",
       "122                                                                                                                                bioMérieux SA<s>321</s>    \n",
       "126                                                                  Rutgers Clinical Genomics Laboratory at RUCDR Infinite Biologics - Rutgers University    \n",
       "131                                                                                                                             GeneMatrix, Inc.<s>329</s>    \n",
       "137                                                                                                                                    P23 Labs <s>335</s>    \n",
       "142                                                                                                                       Oxford Nanopore<s>338,339</s> UK    \n",
       "144                                                                                                                       Oxford Nanopore<s>338,341</s> UK    \n",
       "150                                                                                                                   QIAGEN<s>353-355</s> The Netherlands    \n",
       "158                                                       Sherlock Biosciences<s>34,142,29</s><s>5,367</s> (Plus collaboration with Cepheid)<s>142</s> USA    \n",
       "184                                                                                                         Shenzen YHLO Biotech Co. Ltd (China)<s>401</s>    \n",
       "191                                                                                                                     Hangzhou Realy Tech Co Ltd   China    \n",
       "195                                                                                                      Guangzhou Wondfo Biotech<s>44-</s><s>48</s> China    \n",
       "205                                                                                                                     Shanghai LiangRun <s>420</s> China    \n",
       "211                                                                                                 Atlaslink Beijing Technology Co Ltd (China) <s>425</s>    \n",
       "215                                                                                                          Innovita Biological Technology<s>44</s> China    \n",
       "224  Genscript Biotech (Singapore) Pte Ltd, in collaboration with Duke-NUS Medical School <s>40,41</s> (Professor Wang Linfa) and A*Star DxD Hub<s>446</s>    \n",
       "\n",
       "1              Date  \\\n",
       "2      16 Jan 2020    \n",
       "11                    \n",
       "14                    \n",
       "21     31 Jan 2020    \n",
       "37     11 Mar 2020    \n",
       "42     17 Mar 2020    \n",
       "47     23 Mar 2020    \n",
       "51                    \n",
       "77     29 Jan 2020    \n",
       "83      4 Feb 2020    \n",
       "87     28 Feb 2020    \n",
       "93     10 Mar 2020    \n",
       "98      1 Apr 2020    \n",
       "106    31 Jan 2020    \n",
       "122                   \n",
       "126                   \n",
       "131                   \n",
       "137                   \n",
       "142    22 Jan 2020    \n",
       "144    22 Jan 2020    \n",
       "150    10 Feb 2020    \n",
       "158    24 Jan 2020    \n",
       "184                   \n",
       "191                   \n",
       "195    20 Feb 2020    \n",
       "205  27 April 2020    \n",
       "211                   \n",
       "215    23 Feb 2020    \n",
       "224    26 Feb 2020    \n",
       "\n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Test  \\\n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Primer and Probe Assay 1 (Target: ORF1b-nsp14 gene)  Assay 2 (Target: N gene)   \n",
       "11                                                                                                                                                                                                                                                                                                                                                                                                                                                       <s>GS COVID-19 RT-PCR Kit</s> Real-time reverse transcription polymerase chain reaction test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal/oropharyngeal swabs, nasal swabs, mid-turbinate swabs from individuals suspected of COVID-19. Positive results are indicative of the presence of SARS-CoV-2 RNA.   \n",
       "14                      COVID-19 RT-PCR <s>Detection Kit</s> Real-time RT-PCR for qualitative detection of SARS-CoV-2 ORF1ab, N and E gene targets  Real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper and lower respiratory specimens (such as anterior nasal swabs, mid-turbinate nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) from individuals suspected of COVID-19. Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper and lower respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA.   \n",
       "21                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Cobas SARS-CoV-2 Test Runs on the Cobas 6800/8800 systems. Tests for two gene targets: ORF1ab & E.    \n",
       "37                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   COVID-19 Virus Testing by RT-PCR  Real-time RT-PCR for the qualitative detection of SARS-CoV-2 N1 and N2 genes in upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal direct swab specimens)   \n",
       "42                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Lyra SARS-CoV-2 Assay Identification of the SARS-CoV-2 virus occurs by the use of target specific primers and fluorescent-labeled 102 probes that hybridize to a conserved region of the non-structural Polyprotein (pp1ab) of the SARS-CoV-2 virus.<s>183</s>   \n",
       "47                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               QuantiVirus SARS-CoV-2 Tests for two gene targets: N, ORF1ab, & E    \n",
       "51                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       <s>Amplidiag COVID-19</s> Real-time RT-PCR test with two molecular targets (orf1ab and N) including at least one conserved region and one specific region to mitigate effects of genetic drift and avoid cross- reaction with other endemic coronaviruses.   \n",
       "77                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       qRT-PCR Targets RdRp gene, N gene and E gene in Wuhan-Hu-1 genome (GenBank <s>sequences NC_045512.2)</s>[same as Charite’s first protocol]   \n",
       "83                                                                                                                                                                                                                                                                                                                                                                                                                                                                                TaqPath COVID-19 Combo Kit (previously TaqMan 2019-nCoV Assay Kit) Real-time RT-PCR kit assays specifically target all 44 complete genomes currently available at GISAID, and do not target any of the 2,116 complete genomes of other coronaviruses currently available at NCBIm.  Tests for three gene targets: ORF1ab, N, & S.   \n",
       "87                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 STANDARD M n-CoV Real-Time Detection Kit Tests for two gene targets: E and RdRp.   \n",
       "93                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel Tests for two gene targets: N1 & N2.    \n",
       "98                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 COV-19 IDx assay N1 gene target    \n",
       "106                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Genesig Real-Time PCR COVID-19 (CE) [Previously Coronavirus (Strain 2019-nCoV) Easy/Standard Kit]<s>287</s> Can run on multiple molecular testing platforms, including Primerdesign’s own genesig® q16 and q32 instrument   \n",
       "122                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              ARGENE®  SARS-CoV-2 R-gene test Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes and bronchoalveolar lavage (BAL) fluid.   \n",
       "126                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal swab, mid-turbinate nasal swab, and bronchoalveolar lavage <s>(BAL) fluid.</s>   \n",
       "131                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           NeoPlexTM COVID-19 Detection Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal, oropharyngeal and nasal swab specimens as well as nasopharyngeal wash/aspirate and nasal aspirate specimens.   \n",
       "137                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           P23 Labs TaqPath SARS-CoV-2 Assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens as well as bronchoalveolar lavage (BAL) specimens.   \n",
       "142                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Works with public health labs globally to support rapid sequencing of SARS-CoV-2 through sharing of methods / workflows.   Nanopore sequencing workflows can provide a consensus viral genome from sample within a day.   \n",
       "144                                                                                                                                                                                                                                                                                                                                                                         ARTIC project  A ‘lab-in-a-suitcase’ solution for processing samples from viral outbreaks, to generating real-time epidemiological information interpretable and actionable by public health bodies.  Deployable to remote/resource-limited locations.  Based on viral genome data generated prospectively during similar outbreaks (eg. MERS, SARS etc). Relies on direct amplification of the virus using tiled, multiplexed primers.   \n",
       "150                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                QIAStat-Dx Respiratory SARS-CoV-2 Panel [Plus] Tests for two gene targets: ORF1b recommended by the Chinese CDC and N recommended by the US CDC.   \n",
       "158  SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing)  SHERLOCK platform uses various CRISPR proteins (Cas13, Cas12a, and Csm6) to allow for simultaneous detection of multiple nucleic acids.<s>142</s> Designed to detect RNA from upper respiratory specimens (such as nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, nasopharyngeal wash/aspirate or nasal aspirate) and bronchoalveolar lavage specimens. Step one is a reverse transcriptase loop-mediated amplification (RT-LAMP) where targeted SARS-CoV-2 genomic RNA is reverse transcribed to DNA, and this DNA is amplified by a strand-displacing DNA polymerase. Step two is the transcription of the amplified DNA to activate the collateral cleavage activity of a CRISPR complex programmed to the target RNA sequence.   \n",
       "184                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            iFlash 8000 CLIA analyser<s>402</s> Fully Automated chemiluminescent immunoassay for anti- SARS-CoV-2 IgM and IgG <s>antibodies.</s>   \n",
       "191                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                2019-nCOV/COVID-19 <s>IgG/IgM Rapid Test Device</s> <s>Lateral flow IgG/IgM</s>    \n",
       "195                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Wondfo SARS-CoV-2 Antibody Test (Lateral Flow Method)  Colloidal gold method for IgM and IgG antibody detection.    \n",
       "205                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               LionRun Diagnostic Kit for Antibody IgM-IgG of Novel Coronavirus COVID-19 An in vitro diagnostic test for the qualitative and differential detection of IgM and IgG antibodies against SARS-CoV-2   \n",
       "211                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     NOVA Test® COVID-19 IgG/IgM Antibody Test (Colloidal Gold) Qualitative detection of IgG/IgM antibodies to SARS-CoV-2 in human serum, plasma or whole blood.   \n",
       "215                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2019-nCoV Antibody Test <s>(colloidal gold)</s> IgG and IgM antibody detection from venous whole blood/ plasma/ serum samples    \n",
       "224                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         SARS-CoV-2 Neutralization Antibody Detection Kit  Blocking assay intended for the qualitative detection of neutralization antibodies against SARS-CoV-2 in human serum    \n",
       "\n",
       "1                                                                                                                                                                                                                                                                                                       Sensitivity  \\\n",
       "2                                                                                                                                                                                                             Positive control using SARS-CoV RNA Wide dynamic range of 2<s>-4</s> to 2000 TCID<s>50</s>/reaction.    \n",
       "11                                                                                                                                                                                                                                                                                             <s>100% (32/32)</s>    \n",
       "14                                                                                                                                                                                                                                                                                      99.51% (203/204)<s>106</s>    \n",
       "21                                                                                                                                           100% (50/50)  50 nasopharyngeal swab clinical samples spiked with cultured SARS-CoV-2 virus Low (1.5x LoD) and moderate (4x LoD) contrived positive samples <s>126</s>   \n",
       "37                                                                                                                                                                                                                                                                                             <s>100% (30/30)</s>    \n",
       "42                                                                                                                                                                  100% (92/92)  92 nasopharyngeal swab specimens were spiked with SARS-CoV-2 RNA (1x to 5x LoD) serving as contrived positive samples.<s>182</s>    \n",
       "47                                                                                                                                                                                                                          96.7% Clinically validated in the company's CLIA-certified lab in Richmond, California.   \n",
       "51                                                                                                                                                                                                                                                                                                       (no info)    \n",
       "77                                                                                                                                                                                  “This assay is RUO and has not been tested on clinical samples. We make no claims on the performance of this assay.” <s>236</s>   \n",
       "83                                                                                                   100% (60/60)  30 nasopharyngeal swab specimens and 30 bronchoalveolar lavage specimens were spiked with extracted SARS-CoV-2 viral genomic RNA (2x to 5x LoD) to form 60 contrived positive samples.<s>245</s>   \n",
       "87                                                                                                                                                                                                                                                                             Sensitivity: 100% (30/30)<s>251</s>    \n",
       "93                                                       (42/43)  For the easyMAG extraction, 43 individual sputum samples were spiked with the extracted whole SARS-CoV-2 virus genomic RNA (2x to 200x LoD) to serve as contrived positive samples. Testing was also done with eMAG and EZ1 extraction.<s>260</s>   \n",
       "98                                                                                                                             100% (36/36)  36 nasopharyngeal swabs spiked with BEI ATCC Genomic RNA from SARS Related Coronavirus 2 (not actual clinical sample) serving as contrived positive samples.<s>270</s>   \n",
       "106                                                                                                                                                                                                                                                                                                  96%<s>292</s>    \n",
       "122                                                                                                                                                                                                                                                                                                   100% (76/76)    \n",
       "126                                                                                                                                                                                                                                      100% for nasopharyngeal and oropharyngeal swabs (30/30) as well as saliva    \n",
       "131                                                                                                                                                                                                                                              100% for nasopharyngeal, oropharyngeal and sputum samples (40/40)    \n",
       "137                                                                                                                                                                                                                                                                                                   100% (31/31)    \n",
       "142                                                                                                                                                                                                                                                                                                      (no info)    \n",
       "144                                                                                                                                                                                                                Not stated but described to have high sensitivity compared to metagenomic approaches.<s>342</s>    \n",
       "150                                                                                                            100% (30/30) Evaluated using 10 positive clinical samples and 20 low positive contrived samples (1x–2x LOD) from retrospective nasopharyngeal swab clinical specimens in transport medium.<s>355</s>   \n",
       "158                                                                                                                                                                                                                                                                                                   100% (30/30)    \n",
       "184                                                                                                                                                                                                                                                             Sensitivity: 81.5% for IgM, 100% for IgG<s>402</s>    \n",
       "191                                                                                                                                                                                                                                                                                                      (no info)    \n",
       "195                                                                                                                                                                                                                                                                                                      (no info)    \n",
       "205                                                                                                                                                                                                                                                                                                      (no info)    \n",
       "211                                                                                                                                                                                                                                                                                                      (no info)    \n",
       "215                                                                                                                                                                                                                                                                                               87.3% <s>428</s>    \n",
       "224  At a cutoff inhibition of 20%: 100% (evaluated using 77 COVID-19 patients in Singapore), 98% (evaluated using 50 COVID-19 patients in Nanjing, China)   At a cutoff inhibition of 40%: 95.6% (evaluated using 77 COVID-19 patients in Singapore), 96% (evaluated using 50 COVID-19 patients in Nanjing, China)   \n",
       "\n",
       "1                                                                                                                                                                                                                                             Specificity  \\\n",
       "2    Exclusivity  Negative results against all of these preparations: • RNA extracted from cultured viruses • RNA from retrospective human clinical specimens previously tested positive for other infections • RNA from control human clinical specimens   \n",
       "11                                                                                                                                                                                                                                   <s>100% (32/32)</s>    \n",
       "14                                                                                                                                                                                                                            96.44% (379/393)<s>106</s>    \n",
       "21                                                                                                                                                        100% (100/100)  100 nasopharyngeal swab clinical samples serve as negative controls.<s>126</s>    \n",
       "37                                                                                                                                                                                                                                   <s>100% (64/64)</s>    \n",
       "42                                                                                                                                                               (100% (92/92)  92 nasopharyngeal swab specimens serving as negative controls.<s>182</s>    \n",
       "47                                                                                                                                                                 100% Clinically validated in the company's CLIA-certified lab in Richmond, California.   \n",
       "51                                                                                                                                                                                                                                             (no info)    \n",
       "77                                            “This assay may have cross-reactivity with other coronavirus family members such as causative agents of the Middle East Respiratory Syndrome (MERS) or Severe Acute Respiratory Syndrome (SARS).”<s>236</s>   \n",
       "83                                                                                                                      100% (60/60)  30 nasopharyngeal swab specimens and 30 bronchoalveolar lavage specimens were used as negative controls.<s>245</s>    \n",
       "87                                                                                                                                                                                                                   Specificity: 100% (30/30)<s>251</s>    \n",
       "93                                                                   (29/29)  For the easyMAG extraction, 30 individual sputum samples were used but 1 was invalidated, leaving 29 samples. Testing was also done with eMAG and EZ1 extraction.<s>260</s>   \n",
       "98                                                                                                                                                                           100% (30/30) 30 nasopharyngeal swabs serving as negative controls.<s>270</s>   \n",
       "106                                                                                                                                                                                                                                                 100%    \n",
       "122                                                                                                                                                                                                                                         100% (50/50)    \n",
       "126                                                                                                                                                                            100% for nasopharyngeal and oropharyngeal swabs (30/30) as well as saliva    \n",
       "131                                                                                                                                                                                    100% for nasopharyngeal, oropharyngeal and sputum samples (40/40)    \n",
       "137                                                                                                                                                                                                                                         100% (11/11)    \n",
       "142                                                                                                                                                                                                                                            (no info)    \n",
       "144                                                                                                                                                                                                                                            (no info)    \n",
       "150                                                                                                             100% (30/30) Evaluated using 30 negative samples from retrospective nasopharyngeal swab clinical specimens in transport medium.<s>355</s>   \n",
       "158                                                                                                                                                                                                                                                 100%    \n",
       "184                                                                                                                                                                                                  Specificity: 88.1% for IgM, 92.8% for IgG<s>402</s>    \n",
       "191                                                                                                                                                                                                                                            (no info)    \n",
       "195                                                                                                                                                                                                                                            (no info)    \n",
       "205                                                                                                                                                                                                                                            (no info)    \n",
       "211                                                                                                                                                                                                                                            (no info)    \n",
       "215                                                                                                                                                                                                                                      100% <s>428</s>    \n",
       "224                                                                                                                                                                     100% (75/75 in cohort done in Singapore; 50/50 in cohort done in Nanjing, China)    \n",
       "\n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Availability  \\\n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                   Available • Positive control (Available from HKU) Primers and probes: • HKU-ORF1b-nsp14F • HKU- ORF1b-nsp14R • HKU-ORF1b-nsp141P • HKU-NF • HKU-NR • HKU-NP   \n",
       "11                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Available.  EUA issued on 16th April 2020.    \n",
       "14                                                                                                                                                                                                                                                                                                     Available.  EUA issued on 17th April 2020   Received CE mark on 17 March 2020.   Received emergency approval from the National Medical Products Administration (NMPA) on 27 March 2020.   Approved for inclusion in the Australian Register of Therapeutic Goods on 8 May 2020<s>107</s>   \n",
       "21                                                                                                                                                                                                                                                                                                                                                            Commercially available.   Obtained EUA approval from US FDA 13 Mar 2020.<s>125</s> CE Mark for IVD. Approved for inclusion on the Australia’s ARTG on 20 March 2020.  Date of HSA Provisional Authorisation: 19/03/2020<s>127</s>   \n",
       "37                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Submitted to US FDA for EUA Approval.  Commercially Available<s>169</s> FDA EUA issued on 15/5/2020<s>170</s>   \n",
       "42                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Commercially available.   Obtained EUA approval from US FDA 17 Mar 2020.    \n",
       "47                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Commercially available. Received CE Mark for IVD Mar 2020.   Obtained EUA approval from US FDA 8 Apr 2020.<s>194</s>   \n",
       "51                                                                                                                                                                                                                                                                               Available as an emergency use test in Finland and France, set up for routine use in main clinical laboratories in Finland with capacity to test up to 4000 samples a day.<s>200</s> In the process for obtaining emergency use authorisation in Sweden and the UK. In the process for <s>obtaining CE-IVD.</s>   \n",
       "77                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Commercially available for RUO.    \n",
       "83                                                                                                                                                                                                                                                                                                        Commercially available.  Received CE Mark for IVD 26 Mar 2020.<s>246</s> Obtained EUA approval from US FDA 13 Mar 2020.<s>244</s> Obtained HSA provisional approval on 20 March 2020. Approved for inclusion on the Australian Register of Therapeutic Goods on <s>24 March 2020</s>.   \n",
       "87                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Available. Obtained EUA approval from Korean CDC 27 Feb 2020.<s>151,152</s> FDA EUA issued on 23/04/2020   \n",
       "93                                                                                                                                                                                                                                                                                                                                                                          Available.   Obtained EUA approval from US FDA  for use in Wadsworth Center, New York State Public Department of Health, and the New York City Department of Health and Mental Hygiene, Public Health Laboratories.   \n",
       "98                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Commercially available. Obtained EUA approval from US FDA 1 Apr 2020.   \n",
       "106                                                                                                                                                                                                                                                                                                                                                                                                                                                      Commercially available.   Received CE Mark for IVD 17 Feb 2020.<s>293,294</s> Obtained EUA approval from US FDA 20 Mar 2020.<s>290</s>   \n",
       "122                                                                                                                                                                                                                                                                                                                                                                                                                                                                                FDA EUA issued on 6 May 2020<s>322</s> CE marked on 10 April 2020, validated in France since 11 March 2020.    \n",
       "126                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     FDA EUA issued on 7 May 2020<s>325</s>    \n",
       "131                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              FDA EUA issued on 14 May 2020    \n",
       "137                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              FDA EUA issued on 21 May 2020    \n",
       "142  Available. 28 January: US Centers for Disease Control and Prevention (CDC) releases nCoV genomes sequenced with nanopore sequencing 29 January: A paper in the Lancet characterised full-length genomes of 2019-nCoV patients using Nanopore sequencing, providing important information on possible virus origins and cell-binding receptors that is crucial for determining viral transmission capacity.  30 March: Singapore sequences its genome in less than 7 hours  14 April: In the UK, more than 600 genomes have been uploaded onto GISAID, using nanopore sequencing<s>340</s>.   \n",
       "144                                                                                                                                                                                                                                                                                               Available  3 February: First Belgian nCoV sample arrives in a lab at 5pm and using the ARTIC protocol, the sequence is completed by 9am.  3 March: The SARS-CoV2 virus from Scotland’s first case is sequenced in under 24 hours using nanopore sequencing and the ARTIC protocol<s>340</s>.    \n",
       "150                                                                                                                                                                                                                                                                                                                                                                                                                       Commercially available. Obtained EUA approval from US FDA 30 Mar 2020.<s>354</s> Approved for inclusion in the Australian Register of Therapeutic Goods on 8 May 2020   \n",
       "158                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Protocol published 14 Feb 2020.<s>368,369</s> FDA EUA issued on 6/5/2020<s>370</s>    \n",
       "184                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  (no info)    \n",
       "191                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Approved for inclusion on the Australian Register of Therapeutic Goods on 16 April 2020 <s>143</s>   \n",
       "195                                                                                                                                                                                                                                       Available.   Approved by China’s NMPA.  Received CE Mark Mar 2020.<s>48,49</s> Obtained HSA provisional approval on 9 April 2020, supplied through SkyQuest Pte Ltd.<s>410</s> Approved for inclusion on the Australian Register of Therapeutic Goods on 25 March 2020.<s>143</s> Date of Provisional Authorisation from HSA: 27 April 2020<s>411</s>   \n",
       "205                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Date of Provisional Authorisation from HSA: 27 April 2020    \n",
       "211                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Approved for inclusion into the Australian Register of Therapeutic Goods on 18 May 2020    \n",
       "215                                                                                                                                                                                                                      Available commercially.  Approved by China’s NMPA.  Approved for inclusion on the Australian Register of Therapeutic Goods.<s>81</s> CE-IVD approved. <s>3</s> Partnered with Scanwell Health to be distributed in US, together with an accompanying smartphone app, pending US FDA EUA approval. <s>428</s> Date of Provisional Authorisation from HSA: 27 April 2020   \n",
       "224                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Date of Provisional Authorisation from HSA: 8 May 2020<s>447</s>    \n",
       "\n",
       "1                                                           Turnaround  \\\n",
       "2                          28 min 40 sec of cycle time for each assay    \n",
       "11                                                          (no info)    \n",
       "14                                                     Within 2 Hours    \n",
       "21                                                        3 hr 30 min    \n",
       "37                                                          (no info)    \n",
       "42                                         45 min cycle time per gene    \n",
       "47                                                          (no info)    \n",
       "51                                           <s>48 samples in <3h</s>    \n",
       "77                                                          (no info)    \n",
       "83                                  36 min cycle time per gene target    \n",
       "87                                                  90 min <s>252</s>    \n",
       "93                             42 min 45 s cycle time per gene target    \n",
       "98                                                          (no info)    \n",
       "106                 < 2 hr  64 min 30 s cycle time per gene<s>291</s>    \n",
       "122                                                         4-5 Hours    \n",
       "126                                                         (no info)    \n",
       "131                                                         (no info)    \n",
       "137                                                         (no info)    \n",
       "142                                                         (no info)    \n",
       "144                                                         (no info)    \n",
       "150                          About an hour (Press release:<s>356</s>)    \n",
       "158                                                         (no info)    \n",
       "184                                                         (no info)    \n",
       "191                                                         (no info)    \n",
       "195  15 min (unclear if serum/plasma extraction time included or not)    \n",
       "205                                                         (no info)    \n",
       "211                                                           10 mins    \n",
       "215                                                         (no info)    \n",
       "224                                                         1-2 hours    \n",
       "\n",
       "1                                                                Costs  \n",
       "2                                                           (no info)   \n",
       "11                                                          (no info)   \n",
       "14                                                          (no info)   \n",
       "21                                                          (no info)   \n",
       "37                                                          (no info)   \n",
       "42                                                          (no info)   \n",
       "47                                                          (no info)   \n",
       "51                                                          (no info)   \n",
       "77                                                         (by quote)   \n",
       "83                                                         (by quote)   \n",
       "87                                                          (no info)   \n",
       "93                                                          (no info)   \n",
       "98                                                          (no info)   \n",
       "106                                                        (by quote)   \n",
       "122                                                         (no info)   \n",
       "126                                                         (no info)   \n",
       "131                                                         (no info)   \n",
       "137                                                         (no info)   \n",
       "142                                                         (no info)   \n",
       "144                                                         (no info)   \n",
       "150                                                        (by quote)   \n",
       "158                                                         (no info)   \n",
       "184                                                         (no info)   \n",
       "191                                                         (no info)   \n",
       "195                                                         (no info)   \n",
       "205                                                         (no info)   \n",
       "211                                                         (no info)   \n",
       "215  Projected to be $70 as distributed by Scanwell Health <s>428</s>   \n",
       "224                                                         (no info)   "
      ]
     },
     "execution_count": 38,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merged = to_merge.apply(lambda x: x.str.cat(x.shift(-1), sep = \" \"), axis = 0).loc[index_merge]\n",
    "merged"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Replacing splitted rows with merged ones"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\edidd\\Anaconda3\\lib\\site-packages\\pandas\\core\\indexing.py:671: SettingWithCopyWarning:\n",
      "\n",
      "\n",
      "A value is trying to be set on a copy of a slice from a DataFrame\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "\n",
      "C:\\Users\\edidd\\Anaconda3\\lib\\site-packages\\ipykernel_launcher.py:1: SettingWithCopyWarning:\n",
      "\n",
      "\n",
      "A value is trying to be set on a copy of a slice from a DataFrame\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "\n"
     ]
    }
   ],
   "source": [
    "tests_df.loc[(tests_df.Type.shift(-1) == \"\"), :] = merged"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "tests_df = tests_df.loc[tests_df.Type != \"\", :]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>1</th>\n",
       "      <th>Type</th>\n",
       "      <th>Organisation</th>\n",
       "      <th>Date</th>\n",
       "      <th>Test</th>\n",
       "      <th>Sensitivity</th>\n",
       "      <th>Specificity</th>\n",
       "      <th>Availability</th>\n",
       "      <th>Turnaround</th>\n",
       "      <th>Costs</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>Charité Institute of Virology, Berlin, Germany &lt;s&gt;1,99&lt;/s&gt;</td>\n",
       "      <td>13 Jan 2020</td>\n",
       "      <td>Primer and Probe   First line screening assay: E gene assay  Confirmatory assay: RdRp gene assay  Additional confirmatory assay: N gene assay</td>\n",
       "      <td>First line screening assay  Technical LOD: 5.2 RNA copies/reaction, at 95% hit rate  95% CI: 3.7-9.6 RNA copies/reaction.  Confirmatory assay Technical LOD: 3.8 RNA copies/reaction, at 95% hit rate 95% CI: 2.7-7.6 RNA copies/reaction.  Additional confirmatory assay Technical LOD: 8.3 RNA copies/reaction, at 95% hit rate;  95% CI: 6.1-16.3 RNA copies/reaction.</td>\n",
       "      <td>Chemical stability No positive signal detected for non-specific reactivity of oligonucleotides.  Cross-reactivity with other coronaviruses No reactivity with any of three assays for five coronaviruses: (HCoV) -229E, -NL63, -OC43,  -HKU1, and MERS-CoV  Tests of human clinical samples previously tested to contain respiratory viruses All tests returned negative results for all 75 samples.</td>\n",
       "      <td>Available • SARS-CoV genomic RNA as positive control.</td>\n",
       "      <td>47 min 15 sec of cycle time (plus probe) for each assay</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>Charité Institute of Virology, Berlin, Germany &lt;s&gt;1,12&lt;/s&gt;</td>\n",
       "      <td>17 Jan 2020</td>\n",
       "      <td>Primer and Probe   First line screening assay: E gene assay  Confirmatory assay: RdRp gene assay</td>\n",
       "      <td>First line screening assay  Technical LOD: 5.2 RNA copies/reaction, at 95% hit rate  95% CI: 3.7-9.6 RNA copies/reaction.  Confirmatory assay Technical LOD: 3.8 RNA copies/reaction, at 95% hit rate 95% CI: 2.7-7.6 RNA copies/reaction.  (Preliminary experiment compared single probe assay for SARS-CoV with single probe assay for SARS-CoV-2.)</td>\n",
       "      <td>Chemical stability No positive signal detected for non-specific reactivity of oligonucleotides.  Cross-reactivity with other coronaviruses No reactivity with any of three assays for five coronaviruses: (HCoV) -229E, -NL63, -OC43,  -HKU1, and MERS-CoV  Tests of human clinical samples previously tested to contain respiratory viruses All tests returned negative results for all 75 samples.</td>\n",
       "      <td>Available • SARS-CoV genomic RNA as positive control.  • Synthetic control RNA for SARS-CoV-2 E gene assay is available via EVAg.  • Synthetic control for SARS-CoV-2 RdRp is expected to be available via EVAg from Jan 21st onward.</td>\n",
       "      <td>47 min 15 sec of cycle time (plus probe) for each assay</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>School of Public Health, The University of Hong Kong (HKU)&lt;s&gt;13,14&lt;/s&gt;</td>\n",
       "      <td>16 Jan 2020</td>\n",
       "      <td>Primer and Probe Assay 1 (Target: ORF1b-nsp14 gene)  Assay 2 (Target: N gene)</td>\n",
       "      <td>Positive control using SARS-CoV RNA Wide dynamic range of 2&lt;s&gt;-4&lt;/s&gt; to 2000 TCID&lt;s&gt;50&lt;/s&gt;/reaction.</td>\n",
       "      <td>Exclusivity  Negative results against all of these preparations: • RNA extracted from cultured viruses • RNA from retrospective human clinical specimens previously tested positive for other infections • RNA from control human clinical specimens</td>\n",
       "      <td>Available • Positive control (Available from HKU) Primers and probes: • HKU-ORF1b-nsp14F • HKU- ORF1b-nsp14R • HKU-ORF1b-nsp141P • HKU-NF • HKU-NR • HKU-NP</td>\n",
       "      <td>28 min 40 sec of cycle time for each assay</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>Chinese Center for Disease Control and Prevention, Beijing, China&lt;s&gt;100&lt;/s&gt;</td>\n",
       "      <td>21 Jan 2020</td>\n",
       "      <td>Primer and Probe   Target 1 (ORF1ab gene)  Target 2 (N gene)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Department of Medical Sciences, Ministry of Public Health, Thailand&lt;s&gt;101&lt;/s&gt;</td>\n",
       "      <td>Jan 2020</td>\n",
       "      <td>With gel electrophoresis</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available Primers: • NbatCoV_F1  • NbatCoV_R1</td>\n",
       "      <td>107 min of cycle time</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>National Institute of Infectious Diseases, Japan&lt;s&gt;102&lt;/s&gt;</td>\n",
       "      <td>23 Jan 2020</td>\n",
       "      <td>With gel electrophoresis (Nested RT-PCR)  Primer and Probe (Real-time RT-PCR)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available Primers and probes: • NIID_2019-nCOV_N_F2 • NIID_2019-nCOV_N_R2 • NIID_2019-nCOV_N_P2</td>\n",
       "      <td>81 min for Nested RT-PCR  95 min for Real-time RT-PCR</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>Centers for Disease Control and Prevention, Atlanta, USA&lt;s&gt;15,16&lt;/s&gt;</td>\n",
       "      <td>24 Jan 2020</td>\n",
       "      <td>Primer and Probe   3 N gene targets  1 human RNase P gene control</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available Primers and probes: • 2019-nCOV_N1_F • 2019-nCOV_N1_R • 2019-nCOV_N1_P • 2019-nCOV_N2_F • 2019-nCOV_N2_R • 2019-nCOV_N2_P • 2019-nCOV_N3_F • 2019-nCOV_N3_R • 2019-nCOV_N3_P • RP_F • RP_R • RP_P</td>\n",
       "      <td>43 min 45 sec of cycle time for each assay</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>Institut Pasteur, Paris, France&lt;s&gt;10&lt;/s&gt;</td>\n",
       "      <td>2 Mar 2020</td>\n",
       "      <td>Primer and Probe   2 RdRp gene targets with Charité’s E gene target as confirmatory</td>\n",
       "      <td>100 or more copies of RNA genome equivalent per reaction always detected.  Samples containing 10 copies of RNA genome could be detected with multiplex assay.</td>\n",
       "      <td>Cross-reactivity with other respiratory viruses was tested and were all negative in reactivity with the two RdRp gene targets.</td>\n",
       "      <td>Available Primers and probes: • nCoV_IP2-12669Fw • nCoV_IP2-12759Rv • nCoV_IP2-12696bProbe(+) • nCoV_IP4-14059Fw • nCoV_IP4-14146Rv • nCoV_IP4-14084Probe(+) • E_Sarbeco_F1 • E_Sarbeco_R2 • E_Sarbeco_P1</td>\n",
       "      <td>61 min of cycle time for each assay</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>Genosensor, LLC &lt;s&gt;103&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>&lt;s&gt;GS COVID-19 RT-PCR Kit&lt;/s&gt; Real-time reverse transcription polymerase chain reaction test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal/oropharyngeal swabs, nasal swabs, mid-turbinate swabs from individuals suspected of COVID-19. Positive results are indicative of the presence of SARS-CoV-2 RNA.</td>\n",
       "      <td>&lt;s&gt;100% (32/32)&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;100% (32/32)&lt;/s&gt;</td>\n",
       "      <td>Available.  EUA issued on 16th April 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>KorvaLabs Inc. &lt;s&gt;104&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Curative-Korva SARS-CoV-2 Assay  Real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in oropharyngeal (throat) swab, nasopharyngeal swab, nasal swab, and oral fluid specimens from individuals suspected of COVID-19. Results are for the detection of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA.</td>\n",
       "      <td>100% (5/5)</td>\n",
       "      <td>100% (5/5)</td>\n",
       "      <td>Available.  EUA issued on 16th April 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>Genosensor, LLC &lt;s&gt;103&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>&lt;s&gt;GS COVID-19 RT-PCR Kit&lt;/s&gt; Real-time reverse transcription polymerase chain reaction test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal/oropharyngeal swabs, nasal swabs, mid-turbinate swabs from individuals suspected of COVID-19. Positive results are indicative of the presence of SARS-CoV-2 RNA.</td>\n",
       "      <td>&lt;s&gt;100% (32/32)&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;100% (32/32)&lt;/s&gt;</td>\n",
       "      <td>Available.  EUA issued on 16th April 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>KorvaLabs Inc. &lt;s&gt;104&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Curative-Korva SARS-CoV-2 Assay  Real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in oropharyngeal (throat) swab, nasopharyngeal swab, nasal swab, and oral fluid specimens from individuals suspected of COVID-19. Results are for the detection of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA.</td>\n",
       "      <td>100% (5/5)</td>\n",
       "      <td>100% (5/5)</td>\n",
       "      <td>Available.  EUA issued on 16th April 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>Shanghai Fosun Long March Medical Science Co. Ltd&lt;s&gt;105&lt;/s&gt; Manufactured for: Fosun Pharma USA Inc.</td>\n",
       "      <td></td>\n",
       "      <td>COVID-19 RT-PCR &lt;s&gt;Detection Kit&lt;/s&gt; Real-time RT-PCR for qualitative detection of SARS-CoV-2 ORF1ab, N and E gene targets  Real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper and lower respiratory specimens (such as anterior nasal swabs, mid-turbinate nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) from individuals suspected of COVID-19. Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper and lower respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA.</td>\n",
       "      <td>99.51% (203/204)&lt;s&gt;106&lt;/s&gt;</td>\n",
       "      <td>96.44% (379/393)&lt;s&gt;106&lt;/s&gt;</td>\n",
       "      <td>Available.  EUA issued on 17th April 2020   Received CE mark on 17 March 2020.   Received emergency approval from the National Medical Products Administration (NMPA) on 27 March 2020.   Approved for inclusion in the Australian Register of Therapeutic Goods on 8 May 2020&lt;s&gt;107&lt;/s&gt;</td>\n",
       "      <td>Within 2 Hours</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>RT-PCR assay</td>\n",
       "      <td>Rhoenix, Inc. &lt;s&gt;108&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Rheonix COVID-19 MDx Assay&lt;s&gt;109&lt;/s&gt; Qualitative detection of total nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal washes, nasal aspirates and bronchoalveolar lavage (BAL) fluid.</td>\n",
       "      <td>100%&lt;s&gt;109&lt;/s&gt;</td>\n",
       "      <td>100%</td>\n",
       "      <td>FDA EUA issued on 29/04/2020&lt;s&gt;109&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>RT-PCR assay</td>\n",
       "      <td>LabGenomics Co., Ltd &lt;s&gt;110&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>LabGun COVID-10 RT-PCR Kit &lt;s&gt;111&lt;/s&gt; Qualitative detection of total nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasopharyngeal washes, &lt;s&gt;nasal aspirates and sputum&lt;/s&gt;</td>\n",
       "      <td>100% (50/50)&lt;s&gt;111&lt;/s&gt;</td>\n",
       "      <td>100% (100/100) &lt;s&gt;111&lt;/s&gt;</td>\n",
       "      <td>FDA EUA issued on 29/04/2020 &lt;s&gt;111&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Bioperfectus Technologies&lt;s&gt;112&lt;/s&gt; China</td>\n",
       "      <td>14 Jan 2020</td>\n",
       "      <td>RT-PCR test kit</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available as scientific research product – does not require registration&lt;s&gt;112&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Co-Diagnostics&lt;s&gt;113-&lt;/s&gt;&lt;s&gt;115&lt;/s&gt; USA</td>\n",
       "      <td>23 Jan 2020</td>\n",
       "      <td>Logix Smart Coronavirus COVID-19 test RT-PCR kit with lower false positive</td>\n",
       "      <td>100% (21/21)&lt;s&gt;116&lt;/s&gt;</td>\n",
       "      <td>No specific statistics but claims to have ability to reliably and accurately differentiate between similar genetic sequences, in order to reduce the likelihood of a false-positive diagnosis.   Company shared that it achieves this by creating reactions that are far more specific than competing PCR technologies and 2.5 million times more effective in reducing amplification errors.&lt;s&gt;113,117&lt;/s&gt; 100%&lt;s&gt;116&lt;/s&gt;</td>\n",
       "      <td>Commercially available for sale on 10 Feb 2020.&lt;s&gt;114&lt;/s&gt; Received CE Mark 24 Feb 2020.&lt;s&gt;118&lt;/s&gt; Obtained EUA approval from US FDA 3 Apr 2020.&lt;s&gt;115&lt;/s&gt;</td>\n",
       "      <td>Within 2 hours&lt;s&gt;116&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Altona Diagnostics&lt;s&gt;119,120&lt;/s&gt;Germany</td>\n",
       "      <td>23 Jan 2020</td>\n",
       "      <td>RealStar SARS-CoV-2 RT- &lt;s&gt;PCR Kit 1.0&lt;/s&gt;Real time RT-PCR for qualitative detection of SARS-CoV-2 RNA (target genes E gene and S gene).</td>\n",
       "      <td>95% (24/25) detection for S gene;   100% (25/25) detection for E gene.</td>\n",
       "      <td>35/35 for both S and E gene.</td>\n",
       "      <td>Available FDA EUA issued on 22 April 2020  Received CE mark for IVD  HSA provisional authorisation approved on 15 May 2020 &lt;s&gt;121&lt;/s&gt;</td>\n",
       "      <td>2:15 hours&lt;s&gt;122&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Roche&lt;s&gt;123-126&lt;/s&gt; Switzerland</td>\n",
       "      <td>31 Jan 2020</td>\n",
       "      <td>Cobas SARS-CoV-2 Test Runs on the Cobas 6800/8800 systems. Tests for two gene targets: ORF1ab &amp; E.</td>\n",
       "      <td>100% (50/50)  50 nasopharyngeal swab clinical samples spiked with cultured SARS-CoV-2 virus Low (1.5x LoD) and moderate (4x LoD) contrived positive samples &lt;s&gt;126&lt;/s&gt;</td>\n",
       "      <td>100% (100/100)  100 nasopharyngeal swab clinical samples serve as negative controls.&lt;s&gt;126&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 13 Mar 2020.&lt;s&gt;125&lt;/s&gt; CE Mark for IVD. Approved for inclusion on the Australia’s ARTG on 20 March 2020.  Date of HSA Provisional Authorisation: 19/03/2020&lt;s&gt;127&lt;/s&gt;</td>\n",
       "      <td>3 hr 30 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>A*STAR&lt;s&gt;4,128&lt;/s&gt;(Manufactured by Singapore’s MiRxes which has a nonexclusive license)&lt;s&gt;129&lt;/s&gt; Singapore</td>\n",
       "      <td>1 Feb 2020</td>\n",
       "      <td>A*STAR Fortitude 2.0 Test is based on rRT-PCR, for the qualitative detection of SARS- CoV-2 specific RNA in nasopharyngeal swab specimens.  Supports 188 tests per kit</td>\n",
       "      <td>100%&lt;s&gt;130&lt;/s&gt;</td>\n",
       "      <td>100%</td>\n",
       "      <td>Available but not for commercial sale yet.   Provisional authorization for clinical use from Singapore's HSA.&lt;s&gt;4,129&lt;/s&gt; Date of Provisional Authorisation from HSA: 30 April 2020</td>\n",
       "      <td>90 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>PCL&lt;s&gt;131&lt;/s&gt; South Korea</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>Multiplex diagnostic kit  PCLMD-nCoV one step RT-PCR kit Organisation: PCL&lt;s&gt;132&lt;/s&gt; Qualitative detection of SARS-Co-V-2 by sputum samples</td>\n",
       "      <td>Sensitivity: 100% (35/35) &lt;s&gt;132&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Developed as of 3 Feb 2020.   CE approved &lt;s&gt;132&lt;/s&gt;</td>\n",
       "      <td>1 hr 45 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Biomeme&lt;s&gt;133,134&lt;/s&gt; USA</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>Shelf-stable strip with 3 reaction wells, each reaction contains lyophilized master mix, multiplexed primers, and probes for the following triplex: - 2019-nCoV-Orf1ab - 2019-nCoV-S - MS2 bacteriophage as an RNA extraction and RT-PCR control</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>$300 for 10 strips +  $5,950 for PCR Thermocycler + $450 for sample prep kit</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Livzon&lt;s&gt;135&lt;/s&gt;</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>Novel coronavirus (2019-nCoV) nucleic acid diagnostic kit (PCR-fluorescence method) Detection of ORF1ab and N genes.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Developed.  Undergoing testing. Emergency use approval submitted to China’s NMPA on 27 Jan 2020</td>\n",
       "      <td>30 minutes&lt;s&gt;136&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Acumen Research Laboratories&lt;s&gt;137&lt;/s&gt; Singapore</td>\n",
       "      <td>7 Feb 2020</td>\n",
       "      <td>&lt;s&gt;Acu-Corona™ 2.0/3.0&lt;/s&gt;With specific gene targets.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Prototype developed.  Acu-Corona 2.0 obtained Provisional Authorisation from Singapore Health Sciences Authority on 31 March 2020. Acu-Corona 3.0 obtained Provisional Authorisation from HSA on 14 April 2020. (HSA authorisation for Acu-Corona 2.0: &lt;s&gt;138&lt;/s&gt;HSA authorisation for Acu-Corona 3.0:&lt;s&gt;139&lt;/s&gt; Currently CE-IVD pending and approved for research only, seeking approval from US Food and Drug Authorisation</td>\n",
       "      <td>Allows up to 94 patient samples &lt;s&gt;per 1.5h&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>RT-PCR  [Point-of-Care]</td>\n",
       "      <td>Cepheid&lt;s&gt;27,140,141&lt;/s&gt; (Plus collaboration with Sherlock Biosciences)&lt;s&gt;142&lt;/s&gt; USA</td>\n",
       "      <td>10 Feb 2020</td>\n",
       "      <td>SAR-CoV-2 Xpert Xpress Cartridge-based nucleic acid amplification test. Tests for two gene targets: N2 &amp; E.</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swab specimens were spiked with SARS-CoV- (2x to 5x LoD) serving as contrived positive samples.&lt;s&gt;141&lt;/s&gt;</td>\n",
       "      <td>100% (35/35)  35 nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;141&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 21 Mar 2020.&lt;s&gt;27&lt;/s&gt; Approved for inclusion on the Australian Register of Therapeutic Goods on 22 March 2020. &lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>45 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>TIB-Molbiol&lt;s&gt;124,144&lt;/s&gt;(distributed by Roche)  Germany</td>\n",
       "      <td>12 Feb 2020</td>\n",
       "      <td>2019-nCoV Real-Time Reverse Transcription PCR Kit Tests for three gene targets: E, RdRp, and N.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available. Orders for the kit have been placed from World Health Organisation, national health authorities and laboratories in about 60 countries. &lt;s&gt;144&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>About €160&lt;s&gt;144&lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>AusDiagnostics&lt;s&gt;145-&lt;/s&gt;&lt;s&gt;147&lt;/s&gt; Australia</td>\n",
       "      <td>16 Feb 2020</td>\n",
       "      <td>AusDiagnostics respiratory virus panel (including SARS-CoV-2) test Multiplex panel. Tests for two gene targets: ORF1a &amp; ORF8</td>\n",
       "      <td>100%&lt;s&gt;147&lt;/s&gt;</td>\n",
       "      <td>100%&lt;s&gt;147&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Received CE Mark Mar 2020.&lt;s&gt;147&lt;/s&gt; Approved for inclusion in Australia’s ARTG.&lt;s&gt;81&lt;/s&gt;</td>\n",
       "      <td>3 hr&lt;s&gt;146&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Seegene&lt;s&gt;148,149&lt;/s&gt; South Korea</td>\n",
       "      <td>18 Feb 2020</td>\n",
       "      <td>Allplex 2019-nCoV Assay Single-tube assay that tests for three gene targets: E, RdRp, and N.</td>\n",
       "      <td>100% (49/49) from upper respiratory specimens (nasopharyngeal/ oropharyngeal swabs)  100% (49/49) from lower respiratory specimens (sputum)&lt;s&gt;150&lt;/s&gt;</td>\n",
       "      <td>94% (94/100) from upper respiratory specimens (nasopharyngeal/ oropharyngeal swabs)  97.87% (92/94) from lower respiratory specimens (sputum)  &lt;s&gt;150&lt;/s&gt;</td>\n",
       "      <td>Commercially available.  Obtained EUA approval from Korean FDA 12 Feb 2020.&lt;s&gt;151,152&lt;/s&gt; Product already has CE Mark for IVD.    Obtained HSA provisional approval on 2 April 2020, supplied through All Eights (Singapore) Pte Ltd. &lt;s&gt;153&lt;/s&gt; Approved for inclusion on the Australian Register of Therapeutic Goods on 27 March 2020 &lt;s&gt;143&lt;/s&gt; FDA EUA issued 21/04/2020</td>\n",
       "      <td>1 hour 50 minutes after extraction &lt;s&gt;150&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>RT-PCR  [Point-of-Care]</td>\n",
       "      <td>Credo Diagnostics Biomedical&lt;s&gt;154,155&lt;/s&gt; Singapore</td>\n",
       "      <td>21 Feb 2020</td>\n",
       "      <td>VitaPCR SARS-CoV-2 Assay Runs on Credo’s VitaPCR automated point-of-care molecular testing platform.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.   Received CE Mark 17 Mar 2020.   Submitted to US FDA for EUA approval.  Has provisional authorisation from Singapore’s HSA.</td>\n",
       "      <td>20 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Osang Healthcare&lt;s&gt;156,157&lt;/s&gt;(partnership with Italy’s ELITech Group)  South Korea</td>\n",
       "      <td>3 Mar 2020</td>\n",
       "      <td>GeneFinder COVID-19 Plus RealAmp Kit Tests for three gene targets: RdRp, E, and N.  Runs on all major PCR cyclers as well as on the Sample-to-Result Platform ELITe InGenius.</td>\n",
       "      <td>100% for both upper and lower respiratory tract samples   Evaluated using 30 nasopharyngeal swabs (upper respiratory tract) and sputum (lower respiratory tract) specimens spiked with SARS-CoV-2 virus (1x to 4x LoD) serving as contrived positive samples &lt;s&gt;158&lt;/s&gt;</td>\n",
       "      <td>100% for both upper and lower respiratory tract samples   Evaluated using 30 nasopharyngeal swabs and sputum specimens serving as negative controls&lt;s&gt;158&lt;/s&gt;</td>\n",
       "      <td>Available.   Received CE Mark for IVD.  Obtained EUA approval from US FDA on 18 April 2020. &lt;s&gt;158&lt;/s&gt; Date of Provisional Authorisation from HSA: 14 May 2020, supplied through SPD Scientific Pte Ltd&lt;s&gt;159&lt;/s&gt;</td>\n",
       "      <td>About 120 minutes &lt;s&gt;158&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>RT-PCR  [Point-of-Care]</td>\n",
       "      <td>Mesa Biotech&lt;s&gt;28,30,160-162&lt;/s&gt; USA</td>\n",
       "      <td>4 Mar 2020</td>\n",
       "      <td>Accula SARS-Cov-2 Test Automated PCR test for the qualitative visual detection of nucleic acid from the SARS-CoV-2 virus that runs on the Accula system machines.</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs spiked with SARS-CoV-2 RNA (2x to 50x LoD) serving as contrived positive samples.&lt;s&gt;162&lt;/s&gt;</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs serving as negative controls.&lt;s&gt;162&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 23 Mar 2020.</td>\n",
       "      <td>30 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Luminex&lt;s&gt;163-165&lt;/s&gt; USA</td>\n",
       "      <td>4 Mar 2020</td>\n",
       "      <td>NxTAG CoV Extended Panel Assay Multiplex panel that can be run on Luminex’s MAGPIX System together with optional NxTag Respiratory Pathogen Panel.  Tests for three gene targets: ORF1ab, E, &amp; N</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs spiked with purified SARS-CoV-2 viral genomic RNA (2x to 5x LoD) serving as contrived positive samples.</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs serving as negative controls.</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 27 Mar 2020.  Date of Provisional Authorisation from HSA: 8 May 2020&lt;s&gt;166&lt;/s&gt;</td>\n",
       "      <td>4 hr  (2 hr 15 min to  2 hr 25 min cycle time)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>LGC Biosearch Technologies&lt;s&gt;25,167&lt;/s&gt;</td>\n",
       "      <td>10 Mar 2020</td>\n",
       "      <td>2019-nCoV CDC Probe and Primer Kits for SARS-CoV-2 Lot numbers #143503 and #143764</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.  Obtained EUA approval from US FDA 10 Mar 2020 for lot number #143503 and #143764.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>USD $230 for 1000 rxn&lt;s&gt;167&lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Fulgent Therapeutics, LLC&lt;s&gt;168&lt;/s&gt; USA</td>\n",
       "      <td>11 Mar 2020</td>\n",
       "      <td>COVID-19 Virus Testing by RT-PCR  Real-time RT-PCR for the qualitative detection of SARS-CoV-2 N1 and N2 genes in upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal direct swab specimens)</td>\n",
       "      <td>&lt;s&gt;100% (30/30)&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;100% (64/64)&lt;/s&gt;</td>\n",
       "      <td>Submitted to US FDA for EUA Approval.  Commercially Available&lt;s&gt;169&lt;/s&gt; FDA EUA issued on 15/5/2020&lt;s&gt;170&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>bioMérieux&lt;s&gt;171-173&lt;/s&gt;(subsidiary BioFire Defense)  France</td>\n",
       "      <td>11 Mar 2020</td>\n",
       "      <td>BioFire COVID-19 test Fully automated and designed to run on FILMARRAY® 2.0 and FILMARRAY® TORCH platforms. Tests for two gene targets: ORF1ab &amp; ORF8</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swab specimens were spiked with live SARS-CoV-2 virus (1x to 100x LoD) serving as contrived positive samples.&lt;s&gt;174&lt;/s&gt;</td>\n",
       "      <td>100% (66/66)  66 clinical nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;174&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 24 Mar 2020.&lt;s&gt;173&lt;/s&gt;</td>\n",
       "      <td>45 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Hologic&lt;s&gt;175-177&lt;/s&gt; USA</td>\n",
       "      <td>16 Mar 2020</td>\n",
       "      <td>Panther Fusion SARS-CoV-2 Assay Test for two conserved regions of the ORF1ab gene</td>\n",
       "      <td>100% (69/69)  69 remnant clinical nasopharyngeal specimens were spiked with inactivated cultured SARS-CoV-2 virus (1x to 5x LoD) serving as contrived positive samples.&lt;s&gt;177&lt;/s&gt;</td>\n",
       "      <td>100 (109/109)  109 remnant clinical nasopharyngeal specimens serving as negative controls.&lt;s&gt;177&lt;/s&gt;</td>\n",
       "      <td>Commercially available.  Obtained EUA approval from US FDA 16 Mar 2020.   Approved for inclusion into the Australian Register of Therapeutic Goods on 20 March 2020.&lt;s&gt;81&lt;/s&gt;</td>\n",
       "      <td>Can generate results in 3 hours&lt;s&gt;178&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>LabCorp (Laboratory Corporation of America)&lt;s&gt;176,179&lt;/s&gt; USA</td>\n",
       "      <td>16 Mar 2020</td>\n",
       "      <td>COVID-19 RT-PCR Test Test for three gene targets: N1, N2, &amp; N3</td>\n",
       "      <td>100% (80/80)  40 nasopharyngeal swab specimens and 40 bronchoalveolar lavage specimens were spiked with quantitated live SARS-CoV-2 (1x to 8x LoD) to form 80 contrived positive samples.&lt;s&gt;179&lt;/s&gt;</td>\n",
       "      <td>100% (100/100)   50 nasopharyngeal swab specimens and 50 bronchoalveolar lavage specimens serving as negative controls.&lt;s&gt;179&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 16 Mar 2020.</td>\n",
       "      <td>Approximately 2-4 days from the date of pickup of a specimen for testing to the release of the test result to the health care provider &lt;s&gt;180&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Quidel&lt;s&gt;181,182&lt;/s&gt; USA</td>\n",
       "      <td>17 Mar 2020</td>\n",
       "      <td>Lyra SARS-CoV-2 Assay Identification of the SARS-CoV-2 virus occurs by the use of target specific primers and fluorescent-labeled 102 probes that hybridize to a conserved region of the non-structural Polyprotein (pp1ab) of the SARS-CoV-2 virus.&lt;s&gt;183&lt;/s&gt;</td>\n",
       "      <td>100% (92/92)  92 nasopharyngeal swab specimens were spiked with SARS-CoV-2 RNA (1x to 5x LoD) serving as contrived positive samples.&lt;s&gt;182&lt;/s&gt;</td>\n",
       "      <td>(100% (92/92)  92 nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;182&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 17 Mar 2020.</td>\n",
       "      <td>45 min cycle time per gene</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Quests Diagnostics&lt;s&gt;184,185&lt;/s&gt; USA</td>\n",
       "      <td>17 Mar 2020</td>\n",
       "      <td>Quest SARS-CoV-2 rRT-PCR Tests on two gene targets: N1 &amp; N3</td>\n",
       "      <td>100% (30/30)  12 pairs of nasopharyngeal swab and sputum specimens from actual COVID-19 patient formed 24 samples, together wiith 6 additional randomly selected to be duplicated, serving as total 30 positive samples.&lt;s&gt;185&lt;/s&gt;</td>\n",
       "      <td>100% (72/72)  72 presumed-negative nasopharyngeal/throat swab specimens from before Oct 2019 servings as negative controls.&lt;s&gt;185&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 17 Mar 2020.</td>\n",
       "      <td>58 min 40 s cycle time per gene</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Abbott Molecular&lt;s&gt;27,186,187&lt;/s&gt; USA</td>\n",
       "      <td>18 Mar 2020</td>\n",
       "      <td>Abbott RealTime SARS-CoV-2 assay Will run on the Abbott m2000 RealTime system. Tests for two gene targets: RdRp &amp; N.</td>\n",
       "      <td>100% (60/60)  61 nasopharyngeal swabs spiked with  recombinant virus containing SARS-CoV-2 RNA sequences (1x to 20x LoD) serving as contrived positive samples. 1 sample was invalidated and excluded.&lt;s&gt;187&lt;/s&gt;</td>\n",
       "      <td>100% (31/31)  34 nasopharyngeal swabs serving as negative controls. 3 samples were invalidated and excluded.&lt;s&gt;187&lt;/s&gt;</td>\n",
       "      <td>Commercially available.    Obtained EUA approval from US FDA 18 Mar 2020.  Approved for inclusion on the Australian Register of Therapeutic Goods on 17 April 2020.&lt;s&gt;143&lt;/s&gt;Date of HAS Provisional Authorisation: 01/04/2020 &lt;s&gt;188&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>DiaSorin Molecular&lt;s&gt;189-191&lt;/s&gt; Italy</td>\n",
       "      <td>19 Mar 2020</td>\n",
       "      <td>Simplexa COVID-19 Direct Will run on the DiaSorin’s LIAISOn MDX thermocycler.  Tests for two gene targets: S &amp; ORF1ab.</td>\n",
       "      <td>100% (52/52)  108 fresh nasopharyngeal swab specimens from 3 clinical site2s were compared with one of two brands of established comparator assay.&lt;s&gt;191&lt;/s&gt;</td>\n",
       "      <td>100% (56/56)  108 fresh nasopharyngeal swab specimens from 3 clinical sites were compared with one of two brands of established comparator assay.&lt;s&gt;191&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 19 Mar 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>DiaCarta&lt;s&gt;192,193&lt;/s&gt; USA</td>\n",
       "      <td>23 Mar 2020</td>\n",
       "      <td>QuantiVirus SARS-CoV-2 Tests for two gene targets: N, ORF1ab, &amp; E</td>\n",
       "      <td>96.7% Clinically validated in the company's CLIA-certified lab in Richmond, California.</td>\n",
       "      <td>100% Clinically validated in the company's CLIA-certified lab in Richmond, California.</td>\n",
       "      <td>Commercially available. Received CE Mark for IVD Mar 2020.   Obtained EUA approval from US FDA 8 Apr 2020.&lt;s&gt;194&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>PerkinElmer&lt;s&gt;28,195,19&lt;/s&gt;&lt;s&gt;6&lt;/s&gt; USA</td>\n",
       "      <td>24 Mar 2020</td>\n",
       "      <td>PerkinElmer New Coronavirus Nucleic Acid Detection Kit Tests for two gene targets: N &amp; ORF1ab.</td>\n",
       "      <td>100% (47/47)  47 oropharyngeal and nasopharyngeal swab specimens spiked with inactivated SARS-CoV-2 virus (1x to 5x LoD) serving as contrived positive samples.&lt;s&gt;196&lt;/s&gt;</td>\n",
       "      <td>100% (94/94)  94 oropharyngeal and nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;196&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 24 Mar 2020.  EUA amendment on April 1st to add an additional nucleic acid extraction method which utilizes the chemagic Viral DNA/RNA 300 Kit H96 on a new extraction platform, the chemagic 360 equipped with the chemagic Rod Head Set 96; and (2) make other minor changes and edits to the IFU labeling was granted on 01/04/2020 &lt;s&gt;197&lt;/s&gt;</td>\n",
       "      <td>104 min 30s cycle time per gene target.</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Genetron Health&lt;s&gt;198&lt;/s&gt; China</td>\n",
       "      <td>7 Aor 2020</td>\n",
       "      <td>Detection Kit for Novel Coronavirus (SARS-CoV-2) RNA</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.   Received CE Mark 7 Apr 2020.  Submitted to US FDA for EUA approval.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>51</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Mobidiag&lt;s&gt;199&lt;/s&gt;&lt;s&gt;Finland&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>&lt;s&gt;Amplidiag COVID-19&lt;/s&gt; Real-time RT-PCR test with two molecular targets (orf1ab and N) including at least one conserved region and one specific region to mitigate effects of genetic drift and avoid cross- reaction with other endemic coronaviruses.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available as an emergency use test in Finland and France, set up for routine use in main clinical laboratories in Finland with capacity to test up to 4000 samples a day.&lt;s&gt;200&lt;/s&gt; In the process for obtaining emergency use authorisation in Sweden and the UK. In the process for &lt;s&gt;obtaining CE-IVD.&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;48 samples in &lt;3h&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Genetic &lt;s&gt;Signatures Ltd&lt;/s&gt; Australia</td>\n",
       "      <td></td>\n",
       "      <td>EasyScreen™ SARS-CoV-2 Detection Kit  Real time PCR which enables qualitative detection of SARS-CoV-2 via two targets (SARS-CoV-2 N and &lt;s&gt;E genes)&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available.  CE-IVD marked.&lt;s&gt;201&lt;/s&gt; Approved for inclusion into the Australian Register of Therapeutic Goods on 13 April 2020.&lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Shanghai ZJ Bio-Tech Co Ltd (also called Liferiver)&lt;s&gt;202&lt;/s&gt; China</td>\n",
       "      <td></td>\n",
       "      <td>Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR Kit (Detection for 3 genes) Qualitative detection of SARS-CoV-2 by real time &lt;s&gt;PCR&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available.  Approved for inclusion into the Australian Register of Therapeutic Goods on 22 March 2020.&lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>AITbiotech Pte Ltd&lt;s&gt;203&lt;/s&gt; Singapore</td>\n",
       "      <td></td>\n",
       "      <td>abTES™ COVID-19 qPCR I Kit Qualitative RT-PCR which detects two COVID-19 specific regions from its non-structure polypeptide</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HSA: 05/03/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>DSO National Laboratories&lt;s&gt;204&lt;/s&gt; &lt;s&gt;Singapore&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Real-Time PCR Assay for the Detection of SARSCoV-2 Virus  RT-PCR based on specific detection of the polymerase gene region in SARS-CoV-2 virus.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HSA: &lt;s&gt;10/03/2020&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Biowalker Pte Ltd&lt;s&gt;205&lt;/s&gt; Singapore</td>\n",
       "      <td></td>\n",
       "      <td>Kit for Novel-Coronavirus (2019-nCoV) RNA (Isothermal Amplification-Real Time Fluorescence Assay) Detection of 2019-nCoV RNA in swab and sputum samples</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HSA: 24/03/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>JN Medsys Pte Ltd&lt;s&gt;206&lt;/s&gt; Singapore</td>\n",
       "      <td></td>\n",
       "      <td>ProTect™ COVID-19 RT-qPCR Kit In-vitro qualitative detection of SARS-CoV-2 from samples. The test targets SARS-CoV-2 N1, N2 and N3 genes and the human RNase P control gene.</td>\n",
       "      <td>High sensitivity and specificity, no statistics given</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HSA: 19/03/2020</td>\n",
       "      <td>Within 2 hours&lt;s&gt;207&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Veredus Laboratories Pte Ltd&lt;s&gt;127&lt;/s&gt; Singapore</td>\n",
       "      <td></td>\n",
       "      <td>VereCoV™ Detection Kit  Multiplex RT-PCR/microarray-based in-vitro diagnostic test.</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>Date of Provisional Authorisation by HSA: 18/02/2020</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Vela Operations Singapore Pte Ltd&lt;s&gt;208&lt;/s&gt; Singapore</td>\n",
       "      <td></td>\n",
       "      <td>ViroKey SARS-CoV-2 RT-PCR Test</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HSA: 15/04/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>SPD Scientific Pte Ltd&lt;s&gt;209&lt;/s&gt; Singapore</td>\n",
       "      <td></td>\n",
       "      <td>Cepheid® Xpert® Xpress SARS-CoV-2</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HAS: 26/03/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>PerkinElmer Singapore Pte Ltd &lt;s&gt;210&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>PerkinElmer® SARS-CoV-2 Real-time RT-PCR Assay</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Provisional Authorisation from HSA: 20/04/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>63</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>&lt;s&gt;BioWalker Pte Ltd&lt;/s&gt;&lt;s&gt;211&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>BioWalker SARS-CoV-2 Assay 2.0&lt;s&gt;212&lt;/s&gt;The test  uses rRT-PCR for qualitative detection of SARS-CoV-2 nucleic acids in human nasopharyngeal or oropharyngeal swab samples.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 30 April 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Medicell Pharmaceutical (S) Pte Ltd&lt;s&gt;213&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Sansure Biotech Novel Coronavirus (2019- nCoV) Nucleic Acid Diagnostic Kit</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 23/04/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Trax management Services Inc.&lt;s&gt;214&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>PhoenixDx 2019-CoV</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>100% (10/10)</td>\n",
       "      <td>FDA EUA issued on 20/4/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Ustar Biotechnologies (Hangzhou) Co Ltd (China)&lt;s&gt;215&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>EasyNat Diagnostic Kit for Novel-Coronavirus (2019-nCoV) RNA (Isothermal Amplification-Real Time Fluorescence Assay)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Approved for inclusion on the Australian Register of Therapeutic Goods on 23 April 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>CTK Biotech Inc (United States of America)&lt;s&gt;216&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Aridia COVID-19 Real-Time PCR Test</td>\n",
       "      <td>95.1%</td>\n",
       "      <td>95.9%</td>\n",
       "      <td>Approved for inclusion on the Australian Register of Therapeutic Goods on 24 April 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>PCL&lt;s&gt;132&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>PCL COVID19 Ag Rapid FIA &lt;s&gt;132&lt;/s&gt; Qualitative detection of SARS-CoV-2 antigens from human oropharyngeal and &lt;s&gt;deep sputum samples&lt;/s&gt;</td>\n",
       "      <td>Sensitivity: 100%</td>\n",
       "      <td></td>\n",
       "      <td>CE approved</td>\n",
       "      <td>10 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Seasun Biomaterials &lt;s&gt;217&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>&lt;s&gt;RT-PCR Test&lt;/s&gt;U-TOP COVID-19 Detection Kit &lt;s&gt;218&lt;/s&gt; Qualitative detection of SARS-CoV-2 antigens from oropharyngeal and nasopharyngeal swab specimens, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens and &lt;s&gt;sputum samples&lt;/s&gt;</td>\n",
       "      <td>100% (for both nasopharyngeal and sputum)&lt;s&gt;218&lt;/s&gt;</td>\n",
       "      <td>No cross-reactivity with 33 microorganisms</td>\n",
       "      <td>FDA EUA issued on 27/04/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>bioMérieux SA &lt;s&gt;219&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>BioFire Respiratory Panel 2.1 &lt;s&gt;220&lt;/s&gt; Multiplex RT-PCR test detecting SARS-CoV-2 spike (S) and membrane (M) gene.</td>\n",
       "      <td>98% (48/49)</td>\n",
       "      <td>100% (279/279)</td>\n",
       "      <td>FDA EUA issued on 1 May 2020&lt;s&gt;220&lt;/s&gt; Date of Provisional Authorisation from HSA: 14 May 2020&lt;s&gt;221&lt;/s&gt;</td>\n",
       "      <td>Around 45 mins</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Bio-Rad Laboratories, Inc. &lt;s&gt;222&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Bio-Rad SARS-CoV-2 &lt;s&gt;ddPCR Test&lt;/s&gt;&lt;s&gt;223&lt;/s&gt; Multiplex RT-PCR test detecting SARS-CoV-2 spike (S) and membrane (M) &lt;s&gt;gene&lt;/s&gt;</td>\n",
       "      <td>94.87% (37/39, analysis done after Thermo MagMAX extraction); 94.59% (35/37, analysis done after QIAamp viral RNA extraction)</td>\n",
       "      <td>94.87% (37/39, analysis done after Thermo MagMAX extraction); 95.00% (38/40, analysis done after QIAamp viral RNA extraction)</td>\n",
       "      <td>FDA EUA issued on 1 May 2020 &lt;s&gt;223&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Public Health England&lt;s&gt;224&lt;/s&gt; UK</td>\n",
       "      <td>10 Feb 2020</td>\n",
       "      <td>Real time RT-PCR (RdRp gene) assay which employs the use of two probes; one which detects 2019-nCoV, SARS-CoV and bat-SARS-related-CoVs, and the other 2019-nCoV only. The assay will be evaluated on the ABI 7500 Fast real-time PCR system.&lt;s&gt;225&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available (non-commercially) to 9 labs across the UK.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>Real-time RT-RAA</td>\n",
       "      <td>Beijing Ditan Hospital&lt;s&gt;226&lt;/s&gt; China</td>\n",
       "      <td>29 Jan 2020</td>\n",
       "      <td>Real time Reverse-Transcription Recombinase Aided Amplification (RT-RAA) assay  Novel isothermal nucleic acid amplification technique  for detection of SARS-CoV-2.   Assay was performed at 42°C within 30min using a portable real-time fluorescence detector,</td>\n",
       "      <td>(Recombinant plasmids containing conserved ORF1ab genes was used to analyse the specificity and sensitivity.)</td>\n",
       "      <td>(Recombinant plasmids containing conserved ORF1ab genes was used to analyse the specificity and sensitivity.)</td>\n",
       "      <td>Clinical trials phase.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>ScienCell Research Laboratories&lt;s&gt;227-229&lt;/s&gt; USA</td>\n",
       "      <td>24 Jan 2020</td>\n",
       "      <td>ScienCell SARS-CoV-2 Coronavirus Real-time RT-PCR (RT-qPCR) Detection Kit Tests for two gene targets: N1 &amp; N2</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs spiked with SARS-CoV-2 RNA (not actual clinical sample) serving as contrived positive samples.&lt;s&gt;228&lt;/s&gt;</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs serving as negative controls.&lt;s&gt;228&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 3 Apr 2020.</td>\n",
       "      <td>43 min 45 s cycle time for each gene</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Liferiver Biotech&lt;s&gt;230,231&lt;/s&gt; China</td>\n",
       "      <td>29 Jan 2020</td>\n",
       "      <td>Fluorescent PCR&lt;s&gt;231&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>€ 991&lt;s&gt;232&lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Liferiver Biotech&lt;s&gt;230,233&lt;/s&gt; China</td>\n",
       "      <td>29 Jan 2020</td>\n",
       "      <td>Multiplex RT-PCR&lt;s&gt;233&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.  Date of Provisional Authorisation from HSA: 4 May 2020&lt;s&gt;234&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>€ 1347&lt;s&gt;235&lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>GenScript&lt;s&gt;230,236,237&lt;/s&gt; USA</td>\n",
       "      <td>29 Jan 2020</td>\n",
       "      <td>qRT-PCR Targets RdRp gene, N gene and E gene in Wuhan-Hu-1 genome (GenBank &lt;s&gt;sequences NC_045512.2)&lt;/s&gt;[same as Charite’s first protocol]</td>\n",
       "      <td>“This assay is RUO and has not been tested on clinical samples. We make no claims on the performance of this assay.” &lt;s&gt;236&lt;/s&gt;</td>\n",
       "      <td>“This assay may have cross-reactivity with other coronavirus family members such as causative agents of the Middle East Respiratory Syndrome (MERS) or Severe Acute Respiratory Syndrome (SARS).”&lt;s&gt;236&lt;/s&gt;</td>\n",
       "      <td>Commercially available for RUO.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>CerTest Biotec&lt;s&gt;238&lt;/s&gt; Spain</td>\n",
       "      <td>30 Jan 2020</td>\n",
       "      <td>VIASURE 2019-nCoV Real Time PCR Kit Amplification of a fragment of the S gene.&lt;s&gt;239&lt;/s&gt;</td>\n",
       "      <td>97.5%&lt;s&gt;240&lt;/s&gt;</td>\n",
       "      <td>&gt;99.9%&lt;s&gt;240&lt;/s&gt;</td>\n",
       "      <td>Available.   Received CE Mark for IVD for the version adapted for the BD MAX™ System.&lt;s&gt;239&lt;/s&gt; Approved for inclusion on Australia’s ARTG on 21 March 2020.</td>\n",
       "      <td>120 minutes&lt;s&gt;240&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>GeneFirst&lt;s&gt;241&lt;/s&gt; UK</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>Capable of detecting only the SARS-CoV-2</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available</td>\n",
       "      <td>&lt; 3 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>81</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>GeneFirst&lt;s&gt;241&lt;/s&gt; UK</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>Multiplex assay which simultaneously detects SARS-CoV-2 as well as 17 other common viruses and bacteria</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available.</td>\n",
       "      <td>&lt; 3 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>82</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Kogene Biotech&lt;s&gt;131,151&lt;/s&gt; South Korea</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>Powerchek 2019-nCoV Real-time PCR kit Tests for two gene targets: E and RdRp.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from Korean CDC 4 Feb 2020.&lt;s&gt;151,242&lt;/s&gt; Approved for inclusion on the Australian Register of Therapeutic Goods.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>83</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Thermo Fisher Scientific&lt;s&gt;133,243-245&lt;/s&gt; USA</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>TaqPath COVID-19 Combo Kit (previously TaqMan 2019-nCoV Assay Kit) Real-time RT-PCR kit assays specifically target all 44 complete genomes currently available at GISAID, and do not target any of the 2,116 complete genomes of other coronaviruses currently available at NCBIm.  Tests for three gene targets: ORF1ab, N, &amp; S.</td>\n",
       "      <td>100% (60/60)  30 nasopharyngeal swab specimens and 30 bronchoalveolar lavage specimens were spiked with extracted SARS-CoV-2 viral genomic RNA (2x to 5x LoD) to form 60 contrived positive samples.&lt;s&gt;245&lt;/s&gt;</td>\n",
       "      <td>100% (60/60)  30 nasopharyngeal swab specimens and 30 bronchoalveolar lavage specimens were used as negative controls.&lt;s&gt;245&lt;/s&gt;</td>\n",
       "      <td>Commercially available.  Received CE Mark for IVD 26 Mar 2020.&lt;s&gt;246&lt;/s&gt; Obtained EUA approval from US FDA 13 Mar 2020.&lt;s&gt;244&lt;/s&gt; Obtained HSA provisional approval on 20 March 2020. Approved for inclusion on the Australian Register of Therapeutic Goods on &lt;s&gt;24 March 2020&lt;/s&gt;.</td>\n",
       "      <td>36 min cycle time per gene target</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>85</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>US CDC&lt;s&gt;17,247,248&lt;/s&gt; USA</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>Centers for Disease Control and Prevention (CDC) 2019-Novel Coronavirus (2019-nCoV) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel Tests for three gene targets: N1, N2, and N3 (subsequently removed&lt;s&gt;248&lt;/s&gt;) plus 1 human RNase P gene control.</td>\n",
       "      <td>100% (!3/13)  117 respiratory specimens collected from 46 subjects tested with two analytically validated real-time RT-PCR assays for N4 and N5 gene targets.&lt;s&gt;247&lt;/s&gt;</td>\n",
       "      <td>100% (104/104)  117 respiratory specimens collected from 46 subjects tested with two analytically validated real-time RT-PCR assays for N4 and N5 gene targets.&lt;s&gt;247&lt;/s&gt;</td>\n",
       "      <td>Available to laboratories designated by CDC as qualified, and in the US, certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity tests. Available to qualified international laboratories.  Not available to U.S. hospitals or other primary care settings.   Obtained EUA approval from US FDA 4 Feb 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>86</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>SolGent&lt;s&gt;151,152,249&lt;/s&gt; South Korea</td>\n",
       "      <td>28 Feb 2020</td>\n",
       "      <td>DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit  Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 N, ORF1a and PCRC genes in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes, bronchoalveolar lavage (BAL) fluid and sputum.</td>\n",
       "      <td>100%</td>\n",
       "      <td>100%</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from Korean CDC 27 Feb 2020.&lt;s&gt;151,152&lt;/s&gt; Received CE Mark for IVD.   FDA EUA issued on 21 May 2020 &lt;s&gt;250&lt;/s&gt;</td>\n",
       "      <td>2 hr PCR</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>87</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>SD Biosensor&lt;s&gt;151,152&lt;/s&gt; South Korea</td>\n",
       "      <td>28 Feb 2020</td>\n",
       "      <td>STANDARD M n-CoV Real-Time Detection Kit Tests for two gene targets: E and RdRp.</td>\n",
       "      <td>Sensitivity: 100% (30/30)&lt;s&gt;251&lt;/s&gt;</td>\n",
       "      <td>Specificity: 100% (30/30)&lt;s&gt;251&lt;/s&gt;</td>\n",
       "      <td>Available. Obtained EUA approval from Korean CDC 27 Feb 2020.&lt;s&gt;151,152&lt;/s&gt; FDA EUA issued on 23/04/2020</td>\n",
       "      <td>90 min &lt;s&gt;252&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Integrated DNA Technologies (IDT)&lt;s&gt;24,242&lt;/s&gt; USA</td>\n",
       "      <td>3 Mar 2020</td>\n",
       "      <td>2019-nCoV CDC EUA Kit Follows US CDC protocol to test for 3 N gene targets, and 1 human RNase P gene as control.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.  Obtained EUA approval from US FDA 3 Mar 2020 for lot number #0000500383.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>USD $125&lt;s&gt;24&lt;/s&gt;for 500 rxn</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Luminex&lt;s&gt;164,165,253,25&lt;/s&gt;&lt;s&gt;4&lt;/s&gt; USA</td>\n",
       "      <td>4 Mar 2020</td>\n",
       "      <td>ARIES SARS-CoV-2 Assay Tests for two gene targets: ORF1ab &amp; N</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs spiked with purified SARS-CoV-2 viral genomic RNA (2x to 5x LoD) serving as contrived positive samples.&lt;s&gt;254&lt;/s&gt;</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs serving as negative controls.&lt;s&gt;254&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 3 Apr 2020.</td>\n",
       "      <td>2 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>91</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Genomica&lt;s&gt;255,256&lt;/s&gt; Spain</td>\n",
       "      <td>6 Mar 2020</td>\n",
       "      <td>qCOVID-19 Real-time RT-PCR</td>\n",
       "      <td>Reported 100%.&lt;s&gt;255&lt;/s&gt; Tested at the Carlos III Health Institute with 80 samples (unclear of sample types).</td>\n",
       "      <td>Reported 100%.&lt;s&gt;255&lt;/s&gt; Tested at the Carlos III Health Institute with 80 samples (unclear of sample types).</td>\n",
       "      <td>Available.  Received CE Mark 6 Mar 2020.&lt;s&gt;256&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Avellino Lab&lt;s&gt;257-259&lt;/s&gt; USA</td>\n",
       "      <td>9 Mar 2020</td>\n",
       "      <td>AvellinoCoV2 test Tests for two gene targets from US CDC protocol: N1 &amp; N3</td>\n",
       "      <td>100% (30/30)  30 oropharyngeal and nasopharyngeal swab specimens spiked with whole SARS-CoV-2 viral RNA (1x to 100x LoD) serving as contrived positive samples.&lt;s&gt;259&lt;/s&gt;</td>\n",
       "      <td>100% (30/30)  30 oropharyngeal and nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;259&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 25 Mar 2020.&lt;s&gt;257&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Wadsworth Center, New York State Department of Public Health&lt;s&gt;194,260&lt;/s&gt; USA</td>\n",
       "      <td>10 Mar 2020</td>\n",
       "      <td>New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel Tests for two gene targets: N1 &amp; N2.</td>\n",
       "      <td>(42/43)  For the easyMAG extraction, 43 individual sputum samples were spiked with the extracted whole SARS-CoV-2 virus genomic RNA (2x to 200x LoD) to serve as contrived positive samples. Testing was also done with eMAG and EZ1 extraction.&lt;s&gt;260&lt;/s&gt;</td>\n",
       "      <td>(29/29)  For the easyMAG extraction, 30 individual sputum samples were used but 1 was invalidated, leaving 29 samples. Testing was also done with eMAG and EZ1 extraction.&lt;s&gt;260&lt;/s&gt;</td>\n",
       "      <td>Available.   Obtained EUA approval from US FDA  for use in Wadsworth Center, New York State Public Department of Health, and the New York City Department of Health and Mental Hygiene, Public Health Laboratories.</td>\n",
       "      <td>42 min 45 s cycle time per gene target</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>NeuMoDx&lt;s&gt;261-263&lt;/s&gt;</td>\n",
       "      <td>12 Mar 2020</td>\n",
       "      <td>NeuMoDx™ SARS-CoV-2 Assay Real-time RT-PCR for use on fully automated NeuMoDx™ 288 and 96 Molecular Systems. Tests for two gene targets: Nsp2 &amp; N.</td>\n",
       "      <td>100% (87/87)  87 clinical nasopharyngeal swab specimens were spiked with SARS-CoV-2 genomic RNA (1x to 8x LoD) serving as contrived positive samples.&lt;s&gt;263&lt;/s&gt;</td>\n",
       "      <td>100% (82/82  82 clinical nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;263&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 30 Mar 2020.&lt;s&gt;261&lt;/s&gt;</td>\n",
       "      <td>80 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Becton Dickinson (BD)&lt;s&gt;264-266&lt;/s&gt; USA</td>\n",
       "      <td>17 Mar 2020</td>\n",
       "      <td>BioGX SARS-CoV-2 Reagents for BD MAX System Tests for two gene targets: N1 &amp; N2</td>\n",
       "      <td>100% (29/29)  30 retrospective collected clinical nasopharyngeal swab specimens spiked with quantified genomic RNA of SARS- CoV-2 (1x to 5x LoD) serving as contrived positive samples. 1 sample removed from data analysis.&lt;s&gt;264&lt;/s&gt;</td>\n",
       "      <td>100% (30/30)  30 retrospective collected clinical nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;264&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 2 Apr 2020.  Approved for inclusion on the Australian Register of Therapeutic Goods on 17 April 2020.&lt;s&gt;81&lt;/s&gt;</td>\n",
       "      <td>2 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Maccura Biotechnology&lt;s&gt;257,26&lt;/s&gt;&lt;s&gt;7,268&lt;/s&gt; China</td>\n",
       "      <td>22 Mar 2020</td>\n",
       "      <td>SARS-CoV-2 Fluorescent PCR Kit Tests for three gene targets: ORF1ab, N, &amp; E.</td>\n",
       "      <td>100% (30/30)  15 nasopharyngeal and 15 oropharyngeal swab samples from suspected cases that tested negative had additional aliquot spiked with SARS-CoV-2 whole genomic RNA (2x to 5x LoD) serving as 30 contrived positive samples.&lt;s&gt;268&lt;/s&gt;</td>\n",
       "      <td>100% (30/30)  15 nasopharyngeal and 15 oropharyngeal swab samples from suspected cases that tested negative had additional aliquot serving as 30 negative controls.&lt;s&gt;268&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Received CE Mark in Mar 2020.&lt;s&gt;267&lt;/s&gt; Obtained EUA approval from US FDA 15 Apr 2020.</td>\n",
       "      <td>37 min 10 s cycle time per gene target</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Ipsum Diagnostics&lt;s&gt;269,270&lt;/s&gt;</td>\n",
       "      <td>1 Apr 2020</td>\n",
       "      <td>COV-19 IDx assay N1 gene target</td>\n",
       "      <td>100% (36/36)  36 nasopharyngeal swabs spiked with BEI ATCC Genomic RNA from SARS Related Coronavirus 2 (not actual clinical sample) serving as contrived positive samples.&lt;s&gt;270&lt;/s&gt;</td>\n",
       "      <td>100% (30/30) 30 nasopharyngeal swabs serving as negative controls.&lt;s&gt;270&lt;/s&gt;</td>\n",
       "      <td>Commercially available. Obtained EUA approval from US FDA 1 Apr 2020.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Gnomegen&lt;s&gt;271,272&lt;/s&gt;(Subsidiary of QuestGenomics)  USA (China)</td>\n",
       "      <td>6 Apr 2020</td>\n",
       "      <td>Gnomegen COVID-19 RT-Digital PCR Detection Kit Tests for two gene targets: N1 &amp; N2</td>\n",
       "      <td>100% (30/30)  30 oropharyngeal swabs spiked with quantified SARS-CoV-2 whole viral RNA (1x to 5x LoD) serving as contrived positive samples.&lt;s&gt;272&lt;/s&gt;</td>\n",
       "      <td>100% (30/30)  30 oropharyngeal swabs serving as negative controls.&lt;s&gt;272&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 6 Apr 2020.</td>\n",
       "      <td>129 min 30 s cycle time</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>InBios International&lt;s&gt;248,273,2&lt;/s&gt;&lt;s&gt;74&lt;/s&gt; USA</td>\n",
       "      <td>7 Apr 2020</td>\n",
       "      <td>Smart Detect SARS-CoV-2 rRT-PCR Kit multiplex one-step rRT-PCR that can run on CFX96 Touch Real-Time PCR.  Tests for three gene targets: N, E, &amp; ORF1b</td>\n",
       "      <td>100% (30/30)  30 nasopharyngeal swabs spiked with SARS-CoV-2 viral genomic RNA (1x to 5x LoD) serving as contrived positive samples.&lt;s&gt;273&lt;/s&gt;</td>\n",
       "      <td>96.7% (29/30)  30 nasopharyngeal swabs serving as negative controls.&lt;s&gt;273&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 7 Apr 2020.</td>\n",
       "      <td>4 hr&lt;s&gt;274&lt;/s&gt; (43 min 45 s cycle time for each gene)&lt;s&gt;273&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Becton Dickinson (BD)&lt;s&gt;275,276&lt;/s&gt; USA</td>\n",
       "      <td>8 Apr 2020</td>\n",
       "      <td>BD SARS-CoV-2 Reagents for BD MAX System Test is a rRT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasal, nasopharyngeal and oropharyngeal swab samples from individuals suspected of COVID-19 by their healthcare provider.  Tests for two gene targets: N1 &amp; N2</td>\n",
       "      <td>96% (48/50)  50 retrospective collected clinical nasopharyngeal swabs spiked with quantified genomic RNA of SARS- CoV-2 (1x to 5x LoD) serving as contrived positive samples.&lt;s&gt;276&lt;/s&gt;</td>\n",
       "      <td>100% (29/29)  29 retrospective collected clinical nasopharyngeal swab specimens serving as negative controls.&lt;s&gt;276&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 8 Apr 2020.  Date of Provisional Authorisation from HSA: 6 May 2020&lt;s&gt;277&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>Real-time PCR and microarray technologies  [Point-of-Care]</td>\n",
       "      <td>Mobidiag&lt;s&gt;278&lt;/s&gt;(collaboration with Autobio Diagnostics, China)    Finland</td>\n",
       "      <td>10 Feb 2020</td>\n",
       "      <td>Novodiag Cartridge-based qPCR system, fully automated, allowing the rapid detection of both novel coronavirus and influenzas in around 30 minutes.  Two gene targets for SARS-CoV-2 (orf1ab and N)&lt;s&gt;199&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>In development.</td>\n",
       "      <td>Less than an hour</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>Real Time RT-PCR</td>\n",
       "      <td>BGI&lt;s&gt;279-281&lt;/s&gt; (Pathomics Health as distributor)   China</td>\n",
       "      <td>23 Jan 2020</td>\n",
       "      <td>Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV In vitro RT-PCR combining fluorescent probing.&lt;s&gt;282&lt;/s&gt; Real-time RT-PCR assay for qualitative detection of SARS-CoV-2 in throat swabs and bronchoalveolar lavage fluid (BALF).</td>\n",
       "      <td>BALF: 81% Throat Swab: 91.2% RNA: 97.1% Combined: 88.1%&lt;s&gt;283&lt;/s&gt;</td>\n",
       "      <td>BALF: 100% Throat Swab: 100% RNA: 96.2% Combined: 99.6%&lt;s&gt;283&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Received CE Mark for IVD 2 Mar 2020.&lt;s&gt;284&lt;/s&gt; BGI is also engaged with relevant organizations in Hong Kong, Taiwan, Brunei, Thailand, Nigeria, South Africa, to supply the test kits.&lt;s&gt;279&lt;/s&gt; Passed emergency approval procedure of China’s NMPA.  Obtained EUA approval from US FDA 27 Mar 2020.&lt;s&gt;280,281&lt;/s&gt; Approved for inclusion on Australia’s ARTG on 10 April 2020.  Date of Provisional Authorisation from HSA:  24 April 2020 &lt;s&gt;285&lt;/s&gt;</td>\n",
       "      <td>3 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>CapitalBio&lt;s&gt;45&lt;/s&gt;(collaboration with Tsinghua University and West China Hospital of Sichuan University)  China</td>\n",
       "      <td>24 Feb 2020</td>\n",
       "      <td>Detection of six common respiratory viruses including SARS-CoV-2 within 1.5 hours using samples of patients' oral and pharyngeal Secretions.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available.  Approved by China’s NMPA.</td>\n",
       "      <td>1 hr 30 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>qPCR</td>\n",
       "      <td>Primerdesign&lt;s&gt;286-291&lt;/s&gt;(molecular diagnostics division of Novacyt) France/UK</td>\n",
       "      <td>31 Jan 2020</td>\n",
       "      <td>Genesig Real-Time PCR COVID-19 (CE) [Previously Coronavirus (Strain 2019-nCoV) Easy/Standard Kit]&lt;s&gt;287&lt;/s&gt; Can run on multiple molecular testing platforms, including Primerdesign’s own genesig® q16 and q32 instrument</td>\n",
       "      <td>96%&lt;s&gt;292&lt;/s&gt;</td>\n",
       "      <td>100%</td>\n",
       "      <td>Commercially available.   Received CE Mark for IVD 17 Feb 2020.&lt;s&gt;293,294&lt;/s&gt; Obtained EUA approval from US FDA 20 Mar 2020.&lt;s&gt;290&lt;/s&gt;</td>\n",
       "      <td>&lt; 2 hr  64 min 30 s cycle time per gene&lt;s&gt;291&lt;/s&gt;</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>qPCR</td>\n",
       "      <td>Coyote Bioscience&lt;s&gt;133,295&lt;/s&gt; China</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>2019-nCoV Prep Free QPCR Assay Runs on the Mini8 Portable Molecular Diagnostic QPCR Station (CFDA approved)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available. Reportedly being used in China in over 30 hospitals, 16 local CDC offices, and 8 airports.</td>\n",
       "      <td>1 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>qPCR  [Point-of-Care]</td>\n",
       "      <td>Molbio Diagnostics&lt;s&gt;295&lt;/s&gt; India</td>\n",
       "      <td>12 Feb 2020</td>\n",
       "      <td>qPCR Truenat Beta CoV &lt;s&gt;296&lt;/s&gt;Potentially real-time PCR then detection of wavelengths of fluorescent signal.</td>\n",
       "      <td>100% &lt;s&gt;297&lt;/s&gt;</td>\n",
       "      <td>100% &lt;s&gt;297&lt;/s&gt;</td>\n",
       "      <td>Available.   Approved by the Indian Council of Medical Research for coronavirus testing in India on 4 April 2020.&lt;s&gt;298&lt;/s&gt;</td>\n",
       "      <td>55 min</td>\n",
       "      <td>Rs 1,000 – Rs 1,500) &lt;s&gt;298&lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>110</th>\n",
       "      <td>qPCR  [Point-of-Care]</td>\n",
       "      <td>OnSiteGene&lt;s&gt;295&lt;/s&gt;(San Diego-based subsidiary of Singapore's Star Array)  USA</td>\n",
       "      <td>12 Feb 2020</td>\n",
       "      <td>Star Array 2019 Novel Coronavirus (SARS-CoV-2) Nucleic Acid Detection &lt;s&gt;Kit 1.0 &lt;/s&gt; 2019-nCoV rRT-PCR kit for use on existing Peak V, that performs spatial thermal cycling using a heated liquid metal for direct amplification without the need for sample prep. Genes detected are the SARS-CoV-2 N gene and ORF1ab gene. &lt;s&gt;299&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Developed. Currently seeking collaborators to perform clinical tests in China and the US.&lt;s&gt;299&lt;/s&gt;</td>\n",
       "      <td>10 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>111</th>\n",
       "      <td>PCR-based genotyping</td>\n",
       "      <td>Genomica&lt;s&gt;300,301&lt;/s&gt; Spain</td>\n",
       "      <td>30 Jan 2020</td>\n",
       "      <td>CLART COVID-19 Based on Genomica’s CLART technology of PCR-based genotyping with low-density microarray.</td>\n",
       "      <td>&gt;96%&lt;s&gt;302&lt;/s&gt;</td>\n",
       "      <td>98%</td>\n",
       "      <td>Available.  Received CE Mark 6 Mar 2020.&lt;s&gt;256&lt;/s&gt;</td>\n",
       "      <td>&lt; 5 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>112</th>\n",
       "      <td>ddPCR</td>\n",
       "      <td>Bio-Rad Laboratories&lt;s&gt;303-305&lt;/s&gt; USA</td>\n",
       "      <td>19 Mar 2020</td>\n",
       "      <td>COVID-19 Droplet Digital PCR (ddPCR) Assay Quantitative assay for use on Bio-Rad’s QX200 and QXDx Droplet Digital PCR Systems.</td>\n",
       "      <td>Reported enhanced sensitivity.&lt;s&gt;304&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.   EUA Submission Pending&lt;s&gt;306&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>113</th>\n",
       "      <td>Conventional and Real Time RT-PCR</td>\n",
       "      <td>Genekam&lt;s&gt;307,308&lt;/s&gt; Germany</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>5 options: 1. Conventional PCR 2. Real Time PCR for nCoV only&lt;s&gt;309&lt;/s&gt;3. Multiplex Real Time PCR for nCoV + other Bat CoV&lt;s&gt;310&lt;/s&gt;4. Multiplex Real Time PCR for nCoV + other Bat CoV + MERS&lt;s&gt;311&lt;/s&gt;5. Multiplex Real Time PCR for nCoV + Influenza A&lt;s&gt;312&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>In development as of 6 Feb 2020</td>\n",
       "      <td>126 min 15 s&lt;s&gt;309,311&lt;/s&gt;or 120 min&lt;s&gt;310,312&lt;/s&gt; of cycle time</td>\n",
       "      <td>€ 599&lt;s&gt;308&lt;/s&gt;€ 699&lt;s&gt;308&lt;/s&gt;€ 799&lt;s&gt;308&lt;/s&gt;€ 999&lt;s&gt;308&lt;/s&gt;€ 899&lt;s&gt;308&lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>114</th>\n",
       "      <td>Combination of RT-PCR and meta-genomics detection</td>\n",
       "      <td>BGI&lt;s&gt;279&lt;/s&gt; (Pathomics Health as distributor)&lt;s&gt;313&lt;/s&gt; China</td>\n",
       "      <td>23 Jan 2020</td>\n",
       "      <td>2019-nCoV PMseq Kit   A metagenomics sequencing kit based on combinatorial Probe Anchor Synthesis.  Faster SARS-CoV-2 virus detection, and able to detect both known and novel microorganisms, enabling monitoring of evolution during transmission.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Has been providing technical support for the scientific clinical prevention and control of the epidemic in Wuhan.  Passed emergency approval procedure of China’s NMPA.</td>\n",
       "      <td>SARS-CoV-2 detection stated to be faster than Fluorescent RT-PCR kit.  For detection of unknown pathogens, Within 5 hours, 128 samples can be simultaneously screened and sequenced by SE50, and 128 samples can be simultaneously tested and sequenced by PE100 in 22 hours, as well as possible mutation and evolution monitoring</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Jiangsu Bioperfectus Technologies Co Ltd &lt;s&gt;314&lt;/s&gt;</td>\n",
       "      <td>11 May 2020</td>\n",
       "      <td>COVID-19 Coronavirus Real &lt;s&gt;Time PCR Kit &lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Approved for inclusion in the Australian Register of Therapeutic Goods on 5 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>TCM Biosciences&lt;s&gt;131,315&lt;/s&gt; South Korea</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>TCM-Q Corona Ⅲ RT-PCR using SARS-CoV-2 RdRP gene and E-Sarbeco &lt;s&gt;gene&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;100%&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;100%&lt;/s&gt;</td>\n",
       "      <td>Developed as of 3 Feb 2020.  Submitted to Korean CDC for EUA.</td>\n",
       "      <td>&lt;s&gt;70 min&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Bioneer&lt;s&gt;131&lt;/s&gt; South Korea</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>AccuPower COVID-19 Real-Time RT-PCR kit&lt;s&gt;316&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Assumed developed as of 3 Feb 2020. Submitted to Korean CDC for EUA.  Received CE mark. Distributed to 20 &lt;s&gt;hospitals in Romania&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>CEVI&lt;s&gt;131,317&lt;/s&gt; (Partnership with Wells Bio)  South Korea</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>CareGENE N-CoV RT-PCR &lt;s&gt;Kit&lt;/s&gt;Real time RT-PCR kit to detect SARS-CoV-2 RdRP and E genes in human nasopharyngeal swab, oropharyngeal swab and &lt;s&gt;sputum&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>In development as of 6 Feb 2020.  &lt;s&gt;CE mark on March 3&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;83 minutes&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>QuantuMDx&lt;s&gt;295,318&lt;/s&gt;UK</td>\n",
       "      <td>12 Feb 2020</td>\n",
       "      <td>(SARS-CoV-2 Detection RT-PCR Testing kit. Detect SARS-CoV-2 in human oropharyngeal and nasopharyngeal swab</td>\n",
       "      <td>100%</td>\n",
       "      <td>100%</td>\n",
       "      <td>EUA application submitted to DFA, CE-IVD mark by mid may</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Liferiver Bio-Tech &lt;s&gt;319&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR Kit Test  is used for the in vitro qualitative detection of 2019-nCoV RNA in upper respiratory tract specimens and lower respiratory tract specimens.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 4 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Fast Track Diagnostics Luxembourg Sárl. (a Siemens Healthineers Company)</td>\n",
       "      <td></td>\n",
       "      <td>FTD SARS-CoV-2. Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal swabs, nasopharyngeal swabs, nasopharyngeal wash and bronchoalveolar lavage.</td>\n",
       "      <td>100% (44/44)</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>FDA EUA issued on 5 May 2020&lt;s&gt;320&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>bioMérieux SA&lt;s&gt;321&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>ARGENE®  SARS-CoV-2 R-gene test Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes and bronchoalveolar lavage (BAL) fluid.</td>\n",
       "      <td>100% (76/76)</td>\n",
       "      <td>100% (50/50)</td>\n",
       "      <td>FDA EUA issued on 6 May 2020&lt;s&gt;322&lt;/s&gt; CE marked on 10 April 2020, validated in France since 11 March 2020.</td>\n",
       "      <td>4-5 Hours</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>124</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>OPTI Medical Systems, Inc</td>\n",
       "      <td></td>\n",
       "      <td>OPTI SARS-CoV-2 RT-PCR Test Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in upper and lower respiratory specimens (such as nasal, nasopharyngeal, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate).</td>\n",
       "      <td>100% in both sputum and NP swab</td>\n",
       "      <td>100% in both sputum and NP swab</td>\n",
       "      <td>FDA EUA issued on 6 May 2020&lt;s&gt;323&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>125</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Zymo Research Corporation</td>\n",
       "      <td></td>\n",
       "      <td>Quick SARS-CoV-2 rRT-PCR Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in upper and lower respiratory specimens (such as nasal, nasopharyngeal, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate).</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>FDA EUA issued on 7 May 2020&lt;s&gt;324&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Rutgers Clinical Genomics Laboratory at RUCDR Infinite Biologics - Rutgers University</td>\n",
       "      <td></td>\n",
       "      <td>Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal swab, mid-turbinate nasal swab, and bronchoalveolar lavage &lt;s&gt;(BAL) fluid.&lt;/s&gt;</td>\n",
       "      <td>100% for nasopharyngeal and oropharyngeal swabs (30/30) as well as saliva</td>\n",
       "      <td>100% for nasopharyngeal and oropharyngeal swabs (30/30) as well as saliva</td>\n",
       "      <td>FDA EUA issued on 7 May 2020&lt;s&gt;325&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>128</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Abbott Molecular Inc.&lt;s&gt;326&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Alinity m SARS-CoV-2 assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, nasal swabs, and bronchoalveolar lavage (BAL) fluid</td>\n",
       "      <td>100% (31/31)</td>\n",
       "      <td>100% (40/40)</td>\n",
       "      <td>FDA EUA issued on 11 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>129</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>1drop Inc &lt;s&gt;327&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>1 copy™ covid-19 qPCR multi kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 E and &lt;s&gt;326&lt;/s&gt;RdRp gene in nasopharyngeal, oropharyngeal, anterior nasal, mid-turbinate nasal swab specimens as well as nasopharyngeal wash/aspirate and nasal aspirate specimens.</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>(No info)</td>\n",
       "      <td>FDA EUA issued on 11 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>130</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Applied DNA Sciences, Inc.&lt;s&gt;328&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Linea™ COVID-19 Real Time PCR Assay Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal, oropharyngeal and nasal swab specimens as well as nasopharyngeal wash/aspirate and nasal aspirate specimens.</td>\n",
       "      <td>98% (62/63)</td>\n",
       "      <td>93% (63/67)</td>\n",
       "      <td>FDA EUA issued on 13 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>131</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>GeneMatrix, Inc.&lt;s&gt;329&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>NeoPlexTM COVID-19 Detection Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal, oropharyngeal and nasal swab specimens as well as nasopharyngeal wash/aspirate and nasal aspirate specimens.</td>\n",
       "      <td>100% for nasopharyngeal, oropharyngeal and sputum samples (40/40)</td>\n",
       "      <td>100% for nasopharyngeal, oropharyngeal and sputum samples (40/40)</td>\n",
       "      <td>FDA EUA issued on 14 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>133</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Assurance Scientific Laboratories&lt;s&gt;330&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Assurance SARS-CoV-2 Panel Real-time RT-PCR for the qualitative detection of SARS-CoV-2 E, N1 and N2 genes in upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal swabs).</td>\n",
       "      <td>100% (38/38 using samples extracted with Abnova Precipitor; 34/34 using samples extracted with Zymo Research Kit &lt;s&gt;on the IndiMag)&lt;/s&gt;</td>\n",
       "      <td>100% (30/30 using samples extracted with Abnova Precipitor; 48/48 using samples extracted with Zymo Research Kit on the IndiMag)</td>\n",
       "      <td>FDA EUA issued on 15 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134</th>\n",
       "      <td>Real Time RT-PCR</td>\n",
       "      <td>Quidel Corporation&lt;s&gt;331&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Lyra® Direct SARS-CoV-2 Assay Real-time RT-PCR for the qualitative detection of SARS-CoV-2 RNA in upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal swabs).</td>\n",
       "      <td>97% (29/30)</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>FDA EUA issued on 18 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>135</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Wuhan EasyDiagnosis Biomedicine Co Ltd (China) &lt;s&gt;332&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>COVID-19 (SARS-CoV-2) Nucleic Acid Test kit Real-time RT-PCR test kit, intended for the qualitative detection of nucleic acid from the SARS-CoV-2, in upper and lower respiratory tract specimens. Gene targets are the SARS-CoV-2 N and ORF1ab gene.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Approved for inclusion on the Australian Register of Therapeutic Goods on 19 May 2020.&lt;s&gt;333&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>136</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>AMT Pte Ltd</td>\n",
       "      <td></td>\n",
       "      <td>AMT RESOLUTE 1.0 Real-time RT-PCR for the qualitative detection of SARS-CoV-2 RNA. RNA extraction is not required as this kit is intended for direct amplification of SARS-CoV-2 RNA from nasopharyngeal swabs in universal transport medium.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>HSA provisional authorisation approved on 20 May 2020&lt;s&gt;334&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>137</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>P23 Labs &lt;s&gt;335&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>P23 Labs TaqPath SARS-CoV-2 Assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens as well as bronchoalveolar lavage (BAL) specimens.</td>\n",
       "      <td>100% (31/31)</td>\n",
       "      <td>100% (11/11)</td>\n",
       "      <td>FDA EUA issued on 21 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>139</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>BioCore</td>\n",
       "      <td></td>\n",
       "      <td>BioCore 2019-nCoV Real Time PCR Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 N and RdRp genes in upper respiratory specimens (such as nasal, mid-turbinate, oropharyngeal, and nasopharyngeal swabs) and lower respiratory specimens (such as sputum, bronchoalveolar lavage (BAL), and tracheal aspirates).</td>\n",
       "      <td>100% (20/20) for both nasopharyngeal and sputum specimens</td>\n",
       "      <td>100% (40/40) for both nasopharyngeal and sputum specimens</td>\n",
       "      <td>FDA EUA issued on 21 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>140</th>\n",
       "      <td>NGS</td>\n",
       "      <td>IDbyDNA&lt;s&gt;336,337&lt;/s&gt; USA</td>\n",
       "      <td>29 Jan 2020</td>\n",
       "      <td>Next-generation sequencing-based metagenomics, allows enhanced pathogen detection and profiling in comparison to conventional PCR testing.&lt;s&gt;337&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>141</th>\n",
       "      <td>NGS</td>\n",
       "      <td>Fulgent Genetics&lt;s&gt;168&lt;/s&gt; USA</td>\n",
       "      <td>11 Mar 2020</td>\n",
       "      <td>Kiloplex PCR Plus NGS Next-generation sequencing using thousands of PCR primers to amplify sample viral genetic material before sequencing on the Illumina platform.</td>\n",
       "      <td>Undergoing validation by joint venture Fujian Fujun Gene Biotech.</td>\n",
       "      <td>Undergoing validation by joint venture Fujian Fujun Gene Biotech.</td>\n",
       "      <td>Available.  Soon to be submitted to US FDA for EUA Approval.</td>\n",
       "      <td>4 hr</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>142</th>\n",
       "      <td>Genome sequencing</td>\n",
       "      <td>Oxford Nanopore&lt;s&gt;338,339&lt;/s&gt; UK</td>\n",
       "      <td>22 Jan 2020</td>\n",
       "      <td>Works with public health labs globally to support rapid sequencing of SARS-CoV-2 through sharing of methods / workflows.   Nanopore sequencing workflows can provide a consensus viral genome from sample within a day.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available. 28 January: US Centers for Disease Control and Prevention (CDC) releases nCoV genomes sequenced with nanopore sequencing 29 January: A paper in the Lancet characterised full-length genomes of 2019-nCoV patients using Nanopore sequencing, providing important information on possible virus origins and cell-binding receptors that is crucial for determining viral transmission capacity.  30 March: Singapore sequences its genome in less than 7 hours  14 April: In the UK, more than 600 genomes have been uploaded onto GISAID, using nanopore sequencing&lt;s&gt;340&lt;/s&gt;.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>144</th>\n",
       "      <td>End-to-end solution of sample processing to epidemiological info generation</td>\n",
       "      <td>Oxford Nanopore&lt;s&gt;338,341&lt;/s&gt; UK</td>\n",
       "      <td>22 Jan 2020</td>\n",
       "      <td>ARTIC project  A ‘lab-in-a-suitcase’ solution for processing samples from viral outbreaks, to generating real-time epidemiological information interpretable and actionable by public health bodies.  Deployable to remote/resource-limited locations.  Based on viral genome data generated prospectively during similar outbreaks (eg. MERS, SARS etc). Relies on direct amplification of the virus using tiled, multiplexed primers.</td>\n",
       "      <td>Not stated but described to have high sensitivity compared to metagenomic approaches.&lt;s&gt;342&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available  3 February: First Belgian nCoV sample arrives in a lab at 5pm and using the ARTIC protocol, the sequence is completed by 9am.  3 March: The SARS-CoV2 virus from Scotland’s first case is sequenced in under 24 hours using nanopore sequencing and the ARTIC protocol&lt;s&gt;340&lt;/s&gt;.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>146</th>\n",
       "      <td>Microfluidics   [Point-of-Care]</td>\n",
       "      <td>Abbott Diagnostics&lt;s&gt;29,343&lt;/s&gt; USA</td>\n",
       "      <td>27 Mar 2020</td>\n",
       "      <td>ID Now COVID-19 test Automated assay that runs on Abbott’s ID Now platform.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 27 Mar 2020.</td>\n",
       "      <td>5-13 min  (5 min for positive results, 13 min for negative results)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>147</th>\n",
       "      <td>Microfluidic</td>\n",
       "      <td>Veredus Laboratories&lt;s&gt;344-346&lt;/s&gt; Singapore</td>\n",
       "      <td>24 Jan 2020</td>\n",
       "      <td>VereCoV  Lab-on-Chip platform integrating PCR and microarray  Claims to detect MERS-CoV, SARS-CoV and SARS-CoV-2 in a single test</td>\n",
       "      <td>Stated to be high but with no accompanying statistics.&lt;s&gt;347&lt;/s&gt;</td>\n",
       "      <td>Stated to be high but with no accompanying statistics.&lt;s&gt;347&lt;/s&gt;</td>\n",
       "      <td>Available for RUO since Jan 2020.   Provisional approval for IVD by Singapore’s HSA since Mar 2020.&lt;s&gt;346&lt;/s&gt; Used for testing of swab samples from Singapore’s land, sea and air checkpoints since Mar 2020.&lt;s&gt;348&lt;/s&gt;</td>\n",
       "      <td>2 hours&lt;s&gt;349&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>148</th>\n",
       "      <td>Microfluidic</td>\n",
       "      <td>Lexagene&lt;s&gt;350&lt;/s&gt; USA</td>\n",
       "      <td>27 Jan 2020</td>\n",
       "      <td>Genetic analyser using microfluidic technology</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Expected to be commercially available in Q3 2020.</td>\n",
       "      <td>1 hr</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>149</th>\n",
       "      <td>Microfluidic</td>\n",
       "      <td>Shenzhen Shineway Technology&lt;s&gt;351,352&lt;/s&gt;(collaboration with HKUST)  Hong Kong</td>\n",
       "      <td>6 Feb 2020</td>\n",
       "      <td>Novel silicon-based micro-heater, which has lower thermal mass and a better thermal conductivity, could speed up temperature rises to around 30&lt;s&gt;o&lt;/s&gt;C per second, greatly reducing the detection time compared to conventional PCR devices which has an average of 4-5&lt;s&gt;o&lt;/s&gt;C per second.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available. In use by the Centers for Disease Control and Prevention (CDCP) in Shenzhen and Guangzhou with two more sets being delivered to the CDCP in Hubei and Nansha.&lt;s&gt;352&lt;/s&gt; Device already has CE Mark and is qualified for export to all European Union (EU) countries as well as Hong Kong.&lt;s&gt;351&lt;/s&gt;</td>\n",
       "      <td>40 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>150</th>\n",
       "      <td>Microfluidic</td>\n",
       "      <td>QIAGEN&lt;s&gt;353-355&lt;/s&gt; The Netherlands</td>\n",
       "      <td>10 Feb 2020</td>\n",
       "      <td>QIAStat-Dx Respiratory SARS-CoV-2 Panel [Plus] Tests for two gene targets: ORF1b recommended by the Chinese CDC and N recommended by the US CDC.</td>\n",
       "      <td>100% (30/30) Evaluated using 10 positive clinical samples and 20 low positive contrived samples (1x–2x LOD) from retrospective nasopharyngeal swab clinical specimens in transport medium.&lt;s&gt;355&lt;/s&gt;</td>\n",
       "      <td>100% (30/30) Evaluated using 30 negative samples from retrospective nasopharyngeal swab clinical specimens in transport medium.&lt;s&gt;355&lt;/s&gt;</td>\n",
       "      <td>Commercially available. Obtained EUA approval from US FDA 30 Mar 2020.&lt;s&gt;354&lt;/s&gt; Approved for inclusion in the Australian Register of Therapeutic Goods on 8 May 2020</td>\n",
       "      <td>About an hour (Press release:&lt;s&gt;356&lt;/s&gt;)</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>152</th>\n",
       "      <td>Microfluidic</td>\n",
       "      <td>GenMark Diagnostics&lt;s&gt;291,357,35&lt;/s&gt;&lt;s&gt;8&lt;/s&gt; USA</td>\n",
       "      <td>11 Mar 2020</td>\n",
       "      <td>ePlex SARS-CoV-2 Automated single cartridge using digital microfluidics.</td>\n",
       "      <td>100% (17/17)  65 fresh nasopharyngeal swab specimens from 3 clinical site2s were compared with one of two brands of established comparator assay.&lt;s&gt;291&lt;/s&gt;</td>\n",
       "      <td>97.9% (47/48)  65 fresh nasopharyngeal swab specimens from 3 clinical site2s were compared with one of two brands of established comparator assay.&lt;s&gt;291&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA Approval 19 Mar 2020.&lt;s&gt;358&lt;/s&gt;</td>\n",
       "      <td>Less than 2 hours&lt;s&gt;359&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>153</th>\n",
       "      <td>Microfluidic</td>\n",
       "      <td>Fluidigm&lt;s&gt;360&lt;/s&gt; USA</td>\n",
       "      <td>16 Mar 2020</td>\n",
       "      <td>Aimed at using Fluidigm's Biomark HD system and microfluidics technology, to develop integrated fluidic circuits for parallel assays.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>In development.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>154</th>\n",
       "      <td>LAMP  [Point-of-Care]</td>\n",
       "      <td>HiberGene Diagnostics&lt;s&gt;361,362&lt;/s&gt;(collaboration with distribution partner in Shenzhen, China, Medcaptain Medical Technologies)  Ireland</td>\n",
       "      <td>11 Feb 2020</td>\n",
       "      <td>Loop-mediated isothermal amplification (LAMP)-based Coronavirus test Allows for rapid near-patient testing</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>In development using the template of existing CE-marked Flu and RSV respiratory tests.</td>\n",
       "      <td>60-70 min (including patient sample preparation time)&lt;s&gt;362&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>155</th>\n",
       "      <td>LAMP</td>\n",
       "      <td>Atila BioSystems&lt;s&gt;176,363,3&lt;/s&gt;&lt;s&gt;64&lt;/s&gt; USA</td>\n",
       "      <td>10 Apr 2020</td>\n",
       "      <td>iAMP COVID-19 Detection Kit Real-time fluorescent reverse transcription isothermal amplification without requiring RNA extraction and can run up to 94 samples simultaneously.&lt;s&gt;363,364&lt;/s&gt;Tests for two gene targets: N &amp; ORF1ab.</td>\n",
       "      <td>100% (35/35)  35 oropharyngeal swabs from healthy individuals spiked with iAMP COVID-19 Sample Buffer Mix (2x to 10x LoD) serving as contrived positive samples.&lt;s&gt;363&lt;/s&gt;</td>\n",
       "      <td>100% (40/40)  40 oropharyngeal swabs from healthy individuals serving as negative controls.&lt;s&gt;363&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 10 Apr 2020.</td>\n",
       "      <td>51 min</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>156</th>\n",
       "      <td>RT-LAMP</td>\n",
       "      <td>Seasun Biomaterials&lt;s&gt;365&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>AQ-TOP™ COVID-19 Rapid Detection Kit RT-LAMP test designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens, bronchoalveolar lavage (BAL) specimens as well as sputum.</td>\n",
       "      <td>100% (20/20) for both nasopharyngeal and sputum specimens</td>\n",
       "      <td>100% (25/25) for both nasopharyngeal and sputum specimens</td>\n",
       "      <td>FDA EUA issued on 21 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>157</th>\n",
       "      <td>Enzyme-assisted nanocomplex</td>\n",
       "      <td>iHealthtech&lt;s&gt;345,366&lt;/s&gt;(Asst Prof Shao Huilin)   Singapore</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>enVision (enzyme-assisted nanocomplexes for visual identification of nucleic acids) Uses enzyme-assisted nanocomplexes</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>In development.</td>\n",
       "      <td>30 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>158</th>\n",
       "      <td>CRISPR-based diagnostics</td>\n",
       "      <td>Sherlock Biosciences&lt;s&gt;34,142,29&lt;/s&gt;&lt;s&gt;5,367&lt;/s&gt; (Plus collaboration with Cepheid)&lt;s&gt;142&lt;/s&gt; USA</td>\n",
       "      <td>24 Jan 2020</td>\n",
       "      <td>SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing)  SHERLOCK platform uses various CRISPR proteins (Cas13, Cas12a, and Csm6) to allow for simultaneous detection of multiple nucleic acids.&lt;s&gt;142&lt;/s&gt; Designed to detect RNA from upper respiratory specimens (such as nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, nasopharyngeal wash/aspirate or nasal aspirate) and bronchoalveolar lavage specimens. Step one is a reverse transcriptase loop-mediated amplification (RT-LAMP) where targeted SARS-CoV-2 genomic RNA is reverse transcribed to DNA, and this DNA is amplified by a strand-displacing DNA polymerase. Step two is the transcription of the amplified DNA to activate the collateral cleavage activity of a CRISPR complex programmed to the target RNA sequence.</td>\n",
       "      <td>100% (30/30)</td>\n",
       "      <td>100%</td>\n",
       "      <td>Protocol published 14 Feb 2020.&lt;s&gt;368,369&lt;/s&gt; FDA EUA issued on 6/5/2020&lt;s&gt;370&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>160</th>\n",
       "      <td>CRISPR-based diagnostics</td>\n",
       "      <td>Mammoth Biosciences&lt;s&gt;32-35&lt;/s&gt; (Partnering with UCSF Researchers)  USA</td>\n",
       "      <td>30 Jan 2020</td>\n",
       "      <td>SARS-CoV-2 DNA Endonuclease-Targeted CRISPR Trans Reporter (DETECTR) Using the CRISPR Cas12 that cleaves a FAM-Biotin reporter molecule. Tests for two gene targets:  E &amp; N2.</td>\n",
       "      <td>95% (Using contrived reference samples and clinical samples from US patients, including 36 patients with COVID-19 infection and 42 patients with other viral respiratory infections)  (Press release:&lt;s&gt;371&lt;/s&gt; Study:&lt;s&gt;35&lt;/s&gt;</td>\n",
       "      <td>Specificity: 100% (Using contrived reference samples and clinical samples from US patients, including 36 patients with COVID-19 infection and 42 patients with other viral respiratory infections)   (Press release:&lt;s&gt;371&lt;/s&gt;Study:&lt;s&gt;35&lt;/s&gt;</td>\n",
       "      <td>Developed.   Awaiting EUA from US FDA (pending clinical validation)   (Press release:&lt;s&gt;371&lt;/s&gt;Study:&lt;s&gt;35&lt;/s&gt;</td>\n",
       "      <td>45 minutes (with manual RNA extraction)   (Press release:&lt;s&gt;371&lt;/s&gt;Study:&lt;s&gt;35&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>161</th>\n",
       "      <td>Immunoassay for SARS-CoV-2 viral nucleoprotein antigens</td>\n",
       "      <td>SD Biosensor &lt;s&gt;372&lt;/s&gt;&lt;s&gt;South Korea&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>STANDARD F COVID-19 Ag FIA Fluorescent immunoassay to detect SARS-CoV-2 infection in human nasopharyngeal swab specimen by identifying the existence of SARS-CoV-2 &lt;s&gt;viral nucleoprotein antigens&lt;/s&gt;</td>\n",
       "      <td>Higher sensitivity than &lt;s&gt;rapid test&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available. Obtained &lt;s&gt;CE certification&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;30 minutes&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>162</th>\n",
       "      <td>Immunoassay for SARS-CoV-2 antigens</td>\n",
       "      <td>SD Biosensor &lt;s&gt;53&lt;/s&gt; &lt;s&gt;South Korea&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>STANDARD Q COVID-19 Ag  Rapid chromatographic immunoassay for the qualitative detection of specific antigens to SARS-CoV-2 present in the human &lt;s&gt;nasopharynx&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available. Obtained &lt;s&gt;CE certification&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;30 minutes&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>163</th>\n",
       "      <td>Immunoassay for SARS-CoV-2 antigens  [Point-of-Care]</td>\n",
       "      <td>Sona Nanotech&lt;s&gt;373&lt;/s&gt;(collaboration with GE Healthcare Life Sciences, The Native Antigen Company, Bond)&lt;s&gt;374&lt;/s&gt;&lt;s&gt;375&lt;/s&gt; Canada</td>\n",
       "      <td>10 Feb 2020</td>\n",
       "      <td>Proprietary nanotechnology  lateral flow test using antigens specific to SARS-CoV-2 produced at Native's Oxford facility using proprietary mammalian VirtuE expression system.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>In development.</td>\n",
       "      <td>5-15 min</td>\n",
       "      <td>&lt;$50</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>164</th>\n",
       "      <td>Immunoassay for SARS-CoV-2 antigens</td>\n",
       "      <td>Quidel Corporation&lt;s&gt;376&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Sofia 2 SARS Antigen FIA Lateral flow immunofluorescent sandwich assay that is used with the Sofia 2 instrument intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal (NP) and nasal (NS) swab specimens.</td>\n",
       "      <td>100% (47/47)</td>\n",
       "      <td>80% (84/96)</td>\n",
       "      <td>FDA EUA issued on 8 May 2020</td>\n",
       "      <td>(No info)</td>\n",
       "      <td>(No info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>165</th>\n",
       "      <td>Carbohydrate-based glycation pattern detection</td>\n",
       "      <td>Iceni Diagnostics&lt;s&gt;377&lt;/s&gt; UK</td>\n",
       "      <td>20 Mar 2020</td>\n",
       "      <td>Carbohydrate-based, lateral flow assay for detection of glycation patterns of SARS-CoV-2</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>In development.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>166</th>\n",
       "      <td>(no info)</td>\n",
       "      <td>Lab Geneomics&lt;s&gt;131&lt;/s&gt; South Korea</td>\n",
       "      <td>3 Feb 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Undergoing commercialisation as of 6 Feb 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>167</th>\n",
       "      <td>Target amplification assay</td>\n",
       "      <td>Hologic, Inc.&lt;s&gt;378&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Aptima® SARS-CoV-2 Assay (Panther® System) Nucleic acid amplification in vitro diagnostic test designed to qualitatively detect RNA from SARS-CoV-2 isolated and purified from nasopharyngeal (NP), nasal, mid-turbinate and oropharyngeal (OP) swab specimens, nasopharyngeal wash/ aspirate or nasal aspirates.</td>\n",
       "      <td>98.2% (54/55)</td>\n",
       "      <td>100% (50/50)</td>\n",
       "      <td>FDA EUA issued on 14 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>168</th>\n",
       "      <td>Total Antibody Immunoassay (ELISA)</td>\n",
       "      <td>Bio-Rad Laboratories&lt;s&gt;222&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>&lt;s&gt;ELISA Total Antibodies&lt;/s&gt;Platelia SARS-CoV-2 Total Antibody Assay&lt;s&gt;379&lt;/s&gt; Qualitative detection of total antibodies to SARS-CoV-2 in human serum and plasma &lt;s&gt;EDTA&lt;/s&gt;</td>\n",
       "      <td>100% in Serum, 83.33% in Plasma</td>\n",
       "      <td>99.51% in Serum, 100% in Plasma</td>\n",
       "      <td>FDA EUA issued on 29/04/2020&lt;s&gt;379&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>169</th>\n",
       "      <td>Total antibody immunoassay</td>\n",
       "      <td>Beijing Wantai Biologicalpharmacy Enterprise Co Ltd&lt;s&gt;380&lt;/s&gt; China</td>\n",
       "      <td></td>\n",
       "      <td>Wantai SARS-CoV-2 Ab Rapid Test Kit  Rapid qualitative detection of total antibodies against SARS-CoV-2 in human serum, plasma or whole blood specimens, employing chromatographic lateral flow device in a cassette format &lt;s&gt;(colloidal gold)&lt;/s&gt;</td>\n",
       "      <td>96.6% (131/137)  Evaluated using 137 specimens from confirmed COVID-19 patients and 209 specimens from healthy &lt;s&gt;individuals&lt;/s&gt;</td>\n",
       "      <td>95.2% (199/209)  Evaluated using 137 specimens from confirmed COVID-19 patients and 209 specimens from healthy individuals</td>\n",
       "      <td>Available.  CE-IVD marked. Approved for inclusion into the Australian Register of Therapeutic Goods on 27 March 2020.&lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>170</th>\n",
       "      <td>Total Antibody Immunoassay</td>\n",
       "      <td>Wadsworth Center&lt;s&gt;381&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>New York SARS-CoV Microsphere Immunoassay for Antibody Detection &lt;s&gt;382&lt;/s&gt; Qualitative detection of total antibodies to SARS-CoV-2 in human serum.</td>\n",
       "      <td>88.0% (95/108)</td>\n",
       "      <td>99.6% (Blood donors), 98.7% (Diverse group of viral pathogens), 96.7% (Respiratory infections), 97.1% (Other study with &lt;s&gt;respiratory infections)&lt;/s&gt;</td>\n",
       "      <td>FDA EUA issued on 30/04/2020 &lt;s&gt;382&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>171</th>\n",
       "      <td>Total antibody Immunoassay</td>\n",
       "      <td>Roche Diagnostics</td>\n",
       "      <td></td>\n",
       "      <td>Elecsys Anti-SARS-CoV-2&lt;s&gt;383&lt;/s&gt; Immunoassay for qualitative detection of antibodies to SARS-CoV-2</td>\n",
       "      <td>65.5% (76/116, Day 0-6 post-PCR confirmation); 88.1% (52/59, Day 7-13 post-PCR confirmation); 100% (29/29, &gt;/= 14 days post-PCR confirmation)</td>\n",
       "      <td>99.81% (5262/5272)</td>\n",
       "      <td>FDA EUA issued on 2 May 2020&lt;s&gt;383&lt;/s&gt; Date of Provisional Authorisation from HSA: 5 May 2020 &lt;s&gt;384&lt;/s&gt; Approved for inclusion on the Australian Register of Therapeutic Goods on 20 May 2020.&lt;s&gt;385&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>172</th>\n",
       "      <td>Total Antibody immunoassay  [Point-of-Care]</td>\n",
       "      <td>Mologic (partnership with the Institut Pasteur de Dakar)&lt;s&gt;386,387&lt;/s&gt; UK</td>\n",
       "      <td>25 Feb 2020</td>\n",
       "      <td>Lateral flow immunoassay for detection of antibodies for SARS-CoV-2.</td>\n",
       "      <td>98% at days 14-21 &lt;s&gt;388&lt;/s&gt;&lt;s&gt;389&lt;/s&gt;</td>\n",
       "      <td>98%&lt;s&gt;388&lt;/s&gt;</td>\n",
       "      <td>Developed. Ready for manufacture with CE mark.&lt;s&gt;388&lt;/s&gt;</td>\n",
       "      <td>10 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>173</th>\n",
       "      <td>Total Antibody immunoassay</td>\n",
       "      <td>Ortho Clinical Diagnostics&lt;s&gt;390-392&lt;/s&gt; USA</td>\n",
       "      <td>6 Apr 2020</td>\n",
       "      <td>VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack Runs on VITROS ECi/ECiQ/3600 Immunodiagnostic System and the VITROS 5600/XT 7600 Integrated Systems.  Can run up to 150 samples per hour.&lt;s&gt;392&lt;/s&gt;</td>\n",
       "      <td>83.3% (30/36)  Tested with 36 samples from patients confirmed to be SARS-CoV-2 positive with PCR.&lt;s&gt;391&lt;/s&gt;</td>\n",
       "      <td>100% (400/400)  400 presumed SARS-CoV-2 negative samples from healthy blood donors serving as negative controls.&lt;s&gt;391&lt;/s&gt;</td>\n",
       "      <td>Available.   Obtained EUA approval from US FDA 14 Apr 2020.  Date of Provisional Authorisation from HSA: 8 May 2020&lt;s&gt;393&lt;/s&gt;</td>\n",
       "      <td>48 min  (Up to 150 samples per hour)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>174</th>\n",
       "      <td>IgG/IgM antibody immunoassay (ELISA)</td>\n",
       "      <td>Livzon&lt;s&gt;135&lt;/s&gt;(collaboration with Wuhan Institute of Virology, Chinese Academy of Science)</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>Diagnostics kit for IgM/IgG antibody to novel coronavirus (ELISA) Indirect method for ELISA for in vitro qualitative detection of antibodies to SARS-CoV-2 in human serum or plasma.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Developed.  Undergoing testing. Emergency use approval submitted to China’s NMPA on 28 Jan 2020.   Approved on 14 March for commercial use. &lt;s&gt;394&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>175</th>\n",
       "      <td>IgG/IgM antibody immunoassay (colloidal gold)  [Point-of-Care]</td>\n",
       "      <td>Mobidiag (in collaboration with Autobio &lt;s&gt;Diagnostics)&lt;/s&gt;&lt;s&gt;199&lt;/s&gt;Finland</td>\n",
       "      <td></td>\n",
       "      <td>Anti-SARS-CoV-2 Rapid &lt;s&gt;Test&lt;/s&gt; Immunoassay Anti-SARS-CoV-2 Rapid Test is based on a colloidal gold method for the rapid, qualitative determination of SARS-CoV-2 IgG/IgM antibodies in human serum, plasma or whole blood.</td>\n",
       "      <td>&lt;s&gt;97.4%&lt;/s&gt;</td>\n",
       "      <td>96.2%</td>\n",
       "      <td>CE-IVD marked. For in vitro diagnostic use.  FDA EUA issued on 24/04/2020</td>\n",
       "      <td>&lt;15 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>176</th>\n",
       "      <td>IgG/IgM antibody immunoassay (colloidal gold)</td>\n",
       "      <td>Livzon&lt;s&gt;135&lt;/s&gt;(collaboration with Wuhan Institute of Virology, Chinese Academy of Science)</td>\n",
       "      <td>4 Feb 2020</td>\n",
       "      <td>Diagnostics kit for IgM/IgG antibody to novel coronavirus (colloidal gold) Immunochromatography assay for in vitro qualitative detection of antibodies to SARS-CoV-2 in human serum or plasma.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Developed.  Undergoing testing. Emergency use approval submitted to China’s NMPA on 2 Feb 2020.  Approved for inclusion on the Australian Register of Therapeutic Goods on 23 April 2020.</td>\n",
       "      <td>15 mi</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>177</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Camtech Diagnostics Pte Ltd&lt;s&gt;395&lt;/s&gt;Singapore</td>\n",
       "      <td></td>\n",
       "      <td>Camtech COVID-19 IgM/IgG Immunoassay kit for the rapid and differential detection of IgG and IgM against COVID-19 using serum, plasma and whole &lt;s&gt;blood.&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HSA: 09/04/2020</td>\n",
       "      <td>10 Minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>178</th>\n",
       "      <td>IgG/IgM antibody immunoassay  (CLIA)</td>\n",
       "      <td>Shenzhen Tisenc Medical Device&lt;s&gt;55&lt;/s&gt;(collaboration with Shenzhen University and Shenzhen No.3 People’s Hospital)  China</td>\n",
       "      <td>12 Feb 2020</td>\n",
       "      <td>2019 Novel Coronavirus &lt;s&gt;IgM kit (CLIA)&lt;/s&gt;2019 Novel Coronavirus &lt;s&gt;IgG kit (CLIA)&lt;/s&gt;Chemiluminescence antibody test kit using serum or plasma.</td>\n",
       "      <td>IgM kit - 96.6% (29/30) IgG kit - 96.6% (29/30)&lt;s&gt;396&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available. Received CE certification on 6 March 2020&lt;s&gt;396&lt;/s&gt;</td>\n",
       "      <td>22 min (unclear if serum/plasma extraction time included or not)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>179</th>\n",
       "      <td>IgG/IgM antibody immunoassay (CLIA)</td>\n",
       "      <td>Snibe Diagnostic&lt;s&gt;397,398&lt;/s&gt; China</td>\n",
       "      <td>28 Feb 2020</td>\n",
       "      <td>Maglumi 2019-nCoV (SARS-CoV-2) IgM/IgG kits Fully automated CLIA using 10μL sample volume of serum or plasma.</td>\n",
       "      <td>Differs across different durations from symptom onset &lt;5 days: IgA – 3.3% (1/30); IgG – 10% (3/30)  5-10 days: IgA – 15.4% (2/13); IgG – 53.8% (7/13)  10-21 days: IgA – 60% (3/5); IgG – 100% (5/5)&lt;s&gt;399&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available.   Have been distributed in China and will soon be in Italy.   Received CE Mark 19 Feb 2020.&lt;s&gt;398&lt;/s&gt;</td>\n",
       "      <td>30 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>180</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>GenBody Inc (South Korea)&lt;s&gt;214&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>GenBody COVID-19 &lt;s&gt;IgM/IgG&lt;/s&gt; Point-of-care chromatographic immunoassay kit for the rapid and differential detection of anti-SARS-CoV-2 IgM and IgG using serum, plasma and whole blood from capillary blood samples.&lt;s&gt;214&lt;/s&gt;</td>\n",
       "      <td>Sensitivity : 50% at Day 1-6, 91.7% at after Day 7&lt;s&gt;214&lt;/s&gt;</td>\n",
       "      <td>Specificity : 97.5%&lt;s&gt;214&lt;/s&gt;</td>\n",
       "      <td>Availability: Approved for inclusion on the Australian Register of Therapeutic Goods on &lt;s&gt;28 April 2020.&lt;/s&gt;</td>\n",
       "      <td>10 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>181</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Healgen Scientific Limited Liability Company (USA)&lt;s&gt;400&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>COVID-19 Antibody Rapid Detection Kit&lt;s&gt;400&lt;/s&gt; Rapid test for the qualitative, differential detection of both anti-SARS-CoV-2 IgM and IgG antibodies from whole blood, serum and plasma, using lateral flow method</td>\n",
       "      <td>Sensitivity: IgG 97.2%; IgM 87.9%</td>\n",
       "      <td>Specificity: IgG 100%; IgM 100%</td>\n",
       "      <td>Approved for inclusion on the Australian Register of Therapeutic Goods on 29 April 2020. Pending &lt;s&gt;FDA approval &lt;/s&gt;</td>\n",
       "      <td>10 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>182</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>PCL</td>\n",
       "      <td></td>\n",
       "      <td>PCL COVID19 IgG/IgM Rapid Gold&lt;s&gt;132&lt;/s&gt; Qualitative detection of COVID-19 IgG/IgM antibodies using lateral flow technique</td>\n",
       "      <td>100%</td>\n",
       "      <td></td>\n",
       "      <td>Approved for inclusion on the Australian Register of Therapeutic Goods on 1 May 2020. &lt;s&gt;132&lt;/s&gt;</td>\n",
       "      <td>10 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>183</th>\n",
       "      <td>IgG/IgM antibody immunoassay  [Point-of-Care]</td>\n",
       "      <td>BioMedomics /  Jiangsu Medomics Medical Technology&lt;s&gt;54,57,58&lt;/s&gt; USA / China</td>\n",
       "      <td>21 Feb 2020</td>\n",
       "      <td>COVID-19 IgM/IgG Rapid Test   Lateral flow immunoassay with both IgM and IgG antibodies adhered using colloidal gold.  Can be used with fingerstick whole blood.</td>\n",
       "      <td>88.66%   352 positives out of 397 positive cases: - 256 both IgG and IgM - 72 IgG - 24 IgM</td>\n",
       "      <td>90.63%  12 positives out of 128 negative controls: - 1 both IgG and IgM - 1 IgG - 10 IgM</td>\n",
       "      <td>Commercially available. More than half a million sold in China.  Received CE Mark for IVD 8 Mar 2020. Already sold in Italy.&lt;s&gt;58&lt;/s&gt; Submitted to US FDA for EUA approval.&lt;s&gt;59,60&lt;/s&gt;</td>\n",
       "      <td>15 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>184</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Shenzen YHLO Biotech Co. Ltd (China)&lt;s&gt;401&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>iFlash 8000 CLIA analyser&lt;s&gt;402&lt;/s&gt; Fully Automated chemiluminescent immunoassay for anti- SARS-CoV-2 IgM and IgG &lt;s&gt;antibodies.&lt;/s&gt;</td>\n",
       "      <td>Sensitivity: 81.5% for IgM, 100% for IgG&lt;s&gt;402&lt;/s&gt;</td>\n",
       "      <td>Specificity: 88.1% for IgM, 92.8% for IgG&lt;s&gt;402&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>186</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Biolidics Limited&lt;s&gt;403&lt;/s&gt; Singapore</td>\n",
       "      <td></td>\n",
       "      <td>Nanjing Vazyme 2019-nCoV IgG/IgM Detection &lt;s&gt;Kit&lt;/s&gt;&lt;s&gt;Also marketed as&lt;/s&gt;Biolidics 2019-nCoV IgG/IgM Detection Kit Detection of 2019-nCoV IgG and IgM in human serum, &lt;s&gt;plasma and whole blood&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HSA: 20/03/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>187</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Everest Links Pte Ltd&lt;s&gt;404&lt;/s&gt; Singapore</td>\n",
       "      <td></td>\n",
       "      <td>VivaDiag™ COVID-19 IgM/IgG Rapid Test In vitro diagnostic test for the qualitative determination of COVID-19’s igM and IgG antibodies in human blood, serum and plasma.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation by HSA: 20/03/2020  Date of approval for inclusion into ARTG: &lt;s&gt;26/03/2020&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>188</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Grit Overseas Pte Ltd &lt;s&gt;405&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>DiagnoSure COVID-19 IgG/ IgM Rapid Test Cassette</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 24/04/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>189</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>CTK Biotech Inc&lt;s&gt;406&lt;/s&gt; USA</td>\n",
       "      <td></td>\n",
       "      <td>OnSite COVID-19 IgG/IgM Rapid Test  Designed for initial screening by detecting anti-SAR-CoV-2 IgG and IgM antibodies in human serum, &lt;s&gt;plasma or whole blood&lt;/s&gt;</td>\n",
       "      <td>96.9%</td>\n",
       "      <td>99.4%</td>\n",
       "      <td>Available commercially.  Approved for inclusion into the Australian Register of Therapeutic Goods on 19 March 2020. &lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>10 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>190</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Qingdao Hightop Biotech Co Ltd&lt;s&gt;407&lt;/s&gt; China</td>\n",
       "      <td></td>\n",
       "      <td>SARS-CoV-2 IgM/lgG Antibody Rapid Test  Qualitative detection of SARS-CoV-2 IgG and IgM antibodies in human serum, plasma or whole blood &lt;s&gt;samples&lt;/s&gt;</td>\n",
       "      <td>IgM – 82% &lt;s&gt;IgG – 93%&lt;/s&gt;</td>\n",
       "      <td>IgM – 97% IgG – 97.5%</td>\n",
       "      <td>Available.   Approved for inclusion into the Australian Register of Therapeutic Goods on 31 March 2020. &lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>15 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>191</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Hangzhou Realy Tech Co Ltd   China</td>\n",
       "      <td></td>\n",
       "      <td>2019-nCOV/COVID-19 &lt;s&gt;IgG/IgM Rapid Test Device&lt;/s&gt; &lt;s&gt;Lateral flow IgG/IgM&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Approved for inclusion on the Australian Register of Therapeutic Goods on 16 April 2020 &lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>193</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Hangzhou Clongene Biotech &lt;s&gt;Co Ltd&lt;/s&gt; China</td>\n",
       "      <td></td>\n",
       "      <td>COVID-19 IgG/IgM Rapid &lt;s&gt;Test Cassette&lt;/s&gt; Rapid point-of-care lateral flow chromatographic immunoassay for the qualitative detective of IgG and IgM antibodies to &lt;s&gt;SARS-CoV-2&lt;/s&gt;</td>\n",
       "      <td>IgM – 87.01% (67/77)  IgG – 99.42% (75/77) &lt;s&gt;408&lt;/s&gt;</td>\n",
       "      <td>IgM – 98.89% (89/90) &lt;s&gt;408&lt;/s&gt;</td>\n",
       "      <td>Available.   Received CE mark.&lt;s&gt;408&lt;/s&gt;Approved for inclusion into the Australian Register of Therapeutic Goods on &lt;s&gt;26 March 2020&lt;/s&gt;&lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>194</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Hangzhou Biotest &lt;s&gt;Biotech Co Ltd&lt;/s&gt; China</td>\n",
       "      <td></td>\n",
       "      <td>COVID-19 IgG/IgM Rapid &lt;s&gt;Test Cassette&lt;/s&gt; Rapid chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2 in human whole blood, serum or &lt;s&gt;plasma&lt;/s&gt;</td>\n",
       "      <td>IgG – 100% (75/75) IgM – 91.8% (78/85)&lt;s&gt;409&lt;/s&gt;</td>\n",
       "      <td>IgG – 99.5% (369/371); IgM – 99.2% (368/371)&lt;s&gt;409&lt;/s&gt;</td>\n",
       "      <td>Available.   Received CE mark. Approved for inclusion into the Australian Register of Therapeutic Goods on 4 April 2020.&lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>195</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Guangzhou Wondfo Biotech&lt;s&gt;44-&lt;/s&gt;&lt;s&gt;48&lt;/s&gt; China</td>\n",
       "      <td>20 Feb 2020</td>\n",
       "      <td>Wondfo SARS-CoV-2 Antibody Test (Lateral Flow Method)  Colloidal gold method for IgM and IgG antibody detection.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available.   Approved by China’s NMPA.  Received CE Mark Mar 2020.&lt;s&gt;48,49&lt;/s&gt; Obtained HSA provisional approval on 9 April 2020, supplied through SkyQuest Pte Ltd.&lt;s&gt;410&lt;/s&gt; Approved for inclusion on the Australian Register of Therapeutic Goods on 25 March 2020.&lt;s&gt;143&lt;/s&gt; Date of Provisional Authorisation from HSA: 27 April 2020&lt;s&gt;411&lt;/s&gt;</td>\n",
       "      <td>15 min (unclear if serum/plasma extraction time included or not)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>197</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Hangzhou AllTest Biotech&lt;s&gt;81,412,413&lt;/s&gt; China</td>\n",
       "      <td>2 Mar 2020</td>\n",
       "      <td>2019-nCoV IgG/IgM Rapid Test Cassette Lateral flow chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2 in human whole blood, serum or plasma specimen.</td>\n",
       "      <td>IgM test 85.0% (17/20) IgG test 100.0% (20/20)  Tested with the results compared to leading commercial PCR.</td>\n",
       "      <td>IgM test 96.0% (48/50) IgG test 98.0% (49/50)  Tested with the results compared to leading commercial PCR.</td>\n",
       "      <td>Commercially available.   Received CE Mark for IVD.  Approved for inclusion in Australia’s ARTG.&lt;s&gt;81&lt;/s&gt; Used in study by Lee et al (2020).&lt;s&gt;414&lt;/s&gt;</td>\n",
       "      <td>10 min</td>\n",
       "      <td>(by quote)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>198</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Pharmact AG&lt;s&gt;50&lt;/s&gt; Germany</td>\n",
       "      <td>10 Mar 2020</td>\n",
       "      <td>CoV-2 Rapid Test Using drops of blood from fingerstick onto test cassette, with two drops of buffer solution.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available.</td>\n",
       "      <td>20 min</td>\n",
       "      <td>€39.95</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>199</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Zhejiang Orient Gene Biotech&lt;s&gt;51,52&lt;/s&gt; China</td>\n",
       "      <td>10 Mar 2020</td>\n",
       "      <td>COVID-19 IgG/IgM Rapid Test Solid phase immunochromatography assay for rapid qualitative detection of IgG and IgM antibodies to SARS-CoV-2 using human whole blood, serum or plasma.</td>\n",
       "      <td>IgM test 87.9% (87/99) IgG test 97.2% (35/36)  Tested with 113 blood samples, and the results compared to RT-PCR or clinical diagnosis.</td>\n",
       "      <td>IgM test 100% (14/14) IgG test 100% (14/14)  Tested with 113 blood samples, and the results compared to RT-PCR or clinical diagnosis.</td>\n",
       "      <td>Available.   Received CE Mark. Currently one of only a few tests used for coronavirus screening in China.  Commercialisation and distribution licensing deal with Aytu Bioscience for USA.   Approved for inclusion on Australia’s ARTG on 1 April 2020.&lt;s&gt;81&lt;/s&gt;</td>\n",
       "      <td>2-10 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>200</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>SD Biosensor&lt;s&gt;53&lt;/s&gt; South Korea</td>\n",
       "      <td>(Webpage found as of 12 Mar 2020)</td>\n",
       "      <td>STANDARD Q COVID-19 IgM/IgG Duo Immunochromatography assay for rapid qualitative detection of IgG and IgM antibodies to SARS-CoV-2 using human whole blood, serum or plasma.</td>\n",
       "      <td>Sensitivity at 81.8% (27/33)&lt;s&gt;53&lt;/s&gt;</td>\n",
       "      <td>Specificity at 96.7% (29/30)</td>\n",
       "      <td>Available.</td>\n",
       "      <td>10 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>201</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Chembio Diagnostic Systems&lt;s&gt;415-417&lt;/s&gt; USA</td>\n",
       "      <td>20 Mar 2020</td>\n",
       "      <td>DPP COVID-19 IgM/IgG System Lateral flow assay testing for IgM and IgG, to be read using the DPP Micro Reader or DPP Micro Reader 2 (not visually).</td>\n",
       "      <td>IgM: 50% (3/6) IgG: 100% (6/6)  Tested with fresh, fingerstick blood samples prospectively-collected from 11 hospital workers in the United States (New York), 6 of whom were confirmed positive cases with results from FDA-authorised RT-PCR test.&lt;s&gt;416&lt;/s&gt;</td>\n",
       "      <td>IgM: 100% (6/6) IgG: 100% (6/6)  Tested with fresh, fingerstick blood samples prospectively-collected from 11 hospital workers in the United States (New York), 5 of whom were confirmed negative with results from FDA-authorised RT-PCR test.&lt;s&gt;416&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 14 Apr 2020.</td>\n",
       "      <td>10-15 min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>202</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Cellex&lt;s&gt;61,358&lt;/s&gt; USA</td>\n",
       "      <td>1 Apr 2020</td>\n",
       "      <td>qSARS-CoV-2 IgG/IgM Rapid Test For “aid in the diagnosis of patients with suspected SARS-CoV-2 infection in conjunction with clinical presentation and the results of other laboratory tests.”&lt;s&gt;61&lt;/s&gt;Can be used with serum, plasmas, or whole blood from venepuncture (not fingerstick).</td>\n",
       "      <td>93.8% (120/128)  Tested with 98 positive serum or plasma samples collected from individuals who tested positive with RT- PCR and 30 samples from hospitalised individuals who were clinically confirmed positive and exhibited severe symptoms.&lt;s&gt;61&lt;/s&gt;</td>\n",
       "      <td>96.0% (240/250)  Tested with negative serum or plasma samples collected prior to September 2019.&lt;s&gt;61&lt;/s&gt;</td>\n",
       "      <td>Commercially available.   Obtained EUA approval from US FDA 1 Apr 2020.  Approved for inclusion in Australia’s ARTG 31 Mar 2020.&lt;s&gt;81&lt;/s&gt;</td>\n",
       "      <td>15-20min</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>203</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Nankai University&lt;s&gt;56&lt;/s&gt; (in collaboration with KingFocus Biomedical)  China</td>\n",
       "      <td>17 Feb 2020</td>\n",
       "      <td>Novel Coronavirus (2019-nCoV) IgM/IgG antibody detection kit</td>\n",
       "      <td>75% (30/40) in first clinical trial, but suboptimal in the second trial&lt;s&gt;418&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Available non-commercially in China. &lt;s&gt;418&lt;/s&gt;</td>\n",
       "      <td>15 min  (unclear if serum/plasma extraction time included or not)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>204</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Hangzhou Laihe Biotech Co Ltd&lt;s&gt;419&lt;/s&gt; &lt;s&gt;China&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold)  POCT rapid SARS-CoV-2 &lt;s&gt;IgM/IgG antibody test&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Commercially available.   Approved for inclusion into the Australian Register of Therapeutic Goods on 6 April 2020.&lt;s&gt;143&lt;/s&gt;</td>\n",
       "      <td>Within 10 min</td>\n",
       "      <td>$20 per test kit</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>205</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Shanghai LiangRun &lt;s&gt;420&lt;/s&gt; China</td>\n",
       "      <td>27 April 2020</td>\n",
       "      <td>LionRun Diagnostic Kit for Antibody IgM-IgG of Novel Coronavirus COVID-19 An in vitro diagnostic test for the qualitative and differential detection of IgM and IgG antibodies against SARS-CoV-2</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 27 April 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>207</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Grey Solutions Pte Ltd &lt;s&gt;421&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>i-Test COVID -19 IgM/IgG Antibody Rapid Test (Colloidal Gold)  The test is an in-vitro qualitative determination of Novel coronavirus (COVID2019) Antibody in human serum or plasma or whole blood.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 30 April 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>208</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Innovation Scientific Pty Ltd (Australia) &lt;s&gt;314&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>InnoScreen COVID-19 IgG/IgM Rapid Test Lateral Flow IgG/IgM [Point-of-care]</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Approved for inclusion in the Australian Register of Therapeutic Goods on 11 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>209</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>MP Biomedicals Asia Pacific Pte Ltd&lt;s&gt;422&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>MP Diagnostics ASSURE® SARS-CoV-2 IgG/IgM Rapid Test Qualitative in vitro immunochromatographic test to detect and differentiate IgG/IgM antibodies against SARS- CoV-2 in human plasma, serum or whole blood with anti-coagulants</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 8 May 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>210</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Xiamen Boson Biotech Co.&lt;s&gt;423&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>Xiamen Boson Rapid 2019-nCOV IgG/IgM Combo Test Card Immunochromatography for the rapid qualitative determination of IgG and IgM antibodies to 2019 novel coronavirus (2019- nCoV, SARS-CoV- 2) in human serum, plasma, or whole blood</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 14 May 2020, supplied by Trans Sahara Corporation Pte Ltd &lt;s&gt;424&lt;/s&gt;</td>\n",
       "      <td>15 mins</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>211</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Atlaslink Beijing Technology Co Ltd (China) &lt;s&gt;425&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>NOVA Test® COVID-19 IgG/IgM Antibody Test (Colloidal Gold) Qualitative detection of IgG/IgM antibodies to SARS-CoV-2 in human serum, plasma or whole blood.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Approved for inclusion into the Australian Register of Therapeutic Goods on 18 May 2020</td>\n",
       "      <td>10 mins</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>213</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Healthgroup Medical Pte Ltd (Singapore)</td>\n",
       "      <td></td>\n",
       "      <td>HealthGroup Medical V-CODE Sars-CoV-2 (COVID-19) IgG/IgM Rapid Test Lateral flow immunoassay for the qualitative detection and differentiation of IgG and IgM of Novel Coronavirus (SARS-CoV-2) in human whole blood, serum or plasma.</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>HSA provisional authorisation approved on 18 May 2020&lt;s&gt;426&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>214</th>\n",
       "      <td>IgM antibody immunoassay  [Point-of-Care]</td>\n",
       "      <td>Guangzhou Medical University&lt;s&gt;11,43&lt;/s&gt;(Dr Zhong Nanshan) In collaboration with Jiangsu Medomics Medical Technologies and many other institutes  China</td>\n",
       "      <td>15 Feb 2020</td>\n",
       "      <td>SARS-CoV-2 rapid IgG-IgM combined antibody kit &lt;s&gt;(colloidal gold)&lt;/s&gt; In-vitro detection of IgG/IgM antibodies using lateral flow &lt;s&gt;immunoassay techniques&lt;/s&gt;&lt;s&gt;427&lt;/s&gt;,&lt;s&gt;57&lt;/s&gt;</td>\n",
       "      <td>88.66% (352/397)   Evaluated using blood samples from 397 clinically confirmed (including PCR test) SARS-CoV-2-infected patients.&lt;s&gt;57&lt;/s&gt;</td>\n",
       "      <td>90.63% (116/128)   Evaluated using blood samples from 128 non-SARS-CoV-2-infected patients.&lt;s&gt;57&lt;/s&gt;</td>\n",
       "      <td>Available for use in China but not commercially</td>\n",
       "      <td>15 min (unclear if serum/plasma extraction time included or not)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>215</th>\n",
       "      <td>IgM antibody immunoassay</td>\n",
       "      <td>Innovita Biological Technology&lt;s&gt;44&lt;/s&gt; China</td>\n",
       "      <td>23 Feb 2020</td>\n",
       "      <td>2019-nCoV Antibody Test &lt;s&gt;(colloidal gold)&lt;/s&gt; IgG and IgM antibody detection from venous whole blood/ plasma/ serum samples</td>\n",
       "      <td>87.3% &lt;s&gt;428&lt;/s&gt;</td>\n",
       "      <td>100% &lt;s&gt;428&lt;/s&gt;</td>\n",
       "      <td>Available commercially.  Approved by China’s NMPA.  Approved for inclusion on the Australian Register of Therapeutic Goods.&lt;s&gt;81&lt;/s&gt; CE-IVD approved. &lt;s&gt;3&lt;/s&gt; Partnered with Scanwell Health to be distributed in US, together with an accompanying smartphone app, pending US FDA EUA approval. &lt;s&gt;428&lt;/s&gt; Date of Provisional Authorisation from HSA: 27 April 2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>Projected to be $70 as distributed by Scanwell Health &lt;s&gt;428&lt;/s&gt;</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>217</th>\n",
       "      <td>IgM antibody immunoassay</td>\n",
       "      <td>Epitope Diagnostics</td>\n",
       "      <td></td>\n",
       "      <td>EDI Novel Coronavirus COVID-19 IgM ELISA Kit Qualitative detection of human anti-COVID- 19 IgG antibody in human serum using ELISA.</td>\n",
       "      <td>73.8% (34/42)</td>\n",
       "      <td>100% (153/153)</td>\n",
       "      <td>HSA provisional authorisation approved on 15 May 2020.&lt;s&gt;429&lt;/s&gt; CE marked.&lt;s&gt;430&lt;/s&gt; Pending EUA approval from US FDA.</td>\n",
       "      <td>90 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>218</th>\n",
       "      <td>IgG antibody immunoassay</td>\n",
       "      <td>Abbott Laboratories Inc.&lt;s&gt;431,432&lt;/s&gt; USA</td>\n",
       "      <td>15 Apr 2020</td>\n",
       "      <td>SARS-CoV-2 IgG test Lab-based serology test for the detection of IgG. Can run on ARCHITECT® i1000SR and i2000SR laboratory instruments.</td>\n",
       "      <td>Sensitivity: 0% (Less than 3 days post symptom onset), 25% (3-7 days post symptoms onset), 86.36% (8-13 days post symptoms onset), 100% (more than 14 days post symptoms onset)&lt;s&gt;433&lt;/s&gt;</td>\n",
       "      <td>Specificity: 100% (73/73)&lt;s&gt;433&lt;/s&gt;</td>\n",
       "      <td>Commercially available.  FDA EUA issued on 23/04/2020  Date of Provisional Authorisation from HSA: 30 April 2020 &lt;s&gt;434&lt;/s&gt;</td>\n",
       "      <td>(100-200 tests per hour)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>219</th>\n",
       "      <td>IgG Antibody immunoassay</td>\n",
       "      <td>Mount Sinai Laboratory&lt;s&gt;435&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>COVID-19 ELISA IgG &lt;s&gt;Antibody test&lt;/s&gt; ELISA performed for the qualitative detection of human IgG antibodies in serum and plasma specimens collected from individuals suspected of prior infection with the virus that causes COVID-19. Detection of IgG SARS-CoV-2 antibodies. The presence of IgG antibodies defines IgG antibody seroconversion and generally becomes detectable beginning 10-14 &lt;s&gt;days following infection.&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;92% (37/40)&lt;/s&gt;</td>\n",
       "      <td>&lt;s&gt;100% (74/74)&lt;/s&gt;</td>\n",
       "      <td>Available.  EUA issued on 15th &lt;s&gt;April 2020.&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>220</th>\n",
       "      <td>IgG Antibody detection</td>\n",
       "      <td>Ortho-Clinical &lt;s&gt;Diagnostics, Inc.&lt;/s&gt;&lt;s&gt;436&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack</td>\n",
       "      <td>87.5% (42/48)</td>\n",
       "      <td>100% (407/407)</td>\n",
       "      <td>FDA EUA issued on 24/4/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>221</th>\n",
       "      <td>IgG Antibody detection</td>\n",
       "      <td>Diasorin Inc.&lt;s&gt;437&lt;/s&gt;</td>\n",
       "      <td></td>\n",
       "      <td>LIAISON SARS-CoV-2 S1/S2 IgG</td>\n",
       "      <td>25% (Less than 5 days from diagnosis),  89.8% (6-14 days from diagnosis),  97.56% (More than 15 days from diagnosis)</td>\n",
       "      <td>99.3% (1082/1090)</td>\n",
       "      <td>FDA EUA issued on 24/4/2020</td>\n",
       "      <td>(no info)</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>222</th>\n",
       "      <td>IgG Antibody detection</td>\n",
       "      <td>Epitope Diagnostics</td>\n",
       "      <td></td>\n",
       "      <td>EDI Novel Coronavirus COVID-19 IgG ELISA Kit Qualitative detection of human anti-COVID- 19 IgG antibody in human serum using ELISA.</td>\n",
       "      <td>98.4% (184/187)</td>\n",
       "      <td>99.8% (623/624)</td>\n",
       "      <td>HSA provisional authorisation approved on 15 May 2020.&lt;s&gt;438&lt;/s&gt; CE marked.&lt;s&gt;430&lt;/s&gt; Pending EUA approval from US FDA.</td>\n",
       "      <td>90 minutes</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>223</th>\n",
       "      <td>IgA/IgG antibody immunoassay</td>\n",
       "      <td>EUROIMMUN AG&lt;s&gt;439-441&lt;/s&gt; Germany</td>\n",
       "      <td>21 Feb 2020</td>\n",
       "      <td>&lt;s&gt;Anti-SARS-CoV-2 ELISA&lt;/s&gt; ELISA for IgG and IgA antibody detection.  S1 domain of the spike protein is used as the substrate in the ELISAs as it is considered immunogenic and is evolutionarily less conserved, leading to high specificity. &lt;s&gt;442&lt;/s&gt;</td>\n",
       "      <td>Sensitivity: 90% (27/30) Specificity: 100% (80/80)&lt;s&gt;443&lt;/s&gt;</td>\n",
       "      <td>IgG – 99% IgA – approximately 90%, not recommended for screening &lt;s&gt;444&lt;/s&gt;</td>\n",
       "      <td>Commercially available. CE-marked since 25 March 2020 &lt;s&gt;262&lt;/s&gt;</td>\n",
       "      <td>2 hours &lt;s&gt;445&lt;/s&gt;</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>224</th>\n",
       "      <td>Neutralising Antibodies test</td>\n",
       "      <td>Genscript Biotech (Singapore) Pte Ltd, in collaboration with Duke-NUS Medical School &lt;s&gt;40,41&lt;/s&gt; (Professor Wang Linfa) and A*Star DxD Hub&lt;s&gt;446&lt;/s&gt;</td>\n",
       "      <td>26 Feb 2020</td>\n",
       "      <td>SARS-CoV-2 Neutralization Antibody Detection Kit  Blocking assay intended for the qualitative detection of neutralization antibodies against SARS-CoV-2 in human serum</td>\n",
       "      <td>At a cutoff inhibition of 20%: 100% (evaluated using 77 COVID-19 patients in Singapore), 98% (evaluated using 50 COVID-19 patients in Nanjing, China)   At a cutoff inhibition of 40%: 95.6% (evaluated using 77 COVID-19 patients in Singapore), 96% (evaluated using 50 COVID-19 patients in Nanjing, China)</td>\n",
       "      <td>100% (75/75 in cohort done in Singapore; 50/50 in cohort done in Nanjing, China)</td>\n",
       "      <td>Date of Provisional Authorisation from HSA: 8 May 2020&lt;s&gt;447&lt;/s&gt;</td>\n",
       "      <td>1-2 hours</td>\n",
       "      <td>(no info)</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "1                                                                            Type  \\\n",
       "0                                                                         rRT-PCR   \n",
       "1                                                                         rRT-PCR   \n",
       "2                                                                        rRT-PCR    \n",
       "4                                                                         rRT-PCR   \n",
       "5                                                                          RT-PCR   \n",
       "6                                                                          RT-PCR   \n",
       "7                                                                         rRT-PCR   \n",
       "8                                                                         rRT-PCR   \n",
       "9                                                                      RT-PCR Kit   \n",
       "10                                                                     RT-PCR Kit   \n",
       "11                                                                    RT-PCR Kit    \n",
       "13                                                                     RT-PCR Kit   \n",
       "14                                                                    RT-PCR Kit    \n",
       "16                                                                   RT-PCR assay   \n",
       "17                                                                   RT-PCR assay   \n",
       "18                                                                         RT-PCR   \n",
       "19                                                                         RT-PCR   \n",
       "20                                                                         RT-PCR   \n",
       "21                                                                        RT-PCR    \n",
       "23                                                                         RT-PCR   \n",
       "24                                                                         RT-PCR   \n",
       "25                                                                         RT-PCR   \n",
       "26                                                                         RT-PCR   \n",
       "27                                                                         RT-PCR   \n",
       "28                                                        RT-PCR  [Point-of-Care]   \n",
       "29                                                                         RT-PCR   \n",
       "30                                                                         RT-PCR   \n",
       "31                                                                         RT-PCR   \n",
       "32                                                        RT-PCR  [Point-of-Care]   \n",
       "33                                                                         RT-PCR   \n",
       "34                                                        RT-PCR  [Point-of-Care]   \n",
       "35                                                                         RT-PCR   \n",
       "36                                                                         RT-PCR   \n",
       "37                                                                        RT-PCR    \n",
       "39                                                                         RT-PCR   \n",
       "40                                                                         RT-PCR   \n",
       "41                                                                         RT-PCR   \n",
       "42                                                                        RT-PCR    \n",
       "44                                                                         RT-PCR   \n",
       "45                                                                         RT-PCR   \n",
       "46                                                                         RT-PCR   \n",
       "47                                                                        RT-PCR    \n",
       "49                                                                         RT-PCR   \n",
       "50                                                                         RT-PCR   \n",
       "51                                                                        RT-PCR    \n",
       "53                                                                         RT-PCR   \n",
       "54                                                                         RT-PCR   \n",
       "55                                                                         RT-PCR   \n",
       "56                                                                         RT-PCR   \n",
       "57                                                                         RT-PCR   \n",
       "58                                                                         RT-PCR   \n",
       "59                                                                         RT-PCR   \n",
       "60                                                                         RT-PCR   \n",
       "61                                                                         RT-PCR   \n",
       "62                                                                         RT-PCR   \n",
       "63                                                                         RT-PCR   \n",
       "64                                                                         RT-PCR   \n",
       "65                                                                         RT-PCR   \n",
       "66                                                                         RT-PCR   \n",
       "67                                                                         RT-PCR   \n",
       "68                                                                         RT-PCR   \n",
       "69                                                                         RT-PCR   \n",
       "70                                                                         RT-PCR   \n",
       "71                                                                         RT-PCR   \n",
       "72                                                                         RT-PCR   \n",
       "73                                                               Real-time RT-RAA   \n",
       "74                                                               Real-time RT-PCR   \n",
       "75                                                               Real-time RT-PCR   \n",
       "76                                                               Real-time RT-PCR   \n",
       "77                                                              Real-time RT-PCR    \n",
       "79                                                               Real-time RT-PCR   \n",
       "80                                                               Real-time RT-PCR   \n",
       "81                                                               Real-time RT-PCR   \n",
       "82                                                               Real-time RT-PCR   \n",
       "83                                                              Real-time RT-PCR    \n",
       "85                                                               Real-time RT-PCR   \n",
       "86                                                               Real-time RT-PCR   \n",
       "87                                                              Real-time RT-PCR    \n",
       "89                                                               Real-time RT-PCR   \n",
       "90                                                               Real-time RT-PCR   \n",
       "91                                                               Real-time RT-PCR   \n",
       "92                                                               Real-time RT-PCR   \n",
       "93                                                              Real-time RT-PCR    \n",
       "95                                                               Real-time RT-PCR   \n",
       "96                                                               Real-time RT-PCR   \n",
       "97                                                               Real-time RT-PCR   \n",
       "98                                                              Real-time RT-PCR    \n",
       "100                                                              Real-time RT-PCR   \n",
       "101                                                              Real-time RT-PCR   \n",
       "102                                                              Real-time RT-PCR   \n",
       "103                    Real-time PCR and microarray technologies  [Point-of-Care]   \n",
       "104                                                              Real Time RT-PCR   \n",
       "105                                                                        RT-PCR   \n",
       "106                                                                         qPCR    \n",
       "108                                                                          qPCR   \n",
       "109                                                         qPCR  [Point-of-Care]   \n",
       "110                                                         qPCR  [Point-of-Care]   \n",
       "111                                                          PCR-based genotyping   \n",
       "112                                                                         ddPCR   \n",
       "113                                             Conventional and Real Time RT-PCR   \n",
       "114                             Combination of RT-PCR and meta-genomics detection   \n",
       "115                                                                        RT-PCR   \n",
       "116                                                                        RT-PCR   \n",
       "117                                                                        RT-PCR   \n",
       "118                                                                        RT-PCR   \n",
       "119                                                                        RT-PCR   \n",
       "120                                                                        RT-PCR   \n",
       "121                                                                        RT-PCR   \n",
       "122                                                                       RT-PCR    \n",
       "124                                                                        RT-PCR   \n",
       "125                                                                        RT-PCR   \n",
       "126                                                                       RT-PCR    \n",
       "128                                                                        RT-PCR   \n",
       "129                                                                        RT-PCR   \n",
       "130                                                                        RT-PCR   \n",
       "131                                                                       RT-PCR    \n",
       "133                                                                        RT-PCR   \n",
       "134                                                              Real Time RT-PCR   \n",
       "135                                                                        RT-PCR   \n",
       "136                                                                        RT-PCR   \n",
       "137                                                                       RT-PCR    \n",
       "139                                                                        RT-PCR   \n",
       "140                                                                           NGS   \n",
       "141                                                                           NGS   \n",
       "142                                                            Genome sequencing    \n",
       "144  End-to-end solution of sample processing to epidemiological info generation    \n",
       "146                                               Microfluidics   [Point-of-Care]   \n",
       "147                                                                  Microfluidic   \n",
       "148                                                                  Microfluidic   \n",
       "149                                                                  Microfluidic   \n",
       "150                                                                 Microfluidic    \n",
       "152                                                                  Microfluidic   \n",
       "153                                                                  Microfluidic   \n",
       "154                                                         LAMP  [Point-of-Care]   \n",
       "155                                                                          LAMP   \n",
       "156                                                                       RT-LAMP   \n",
       "157                                                   Enzyme-assisted nanocomplex   \n",
       "158                                                     CRISPR-based diagnostics    \n",
       "160                                                      CRISPR-based diagnostics   \n",
       "161                       Immunoassay for SARS-CoV-2 viral nucleoprotein antigens   \n",
       "162                                           Immunoassay for SARS-CoV-2 antigens   \n",
       "163                          Immunoassay for SARS-CoV-2 antigens  [Point-of-Care]   \n",
       "164                                           Immunoassay for SARS-CoV-2 antigens   \n",
       "165                                Carbohydrate-based glycation pattern detection   \n",
       "166                                                                     (no info)   \n",
       "167                                                    Target amplification assay   \n",
       "168                                            Total Antibody Immunoassay (ELISA)   \n",
       "169                                                    Total antibody immunoassay   \n",
       "170                                                    Total Antibody Immunoassay   \n",
       "171                                                    Total antibody Immunoassay   \n",
       "172                                   Total Antibody immunoassay  [Point-of-Care]   \n",
       "173                                                    Total Antibody immunoassay   \n",
       "174                                          IgG/IgM antibody immunoassay (ELISA)   \n",
       "175                IgG/IgM antibody immunoassay (colloidal gold)  [Point-of-Care]   \n",
       "176                                 IgG/IgM antibody immunoassay (colloidal gold)   \n",
       "177                                                  IgG/IgM antibody immunoassay   \n",
       "178                                          IgG/IgM antibody immunoassay  (CLIA)   \n",
       "179                                           IgG/IgM antibody immunoassay (CLIA)   \n",
       "180                                                  IgG/IgM antibody immunoassay   \n",
       "181                                                  IgG/IgM antibody immunoassay   \n",
       "182                                                  IgG/IgM antibody immunoassay   \n",
       "183                                 IgG/IgM antibody immunoassay  [Point-of-Care]   \n",
       "184                                                 IgG/IgM antibody immunoassay    \n",
       "186                                                  IgG/IgM antibody immunoassay   \n",
       "187                                                  IgG/IgM antibody immunoassay   \n",
       "188                                                  IgG/IgM antibody immunoassay   \n",
       "189                                                  IgG/IgM antibody immunoassay   \n",
       "190                                                  IgG/IgM antibody immunoassay   \n",
       "191                                                 IgG/IgM antibody immunoassay    \n",
       "193                                                  IgG/IgM antibody immunoassay   \n",
       "194                                                  IgG/IgM antibody immunoassay   \n",
       "195                                 IgG/IgM antibody immunoassay [Point-of-Care]    \n",
       "197                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "198                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "199                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "200                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "201                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "202                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "203                                                  IgG/IgM antibody immunoassay   \n",
       "204                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "205                                                 IgG/IgM antibody immunoassay    \n",
       "207                                                  IgG/IgM antibody immunoassay   \n",
       "208                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "209                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "210                                                  IgG/IgM antibody immunoassay   \n",
       "211                                 IgG/IgM antibody immunoassay [Point-of-Care]    \n",
       "213                                  IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "214                                     IgM antibody immunoassay  [Point-of-Care]   \n",
       "215                                                     IgM antibody immunoassay    \n",
       "217                                                      IgM antibody immunoassay   \n",
       "218                                                      IgG antibody immunoassay   \n",
       "219                                                      IgG Antibody immunoassay   \n",
       "220                                                        IgG Antibody detection   \n",
       "221                                                        IgG Antibody detection   \n",
       "222                                                        IgG Antibody detection   \n",
       "223                                                  IgA/IgG antibody immunoassay   \n",
       "224                                                 Neutralising Antibodies test    \n",
       "\n",
       "1                                                                                                                                               Organisation  \\\n",
       "0                                                                                                 Charité Institute of Virology, Berlin, Germany <s>1,99</s>   \n",
       "1                                                                                                 Charité Institute of Virology, Berlin, Germany <s>1,12</s>   \n",
       "2                                                                                     School of Public Health, The University of Hong Kong (HKU)<s>13,14</s>   \n",
       "4                                                                                Chinese Center for Disease Control and Prevention, Beijing, China<s>100</s>   \n",
       "5                                                                              Department of Medical Sciences, Ministry of Public Health, Thailand<s>101</s>   \n",
       "6                                                                                                 National Institute of Infectious Diseases, Japan<s>102</s>   \n",
       "7                                                                                       Centers for Disease Control and Prevention, Atlanta, USA<s>15,16</s>   \n",
       "8                                                                                                                   Institut Pasteur, Paris, France<s>10</s>   \n",
       "9                                                                                                                                 Genosensor, LLC <s>103</s>   \n",
       "10                                                                                                                                 KorvaLabs Inc. <s>104</s>   \n",
       "11                                                                                                                               Genosensor, LLC <s>103</s>    \n",
       "13                                                                                                                                 KorvaLabs Inc. <s>104</s>   \n",
       "14                                                      Shanghai Fosun Long March Medical Science Co. Ltd<s>105</s> Manufactured for: Fosun Pharma USA Inc.    \n",
       "16                                                                                                                                  Rhoenix, Inc. <s>108</s>   \n",
       "17                                                                                                                           LabGenomics Co., Ltd <s>110</s>   \n",
       "18                                                                                                                 Bioperfectus Technologies<s>112</s> China   \n",
       "19                                                                                                                   Co-Diagnostics<s>113-</s><s>115</s> USA   \n",
       "20                                                                                                                   Altona Diagnostics<s>119,120</s>Germany   \n",
       "21                                                                                                                          Roche<s>123-126</s> Switzerland    \n",
       "23                                               A*STAR<s>4,128</s>(Manufactured by Singapore’s MiRxes which has a nonexclusive license)<s>129</s> Singapore   \n",
       "24                                                                                                                                 PCL<s>131</s> South Korea   \n",
       "25                                                                                                                                 Biomeme<s>133,134</s> USA   \n",
       "26                                                                                                                                          Livzon<s>135</s>   \n",
       "27                                                                                                          Acumen Research Laboratories<s>137</s> Singapore   \n",
       "28                                                                     Cepheid<s>27,140,141</s> (Plus collaboration with Sherlock Biosciences)<s>142</s> USA   \n",
       "29                                                                                                  TIB-Molbiol<s>124,144</s>(distributed by Roche)  Germany   \n",
       "30                                                                                                             AusDiagnostics<s>145-</s><s>147</s> Australia   \n",
       "31                                                                                                                         Seegene<s>148,149</s> South Korea   \n",
       "32                                                                                                      Credo Diagnostics Biomedical<s>154,155</s> Singapore   \n",
       "33                                                                       Osang Healthcare<s>156,157</s>(partnership with Italy’s ELITech Group)  South Korea   \n",
       "34                                                                                                                      Mesa Biotech<s>28,30,160-162</s> USA   \n",
       "35                                                                                                                                 Luminex<s>163-165</s> USA   \n",
       "36                                                                                                                   LGC Biosearch Technologies<s>25,167</s>   \n",
       "37                                                                                                                  Fulgent Therapeutics, LLC<s>168</s> USA    \n",
       "39                                                                                              bioMérieux<s>171-173</s>(subsidiary BioFire Defense)  France   \n",
       "40                                                                                                                                 Hologic<s>175-177</s> USA   \n",
       "41                                                                                             LabCorp (Laboratory Corporation of America)<s>176,179</s> USA   \n",
       "42                                                                                                                                 Quidel<s>181,182</s> USA    \n",
       "44                                                                                                                      Quests Diagnostics<s>184,185</s> USA   \n",
       "45                                                                                                                     Abbott Molecular<s>27,186,187</s> USA   \n",
       "46                                                                                                                    DiaSorin Molecular<s>189-191</s> Italy   \n",
       "47                                                                                                                               DiaCarta<s>192,193</s> USA    \n",
       "49                                                                                                                   PerkinElmer<s>28,195,19</s><s>6</s> USA   \n",
       "50                                                                                                                           Genetron Health<s>198</s> China   \n",
       "51                                                                                                                         Mobidiag<s>199</s><s>Finland</s>    \n",
       "53                                                                                                                   Genetic <s>Signatures Ltd</s> Australia   \n",
       "54                                                                                       Shanghai ZJ Bio-Tech Co Ltd (also called Liferiver)<s>202</s> China   \n",
       "55                                                                                                                    AITbiotech Pte Ltd<s>203</s> Singapore   \n",
       "56                                                                                                      DSO National Laboratories<s>204</s> <s>Singapore</s>   \n",
       "57                                                                                                                     Biowalker Pte Ltd<s>205</s> Singapore   \n",
       "58                                                                                                                     JN Medsys Pte Ltd<s>206</s> Singapore   \n",
       "59                                                                                                          Veredus Laboratories Pte Ltd<s>127</s> Singapore   \n",
       "60                                                                                                     Vela Operations Singapore Pte Ltd<s>208</s> Singapore   \n",
       "61                                                                                                                SPD Scientific Pte Ltd<s>209</s> Singapore   \n",
       "62                                                                                                                  PerkinElmer Singapore Pte Ltd <s>210</s>   \n",
       "63                                                                                                                        <s>BioWalker Pte Ltd</s><s>211</s>   \n",
       "64                                                                                                             Medicell Pharmaceutical (S) Pte Ltd<s>213</s>   \n",
       "65                                                                                                                   Trax management Services Inc.<s>214</s>   \n",
       "66                                                                                                 Ustar Biotechnologies (Hangzhou) Co Ltd (China)<s>215</s>   \n",
       "67                                                                                                      CTK Biotech Inc (United States of America)<s>216</s>   \n",
       "68                                                                                                                                             PCL<s>132</s>   \n",
       "69                                                                                                                            Seasun Biomaterials <s>217</s>   \n",
       "70                                                                                                                                  bioMérieux SA <s>219</s>   \n",
       "71                                                                                                                     Bio-Rad Laboratories, Inc. <s>222</s>   \n",
       "72                                                                                                                        Public Health England<s>224</s> UK   \n",
       "73                                                                                                                    Beijing Ditan Hospital<s>226</s> China   \n",
       "74                                                                                                         ScienCell Research Laboratories<s>227-229</s> USA   \n",
       "75                                                                                                                     Liferiver Biotech<s>230,231</s> China   \n",
       "76                                                                                                                     Liferiver Biotech<s>230,233</s> China   \n",
       "77                                                                                                                          GenScript<s>230,236,237</s> USA    \n",
       "79                                                                                                                            CerTest Biotec<s>238</s> Spain   \n",
       "80                                                                                                                                    GeneFirst<s>241</s> UK   \n",
       "81                                                                                                                                    GeneFirst<s>241</s> UK   \n",
       "82                                                                                                                  Kogene Biotech<s>131,151</s> South Korea   \n",
       "83                                                                                                           Thermo Fisher Scientific<s>133,243-245</s> USA    \n",
       "85                                                                                                                               US CDC<s>17,247,248</s> USA   \n",
       "86                                                                                                                     SolGent<s>151,152,249</s> South Korea   \n",
       "87                                                                                                                   SD Biosensor<s>151,152</s> South Korea    \n",
       "89                                                                                                        Integrated DNA Technologies (IDT)<s>24,242</s> USA   \n",
       "90                                                                                                                  Luminex<s>164,165,253,25</s><s>4</s> USA   \n",
       "91                                                                                                                              Genomica<s>255,256</s> Spain   \n",
       "92                                                                                                                            Avellino Lab<s>257-259</s> USA   \n",
       "93                                                                           Wadsworth Center, New York State Department of Public Health<s>194,260</s> USA    \n",
       "95                                                                                                                                     NeuMoDx<s>261-263</s>   \n",
       "96                                                                                                                   Becton Dickinson (BD)<s>264-266</s> USA   \n",
       "97                                                                                                      Maccura Biotechnology<s>257,26</s><s>7,268</s> China   \n",
       "98                                                                                                                          Ipsum Diagnostics<s>269,270</s>    \n",
       "100                                                                                         Gnomegen<s>271,272</s>(Subsidiary of QuestGenomics)  USA (China)   \n",
       "101                                                                                                        InBios International<s>248,273,2</s><s>74</s> USA   \n",
       "102                                                                                                                  Becton Dickinson (BD)<s>275,276</s> USA   \n",
       "103                                                                             Mobidiag<s>278</s>(collaboration with Autobio Diagnostics, China)    Finland   \n",
       "104                                                                                              BGI<s>279-281</s> (Pathomics Health as distributor)   China   \n",
       "105                                         CapitalBio<s>45</s>(collaboration with Tsinghua University and West China Hospital of Sichuan University)  China   \n",
       "106                                                                          Primerdesign<s>286-291</s>(molecular diagnostics division of Novacyt) France/UK   \n",
       "108                                                                                                                    Coyote Bioscience<s>133,295</s> China   \n",
       "109                                                                                                                       Molbio Diagnostics<s>295</s> India   \n",
       "110                                                                          OnSiteGene<s>295</s>(San Diego-based subsidiary of Singapore's Star Array)  USA   \n",
       "111                                                                                                                             Genomica<s>300,301</s> Spain   \n",
       "112                                                                                                                   Bio-Rad Laboratories<s>303-305</s> USA   \n",
       "113                                                                                                                            Genekam<s>307,308</s> Germany   \n",
       "114                                                                                          BGI<s>279</s> (Pathomics Health as distributor)<s>313</s> China   \n",
       "115                                                                                                      Jiangsu Bioperfectus Technologies Co Ltd <s>314</s>   \n",
       "116                                                                                                                TCM Biosciences<s>131,315</s> South Korea   \n",
       "117                                                                                                                            Bioneer<s>131</s> South Korea   \n",
       "118                                                                                             CEVI<s>131,317</s> (Partnership with Wells Bio)  South Korea   \n",
       "119                                                                                                                                QuantuMDx<s>295,318</s>UK   \n",
       "120                                                                                                                            Liferiver Bio-Tech <s>319</s>   \n",
       "121                                                                                 Fast Track Diagnostics Luxembourg Sárl. (a Siemens Healthineers Company)   \n",
       "122                                                                                                                                 bioMérieux SA<s>321</s>    \n",
       "124                                                                                                                                OPTI Medical Systems, Inc   \n",
       "125                                                                                                                                Zymo Research Corporation   \n",
       "126                                                                   Rutgers Clinical Genomics Laboratory at RUCDR Infinite Biologics - Rutgers University    \n",
       "128                                                                                                                          Abbott Molecular Inc.<s>326</s>   \n",
       "129                                                                                                                                     1drop Inc <s>327</s>   \n",
       "130                                                                                                                     Applied DNA Sciences, Inc.<s>328</s>   \n",
       "131                                                                                                                              GeneMatrix, Inc.<s>329</s>    \n",
       "133                                                                                                              Assurance Scientific Laboratories<s>330</s>   \n",
       "134                                                                                                                             Quidel Corporation<s>331</s>   \n",
       "135                                                                                                Wuhan EasyDiagnosis Biomedicine Co Ltd (China) <s>332</s>   \n",
       "136                                                                                                                                              AMT Pte Ltd   \n",
       "137                                                                                                                                     P23 Labs <s>335</s>    \n",
       "139                                                                                                                                                  BioCore   \n",
       "140                                                                                                                                IDbyDNA<s>336,337</s> USA   \n",
       "141                                                                                                                           Fulgent Genetics<s>168</s> USA   \n",
       "142                                                                                                                        Oxford Nanopore<s>338,339</s> UK    \n",
       "144                                                                                                                        Oxford Nanopore<s>338,341</s> UK    \n",
       "146                                                                                                                      Abbott Diagnostics<s>29,343</s> USA   \n",
       "147                                                                                                             Veredus Laboratories<s>344-346</s> Singapore   \n",
       "148                                                                                                                                   Lexagene<s>350</s> USA   \n",
       "149                                                                          Shenzhen Shineway Technology<s>351,352</s>(collaboration with HKUST)  Hong Kong   \n",
       "150                                                                                                                    QIAGEN<s>353-355</s> The Netherlands    \n",
       "152                                                                                                         GenMark Diagnostics<s>291,357,35</s><s>8</s> USA   \n",
       "153                                                                                                                                   Fluidigm<s>360</s> USA   \n",
       "154                HiberGene Diagnostics<s>361,362</s>(collaboration with distribution partner in Shenzhen, China, Medcaptain Medical Technologies)  Ireland   \n",
       "155                                                                                                            Atila BioSystems<s>176,363,3</s><s>64</s> USA   \n",
       "156                                                                                                                            Seasun Biomaterials<s>365</s>   \n",
       "157                                                                                             iHealthtech<s>345,366</s>(Asst Prof Shao Huilin)   Singapore   \n",
       "158                                                        Sherlock Biosciences<s>34,142,29</s><s>5,367</s> (Plus collaboration with Cepheid)<s>142</s> USA    \n",
       "160                                                                                  Mammoth Biosciences<s>32-35</s> (Partnering with UCSF Researchers)  USA   \n",
       "161                                                                                                                SD Biosensor <s>372</s><s>South Korea</s>   \n",
       "162                                                                                                                SD Biosensor <s>53</s> <s>South Korea</s>   \n",
       "163                     Sona Nanotech<s>373</s>(collaboration with GE Healthcare Life Sciences, The Native Antigen Company, Bond)<s>374</s><s>375</s> Canada   \n",
       "164                                                                                                                             Quidel Corporation<s>376</s>   \n",
       "165                                                                                                                           Iceni Diagnostics<s>377</s> UK   \n",
       "166                                                                                                                      Lab Geneomics<s>131</s> South Korea   \n",
       "167                                                                                                                                  Hologic, Inc.<s>378</s>   \n",
       "168                                                                                                                           Bio-Rad Laboratories<s>222</s>   \n",
       "169                                                                                      Beijing Wantai Biologicalpharmacy Enterprise Co Ltd<s>380</s> China   \n",
       "170                                                                                                                               Wadsworth Center<s>381</s>   \n",
       "171                                                                                                                                        Roche Diagnostics   \n",
       "172                                                                                Mologic (partnership with the Institut Pasteur de Dakar)<s>386,387</s> UK   \n",
       "173                                                                                                             Ortho Clinical Diagnostics<s>390-392</s> USA   \n",
       "174                                                             Livzon<s>135</s>(collaboration with Wuhan Institute of Virology, Chinese Academy of Science)   \n",
       "175                                                                             Mobidiag (in collaboration with Autobio <s>Diagnostics)</s><s>199</s>Finland   \n",
       "176                                                             Livzon<s>135</s>(collaboration with Wuhan Institute of Virology, Chinese Academy of Science)   \n",
       "177                                                                                                           Camtech Diagnostics Pte Ltd<s>395</s>Singapore   \n",
       "178                               Shenzhen Tisenc Medical Device<s>55</s>(collaboration with Shenzhen University and Shenzhen No.3 People’s Hospital)  China   \n",
       "179                                                                                                                     Snibe Diagnostic<s>397,398</s> China   \n",
       "180                                                                                                                      GenBody Inc (South Korea)<s>214</s>   \n",
       "181                                                                                             Healgen Scientific Limited Liability Company (USA)<s>400</s>   \n",
       "182                                                                                                                                                      PCL   \n",
       "183                                                                            BioMedomics /  Jiangsu Medomics Medical Technology<s>54,57,58</s> USA / China   \n",
       "184                                                                                                          Shenzen YHLO Biotech Co. Ltd (China)<s>401</s>    \n",
       "186                                                                                                                    Biolidics Limited<s>403</s> Singapore   \n",
       "187                                                                                                                Everest Links Pte Ltd<s>404</s> Singapore   \n",
       "188                                                                                                                         Grit Overseas Pte Ltd <s>405</s>   \n",
       "189                                                                                                                            CTK Biotech Inc<s>406</s> USA   \n",
       "190                                                                                                           Qingdao Hightop Biotech Co Ltd<s>407</s> China   \n",
       "191                                                                                                                      Hangzhou Realy Tech Co Ltd   China    \n",
       "193                                                                                                            Hangzhou Clongene Biotech <s>Co Ltd</s> China   \n",
       "194                                                                                                             Hangzhou Biotest <s>Biotech Co Ltd</s> China   \n",
       "195                                                                                                       Guangzhou Wondfo Biotech<s>44-</s><s>48</s> China    \n",
       "197                                                                                                          Hangzhou AllTest Biotech<s>81,412,413</s> China   \n",
       "198                                                                                                                             Pharmact AG<s>50</s> Germany   \n",
       "199                                                                                                           Zhejiang Orient Gene Biotech<s>51,52</s> China   \n",
       "200                                                                                                                        SD Biosensor<s>53</s> South Korea   \n",
       "201                                                                                                             Chembio Diagnostic Systems<s>415-417</s> USA   \n",
       "202                                                                                                                                  Cellex<s>61,358</s> USA   \n",
       "203                                                                           Nankai University<s>56</s> (in collaboration with KingFocus Biomedical)  China   \n",
       "204                                                                                                     Hangzhou Laihe Biotech Co Ltd<s>419</s> <s>China</s>   \n",
       "205                                                                                                                      Shanghai LiangRun <s>420</s> China    \n",
       "207                                                                                                                        Grey Solutions Pte Ltd <s>421</s>   \n",
       "208                                                                                                     Innovation Scientific Pty Ltd (Australia) <s>314</s>   \n",
       "209                                                                                                            MP Biomedicals Asia Pacific Pte Ltd<s>422</s>   \n",
       "210                                                                                                                       Xiamen Boson Biotech Co.<s>423</s>   \n",
       "211                                                                                                  Atlaslink Beijing Technology Co Ltd (China) <s>425</s>    \n",
       "213                                                                                                                  Healthgroup Medical Pte Ltd (Singapore)   \n",
       "214  Guangzhou Medical University<s>11,43</s>(Dr Zhong Nanshan) In collaboration with Jiangsu Medomics Medical Technologies and many other institutes  China   \n",
       "215                                                                                                           Innovita Biological Technology<s>44</s> China    \n",
       "217                                                                                                                                      Epitope Diagnostics   \n",
       "218                                                                                                               Abbott Laboratories Inc.<s>431,432</s> USA   \n",
       "219                                                                                                                         Mount Sinai Laboratory<s>435</s>   \n",
       "220                                                                                                        Ortho-Clinical <s>Diagnostics, Inc.</s><s>436</s>   \n",
       "221                                                                                                                                  Diasorin Inc.<s>437</s>   \n",
       "222                                                                                                                                      Epitope Diagnostics   \n",
       "223                                                                                                                       EUROIMMUN AG<s>439-441</s> Germany   \n",
       "224   Genscript Biotech (Singapore) Pte Ltd, in collaboration with Duke-NUS Medical School <s>40,41</s> (Professor Wang Linfa) and A*Star DxD Hub<s>446</s>    \n",
       "\n",
       "1                                 Date  \\\n",
       "0                          13 Jan 2020   \n",
       "1                          17 Jan 2020   \n",
       "2                         16 Jan 2020    \n",
       "4                          21 Jan 2020   \n",
       "5                             Jan 2020   \n",
       "6                          23 Jan 2020   \n",
       "7                          24 Jan 2020   \n",
       "8                           2 Mar 2020   \n",
       "9                                        \n",
       "10                                       \n",
       "11                                       \n",
       "13                                       \n",
       "14                                       \n",
       "16                                       \n",
       "17                                       \n",
       "18                         14 Jan 2020   \n",
       "19                         23 Jan 2020   \n",
       "20                         23 Jan 2020   \n",
       "21                        31 Jan 2020    \n",
       "23                          1 Feb 2020   \n",
       "24                          3 Feb 2020   \n",
       "25                          4 Feb 2020   \n",
       "26                          4 Feb 2020   \n",
       "27                          7 Feb 2020   \n",
       "28                         10 Feb 2020   \n",
       "29                         12 Feb 2020   \n",
       "30                         16 Feb 2020   \n",
       "31                         18 Feb 2020   \n",
       "32                         21 Feb 2020   \n",
       "33                          3 Mar 2020   \n",
       "34                          4 Mar 2020   \n",
       "35                          4 Mar 2020   \n",
       "36                         10 Mar 2020   \n",
       "37                        11 Mar 2020    \n",
       "39                         11 Mar 2020   \n",
       "40                         16 Mar 2020   \n",
       "41                         16 Mar 2020   \n",
       "42                        17 Mar 2020    \n",
       "44                         17 Mar 2020   \n",
       "45                         18 Mar 2020   \n",
       "46                         19 Mar 2020   \n",
       "47                        23 Mar 2020    \n",
       "49                         24 Mar 2020   \n",
       "50                          7 Aor 2020   \n",
       "51                                       \n",
       "53                                       \n",
       "54                                       \n",
       "55                                       \n",
       "56                                       \n",
       "57                                       \n",
       "58                                       \n",
       "59                                       \n",
       "60                                       \n",
       "61                                       \n",
       "62                                       \n",
       "63                                       \n",
       "64                                       \n",
       "65                                       \n",
       "66                                       \n",
       "67                                       \n",
       "68                                       \n",
       "69                                       \n",
       "70                                       \n",
       "71                                       \n",
       "72                         10 Feb 2020   \n",
       "73                         29 Jan 2020   \n",
       "74                         24 Jan 2020   \n",
       "75                         29 Jan 2020   \n",
       "76                         29 Jan 2020   \n",
       "77                        29 Jan 2020    \n",
       "79                         30 Jan 2020   \n",
       "80                          3 Feb 2020   \n",
       "81                          3 Feb 2020   \n",
       "82                          3 Feb 2020   \n",
       "83                         4 Feb 2020    \n",
       "85                          4 Feb 2020   \n",
       "86                         28 Feb 2020   \n",
       "87                        28 Feb 2020    \n",
       "89                          3 Mar 2020   \n",
       "90                          4 Mar 2020   \n",
       "91                          6 Mar 2020   \n",
       "92                          9 Mar 2020   \n",
       "93                        10 Mar 2020    \n",
       "95                         12 Mar 2020   \n",
       "96                         17 Mar 2020   \n",
       "97                         22 Mar 2020   \n",
       "98                         1 Apr 2020    \n",
       "100                         6 Apr 2020   \n",
       "101                         7 Apr 2020   \n",
       "102                         8 Apr 2020   \n",
       "103                        10 Feb 2020   \n",
       "104                        23 Jan 2020   \n",
       "105                        24 Feb 2020   \n",
       "106                       31 Jan 2020    \n",
       "108                         4 Feb 2020   \n",
       "109                        12 Feb 2020   \n",
       "110                        12 Feb 2020   \n",
       "111                        30 Jan 2020   \n",
       "112                        19 Mar 2020   \n",
       "113                         4 Feb 2020   \n",
       "114                        23 Jan 2020   \n",
       "115                        11 May 2020   \n",
       "116                         3 Feb 2020   \n",
       "117                         3 Feb 2020   \n",
       "118                         3 Feb 2020   \n",
       "119                        12 Feb 2020   \n",
       "120                                      \n",
       "121                                      \n",
       "122                                      \n",
       "124                                      \n",
       "125                                      \n",
       "126                                      \n",
       "128                                      \n",
       "129                                      \n",
       "130                                      \n",
       "131                                      \n",
       "133                                      \n",
       "134                                      \n",
       "135                                      \n",
       "136                                      \n",
       "137                                      \n",
       "139                                      \n",
       "140                        29 Jan 2020   \n",
       "141                        11 Mar 2020   \n",
       "142                       22 Jan 2020    \n",
       "144                       22 Jan 2020    \n",
       "146                        27 Mar 2020   \n",
       "147                        24 Jan 2020   \n",
       "148                        27 Jan 2020   \n",
       "149                         6 Feb 2020   \n",
       "150                       10 Feb 2020    \n",
       "152                        11 Mar 2020   \n",
       "153                        16 Mar 2020   \n",
       "154                        11 Feb 2020   \n",
       "155                        10 Apr 2020   \n",
       "156                                      \n",
       "157                         3 Feb 2020   \n",
       "158                       24 Jan 2020    \n",
       "160                        30 Jan 2020   \n",
       "161                                      \n",
       "162                                      \n",
       "163                        10 Feb 2020   \n",
       "164                                      \n",
       "165                        20 Mar 2020   \n",
       "166                         3 Feb 2020   \n",
       "167                                      \n",
       "168                                      \n",
       "169                                      \n",
       "170                                      \n",
       "171                                      \n",
       "172                        25 Feb 2020   \n",
       "173                         6 Apr 2020   \n",
       "174                         4 Feb 2020   \n",
       "175                                      \n",
       "176                         4 Feb 2020   \n",
       "177                                      \n",
       "178                        12 Feb 2020   \n",
       "179                        28 Feb 2020   \n",
       "180                                      \n",
       "181                                      \n",
       "182                                      \n",
       "183                        21 Feb 2020   \n",
       "184                                      \n",
       "186                                      \n",
       "187                                      \n",
       "188                                      \n",
       "189                                      \n",
       "190                                      \n",
       "191                                      \n",
       "193                                      \n",
       "194                                      \n",
       "195                       20 Feb 2020    \n",
       "197                         2 Mar 2020   \n",
       "198                        10 Mar 2020   \n",
       "199                        10 Mar 2020   \n",
       "200  (Webpage found as of 12 Mar 2020)   \n",
       "201                        20 Mar 2020   \n",
       "202                         1 Apr 2020   \n",
       "203                        17 Feb 2020   \n",
       "204                                      \n",
       "205                     27 April 2020    \n",
       "207                                      \n",
       "208                                      \n",
       "209                                      \n",
       "210                                      \n",
       "211                                      \n",
       "213                                      \n",
       "214                        15 Feb 2020   \n",
       "215                       23 Feb 2020    \n",
       "217                                      \n",
       "218                        15 Apr 2020   \n",
       "219                                      \n",
       "220                                      \n",
       "221                                      \n",
       "222                                      \n",
       "223                        21 Feb 2020   \n",
       "224                       26 Feb 2020    \n",
       "\n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Test  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Primer and Probe   First line screening assay: E gene assay  Confirmatory assay: RdRp gene assay  Additional confirmatory assay: N gene assay   \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Primer and Probe   First line screening assay: E gene assay  Confirmatory assay: RdRp gene assay   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Primer and Probe Assay 1 (Target: ORF1b-nsp14 gene)  Assay 2 (Target: N gene)   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Primer and Probe   Target 1 (ORF1ab gene)  Target 2 (N gene)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          With gel electrophoresis   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     With gel electrophoresis (Nested RT-PCR)  Primer and Probe (Real-time RT-PCR)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Primer and Probe   3 N gene targets  1 human RNase P gene control   \n",
       "8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Primer and Probe   2 RdRp gene targets with Charité’s E gene target as confirmatory   \n",
       "9                                                                                                                                                                                                                                                                                                                                                                                                                                                        <s>GS COVID-19 RT-PCR Kit</s> Real-time reverse transcription polymerase chain reaction test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal/oropharyngeal swabs, nasal swabs, mid-turbinate swabs from individuals suspected of COVID-19. Positive results are indicative of the presence of SARS-CoV-2 RNA.   \n",
       "10                                                                                                                                                                                                                                                                                                                 Curative-Korva SARS-CoV-2 Assay  Real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in oropharyngeal (throat) swab, nasopharyngeal swab, nasal swab, and oral fluid specimens from individuals suspected of COVID-19. Results are for the detection of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA.   \n",
       "11                                                                                                                                                                                                                                                                                                                                                                                                                                                       <s>GS COVID-19 RT-PCR Kit</s> Real-time reverse transcription polymerase chain reaction test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal/oropharyngeal swabs, nasal swabs, mid-turbinate swabs from individuals suspected of COVID-19. Positive results are indicative of the presence of SARS-CoV-2 RNA.   \n",
       "13                                                                                                                                                                                                                                                                                                                 Curative-Korva SARS-CoV-2 Assay  Real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in oropharyngeal (throat) swab, nasopharyngeal swab, nasal swab, and oral fluid specimens from individuals suspected of COVID-19. Results are for the detection of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA.   \n",
       "14                      COVID-19 RT-PCR <s>Detection Kit</s> Real-time RT-PCR for qualitative detection of SARS-CoV-2 ORF1ab, N and E gene targets  Real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper and lower respiratory specimens (such as anterior nasal swabs, mid-turbinate nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate) from individuals suspected of COVID-19. Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper and lower respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA.   \n",
       "16                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Rheonix COVID-19 MDx Assay<s>109</s> Qualitative detection of total nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal washes, nasal aspirates and bronchoalveolar lavage (BAL) fluid.   \n",
       "17                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               LabGun COVID-10 RT-PCR Kit <s>111</s> Qualitative detection of total nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasopharyngeal washes, <s>nasal aspirates and sputum</s>   \n",
       "18                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  RT-PCR test kit   \n",
       "19                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Logix Smart Coronavirus COVID-19 test RT-PCR kit with lower false positive   \n",
       "20                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         RealStar SARS-CoV-2 RT- <s>PCR Kit 1.0</s>Real time RT-PCR for qualitative detection of SARS-CoV-2 RNA (target genes E gene and S gene).   \n",
       "21                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Cobas SARS-CoV-2 Test Runs on the Cobas 6800/8800 systems. Tests for two gene targets: ORF1ab & E.    \n",
       "23                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           A*STAR Fortitude 2.0 Test is based on rRT-PCR, for the qualitative detection of SARS- CoV-2 specific RNA in nasopharyngeal swab specimens.  Supports 188 tests per kit   \n",
       "24                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Multiplex diagnostic kit  PCLMD-nCoV one step RT-PCR kit Organisation: PCL<s>132</s> Qualitative detection of SARS-Co-V-2 by sputum samples   \n",
       "25                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Shelf-stable strip with 3 reaction wells, each reaction contains lyophilized master mix, multiplexed primers, and probes for the following triplex: - 2019-nCoV-Orf1ab - 2019-nCoV-S - MS2 bacteriophage as an RNA extraction and RT-PCR control   \n",
       "26                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Novel coronavirus (2019-nCoV) nucleic acid diagnostic kit (PCR-fluorescence method) Detection of ORF1ab and N genes.   \n",
       "27                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            <s>Acu-Corona™ 2.0/3.0</s>With specific gene targets.   \n",
       "28                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      SAR-CoV-2 Xpert Xpress Cartridge-based nucleic acid amplification test. Tests for two gene targets: N2 & E.   \n",
       "29                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2019-nCoV Real-Time Reverse Transcription PCR Kit Tests for three gene targets: E, RdRp, and N.   \n",
       "30                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     AusDiagnostics respiratory virus panel (including SARS-CoV-2) test Multiplex panel. Tests for two gene targets: ORF1a & ORF8   \n",
       "31                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Allplex 2019-nCoV Assay Single-tube assay that tests for three gene targets: E, RdRp, and N.   \n",
       "32                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             VitaPCR SARS-CoV-2 Assay Runs on Credo’s VitaPCR automated point-of-care molecular testing platform.   \n",
       "33                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    GeneFinder COVID-19 Plus RealAmp Kit Tests for three gene targets: RdRp, E, and N.  Runs on all major PCR cyclers as well as on the Sample-to-Result Platform ELITe InGenius.   \n",
       "34                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Accula SARS-Cov-2 Test Automated PCR test for the qualitative visual detection of nucleic acid from the SARS-CoV-2 virus that runs on the Accula system machines.   \n",
       "35                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 NxTAG CoV Extended Panel Assay Multiplex panel that can be run on Luminex’s MAGPIX System together with optional NxTag Respiratory Pathogen Panel.  Tests for three gene targets: ORF1ab, E, & N   \n",
       "36                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               2019-nCoV CDC Probe and Primer Kits for SARS-CoV-2 Lot numbers #143503 and #143764   \n",
       "37                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   COVID-19 Virus Testing by RT-PCR  Real-time RT-PCR for the qualitative detection of SARS-CoV-2 N1 and N2 genes in upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal direct swab specimens)   \n",
       "39                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            BioFire COVID-19 test Fully automated and designed to run on FILMARRAY® 2.0 and FILMARRAY® TORCH platforms. Tests for two gene targets: ORF1ab & ORF8   \n",
       "40                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Panther Fusion SARS-CoV-2 Assay Test for two conserved regions of the ORF1ab gene   \n",
       "41                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   COVID-19 RT-PCR Test Test for three gene targets: N1, N2, & N3   \n",
       "42                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Lyra SARS-CoV-2 Assay Identification of the SARS-CoV-2 virus occurs by the use of target specific primers and fluorescent-labeled 102 probes that hybridize to a conserved region of the non-structural Polyprotein (pp1ab) of the SARS-CoV-2 virus.<s>183</s>   \n",
       "44                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Quest SARS-CoV-2 rRT-PCR Tests on two gene targets: N1 & N3   \n",
       "45                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Abbott RealTime SARS-CoV-2 assay Will run on the Abbott m2000 RealTime system. Tests for two gene targets: RdRp & N.   \n",
       "46                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Simplexa COVID-19 Direct Will run on the DiaSorin’s LIAISOn MDX thermocycler.  Tests for two gene targets: S & ORF1ab.   \n",
       "47                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               QuantiVirus SARS-CoV-2 Tests for two gene targets: N, ORF1ab, & E    \n",
       "49                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   PerkinElmer New Coronavirus Nucleic Acid Detection Kit Tests for two gene targets: N & ORF1ab.   \n",
       "50                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Detection Kit for Novel Coronavirus (SARS-CoV-2) RNA   \n",
       "51                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       <s>Amplidiag COVID-19</s> Real-time RT-PCR test with two molecular targets (orf1ab and N) including at least one conserved region and one specific region to mitigate effects of genetic drift and avoid cross- reaction with other endemic coronaviruses.   \n",
       "53                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          EasyScreen™ SARS-CoV-2 Detection Kit  Real time PCR which enables qualitative detection of SARS-CoV-2 via two targets (SARS-CoV-2 N and <s>E genes)</s>   \n",
       "54                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR Kit (Detection for 3 genes) Qualitative detection of SARS-CoV-2 by real time <s>PCR</s>   \n",
       "55                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     abTES™ COVID-19 qPCR I Kit Qualitative RT-PCR which detects two COVID-19 specific regions from its non-structure polypeptide   \n",
       "56                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Real-Time PCR Assay for the Detection of SARSCoV-2 Virus  RT-PCR based on specific detection of the polymerase gene region in SARS-CoV-2 virus.   \n",
       "57                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Kit for Novel-Coronavirus (2019-nCoV) RNA (Isothermal Amplification-Real Time Fluorescence Assay) Detection of 2019-nCoV RNA in swab and sputum samples   \n",
       "58                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     ProTect™ COVID-19 RT-qPCR Kit In-vitro qualitative detection of SARS-CoV-2 from samples. The test targets SARS-CoV-2 N1, N2 and N3 genes and the human RNase P control gene.   \n",
       "59                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              VereCoV™ Detection Kit  Multiplex RT-PCR/microarray-based in-vitro diagnostic test.   \n",
       "60                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   ViroKey SARS-CoV-2 RT-PCR Test   \n",
       "61                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Cepheid® Xpert® Xpress SARS-CoV-2   \n",
       "62                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   PerkinElmer® SARS-CoV-2 Real-time RT-PCR Assay   \n",
       "63                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      BioWalker SARS-CoV-2 Assay 2.0<s>212</s>The test  uses rRT-PCR for qualitative detection of SARS-CoV-2 nucleic acids in human nasopharyngeal or oropharyngeal swab samples.   \n",
       "64                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Sansure Biotech Novel Coronavirus (2019- nCoV) Nucleic Acid Diagnostic Kit   \n",
       "65                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               PhoenixDx 2019-CoV   \n",
       "66                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             EasyNat Diagnostic Kit for Novel-Coronavirus (2019-nCoV) RNA (Isothermal Amplification-Real Time Fluorescence Assay)   \n",
       "67                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Aridia COVID-19 Real-Time PCR Test   \n",
       "68                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         PCL COVID19 Ag Rapid FIA <s>132</s> Qualitative detection of SARS-CoV-2 antigens from human oropharyngeal and <s>deep sputum samples</s>   \n",
       "69                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    <s>RT-PCR Test</s>U-TOP COVID-19 Detection Kit <s>218</s> Qualitative detection of SARS-CoV-2 antigens from oropharyngeal and nasopharyngeal swab specimens, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens and <s>sputum samples</s>   \n",
       "70                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             BioFire Respiratory Panel 2.1 <s>220</s> Multiplex RT-PCR test detecting SARS-CoV-2 spike (S) and membrane (M) gene.   \n",
       "71                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Bio-Rad SARS-CoV-2 <s>ddPCR Test</s><s>223</s> Multiplex RT-PCR test detecting SARS-CoV-2 spike (S) and membrane (M) <s>gene</s>   \n",
       "72                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Real time RT-PCR (RdRp gene) assay which employs the use of two probes; one which detects 2019-nCoV, SARS-CoV and bat-SARS-related-CoVs, and the other 2019-nCoV only. The assay will be evaluated on the ABI 7500 Fast real-time PCR system.<s>225</s>   \n",
       "73                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Real time Reverse-Transcription Recombinase Aided Amplification (RT-RAA) assay  Novel isothermal nucleic acid amplification technique  for detection of SARS-CoV-2.   Assay was performed at 42°C within 30min using a portable real-time fluorescence detector,   \n",
       "74                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    ScienCell SARS-CoV-2 Coronavirus Real-time RT-PCR (RT-qPCR) Detection Kit Tests for two gene targets: N1 & N2   \n",
       "75                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Fluorescent PCR<s>231</s>   \n",
       "76                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Multiplex RT-PCR<s>233</s>   \n",
       "77                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       qRT-PCR Targets RdRp gene, N gene and E gene in Wuhan-Hu-1 genome (GenBank <s>sequences NC_045512.2)</s>[same as Charite’s first protocol]   \n",
       "79                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         VIASURE 2019-nCoV Real Time PCR Kit Amplification of a fragment of the S gene.<s>239</s>   \n",
       "80                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Capable of detecting only the SARS-CoV-2   \n",
       "81                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Multiplex assay which simultaneously detects SARS-CoV-2 as well as 17 other common viruses and bacteria   \n",
       "82                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Powerchek 2019-nCoV Real-time PCR kit Tests for two gene targets: E and RdRp.   \n",
       "83                                                                                                                                                                                                                                                                                                                                                                                                                                                                                TaqPath COVID-19 Combo Kit (previously TaqMan 2019-nCoV Assay Kit) Real-time RT-PCR kit assays specifically target all 44 complete genomes currently available at GISAID, and do not target any of the 2,116 complete genomes of other coronaviruses currently available at NCBIm.  Tests for three gene targets: ORF1ab, N, & S.   \n",
       "85                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Centers for Disease Control and Prevention (CDC) 2019-Novel Coronavirus (2019-nCoV) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel Tests for three gene targets: N1, N2, and N3 (subsequently removed<s>248</s>) plus 1 human RNase P gene control.   \n",
       "86                                                                                                                                                                                                                                                                                                                                                                                                                                                                            DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit  Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 N, ORF1a and PCRC genes in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes, bronchoalveolar lavage (BAL) fluid and sputum.   \n",
       "87                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 STANDARD M n-CoV Real-Time Detection Kit Tests for two gene targets: E and RdRp.   \n",
       "89                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 2019-nCoV CDC EUA Kit Follows US CDC protocol to test for 3 N gene targets, and 1 human RNase P gene as control.   \n",
       "90                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    ARIES SARS-CoV-2 Assay Tests for two gene targets: ORF1ab & N   \n",
       "91                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       qCOVID-19 Real-time RT-PCR   \n",
       "92                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       AvellinoCoV2 test Tests for two gene targets from US CDC protocol: N1 & N3   \n",
       "93                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel Tests for two gene targets: N1 & N2.    \n",
       "95                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               NeuMoDx™ SARS-CoV-2 Assay Real-time RT-PCR for use on fully automated NeuMoDx™ 288 and 96 Molecular Systems. Tests for two gene targets: Nsp2 & N.   \n",
       "96                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  BioGX SARS-CoV-2 Reagents for BD MAX System Tests for two gene targets: N1 & N2   \n",
       "97                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     SARS-CoV-2 Fluorescent PCR Kit Tests for three gene targets: ORF1ab, N, & E.   \n",
       "98                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 COV-19 IDx assay N1 gene target    \n",
       "100                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Gnomegen COVID-19 RT-Digital PCR Detection Kit Tests for two gene targets: N1 & N2   \n",
       "101                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Smart Detect SARS-CoV-2 rRT-PCR Kit multiplex one-step rRT-PCR that can run on CFX96 Touch Real-Time PCR.  Tests for three gene targets: N, E, & ORF1b   \n",
       "102                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    BD SARS-CoV-2 Reagents for BD MAX System Test is a rRT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasal, nasopharyngeal and oropharyngeal swab samples from individuals suspected of COVID-19 by their healthcare provider.  Tests for two gene targets: N1 & N2   \n",
       "103                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Novodiag Cartridge-based qPCR system, fully automated, allowing the rapid detection of both novel coronavirus and influenzas in around 30 minutes.  Two gene targets for SARS-CoV-2 (orf1ab and N)<s>199</s>   \n",
       "104                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV In vitro RT-PCR combining fluorescent probing.<s>282</s> Real-time RT-PCR assay for qualitative detection of SARS-CoV-2 in throat swabs and bronchoalveolar lavage fluid (BALF).   \n",
       "105                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Detection of six common respiratory viruses including SARS-CoV-2 within 1.5 hours using samples of patients' oral and pharyngeal Secretions.   \n",
       "106                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Genesig Real-Time PCR COVID-19 (CE) [Previously Coronavirus (Strain 2019-nCoV) Easy/Standard Kit]<s>287</s> Can run on multiple molecular testing platforms, including Primerdesign’s own genesig® q16 and q32 instrument   \n",
       "108                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     2019-nCoV Prep Free QPCR Assay Runs on the Mini8 Portable Molecular Diagnostic QPCR Station (CFDA approved)   \n",
       "109                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  qPCR Truenat Beta CoV <s>296</s>Potentially real-time PCR then detection of wavelengths of fluorescent signal.   \n",
       "110                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Star Array 2019 Novel Coronavirus (SARS-CoV-2) Nucleic Acid Detection <s>Kit 1.0 </s> 2019-nCoV rRT-PCR kit for use on existing Peak V, that performs spatial thermal cycling using a heated liquid metal for direct amplification without the need for sample prep. Genes detected are the SARS-CoV-2 N gene and ORF1ab gene. <s>299</s>   \n",
       "111                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        CLART COVID-19 Based on Genomica’s CLART technology of PCR-based genotyping with low-density microarray.   \n",
       "112                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  COVID-19 Droplet Digital PCR (ddPCR) Assay Quantitative assay for use on Bio-Rad’s QX200 and QXDx Droplet Digital PCR Systems.   \n",
       "113                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             5 options: 1. Conventional PCR 2. Real Time PCR for nCoV only<s>309</s>3. Multiplex Real Time PCR for nCoV + other Bat CoV<s>310</s>4. Multiplex Real Time PCR for nCoV + other Bat CoV + MERS<s>311</s>5. Multiplex Real Time PCR for nCoV + Influenza A<s>312</s>   \n",
       "114                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            2019-nCoV PMseq Kit   A metagenomics sequencing kit based on combinatorial Probe Anchor Synthesis.  Faster SARS-CoV-2 virus detection, and able to detect both known and novel microorganisms, enabling monitoring of evolution during transmission.   \n",
       "115                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  COVID-19 Coronavirus Real <s>Time PCR Kit </s>   \n",
       "116                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      TCM-Q Corona Ⅲ RT-PCR using SARS-CoV-2 RdRP gene and E-Sarbeco <s>gene</s>   \n",
       "117                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               AccuPower COVID-19 Real-Time RT-PCR kit<s>316</s>   \n",
       "118                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CareGENE N-CoV RT-PCR <s>Kit</s>Real time RT-PCR kit to detect SARS-CoV-2 RdRP and E genes in human nasopharyngeal swab, oropharyngeal swab and <s>sputum</s>   \n",
       "119                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      (SARS-CoV-2 Detection RT-PCR Testing kit. Detect SARS-CoV-2 in human oropharyngeal and nasopharyngeal swab   \n",
       "120                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR Kit Test  is used for the in vitro qualitative detection of 2019-nCoV RNA in upper respiratory tract specimens and lower respiratory tract specimens.   \n",
       "121                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              FTD SARS-CoV-2. Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal swabs, nasopharyngeal swabs, nasopharyngeal wash and bronchoalveolar lavage.   \n",
       "122                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              ARGENE®  SARS-CoV-2 R-gene test Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes and bronchoalveolar lavage (BAL) fluid.   \n",
       "124                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          OPTI SARS-CoV-2 RT-PCR Test Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in upper and lower respiratory specimens (such as nasal, nasopharyngeal, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate).   \n",
       "125                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Quick SARS-CoV-2 rRT-PCR Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in upper and lower respiratory specimens (such as nasal, nasopharyngeal, oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate).   \n",
       "126                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Rutgers Clinical Genomics Laboratory TaqPath SARS-CoV-2 Assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal swab, mid-turbinate nasal swab, and bronchoalveolar lavage <s>(BAL) fluid.</s>   \n",
       "128                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Alinity m SARS-CoV-2 assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, nasal swabs, and bronchoalveolar lavage (BAL) fluid   \n",
       "129                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1 copy™ covid-19 qPCR multi kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 E and <s>326</s>RdRp gene in nasopharyngeal, oropharyngeal, anterior nasal, mid-turbinate nasal swab specimens as well as nasopharyngeal wash/aspirate and nasal aspirate specimens.   \n",
       "130                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Linea™ COVID-19 Real Time PCR Assay Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal, oropharyngeal and nasal swab specimens as well as nasopharyngeal wash/aspirate and nasal aspirate specimens.   \n",
       "131                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           NeoPlexTM COVID-19 Detection Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in nasopharyngeal, oropharyngeal and nasal swab specimens as well as nasopharyngeal wash/aspirate and nasal aspirate specimens.   \n",
       "133                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Assurance SARS-CoV-2 Panel Real-time RT-PCR for the qualitative detection of SARS-CoV-2 E, N1 and N2 genes in upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal swabs).   \n",
       "134                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Lyra® Direct SARS-CoV-2 Assay Real-time RT-PCR for the qualitative detection of SARS-CoV-2 RNA in upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal swabs).   \n",
       "135                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           COVID-19 (SARS-CoV-2) Nucleic Acid Test kit Real-time RT-PCR test kit, intended for the qualitative detection of nucleic acid from the SARS-CoV-2, in upper and lower respiratory tract specimens. Gene targets are the SARS-CoV-2 N and ORF1ab gene.   \n",
       "136                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   AMT RESOLUTE 1.0 Real-time RT-PCR for the qualitative detection of SARS-CoV-2 RNA. RNA extraction is not required as this kit is intended for direct amplification of SARS-CoV-2 RNA from nasopharyngeal swabs in universal transport medium.   \n",
       "137                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           P23 Labs TaqPath SARS-CoV-2 Assay Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens as well as bronchoalveolar lavage (BAL) specimens.   \n",
       "139                                                                                                                                                                                                                                                                                                                                                                                                                                                                            BioCore 2019-nCoV Real Time PCR Kit Real time RT-PCR Kit designed to qualitatively detect SARS-CoV-2 N and RdRp genes in upper respiratory specimens (such as nasal, mid-turbinate, oropharyngeal, and nasopharyngeal swabs) and lower respiratory specimens (such as sputum, bronchoalveolar lavage (BAL), and tracheal aspirates).   \n",
       "140                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Next-generation sequencing-based metagenomics, allows enhanced pathogen detection and profiling in comparison to conventional PCR testing.<s>337</s>   \n",
       "141                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Kiloplex PCR Plus NGS Next-generation sequencing using thousands of PCR primers to amplify sample viral genetic material before sequencing on the Illumina platform.   \n",
       "142                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Works with public health labs globally to support rapid sequencing of SARS-CoV-2 through sharing of methods / workflows.   Nanopore sequencing workflows can provide a consensus viral genome from sample within a day.   \n",
       "144                                                                                                                                                                                                                                                                                                                                                                         ARTIC project  A ‘lab-in-a-suitcase’ solution for processing samples from viral outbreaks, to generating real-time epidemiological information interpretable and actionable by public health bodies.  Deployable to remote/resource-limited locations.  Based on viral genome data generated prospectively during similar outbreaks (eg. MERS, SARS etc). Relies on direct amplification of the virus using tiled, multiplexed primers.   \n",
       "146                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     ID Now COVID-19 test Automated assay that runs on Abbott’s ID Now platform.   \n",
       "147                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               VereCoV  Lab-on-Chip platform integrating PCR and microarray  Claims to detect MERS-CoV, SARS-CoV and SARS-CoV-2 in a single test   \n",
       "148                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Genetic analyser using microfluidic technology   \n",
       "149                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Novel silicon-based micro-heater, which has lower thermal mass and a better thermal conductivity, could speed up temperature rises to around 30<s>o</s>C per second, greatly reducing the detection time compared to conventional PCR devices which has an average of 4-5<s>o</s>C per second.   \n",
       "150                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                QIAStat-Dx Respiratory SARS-CoV-2 Panel [Plus] Tests for two gene targets: ORF1b recommended by the Chinese CDC and N recommended by the US CDC.   \n",
       "152                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        ePlex SARS-CoV-2 Automated single cartridge using digital microfluidics.   \n",
       "153                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Aimed at using Fluidigm's Biomark HD system and microfluidics technology, to develop integrated fluidic circuits for parallel assays.   \n",
       "154                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Loop-mediated isothermal amplification (LAMP)-based Coronavirus test Allows for rapid near-patient testing   \n",
       "155                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             iAMP COVID-19 Detection Kit Real-time fluorescent reverse transcription isothermal amplification without requiring RNA extraction and can run up to 94 samples simultaneously.<s>363,364</s>Tests for two gene targets: N & ORF1ab.   \n",
       "156                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        AQ-TOP™ COVID-19 Rapid Detection Kit RT-LAMP test designed to qualitatively detect SARS-CoV-2 RNA in oropharyngeal (throat) swab, nasopharyngeal swab, anterior nasal and mid-turbinate nasal swabs, nasopharyngeal wash/aspirate or nasal aspirate specimens, bronchoalveolar lavage (BAL) specimens as well as sputum.   \n",
       "157                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          enVision (enzyme-assisted nanocomplexes for visual identification of nucleic acids) Uses enzyme-assisted nanocomplexes   \n",
       "158  SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing)  SHERLOCK platform uses various CRISPR proteins (Cas13, Cas12a, and Csm6) to allow for simultaneous detection of multiple nucleic acids.<s>142</s> Designed to detect RNA from upper respiratory specimens (such as nasal swabs, nasopharyngeal swabs, oropharyngeal swabs, nasopharyngeal wash/aspirate or nasal aspirate) and bronchoalveolar lavage specimens. Step one is a reverse transcriptase loop-mediated amplification (RT-LAMP) where targeted SARS-CoV-2 genomic RNA is reverse transcribed to DNA, and this DNA is amplified by a strand-displacing DNA polymerase. Step two is the transcription of the amplified DNA to activate the collateral cleavage activity of a CRISPR complex programmed to the target RNA sequence.   \n",
       "160                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   SARS-CoV-2 DNA Endonuclease-Targeted CRISPR Trans Reporter (DETECTR) Using the CRISPR Cas12 that cleaves a FAM-Biotin reporter molecule. Tests for two gene targets:  E & N2.   \n",
       "161                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          STANDARD F COVID-19 Ag FIA Fluorescent immunoassay to detect SARS-CoV-2 infection in human nasopharyngeal swab specimen by identifying the existence of SARS-CoV-2 <s>viral nucleoprotein antigens</s>   \n",
       "162                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              STANDARD Q COVID-19 Ag  Rapid chromatographic immunoassay for the qualitative detection of specific antigens to SARS-CoV-2 present in the human <s>nasopharynx</s>   \n",
       "163                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Proprietary nanotechnology  lateral flow test using antigens specific to SARS-CoV-2 produced at Native's Oxford facility using proprietary mammalian VirtuE expression system.   \n",
       "164                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Sofia 2 SARS Antigen FIA Lateral flow immunofluorescent sandwich assay that is used with the Sofia 2 instrument intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal (NP) and nasal (NS) swab specimens.   \n",
       "165                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Carbohydrate-based, lateral flow assay for detection of glycation patterns of SARS-CoV-2   \n",
       "166                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       (no info)   \n",
       "167                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Aptima® SARS-CoV-2 Assay (Panther® System) Nucleic acid amplification in vitro diagnostic test designed to qualitatively detect RNA from SARS-CoV-2 isolated and purified from nasopharyngeal (NP), nasal, mid-turbinate and oropharyngeal (OP) swab specimens, nasopharyngeal wash/ aspirate or nasal aspirates.   \n",
       "168                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   <s>ELISA Total Antibodies</s>Platelia SARS-CoV-2 Total Antibody Assay<s>379</s> Qualitative detection of total antibodies to SARS-CoV-2 in human serum and plasma <s>EDTA</s>   \n",
       "169                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Wantai SARS-CoV-2 Ab Rapid Test Kit  Rapid qualitative detection of total antibodies against SARS-CoV-2 in human serum, plasma or whole blood specimens, employing chromatographic lateral flow device in a cassette format <s>(colloidal gold)</s>   \n",
       "170                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             New York SARS-CoV Microsphere Immunoassay for Antibody Detection <s>382</s> Qualitative detection of total antibodies to SARS-CoV-2 in human serum.   \n",
       "171                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Elecsys Anti-SARS-CoV-2<s>383</s> Immunoassay for qualitative detection of antibodies to SARS-CoV-2   \n",
       "172                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Lateral flow immunoassay for detection of antibodies for SARS-CoV-2.   \n",
       "173                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         VITROS Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack Runs on VITROS ECi/ECiQ/3600 Immunodiagnostic System and the VITROS 5600/XT 7600 Integrated Systems.  Can run up to 150 samples per hour.<s>392</s>   \n",
       "174                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Diagnostics kit for IgM/IgG antibody to novel coronavirus (ELISA) Indirect method for ELISA for in vitro qualitative detection of antibodies to SARS-CoV-2 in human serum or plasma.   \n",
       "175                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Anti-SARS-CoV-2 Rapid <s>Test</s> Immunoassay Anti-SARS-CoV-2 Rapid Test is based on a colloidal gold method for the rapid, qualitative determination of SARS-CoV-2 IgG/IgM antibodies in human serum, plasma or whole blood.   \n",
       "176                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Diagnostics kit for IgM/IgG antibody to novel coronavirus (colloidal gold) Immunochromatography assay for in vitro qualitative detection of antibodies to SARS-CoV-2 in human serum or plasma.   \n",
       "177                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Camtech COVID-19 IgM/IgG Immunoassay kit for the rapid and differential detection of IgG and IgM against COVID-19 using serum, plasma and whole <s>blood.</s>   \n",
       "178                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              2019 Novel Coronavirus <s>IgM kit (CLIA)</s>2019 Novel Coronavirus <s>IgG kit (CLIA)</s>Chemiluminescence antibody test kit using serum or plasma.   \n",
       "179                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Maglumi 2019-nCoV (SARS-CoV-2) IgM/IgG kits Fully automated CLIA using 10μL sample volume of serum or plasma.   \n",
       "180                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               GenBody COVID-19 <s>IgM/IgG</s> Point-of-care chromatographic immunoassay kit for the rapid and differential detection of anti-SARS-CoV-2 IgM and IgG using serum, plasma and whole blood from capillary blood samples.<s>214</s>   \n",
       "181                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             COVID-19 Antibody Rapid Detection Kit<s>400</s> Rapid test for the qualitative, differential detection of both anti-SARS-CoV-2 IgM and IgG antibodies from whole blood, serum and plasma, using lateral flow method   \n",
       "182                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      PCL COVID19 IgG/IgM Rapid Gold<s>132</s> Qualitative detection of COVID-19 IgG/IgM antibodies using lateral flow technique   \n",
       "183                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                COVID-19 IgM/IgG Rapid Test   Lateral flow immunoassay with both IgM and IgG antibodies adhered using colloidal gold.  Can be used with fingerstick whole blood.   \n",
       "184                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            iFlash 8000 CLIA analyser<s>402</s> Fully Automated chemiluminescent immunoassay for anti- SARS-CoV-2 IgM and IgG <s>antibodies.</s>   \n",
       "186                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Nanjing Vazyme 2019-nCoV IgG/IgM Detection <s>Kit</s><s>Also marketed as</s>Biolidics 2019-nCoV IgG/IgM Detection Kit Detection of 2019-nCoV IgG and IgM in human serum, <s>plasma and whole blood</s>   \n",
       "187                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         VivaDiag™ COVID-19 IgM/IgG Rapid Test In vitro diagnostic test for the qualitative determination of COVID-19’s igM and IgG antibodies in human blood, serum and plasma.   \n",
       "188                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                DiagnoSure COVID-19 IgG/ IgM Rapid Test Cassette   \n",
       "189                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              OnSite COVID-19 IgG/IgM Rapid Test  Designed for initial screening by detecting anti-SAR-CoV-2 IgG and IgM antibodies in human serum, <s>plasma or whole blood</s>   \n",
       "190                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         SARS-CoV-2 IgM/lgG Antibody Rapid Test  Qualitative detection of SARS-CoV-2 IgG and IgM antibodies in human serum, plasma or whole blood <s>samples</s>   \n",
       "191                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                2019-nCOV/COVID-19 <s>IgG/IgM Rapid Test Device</s> <s>Lateral flow IgG/IgM</s>    \n",
       "193                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           COVID-19 IgG/IgM Rapid <s>Test Cassette</s> Rapid point-of-care lateral flow chromatographic immunoassay for the qualitative detective of IgG and IgM antibodies to <s>SARS-CoV-2</s>   \n",
       "194                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                COVID-19 IgG/IgM Rapid <s>Test Cassette</s> Rapid chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2 in human whole blood, serum or <s>plasma</s>   \n",
       "195                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Wondfo SARS-CoV-2 Antibody Test (Lateral Flow Method)  Colloidal gold method for IgM and IgG antibody detection.    \n",
       "197                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            2019-nCoV IgG/IgM Rapid Test Cassette Lateral flow chromatographic immunoassay for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2 in human whole blood, serum or plasma specimen.   \n",
       "198                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CoV-2 Rapid Test Using drops of blood from fingerstick onto test cassette, with two drops of buffer solution.   \n",
       "199                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            COVID-19 IgG/IgM Rapid Test Solid phase immunochromatography assay for rapid qualitative detection of IgG and IgM antibodies to SARS-CoV-2 using human whole blood, serum or plasma.   \n",
       "200                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    STANDARD Q COVID-19 IgM/IgG Duo Immunochromatography assay for rapid qualitative detection of IgG and IgM antibodies to SARS-CoV-2 using human whole blood, serum or plasma.   \n",
       "201                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             DPP COVID-19 IgM/IgG System Lateral flow assay testing for IgM and IgG, to be read using the DPP Micro Reader or DPP Micro Reader 2 (not visually).   \n",
       "202                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     qSARS-CoV-2 IgG/IgM Rapid Test For “aid in the diagnosis of patients with suspected SARS-CoV-2 infection in conjunction with clinical presentation and the results of other laboratory tests.”<s>61</s>Can be used with serum, plasmas, or whole blood from venepuncture (not fingerstick).   \n",
       "203                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Novel Coronavirus (2019-nCoV) IgM/IgG antibody detection kit   \n",
       "204                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold)  POCT rapid SARS-CoV-2 <s>IgM/IgG antibody test</s>   \n",
       "205                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               LionRun Diagnostic Kit for Antibody IgM-IgG of Novel Coronavirus COVID-19 An in vitro diagnostic test for the qualitative and differential detection of IgM and IgG antibodies against SARS-CoV-2   \n",
       "207                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             i-Test COVID -19 IgM/IgG Antibody Rapid Test (Colloidal Gold)  The test is an in-vitro qualitative determination of Novel coronavirus (COVID2019) Antibody in human serum or plasma or whole blood.   \n",
       "208                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     InnoScreen COVID-19 IgG/IgM Rapid Test Lateral Flow IgG/IgM [Point-of-care]   \n",
       "209                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              MP Diagnostics ASSURE® SARS-CoV-2 IgG/IgM Rapid Test Qualitative in vitro immunochromatographic test to detect and differentiate IgG/IgM antibodies against SARS- CoV-2 in human plasma, serum or whole blood with anti-coagulants   \n",
       "210                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Xiamen Boson Rapid 2019-nCOV IgG/IgM Combo Test Card Immunochromatography for the rapid qualitative determination of IgG and IgM antibodies to 2019 novel coronavirus (2019- nCoV, SARS-CoV- 2) in human serum, plasma, or whole blood   \n",
       "211                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     NOVA Test® COVID-19 IgG/IgM Antibody Test (Colloidal Gold) Qualitative detection of IgG/IgM antibodies to SARS-CoV-2 in human serum, plasma or whole blood.   \n",
       "213                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          HealthGroup Medical V-CODE Sars-CoV-2 (COVID-19) IgG/IgM Rapid Test Lateral flow immunoassay for the qualitative detection and differentiation of IgG and IgM of Novel Coronavirus (SARS-CoV-2) in human whole blood, serum or plasma.   \n",
       "214                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            SARS-CoV-2 rapid IgG-IgM combined antibody kit <s>(colloidal gold)</s> In-vitro detection of IgG/IgM antibodies using lateral flow <s>immunoassay techniques</s><s>427</s>,<s>57</s>   \n",
       "215                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  2019-nCoV Antibody Test <s>(colloidal gold)</s> IgG and IgM antibody detection from venous whole blood/ plasma/ serum samples    \n",
       "217                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             EDI Novel Coronavirus COVID-19 IgM ELISA Kit Qualitative detection of human anti-COVID- 19 IgG antibody in human serum using ELISA.   \n",
       "218                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         SARS-CoV-2 IgG test Lab-based serology test for the detection of IgG. Can run on ARCHITECT® i1000SR and i2000SR laboratory instruments.   \n",
       "219                                                                                                                                                                                                                                                                                                                                                                           COVID-19 ELISA IgG <s>Antibody test</s> ELISA performed for the qualitative detection of human IgG antibodies in serum and plasma specimens collected from individuals suspected of prior infection with the virus that causes COVID-19. Detection of IgG SARS-CoV-2 antibodies. The presence of IgG antibodies defines IgG antibody seroconversion and generally becomes detectable beginning 10-14 <s>days following infection.</s>   \n",
       "220                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack   \n",
       "221                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    LIAISON SARS-CoV-2 S1/S2 IgG   \n",
       "222                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             EDI Novel Coronavirus COVID-19 IgG ELISA Kit Qualitative detection of human anti-COVID- 19 IgG antibody in human serum using ELISA.   \n",
       "223                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     <s>Anti-SARS-CoV-2 ELISA</s> ELISA for IgG and IgA antibody detection.  S1 domain of the spike protein is used as the substrate in the ELISAs as it is considered immunogenic and is evolutionarily less conserved, leading to high specificity. <s>442</s>   \n",
       "224                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         SARS-CoV-2 Neutralization Antibody Detection Kit  Blocking assay intended for the qualitative detection of neutralization antibodies against SARS-CoV-2 in human serum    \n",
       "\n",
       "1                                                                                                                                                                                                                                                                                                                                                                  Sensitivity  \\\n",
       "0    First line screening assay  Technical LOD: 5.2 RNA copies/reaction, at 95% hit rate  95% CI: 3.7-9.6 RNA copies/reaction.  Confirmatory assay Technical LOD: 3.8 RNA copies/reaction, at 95% hit rate 95% CI: 2.7-7.6 RNA copies/reaction.  Additional confirmatory assay Technical LOD: 8.3 RNA copies/reaction, at 95% hit rate;  95% CI: 6.1-16.3 RNA copies/reaction.   \n",
       "1                        First line screening assay  Technical LOD: 5.2 RNA copies/reaction, at 95% hit rate  95% CI: 3.7-9.6 RNA copies/reaction.  Confirmatory assay Technical LOD: 3.8 RNA copies/reaction, at 95% hit rate 95% CI: 2.7-7.6 RNA copies/reaction.  (Preliminary experiment compared single probe assay for SARS-CoV with single probe assay for SARS-CoV-2.)   \n",
       "2                                                                                                                                                                                                                                                                        Positive control using SARS-CoV RNA Wide dynamic range of 2<s>-4</s> to 2000 TCID<s>50</s>/reaction.    \n",
       "4                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "8                                                                                                                                                                                                                100 or more copies of RNA genome equivalent per reaction always detected.  Samples containing 10 copies of RNA genome could be detected with multiplex assay.   \n",
       "9                                                                                                                                                                                                                                                                                                                                                          <s>100% (32/32)</s>   \n",
       "10                                                                                                                                                                                                                                                                                                                                                                  100% (5/5)   \n",
       "11                                                                                                                                                                                                                                                                                                                                                        <s>100% (32/32)</s>    \n",
       "13                                                                                                                                                                                                                                                                                                                                                                  100% (5/5)   \n",
       "14                                                                                                                                                                                                                                                                                                                                                 99.51% (203/204)<s>106</s>    \n",
       "16                                                                                                                                                                                                                                                                                                                                                              100%<s>109</s>   \n",
       "17                                                                                                                                                                                                                                                                                                                                                      100% (50/50)<s>111</s>   \n",
       "18                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "19                                                                                                                                                                                                                                                                                                                                                      100% (21/21)<s>116</s>   \n",
       "20                                                                                                                                                                                                                                                                                                      95% (24/25) detection for S gene;   100% (25/25) detection for E gene.   \n",
       "21                                                                                                                                                                                                      100% (50/50)  50 nasopharyngeal swab clinical samples spiked with cultured SARS-CoV-2 virus Low (1.5x LoD) and moderate (4x LoD) contrived positive samples <s>126</s>   \n",
       "23                                                                                                                                                                                                                                                                                                                                                              100%<s>130</s>   \n",
       "24                                                                                                                                                                                                                                                                                                                                        Sensitivity: 100% (35/35) <s>132</s>   \n",
       "25                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "26                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "27                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "28                                                                                                                                                                                                                                   100% (30/30)  30 nasopharyngeal swab specimens were spiked with SARS-CoV- (2x to 5x LoD) serving as contrived positive samples.<s>141</s>   \n",
       "29                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "30                                                                                                                                                                                                                                                                                                                                                              100%<s>147</s>   \n",
       "31                                                                                                                                                                                                                       100% (49/49) from upper respiratory specimens (nasopharyngeal/ oropharyngeal swabs)  100% (49/49) from lower respiratory specimens (sputum)<s>150</s>   \n",
       "32                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "33                                                                                                     100% for both upper and lower respiratory tract samples   Evaluated using 30 nasopharyngeal swabs (upper respiratory tract) and sputum (lower respiratory tract) specimens spiked with SARS-CoV-2 virus (1x to 4x LoD) serving as contrived positive samples <s>158</s>   \n",
       "34                                                                                                                                                                                                                                           100% (30/30)  30 nasopharyngeal swabs spiked with SARS-CoV-2 RNA (2x to 50x LoD) serving as contrived positive samples.<s>162</s>   \n",
       "35                                                                                                                                                                                                                               100% (30/30)  30 nasopharyngeal swabs spiked with purified SARS-CoV-2 viral genomic RNA (2x to 5x LoD) serving as contrived positive samples.   \n",
       "36                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "37                                                                                                                                                                                                                                                                                                                                                        <s>100% (30/30)</s>    \n",
       "39                                                                                                                                                                                                                     100% (30/30)  30 nasopharyngeal swab specimens were spiked with live SARS-CoV-2 virus (1x to 100x LoD) serving as contrived positive samples.<s>174</s>   \n",
       "40                                                                                                                                                                                           100% (69/69)  69 remnant clinical nasopharyngeal specimens were spiked with inactivated cultured SARS-CoV-2 virus (1x to 5x LoD) serving as contrived positive samples.<s>177</s>   \n",
       "41                                                                                                                                                                         100% (80/80)  40 nasopharyngeal swab specimens and 40 bronchoalveolar lavage specimens were spiked with quantitated live SARS-CoV-2 (1x to 8x LoD) to form 80 contrived positive samples.<s>179</s>   \n",
       "42                                                                                                                                                                                                                             100% (92/92)  92 nasopharyngeal swab specimens were spiked with SARS-CoV-2 RNA (1x to 5x LoD) serving as contrived positive samples.<s>182</s>    \n",
       "44                                                                                                                                          100% (30/30)  12 pairs of nasopharyngeal swab and sputum specimens from actual COVID-19 patient formed 24 samples, together wiith 6 additional randomly selected to be duplicated, serving as total 30 positive samples.<s>185</s>   \n",
       "45                                                                                                                                                            100% (60/60)  61 nasopharyngeal swabs spiked with  recombinant virus containing SARS-CoV-2 RNA sequences (1x to 20x LoD) serving as contrived positive samples. 1 sample was invalidated and excluded.<s>187</s>   \n",
       "46                                                                                                                                                                                                                100% (52/52)  108 fresh nasopharyngeal swab specimens from 3 clinical site2s were compared with one of two brands of established comparator assay.<s>191</s>   \n",
       "47                                                                                                                                                                                                                                                                                     96.7% Clinically validated in the company's CLIA-certified lab in Richmond, California.   \n",
       "49                                                                                                                                                                                                   100% (47/47)  47 oropharyngeal and nasopharyngeal swab specimens spiked with inactivated SARS-CoV-2 virus (1x to 5x LoD) serving as contrived positive samples.<s>196</s>   \n",
       "50                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "51                                                                                                                                                                                                                                                                                                                                                                  (no info)    \n",
       "53                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "54                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "55                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "56                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "57                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "58                                                                                                                                                                                                                                                                                                                       High sensitivity and specificity, no statistics given   \n",
       "59                                                                                                                                                                                                                                                                                                                                                                               \n",
       "60                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "61                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "62                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "63                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "64                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "65                                                                                                                                                                                                                                                                                                                                                                100% (30/30)   \n",
       "66                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "67                                                                                                                                                                                                                                                                                                                                                                       95.1%   \n",
       "68                                                                                                                                                                                                                                                                                                                                                           Sensitivity: 100%   \n",
       "69                                                                                                                                                                                                                                                                                                                         100% (for both nasopharyngeal and sputum)<s>218</s>   \n",
       "70                                                                                                                                                                                                                                                                                                                                                                 98% (48/49)   \n",
       "71                                                                                                                                                                                                                                               94.87% (37/39, analysis done after Thermo MagMAX extraction); 94.59% (35/37, analysis done after QIAamp viral RNA extraction)   \n",
       "72                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "73                                                                                                                                                                                                                                                               (Recombinant plasmids containing conserved ORF1ab genes was used to analyse the specificity and sensitivity.)   \n",
       "74                                                                                                                                                                                                                              100% (30/30)  30 nasopharyngeal swabs spiked with SARS-CoV-2 RNA (not actual clinical sample) serving as contrived positive samples.<s>228</s>   \n",
       "75                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "76                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "77                                                                                                                                                                                                                                             “This assay is RUO and has not been tested on clinical samples. We make no claims on the performance of this assay.” <s>236</s>   \n",
       "79                                                                                                                                                                                                                                                                                                                                                             97.5%<s>240</s>   \n",
       "80                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "81                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "82                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "83                                                                                                                                                              100% (60/60)  30 nasopharyngeal swab specimens and 30 bronchoalveolar lavage specimens were spiked with extracted SARS-CoV-2 viral genomic RNA (2x to 5x LoD) to form 60 contrived positive samples.<s>245</s>   \n",
       "85                                                                                                                                                                                                     100% (!3/13)  117 respiratory specimens collected from 46 subjects tested with two analytically validated real-time RT-PCR assays for N4 and N5 gene targets.<s>247</s>   \n",
       "86                                                                                                                                                                                                                                                                                                                                                                        100%   \n",
       "87                                                                                                                                                                                                                                                                                                                                        Sensitivity: 100% (30/30)<s>251</s>    \n",
       "89                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "90                                                                                                                                                                                                                     100% (30/30)  30 nasopharyngeal swabs spiked with purified SARS-CoV-2 viral genomic RNA (2x to 5x LoD) serving as contrived positive samples.<s>254</s>   \n",
       "91                                                                                                                                                                                                                                                               Reported 100%.<s>255</s> Tested at the Carlos III Health Institute with 80 samples (unclear of sample types).   \n",
       "92                                                                                                                                                                                                   100% (30/30)  30 oropharyngeal and nasopharyngeal swab specimens spiked with whole SARS-CoV-2 viral RNA (1x to 100x LoD) serving as contrived positive samples.<s>259</s>   \n",
       "93                                                                                                                  (42/43)  For the easyMAG extraction, 43 individual sputum samples were spiked with the extracted whole SARS-CoV-2 virus genomic RNA (2x to 200x LoD) to serve as contrived positive samples. Testing was also done with eMAG and EZ1 extraction.<s>260</s>   \n",
       "95                                                                                                                                                                                                             100% (87/87)  87 clinical nasopharyngeal swab specimens were spiked with SARS-CoV-2 genomic RNA (1x to 8x LoD) serving as contrived positive samples.<s>263</s>   \n",
       "96                                                                                                                                      100% (29/29)  30 retrospective collected clinical nasopharyngeal swab specimens spiked with quantified genomic RNA of SARS- CoV-2 (1x to 5x LoD) serving as contrived positive samples. 1 sample removed from data analysis.<s>264</s>   \n",
       "97                                                                                                                              100% (30/30)  15 nasopharyngeal and 15 oropharyngeal swab samples from suspected cases that tested negative had additional aliquot spiked with SARS-CoV-2 whole genomic RNA (2x to 5x LoD) serving as 30 contrived positive samples.<s>268</s>   \n",
       "98                                                                                                                                                                                        100% (36/36)  36 nasopharyngeal swabs spiked with BEI ATCC Genomic RNA from SARS Related Coronavirus 2 (not actual clinical sample) serving as contrived positive samples.<s>270</s>   \n",
       "100                                                                                                                                                                                                                     100% (30/30)  30 oropharyngeal swabs spiked with quantified SARS-CoV-2 whole viral RNA (1x to 5x LoD) serving as contrived positive samples.<s>272</s>   \n",
       "101                                                                                                                                                                                                                             100% (30/30)  30 nasopharyngeal swabs spiked with SARS-CoV-2 viral genomic RNA (1x to 5x LoD) serving as contrived positive samples.<s>273</s>   \n",
       "102                                                                                                                                                                                    96% (48/50)  50 retrospective collected clinical nasopharyngeal swabs spiked with quantified genomic RNA of SARS- CoV-2 (1x to 5x LoD) serving as contrived positive samples.<s>276</s>   \n",
       "103                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "104                                                                                                                                                                                                                                                                                                          BALF: 81% Throat Swab: 91.2% RNA: 97.1% Combined: 88.1%<s>283</s>   \n",
       "105                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "106                                                                                                                                                                                                                                                                                                                                                             96%<s>292</s>    \n",
       "108                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "109                                                                                                                                                                                                                                                                                                                                                            100% <s>297</s>   \n",
       "110                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "111                                                                                                                                                                                                                                                                                                                                                             >96%<s>302</s>   \n",
       "112                                                                                                                                                                                                                                                                                                                                   Reported enhanced sensitivity.<s>304</s>   \n",
       "113                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "114                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "115                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "116                                                                                                                                                                                                                                                                                                                                                                <s>100%</s>   \n",
       "117                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "118                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "119                                                                                                                                                                                                                                                                                                                                                                       100%   \n",
       "120                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "121                                                                                                                                                                                                                                                                                                                                                               100% (44/44)   \n",
       "122                                                                                                                                                                                                                                                                                                                                                              100% (76/76)    \n",
       "124                                                                                                                                                                                                                                                                                                                                            100% in both sputum and NP swab   \n",
       "125                                                                                                                                                                                                                                                                                                                                                               100% (30/30)   \n",
       "126                                                                                                                                                                                                                                                                                                 100% for nasopharyngeal and oropharyngeal swabs (30/30) as well as saliva    \n",
       "128                                                                                                                                                                                                                                                                                                                                                               100% (31/31)   \n",
       "129                                                                                                                                                                                                                                                                                                                                                               100% (30/30)   \n",
       "130                                                                                                                                                                                                                                                                                                                                                                98% (62/63)   \n",
       "131                                                                                                                                                                                                                                                                                                         100% for nasopharyngeal, oropharyngeal and sputum samples (40/40)    \n",
       "133                                                                                                                                                                                                                                    100% (38/38 using samples extracted with Abnova Precipitor; 34/34 using samples extracted with Zymo Research Kit <s>on the IndiMag)</s>   \n",
       "134                                                                                                                                                                                                                                                                                                                                                                97% (29/30)   \n",
       "135                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "136                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "137                                                                                                                                                                                                                                                                                                                                                              100% (31/31)    \n",
       "139                                                                                                                                                                                                                                                                                                                  100% (20/20) for both nasopharyngeal and sputum specimens   \n",
       "140                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "141                                                                                                                                                                                                                                                                                                          Undergoing validation by joint venture Fujian Fujun Gene Biotech.   \n",
       "142                                                                                                                                                                                                                                                                                                                                                                 (no info)    \n",
       "144                                                                                                                                                                                                                                                                           Not stated but described to have high sensitivity compared to metagenomic approaches.<s>342</s>    \n",
       "146                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "147                                                                                                                                                                                                                                                                                                           Stated to be high but with no accompanying statistics.<s>347</s>   \n",
       "148                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "149                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "150                                                                                                                                                                       100% (30/30) Evaluated using 10 positive clinical samples and 20 low positive contrived samples (1x–2x LOD) from retrospective nasopharyngeal swab clinical specimens in transport medium.<s>355</s>   \n",
       "152                                                                                                                                                                                                                100% (17/17)  65 fresh nasopharyngeal swab specimens from 3 clinical site2s were compared with one of two brands of established comparator assay.<s>291</s>   \n",
       "153                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "154                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "155                                                                                                                                                                                                 100% (35/35)  35 oropharyngeal swabs from healthy individuals spiked with iAMP COVID-19 Sample Buffer Mix (2x to 10x LoD) serving as contrived positive samples.<s>363</s>   \n",
       "156                                                                                                                                                                                                                                                                                                                  100% (20/20) for both nasopharyngeal and sputum specimens   \n",
       "157                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "158                                                                                                                                                                                                                                                                                                                                                              100% (30/30)    \n",
       "160                                                                                                                                            95% (Using contrived reference samples and clinical samples from US patients, including 36 patients with COVID-19 infection and 42 patients with other viral respiratory infections)  (Press release:<s>371</s> Study:<s>35</s>   \n",
       "161                                                                                                                                                                                                                                                                                                                                  Higher sensitivity than <s>rapid test</s>   \n",
       "162                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "163                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "164                                                                                                                                                                                                                                                                                                                                                               100% (47/47)   \n",
       "165                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "166                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "167                                                                                                                                                                                                                                                                                                                                                              98.2% (54/55)   \n",
       "168                                                                                                                                                                                                                                                                                                                                            100% in Serum, 83.33% in Plasma   \n",
       "169                                                                                                                                                                                                                                          96.6% (131/137)  Evaluated using 137 specimens from confirmed COVID-19 patients and 209 specimens from healthy <s>individuals</s>   \n",
       "170                                                                                                                                                                                                                                                                                                                                                             88.0% (95/108)   \n",
       "171                                                                                                                                                                                                                              65.5% (76/116, Day 0-6 post-PCR confirmation); 88.1% (52/59, Day 7-13 post-PCR confirmation); 100% (29/29, >/= 14 days post-PCR confirmation)   \n",
       "172                                                                                                                                                                                                                                                                                                                                     98% at days 14-21 <s>388</s><s>389</s>   \n",
       "173                                                                                                                                                                                                                                                                83.3% (30/36)  Tested with 36 samples from patients confirmed to be SARS-CoV-2 positive with PCR.<s>391</s>   \n",
       "174                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "175                                                                                                                                                                                                                                                                                                                                                               <s>97.4%</s>   \n",
       "176                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "177                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "178                                                                                                                                                                                                                                                                                                                  IgM kit - 96.6% (29/30) IgG kit - 96.6% (29/30)<s>396</s>   \n",
       "179                                                                                                                                                             Differs across different durations from symptom onset <5 days: IgA – 3.3% (1/30); IgG – 10% (3/30)  5-10 days: IgA – 15.4% (2/13); IgG – 53.8% (7/13)  10-21 days: IgA – 60% (3/5); IgG – 100% (5/5)<s>399</s>   \n",
       "180                                                                                                                                                                                                                                                                                                               Sensitivity : 50% at Day 1-6, 91.7% at after Day 7<s>214</s>   \n",
       "181                                                                                                                                                                                                                                                                                                                                          Sensitivity: IgG 97.2%; IgM 87.9%   \n",
       "182                                                                                                                                                                                                                                                                                                                                                                       100%   \n",
       "183                                                                                                                                                                                                                                                                                 88.66%   352 positives out of 397 positive cases: - 256 both IgG and IgM - 72 IgG - 24 IgM   \n",
       "184                                                                                                                                                                                                                                                                                                                        Sensitivity: 81.5% for IgM, 100% for IgG<s>402</s>    \n",
       "186                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "187                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "188                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "189                                                                                                                                                                                                                                                                                                                                                                      96.9%   \n",
       "190                                                                                                                                                                                                                                                                                                                                                 IgM – 82% <s>IgG – 93%</s>   \n",
       "191                                                                                                                                                                                                                                                                                                                                                                 (no info)    \n",
       "193                                                                                                                                                                                                                                                                                                                      IgM – 87.01% (67/77)  IgG – 99.42% (75/77) <s>408</s>   \n",
       "194                                                                                                                                                                                                                                                                                                                           IgG – 100% (75/75) IgM – 91.8% (78/85)<s>409</s>   \n",
       "195                                                                                                                                                                                                                                                                                                                                                                 (no info)    \n",
       "197                                                                                                                                                                                                                                                                IgM test 85.0% (17/20) IgG test 100.0% (20/20)  Tested with the results compared to leading commercial PCR.   \n",
       "198                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "199                                                                                                                                                                                                                                    IgM test 87.9% (87/99) IgG test 97.2% (35/36)  Tested with 113 blood samples, and the results compared to RT-PCR or clinical diagnosis.   \n",
       "200                                                                                                                                                                                                                                                                                                                                      Sensitivity at 81.8% (27/33)<s>53</s>   \n",
       "201                                                                                                             IgM: 50% (3/6) IgG: 100% (6/6)  Tested with fresh, fingerstick blood samples prospectively-collected from 11 hospital workers in the United States (New York), 6 of whom were confirmed positive cases with results from FDA-authorised RT-PCR test.<s>416</s>   \n",
       "202                                                                                                                   93.8% (120/128)  Tested with 98 positive serum or plasma samples collected from individuals who tested positive with RT- PCR and 30 samples from hospitalised individuals who were clinically confirmed positive and exhibited severe symptoms.<s>61</s>   \n",
       "203                                                                                                                                                                                                                                                                                          75% (30/40) in first clinical trial, but suboptimal in the second trial<s>418</s>   \n",
       "204                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "205                                                                                                                                                                                                                                                                                                                                                                 (no info)    \n",
       "207                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "208                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "209                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "210                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "211                                                                                                                                                                                                                                                                                                                                                                 (no info)    \n",
       "213                                                                                                                                                                                                                                                                                                                                                                  (no info)   \n",
       "214                                                                                                                                                                                                                                 88.66% (352/397)   Evaluated using blood samples from 397 clinically confirmed (including PCR test) SARS-CoV-2-infected patients.<s>57</s>   \n",
       "215                                                                                                                                                                                                                                                                                                                                                          87.3% <s>428</s>    \n",
       "217                                                                                                                                                                                                                                                                                                                                                              73.8% (34/42)   \n",
       "218                                                                                                                                                                                  Sensitivity: 0% (Less than 3 days post symptom onset), 25% (3-7 days post symptoms onset), 86.36% (8-13 days post symptoms onset), 100% (more than 14 days post symptoms onset)<s>433</s>   \n",
       "219                                                                                                                                                                                                                                                                                                                                                         <s>92% (37/40)</s>   \n",
       "220                                                                                                                                                                                                                                                                                                                                                              87.5% (42/48)   \n",
       "221                                                                                                                                                                                                                                                       25% (Less than 5 days from diagnosis),  89.8% (6-14 days from diagnosis),  97.56% (More than 15 days from diagnosis)   \n",
       "222                                                                                                                                                                                                                                                                                                                                                            98.4% (184/187)   \n",
       "223                                                                                                                                                                                                                                                                                                               Sensitivity: 90% (27/30) Specificity: 100% (80/80)<s>443</s>   \n",
       "224                                                             At a cutoff inhibition of 20%: 100% (evaluated using 77 COVID-19 patients in Singapore), 98% (evaluated using 50 COVID-19 patients in Nanjing, China)   At a cutoff inhibition of 40%: 95.6% (evaluated using 77 COVID-19 patients in Singapore), 96% (evaluated using 50 COVID-19 patients in Nanjing, China)   \n",
       "\n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                   Specificity  \\\n",
       "0                          Chemical stability No positive signal detected for non-specific reactivity of oligonucleotides.  Cross-reactivity with other coronaviruses No reactivity with any of three assays for five coronaviruses: (HCoV) -229E, -NL63, -OC43,  -HKU1, and MERS-CoV  Tests of human clinical samples previously tested to contain respiratory viruses All tests returned negative results for all 75 samples.   \n",
       "1                          Chemical stability No positive signal detected for non-specific reactivity of oligonucleotides.  Cross-reactivity with other coronaviruses No reactivity with any of three assays for five coronaviruses: (HCoV) -229E, -NL63, -OC43,  -HKU1, and MERS-CoV  Tests of human clinical samples previously tested to contain respiratory viruses All tests returned negative results for all 75 samples.   \n",
       "2                                                                                                                                                                          Exclusivity  Negative results against all of these preparations: • RNA extracted from cultured viruses • RNA from retrospective human clinical specimens previously tested positive for other infections • RNA from control human clinical specimens   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                     (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                     (no info)   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                     (no info)   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                                                     (no info)   \n",
       "8                                                                                                                                                                                                                                                                                                Cross-reactivity with other respiratory viruses was tested and were all negative in reactivity with the two RdRp gene targets.   \n",
       "9                                                                                                                                                                                                                                                                                                                                                                                                           <s>100% (32/32)</s>   \n",
       "10                                                                                                                                                                                                                                                                                                                                                                                                                   100% (5/5)   \n",
       "11                                                                                                                                                                                                                                                                                                                                                                                                         <s>100% (32/32)</s>    \n",
       "13                                                                                                                                                                                                                                                                                                                                                                                                                   100% (5/5)   \n",
       "14                                                                                                                                                                                                                                                                                                                                                                                                  96.44% (379/393)<s>106</s>    \n",
       "16                                                                                                                                                                                                                                                                                                                                                                                                                         100%   \n",
       "17                                                                                                                                                                                                                                                                                                                                                                                                    100% (100/100) <s>111</s>   \n",
       "18                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "19   No specific statistics but claims to have ability to reliably and accurately differentiate between similar genetic sequences, in order to reduce the likelihood of a false-positive diagnosis.   Company shared that it achieves this by creating reactions that are far more specific than competing PCR technologies and 2.5 million times more effective in reducing amplification errors.<s>113,117</s> 100%<s>116</s>   \n",
       "20                                                                                                                                                                                                                                                                                                                                                                                                 35/35 for both S and E gene.   \n",
       "21                                                                                                                                                                                                                                                                                                                              100% (100/100)  100 nasopharyngeal swab clinical samples serve as negative controls.<s>126</s>    \n",
       "23                                                                                                                                                                                                                                                                                                                                                                                                                         100%   \n",
       "24                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "25                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "26                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "27                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "28                                                                                                                                                                                                                                                                                                                                       100% (35/35)  35 nasopharyngeal swab specimens serving as negative controls.<s>141</s>   \n",
       "29                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "30                                                                                                                                                                                                                                                                                                                                                                                                               100%<s>147</s>   \n",
       "31                                                                                                                                                                                                                                                                    94% (94/100) from upper respiratory specimens (nasopharyngeal/ oropharyngeal swabs)  97.87% (92/94) from lower respiratory specimens (sputum)  <s>150</s>   \n",
       "32                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "33                                                                                                                                                                                                                                                                100% for both upper and lower respiratory tract samples   Evaluated using 30 nasopharyngeal swabs and sputum specimens serving as negative controls<s>158</s>   \n",
       "34                                                                                                                                                                                                                                                                                                                                                100% (30/30)  30 nasopharyngeal swabs serving as negative controls.<s>162</s>   \n",
       "35                                                                                                                                                                                                                                                                                                                                                          100% (30/30)  30 nasopharyngeal swabs serving as negative controls.   \n",
       "36                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "37                                                                                                                                                                                                                                                                                                                                                                                                         <s>100% (64/64)</s>    \n",
       "39                                                                                                                                                                                                                                                                                                                              100% (66/66)  66 clinical nasopharyngeal swab specimens serving as negative controls.<s>174</s>   \n",
       "40                                                                                                                                                                                                                                                                                                                         100 (109/109)  109 remnant clinical nasopharyngeal specimens serving as negative controls.<s>177</s>   \n",
       "41                                                                                                                                                                                                                                                                                            100% (100/100)   50 nasopharyngeal swab specimens and 50 bronchoalveolar lavage specimens serving as negative controls.<s>179</s>   \n",
       "42                                                                                                                                                                                                                                                                                                                                     (100% (92/92)  92 nasopharyngeal swab specimens serving as negative controls.<s>182</s>    \n",
       "44                                                                                                                                                                                                                                                                                        100% (72/72)  72 presumed-negative nasopharyngeal/throat swab specimens from before Oct 2019 servings as negative controls.<s>185</s>   \n",
       "45                                                                                                                                                                                                                                                                                                       100% (31/31)  34 nasopharyngeal swabs serving as negative controls. 3 samples were invalidated and excluded.<s>187</s>   \n",
       "46                                                                                                                                                                                                                                                                  100% (56/56)  108 fresh nasopharyngeal swab specimens from 3 clinical sites were compared with one of two brands of established comparator assay.<s>191</s>   \n",
       "47                                                                                                                                                                                                                                                                                                                                       100% Clinically validated in the company's CLIA-certified lab in Richmond, California.   \n",
       "49                                                                                                                                                                                                                                                                                                                     100% (94/94)  94 oropharyngeal and nasopharyngeal swab specimens serving as negative controls.<s>196</s>   \n",
       "50                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "51                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)    \n",
       "53                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "54                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "55                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "56                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "57                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "58                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "59                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "60                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "61                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "62                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "63                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "64                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "65                                                                                                                                                                                                                                                                                                                                                                                                                 100% (10/10)   \n",
       "66                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "67                                                                                                                                                                                                                                                                                                                                                                                                                        95.9%   \n",
       "68                                                                                                                                                                                                                                                                                                                                                                                                                                \n",
       "69                                                                                                                                                                                                                                                                                                                                                                                   No cross-reactivity with 33 microorganisms   \n",
       "70                                                                                                                                                                                                                                                                                                                                                                                                               100% (279/279)   \n",
       "71                                                                                                                                                                                                                                                                                                94.87% (37/39, analysis done after Thermo MagMAX extraction); 95.00% (38/40, analysis done after QIAamp viral RNA extraction)   \n",
       "72                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "73                                                                                                                                                                                                                                                                                                                (Recombinant plasmids containing conserved ORF1ab genes was used to analyse the specificity and sensitivity.)   \n",
       "74                                                                                                                                                                                                                                                                                                                                                100% (30/30)  30 nasopharyngeal swabs serving as negative controls.<s>228</s>   \n",
       "75                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "76                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "77                                                                                                                                                                                                                  “This assay may have cross-reactivity with other coronavirus family members such as causative agents of the Middle East Respiratory Syndrome (MERS) or Severe Acute Respiratory Syndrome (SARS).”<s>236</s>   \n",
       "79                                                                                                                                                                                                                                                                                                                                                                                                             >99.9%<s>240</s>   \n",
       "80                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "81                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "82                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "83                                                                                                                                                                                                                                                                                            100% (60/60)  30 nasopharyngeal swab specimens and 30 bronchoalveolar lavage specimens were used as negative controls.<s>245</s>    \n",
       "85                                                                                                                                                                                                                                                    100% (104/104)  117 respiratory specimens collected from 46 subjects tested with two analytically validated real-time RT-PCR assays for N4 and N5 gene targets.<s>247</s>   \n",
       "86                                                                                                                                                                                                                                                                                                                                                                                                                         100%   \n",
       "87                                                                                                                                                                                                                                                                                                                                                                                         Specificity: 100% (30/30)<s>251</s>    \n",
       "89                                                                                                                                                                                                                                                                                                                                                                                                                    (no info)   \n",
       "90                                                                                                                                                                                                                                                                                                                                                100% (30/30)  30 nasopharyngeal swabs serving as negative controls.<s>254</s>   \n",
       "91                                                                                                                                                                                                                                                                                                                Reported 100%.<s>255</s> Tested at the Carlos III Health Institute with 80 samples (unclear of sample types).   \n",
       "92                                                                                                                                                                                                                                                                                                                     100% (30/30)  30 oropharyngeal and nasopharyngeal swab specimens serving as negative controls.<s>259</s>   \n",
       "93                                                                                                                                                                                                                                         (29/29)  For the easyMAG extraction, 30 individual sputum samples were used but 1 was invalidated, leaving 29 samples. Testing was also done with eMAG and EZ1 extraction.<s>260</s>   \n",
       "95                                                                                                                                                                                                                                                                                                                               100% (82/82  82 clinical nasopharyngeal swab specimens serving as negative controls.<s>263</s>   \n",
       "96                                                                                                                                                                                                                                                                                                      100% (30/30)  30 retrospective collected clinical nasopharyngeal swab specimens serving as negative controls.<s>264</s>   \n",
       "97                                                                                                                                                                                                                                                100% (30/30)  15 nasopharyngeal and 15 oropharyngeal swab samples from suspected cases that tested negative had additional aliquot serving as 30 negative controls.<s>268</s>   \n",
       "98                                                                                                                                                                                                                                                                                                                                                 100% (30/30) 30 nasopharyngeal swabs serving as negative controls.<s>270</s>   \n",
       "100                                                                                                                                                                                                                                                                                                                                                100% (30/30)  30 oropharyngeal swabs serving as negative controls.<s>272</s>   \n",
       "101                                                                                                                                                                                                                                                                                                                                              96.7% (29/30)  30 nasopharyngeal swabs serving as negative controls.<s>273</s>   \n",
       "102                                                                                                                                                                                                                                                                                                     100% (29/29)  29 retrospective collected clinical nasopharyngeal swab specimens serving as negative controls.<s>276</s>   \n",
       "103                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "104                                                                                                                                                                                                                                                                                                                                                           BALF: 100% Throat Swab: 100% RNA: 96.2% Combined: 99.6%<s>283</s>   \n",
       "105                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "106                                                                                                                                                                                                                                                                                                                                                                                                                       100%    \n",
       "108                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "109                                                                                                                                                                                                                                                                                                                                                                                                             100% <s>297</s>   \n",
       "110                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "111                                                                                                                                                                                                                                                                                                                                                                                                                         98%   \n",
       "112                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "113                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "114                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "115                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "116                                                                                                                                                                                                                                                                                                                                                                                                                 <s>100%</s>   \n",
       "117                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "118                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "119                                                                                                                                                                                                                                                                                                                                                                                                                        100%   \n",
       "120                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "121                                                                                                                                                                                                                                                                                                                                                                                                                100% (30/30)   \n",
       "122                                                                                                                                                                                                                                                                                                                                                                                                               100% (50/50)    \n",
       "124                                                                                                                                                                                                                                                                                                                                                                                             100% in both sputum and NP swab   \n",
       "125                                                                                                                                                                                                                                                                                                                                                                                                                100% (30/30)   \n",
       "126                                                                                                                                                                                                                                                                                                                                                  100% for nasopharyngeal and oropharyngeal swabs (30/30) as well as saliva    \n",
       "128                                                                                                                                                                                                                                                                                                                                                                                                                100% (40/40)   \n",
       "129                                                                                                                                                                                                                                                                                                                                                                                                                   (No info)   \n",
       "130                                                                                                                                                                                                                                                                                                                                                                                                                 93% (63/67)   \n",
       "131                                                                                                                                                                                                                                                                                                                                                          100% for nasopharyngeal, oropharyngeal and sputum samples (40/40)    \n",
       "133                                                                                                                                                                                                                                                                                            100% (30/30 using samples extracted with Abnova Precipitor; 48/48 using samples extracted with Zymo Research Kit on the IndiMag)   \n",
       "134                                                                                                                                                                                                                                                                                                                                                                                                                100% (30/30)   \n",
       "135                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "136                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "137                                                                                                                                                                                                                                                                                                                                                                                                               100% (11/11)    \n",
       "139                                                                                                                                                                                                                                                                                                                                                                   100% (40/40) for both nasopharyngeal and sputum specimens   \n",
       "140                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "141                                                                                                                                                                                                                                                                                                                                                           Undergoing validation by joint venture Fujian Fujun Gene Biotech.   \n",
       "142                                                                                                                                                                                                                                                                                                                                                                                                                  (no info)    \n",
       "144                                                                                                                                                                                                                                                                                                                                                                                                                  (no info)    \n",
       "146                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "147                                                                                                                                                                                                                                                                                                                                                            Stated to be high but with no accompanying statistics.<s>347</s>   \n",
       "148                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "149                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "150                                                                                                                                                                                                                                                                                   100% (30/30) Evaluated using 30 negative samples from retrospective nasopharyngeal swab clinical specimens in transport medium.<s>355</s>   \n",
       "152                                                                                                                                                                                                                                                                97.9% (47/48)  65 fresh nasopharyngeal swab specimens from 3 clinical site2s were compared with one of two brands of established comparator assay.<s>291</s>   \n",
       "153                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "154                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "155                                                                                                                                                                                                                                                                                                                       100% (40/40)  40 oropharyngeal swabs from healthy individuals serving as negative controls.<s>363</s>   \n",
       "156                                                                                                                                                                                                                                                                                                                                                                   100% (25/25) for both nasopharyngeal and sputum specimens   \n",
       "157                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "158                                                                                                                                                                                                                                                                                                                                                                                                                       100%    \n",
       "160                                                                                                                                                                               Specificity: 100% (Using contrived reference samples and clinical samples from US patients, including 36 patients with COVID-19 infection and 42 patients with other viral respiratory infections)   (Press release:<s>371</s>Study:<s>35</s>   \n",
       "161                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "162                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "163                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "164                                                                                                                                                                                                                                                                                                                                                                                                                 80% (84/96)   \n",
       "165                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "166                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "167                                                                                                                                                                                                                                                                                                                                                                                                                100% (50/50)   \n",
       "168                                                                                                                                                                                                                                                                                                                                                                                             99.51% in Serum, 100% in Plasma   \n",
       "169                                                                                                                                                                                                                                                                                                  95.2% (199/209)  Evaluated using 137 specimens from confirmed COVID-19 patients and 209 specimens from healthy individuals   \n",
       "170                                                                                                                                                                                                                                                                      99.6% (Blood donors), 98.7% (Diverse group of viral pathogens), 96.7% (Respiratory infections), 97.1% (Other study with <s>respiratory infections)</s>   \n",
       "171                                                                                                                                                                                                                                                                                                                                                                                                          99.81% (5262/5272)   \n",
       "172                                                                                                                                                                                                                                                                                                                                                                                                               98%<s>388</s>   \n",
       "173                                                                                                                                                                                                                                                                                                  100% (400/400)  400 presumed SARS-CoV-2 negative samples from healthy blood donors serving as negative controls.<s>391</s>   \n",
       "174                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "175                                                                                                                                                                                                                                                                                                                                                                                                                       96.2%   \n",
       "176                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "177                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "178                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "179                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "180                                                                                                                                                                                                                                                                                                                                                                                               Specificity : 97.5%<s>214</s>   \n",
       "181                                                                                                                                                                                                                                                                                                                                                                                             Specificity: IgG 100%; IgM 100%   \n",
       "182                                                                                                                                                                                                                                                                                                                                                                                                                               \n",
       "183                                                                                                                                                                                                                                                                                                                                    90.63%  12 positives out of 128 negative controls: - 1 both IgG and IgM - 1 IgG - 10 IgM   \n",
       "184                                                                                                                                                                                                                                                                                                                                                                        Specificity: 88.1% for IgM, 92.8% for IgG<s>402</s>    \n",
       "186                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "187                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "188                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "189                                                                                                                                                                                                                                                                                                                                                                                                                       99.4%   \n",
       "190                                                                                                                                                                                                                                                                                                                                                                                                       IgM – 97% IgG – 97.5%   \n",
       "191                                                                                                                                                                                                                                                                                                                                                                                                                  (no info)    \n",
       "193                                                                                                                                                                                                                                                                                                                                                                                             IgM – 98.89% (89/90) <s>408</s>   \n",
       "194                                                                                                                                                                                                                                                                                                                                                                      IgG – 99.5% (369/371); IgM – 99.2% (368/371)<s>409</s>   \n",
       "195                                                                                                                                                                                                                                                                                                                                                                                                                  (no info)    \n",
       "197                                                                                                                                                                                                                                                                                                                  IgM test 96.0% (48/50) IgG test 98.0% (49/50)  Tested with the results compared to leading commercial PCR.   \n",
       "198                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "199                                                                                                                                                                                                                                                                                       IgM test 100% (14/14) IgG test 100% (14/14)  Tested with 113 blood samples, and the results compared to RT-PCR or clinical diagnosis.   \n",
       "200                                                                                                                                                                                                                                                                                                                                                                                                Specificity at 96.7% (29/30)   \n",
       "201                                                                                                                                                                   IgM: 100% (6/6) IgG: 100% (6/6)  Tested with fresh, fingerstick blood samples prospectively-collected from 11 hospital workers in the United States (New York), 5 of whom were confirmed negative with results from FDA-authorised RT-PCR test.<s>416</s>   \n",
       "202                                                                                                                                                                                                                                                                                                                   96.0% (240/250)  Tested with negative serum or plasma samples collected prior to September 2019.<s>61</s>   \n",
       "203                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "204                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "205                                                                                                                                                                                                                                                                                                                                                                                                                  (no info)    \n",
       "207                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "208                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "209                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "210                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "211                                                                                                                                                                                                                                                                                                                                                                                                                  (no info)    \n",
       "213                                                                                                                                                                                                                                                                                                                                                                                                                   (no info)   \n",
       "214                                                                                                                                                                                                                                                                                                                        90.63% (116/128)   Evaluated using blood samples from 128 non-SARS-CoV-2-infected patients.<s>57</s>   \n",
       "215                                                                                                                                                                                                                                                                                                                                                                                                            100% <s>428</s>    \n",
       "217                                                                                                                                                                                                                                                                                                                                                                                                              100% (153/153)   \n",
       "218                                                                                                                                                                                                                                                                                                                                                                                         Specificity: 100% (73/73)<s>433</s>   \n",
       "219                                                                                                                                                                                                                                                                                                                                                                                                         <s>100% (74/74)</s>   \n",
       "220                                                                                                                                                                                                                                                                                                                                                                                                              100% (407/407)   \n",
       "221                                                                                                                                                                                                                                                                                                                                                                                                           99.3% (1082/1090)   \n",
       "222                                                                                                                                                                                                                                                                                                                                                                                                             99.8% (623/624)   \n",
       "223                                                                                                                                                                                                                                                                                                                                                 IgG – 99% IgA – approximately 90%, not recommended for screening <s>444</s>   \n",
       "224                                                                                                                                                                                                                                                                                                                                           100% (75/75 in cohort done in Singapore; 50/50 in cohort done in Nanjing, China)    \n",
       "\n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Availability  \\\n",
       "0                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Available • SARS-CoV genomic RNA as positive control.   \n",
       "1                                                                                                                                                                                                                                                                                                                                                         Available • SARS-CoV genomic RNA as positive control.  • Synthetic control RNA for SARS-CoV-2 E gene assay is available via EVAg.  • Synthetic control for SARS-CoV-2 RdRp is expected to be available via EVAg from Jan 21st onward.   \n",
       "2                                                                                                                                                                                                                                                                                                                                                                                                                                   Available • Positive control (Available from HKU) Primers and probes: • HKU-ORF1b-nsp14F • HKU- ORF1b-nsp14R • HKU-ORF1b-nsp141P • HKU-NF • HKU-NR • HKU-NP   \n",
       "4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Available   \n",
       "5                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Available Primers: • NbatCoV_F1  • NbatCoV_R1   \n",
       "6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Available Primers and probes: • NIID_2019-nCOV_N_F2 • NIID_2019-nCOV_N_R2 • NIID_2019-nCOV_N_P2   \n",
       "7                                                                                                                                                                                                                                                                                                                                                                                   Available Primers and probes: • 2019-nCOV_N1_F • 2019-nCOV_N1_R • 2019-nCOV_N1_P • 2019-nCOV_N2_F • 2019-nCOV_N2_R • 2019-nCOV_N2_P • 2019-nCOV_N3_F • 2019-nCOV_N3_R • 2019-nCOV_N3_P • RP_F • RP_R • RP_P   \n",
       "8                                                                                                                                                                                                                                                                                                                                                                                     Available Primers and probes: • nCoV_IP2-12669Fw • nCoV_IP2-12759Rv • nCoV_IP2-12696bProbe(+) • nCoV_IP4-14059Fw • nCoV_IP4-14146Rv • nCoV_IP4-14084Probe(+) • E_Sarbeco_F1 • E_Sarbeco_R2 • E_Sarbeco_P1   \n",
       "9                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Available.  EUA issued on 16th April 2020.   \n",
       "10                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Available.  EUA issued on 16th April 2020.   \n",
       "11                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Available.  EUA issued on 16th April 2020.    \n",
       "13                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Available.  EUA issued on 16th April 2020.   \n",
       "14                                                                                                                                                                                                                                                                                                     Available.  EUA issued on 17th April 2020   Received CE mark on 17 March 2020.   Received emergency approval from the National Medical Products Administration (NMPA) on 27 March 2020.   Approved for inclusion in the Australian Register of Therapeutic Goods on 8 May 2020<s>107</s>   \n",
       "16                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       FDA EUA issued on 29/04/2020<s>109</s>   \n",
       "17                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      FDA EUA issued on 29/04/2020 <s>111</s>   \n",
       "18                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Available as scientific research product – does not require registration<s>112</s>   \n",
       "19                                                                                                                                                                                                                                                                                                                                                                                                                                    Commercially available for sale on 10 Feb 2020.<s>114</s> Received CE Mark 24 Feb 2020.<s>118</s> Obtained EUA approval from US FDA 3 Apr 2020.<s>115</s>   \n",
       "20                                                                                                                                                                                                                                                                                                                                                                                                                                                        Available FDA EUA issued on 22 April 2020  Received CE mark for IVD  HSA provisional authorisation approved on 15 May 2020 <s>121</s>   \n",
       "21                                                                                                                                                                                                                                                                                                                                                            Commercially available.   Obtained EUA approval from US FDA 13 Mar 2020.<s>125</s> CE Mark for IVD. Approved for inclusion on the Australia’s ARTG on 20 March 2020.  Date of HSA Provisional Authorisation: 19/03/2020<s>127</s>   \n",
       "23                                                                                                                                                                                                                                                                                                                                                                                                          Available but not for commercial sale yet.   Provisional authorization for clinical use from Singapore's HSA.<s>4,129</s> Date of Provisional Authorisation from HSA: 30 April 2020   \n",
       "24                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Developed as of 3 Feb 2020.   CE approved <s>132</s>   \n",
       "25                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Commercially available.   \n",
       "26                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Developed.  Undergoing testing. Emergency use approval submitted to China’s NMPA on 27 Jan 2020   \n",
       "27                                                                                                                                                               Prototype developed.  Acu-Corona 2.0 obtained Provisional Authorisation from Singapore Health Sciences Authority on 31 March 2020. Acu-Corona 3.0 obtained Provisional Authorisation from HSA on 14 April 2020. (HSA authorisation for Acu-Corona 2.0: <s>138</s>HSA authorisation for Acu-Corona 3.0:<s>139</s> Currently CE-IVD pending and approved for research only, seeking approval from US Food and Drug Authorisation   \n",
       "28                                                                                                                                                                                                                                                                                                                                                                                                        Commercially available.   Obtained EUA approval from US FDA 21 Mar 2020.<s>27</s> Approved for inclusion on the Australian Register of Therapeutic Goods on 22 March 2020. <s>143</s>   \n",
       "29                                                                                                                                                                                                                                                                                                                                                                                                                                Available. Orders for the kit have been placed from World Health Organisation, national health authorities and laboratories in about 60 countries. <s>144</s>   \n",
       "30                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Commercially available.   Received CE Mark Mar 2020.<s>147</s> Approved for inclusion in Australia’s ARTG.<s>81</s>   \n",
       "31                                                                                                                                                                                                                Commercially available.  Obtained EUA approval from Korean FDA 12 Feb 2020.<s>151,152</s> Product already has CE Mark for IVD.    Obtained HSA provisional approval on 2 April 2020, supplied through All Eights (Singapore) Pte Ltd. <s>153</s> Approved for inclusion on the Australian Register of Therapeutic Goods on 27 March 2020 <s>143</s> FDA EUA issued 21/04/2020   \n",
       "32                                                                                                                                                                                                                                                                                                                                                                                                                                         Commercially available.   Received CE Mark 17 Mar 2020.   Submitted to US FDA for EUA approval.  Has provisional authorisation from Singapore’s HSA.   \n",
       "33                                                                                                                                                                                                                                                                                                                                                                            Available.   Received CE Mark for IVD.  Obtained EUA approval from US FDA on 18 April 2020. <s>158</s> Date of Provisional Authorisation from HSA: 14 May 2020, supplied through SPD Scientific Pte Ltd<s>159</s>   \n",
       "34                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Commercially available.   Obtained EUA approval from US FDA 23 Mar 2020.   \n",
       "35                                                                                                                                                                                                                                                                                                                                                                                                                                                   Commercially available.   Obtained EUA approval from US FDA 27 Mar 2020.  Date of Provisional Authorisation from HSA: 8 May 2020<s>166</s>   \n",
       "36                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Commercially available.  Obtained EUA approval from US FDA 10 Mar 2020 for lot number #143503 and #143764.   \n",
       "37                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Submitted to US FDA for EUA Approval.  Commercially Available<s>169</s> FDA EUA issued on 15/5/2020<s>170</s>   \n",
       "39                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Commercially available.   Obtained EUA approval from US FDA 24 Mar 2020.<s>173</s>   \n",
       "40                                                                                                                                                                                                                                                                                                                                                                                                                Commercially available.  Obtained EUA approval from US FDA 16 Mar 2020.   Approved for inclusion into the Australian Register of Therapeutic Goods on 20 March 2020.<s>81</s>   \n",
       "41                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Commercially available.   Obtained EUA approval from US FDA 16 Mar 2020.   \n",
       "42                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Commercially available.   Obtained EUA approval from US FDA 17 Mar 2020.    \n",
       "44                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Commercially available.   Obtained EUA approval from US FDA 17 Mar 2020.   \n",
       "45                                                                                                                                                                                                                                                                                                                                                    Commercially available.    Obtained EUA approval from US FDA 18 Mar 2020.  Approved for inclusion on the Australian Register of Therapeutic Goods on 17 April 2020.<s>143</s>Date of HAS Provisional Authorisation: 01/04/2020 <s>188</s>   \n",
       "46                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Commercially available.   Obtained EUA approval from US FDA 19 Mar 2020.   \n",
       "47                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Commercially available. Received CE Mark for IVD Mar 2020.   Obtained EUA approval from US FDA 8 Apr 2020.<s>194</s>   \n",
       "49                                                                                                                                                                                Commercially available.   Obtained EUA approval from US FDA 24 Mar 2020.  EUA amendment on April 1st to add an additional nucleic acid extraction method which utilizes the chemagic Viral DNA/RNA 300 Kit H96 on a new extraction platform, the chemagic 360 equipped with the chemagic Rod Head Set 96; and (2) make other minor changes and edits to the IFU labeling was granted on 01/04/2020 <s>197</s>   \n",
       "50                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Commercially available.   Received CE Mark 7 Apr 2020.  Submitted to US FDA for EUA approval.   \n",
       "51                                                                                                                                                                                                                                                                               Available as an emergency use test in Finland and France, set up for routine use in main clinical laboratories in Finland with capacity to test up to 4000 samples a day.<s>200</s> In the process for obtaining emergency use authorisation in Sweden and the UK. In the process for <s>obtaining CE-IVD.</s>   \n",
       "53                                                                                                                                                                                                                                                                                                                                                                                                                                                    Available.  CE-IVD marked.<s>201</s> Approved for inclusion into the Australian Register of Therapeutic Goods on 13 April 2020.<s>143</s>   \n",
       "54                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Available.  Approved for inclusion into the Australian Register of Therapeutic Goods on 22 March 2020.<s>143</s>   \n",
       "55                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Date of Provisional Authorisation by HSA: 05/03/2020   \n",
       "56                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Date of Provisional Authorisation by HSA: <s>10/03/2020</s>   \n",
       "57                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Date of Provisional Authorisation by HSA: 24/03/2020   \n",
       "58                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Date of Provisional Authorisation by HSA: 19/03/2020   \n",
       "59                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Date of Provisional Authorisation by HSA: 18/02/2020   \n",
       "60                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Date of Provisional Authorisation by HSA: 15/04/2020   \n",
       "61                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Date of Provisional Authorisation by HAS: 26/03/2020   \n",
       "62                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Provisional Authorisation from HSA: 20/04/2020   \n",
       "63                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Date of Provisional Authorisation from HSA: 30 April 2020   \n",
       "64                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Date of Provisional Authorisation from HSA: 23/04/2020   \n",
       "65                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  FDA EUA issued on 20/4/2020   \n",
       "66                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Approved for inclusion on the Australian Register of Therapeutic Goods on 23 April 2020.   \n",
       "67                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Approved for inclusion on the Australian Register of Therapeutic Goods on 24 April 2020.   \n",
       "68                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  CE approved   \n",
       "69                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 FDA EUA issued on 27/04/2020   \n",
       "70                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     FDA EUA issued on 1 May 2020<s>220</s> Date of Provisional Authorisation from HSA: 14 May 2020<s>221</s>   \n",
       "71                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      FDA EUA issued on 1 May 2020 <s>223</s>   \n",
       "72                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Available (non-commercially) to 9 labs across the UK.   \n",
       "73                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Clinical trials phase.   \n",
       "74                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Commercially available.   Obtained EUA approval from US FDA 3 Apr 2020.   \n",
       "75                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Commercially available.   \n",
       "76                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Commercially available.  Date of Provisional Authorisation from HSA: 4 May 2020<s>234</s>   \n",
       "77                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Commercially available for RUO.    \n",
       "79                                                                                                                                                                                                                                                                                                                                                                                                                                 Available.   Received CE Mark for IVD for the version adapted for the BD MAX™ System.<s>239</s> Approved for inclusion on Australia’s ARTG on 21 March 2020.   \n",
       "80                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Available   \n",
       "81                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Available.   \n",
       "82                                                                                                                                                                                                                                                                                                                                                                                                                            Commercially available.   Obtained EUA approval from Korean CDC 4 Feb 2020.<s>151,242</s> Approved for inclusion on the Australian Register of Therapeutic Goods.   \n",
       "83                                                                                                                                                                                                                                                                                                        Commercially available.  Received CE Mark for IVD 26 Mar 2020.<s>246</s> Obtained EUA approval from US FDA 13 Mar 2020.<s>244</s> Obtained HSA provisional approval on 20 March 2020. Approved for inclusion on the Australian Register of Therapeutic Goods on <s>24 March 2020</s>.   \n",
       "85                                                                                                                                                                                                                                         Available to laboratories designated by CDC as qualified, and in the US, certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity tests. Available to qualified international laboratories.  Not available to U.S. hospitals or other primary care settings.   Obtained EUA approval from US FDA 4 Feb 2020.   \n",
       "86                                                                                                                                                                                                                                                                                                                                                                                                                              Commercially available.   Obtained EUA approval from Korean CDC 27 Feb 2020.<s>151,152</s> Received CE Mark for IVD.   FDA EUA issued on 21 May 2020 <s>250</s>   \n",
       "87                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Available. Obtained EUA approval from Korean CDC 27 Feb 2020.<s>151,152</s> FDA EUA issued on 23/04/2020   \n",
       "89                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Commercially available.  Obtained EUA approval from US FDA 3 Mar 2020 for lot number #0000500383.   \n",
       "90                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Commercially available.   Obtained EUA approval from US FDA 3 Apr 2020.   \n",
       "91                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Available.  Received CE Mark 6 Mar 2020.<s>256</s>   \n",
       "92                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Commercially available.   Obtained EUA approval from US FDA 25 Mar 2020.<s>257</s>   \n",
       "93                                                                                                                                                                                                                                                                                                                                                                          Available.   Obtained EUA approval from US FDA  for use in Wadsworth Center, New York State Public Department of Health, and the New York City Department of Health and Mental Hygiene, Public Health Laboratories.   \n",
       "95                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Commercially available.   Obtained EUA approval from US FDA 30 Mar 2020.<s>261</s>   \n",
       "96                                                                                                                                                                                                                                                                                                                                                                                                                   Commercially available.   Obtained EUA approval from US FDA 2 Apr 2020.  Approved for inclusion on the Australian Register of Therapeutic Goods on 17 April 2020.<s>81</s>   \n",
       "97                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Commercially available.   Received CE Mark in Mar 2020.<s>267</s> Obtained EUA approval from US FDA 15 Apr 2020.   \n",
       "98                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Commercially available. Obtained EUA approval from US FDA 1 Apr 2020.   \n",
       "100                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Commercially available.   Obtained EUA approval from US FDA 6 Apr 2020.   \n",
       "101                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Commercially available.   Obtained EUA approval from US FDA 7 Apr 2020.   \n",
       "102                                                                                                                                                                                                                                                                                                                                                                                                                                                   Commercially available.   Obtained EUA approval from US FDA 8 Apr 2020.  Date of Provisional Authorisation from HSA: 6 May 2020<s>277</s>   \n",
       "103                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             In development.   \n",
       "104                                                                                                           Commercially available.   Received CE Mark for IVD 2 Mar 2020.<s>284</s> BGI is also engaged with relevant organizations in Hong Kong, Taiwan, Brunei, Thailand, Nigeria, South Africa, to supply the test kits.<s>279</s> Passed emergency approval procedure of China’s NMPA.  Obtained EUA approval from US FDA 27 Mar 2020.<s>280,281</s> Approved for inclusion on Australia’s ARTG on 10 April 2020.  Date of Provisional Authorisation from HSA:  24 April 2020 <s>285</s>   \n",
       "105                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Available.  Approved by China’s NMPA.   \n",
       "106                                                                                                                                                                                                                                                                                                                                                                                                                                                      Commercially available.   Received CE Mark for IVD 17 Feb 2020.<s>293,294</s> Obtained EUA approval from US FDA 20 Mar 2020.<s>290</s>   \n",
       "108                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Available. Reportedly being used in China in over 30 hospitals, 16 local CDC offices, and 8 airports.   \n",
       "109                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Available.   Approved by the Indian Council of Medical Research for coronavirus testing in India on 4 April 2020.<s>298</s>   \n",
       "110                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Developed. Currently seeking collaborators to perform clinical tests in China and the US.<s>299</s>   \n",
       "111                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Available.  Received CE Mark 6 Mar 2020.<s>256</s>   \n",
       "112                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Commercially available.   EUA Submission Pending<s>306</s>   \n",
       "113                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             In development as of 6 Feb 2020   \n",
       "114                                                                                                                                                                                                                                                                                                                                                                                                                     Has been providing technical support for the scientific clinical prevention and control of the epidemic in Wuhan.  Passed emergency approval procedure of China’s NMPA.   \n",
       "115                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Approved for inclusion in the Australian Register of Therapeutic Goods on 5 May 2020   \n",
       "116                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Developed as of 3 Feb 2020.  Submitted to Korean CDC for EUA.   \n",
       "117                                                                                                                                                                                                                                                                                                                                                                                                                                                       Assumed developed as of 3 Feb 2020. Submitted to Korean CDC for EUA.  Received CE mark. Distributed to 20 <s>hospitals in Romania</s>   \n",
       "118                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 In development as of 6 Feb 2020.  <s>CE mark on March 3</s>   \n",
       "119                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    EUA application submitted to DFA, CE-IVD mark by mid may   \n",
       "120                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Date of Provisional Authorisation from HSA: 4 May 2020   \n",
       "121                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      FDA EUA issued on 5 May 2020<s>320</s>   \n",
       "122                                                                                                                                                                                                                                                                                                                                                                                                                                                                                FDA EUA issued on 6 May 2020<s>322</s> CE marked on 10 April 2020, validated in France since 11 March 2020.    \n",
       "124                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      FDA EUA issued on 6 May 2020<s>323</s>   \n",
       "125                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      FDA EUA issued on 7 May 2020<s>324</s>   \n",
       "126                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     FDA EUA issued on 7 May 2020<s>325</s>    \n",
       "128                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               FDA EUA issued on 11 May 2020   \n",
       "129                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               FDA EUA issued on 11 May 2020   \n",
       "130                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               FDA EUA issued on 13 May 2020   \n",
       "131                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              FDA EUA issued on 14 May 2020    \n",
       "133                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               FDA EUA issued on 15 May 2020   \n",
       "134                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               FDA EUA issued on 18 May 2020   \n",
       "135                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Approved for inclusion on the Australian Register of Therapeutic Goods on 19 May 2020.<s>333</s>   \n",
       "136                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             HSA provisional authorisation approved on 20 May 2020<s>334</s>   \n",
       "137                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              FDA EUA issued on 21 May 2020    \n",
       "139                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               FDA EUA issued on 21 May 2020   \n",
       "140                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Commercially available.   \n",
       "141                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Available.  Soon to be submitted to US FDA for EUA Approval.   \n",
       "142  Available. 28 January: US Centers for Disease Control and Prevention (CDC) releases nCoV genomes sequenced with nanopore sequencing 29 January: A paper in the Lancet characterised full-length genomes of 2019-nCoV patients using Nanopore sequencing, providing important information on possible virus origins and cell-binding receptors that is crucial for determining viral transmission capacity.  30 March: Singapore sequences its genome in less than 7 hours  14 April: In the UK, more than 600 genomes have been uploaded onto GISAID, using nanopore sequencing<s>340</s>.   \n",
       "144                                                                                                                                                                                                                                                                                               Available  3 February: First Belgian nCoV sample arrives in a lab at 5pm and using the ARTIC protocol, the sequence is completed by 9am.  3 March: The SARS-CoV2 virus from Scotland’s first case is sequenced in under 24 hours using nanopore sequencing and the ARTIC protocol<s>340</s>.    \n",
       "146                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Commercially available.   Obtained EUA approval from US FDA 27 Mar 2020.   \n",
       "147                                                                                                                                                                                                                                                                                                                                                                     Available for RUO since Jan 2020.   Provisional approval for IVD by Singapore’s HSA since Mar 2020.<s>346</s> Used for testing of swab samples from Singapore’s land, sea and air checkpoints since Mar 2020.<s>348</s>   \n",
       "148                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Expected to be commercially available in Q3 2020.   \n",
       "149                                                                                                                                                                                                                                                                              Available. In use by the Centers for Disease Control and Prevention (CDCP) in Shenzhen and Guangzhou with two more sets being delivered to the CDCP in Hubei and Nansha.<s>352</s> Device already has CE Mark and is qualified for export to all European Union (EU) countries as well as Hong Kong.<s>351</s>   \n",
       "150                                                                                                                                                                                                                                                                                                                                                                                                                       Commercially available. Obtained EUA approval from US FDA 30 Mar 2020.<s>354</s> Approved for inclusion in the Australian Register of Therapeutic Goods on 8 May 2020   \n",
       "152                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Commercially available.   Obtained EUA Approval 19 Mar 2020.<s>358</s>   \n",
       "153                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             In development.   \n",
       "154                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      In development using the template of existing CE-marked Flu and RSV respiratory tests.   \n",
       "155                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Commercially available.   Obtained EUA approval from US FDA 10 Apr 2020.   \n",
       "156                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               FDA EUA issued on 21 May 2020   \n",
       "157                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             In development.   \n",
       "158                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         Protocol published 14 Feb 2020.<s>368,369</s> FDA EUA issued on 6/5/2020<s>370</s>    \n",
       "160                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Developed.   Awaiting EUA from US FDA (pending clinical validation)   (Press release:<s>371</s>Study:<s>35</s>   \n",
       "161                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Available. Obtained <s>CE certification</s>   \n",
       "162                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Available. Obtained <s>CE certification</s>   \n",
       "163                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             In development.   \n",
       "164                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                FDA EUA issued on 8 May 2020   \n",
       "165                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             In development.   \n",
       "166                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Undergoing commercialisation as of 6 Feb 2020   \n",
       "167                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               FDA EUA issued on 14 May 2020   \n",
       "168                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      FDA EUA issued on 29/04/2020<s>379</s>   \n",
       "169                                                                                                                                                                                                                                                                                                                                                                                                                                                             Available.  CE-IVD marked. Approved for inclusion into the Australian Register of Therapeutic Goods on 27 March 2020.<s>143</s>   \n",
       "170                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     FDA EUA issued on 30/04/2020 <s>382</s>   \n",
       "171                                                                                                                                                                                                                                                                                                                                                                                   FDA EUA issued on 2 May 2020<s>383</s> Date of Provisional Authorisation from HSA: 5 May 2020 <s>384</s> Approved for inclusion on the Australian Register of Therapeutic Goods on 20 May 2020.<s>385</s>   \n",
       "172                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Developed. Ready for manufacture with CE mark.<s>388</s>   \n",
       "173                                                                                                                                                                                                                                                                                                                                                                                                                                                               Available.   Obtained EUA approval from US FDA 14 Apr 2020.  Date of Provisional Authorisation from HSA: 8 May 2020<s>393</s>   \n",
       "174                                                                                                                                                                                                                                                                                                                                                                                                                                      Developed.  Undergoing testing. Emergency use approval submitted to China’s NMPA on 28 Jan 2020.   Approved on 14 March for commercial use. <s>394</s>   \n",
       "175                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   CE-IVD marked. For in vitro diagnostic use.  FDA EUA issued on 24/04/2020   \n",
       "176                                                                                                                                                                                                                                                                                                                                                                                                   Developed.  Undergoing testing. Emergency use approval submitted to China’s NMPA on 2 Feb 2020.  Approved for inclusion on the Australian Register of Therapeutic Goods on 23 April 2020.   \n",
       "177                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Date of Provisional Authorisation by HSA: 09/04/2020   \n",
       "178                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Available. Received CE certification on 6 March 2020<s>396</s>   \n",
       "179                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Available.   Have been distributed in China and will soon be in Italy.   Received CE Mark 19 Feb 2020.<s>398</s>   \n",
       "180                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Availability: Approved for inclusion on the Australian Register of Therapeutic Goods on <s>28 April 2020.</s>   \n",
       "181                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Approved for inclusion on the Australian Register of Therapeutic Goods on 29 April 2020. Pending <s>FDA approval </s>   \n",
       "182                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Approved for inclusion on the Australian Register of Therapeutic Goods on 1 May 2020. <s>132</s>   \n",
       "183                                                                                                                                                                                                                                                                                                                                                                                                     Commercially available. More than half a million sold in China.  Received CE Mark for IVD 8 Mar 2020. Already sold in Italy.<s>58</s> Submitted to US FDA for EUA approval.<s>59,60</s>   \n",
       "184                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  (no info)    \n",
       "186                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Date of Provisional Authorisation by HSA: 20/03/2020   \n",
       "187                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Date of Provisional Authorisation by HSA: 20/03/2020  Date of approval for inclusion into ARTG: <s>26/03/2020</s>   \n",
       "188                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Date of Provisional Authorisation from HSA: 24/04/2020   \n",
       "189                                                                                                                                                                                                                                                                                                                                                                                                                                                              Available commercially.  Approved for inclusion into the Australian Register of Therapeutic Goods on 19 March 2020. <s>143</s>   \n",
       "190                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Available.   Approved for inclusion into the Australian Register of Therapeutic Goods on 31 March 2020. <s>143</s>   \n",
       "191                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Approved for inclusion on the Australian Register of Therapeutic Goods on 16 April 2020 <s>143</s>   \n",
       "193                                                                                                                                                                                                                                                                                                                                                                                                                                          Available.   Received CE mark.<s>408</s>Approved for inclusion into the Australian Register of Therapeutic Goods on <s>26 March 2020</s><s>143</s>   \n",
       "194                                                                                                                                                                                                                                                                                                                                                                                                                                                          Available.   Received CE mark. Approved for inclusion into the Australian Register of Therapeutic Goods on 4 April 2020.<s>143</s>   \n",
       "195                                                                                                                                                                                                                                       Available.   Approved by China’s NMPA.  Received CE Mark Mar 2020.<s>48,49</s> Obtained HSA provisional approval on 9 April 2020, supplied through SkyQuest Pte Ltd.<s>410</s> Approved for inclusion on the Australian Register of Therapeutic Goods on 25 March 2020.<s>143</s> Date of Provisional Authorisation from HSA: 27 April 2020<s>411</s>   \n",
       "197                                                                                                                                                                                                                                                                                                                                                                                                                                      Commercially available.   Received CE Mark for IVD.  Approved for inclusion in Australia’s ARTG.<s>81</s> Used in study by Lee et al (2020).<s>414</s>   \n",
       "198                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Available.   \n",
       "199                                                                                                                                                                                                                                                                                                                           Available.   Received CE Mark. Currently one of only a few tests used for coronavirus screening in China.  Commercialisation and distribution licensing deal with Aytu Bioscience for USA.   Approved for inclusion on Australia’s ARTG on 1 April 2020.<s>81</s>   \n",
       "200                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Available.   \n",
       "201                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Commercially available.   Obtained EUA approval from US FDA 14 Apr 2020.   \n",
       "202                                                                                                                                                                                                                                                                                                                                                                                                                                                   Commercially available.   Obtained EUA approval from US FDA 1 Apr 2020.  Approved for inclusion in Australia’s ARTG 31 Mar 2020.<s>81</s>   \n",
       "203                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Available non-commercially in China. <s>418</s>   \n",
       "204                                                                                                                                                                                                                                                                                                                                                                                                                                                               Commercially available.   Approved for inclusion into the Australian Register of Therapeutic Goods on 6 April 2020.<s>143</s>   \n",
       "205                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Date of Provisional Authorisation from HSA: 27 April 2020    \n",
       "207                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Date of Provisional Authorisation from HSA: 30 April 2020   \n",
       "208                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Approved for inclusion in the Australian Register of Therapeutic Goods on 11 May 2020   \n",
       "209                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Date of Provisional Authorisation from HSA: 8 May 2020   \n",
       "210                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Date of Provisional Authorisation from HSA: 14 May 2020, supplied by Trans Sahara Corporation Pte Ltd <s>424</s>   \n",
       "211                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Approved for inclusion into the Australian Register of Therapeutic Goods on 18 May 2020    \n",
       "213                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             HSA provisional authorisation approved on 18 May 2020<s>426</s>   \n",
       "214                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Available for use in China but not commercially   \n",
       "215                                                                                                                                                                                                                      Available commercially.  Approved by China’s NMPA.  Approved for inclusion on the Australian Register of Therapeutic Goods.<s>81</s> CE-IVD approved. <s>3</s> Partnered with Scanwell Health to be distributed in US, together with an accompanying smartphone app, pending US FDA EUA approval. <s>428</s> Date of Provisional Authorisation from HSA: 27 April 2020   \n",
       "217                                                                                                                                                                                                                                                                                                                                                                                                                                                                     HSA provisional authorisation approved on 15 May 2020.<s>429</s> CE marked.<s>430</s> Pending EUA approval from US FDA.   \n",
       "218                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Commercially available.  FDA EUA issued on 23/04/2020  Date of Provisional Authorisation from HSA: 30 April 2020 <s>434</s>   \n",
       "219                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Available.  EUA issued on 15th <s>April 2020.</s>   \n",
       "220                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 FDA EUA issued on 24/4/2020   \n",
       "221                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 FDA EUA issued on 24/4/2020   \n",
       "222                                                                                                                                                                                                                                                                                                                                                                                                                                                                     HSA provisional authorisation approved on 15 May 2020.<s>438</s> CE marked.<s>430</s> Pending EUA approval from US FDA.   \n",
       "223                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Commercially available. CE-marked since 25 March 2020 <s>262</s>   \n",
       "224                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Date of Provisional Authorisation from HSA: 8 May 2020<s>447</s>    \n",
       "\n",
       "1                                                                                                                                                                                                                                                                                                                             Turnaround  \\\n",
       "0                                                                                                                                                                                                                                                                                47 min 15 sec of cycle time (plus probe) for each assay   \n",
       "1                                                                                                                                                                                                                                                                                47 min 15 sec of cycle time (plus probe) for each assay   \n",
       "2                                                                                                                                                                                                                                                                                            28 min 40 sec of cycle time for each assay    \n",
       "4                                                                                                                                                                                                                                                                                                                              (no info)   \n",
       "5                                                                                                                                                                                                                                                                                                                  107 min of cycle time   \n",
       "6                                                                                                                                                                                                                                                                                  81 min for Nested RT-PCR  95 min for Real-time RT-PCR   \n",
       "7                                                                                                                                                                                                                                                                                             43 min 45 sec of cycle time for each assay   \n",
       "8                                                                                                                                                                                                                                                                                                    61 min of cycle time for each assay   \n",
       "9                                                                                                                                                                                                                                                                                                                              (no info)   \n",
       "10                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "11                                                                                                                                                                                                                                                                                                                            (no info)    \n",
       "13                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "14                                                                                                                                                                                                                                                                                                                       Within 2 Hours    \n",
       "16                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "17                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "18                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "19                                                                                                                                                                                                                                                                                                              Within 2 hours<s>116</s>   \n",
       "20                                                                                                                                                                                                                                                                                                                  2:15 hours<s>122</s>   \n",
       "21                                                                                                                                                                                                                                                                                                                          3 hr 30 min    \n",
       "23                                                                                                                                                                                                                                                                                                                            90 minutes   \n",
       "24                                                                                                                                                                                                                                                                                                                           1 hr 45 min   \n",
       "25                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "26                                                                                                                                                                                                                                                                                                                  30 minutes<s>136</s>   \n",
       "27                                                                                                                                                                                                                                                                                       Allows up to 94 patient samples <s>per 1.5h</s>   \n",
       "28                                                                                                                                                                                                                                                                                                                                45 min   \n",
       "29                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "30                                                                                                                                                                                                                                                                                                                        3 hr<s>146</s>   \n",
       "31                                                                                                                                                                                                                                                                                         1 hour 50 minutes after extraction <s>150</s>   \n",
       "32                                                                                                                                                                                                                                                                                                                                20 min   \n",
       "33                                                                                                                                                                                                                                                                                                          About 120 minutes <s>158</s>   \n",
       "34                                                                                                                                                                                                                                                                                                                                30 min   \n",
       "35                                                                                                                                                                                                                                                                                        4 hr  (2 hr 15 min to  2 hr 25 min cycle time)   \n",
       "36                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "37                                                                                                                                                                                                                                                                                                                            (no info)    \n",
       "39                                                                                                                                                                                                                                                                                                                                45 min   \n",
       "40                                                                                                                                                                                                                                                                                             Can generate results in 3 hours<s>178</s>   \n",
       "41                                                                                                                                                                                     Approximately 2-4 days from the date of pickup of a specimen for testing to the release of the test result to the health care provider <s>180</s>   \n",
       "42                                                                                                                                                                                                                                                                                                           45 min cycle time per gene    \n",
       "44                                                                                                                                                                                                                                                                                                       58 min 40 s cycle time per gene   \n",
       "45                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "46                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "47                                                                                                                                                                                                                                                                                                                            (no info)    \n",
       "49                                                                                                                                                                                                                                                                                               104 min 30s cycle time per gene target.   \n",
       "50                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "51                                                                                                                                                                                                                                                                                                             <s>48 samples in <3h</s>    \n",
       "53                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "54                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "55                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "56                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "57                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "58                                                                                                                                                                                                                                                                                                              Within 2 hours<s>207</s>   \n",
       "59                                                                                                                                                                                                                                                                                                                                         \n",
       "60                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "61                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "62                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "63                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "64                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "65                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "66                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "67                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "68                                                                                                                                                                                                                                                                                                                            10 minutes   \n",
       "69                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "70                                                                                                                                                                                                                                                                                                                        Around 45 mins   \n",
       "71                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "72                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "73                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "74                                                                                                                                                                                                                                                                                                  43 min 45 s cycle time for each gene   \n",
       "75                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "76                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "77                                                                                                                                                                                                                                                                                                                            (no info)    \n",
       "79                                                                                                                                                                                                                                                                                                                 120 minutes<s>240</s>   \n",
       "80                                                                                                                                                                                                                                                                                                                                < 3 hr   \n",
       "81                                                                                                                                                                                                                                                                                                                                < 3 hr   \n",
       "82                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "83                                                                                                                                                                                                                                                                                                    36 min cycle time per gene target    \n",
       "85                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "86                                                                                                                                                                                                                                                                                                                              2 hr PCR   \n",
       "87                                                                                                                                                                                                                                                                                                                    90 min <s>252</s>    \n",
       "89                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "90                                                                                                                                                                                                                                                                                                                                  2 hr   \n",
       "91                                                                                                                                                                                                                                                                                                                             (no info)   \n",
       "92                                                                                                                                                                                                                                                                                                                                         \n",
       "93                                                                                                                                                                                                                                                                                               42 min 45 s cycle time per gene target    \n",
       "95                                                                                                                                                                                                                                                                                                                                80 min   \n",
       "96                                                                                                                                                                                                                                                                                                                                  2 hr   \n",
       "97                                                                                                                                                                                                                                                                                                37 min 10 s cycle time per gene target   \n",
       "98                                                                                                                                                                                                                                                                                                                            (no info)    \n",
       "100                                                                                                                                                                                                                                                                                                              129 min 30 s cycle time   \n",
       "101                                                                                                                                                                                                                                                                      4 hr<s>274</s> (43 min 45 s cycle time for each gene)<s>273</s>   \n",
       "102                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "103                                                                                                                                                                                                                                                                                                                    Less than an hour   \n",
       "104                                                                                                                                                                                                                                                                                                                                 3 hr   \n",
       "105                                                                                                                                                                                                                                                                                                                          1 hr 30 min   \n",
       "106                                                                                                                                                                                                                                                                                   < 2 hr  64 min 30 s cycle time per gene<s>291</s>    \n",
       "108                                                                                                                                                                                                                                                                                                                                 1 hr   \n",
       "109                                                                                                                                                                                                                                                                                                                               55 min   \n",
       "110                                                                                                                                                                                                                                                                                                                               10 min   \n",
       "111                                                                                                                                                                                                                                                                                                                               < 5 hr   \n",
       "112                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "113                                                                                                                                                                                                                                                                     126 min 15 s<s>309,311</s>or 120 min<s>310,312</s> of cycle time   \n",
       "114  SARS-CoV-2 detection stated to be faster than Fluorescent RT-PCR kit.  For detection of unknown pathogens, Within 5 hours, 128 samples can be simultaneously screened and sequenced by SE50, and 128 samples can be simultaneously tested and sequenced by PE100 in 22 hours, as well as possible mutation and evolution monitoring   \n",
       "115                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "116                                                                                                                                                                                                                                                                                                                        <s>70 min</s>   \n",
       "117                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "118                                                                                                                                                                                                                                                                                                                    <s>83 minutes</s>   \n",
       "119                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "120                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "121                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "122                                                                                                                                                                                                                                                                                                                           4-5 Hours    \n",
       "124                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "125                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "126                                                                                                                                                                                                                                                                                                                           (no info)    \n",
       "128                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "129                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "130                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "131                                                                                                                                                                                                                                                                                                                           (no info)    \n",
       "133                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "134                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "135                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "136                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "137                                                                                                                                                                                                                                                                                                                           (no info)    \n",
       "139                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "140                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "141                                                                                                                                                                                                                                                                                                                                 4 hr   \n",
       "142                                                                                                                                                                                                                                                                                                                           (no info)    \n",
       "144                                                                                                                                                                                                                                                                                                                           (no info)    \n",
       "146                                                                                                                                                                                                                                                                  5-13 min  (5 min for positive results, 13 min for negative results)   \n",
       "147                                                                                                                                                                                                                                                                                                                    2 hours<s>349</s>   \n",
       "148                                                                                                                                                                                                                                                                                                                                 1 hr   \n",
       "149                                                                                                                                                                                                                                                                                                                               40 min   \n",
       "150                                                                                                                                                                                                                                                                                            About an hour (Press release:<s>356</s>)    \n",
       "152                                                                                                                                                                                                                                                                                                          Less than 2 hours<s>359</s>   \n",
       "153                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "154                                                                                                                                                                                                                                                                      60-70 min (including patient sample preparation time)<s>362</s>   \n",
       "155                                                                                                                                                                                                                                                                                                                               51 min   \n",
       "156                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "157                                                                                                                                                                                                                                                                                                                               30 min   \n",
       "158                                                                                                                                                                                                                                                                                                                           (no info)    \n",
       "160                                                                                                                                                                                                                                                   45 minutes (with manual RNA extraction)   (Press release:<s>371</s>Study:<s>35</s>   \n",
       "161                                                                                                                                                                                                                                                                                                                    <s>30 minutes</s>   \n",
       "162                                                                                                                                                                                                                                                                                                                    <s>30 minutes</s>   \n",
       "163                                                                                                                                                                                                                                                                                                                             5-15 min   \n",
       "164                                                                                                                                                                                                                                                                                                                            (No info)   \n",
       "165                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "166                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "167                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "168                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "169                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "170                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "171                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "172                                                                                                                                                                                                                                                                                                                               10 min   \n",
       "173                                                                                                                                                                                                                                                                                                 48 min  (Up to 150 samples per hour)   \n",
       "174                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "175                                                                                                                                                                                                                                                                                                                              <15 min   \n",
       "176                                                                                                                                                                                                                                                                                                                                15 mi   \n",
       "177                                                                                                                                                                                                                                                                                                                           10 Minutes   \n",
       "178                                                                                                                                                                                                                                                                     22 min (unclear if serum/plasma extraction time included or not)   \n",
       "179                                                                                                                                                                                                                                                                                                                               30 min   \n",
       "180                                                                                                                                                                                                                                                                                                                           10 minutes   \n",
       "181                                                                                                                                                                                                                                                                                                                           10 minutes   \n",
       "182                                                                                                                                                                                                                                                                                                                           10 minutes   \n",
       "183                                                                                                                                                                                                                                                                                                                               15 min   \n",
       "184                                                                                                                                                                                                                                                                                                                           (no info)    \n",
       "186                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "187                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "188                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "189                                                                                                                                                                                                                                                                                                                           10 minutes   \n",
       "190                                                                                                                                                                                                                                                                                                                           15 minutes   \n",
       "191                                                                                                                                                                                                                                                                                                                           (no info)    \n",
       "193                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "194                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "195                                                                                                                                                                                                                                                                    15 min (unclear if serum/plasma extraction time included or not)    \n",
       "197                                                                                                                                                                                                                                                                                                                               10 min   \n",
       "198                                                                                                                                                                                                                                                                                                                               20 min   \n",
       "199                                                                                                                                                                                                                                                                                                                             2-10 min   \n",
       "200                                                                                                                                                                                                                                                                                                                               10 min   \n",
       "201                                                                                                                                                                                                                                                                                                                            10-15 min   \n",
       "202                                                                                                                                                                                                                                                                                                                             15-20min   \n",
       "203                                                                                                                                                                                                                                                                    15 min  (unclear if serum/plasma extraction time included or not)   \n",
       "204                                                                                                                                                                                                                                                                                                                        Within 10 min   \n",
       "205                                                                                                                                                                                                                                                                                                                           (no info)    \n",
       "207                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "208                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "209                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "210                                                                                                                                                                                                                                                                                                                              15 mins   \n",
       "211                                                                                                                                                                                                                                                                                                                             10 mins    \n",
       "213                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "214                                                                                                                                                                                                                                                                     15 min (unclear if serum/plasma extraction time included or not)   \n",
       "215                                                                                                                                                                                                                                                                                                                           (no info)    \n",
       "217                                                                                                                                                                                                                                                                                                                           90 minutes   \n",
       "218                                                                                                                                                                                                                                                                                                             (100-200 tests per hour)   \n",
       "219                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "220                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "221                                                                                                                                                                                                                                                                                                                            (no info)   \n",
       "222                                                                                                                                                                                                                                                                                                                           90 minutes   \n",
       "223                                                                                                                                                                                                                                                                                                                   2 hours <s>445</s>   \n",
       "224                                                                                                                                                                                                                                                                                                                           1-2 hours    \n",
       "\n",
       "1                                                                           Costs  \n",
       "0                                                                       (no info)  \n",
       "1                                                                       (no info)  \n",
       "2                                                                      (no info)   \n",
       "4                                                                       (no info)  \n",
       "5                                                                       (no info)  \n",
       "6                                                                       (no info)  \n",
       "7                                                                       (no info)  \n",
       "8                                                                       (no info)  \n",
       "9                                                                       (no info)  \n",
       "10                                                                      (no info)  \n",
       "11                                                                     (no info)   \n",
       "13                                                                      (no info)  \n",
       "14                                                                     (no info)   \n",
       "16                                                                      (no info)  \n",
       "17                                                                      (no info)  \n",
       "18                                                                      (no info)  \n",
       "19                                                                      (no info)  \n",
       "20                                                                      (no info)  \n",
       "21                                                                     (no info)   \n",
       "23                                                                      (no info)  \n",
       "24                                                                      (no info)  \n",
       "25   $300 for 10 strips +  $5,950 for PCR Thermocycler + $450 for sample prep kit  \n",
       "26                                                                      (no info)  \n",
       "27                                                                      (no info)  \n",
       "28                                                                      (no info)  \n",
       "29                                                           About €160<s>144</s>  \n",
       "30                                                                      (no info)  \n",
       "31                                                                      (no info)  \n",
       "32                                                                      (no info)  \n",
       "33                                                                      (no info)  \n",
       "34                                                                      (no info)  \n",
       "35                                                                      (no info)  \n",
       "36                                                USD $230 for 1000 rxn<s>167</s>  \n",
       "37                                                                     (no info)   \n",
       "39                                                                      (no info)  \n",
       "40                                                                      (no info)  \n",
       "41                                                                      (no info)  \n",
       "42                                                                     (no info)   \n",
       "44                                                                      (no info)  \n",
       "45                                                                      (no info)  \n",
       "46                                                                      (no info)  \n",
       "47                                                                     (no info)   \n",
       "49                                                                      (no info)  \n",
       "50                                                                      (no info)  \n",
       "51                                                                     (no info)   \n",
       "53                                                                      (no info)  \n",
       "54                                                                                 \n",
       "55                                                                      (no info)  \n",
       "56                                                                      (no info)  \n",
       "57                                                                      (no info)  \n",
       "58                                                                      (no info)  \n",
       "59                                                                                 \n",
       "60                                                                      (no info)  \n",
       "61                                                                      (no info)  \n",
       "62                                                                      (no info)  \n",
       "63                                                                      (no info)  \n",
       "64                                                                      (no info)  \n",
       "65                                                                      (no info)  \n",
       "66                                                                      (no info)  \n",
       "67                                                                      (no info)  \n",
       "68                                                                      (no info)  \n",
       "69                                                                      (no info)  \n",
       "70                                                                      (no info)  \n",
       "71                                                                      (no info)  \n",
       "72                                                                      (no info)  \n",
       "73                                                                      (no info)  \n",
       "74                                                                     (by quote)  \n",
       "75                                                                € 991<s>232</s>  \n",
       "76                                                               € 1347<s>235</s>  \n",
       "77                                                                    (by quote)   \n",
       "79                                                                      (no info)  \n",
       "80                                                                      (no info)  \n",
       "81                                                                      (no info)  \n",
       "82                                                                      (no info)  \n",
       "83                                                                    (by quote)   \n",
       "85                                                                      (no info)  \n",
       "86                                                                      (no info)  \n",
       "87                                                                     (no info)   \n",
       "89                                                   USD $125<s>24</s>for 500 rxn  \n",
       "90                                                                      (no info)  \n",
       "91                                                                      (no info)  \n",
       "92                                                                      (no info)  \n",
       "93                                                                     (no info)   \n",
       "95                                                                      (no info)  \n",
       "96                                                                      (no info)  \n",
       "97                                                                      (no info)  \n",
       "98                                                                     (no info)   \n",
       "100                                                                     (no info)  \n",
       "101                                                                     (no info)  \n",
       "102                                                                     (no info)  \n",
       "103                                                                     (no info)  \n",
       "104                                                                     (no info)  \n",
       "105                                                                     (no info)  \n",
       "106                                                                   (by quote)   \n",
       "108                                                                     (no info)  \n",
       "109                                               Rs 1,000 – Rs 1,500) <s>298</s>  \n",
       "110                                                                     (no info)  \n",
       "111                                                                     (no info)  \n",
       "112                                                                    (by quote)  \n",
       "113   € 599<s>308</s>€ 699<s>308</s>€ 799<s>308</s>€ 999<s>308</s>€ 899<s>308</s>  \n",
       "114                                                                     (no info)  \n",
       "115                                                                     (no info)  \n",
       "116                                                                     (no info)  \n",
       "117                                                                     (no info)  \n",
       "118                                                                     (no info)  \n",
       "119                                                                     (no info)  \n",
       "120                                                                     (no info)  \n",
       "121                                                                     (no info)  \n",
       "122                                                                    (no info)   \n",
       "124                                                                     (no info)  \n",
       "125                                                                     (no info)  \n",
       "126                                                                    (no info)   \n",
       "128                                                                     (no info)  \n",
       "129                                                                     (no info)  \n",
       "130                                                                     (no info)  \n",
       "131                                                                    (no info)   \n",
       "133                                                                     (no info)  \n",
       "134                                                                     (no info)  \n",
       "135                                                                     (no info)  \n",
       "136                                                                     (no info)  \n",
       "137                                                                    (no info)   \n",
       "139                                                                     (no info)  \n",
       "140                                                                    (by quote)  \n",
       "141                                                                    (by quote)  \n",
       "142                                                                    (no info)   \n",
       "144                                                                    (no info)   \n",
       "146                                                                     (no info)  \n",
       "147                                                                     (no info)  \n",
       "148                                                                     (no info)  \n",
       "149                                                                     (no info)  \n",
       "150                                                                   (by quote)   \n",
       "152                                                                     (no info)  \n",
       "153                                                                     (no info)  \n",
       "154                                                                     (no info)  \n",
       "155                                                                    (by quote)  \n",
       "156                                                                     (no info)  \n",
       "157                                                                     (no info)  \n",
       "158                                                                    (no info)   \n",
       "160                                                                     (no info)  \n",
       "161                                                                     (no info)  \n",
       "162                                                                     (no info)  \n",
       "163                                                                          <$50  \n",
       "164                                                                     (No info)  \n",
       "165                                                                     (no info)  \n",
       "166                                                                     (no info)  \n",
       "167                                                                     (no info)  \n",
       "168                                                                     (no info)  \n",
       "169                                                                     (no info)  \n",
       "170                                                                     (no info)  \n",
       "171                                                                     (no info)  \n",
       "172                                                                     (no info)  \n",
       "173                                                                     (no info)  \n",
       "174                                                                     (no info)  \n",
       "175                                                                     (no info)  \n",
       "176                                                                     (no info)  \n",
       "177                                                                     (no info)  \n",
       "178                                                                     (no info)  \n",
       "179                                                                     (no info)  \n",
       "180                                                                     (no info)  \n",
       "181                                                                     (no info)  \n",
       "182                                                                     (no info)  \n",
       "183                                                                     (no info)  \n",
       "184                                                                    (no info)   \n",
       "186                                                                     (no info)  \n",
       "187                                                                     (no info)  \n",
       "188                                                                     (no info)  \n",
       "189                                                                     (no info)  \n",
       "190                                                                     (no info)  \n",
       "191                                                                    (no info)   \n",
       "193                                                                     (no info)  \n",
       "194                                                                     (no info)  \n",
       "195                                                                    (no info)   \n",
       "197                                                                    (by quote)  \n",
       "198                                                                        €39.95  \n",
       "199                                                                     (no info)  \n",
       "200                                                                     (no info)  \n",
       "201                                                                     (no info)  \n",
       "202                                                                     (no info)  \n",
       "203                                                                     (no info)  \n",
       "204                                                              $20 per test kit  \n",
       "205                                                                    (no info)   \n",
       "207                                                                     (no info)  \n",
       "208                                                                     (no info)  \n",
       "209                                                                     (no info)  \n",
       "210                                                                     (no info)  \n",
       "211                                                                    (no info)   \n",
       "213                                                                     (no info)  \n",
       "214                                                                     (no info)  \n",
       "215             Projected to be $70 as distributed by Scanwell Health <s>428</s>   \n",
       "217                                                                     (no info)  \n",
       "218                                                                     (no info)  \n",
       "219                                                                     (no info)  \n",
       "220                                                                     (no info)  \n",
       "221                                                                     (no info)  \n",
       "222                                                                     (no info)  \n",
       "223                                                                     (no info)  \n",
       "224                                                                    (no info)   "
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tests_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df.reset_index(inplace = True, drop = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df = tests_df.replace(\"\", np.nan)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1\n",
       "Type            False\n",
       "Organisation    False\n",
       "Date             True\n",
       "Test            False\n",
       "Sensitivity      True\n",
       "Specificity      True\n",
       "Availability    False\n",
       "Turnaround       True\n",
       "Costs            True\n",
       "dtype: bool"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tests_df.isnull().any()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Pre-processing data frame"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics = tests_df.loc[:,(\"Type\", \"Organisation\", \"Sensitivity\", \"Specificity\")]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics = tests_df_metrics.replace(\"nan\", np.nan)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics = tests_df_metrics.replace(\"(no info)\", np.nan)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics = tests_df_metrics.dropna(how= \"all\", subset=[\"Sensitivity\", \"Specificity\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.reset_index(inplace = True, drop = True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Cleaning out values for sensitivity and specificity"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th>1</th>\n",
       "      <th>Type</th>\n",
       "      <th>Organisation</th>\n",
       "      <th>Sensitivity</th>\n",
       "      <th>Specificity</th>\n",
       "      <th>Category</th>\n",
       "      <th>sub_category</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>Charité Institute of Virology, Berlin, Germany &lt;s&gt;1,12&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>School of Public Health, The University of Hong Kong (HKU)&lt;s&gt;13,14&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>rRT-PCR</td>\n",
       "      <td>Institut Pasteur, Paris, France&lt;s&gt;10&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>Genosensor, LLC &lt;s&gt;103&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>KorvaLabs Inc. &lt;s&gt;104&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>Genosensor, LLC &lt;s&gt;103&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>KorvaLabs Inc. &lt;s&gt;104&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>RT-PCR Kit</td>\n",
       "      <td>Shanghai Fosun Long March Medical Science Co. Ltd&lt;s&gt;105&lt;/s&gt; Manufactured for: Fosun Pharma USA Inc.</td>\n",
       "      <td>99.51</td>\n",
       "      <td>96.44</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>RT-PCR assay</td>\n",
       "      <td>Rhoenix, Inc. &lt;s&gt;108&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>RT-PCR assay</td>\n",
       "      <td>LabGenomics Co., Ltd &lt;s&gt;110&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Co-Diagnostics&lt;s&gt;113-&lt;/s&gt;&lt;s&gt;115&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Altona Diagnostics&lt;s&gt;119,120&lt;/s&gt;Germany</td>\n",
       "      <td>100.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Roche&lt;s&gt;123-126&lt;/s&gt; Switzerland</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>A*STAR&lt;s&gt;4,128&lt;/s&gt;(Manufactured by Singapore’s MiRxes which has a nonexclusive license)&lt;s&gt;129&lt;/s&gt; Singapore</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>PCL&lt;s&gt;131&lt;/s&gt; South Korea</td>\n",
       "      <td>100.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>RT-PCR  [Point-of-Care]</td>\n",
       "      <td>Cepheid&lt;s&gt;27,140,141&lt;/s&gt; (Plus collaboration with Sherlock Biosciences)&lt;s&gt;142&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>AusDiagnostics&lt;s&gt;145-&lt;/s&gt;&lt;s&gt;147&lt;/s&gt; Australia</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Seegene&lt;s&gt;148,149&lt;/s&gt; South Korea</td>\n",
       "      <td>100.00</td>\n",
       "      <td>97.87</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Osang Healthcare&lt;s&gt;156,157&lt;/s&gt;(partnership with Italy’s ELITech Group)  South Korea</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>RT-PCR  [Point-of-Care]</td>\n",
       "      <td>Mesa Biotech&lt;s&gt;28,30,160-162&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Luminex&lt;s&gt;163-165&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Fulgent Therapeutics, LLC&lt;s&gt;168&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>bioMérieux&lt;s&gt;171-173&lt;/s&gt;(subsidiary BioFire Defense)  France</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Hologic&lt;s&gt;175-177&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>LabCorp (Laboratory Corporation of America)&lt;s&gt;176,179&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Quidel&lt;s&gt;181,182&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Quests Diagnostics&lt;s&gt;184,185&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Abbott Molecular&lt;s&gt;27,186,187&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>DiaSorin Molecular&lt;s&gt;189-191&lt;/s&gt; Italy</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>DiaCarta&lt;s&gt;192,193&lt;/s&gt; USA</td>\n",
       "      <td>96.70</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>PerkinElmer&lt;s&gt;28,195,19&lt;/s&gt;&lt;s&gt;6&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Trax management Services Inc.&lt;s&gt;214&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>CTK Biotech Inc (United States of America)&lt;s&gt;216&lt;/s&gt;</td>\n",
       "      <td>95.10</td>\n",
       "      <td>95.90</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>PCL&lt;s&gt;132&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Seasun Biomaterials &lt;s&gt;217&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>bioMérieux SA &lt;s&gt;219&lt;/s&gt;</td>\n",
       "      <td>98.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Bio-Rad Laboratories, Inc. &lt;s&gt;222&lt;/s&gt;</td>\n",
       "      <td>94.87</td>\n",
       "      <td>95.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>ScienCell Research Laboratories&lt;s&gt;227-229&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>CerTest Biotec&lt;s&gt;238&lt;/s&gt; Spain</td>\n",
       "      <td>97.50</td>\n",
       "      <td>99.90</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Thermo Fisher Scientific&lt;s&gt;133,243-245&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>US CDC&lt;s&gt;17,247,248&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>46</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>SolGent&lt;s&gt;151,152,249&lt;/s&gt; South Korea</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>SD Biosensor&lt;s&gt;151,152&lt;/s&gt; South Korea</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>48</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Luminex&lt;s&gt;164,165,253,25&lt;/s&gt;&lt;s&gt;4&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>49</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Genomica&lt;s&gt;255,256&lt;/s&gt; Spain</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Avellino Lab&lt;s&gt;257-259&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>52</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>NeuMoDx&lt;s&gt;261-263&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>53</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Becton Dickinson (BD)&lt;s&gt;264-266&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>54</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Maccura Biotechnology&lt;s&gt;257,26&lt;/s&gt;&lt;s&gt;7,268&lt;/s&gt; China</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>55</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Ipsum Diagnostics&lt;s&gt;269,270&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>56</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Gnomegen&lt;s&gt;271,272&lt;/s&gt;(Subsidiary of QuestGenomics)  USA (China)</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>57</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>InBios International&lt;s&gt;248,273,2&lt;/s&gt;&lt;s&gt;74&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>96.70</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>58</th>\n",
       "      <td>Real-time RT-PCR</td>\n",
       "      <td>Becton Dickinson (BD)&lt;s&gt;275,276&lt;/s&gt; USA</td>\n",
       "      <td>96.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>59</th>\n",
       "      <td>Real Time RT-PCR</td>\n",
       "      <td>BGI&lt;s&gt;279-281&lt;/s&gt; (Pathomics Health as distributor)   China</td>\n",
       "      <td>97.10</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>60</th>\n",
       "      <td>qPCR</td>\n",
       "      <td>Primerdesign&lt;s&gt;286-291&lt;/s&gt;(molecular diagnostics division of Novacyt) France/UK</td>\n",
       "      <td>96.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>61</th>\n",
       "      <td>qPCR  [Point-of-Care]</td>\n",
       "      <td>Molbio Diagnostics&lt;s&gt;295&lt;/s&gt; India</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>62</th>\n",
       "      <td>PCR-based genotyping</td>\n",
       "      <td>Genomica&lt;s&gt;300,301&lt;/s&gt; Spain</td>\n",
       "      <td>96.00</td>\n",
       "      <td>98.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>64</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>TCM Biosciences&lt;s&gt;131,315&lt;/s&gt; South Korea</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>QuantuMDx&lt;s&gt;295,318&lt;/s&gt;UK</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>66</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Fast Track Diagnostics Luxembourg Sárl. (a Siemens Healthineers Company)</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>67</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>bioMérieux SA&lt;s&gt;321&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>OPTI Medical Systems, Inc</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>69</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Zymo Research Corporation</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Rutgers Clinical Genomics Laboratory at RUCDR Infinite Biologics - Rutgers University</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>71</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Abbott Molecular Inc.&lt;s&gt;326&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>72</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>1drop Inc &lt;s&gt;327&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Applied DNA Sciences, Inc.&lt;s&gt;328&lt;/s&gt;</td>\n",
       "      <td>98.00</td>\n",
       "      <td>93.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>74</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>GeneMatrix, Inc.&lt;s&gt;329&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>Assurance Scientific Laboratories&lt;s&gt;330&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>Real Time RT-PCR</td>\n",
       "      <td>Quidel Corporation&lt;s&gt;331&lt;/s&gt;</td>\n",
       "      <td>97.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>P23 Labs &lt;s&gt;335&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>RT-PCR</td>\n",
       "      <td>BioCore</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Molecular</td>\n",
       "      <td>PCR</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>92</th>\n",
       "      <td>Total Antibody Immunoassay (ELISA)</td>\n",
       "      <td>Bio-Rad Laboratories&lt;s&gt;222&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Serological</td>\n",
       "      <td>Total antibody</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>93</th>\n",
       "      <td>Total antibody immunoassay</td>\n",
       "      <td>Beijing Wantai Biologicalpharmacy Enterprise Co Ltd&lt;s&gt;380&lt;/s&gt; China</td>\n",
       "      <td>96.60</td>\n",
       "      <td>95.20</td>\n",
       "      <td>Serological</td>\n",
       "      <td>Total antibody</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>94</th>\n",
       "      <td>Total Antibody Immunoassay</td>\n",
       "      <td>Wadsworth Center&lt;s&gt;381&lt;/s&gt;</td>\n",
       "      <td>88.00</td>\n",
       "      <td>99.60</td>\n",
       "      <td>Serological</td>\n",
       "      <td>Total antibody</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>Total antibody Immunoassay</td>\n",
       "      <td>Roche Diagnostics</td>\n",
       "      <td>100.00</td>\n",
       "      <td>99.81</td>\n",
       "      <td>Serological</td>\n",
       "      <td>Total antibody</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>Total Antibody immunoassay  [Point-of-Care]</td>\n",
       "      <td>Mologic (partnership with the Institut Pasteur de Dakar)&lt;s&gt;386,387&lt;/s&gt; UK</td>\n",
       "      <td>98.00</td>\n",
       "      <td>98.00</td>\n",
       "      <td>Serological</td>\n",
       "      <td>Total antibody</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>Total Antibody immunoassay</td>\n",
       "      <td>Ortho Clinical Diagnostics&lt;s&gt;390-392&lt;/s&gt; USA</td>\n",
       "      <td>83.30</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Serological</td>\n",
       "      <td>Total antibody</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>IgG/IgM antibody immunoassay (colloidal gold)  [Point-of-Care]</td>\n",
       "      <td>Mobidiag (in collaboration with Autobio &lt;s&gt;Diagnostics)&lt;/s&gt;&lt;s&gt;199&lt;/s&gt;Finland</td>\n",
       "      <td>97.40</td>\n",
       "      <td>96.20</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>IgG/IgM antibody immunoassay  (CLIA)</td>\n",
       "      <td>Shenzhen Tisenc Medical Device&lt;s&gt;55&lt;/s&gt;(collaboration with Shenzhen University and Shenzhen No.3 People’s Hospital)  China</td>\n",
       "      <td>96.60</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>IgG/IgM antibody immunoassay (CLIA)</td>\n",
       "      <td>Snibe Diagnostic&lt;s&gt;397,398&lt;/s&gt; China</td>\n",
       "      <td>100.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>GenBody Inc (South Korea)&lt;s&gt;214&lt;/s&gt;</td>\n",
       "      <td>91.70</td>\n",
       "      <td>97.50</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Healgen Scientific Limited Liability Company (USA)&lt;s&gt;400&lt;/s&gt;</td>\n",
       "      <td>97.20</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>PCL</td>\n",
       "      <td>100.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>IgG/IgM antibody immunoassay  [Point-of-Care]</td>\n",
       "      <td>BioMedomics /  Jiangsu Medomics Medical Technology&lt;s&gt;54,57,58&lt;/s&gt; USA / China</td>\n",
       "      <td>88.66</td>\n",
       "      <td>90.63</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Shenzen YHLO Biotech Co. Ltd (China)&lt;s&gt;401&lt;/s&gt;</td>\n",
       "      <td>100.00</td>\n",
       "      <td>92.80</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>CTK Biotech Inc&lt;s&gt;406&lt;/s&gt; USA</td>\n",
       "      <td>96.90</td>\n",
       "      <td>99.40</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Qingdao Hightop Biotech Co Ltd&lt;s&gt;407&lt;/s&gt; China</td>\n",
       "      <td>93.00</td>\n",
       "      <td>97.50</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Hangzhou Clongene Biotech &lt;s&gt;Co Ltd&lt;/s&gt; China</td>\n",
       "      <td>99.42</td>\n",
       "      <td>98.89</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>110</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Hangzhou Biotest &lt;s&gt;Biotech Co Ltd&lt;/s&gt; China</td>\n",
       "      <td>100.00</td>\n",
       "      <td>99.50</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>112</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Hangzhou AllTest Biotech&lt;s&gt;81,412,413&lt;/s&gt; China</td>\n",
       "      <td>100.00</td>\n",
       "      <td>98.00</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>113</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Zhejiang Orient Gene Biotech&lt;s&gt;51,52&lt;/s&gt; China</td>\n",
       "      <td>97.20</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>114</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>SD Biosensor&lt;s&gt;53&lt;/s&gt; South Korea</td>\n",
       "      <td>81.80</td>\n",
       "      <td>96.70</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Chembio Diagnostic Systems&lt;s&gt;415-417&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>IgG/IgM antibody immunoassay [Point-of-Care]</td>\n",
       "      <td>Cellex&lt;s&gt;61,358&lt;/s&gt; USA</td>\n",
       "      <td>93.80</td>\n",
       "      <td>96.00</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>IgG/IgM antibody immunoassay</td>\n",
       "      <td>Nankai University&lt;s&gt;56&lt;/s&gt; (in collaboration with KingFocus Biomedical)  China</td>\n",
       "      <td>75.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG/IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>IgM antibody immunoassay  [Point-of-Care]</td>\n",
       "      <td>Guangzhou Medical University&lt;s&gt;11,43&lt;/s&gt;(Dr Zhong Nanshan) In collaboration with Jiangsu Medomics Medical Technologies and many other institutes  China</td>\n",
       "      <td>88.66</td>\n",
       "      <td>90.63</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121</th>\n",
       "      <td>IgM antibody immunoassay</td>\n",
       "      <td>Innovita Biological Technology&lt;s&gt;44&lt;/s&gt; China</td>\n",
       "      <td>87.30</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122</th>\n",
       "      <td>IgM antibody immunoassay</td>\n",
       "      <td>Epitope Diagnostics</td>\n",
       "      <td>73.80</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgM</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123</th>\n",
       "      <td>IgG antibody immunoassay</td>\n",
       "      <td>Abbott Laboratories Inc.&lt;s&gt;431,432&lt;/s&gt; USA</td>\n",
       "      <td>100.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>124</th>\n",
       "      <td>IgG Antibody immunoassay</td>\n",
       "      <td>Mount Sinai Laboratory&lt;s&gt;435&lt;/s&gt;</td>\n",
       "      <td>92.00</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>125</th>\n",
       "      <td>IgG Antibody detection</td>\n",
       "      <td>Ortho-Clinical &lt;s&gt;Diagnostics, Inc.&lt;/s&gt;&lt;s&gt;436&lt;/s&gt;</td>\n",
       "      <td>87.50</td>\n",
       "      <td>100.00</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>IgG Antibody detection</td>\n",
       "      <td>Diasorin Inc.&lt;s&gt;437&lt;/s&gt;</td>\n",
       "      <td>97.56</td>\n",
       "      <td>99.30</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>127</th>\n",
       "      <td>IgG Antibody detection</td>\n",
       "      <td>Epitope Diagnostics</td>\n",
       "      <td>98.40</td>\n",
       "      <td>99.80</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgG</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>128</th>\n",
       "      <td>IgA/IgG antibody immunoassay</td>\n",
       "      <td>EUROIMMUN AG&lt;s&gt;439-441&lt;/s&gt; Germany</td>\n",
       "      <td>100.00</td>\n",
       "      <td>99.00</td>\n",
       "      <td>Serological</td>\n",
       "      <td>IgA/IgG</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "1                                                              Type  \\\n",
       "1                                                           rRT-PCR   \n",
       "2                                                          rRT-PCR    \n",
       "3                                                           rRT-PCR   \n",
       "4                                                        RT-PCR Kit   \n",
       "5                                                        RT-PCR Kit   \n",
       "6                                                       RT-PCR Kit    \n",
       "7                                                        RT-PCR Kit   \n",
       "8                                                       RT-PCR Kit    \n",
       "9                                                      RT-PCR assay   \n",
       "10                                                     RT-PCR assay   \n",
       "11                                                           RT-PCR   \n",
       "12                                                           RT-PCR   \n",
       "13                                                          RT-PCR    \n",
       "14                                                           RT-PCR   \n",
       "15                                                           RT-PCR   \n",
       "16                                          RT-PCR  [Point-of-Care]   \n",
       "17                                                           RT-PCR   \n",
       "18                                                           RT-PCR   \n",
       "19                                                           RT-PCR   \n",
       "20                                          RT-PCR  [Point-of-Care]   \n",
       "21                                                           RT-PCR   \n",
       "22                                                          RT-PCR    \n",
       "23                                                           RT-PCR   \n",
       "24                                                           RT-PCR   \n",
       "25                                                           RT-PCR   \n",
       "26                                                          RT-PCR    \n",
       "27                                                           RT-PCR   \n",
       "28                                                           RT-PCR   \n",
       "29                                                           RT-PCR   \n",
       "30                                                          RT-PCR    \n",
       "31                                                           RT-PCR   \n",
       "34                                                           RT-PCR   \n",
       "35                                                           RT-PCR   \n",
       "36                                                           RT-PCR   \n",
       "37                                                           RT-PCR   \n",
       "38                                                           RT-PCR   \n",
       "39                                                           RT-PCR   \n",
       "41                                                 Real-time RT-PCR   \n",
       "43                                                 Real-time RT-PCR   \n",
       "44                                                Real-time RT-PCR    \n",
       "45                                                 Real-time RT-PCR   \n",
       "46                                                 Real-time RT-PCR   \n",
       "47                                                Real-time RT-PCR    \n",
       "48                                                 Real-time RT-PCR   \n",
       "49                                                 Real-time RT-PCR   \n",
       "50                                                 Real-time RT-PCR   \n",
       "52                                                 Real-time RT-PCR   \n",
       "53                                                 Real-time RT-PCR   \n",
       "54                                                 Real-time RT-PCR   \n",
       "55                                                Real-time RT-PCR    \n",
       "56                                                 Real-time RT-PCR   \n",
       "57                                                 Real-time RT-PCR   \n",
       "58                                                 Real-time RT-PCR   \n",
       "59                                                 Real Time RT-PCR   \n",
       "60                                                            qPCR    \n",
       "61                                            qPCR  [Point-of-Care]   \n",
       "62                                             PCR-based genotyping   \n",
       "64                                                           RT-PCR   \n",
       "65                                                           RT-PCR   \n",
       "66                                                           RT-PCR   \n",
       "67                                                          RT-PCR    \n",
       "68                                                           RT-PCR   \n",
       "69                                                           RT-PCR   \n",
       "70                                                          RT-PCR    \n",
       "71                                                           RT-PCR   \n",
       "72                                                           RT-PCR   \n",
       "73                                                           RT-PCR   \n",
       "74                                                          RT-PCR    \n",
       "75                                                           RT-PCR   \n",
       "76                                                 Real Time RT-PCR   \n",
       "77                                                          RT-PCR    \n",
       "78                                                           RT-PCR   \n",
       "92                               Total Antibody Immunoassay (ELISA)   \n",
       "93                                       Total antibody immunoassay   \n",
       "94                                       Total Antibody Immunoassay   \n",
       "95                                       Total antibody Immunoassay   \n",
       "96                      Total Antibody immunoassay  [Point-of-Care]   \n",
       "97                                       Total Antibody immunoassay   \n",
       "98   IgG/IgM antibody immunoassay (colloidal gold)  [Point-of-Care]   \n",
       "99                             IgG/IgM antibody immunoassay  (CLIA)   \n",
       "100                             IgG/IgM antibody immunoassay (CLIA)   \n",
       "101                                    IgG/IgM antibody immunoassay   \n",
       "102                                    IgG/IgM antibody immunoassay   \n",
       "103                                    IgG/IgM antibody immunoassay   \n",
       "104                   IgG/IgM antibody immunoassay  [Point-of-Care]   \n",
       "105                                   IgG/IgM antibody immunoassay    \n",
       "106                                    IgG/IgM antibody immunoassay   \n",
       "107                                    IgG/IgM antibody immunoassay   \n",
       "109                                    IgG/IgM antibody immunoassay   \n",
       "110                                    IgG/IgM antibody immunoassay   \n",
       "112                    IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "113                    IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "114                    IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "115                    IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "116                    IgG/IgM antibody immunoassay [Point-of-Care]   \n",
       "117                                    IgG/IgM antibody immunoassay   \n",
       "120                       IgM antibody immunoassay  [Point-of-Care]   \n",
       "121                                       IgM antibody immunoassay    \n",
       "122                                        IgM antibody immunoassay   \n",
       "123                                        IgG antibody immunoassay   \n",
       "124                                        IgG Antibody immunoassay   \n",
       "125                                          IgG Antibody detection   \n",
       "126                                          IgG Antibody detection   \n",
       "127                                          IgG Antibody detection   \n",
       "128                                    IgA/IgG antibody immunoassay   \n",
       "\n",
       "1                                                                                                                                               Organisation  \\\n",
       "1                                                                                                 Charité Institute of Virology, Berlin, Germany <s>1,12</s>   \n",
       "2                                                                                     School of Public Health, The University of Hong Kong (HKU)<s>13,14</s>   \n",
       "3                                                                                                                   Institut Pasteur, Paris, France<s>10</s>   \n",
       "4                                                                                                                                 Genosensor, LLC <s>103</s>   \n",
       "5                                                                                                                                  KorvaLabs Inc. <s>104</s>   \n",
       "6                                                                                                                                Genosensor, LLC <s>103</s>    \n",
       "7                                                                                                                                  KorvaLabs Inc. <s>104</s>   \n",
       "8                                                       Shanghai Fosun Long March Medical Science Co. Ltd<s>105</s> Manufactured for: Fosun Pharma USA Inc.    \n",
       "9                                                                                                                                   Rhoenix, Inc. <s>108</s>   \n",
       "10                                                                                                                           LabGenomics Co., Ltd <s>110</s>   \n",
       "11                                                                                                                   Co-Diagnostics<s>113-</s><s>115</s> USA   \n",
       "12                                                                                                                   Altona Diagnostics<s>119,120</s>Germany   \n",
       "13                                                                                                                          Roche<s>123-126</s> Switzerland    \n",
       "14                                               A*STAR<s>4,128</s>(Manufactured by Singapore’s MiRxes which has a nonexclusive license)<s>129</s> Singapore   \n",
       "15                                                                                                                                 PCL<s>131</s> South Korea   \n",
       "16                                                                     Cepheid<s>27,140,141</s> (Plus collaboration with Sherlock Biosciences)<s>142</s> USA   \n",
       "17                                                                                                             AusDiagnostics<s>145-</s><s>147</s> Australia   \n",
       "18                                                                                                                         Seegene<s>148,149</s> South Korea   \n",
       "19                                                                       Osang Healthcare<s>156,157</s>(partnership with Italy’s ELITech Group)  South Korea   \n",
       "20                                                                                                                      Mesa Biotech<s>28,30,160-162</s> USA   \n",
       "21                                                                                                                                 Luminex<s>163-165</s> USA   \n",
       "22                                                                                                                  Fulgent Therapeutics, LLC<s>168</s> USA    \n",
       "23                                                                                              bioMérieux<s>171-173</s>(subsidiary BioFire Defense)  France   \n",
       "24                                                                                                                                 Hologic<s>175-177</s> USA   \n",
       "25                                                                                             LabCorp (Laboratory Corporation of America)<s>176,179</s> USA   \n",
       "26                                                                                                                                 Quidel<s>181,182</s> USA    \n",
       "27                                                                                                                      Quests Diagnostics<s>184,185</s> USA   \n",
       "28                                                                                                                     Abbott Molecular<s>27,186,187</s> USA   \n",
       "29                                                                                                                    DiaSorin Molecular<s>189-191</s> Italy   \n",
       "30                                                                                                                               DiaCarta<s>192,193</s> USA    \n",
       "31                                                                                                                   PerkinElmer<s>28,195,19</s><s>6</s> USA   \n",
       "34                                                                                                                   Trax management Services Inc.<s>214</s>   \n",
       "35                                                                                                      CTK Biotech Inc (United States of America)<s>216</s>   \n",
       "36                                                                                                                                             PCL<s>132</s>   \n",
       "37                                                                                                                            Seasun Biomaterials <s>217</s>   \n",
       "38                                                                                                                                  bioMérieux SA <s>219</s>   \n",
       "39                                                                                                                     Bio-Rad Laboratories, Inc. <s>222</s>   \n",
       "41                                                                                                         ScienCell Research Laboratories<s>227-229</s> USA   \n",
       "43                                                                                                                            CerTest Biotec<s>238</s> Spain   \n",
       "44                                                                                                           Thermo Fisher Scientific<s>133,243-245</s> USA    \n",
       "45                                                                                                                               US CDC<s>17,247,248</s> USA   \n",
       "46                                                                                                                     SolGent<s>151,152,249</s> South Korea   \n",
       "47                                                                                                                   SD Biosensor<s>151,152</s> South Korea    \n",
       "48                                                                                                                  Luminex<s>164,165,253,25</s><s>4</s> USA   \n",
       "49                                                                                                                              Genomica<s>255,256</s> Spain   \n",
       "50                                                                                                                            Avellino Lab<s>257-259</s> USA   \n",
       "52                                                                                                                                     NeuMoDx<s>261-263</s>   \n",
       "53                                                                                                                   Becton Dickinson (BD)<s>264-266</s> USA   \n",
       "54                                                                                                      Maccura Biotechnology<s>257,26</s><s>7,268</s> China   \n",
       "55                                                                                                                          Ipsum Diagnostics<s>269,270</s>    \n",
       "56                                                                                          Gnomegen<s>271,272</s>(Subsidiary of QuestGenomics)  USA (China)   \n",
       "57                                                                                                         InBios International<s>248,273,2</s><s>74</s> USA   \n",
       "58                                                                                                                   Becton Dickinson (BD)<s>275,276</s> USA   \n",
       "59                                                                                               BGI<s>279-281</s> (Pathomics Health as distributor)   China   \n",
       "60                                                                           Primerdesign<s>286-291</s>(molecular diagnostics division of Novacyt) France/UK   \n",
       "61                                                                                                                        Molbio Diagnostics<s>295</s> India   \n",
       "62                                                                                                                              Genomica<s>300,301</s> Spain   \n",
       "64                                                                                                                 TCM Biosciences<s>131,315</s> South Korea   \n",
       "65                                                                                                                                 QuantuMDx<s>295,318</s>UK   \n",
       "66                                                                                  Fast Track Diagnostics Luxembourg Sárl. (a Siemens Healthineers Company)   \n",
       "67                                                                                                                                  bioMérieux SA<s>321</s>    \n",
       "68                                                                                                                                 OPTI Medical Systems, Inc   \n",
       "69                                                                                                                                 Zymo Research Corporation   \n",
       "70                                                                    Rutgers Clinical Genomics Laboratory at RUCDR Infinite Biologics - Rutgers University    \n",
       "71                                                                                                                           Abbott Molecular Inc.<s>326</s>   \n",
       "72                                                                                                                                      1drop Inc <s>327</s>   \n",
       "73                                                                                                                      Applied DNA Sciences, Inc.<s>328</s>   \n",
       "74                                                                                                                               GeneMatrix, Inc.<s>329</s>    \n",
       "75                                                                                                               Assurance Scientific Laboratories<s>330</s>   \n",
       "76                                                                                                                              Quidel Corporation<s>331</s>   \n",
       "77                                                                                                                                      P23 Labs <s>335</s>    \n",
       "78                                                                                                                                                   BioCore   \n",
       "92                                                                                                                            Bio-Rad Laboratories<s>222</s>   \n",
       "93                                                                                       Beijing Wantai Biologicalpharmacy Enterprise Co Ltd<s>380</s> China   \n",
       "94                                                                                                                                Wadsworth Center<s>381</s>   \n",
       "95                                                                                                                                         Roche Diagnostics   \n",
       "96                                                                                 Mologic (partnership with the Institut Pasteur de Dakar)<s>386,387</s> UK   \n",
       "97                                                                                                              Ortho Clinical Diagnostics<s>390-392</s> USA   \n",
       "98                                                                              Mobidiag (in collaboration with Autobio <s>Diagnostics)</s><s>199</s>Finland   \n",
       "99                                Shenzhen Tisenc Medical Device<s>55</s>(collaboration with Shenzhen University and Shenzhen No.3 People’s Hospital)  China   \n",
       "100                                                                                                                     Snibe Diagnostic<s>397,398</s> China   \n",
       "101                                                                                                                      GenBody Inc (South Korea)<s>214</s>   \n",
       "102                                                                                             Healgen Scientific Limited Liability Company (USA)<s>400</s>   \n",
       "103                                                                                                                                                      PCL   \n",
       "104                                                                            BioMedomics /  Jiangsu Medomics Medical Technology<s>54,57,58</s> USA / China   \n",
       "105                                                                                                          Shenzen YHLO Biotech Co. Ltd (China)<s>401</s>    \n",
       "106                                                                                                                            CTK Biotech Inc<s>406</s> USA   \n",
       "107                                                                                                           Qingdao Hightop Biotech Co Ltd<s>407</s> China   \n",
       "109                                                                                                            Hangzhou Clongene Biotech <s>Co Ltd</s> China   \n",
       "110                                                                                                             Hangzhou Biotest <s>Biotech Co Ltd</s> China   \n",
       "112                                                                                                          Hangzhou AllTest Biotech<s>81,412,413</s> China   \n",
       "113                                                                                                           Zhejiang Orient Gene Biotech<s>51,52</s> China   \n",
       "114                                                                                                                        SD Biosensor<s>53</s> South Korea   \n",
       "115                                                                                                             Chembio Diagnostic Systems<s>415-417</s> USA   \n",
       "116                                                                                                                                  Cellex<s>61,358</s> USA   \n",
       "117                                                                           Nankai University<s>56</s> (in collaboration with KingFocus Biomedical)  China   \n",
       "120  Guangzhou Medical University<s>11,43</s>(Dr Zhong Nanshan) In collaboration with Jiangsu Medomics Medical Technologies and many other institutes  China   \n",
       "121                                                                                                           Innovita Biological Technology<s>44</s> China    \n",
       "122                                                                                                                                      Epitope Diagnostics   \n",
       "123                                                                                                               Abbott Laboratories Inc.<s>431,432</s> USA   \n",
       "124                                                                                                                         Mount Sinai Laboratory<s>435</s>   \n",
       "125                                                                                                        Ortho-Clinical <s>Diagnostics, Inc.</s><s>436</s>   \n",
       "126                                                                                                                                  Diasorin Inc.<s>437</s>   \n",
       "127                                                                                                                                      Epitope Diagnostics   \n",
       "128                                                                                                                       EUROIMMUN AG<s>439-441</s> Germany   \n",
       "\n",
       "1    Sensitivity  Specificity     Category    sub_category  \n",
       "1         100.00       100.00    Molecular             PCR  \n",
       "2         100.00       100.00    Molecular             PCR  \n",
       "3         100.00       100.00    Molecular             PCR  \n",
       "4         100.00       100.00    Molecular             PCR  \n",
       "5         100.00       100.00    Molecular             PCR  \n",
       "6         100.00       100.00    Molecular             PCR  \n",
       "7         100.00       100.00    Molecular             PCR  \n",
       "8          99.51        96.44    Molecular             PCR  \n",
       "9         100.00       100.00    Molecular             PCR  \n",
       "10        100.00       100.00    Molecular             PCR  \n",
       "11        100.00       100.00    Molecular             PCR  \n",
       "12        100.00          NaN    Molecular             PCR  \n",
       "13        100.00       100.00    Molecular             PCR  \n",
       "14        100.00       100.00    Molecular             PCR  \n",
       "15        100.00          NaN    Molecular             PCR  \n",
       "16        100.00       100.00    Molecular             PCR  \n",
       "17        100.00       100.00    Molecular             PCR  \n",
       "18        100.00        97.87    Molecular             PCR  \n",
       "19        100.00       100.00    Molecular             PCR  \n",
       "20        100.00       100.00    Molecular             PCR  \n",
       "21        100.00       100.00    Molecular             PCR  \n",
       "22        100.00       100.00    Molecular             PCR  \n",
       "23        100.00       100.00    Molecular             PCR  \n",
       "24        100.00          NaN    Molecular             PCR  \n",
       "25        100.00       100.00    Molecular             PCR  \n",
       "26        100.00       100.00    Molecular             PCR  \n",
       "27        100.00       100.00    Molecular             PCR  \n",
       "28        100.00       100.00    Molecular             PCR  \n",
       "29        100.00       100.00    Molecular             PCR  \n",
       "30         96.70       100.00    Molecular             PCR  \n",
       "31        100.00       100.00    Molecular             PCR  \n",
       "34        100.00       100.00    Molecular             PCR  \n",
       "35         95.10        95.90    Molecular             PCR  \n",
       "36        100.00          NaN    Molecular             PCR  \n",
       "37        100.00          NaN    Molecular             PCR  \n",
       "38         98.00       100.00    Molecular             PCR  \n",
       "39         94.87        95.00    Molecular             PCR  \n",
       "41        100.00       100.00    Molecular             PCR  \n",
       "43         97.50        99.90    Molecular             PCR  \n",
       "44        100.00       100.00    Molecular             PCR  \n",
       "45        100.00       100.00    Molecular             PCR  \n",
       "46        100.00       100.00    Molecular             PCR  \n",
       "47        100.00       100.00    Molecular             PCR  \n",
       "48        100.00       100.00    Molecular             PCR  \n",
       "49        100.00       100.00    Molecular             PCR  \n",
       "50        100.00       100.00    Molecular             PCR  \n",
       "52        100.00       100.00    Molecular             PCR  \n",
       "53        100.00       100.00    Molecular             PCR  \n",
       "54        100.00       100.00    Molecular             PCR  \n",
       "55        100.00       100.00    Molecular             PCR  \n",
       "56        100.00       100.00    Molecular             PCR  \n",
       "57        100.00        96.70    Molecular             PCR  \n",
       "58         96.00       100.00    Molecular             PCR  \n",
       "59         97.10       100.00    Molecular             PCR  \n",
       "60         96.00       100.00    Molecular             PCR  \n",
       "61        100.00       100.00    Molecular             PCR  \n",
       "62         96.00        98.00    Molecular             PCR  \n",
       "64        100.00       100.00    Molecular             PCR  \n",
       "65        100.00       100.00    Molecular             PCR  \n",
       "66        100.00       100.00    Molecular             PCR  \n",
       "67        100.00       100.00    Molecular             PCR  \n",
       "68        100.00       100.00    Molecular             PCR  \n",
       "69        100.00       100.00    Molecular             PCR  \n",
       "70        100.00       100.00    Molecular             PCR  \n",
       "71        100.00       100.00    Molecular             PCR  \n",
       "72        100.00          NaN    Molecular             PCR  \n",
       "73         98.00        93.00    Molecular             PCR  \n",
       "74        100.00       100.00    Molecular             PCR  \n",
       "75        100.00       100.00    Molecular             PCR  \n",
       "76         97.00       100.00    Molecular             PCR  \n",
       "77        100.00       100.00    Molecular             PCR  \n",
       "78        100.00       100.00    Molecular             PCR  \n",
       "92        100.00       100.00  Serological  Total antibody  \n",
       "93         96.60        95.20  Serological  Total antibody  \n",
       "94         88.00        99.60  Serological  Total antibody  \n",
       "95        100.00        99.81  Serological  Total antibody  \n",
       "96         98.00        98.00  Serological  Total antibody  \n",
       "97         83.30       100.00  Serological  Total antibody  \n",
       "98         97.40        96.20  Serological         IgG/IgM  \n",
       "99         96.60          NaN  Serological         IgG/IgM  \n",
       "100       100.00          NaN  Serological         IgG/IgM  \n",
       "101        91.70        97.50  Serological         IgG/IgM  \n",
       "102        97.20       100.00  Serological         IgG/IgM  \n",
       "103       100.00          NaN  Serological         IgG/IgM  \n",
       "104        88.66        90.63  Serological         IgG/IgM  \n",
       "105       100.00        92.80  Serological         IgG/IgM  \n",
       "106        96.90        99.40  Serological         IgG/IgM  \n",
       "107        93.00        97.50  Serological         IgG/IgM  \n",
       "109        99.42        98.89  Serological         IgG/IgM  \n",
       "110       100.00        99.50  Serological         IgG/IgM  \n",
       "112       100.00        98.00  Serological         IgG/IgM  \n",
       "113        97.20       100.00  Serological         IgG/IgM  \n",
       "114        81.80        96.70  Serological         IgG/IgM  \n",
       "115       100.00       100.00  Serological         IgG/IgM  \n",
       "116        93.80        96.00  Serological         IgG/IgM  \n",
       "117        75.00          NaN  Serological         IgG/IgM  \n",
       "120        88.66        90.63  Serological             IgM  \n",
       "121        87.30       100.00  Serological             IgM  \n",
       "122        73.80       100.00  Serological             IgM  \n",
       "123       100.00       100.00  Serological             IgG  \n",
       "124        92.00       100.00  Serological             IgG  \n",
       "125        87.50       100.00  Serological             IgG  \n",
       "126        97.56        99.30  Serological             IgG  \n",
       "127        98.40        99.80  Serological             IgG  \n",
       "128       100.00        99.00  Serological         IgA/IgG  "
      ]
     },
     "execution_count": 69,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "tests_df_metrics"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# rule = re.compile(\"[\\d,.]?[\\d,.]*[\\d,.]*[\\d,.]*[\\d,.]*%|IgM|IgG|IgA\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# rule = re.compile(\"(\\d\\d(\\.\\d\\d?)?%|1?00%)\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Regex rule to get the sensitivitz and specificitz values out of the long texts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {},
   "outputs": [],
   "source": [
    "rule = re.compile(\"(\\d?\\d\\d(\\.\\d\\d?)?%)\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.Sensitivity = tests_df_metrics.Sensitivity.apply(lambda x: rule.findall(str(x)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.Specificity = tests_df_metrics.Specificity.apply(lambda x: rule.findall(str(x)))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The function *groupzero* returns only the output of regex function *findall* which corresponds to the regex *rule* as a whole"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [],
   "source": [
    "def groupzero(x):\n",
    "    list = []\n",
    "    for i in x:\n",
    "        list.append(i[0])\n",
    "    return(list)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The function *maxvalue* returns the max value of all outputs after applying *groupzero*"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [],
   "source": [
    "def maxvalue(x):\n",
    "    if x:\n",
    "        return((np.array([float(i.replace(\"%\", \"\")) for i in x])).max())\n",
    "    else:\n",
    "        return(np.nan)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.Sensitivity = tests_df_metrics.Sensitivity.apply(lambda x: groupzero(x))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.Specificity = tests_df_metrics.Specificity.apply(lambda x: groupzero(x))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The 4 first tests report in the text to have 100% sensitivity and specificity."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.iloc[0][2] = tests_df_metrics.iloc[0][3] = [\"100%\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.iloc[1][2] = tests_df_metrics.iloc[1][3] = [\"100%\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.iloc[2][2] = tests_df_metrics.iloc[2][3] = [\"100%\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.iloc[3][2] = tests_df_metrics.iloc[3][3] = [\"100%\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# tests_df_3.Sensitivity = tests_df_3.Sensitivity.apply(lambda x: np.nan if len(x)==0 else x)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# tests_df_3.Specificity = tests_df_3.Specificity.apply(lambda x: np.nan if len(x)==0 else x)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Selecting only the highest specificty and sensitivity values for a specific test. Different values of sensitivity and specificity are sometimes given for serological tests in the following cases:\n",
    "- Two or three values reffering to: IgM / IgG / IgA. Selecting the highest value means at least one of the two (or three) antibody tests has the given metric.\n",
    "- Different values accounting for different stages of the infection. The highest value accounts only for a specific infection stage."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.Sensitivity = tests_df_metrics.Sensitivity.apply(lambda x: maxvalue(x))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.Specificity = tests_df_metrics.Specificity.apply(lambda x: maxvalue(x))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Dropping rows which have both sensitivity and specificity as NA"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.dropna(how = \"all\", subset = [\"Sensitivity\", \"Specificity\"], inplace = True )"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Deleting repeted tests"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.drop(0, inplace = True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Adding column for test category"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics[\"Category\"] = \"Molecular\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.loc[92:, \"Category\"] = \"Serological\""
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Adding sub-categories"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {},
   "outputs": [],
   "source": [
    "rule = re.compile(\"PCR\")\n",
    "tests_df_metrics[\"sub_category\"] = tests_df_metrics.Type.apply(lambda x: rule.findall(x)[0] if rule.findall(x) else \"\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [],
   "source": [
    "def sub_cat(x, df):\n",
    "    rule = re.compile(x.lower())\n",
    "    df.loc[\n",
    "        df.Type.apply(\n",
    "            lambda x: rule.findall(x.lower())[0] if rule.findall(x.lower()) else \"\"\n",
    "        ) == x.lower(), \n",
    "        \"sub_category\"\n",
    "    ] = x "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {},
   "outputs": [],
   "source": [
    "sub_cat(\"Total antibody\", tests_df_metrics)\n",
    "sub_cat(\"IgG\", tests_df_metrics)\n",
    "sub_cat(\"IgM\", tests_df_metrics)\n",
    "sub_cat(\"IgA\", tests_df_metrics)\n",
    "sub_cat(\"IgG/IgM\", tests_df_metrics)\n",
    "sub_cat(\"IgA/IgG\", tests_df_metrics)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Dropping other tests"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.replace(\"\", np.nan, inplace = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.dropna(subset = [\"sub_category\"], inplace = True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Writing pre-processed dataframe to csv"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "metadata": {},
   "outputs": [],
   "source": [
    "tests_df_metrics.to_csv(\"C:\\\\Users\\\\edidd\\\\Documents\\\\Ubiqum\\\\Data Analytics Course\\\\covid19\\\\data\\\\tests_df_metrics.csv\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Boxplots for sensitivity / specificity per test categories"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "        \n",
       "        \n",
       "            <div id=\"7595c953-4ecc-4062-82b0-06583867c1d6\" class=\"plotly-graph-div\" style=\"height:525px; width:100%;\"></div>\n",
       "            <script type=\"text/javascript\">\n",
       "                require([\"plotly\"], function(Plotly) {\n",
       "                    window.PLOTLYENV=window.PLOTLYENV || {};\n",
       "                    \n",
       "                if (document.getElementById(\"7595c953-4ecc-4062-82b0-06583867c1d6\")) {\n",
       "                    Plotly.newPlot(\n",
       "                        '7595c953-4ecc-4062-82b0-06583867c1d6',\n",
       "                        [{\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"sub_category=PCR<br>Sensitivity=%{y}\", \"legendgroup\": \"sub_category=PCR\", \"marker\": {\"color\": \"#636efa\"}, \"name\": \"sub_category=PCR\", \"notched\": false, \"offsetgroup\": \"sub_category=PCR\", \"orientation\": \"v\", \"showlegend\": true, \"type\": \"box\", \"x0\": \" \", \"xaxis\": \"x\", \"y\": [100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 99.51, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 96.7, 100.0, 100.0, 95.1, 100.0, 100.0, 98.0, 94.87, 100.0, 97.5, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 96.0, 97.1, 96.0, 100.0, 96.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 98.0, 100.0, 100.0, 97.0, 100.0, 100.0], \"y0\": \" \", \"yaxis\": \"y\"}, {\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"sub_category=Total antibody<br>Sensitivity=%{y}\", \"legendgroup\": \"sub_category=Total antibody\", \"marker\": {\"color\": \"#EF553B\"}, \"name\": \"sub_category=Total antibody\", \"notched\": false, \"offsetgroup\": \"sub_category=Total antibody\", \"orientation\": \"v\", \"showlegend\": true, \"type\": \"box\", \"x0\": \" \", \"xaxis\": \"x\", \"y\": [100.0, 96.6, 88.0, 100.0, 98.0, 83.3], \"y0\": \" \", \"yaxis\": \"y\"}, {\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"sub_category=IgG/IgM<br>Sensitivity=%{y}\", \"legendgroup\": \"sub_category=IgG/IgM\", \"marker\": {\"color\": \"#00cc96\"}, \"name\": \"sub_category=IgG/IgM\", \"notched\": false, \"offsetgroup\": \"sub_category=IgG/IgM\", \"orientation\": \"v\", \"showlegend\": true, \"type\": \"box\", \"x0\": \" \", \"xaxis\": \"x\", \"y\": [97.4, 96.6, 100.0, 91.7, 97.2, 100.0, 88.66, 100.0, 96.9, 93.0, 99.42, 100.0, 100.0, 97.2, 81.8, 100.0, 93.8, 75.0], \"y0\": \" \", \"yaxis\": \"y\"}, {\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"sub_category=IgM<br>Sensitivity=%{y}\", \"legendgroup\": \"sub_category=IgM\", \"marker\": {\"color\": \"#ab63fa\"}, \"name\": \"sub_category=IgM\", \"notched\": false, \"offsetgroup\": \"sub_category=IgM\", \"orientation\": \"v\", \"showlegend\": true, \"type\": \"box\", \"x0\": \" \", \"xaxis\": \"x\", \"y\": [88.66, 87.3, 73.8], \"y0\": \" \", \"yaxis\": \"y\"}, {\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"sub_category=IgG<br>Sensitivity=%{y}\", \"legendgroup\": \"sub_category=IgG\", \"marker\": {\"color\": \"#FFA15A\"}, \"name\": \"sub_category=IgG\", \"notched\": false, \"offsetgroup\": \"sub_category=IgG\", \"orientation\": \"v\", \"showlegend\": true, \"type\": \"box\", \"x0\": \" \", \"xaxis\": \"x\", \"y\": [100.0, 92.0, 87.5, 97.56, 98.4], \"y0\": \" \", \"yaxis\": \"y\"}, {\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"sub_category=IgA/IgG<br>Sensitivity=%{y}\", \"legendgroup\": \"sub_category=IgA/IgG\", \"marker\": {\"color\": \"#19d3f3\"}, \"name\": \"sub_category=IgA/IgG\", \"notched\": false, \"offsetgroup\": \"sub_category=IgA/IgG\", \"orientation\": \"v\", \"showlegend\": true, \"type\": \"box\", \"x0\": \" \", \"xaxis\": \"x\", \"y\": [100.0], \"y0\": \" \", \"yaxis\": \"y\"}],\n",
       "                        {\"boxmode\": \"group\", \"legend\": {\"orientation\": \"v\", \"tracegroupgap\": 0}, \"margin\": {\"t\": 60}, \"template\": {\"data\": {\"bar\": [{\"error_x\": {\"color\": \"#2a3f5f\"}, \"error_y\": {\"color\": \"#2a3f5f\"}, \"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"bar\"}], \"barpolar\": [{\"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"barpolar\"}], \"carpet\": [{\"aaxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"baxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"type\": \"carpet\"}], \"choropleth\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"choropleth\"}], \"contour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"contour\"}], \"contourcarpet\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"contourcarpet\"}], \"heatmap\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmap\"}], \"heatmapgl\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmapgl\"}], \"histogram\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"histogram\"}], \"histogram2d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2d\"}], \"histogram2dcontour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2dcontour\"}], \"mesh3d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"mesh3d\"}], \"parcoords\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"parcoords\"}], \"pie\": [{\"automargin\": true, \"type\": \"pie\"}], \"scatter\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter\"}], \"scatter3d\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter3d\"}], \"scattercarpet\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattercarpet\"}], \"scattergeo\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergeo\"}], \"scattergl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergl\"}], \"scattermapbox\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattermapbox\"}], \"scatterpolar\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolar\"}], \"scatterpolargl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolargl\"}], \"scatterternary\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterternary\"}], \"surface\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"surface\"}], \"table\": [{\"cells\": {\"fill\": {\"color\": \"#EBF0F8\"}, \"line\": {\"color\": \"white\"}}, \"header\": {\"fill\": {\"color\": \"#C8D4E3\"}, \"line\": {\"color\": \"white\"}}, \"type\": \"table\"}]}, \"layout\": {\"annotationdefaults\": {\"arrowcolor\": \"#2a3f5f\", \"arrowhead\": 0, \"arrowwidth\": 1}, \"coloraxis\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"colorscale\": {\"diverging\": [[0, \"#8e0152\"], [0.1, \"#c51b7d\"], [0.2, \"#de77ae\"], [0.3, \"#f1b6da\"], [0.4, \"#fde0ef\"], [0.5, \"#f7f7f7\"], [0.6, \"#e6f5d0\"], [0.7, \"#b8e186\"], [0.8, \"#7fbc41\"], [0.9, \"#4d9221\"], [1, \"#276419\"]], \"sequential\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"sequentialminus\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]]}, \"colorway\": [\"#636efa\", \"#EF553B\", \"#00cc96\", \"#ab63fa\", \"#FFA15A\", \"#19d3f3\", \"#FF6692\", \"#B6E880\", \"#FF97FF\", \"#FECB52\"], \"font\": {\"color\": \"#2a3f5f\"}, \"geo\": {\"bgcolor\": \"white\", \"lakecolor\": \"white\", \"landcolor\": \"#E5ECF6\", \"showlakes\": true, \"showland\": true, \"subunitcolor\": \"white\"}, \"hoverlabel\": {\"align\": \"left\"}, \"hovermode\": \"closest\", \"mapbox\": {\"style\": \"light\"}, \"paper_bgcolor\": \"white\", \"plot_bgcolor\": \"#E5ECF6\", \"polar\": {\"angularaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"radialaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"scene\": {\"xaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"yaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"zaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}}, \"shapedefaults\": {\"line\": {\"color\": \"#2a3f5f\"}}, \"ternary\": {\"aaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"baxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"caxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"title\": {\"x\": 0.05}, \"xaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"title\": {\"standoff\": 15}, \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}, \"yaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"title\": {\"standoff\": 15}, \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}}}, \"title\": {\"text\": \"Sensitivity of COVID-19 tests\", \"x\": 0.5, \"xanchor\": \"center\", \"y\": 0.95, \"yanchor\": \"middle\"}, \"xaxis\": {\"anchor\": \"y\", \"domain\": [0.0, 1.0]}, \"yaxis\": {\"anchor\": \"x\", \"domain\": [0.0, 1.0], \"title\": {\"text\": \"Sensitivity\"}}},\n",
       "                        {\"responsive\": true}\n",
       "                    ).then(function(){\n",
       "                            \n",
       "var gd = document.getElementById('7595c953-4ecc-4062-82b0-06583867c1d6');\n",
       "var x = new MutationObserver(function (mutations, observer) {{\n",
       "        var display = window.getComputedStyle(gd).display;\n",
       "        if (!display || display === 'none') {{\n",
       "            console.log([gd, 'removed!']);\n",
       "            Plotly.purge(gd);\n",
       "            observer.disconnect();\n",
       "        }}\n",
       "}});\n",
       "\n",
       "// Listen for the removal of the full notebook cells\n",
       "var notebookContainer = gd.closest('#notebook-container');\n",
       "if (notebookContainer) {{\n",
       "    x.observe(notebookContainer, {childList: true});\n",
       "}}\n",
       "\n",
       "// Listen for the clearing of the current output cell\n",
       "var outputEl = gd.closest('.output');\n",
       "if (outputEl) {{\n",
       "    x.observe(outputEl, {childList: true});\n",
       "}}\n",
       "\n",
       "                        })\n",
       "                };\n",
       "                });\n",
       "            </script>\n",
       "        </div>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "fig = px.box(tests_df_metrics, y=\"Sensitivity\", color=\"sub_category\")\n",
    "# fig.update_traces(quartilemethod=\"exclusive\") # or \"inclusive\", or \"linear\" by default\n",
    "\n",
    "fig.update_layout(\n",
    "    title = \n",
    "    {\n",
    "        'text': \"Sensitivity of COVID-19 tests\",\n",
    "        'y':.95,\n",
    "        'x':0.5,\n",
    "        'xanchor': 'center',\n",
    "        'yanchor': 'middle'\n",
    "    }, \n",
    "    legend_orientation=\"v\"\n",
    ")\n",
    "pio.show(fig)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "        \n",
       "        \n",
       "            <div id=\"0db1aaa5-4894-448b-9ff0-ae18f6fdbef5\" class=\"plotly-graph-div\" style=\"height:525px; width:100%;\"></div>\n",
       "            <script type=\"text/javascript\">\n",
       "                require([\"plotly\"], function(Plotly) {\n",
       "                    window.PLOTLYENV=window.PLOTLYENV || {};\n",
       "                    \n",
       "                if (document.getElementById(\"0db1aaa5-4894-448b-9ff0-ae18f6fdbef5\")) {\n",
       "                    Plotly.newPlot(\n",
       "                        '0db1aaa5-4894-448b-9ff0-ae18f6fdbef5',\n",
       "                        [{\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"sub_category=PCR<br>Specificity=%{y}\", \"legendgroup\": \"sub_category=PCR\", \"marker\": {\"color\": \"#636efa\"}, \"name\": \"sub_category=PCR\", \"notched\": false, \"offsetgroup\": \"sub_category=PCR\", \"orientation\": \"v\", \"showlegend\": true, \"type\": \"box\", \"x0\": \" \", \"xaxis\": \"x\", \"y\": [100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 96.44, 100.0, 100.0, 100.0, null, 100.0, 100.0, null, 100.0, 100.0, 97.87, 100.0, 100.0, 100.0, 100.0, 100.0, null, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 95.9, null, null, 100.0, 95.0, 100.0, 99.9, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 96.7, 100.0, 100.0, 100.0, 100.0, 98.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, null, 93.0, 100.0, 100.0, 100.0, 100.0, 100.0], \"y0\": \" \", \"yaxis\": \"y\"}, {\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"sub_category=Total antibody<br>Specificity=%{y}\", \"legendgroup\": \"sub_category=Total antibody\", \"marker\": {\"color\": \"#EF553B\"}, \"name\": \"sub_category=Total antibody\", \"notched\": false, \"offsetgroup\": \"sub_category=Total antibody\", \"orientation\": \"v\", \"showlegend\": true, \"type\": \"box\", \"x0\": \" \", \"xaxis\": \"x\", \"y\": [100.0, 95.2, 99.6, 99.81, 98.0, 100.0], \"y0\": \" \", \"yaxis\": \"y\"}, {\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"sub_category=IgG/IgM<br>Specificity=%{y}\", \"legendgroup\": \"sub_category=IgG/IgM\", \"marker\": {\"color\": \"#00cc96\"}, \"name\": \"sub_category=IgG/IgM\", \"notched\": false, \"offsetgroup\": \"sub_category=IgG/IgM\", \"orientation\": \"v\", \"showlegend\": true, \"type\": \"box\", \"x0\": \" \", \"xaxis\": \"x\", \"y\": [96.2, null, null, 97.5, 100.0, null, 90.63, 92.8, 99.4, 97.5, 98.89, 99.5, 98.0, 100.0, 96.7, 100.0, 96.0, null], \"y0\": \" \", \"yaxis\": \"y\"}, {\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"sub_category=IgM<br>Specificity=%{y}\", \"legendgroup\": \"sub_category=IgM\", \"marker\": {\"color\": \"#ab63fa\"}, \"name\": \"sub_category=IgM\", \"notched\": false, \"offsetgroup\": \"sub_category=IgM\", \"orientation\": \"v\", \"showlegend\": true, \"type\": \"box\", \"x0\": \" \", \"xaxis\": \"x\", \"y\": [90.63, 100.0, 100.0], \"y0\": \" \", \"yaxis\": \"y\"}, {\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"sub_category=IgG<br>Specificity=%{y}\", \"legendgroup\": \"sub_category=IgG\", \"marker\": {\"color\": \"#FFA15A\"}, \"name\": \"sub_category=IgG\", \"notched\": false, \"offsetgroup\": \"sub_category=IgG\", \"orientation\": \"v\", \"showlegend\": true, \"type\": \"box\", \"x0\": \" \", \"xaxis\": \"x\", \"y\": [100.0, 100.0, 100.0, 99.3, 99.8], \"y0\": \" \", \"yaxis\": \"y\"}, {\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"sub_category=IgA/IgG<br>Specificity=%{y}\", \"legendgroup\": \"sub_category=IgA/IgG\", \"marker\": {\"color\": \"#19d3f3\"}, \"name\": \"sub_category=IgA/IgG\", \"notched\": false, \"offsetgroup\": \"sub_category=IgA/IgG\", \"orientation\": \"v\", \"showlegend\": true, \"type\": \"box\", \"x0\": \" \", \"xaxis\": \"x\", \"y\": [99.0], \"y0\": \" \", \"yaxis\": \"y\"}],\n",
       "                        {\"boxmode\": \"group\", \"legend\": {\"orientation\": \"v\", \"tracegroupgap\": 0}, \"margin\": {\"t\": 60}, \"template\": {\"data\": {\"bar\": [{\"error_x\": {\"color\": \"#2a3f5f\"}, \"error_y\": {\"color\": \"#2a3f5f\"}, \"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"bar\"}], \"barpolar\": [{\"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"barpolar\"}], \"carpet\": [{\"aaxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"baxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"type\": \"carpet\"}], \"choropleth\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"choropleth\"}], \"contour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"contour\"}], \"contourcarpet\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"contourcarpet\"}], \"heatmap\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmap\"}], \"heatmapgl\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmapgl\"}], \"histogram\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"histogram\"}], \"histogram2d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2d\"}], \"histogram2dcontour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2dcontour\"}], \"mesh3d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"mesh3d\"}], \"parcoords\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"parcoords\"}], \"pie\": [{\"automargin\": true, \"type\": \"pie\"}], \"scatter\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter\"}], \"scatter3d\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter3d\"}], \"scattercarpet\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattercarpet\"}], \"scattergeo\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergeo\"}], \"scattergl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergl\"}], \"scattermapbox\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattermapbox\"}], \"scatterpolar\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolar\"}], \"scatterpolargl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolargl\"}], \"scatterternary\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterternary\"}], \"surface\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"surface\"}], \"table\": [{\"cells\": {\"fill\": {\"color\": \"#EBF0F8\"}, \"line\": {\"color\": \"white\"}}, \"header\": {\"fill\": {\"color\": \"#C8D4E3\"}, \"line\": {\"color\": \"white\"}}, \"type\": \"table\"}]}, \"layout\": {\"annotationdefaults\": {\"arrowcolor\": \"#2a3f5f\", \"arrowhead\": 0, \"arrowwidth\": 1}, \"coloraxis\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"colorscale\": {\"diverging\": [[0, \"#8e0152\"], [0.1, \"#c51b7d\"], [0.2, \"#de77ae\"], [0.3, \"#f1b6da\"], [0.4, \"#fde0ef\"], [0.5, \"#f7f7f7\"], [0.6, \"#e6f5d0\"], [0.7, \"#b8e186\"], [0.8, \"#7fbc41\"], [0.9, \"#4d9221\"], [1, \"#276419\"]], \"sequential\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"sequentialminus\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]]}, \"colorway\": [\"#636efa\", \"#EF553B\", \"#00cc96\", \"#ab63fa\", \"#FFA15A\", \"#19d3f3\", \"#FF6692\", \"#B6E880\", \"#FF97FF\", \"#FECB52\"], \"font\": {\"color\": \"#2a3f5f\"}, \"geo\": {\"bgcolor\": \"white\", \"lakecolor\": \"white\", \"landcolor\": \"#E5ECF6\", \"showlakes\": true, \"showland\": true, \"subunitcolor\": \"white\"}, \"hoverlabel\": {\"align\": \"left\"}, \"hovermode\": \"closest\", \"mapbox\": {\"style\": \"light\"}, \"paper_bgcolor\": \"white\", \"plot_bgcolor\": \"#E5ECF6\", \"polar\": {\"angularaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"radialaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"scene\": {\"xaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"yaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"zaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}}, \"shapedefaults\": {\"line\": {\"color\": \"#2a3f5f\"}}, \"ternary\": {\"aaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"baxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"caxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"title\": {\"x\": 0.05}, \"xaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"title\": {\"standoff\": 15}, \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}, \"yaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"title\": {\"standoff\": 15}, \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}}}, \"title\": {\"text\": \"Specificity of COVID-19 tests\", \"x\": 0.5, \"xanchor\": \"center\", \"y\": 0.95, \"yanchor\": \"middle\"}, \"xaxis\": {\"anchor\": \"y\", \"domain\": [0.0, 1.0]}, \"yaxis\": {\"anchor\": \"x\", \"domain\": [0.0, 1.0], \"title\": {\"text\": \"Specificity\"}}},\n",
       "                        {\"responsive\": true}\n",
       "                    ).then(function(){\n",
       "                            \n",
       "var gd = document.getElementById('0db1aaa5-4894-448b-9ff0-ae18f6fdbef5');\n",
       "var x = new MutationObserver(function (mutations, observer) {{\n",
       "        var display = window.getComputedStyle(gd).display;\n",
       "        if (!display || display === 'none') {{\n",
       "            console.log([gd, 'removed!']);\n",
       "            Plotly.purge(gd);\n",
       "            observer.disconnect();\n",
       "        }}\n",
       "}});\n",
       "\n",
       "// Listen for the removal of the full notebook cells\n",
       "var notebookContainer = gd.closest('#notebook-container');\n",
       "if (notebookContainer) {{\n",
       "    x.observe(notebookContainer, {childList: true});\n",
       "}}\n",
       "\n",
       "// Listen for the clearing of the current output cell\n",
       "var outputEl = gd.closest('.output');\n",
       "if (outputEl) {{\n",
       "    x.observe(outputEl, {childList: true});\n",
       "}}\n",
       "\n",
       "                        })\n",
       "                };\n",
       "                });\n",
       "            </script>\n",
       "        </div>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "fig = px.box(tests_df_metrics, y=\"Specificity\", color=\"sub_category\")\n",
    "# fig.update_traces(quartilemethod=\"exclusive\") # or \"inclusive\", or \"linear\" by default\n",
    "fig.update_layout(\n",
    "    title = \n",
    "    {\n",
    "        'text': \"Specificity of COVID-19 tests\",\n",
    "        'y':.95,\n",
    "        'x':0.5,\n",
    "        'xanchor': 'center',\n",
    "        'yanchor': 'middle'\n",
    "    }, \n",
    "    legend_orientation=\"v\"\n",
    ")\n",
    "pio.show(fig)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "        \n",
       "        \n",
       "            <div id=\"d3a116fc-b535-463d-846a-e3c0da07763a\" class=\"plotly-graph-div\" style=\"height:525px; width:100%;\"></div>\n",
       "            <script type=\"text/javascript\">\n",
       "                require([\"plotly\"], function(Plotly) {\n",
       "                    window.PLOTLYENV=window.PLOTLYENV || {};\n",
       "                    \n",
       "                if (document.getElementById(\"d3a116fc-b535-463d-846a-e3c0da07763a\")) {\n",
       "                    Plotly.newPlot(\n",
       "                        'd3a116fc-b535-463d-846a-e3c0da07763a',\n",
       "                        [{\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Category=Molecular<br>Sensitivity=%{y}\", \"legendgroup\": \"Category=Molecular\", \"marker\": {\"color\": \"#636efa\"}, \"name\": \"Category=Molecular\", \"notched\": false, \"offsetgroup\": \"Category=Molecular\", \"orientation\": \"v\", \"showlegend\": true, \"type\": \"box\", \"x0\": \" \", \"xaxis\": \"x\", \"y\": [100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 99.51, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 96.7, 100.0, 100.0, 95.1, 100.0, 100.0, 98.0, 94.87, 100.0, 97.5, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 96.0, 97.1, 96.0, 100.0, 96.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 98.0, 100.0, 100.0, 97.0, 100.0, 100.0], \"y0\": \" \", \"yaxis\": \"y\"}, {\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Category=Serological<br>Sensitivity=%{y}\", \"legendgroup\": \"Category=Serological\", \"marker\": {\"color\": \"#EF553B\"}, \"name\": \"Category=Serological\", \"notched\": false, \"offsetgroup\": \"Category=Serological\", \"orientation\": \"v\", \"showlegend\": true, \"type\": \"box\", \"x0\": \" \", \"xaxis\": \"x\", \"y\": [100.0, 96.6, 88.0, 100.0, 98.0, 83.3, 97.4, 96.6, 100.0, 91.7, 97.2, 100.0, 88.66, 100.0, 96.9, 93.0, 99.42, 100.0, 100.0, 97.2, 81.8, 100.0, 93.8, 75.0, 88.66, 87.3, 73.8, 100.0, 92.0, 87.5, 97.56, 98.4, 100.0], \"y0\": \" \", \"yaxis\": \"y\"}],\n",
       "                        {\"boxmode\": \"group\", \"legend\": {\"orientation\": \"v\", \"tracegroupgap\": 0}, \"margin\": {\"t\": 60}, \"template\": {\"data\": {\"bar\": [{\"error_x\": {\"color\": \"#2a3f5f\"}, \"error_y\": {\"color\": \"#2a3f5f\"}, \"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"bar\"}], \"barpolar\": [{\"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"barpolar\"}], \"carpet\": [{\"aaxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"baxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"type\": \"carpet\"}], \"choropleth\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"choropleth\"}], \"contour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"contour\"}], \"contourcarpet\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"contourcarpet\"}], \"heatmap\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmap\"}], \"heatmapgl\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmapgl\"}], \"histogram\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"histogram\"}], \"histogram2d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2d\"}], \"histogram2dcontour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2dcontour\"}], \"mesh3d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"mesh3d\"}], \"parcoords\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"parcoords\"}], \"pie\": [{\"automargin\": true, \"type\": \"pie\"}], \"scatter\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter\"}], \"scatter3d\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter3d\"}], \"scattercarpet\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattercarpet\"}], \"scattergeo\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergeo\"}], \"scattergl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergl\"}], \"scattermapbox\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattermapbox\"}], \"scatterpolar\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolar\"}], \"scatterpolargl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolargl\"}], \"scatterternary\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterternary\"}], \"surface\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"surface\"}], \"table\": [{\"cells\": {\"fill\": {\"color\": \"#EBF0F8\"}, \"line\": {\"color\": \"white\"}}, \"header\": {\"fill\": {\"color\": \"#C8D4E3\"}, \"line\": {\"color\": \"white\"}}, \"type\": \"table\"}]}, \"layout\": {\"annotationdefaults\": {\"arrowcolor\": \"#2a3f5f\", \"arrowhead\": 0, \"arrowwidth\": 1}, \"coloraxis\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"colorscale\": {\"diverging\": [[0, \"#8e0152\"], [0.1, \"#c51b7d\"], [0.2, \"#de77ae\"], [0.3, \"#f1b6da\"], [0.4, \"#fde0ef\"], [0.5, \"#f7f7f7\"], [0.6, \"#e6f5d0\"], [0.7, \"#b8e186\"], [0.8, \"#7fbc41\"], [0.9, \"#4d9221\"], [1, \"#276419\"]], \"sequential\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"sequentialminus\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]]}, \"colorway\": [\"#636efa\", \"#EF553B\", \"#00cc96\", \"#ab63fa\", \"#FFA15A\", \"#19d3f3\", \"#FF6692\", \"#B6E880\", \"#FF97FF\", \"#FECB52\"], \"font\": {\"color\": \"#2a3f5f\"}, \"geo\": {\"bgcolor\": \"white\", \"lakecolor\": \"white\", \"landcolor\": \"#E5ECF6\", \"showlakes\": true, \"showland\": true, \"subunitcolor\": \"white\"}, \"hoverlabel\": {\"align\": \"left\"}, \"hovermode\": \"closest\", \"mapbox\": {\"style\": \"light\"}, \"paper_bgcolor\": \"white\", \"plot_bgcolor\": \"#E5ECF6\", \"polar\": {\"angularaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"radialaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"scene\": {\"xaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"yaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"zaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}}, \"shapedefaults\": {\"line\": {\"color\": \"#2a3f5f\"}}, \"ternary\": {\"aaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"baxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"caxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"title\": {\"x\": 0.05}, \"xaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"title\": {\"standoff\": 15}, \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}, \"yaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"title\": {\"standoff\": 15}, \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}}}, \"title\": {\"text\": \"Sensitivity of COVID-19 tests\", \"x\": 0.5, \"xanchor\": \"center\", \"y\": 0.95, \"yanchor\": \"top\"}, \"xaxis\": {\"anchor\": \"y\", \"domain\": [0.0, 1.0]}, \"yaxis\": {\"anchor\": \"x\", \"domain\": [0.0, 1.0], \"title\": {\"text\": \"Sensitivity\"}}},\n",
       "                        {\"responsive\": true}\n",
       "                    ).then(function(){\n",
       "                            \n",
       "var gd = document.getElementById('d3a116fc-b535-463d-846a-e3c0da07763a');\n",
       "var x = new MutationObserver(function (mutations, observer) {{\n",
       "        var display = window.getComputedStyle(gd).display;\n",
       "        if (!display || display === 'none') {{\n",
       "            console.log([gd, 'removed!']);\n",
       "            Plotly.purge(gd);\n",
       "            observer.disconnect();\n",
       "        }}\n",
       "}});\n",
       "\n",
       "// Listen for the removal of the full notebook cells\n",
       "var notebookContainer = gd.closest('#notebook-container');\n",
       "if (notebookContainer) {{\n",
       "    x.observe(notebookContainer, {childList: true});\n",
       "}}\n",
       "\n",
       "// Listen for the clearing of the current output cell\n",
       "var outputEl = gd.closest('.output');\n",
       "if (outputEl) {{\n",
       "    x.observe(outputEl, {childList: true});\n",
       "}}\n",
       "\n",
       "                        })\n",
       "                };\n",
       "                });\n",
       "            </script>\n",
       "        </div>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "fig = px.box(tests_df_metrics, y=\"Sensitivity\", color=\"Category\")\n",
    "# fig.update_traces(quartilemethod=\"exclusive\") # or \"inclusive\", or \"linear\" by default\n",
    "fig.update_layout(title= \"Sensitivity of COVID-19 tests\")\n",
    "fig.update_layout(\n",
    "    title = \n",
    "    {\n",
    "        'text': \"Sensitivity of COVID-19 tests\",\n",
    "        'y':.95,\n",
    "        'x':0.5,\n",
    "        'xanchor': 'center',\n",
    "        'yanchor': 'top'\n",
    "    }, \n",
    "    legend_orientation=\"v\"\n",
    ")\n",
    "pio.show(fig)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "        \n",
       "        \n",
       "            <div id=\"1072920b-ed72-4b5a-ae95-8a647b44eac1\" class=\"plotly-graph-div\" style=\"height:525px; width:100%;\"></div>\n",
       "            <script type=\"text/javascript\">\n",
       "                require([\"plotly\"], function(Plotly) {\n",
       "                    window.PLOTLYENV=window.PLOTLYENV || {};\n",
       "                    \n",
       "                if (document.getElementById(\"1072920b-ed72-4b5a-ae95-8a647b44eac1\")) {\n",
       "                    Plotly.newPlot(\n",
       "                        '1072920b-ed72-4b5a-ae95-8a647b44eac1',\n",
       "                        [{\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Category=Molecular<br>Specificity=%{y}\", \"legendgroup\": \"Category=Molecular\", \"marker\": {\"color\": \"#636efa\"}, \"name\": \"Category=Molecular\", \"notched\": false, \"offsetgroup\": \"Category=Molecular\", \"orientation\": \"v\", \"showlegend\": true, \"type\": \"box\", \"x0\": \" \", \"xaxis\": \"x\", \"y\": [100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 96.44, 100.0, 100.0, 100.0, null, 100.0, 100.0, null, 100.0, 100.0, 97.87, 100.0, 100.0, 100.0, 100.0, 100.0, null, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 95.9, null, null, 100.0, 95.0, 100.0, 99.9, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 96.7, 100.0, 100.0, 100.0, 100.0, 98.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, 100.0, null, 93.0, 100.0, 100.0, 100.0, 100.0, 100.0], \"y0\": \" \", \"yaxis\": \"y\"}, {\"alignmentgroup\": \"True\", \"hoverlabel\": {\"namelength\": 0}, \"hovertemplate\": \"Category=Serological<br>Specificity=%{y}\", \"legendgroup\": \"Category=Serological\", \"marker\": {\"color\": \"#EF553B\"}, \"name\": \"Category=Serological\", \"notched\": false, \"offsetgroup\": \"Category=Serological\", \"orientation\": \"v\", \"showlegend\": true, \"type\": \"box\", \"x0\": \" \", \"xaxis\": \"x\", \"y\": [100.0, 95.2, 99.6, 99.81, 98.0, 100.0, 96.2, null, null, 97.5, 100.0, null, 90.63, 92.8, 99.4, 97.5, 98.89, 99.5, 98.0, 100.0, 96.7, 100.0, 96.0, null, 90.63, 100.0, 100.0, 100.0, 100.0, 100.0, 99.3, 99.8, 99.0], \"y0\": \" \", \"yaxis\": \"y\"}],\n",
       "                        {\"boxmode\": \"group\", \"legend\": {\"orientation\": \"v\", \"tracegroupgap\": 0}, \"margin\": {\"t\": 60}, \"template\": {\"data\": {\"bar\": [{\"error_x\": {\"color\": \"#2a3f5f\"}, \"error_y\": {\"color\": \"#2a3f5f\"}, \"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"bar\"}], \"barpolar\": [{\"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"barpolar\"}], \"carpet\": [{\"aaxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"baxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"type\": \"carpet\"}], \"choropleth\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"choropleth\"}], \"contour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"contour\"}], \"contourcarpet\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"contourcarpet\"}], \"heatmap\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmap\"}], \"heatmapgl\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmapgl\"}], \"histogram\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"histogram\"}], \"histogram2d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2d\"}], \"histogram2dcontour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2dcontour\"}], \"mesh3d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"mesh3d\"}], \"parcoords\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"parcoords\"}], \"pie\": [{\"automargin\": true, \"type\": \"pie\"}], \"scatter\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter\"}], \"scatter3d\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter3d\"}], \"scattercarpet\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattercarpet\"}], \"scattergeo\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergeo\"}], \"scattergl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergl\"}], \"scattermapbox\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattermapbox\"}], \"scatterpolar\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolar\"}], \"scatterpolargl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolargl\"}], \"scatterternary\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterternary\"}], \"surface\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"surface\"}], \"table\": [{\"cells\": {\"fill\": {\"color\": \"#EBF0F8\"}, \"line\": {\"color\": \"white\"}}, \"header\": {\"fill\": {\"color\": \"#C8D4E3\"}, \"line\": {\"color\": \"white\"}}, \"type\": \"table\"}]}, \"layout\": {\"annotationdefaults\": {\"arrowcolor\": \"#2a3f5f\", \"arrowhead\": 0, \"arrowwidth\": 1}, \"coloraxis\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"colorscale\": {\"diverging\": [[0, \"#8e0152\"], [0.1, \"#c51b7d\"], [0.2, \"#de77ae\"], [0.3, \"#f1b6da\"], [0.4, \"#fde0ef\"], [0.5, \"#f7f7f7\"], [0.6, \"#e6f5d0\"], [0.7, \"#b8e186\"], [0.8, \"#7fbc41\"], [0.9, \"#4d9221\"], [1, \"#276419\"]], \"sequential\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"sequentialminus\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]]}, \"colorway\": [\"#636efa\", \"#EF553B\", \"#00cc96\", \"#ab63fa\", \"#FFA15A\", \"#19d3f3\", \"#FF6692\", \"#B6E880\", \"#FF97FF\", \"#FECB52\"], \"font\": {\"color\": \"#2a3f5f\"}, \"geo\": {\"bgcolor\": \"white\", \"lakecolor\": \"white\", \"landcolor\": \"#E5ECF6\", \"showlakes\": true, \"showland\": true, \"subunitcolor\": \"white\"}, \"hoverlabel\": {\"align\": \"left\"}, \"hovermode\": \"closest\", \"mapbox\": {\"style\": \"light\"}, \"paper_bgcolor\": \"white\", \"plot_bgcolor\": \"#E5ECF6\", \"polar\": {\"angularaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"radialaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"scene\": {\"xaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"yaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"zaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}}, \"shapedefaults\": {\"line\": {\"color\": \"#2a3f5f\"}}, \"ternary\": {\"aaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"baxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"caxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"title\": {\"x\": 0.05}, \"xaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"title\": {\"standoff\": 15}, \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}, \"yaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"title\": {\"standoff\": 15}, \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}}}, \"title\": {\"text\": \"Specificity of COVID-19 tests\", \"x\": 0.5, \"xanchor\": \"center\", \"y\": 0.95, \"yanchor\": \"middle\"}, \"xaxis\": {\"anchor\": \"y\", \"domain\": [0.0, 1.0]}, \"yaxis\": {\"anchor\": \"x\", \"domain\": [0.0, 1.0], \"title\": {\"text\": \"Specificity\"}}},\n",
       "                        {\"responsive\": true}\n",
       "                    ).then(function(){\n",
       "                            \n",
       "var gd = document.getElementById('1072920b-ed72-4b5a-ae95-8a647b44eac1');\n",
       "var x = new MutationObserver(function (mutations, observer) {{\n",
       "        var display = window.getComputedStyle(gd).display;\n",
       "        if (!display || display === 'none') {{\n",
       "            console.log([gd, 'removed!']);\n",
       "            Plotly.purge(gd);\n",
       "            observer.disconnect();\n",
       "        }}\n",
       "}});\n",
       "\n",
       "// Listen for the removal of the full notebook cells\n",
       "var notebookContainer = gd.closest('#notebook-container');\n",
       "if (notebookContainer) {{\n",
       "    x.observe(notebookContainer, {childList: true});\n",
       "}}\n",
       "\n",
       "// Listen for the clearing of the current output cell\n",
       "var outputEl = gd.closest('.output');\n",
       "if (outputEl) {{\n",
       "    x.observe(outputEl, {childList: true});\n",
       "}}\n",
       "\n",
       "                        })\n",
       "                };\n",
       "                });\n",
       "            </script>\n",
       "        </div>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "fig = px.box(tests_df_metrics, y=\"Specificity\", color=\"Category\")\n",
    "# fig.update_traces(quartilemethod=\"exclusive\") # or \"inclusive\", or \"linear\" by default\n",
    "\n",
    "fig.update_layout(\n",
    "    title = \n",
    "    {\n",
    "        'text': \"Specificity of COVID-19 tests\",\n",
    "        'y':.95,\n",
    "        'x':0.5,\n",
    "        'xanchor': 'center',\n",
    "        'yanchor': 'middle'\n",
    "    }, \n",
    "    legend_orientation=\"v\"\n",
    ")\n",
    "pio.show(fig)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Calculating the median of sensitivity /specificity for each test types"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 94,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['PCR', 'Total antibody', 'IgG/IgM', 'IgM', 'IgG', 'IgA/IgG'],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 94,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sub_categories = tests_df_metrics.sub_category.unique()\n",
    "sub_categories"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "metadata": {},
   "outputs": [],
   "source": [
    "metrics = [\"Sensitivity\", \"Specificity\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "metadata": {},
   "outputs": [],
   "source": [
    "metrics_summary = pd.DataFrame(columns= metrics, index= sub_categories)\n",
    "for i, sc in enumerate(sub_categories):\n",
    "    for j, metric in enumerate(metrics):\n",
    "        metrics_summary.iloc[i, j] = \\\n",
    "        tests_df_metrics.loc[tests_df_metrics.sub_category == sc, metric].median()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 140,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sensitivity</th>\n",
       "      <th>Specificity</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>PCR</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Total antibody</th>\n",
       "      <td>0.973</td>\n",
       "      <td>0.99705</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>IgG/IgM</th>\n",
       "      <td>0.972</td>\n",
       "      <td>0.9775</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>IgM</th>\n",
       "      <td>0.873</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>IgG</th>\n",
       "      <td>0.9756</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>IgA/IgG</th>\n",
       "      <td>1</td>\n",
       "      <td>0.99</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "               Sensitivity Specificity\n",
       "PCR                      1           1\n",
       "Total antibody       0.973     0.99705\n",
       "IgG/IgM              0.972      0.9775\n",
       "IgM                  0.873           1\n",
       "IgG                 0.9756           1\n",
       "IgA/IgG                  1        0.99"
      ]
     },
     "execution_count": 140,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metrics_summary = metrics_summary / 100\n",
    "metrics_summary"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['Molecular', 'Serological'], dtype=object)"
      ]
     },
     "execution_count": 99,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "categories = tests_df_metrics.Category.unique()\n",
    "categories"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "metadata": {},
   "outputs": [],
   "source": [
    "metrics_summary_cat = pd.DataFrame(columns= metrics, index= categories)\n",
    "for i, c in enumerate(categories):\n",
    "    for j, metric in enumerate(metrics):\n",
    "        metrics_summary_cat.iloc[i, j] = \\\n",
    "        tests_df_metrics.loc[tests_df_metrics.Category == c, metric].median()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Sensitivity</th>\n",
       "      <th>Specificity</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>Molecular</th>\n",
       "      <td>100</td>\n",
       "      <td>100</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Serological</th>\n",
       "      <td>97.2</td>\n",
       "      <td>99.4</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "            Sensitivity Specificity\n",
       "Molecular           100         100\n",
       "Serological        97.2        99.4"
      ]
     },
     "execution_count": 102,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metrics_summary_cat"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Probability of being sick when tested positive"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "As of 15.06.2020 there are 126 reported active cases of COVID-19 in Bremen city. However, according to different studies, the actual number of cases can be estimated to be between 10 to 20 times higher.\n",
    "\n",
    "The population of Bremen city is estimated to be around 570k by the end of 2019.\n",
    "\n",
    "Therefore, the probability of being sick of COVID-19 in Bremen city is:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 166,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.004421052631578947"
      ]
     },
     "execution_count": 166,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "126 * 20 / 570000"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 163,
   "metadata": {},
   "outputs": [],
   "source": [
    "prob_sick = np.arange(0.0001, .0201, .0001)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 164,
   "metadata": {},
   "outputs": [],
   "source": [
    "prob_healthy = 1 - prob_sick"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 169,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "        \n",
       "        \n",
       "            <div id=\"22d18468-1aaa-4042-b43b-179f09ad012e\" class=\"plotly-graph-div\" style=\"height:525px; width:100%;\"></div>\n",
       "            <script type=\"text/javascript\">\n",
       "                require([\"plotly\"], function(Plotly) {\n",
       "                    window.PLOTLYENV=window.PLOTLYENV || {};\n",
       "                    \n",
       "                if (document.getElementById(\"22d18468-1aaa-4042-b43b-179f09ad012e\")) {\n",
       "                    Plotly.newPlot(\n",
       "                        '22d18468-1aaa-4042-b43b-179f09ad012e',\n",
       "                        [{\"mode\": \"lines\", \"name\": \"PCR\", \"type\": \"scatter\", \"x\": [0.0001, 0.0002, 0.00030000000000000003, 0.0004, 0.0005, 0.0006000000000000001, 0.0007000000000000001, 0.0008, 0.0009000000000000001, 0.001, 0.0011, 0.0012000000000000001, 0.0013000000000000002, 0.0014000000000000002, 0.0015, 0.0016, 0.0017000000000000001, 0.0018000000000000002, 0.0019000000000000002, 0.002, 0.0021, 0.0022, 0.0023, 0.0024, 0.0025, 0.0026, 0.0027, 0.0028, 0.0029, 0.003, 0.0031, 0.0032, 0.0033, 0.0034, 0.0035, 0.0036, 0.0037, 0.0038, 0.0039, 0.004, 0.0041, 0.004200000000000001, 0.004300000000000001, 0.0044, 0.0045000000000000005, 0.004600000000000001, 0.0047, 0.0048000000000000004, 0.004900000000000001, 0.005, 0.0051, 0.005200000000000001, 0.005300000000000001, 0.0054, 0.0055000000000000005, 0.005600000000000001, 0.0057, 0.0058000000000000005, 0.005900000000000001, 0.006, 0.0061, 0.006200000000000001, 0.006300000000000001, 0.0064, 0.006500000000000001, 0.006600000000000001, 0.0067, 0.0068000000000000005, 0.006900000000000001, 0.007000000000000001, 0.0071, 0.007200000000000001, 0.007300000000000001, 0.0074, 0.007500000000000001, 0.007600000000000001, 0.0077, 0.0078000000000000005, 0.0079, 0.008, 0.0081, 0.008199999999999999, 0.0083, 0.0084, 0.0085, 0.0086, 0.0087, 0.0088, 0.0089, 0.009, 0.0091, 0.0092, 0.0093, 0.0094, 0.0095, 0.0096, 0.0097, 0.0098, 0.009899999999999999, 0.01, 0.0101, 0.0102, 0.0103, 0.0104, 0.0105, 0.0106, 0.0107, 0.0108, 0.0109, 0.011, 0.0111, 0.0112, 0.0113, 0.0114, 0.0115, 0.0116, 0.0117, 0.0118, 0.011899999999999999, 0.012, 0.0121, 0.0122, 0.0123, 0.0124, 0.0125, 0.0126, 0.0127, 0.0128, 0.0129, 0.013, 0.0131, 0.0132, 0.0133, 0.0134, 0.0135, 0.0136, 0.0137, 0.0138, 0.013900000000000001, 0.014, 0.0141, 0.0142, 0.0143, 0.0144, 0.0145, 0.0146, 0.0147, 0.0148, 0.0149, 0.015, 0.0151, 0.0152, 0.0153, 0.0154, 0.0155, 0.0156, 0.015700000000000002, 0.0158, 0.0159, 0.016, 0.0161, 0.0162, 0.0163, 0.0164, 0.0165, 0.0166, 0.0167, 0.0168, 0.016900000000000002, 0.017, 0.0171, 0.0172, 0.0173, 0.0174, 0.0175, 0.0176, 0.0177, 0.0178, 0.0179, 0.018, 0.0181, 0.0182, 0.0183, 0.0184, 0.0185, 0.018600000000000002, 0.0187, 0.0188, 0.0189, 0.019, 0.0191, 0.019200000000000002, 0.0193, 0.0194, 0.0195, 0.0196, 0.0197, 0.0198, 0.0199, 0.02], \"y\": [1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0]}, {\"mode\": \"lines\", \"name\": \"Total antibody\", \"type\": \"scatter\", \"x\": [0.0001, 0.0002, 0.00030000000000000003, 0.0004, 0.0005, 0.0006000000000000001, 0.0007000000000000001, 0.0008, 0.0009000000000000001, 0.001, 0.0011, 0.0012000000000000001, 0.0013000000000000002, 0.0014000000000000002, 0.0015, 0.0016, 0.0017000000000000001, 0.0018000000000000002, 0.0019000000000000002, 0.002, 0.0021, 0.0022, 0.0023, 0.0024, 0.0025, 0.0026, 0.0027, 0.0028, 0.0029, 0.003, 0.0031, 0.0032, 0.0033, 0.0034, 0.0035, 0.0036, 0.0037, 0.0038, 0.0039, 0.004, 0.0041, 0.004200000000000001, 0.004300000000000001, 0.0044, 0.0045000000000000005, 0.004600000000000001, 0.0047, 0.0048000000000000004, 0.004900000000000001, 0.005, 0.0051, 0.005200000000000001, 0.005300000000000001, 0.0054, 0.0055000000000000005, 0.005600000000000001, 0.0057, 0.0058000000000000005, 0.005900000000000001, 0.006, 0.0061, 0.006200000000000001, 0.006300000000000001, 0.0064, 0.006500000000000001, 0.006600000000000001, 0.0067, 0.0068000000000000005, 0.006900000000000001, 0.007000000000000001, 0.0071, 0.007200000000000001, 0.007300000000000001, 0.0074, 0.007500000000000001, 0.007600000000000001, 0.0077, 0.0078000000000000005, 0.0079, 0.008, 0.0081, 0.008199999999999999, 0.0083, 0.0084, 0.0085, 0.0086, 0.0087, 0.0088, 0.0089, 0.009, 0.0091, 0.0092, 0.0093, 0.0094, 0.0095, 0.0096, 0.0097, 0.0098, 0.009899999999999999, 0.01, 0.0101, 0.0102, 0.0103, 0.0104, 0.0105, 0.0106, 0.0107, 0.0108, 0.0109, 0.011, 0.0111, 0.0112, 0.0113, 0.0114, 0.0115, 0.0116, 0.0117, 0.0118, 0.011899999999999999, 0.012, 0.0121, 0.0122, 0.0123, 0.0124, 0.0125, 0.0126, 0.0127, 0.0128, 0.0129, 0.013, 0.0131, 0.0132, 0.0133, 0.0134, 0.0135, 0.0136, 0.0137, 0.0138, 0.013900000000000001, 0.014, 0.0141, 0.0142, 0.0143, 0.0144, 0.0145, 0.0146, 0.0147, 0.0148, 0.0149, 0.015, 0.0151, 0.0152, 0.0153, 0.0154, 0.0155, 0.0156, 0.015700000000000002, 0.0158, 0.0159, 0.016, 0.0161, 0.0162, 0.0163, 0.0164, 0.0165, 0.0166, 0.0167, 0.0168, 0.016900000000000002, 0.017, 0.0171, 0.0172, 0.0173, 0.0174, 0.0175, 0.0176, 0.0177, 0.0178, 0.0179, 0.018, 0.0181, 0.0182, 0.0183, 0.0184, 0.0185, 0.018600000000000002, 0.0187, 0.0188, 0.0189, 0.019, 0.0191, 0.019200000000000002, 0.0193, 0.0194, 0.0195, 0.0196, 0.0197, 0.0198, 0.0199, 0.02], \"y\": [0.03193299649984157, 0.0618954774316874, 0.09006437798035469, 0.11659606593130031, 0.14162924578423705, 0.16528738430873993, 0.18768074708565738, 0.20890811692842756, 0.22905825068760585, 0.24821111975612503, 0.26643897083808854, 0.28380723664700996, 0.30037532073240325, 0.3161972762745261, 0.3313223951919087, 0.3457957210889183, 0.35965849728804694, 0.37294855933340226, 0.38570067983213285, 0.3979468722521005, 0.40971665926424183, 0.4210373103650386, 0.4319340528052352, 0.44243025925897794, 0.4525476151717395, 0.4623062683086835, 0.4717249626737359, 0.48082115867239356, 0.4896111411390822, 0.498110116635239, 0.5063323012411118, 0.5142909999075009, 0.5219986782991507, 0.5294670279457818, 0.5367070254169499, 0.5437289861506502, 0.5505426134908242, 0.5571570434240122, 0.5635808854488835, 0.5698222599631043, 0.5758888325089261, 0.5817878451811657, 0.5875261454681533, 0.5931102127671358, 0.5985461827900024, 0.6038398700526016, 0.6089967886209441, 0.614022171269904, 0.6189209871943571, 0.6236979583987686, 0.6283575748788655, 0.6329041086979902, 0.6373416270508994, 0.641674004398975, 0.6459049337529527, 0.6500379371722246, 0.6540763755434561, 0.6580234576955764, 0.661882248903098, 0.6656556788251251, 0.669346548923263, 0.6729575393979006, 0.6764912156789599, 0.6799500345041444, 0.6833363496149508, 0.6866524170981985, 0.6899004003985459, 0.6930823750254018, 0.6962003329757459, 0.6992561868926677, 0.7022517739778624, 0.7051888596749055, 0.7080691411388175, 0.7108942505062508, 0.7136657579795356, 0.7163851747368334, 0.7190539556797252, 0.7216735020287374, 0.724245163776529, 0.7267702420077675, 0.7292499910940687, 0.7316856207717789, 0.7340782981098335, 0.736429149374415, 0.7387392617966708, 0.7410096852493213, 0.7432414338375868, 0.7454354874095015, 0.7475927929903404, 0.7497142661455675, 0.7518007922764293, 0.7538532278520449, 0.7558724015815936, 0.7578591155299714, 0.7598141461800705, 0.7617382454446404, 0.7636321416304963, 0.7654965403576764, 0.7673321254359836, 0.7691395597011971, 0.7709194858131058, 0.7726725270173789, 0.7743992878731736, 0.7761003549482605, 0.7777762974833509, 0.7794276680272022, 0.7810550030439917, 0.7826588234943622, 0.7842396353914595, 0.7857979303332092, 0.7873341860120112, 0.7888488667029564, 0.7903424237316214, 0.7918152959224242, 0.7932679100284811, 0.7947006811438481, 0.7961140130989811, 0.797508298840211, 0.7988839207939779, 0.8002412512165362, 0.8015806525298027, 0.802902477643982, 0.8042070702675748, 0.8054947652053389, 0.806765888644749, 0.8080207584314646, 0.809259684334301, 0.8104829683001615, 0.8116909046993768, 0.8128837805618655, 0.8140618758045182, 0.8152254634501789, 0.8163748098385875, 0.8175101748296248, 0.8186318119991831, 0.8197399688279762, 0.8208348868835814, 0.8219168019959975, 0.8229859444269834, 0.8240425390334343, 0.8250868054250418, 0.8261189581164633, 0.8271392066742299, 0.8281477558585988, 0.8291448057605534, 0.8301305519341445, 0.8311051855243554, 0.8320688933906671, 0.8330218582264906, 0.8339642586746279, 0.8348962694389139, 0.8358180613921858, 0.836729801680721, 0.8376316538252766, 0.8385237778188591, 0.8394063302213484, 0.8402794642510896, 0.8411433298735715, 0.841998073887294, 0.8428438400069295, 0.8436807689438787, 0.844508998484313, 0.8453286635647986, 0.8461398963455823, 0.8469428262816308, 0.8477375801914987, 0.8485242823241032, 0.849303054423479, 0.8500740157915861, 0.8508372833492359, 0.8515929716952036, 0.8523411931635873, 0.8530820578794753, 0.8538156738129804, 0.8545421468316946, 0.8552615807516198, 0.8559740773866249, 0.8566797365964791, 0.8573786563335093, 0.8580709326879262, 0.858756659931865, 0.8594359305621811, 0.8601088353420441, 0.8607754633413655, 0.8614359019761026, 0.8620902370464719, 0.8627385527741073, 0.8633809318381981, 0.864017455410639, 0.8646482031902227, 0.8652732534359063, 0.8658926829991802, 0.8665065673555672, 0.8671149806352801, 0.8677179956530634, 0.8683156839372431, 0.8689081157580113, 0.8694953601549666, 0.8700774849639353, 0.870654556843094]}, {\"mode\": \"lines\", \"name\": \"IgG/IgM\", \"type\": \"scatter\", \"x\": [0.0001, 0.0002, 0.00030000000000000003, 0.0004, 0.0005, 0.0006000000000000001, 0.0007000000000000001, 0.0008, 0.0009000000000000001, 0.001, 0.0011, 0.0012000000000000001, 0.0013000000000000002, 0.0014000000000000002, 0.0015, 0.0016, 0.0017000000000000001, 0.0018000000000000002, 0.0019000000000000002, 0.002, 0.0021, 0.0022, 0.0023, 0.0024, 0.0025, 0.0026, 0.0027, 0.0028, 0.0029, 0.003, 0.0031, 0.0032, 0.0033, 0.0034, 0.0035, 0.0036, 0.0037, 0.0038, 0.0039, 0.004, 0.0041, 0.004200000000000001, 0.004300000000000001, 0.0044, 0.0045000000000000005, 0.004600000000000001, 0.0047, 0.0048000000000000004, 0.004900000000000001, 0.005, 0.0051, 0.005200000000000001, 0.005300000000000001, 0.0054, 0.0055000000000000005, 0.005600000000000001, 0.0057, 0.0058000000000000005, 0.005900000000000001, 0.006, 0.0061, 0.006200000000000001, 0.006300000000000001, 0.0064, 0.006500000000000001, 0.006600000000000001, 0.0067, 0.0068000000000000005, 0.006900000000000001, 0.007000000000000001, 0.0071, 0.007200000000000001, 0.007300000000000001, 0.0074, 0.007500000000000001, 0.007600000000000001, 0.0077, 0.0078000000000000005, 0.0079, 0.008, 0.0081, 0.008199999999999999, 0.0083, 0.0084, 0.0085, 0.0086, 0.0087, 0.0088, 0.0089, 0.009, 0.0091, 0.0092, 0.0093, 0.0094, 0.0095, 0.0096, 0.0097, 0.0098, 0.009899999999999999, 0.01, 0.0101, 0.0102, 0.0103, 0.0104, 0.0105, 0.0106, 0.0107, 0.0108, 0.0109, 0.011, 0.0111, 0.0112, 0.0113, 0.0114, 0.0115, 0.0116, 0.0117, 0.0118, 0.011899999999999999, 0.012, 0.0121, 0.0122, 0.0123, 0.0124, 0.0125, 0.0126, 0.0127, 0.0128, 0.0129, 0.013, 0.0131, 0.0132, 0.0133, 0.0134, 0.0135, 0.0136, 0.0137, 0.0138, 0.013900000000000001, 0.014, 0.0141, 0.0142, 0.0143, 0.0144, 0.0145, 0.0146, 0.0147, 0.0148, 0.0149, 0.015, 0.0151, 0.0152, 0.0153, 0.0154, 0.0155, 0.0156, 0.015700000000000002, 0.0158, 0.0159, 0.016, 0.0161, 0.0162, 0.0163, 0.0164, 0.0165, 0.0166, 0.0167, 0.0168, 0.016900000000000002, 0.017, 0.0171, 0.0172, 0.0173, 0.0174, 0.0175, 0.0176, 0.0177, 0.0178, 0.0179, 0.018, 0.0181, 0.0182, 0.0183, 0.0184, 0.0185, 0.018600000000000002, 0.0187, 0.0188, 0.0189, 0.019, 0.0191, 0.019200000000000002, 0.0193, 0.0194, 0.0195, 0.0196, 0.0197, 0.0198, 0.0199, 0.02], \"y\": [0.004301846208998036, 0.008567688707310315, 0.012797977603539215, 0.016993155534576376, 0.021153657819998072, 0.025279912612647802, 0.02937234104551552, 0.0334313573750194, 0.037457369120792366, 0.0414507772020726, 0.04541197607079382, 0.049341353841468136, 0.05323929241795128, 0.05710616761717727, 0.06094234928994648, 0.06474820143884902, 0.06852408233340186, 0.07227034462247678, 0.07598733544409278, 0.0796753965326449, 0.08333486432363922, 0.08696607005600102, 0.0905693398720217, 0.09414499491500812, 0.09769335142469483, 0.1012147208304799, 0.10470940984254107, 0.10817772054088874, 0.11161995046241038, 0.11503639268595793, 0.11842733591553048, 0.12179306456160152, 0.12513385882063813, 0.12844999475285987, 0.13174174435828195, 0.13500937565108706, 0.13825315273236824, 0.1414733358612846, 0.14467018152467, 0.14784394250513366, 0.1509948679476908, 0.15412320342496033, 0.15722919100096514, 0.16031306929357014, 0.16337507353559144, 0.1664154356346098, 0.16943438423152052, 0.17243214475785015, 0.17540893949187114, 0.17836498761354277, 0.1813005052583074, 0.18421570556977, 0.18711079875128736, 0.18998599211649372, 0.19284149013878768, 0.19567749449980615, 0.19849420413690835, 0.2012918152896947, 0.20407052154558147, 0.20683051388445606, 0.2095719807224319, 0.21229510795472586, 0.21500007899767776, 0.21768707482993224, 0.22035627403280258, 0.2230078528298348, 0.22564198512559083, 0.2282588425436691, 0.23085859446397897, 0.23344140805928704, 0.23600744833105092, 0.23855687814455792, 0.2410898582633827, 0.24360654738318072, 0.24610710216483128, 0.24859167726694564, 0.25106042537775325, 0.2535134972463815, 0.25595104171354033, 0.2583732057416271, 0.2607801344442625, 0.26317197111527174, 0.26554885725712113, 0.26791093260882437, 0.27025833517332776, 0.27259120124438735, 0.2749096654329479, 0.277213860693035, 0.27950391834717025, 0.2817799681113208, 0.28404213811939166, 0.2862905549472717, 0.2885253436364422, 0.2907466277171582, 0.2929545292312088, 0.29514916875427044, 0.2973306654178555, 0.2994991369308699, 0.3016546996007846, 0.30379746835443067, 0.3059275567584247, 0.30804507703923306, 0.3101501401028819, 0.3122428555543203, 0.3143233317164441, 0.3163916756487857, 0.3184479931658793, 0.3204923888553062, 0.3225249660954263, 0.3245458270728046, 0.3265550727993357, 0.32855280312907464, 0.33053911677477926, 0.3325141113241692, 0.3344778832559082, 0.33643052795531475, 0.33837213972980607, 0.3403028118240812, 0.3422226364350481, 0.3441317047265006, 0.34603010684354807, 0.3479179319268045, 0.3497952681263416, 0.3516622026154092, 0.3535188216039284, 0.3553652103517618, 0.35720145318176527, 0.3590276334926245, 0.3608438337714815, 0.3626501356063545, 0.36444661969835557, 0.3662333658737094, 0.36801045309557695, 0.3697779594756883, 0.37153596228578745, 0.37328453796889327, 0.3750237621503799, 0.3767537096488793, 0.3784744544870101, 0.38018606990193654, 0.3818886283557576, 0.38358220154573464, 0.3852668604143543, 0.386942675159236, 0.38860971524288146, 0.3902680494022725, 0.391917745658319, 0.3935588713251592, 0.39519149301931544, 0.39681567666870826, 0.39843148752153074, 0.4000389901549863, 0.4016382484838913, 0.4032293257691472, 0.404812284626081, 0.4063871870326599, 0.4079540943375803, 0.4095130672682334, 0.41106416593855144, 0.4126074498567339, 0.4141429779328581, 0.4156708084863751, 0.41719099925349296, 0.41870360739444984, 0.42020868950067836, 0.4217063016018633, 0.4231964991728947, 0.4246793371407176, 0.4261548698910801, 0.4276231512751838, 0.4290842346162339, 0.4305381727158953, 0.43198501786065263, 0.43342482182807884, 0.43485763589301163, 0.4362835108336397, 0.4377024969375025, 0.4391146440074012, 0.4405200013672257, 0.4419186178676976, 0.4433105418920301, 0.4446958213615081, 0.4460745037409865, 0.44744663604431273, 0.4488122648396702, 0.45017143625484657, 0.45152419598242777, 0.4528705892849181, 0.45421066099978896, 0.4555444555444559, 0.4568720169211862, 0.4581933887219378, 0.4595086141331309, 0.46081773594035275, 0.46212079653299726, 0.46341783790884045, 0.46470890167855267, 0.465994029070148, 0.4672732609333729, 0.4685466377440351]}, {\"mode\": \"lines\", \"name\": \"IgM\", \"type\": \"scatter\", \"x\": [0.0001, 0.0002, 0.00030000000000000003, 0.0004, 0.0005, 0.0006000000000000001, 0.0007000000000000001, 0.0008, 0.0009000000000000001, 0.001, 0.0011, 0.0012000000000000001, 0.0013000000000000002, 0.0014000000000000002, 0.0015, 0.0016, 0.0017000000000000001, 0.0018000000000000002, 0.0019000000000000002, 0.002, 0.0021, 0.0022, 0.0023, 0.0024, 0.0025, 0.0026, 0.0027, 0.0028, 0.0029, 0.003, 0.0031, 0.0032, 0.0033, 0.0034, 0.0035, 0.0036, 0.0037, 0.0038, 0.0039, 0.004, 0.0041, 0.004200000000000001, 0.004300000000000001, 0.0044, 0.0045000000000000005, 0.004600000000000001, 0.0047, 0.0048000000000000004, 0.004900000000000001, 0.005, 0.0051, 0.005200000000000001, 0.005300000000000001, 0.0054, 0.0055000000000000005, 0.005600000000000001, 0.0057, 0.0058000000000000005, 0.005900000000000001, 0.006, 0.0061, 0.006200000000000001, 0.006300000000000001, 0.0064, 0.006500000000000001, 0.006600000000000001, 0.0067, 0.0068000000000000005, 0.006900000000000001, 0.007000000000000001, 0.0071, 0.007200000000000001, 0.007300000000000001, 0.0074, 0.007500000000000001, 0.007600000000000001, 0.0077, 0.0078000000000000005, 0.0079, 0.008, 0.0081, 0.008199999999999999, 0.0083, 0.0084, 0.0085, 0.0086, 0.0087, 0.0088, 0.0089, 0.009, 0.0091, 0.0092, 0.0093, 0.0094, 0.0095, 0.0096, 0.0097, 0.0098, 0.009899999999999999, 0.01, 0.0101, 0.0102, 0.0103, 0.0104, 0.0105, 0.0106, 0.0107, 0.0108, 0.0109, 0.011, 0.0111, 0.0112, 0.0113, 0.0114, 0.0115, 0.0116, 0.0117, 0.0118, 0.011899999999999999, 0.012, 0.0121, 0.0122, 0.0123, 0.0124, 0.0125, 0.0126, 0.0127, 0.0128, 0.0129, 0.013, 0.0131, 0.0132, 0.0133, 0.0134, 0.0135, 0.0136, 0.0137, 0.0138, 0.013900000000000001, 0.014, 0.0141, 0.0142, 0.0143, 0.0144, 0.0145, 0.0146, 0.0147, 0.0148, 0.0149, 0.015, 0.0151, 0.0152, 0.0153, 0.0154, 0.0155, 0.0156, 0.015700000000000002, 0.0158, 0.0159, 0.016, 0.0161, 0.0162, 0.0163, 0.0164, 0.0165, 0.0166, 0.0167, 0.0168, 0.016900000000000002, 0.017, 0.0171, 0.0172, 0.0173, 0.0174, 0.0175, 0.0176, 0.0177, 0.0178, 0.0179, 0.018, 0.0181, 0.0182, 0.0183, 0.0184, 0.0185, 0.018600000000000002, 0.0187, 0.0188, 0.0189, 0.019, 0.0191, 0.019200000000000002, 0.0193, 0.0194, 0.0195, 0.0196, 0.0197, 0.0198, 0.0199, 0.02], \"y\": [1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0]}, {\"mode\": \"lines\", \"name\": \"IgG\", \"type\": \"scatter\", \"x\": [0.0001, 0.0002, 0.00030000000000000003, 0.0004, 0.0005, 0.0006000000000000001, 0.0007000000000000001, 0.0008, 0.0009000000000000001, 0.001, 0.0011, 0.0012000000000000001, 0.0013000000000000002, 0.0014000000000000002, 0.0015, 0.0016, 0.0017000000000000001, 0.0018000000000000002, 0.0019000000000000002, 0.002, 0.0021, 0.0022, 0.0023, 0.0024, 0.0025, 0.0026, 0.0027, 0.0028, 0.0029, 0.003, 0.0031, 0.0032, 0.0033, 0.0034, 0.0035, 0.0036, 0.0037, 0.0038, 0.0039, 0.004, 0.0041, 0.004200000000000001, 0.004300000000000001, 0.0044, 0.0045000000000000005, 0.004600000000000001, 0.0047, 0.0048000000000000004, 0.004900000000000001, 0.005, 0.0051, 0.005200000000000001, 0.005300000000000001, 0.0054, 0.0055000000000000005, 0.005600000000000001, 0.0057, 0.0058000000000000005, 0.005900000000000001, 0.006, 0.0061, 0.006200000000000001, 0.006300000000000001, 0.0064, 0.006500000000000001, 0.006600000000000001, 0.0067, 0.0068000000000000005, 0.006900000000000001, 0.007000000000000001, 0.0071, 0.007200000000000001, 0.007300000000000001, 0.0074, 0.007500000000000001, 0.007600000000000001, 0.0077, 0.0078000000000000005, 0.0079, 0.008, 0.0081, 0.008199999999999999, 0.0083, 0.0084, 0.0085, 0.0086, 0.0087, 0.0088, 0.0089, 0.009, 0.0091, 0.0092, 0.0093, 0.0094, 0.0095, 0.0096, 0.0097, 0.0098, 0.009899999999999999, 0.01, 0.0101, 0.0102, 0.0103, 0.0104, 0.0105, 0.0106, 0.0107, 0.0108, 0.0109, 0.011, 0.0111, 0.0112, 0.0113, 0.0114, 0.0115, 0.0116, 0.0117, 0.0118, 0.011899999999999999, 0.012, 0.0121, 0.0122, 0.0123, 0.0124, 0.0125, 0.0126, 0.0127, 0.0128, 0.0129, 0.013, 0.0131, 0.0132, 0.0133, 0.0134, 0.0135, 0.0136, 0.0137, 0.0138, 0.013900000000000001, 0.014, 0.0141, 0.0142, 0.0143, 0.0144, 0.0145, 0.0146, 0.0147, 0.0148, 0.0149, 0.015, 0.0151, 0.0152, 0.0153, 0.0154, 0.0155, 0.0156, 0.015700000000000002, 0.0158, 0.0159, 0.016, 0.0161, 0.0162, 0.0163, 0.0164, 0.0165, 0.0166, 0.0167, 0.0168, 0.016900000000000002, 0.017, 0.0171, 0.0172, 0.0173, 0.0174, 0.0175, 0.0176, 0.0177, 0.0178, 0.0179, 0.018, 0.0181, 0.0182, 0.0183, 0.0184, 0.0185, 0.018600000000000002, 0.0187, 0.0188, 0.0189, 0.019, 0.0191, 0.019200000000000002, 0.0193, 0.0194, 0.0195, 0.0196, 0.0197, 0.0198, 0.0199, 0.02], \"y\": [1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0]}, {\"mode\": \"lines\", \"name\": \"IgA/IgG\", \"type\": \"scatter\", \"x\": [0.0001, 0.0002, 0.00030000000000000003, 0.0004, 0.0005, 0.0006000000000000001, 0.0007000000000000001, 0.0008, 0.0009000000000000001, 0.001, 0.0011, 0.0012000000000000001, 0.0013000000000000002, 0.0014000000000000002, 0.0015, 0.0016, 0.0017000000000000001, 0.0018000000000000002, 0.0019000000000000002, 0.002, 0.0021, 0.0022, 0.0023, 0.0024, 0.0025, 0.0026, 0.0027, 0.0028, 0.0029, 0.003, 0.0031, 0.0032, 0.0033, 0.0034, 0.0035, 0.0036, 0.0037, 0.0038, 0.0039, 0.004, 0.0041, 0.004200000000000001, 0.004300000000000001, 0.0044, 0.0045000000000000005, 0.004600000000000001, 0.0047, 0.0048000000000000004, 0.004900000000000001, 0.005, 0.0051, 0.005200000000000001, 0.005300000000000001, 0.0054, 0.0055000000000000005, 0.005600000000000001, 0.0057, 0.0058000000000000005, 0.005900000000000001, 0.006, 0.0061, 0.006200000000000001, 0.006300000000000001, 0.0064, 0.006500000000000001, 0.006600000000000001, 0.0067, 0.0068000000000000005, 0.006900000000000001, 0.007000000000000001, 0.0071, 0.007200000000000001, 0.007300000000000001, 0.0074, 0.007500000000000001, 0.007600000000000001, 0.0077, 0.0078000000000000005, 0.0079, 0.008, 0.0081, 0.008199999999999999, 0.0083, 0.0084, 0.0085, 0.0086, 0.0087, 0.0088, 0.0089, 0.009, 0.0091, 0.0092, 0.0093, 0.0094, 0.0095, 0.0096, 0.0097, 0.0098, 0.009899999999999999, 0.01, 0.0101, 0.0102, 0.0103, 0.0104, 0.0105, 0.0106, 0.0107, 0.0108, 0.0109, 0.011, 0.0111, 0.0112, 0.0113, 0.0114, 0.0115, 0.0116, 0.0117, 0.0118, 0.011899999999999999, 0.012, 0.0121, 0.0122, 0.0123, 0.0124, 0.0125, 0.0126, 0.0127, 0.0128, 0.0129, 0.013, 0.0131, 0.0132, 0.0133, 0.0134, 0.0135, 0.0136, 0.0137, 0.0138, 0.013900000000000001, 0.014, 0.0141, 0.0142, 0.0143, 0.0144, 0.0145, 0.0146, 0.0147, 0.0148, 0.0149, 0.015, 0.0151, 0.0152, 0.0153, 0.0154, 0.0155, 0.0156, 0.015700000000000002, 0.0158, 0.0159, 0.016, 0.0161, 0.0162, 0.0163, 0.0164, 0.0165, 0.0166, 0.0167, 0.0168, 0.016900000000000002, 0.017, 0.0171, 0.0172, 0.0173, 0.0174, 0.0175, 0.0176, 0.0177, 0.0178, 0.0179, 0.018, 0.0181, 0.0182, 0.0183, 0.0184, 0.0185, 0.018600000000000002, 0.0187, 0.0188, 0.0189, 0.019, 0.0191, 0.019200000000000002, 0.0193, 0.0194, 0.0195, 0.0196, 0.0197, 0.0198, 0.0199, 0.02], \"y\": [0.009901970492127925, 0.019611688566385548, 0.029134699427017553, 0.03847633705271255, 0.04764173415912335, 0.056635831602794, 0.06546338726269518, 0.07412898443291321, 0.08263703975759797, 0.09099181073703358, 0.09919740283163488, 0.10725777618877361, 0.11517675201559306, 0.12295801861935703, 0.1306051371353939, 0.13812154696132586, 0.1455105709150046, 0.15277542013240528, 0.1599191987206463, 0.16694490818030036, 0.1738554516102325, 0.18065363770734097, 0.18734218457277824, 0.19392372333548788, 0.20040080160320625, 0.20677588675043726, 0.21305136905231584, 0.21922956467272142, 0.22531271851448975, 0.23130300693909003, 0.23720254036269015, 0.24301336573511526, 0.24873746890781623, 0.2543767768966031, 0.2599331600445598, 0.26540843409023873, 0.27080436214594145, 0.27612265659061164, 0.2813649808816101, 0.2865329512893981, 0.29162813855893005, 0.2966520695013419, 0.3016062285193237, 0.30649205906937843, 0.31131096506399153, 0.31606431221657266, 0.3207534293318772, 0.3253796095444684, 0.3299441115076424, 0.3344481605351169, 0.33889294969765416, 0.3432796408766832, 0.34760936577687396, 0.3518832268995176, 0.3561022984784718, 0.3602676273803395, 0.36438023397046576, 0.3684411129462582, 0.37245123413925874, 0.37641154328732723, 0.3803229627782279, 0.3841863923658444, 0.3880027098601957, 0.3917727717923602, 0.39549741405536937, 0.39917745252207554, 0.40281368364095455, 0.4064068850107576, 0.4099578159348819, 0.4134672179562905, 0.41693581537377394, 0.420364315740308, 0.4237534103442269, 0.4271037746739003, 0.4304160688665708, 0.43369093814197657, 0.4369290132213583, 0.4401309107324228, 0.4432972336008078, 0.44642857142857123, 0.44952550086020293, 0.4525885859366373, 0.45561837843772274, 0.4586154182135835, 0.4615802335052944, 0.46451334125526605, 0.46741524740772555, 0.47028644719965773, 0.47312742544256, 0.4759386567953461, 0.4787206060287231, 0.48147372828134793, 0.4841984693080645, 0.4868952657205011, 0.4895645452203038, 0.4922067268252664, 0.4948222210886087, 0.49741143031164325, 0.4999747487500629, 0.5025125628140702, 0.5050252512625628, 0.507513185391581, 0.5099767292172103, 0.5124162396531334, 0.5148320666830103, 0.5172245535278616, 0.519594036808624, 0.5219408467040401, 0.5242653071040351, 0.526567735758736, 0.5288484444232692, 0.5311077389984823, 0.5333459196677205, 0.5355632810297846, 0.5377601122281971, 0.5399366970768942, 0.5420933141824582, 0.5442302370630013, 0.5463477342638077, 0.5484460694698352, 0.5505255016151779, 0.5525862849895823, 0.554628669342111, 0.5566528999820431, 0.5586592178770947, 0.5606478597490432, 0.5626190581668362, 0.5645730416372615, 0.56651003469325, 0.5684302579798861, 0.5703339283381947, 0.5722212588867693, 0.5740924591013077, 0.575947734892117, 0.5777872886796488, 0.5796113194681212, 0.5814200229172855, 0.5832135914123909, 0.5849922141324015, 0.5867560771165128, 0.5885053633290201, 0.5902402527225868, 0.5919609222999542, 0.5936675461741423, 0.5953602956271811, 0.5970393391674161, 0.5987048425854273, 0.6003569690085996, 0.6019958789543854, 0.6036217303822936, 0.6052346787446389, 0.6068348770360905, 0.6084224758420484, 0.6099976233858827, 0.6115604655750638, 0.613111146046219, 0.6146498062091373, 0.6161765852897587, 0.6176916203721687, 0.6191950464396283, 0.620686996414665, 0.6221676011982485, 0.6236369897080765, 0.6250952889159931, 0.626542623884564, 0.6279791178028294, 0.6294048920212564, 0.6308200660859115, 0.6322247577718751, 0.6336190831159149, 0.6350031564484383, 0.6363770904247444, 0.6377409960555901, 0.6390949827370893, 0.6404391582799632, 0.6417736289381561, 0.6430984994368344, 0.6444138729997826, 0.6457198513762127, 0.647016534867002, 0.6483040223503705, 0.6495824113070168, 0.65085179784472, 0.6521122767224268, 0.6533639413738299, 0.6546068839304567, 0.6558411952442743, 0.6570669649098279, 0.6582842812859181, 0.6594932315168343, 0.6606939015531493, 0.6618863761720902, 0.6630707389974919, 0.6642470725193451, 0.6654154581129498, 0.666575976057679, 0.667728705555367, 0.6688737247483276, 0.670011110737012, 0.6711409395973152]}],\n",
       "                        {\"template\": {\"data\": {\"bar\": [{\"error_x\": {\"color\": \"#2a3f5f\"}, \"error_y\": {\"color\": \"#2a3f5f\"}, \"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"bar\"}], \"barpolar\": [{\"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"barpolar\"}], \"carpet\": [{\"aaxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"baxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"type\": \"carpet\"}], \"choropleth\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"choropleth\"}], \"contour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"contour\"}], \"contourcarpet\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"contourcarpet\"}], \"heatmap\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmap\"}], \"heatmapgl\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmapgl\"}], \"histogram\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"histogram\"}], \"histogram2d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2d\"}], \"histogram2dcontour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2dcontour\"}], \"mesh3d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"mesh3d\"}], \"parcoords\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"parcoords\"}], \"pie\": [{\"automargin\": true, \"type\": \"pie\"}], \"scatter\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter\"}], \"scatter3d\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter3d\"}], \"scattercarpet\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattercarpet\"}], \"scattergeo\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergeo\"}], \"scattergl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergl\"}], \"scattermapbox\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattermapbox\"}], \"scatterpolar\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolar\"}], \"scatterpolargl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolargl\"}], \"scatterternary\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterternary\"}], \"surface\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"surface\"}], \"table\": [{\"cells\": {\"fill\": {\"color\": \"#EBF0F8\"}, \"line\": {\"color\": \"white\"}}, \"header\": {\"fill\": {\"color\": \"#C8D4E3\"}, \"line\": {\"color\": \"white\"}}, \"type\": \"table\"}]}, \"layout\": {\"annotationdefaults\": {\"arrowcolor\": \"#2a3f5f\", \"arrowhead\": 0, \"arrowwidth\": 1}, \"coloraxis\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"colorscale\": {\"diverging\": [[0, \"#8e0152\"], [0.1, \"#c51b7d\"], [0.2, \"#de77ae\"], [0.3, \"#f1b6da\"], [0.4, \"#fde0ef\"], [0.5, \"#f7f7f7\"], [0.6, \"#e6f5d0\"], [0.7, \"#b8e186\"], [0.8, \"#7fbc41\"], [0.9, \"#4d9221\"], [1, \"#276419\"]], \"sequential\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"sequentialminus\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]]}, \"colorway\": [\"#636efa\", \"#EF553B\", \"#00cc96\", \"#ab63fa\", \"#FFA15A\", \"#19d3f3\", \"#FF6692\", \"#B6E880\", \"#FF97FF\", \"#FECB52\"], \"font\": {\"color\": \"#2a3f5f\"}, \"geo\": {\"bgcolor\": \"white\", \"lakecolor\": \"white\", \"landcolor\": \"#E5ECF6\", \"showlakes\": true, \"showland\": true, \"subunitcolor\": \"white\"}, \"hoverlabel\": {\"align\": \"left\"}, \"hovermode\": \"closest\", \"mapbox\": {\"style\": \"light\"}, \"paper_bgcolor\": \"white\", \"plot_bgcolor\": \"#E5ECF6\", \"polar\": {\"angularaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"radialaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"scene\": {\"xaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"yaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"zaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}}, \"shapedefaults\": {\"line\": {\"color\": \"#2a3f5f\"}}, \"ternary\": {\"aaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"baxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"caxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"title\": {\"x\": 0.05}, \"xaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"title\": {\"standoff\": 15}, \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}, \"yaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"title\": {\"standoff\": 15}, \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}}}, \"title\": {\"text\": \"Probabilities of being sick when tested positive\", \"x\": 0.5, \"xanchor\": \"center\", \"y\": 0.9, \"yanchor\": \"middle\"}, \"xaxis\": {\"title\": {\"text\": \"Probabilities of being sick\"}}},\n",
       "                        {\"responsive\": true}\n",
       "                    ).then(function(){\n",
       "                            \n",
       "var gd = document.getElementById('22d18468-1aaa-4042-b43b-179f09ad012e');\n",
       "var x = new MutationObserver(function (mutations, observer) {{\n",
       "        var display = window.getComputedStyle(gd).display;\n",
       "        if (!display || display === 'none') {{\n",
       "            console.log([gd, 'removed!']);\n",
       "            Plotly.purge(gd);\n",
       "            observer.disconnect();\n",
       "        }}\n",
       "}});\n",
       "\n",
       "// Listen for the removal of the full notebook cells\n",
       "var notebookContainer = gd.closest('#notebook-container');\n",
       "if (notebookContainer) {{\n",
       "    x.observe(notebookContainer, {childList: true});\n",
       "}}\n",
       "\n",
       "// Listen for the clearing of the current output cell\n",
       "var outputEl = gd.closest('.output');\n",
       "if (outputEl) {{\n",
       "    x.observe(outputEl, {childList: true});\n",
       "}}\n",
       "\n",
       "                        })\n",
       "                };\n",
       "                });\n",
       "            </script>\n",
       "        </div>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "fig = go.Figure()\n",
    "                       \n",
    "for i, test in enumerate(metrics_summary.index):\n",
    "    metrics = metrics_summary.loc[test]\n",
    "    fig.add_trace(go.Scatter(x= prob_sick,\n",
    "                             y= metrics.Sensitivity*prob_sick/(metrics.Sensitivity*prob_sick + (1 - metrics.Specificity)*prob_healthy),\n",
    "                                mode= \"lines\", \n",
    "                                name= test)\n",
    "                  )\n",
    "\n",
    "fig.update_layout(title= {\"text\": \"Probability of having COVID-19 when tested positive\", \n",
    "                          'y':.9,\n",
    "                          'x':0.5,\n",
    "                          'xanchor': 'center',\n",
    "                          'yanchor': 'middle'\n",
    "                         }, \n",
    "                 xaxis_title= \"Probability of having COVID-19\")\n",
    "fig.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 167,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "        \n",
       "        \n",
       "            <div id=\"d5cb8efb-18f0-4e0e-b9c3-61f8c83dc1ee\" class=\"plotly-graph-div\" style=\"height:525px; width:100%;\"></div>\n",
       "            <script type=\"text/javascript\">\n",
       "                require([\"plotly\"], function(Plotly) {\n",
       "                    window.PLOTLYENV=window.PLOTLYENV || {};\n",
       "                    \n",
       "                if (document.getElementById(\"d5cb8efb-18f0-4e0e-b9c3-61f8c83dc1ee\")) {\n",
       "                    Plotly.newPlot(\n",
       "                        'd5cb8efb-18f0-4e0e-b9c3-61f8c83dc1ee',\n",
       "                        [{\"mode\": \"lines\", \"name\": \"PCR\", \"type\": \"scatter\", \"x\": [0.0001, 0.0002, 0.00030000000000000003, 0.0004, 0.0005, 0.0006000000000000001, 0.0007000000000000001, 0.0008, 0.0009000000000000001, 0.001, 0.0011, 0.0012000000000000001, 0.0013000000000000002, 0.0014000000000000002, 0.0015, 0.0016, 0.0017000000000000001, 0.0018000000000000002, 0.0019000000000000002, 0.002, 0.0021, 0.0022, 0.0023, 0.0024, 0.0025, 0.0026, 0.0027, 0.0028, 0.0029, 0.003, 0.0031, 0.0032, 0.0033, 0.0034, 0.0035, 0.0036, 0.0037, 0.0038, 0.0039, 0.004, 0.0041, 0.004200000000000001, 0.004300000000000001, 0.0044, 0.0045000000000000005, 0.004600000000000001, 0.0047, 0.0048000000000000004, 0.004900000000000001, 0.005, 0.0051, 0.005200000000000001, 0.005300000000000001, 0.0054, 0.0055000000000000005, 0.005600000000000001, 0.0057, 0.0058000000000000005, 0.005900000000000001, 0.006, 0.0061, 0.006200000000000001, 0.006300000000000001, 0.0064, 0.006500000000000001, 0.006600000000000001, 0.0067, 0.0068000000000000005, 0.006900000000000001, 0.007000000000000001, 0.0071, 0.007200000000000001, 0.007300000000000001, 0.0074, 0.007500000000000001, 0.007600000000000001, 0.0077, 0.0078000000000000005, 0.0079, 0.008, 0.0081, 0.008199999999999999, 0.0083, 0.0084, 0.0085, 0.0086, 0.0087, 0.0088, 0.0089, 0.009, 0.0091, 0.0092, 0.0093, 0.0094, 0.0095, 0.0096, 0.0097, 0.0098, 0.009899999999999999, 0.01, 0.0101, 0.0102, 0.0103, 0.0104, 0.0105, 0.0106, 0.0107, 0.0108, 0.0109, 0.011, 0.0111, 0.0112, 0.0113, 0.0114, 0.0115, 0.0116, 0.0117, 0.0118, 0.011899999999999999, 0.012, 0.0121, 0.0122, 0.0123, 0.0124, 0.0125, 0.0126, 0.0127, 0.0128, 0.0129, 0.013, 0.0131, 0.0132, 0.0133, 0.0134, 0.0135, 0.0136, 0.0137, 0.0138, 0.013900000000000001, 0.014, 0.0141, 0.0142, 0.0143, 0.0144, 0.0145, 0.0146, 0.0147, 0.0148, 0.0149, 0.015, 0.0151, 0.0152, 0.0153, 0.0154, 0.0155, 0.0156, 0.015700000000000002, 0.0158, 0.0159, 0.016, 0.0161, 0.0162, 0.0163, 0.0164, 0.0165, 0.0166, 0.0167, 0.0168, 0.016900000000000002, 0.017, 0.0171, 0.0172, 0.0173, 0.0174, 0.0175, 0.0176, 0.0177, 0.0178, 0.0179, 0.018, 0.0181, 0.0182, 0.0183, 0.0184, 0.0185, 0.018600000000000002, 0.0187, 0.0188, 0.0189, 0.019, 0.0191, 0.019200000000000002, 0.0193, 0.0194, 0.0195, 0.0196, 0.0197, 0.0198, 0.0199, 0.02], \"y\": [1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0]}, {\"mode\": \"lines\", \"name\": \"Total antibody\", \"type\": \"scatter\", \"x\": [0.0001, 0.0002, 0.00030000000000000003, 0.0004, 0.0005, 0.0006000000000000001, 0.0007000000000000001, 0.0008, 0.0009000000000000001, 0.001, 0.0011, 0.0012000000000000001, 0.0013000000000000002, 0.0014000000000000002, 0.0015, 0.0016, 0.0017000000000000001, 0.0018000000000000002, 0.0019000000000000002, 0.002, 0.0021, 0.0022, 0.0023, 0.0024, 0.0025, 0.0026, 0.0027, 0.0028, 0.0029, 0.003, 0.0031, 0.0032, 0.0033, 0.0034, 0.0035, 0.0036, 0.0037, 0.0038, 0.0039, 0.004, 0.0041, 0.004200000000000001, 0.004300000000000001, 0.0044, 0.0045000000000000005, 0.004600000000000001, 0.0047, 0.0048000000000000004, 0.004900000000000001, 0.005, 0.0051, 0.005200000000000001, 0.005300000000000001, 0.0054, 0.0055000000000000005, 0.005600000000000001, 0.0057, 0.0058000000000000005, 0.005900000000000001, 0.006, 0.0061, 0.006200000000000001, 0.006300000000000001, 0.0064, 0.006500000000000001, 0.006600000000000001, 0.0067, 0.0068000000000000005, 0.006900000000000001, 0.007000000000000001, 0.0071, 0.007200000000000001, 0.007300000000000001, 0.0074, 0.007500000000000001, 0.007600000000000001, 0.0077, 0.0078000000000000005, 0.0079, 0.008, 0.0081, 0.008199999999999999, 0.0083, 0.0084, 0.0085, 0.0086, 0.0087, 0.0088, 0.0089, 0.009, 0.0091, 0.0092, 0.0093, 0.0094, 0.0095, 0.0096, 0.0097, 0.0098, 0.009899999999999999, 0.01, 0.0101, 0.0102, 0.0103, 0.0104, 0.0105, 0.0106, 0.0107, 0.0108, 0.0109, 0.011, 0.0111, 0.0112, 0.0113, 0.0114, 0.0115, 0.0116, 0.0117, 0.0118, 0.011899999999999999, 0.012, 0.0121, 0.0122, 0.0123, 0.0124, 0.0125, 0.0126, 0.0127, 0.0128, 0.0129, 0.013, 0.0131, 0.0132, 0.0133, 0.0134, 0.0135, 0.0136, 0.0137, 0.0138, 0.013900000000000001, 0.014, 0.0141, 0.0142, 0.0143, 0.0144, 0.0145, 0.0146, 0.0147, 0.0148, 0.0149, 0.015, 0.0151, 0.0152, 0.0153, 0.0154, 0.0155, 0.0156, 0.015700000000000002, 0.0158, 0.0159, 0.016, 0.0161, 0.0162, 0.0163, 0.0164, 0.0165, 0.0166, 0.0167, 0.0168, 0.016900000000000002, 0.017, 0.0171, 0.0172, 0.0173, 0.0174, 0.0175, 0.0176, 0.0177, 0.0178, 0.0179, 0.018, 0.0181, 0.0182, 0.0183, 0.0184, 0.0185, 0.018600000000000002, 0.0187, 0.0188, 0.0189, 0.019, 0.0191, 0.019200000000000002, 0.0193, 0.0194, 0.0195, 0.0196, 0.0197, 0.0198, 0.0199, 0.02], \"y\": [0.9999972917479424, 0.9999945829687997, 0.999991873662418, 0.9999891638286433, 0.9999864534673216, 0.9999837425782988, 0.9999810311614209, 0.9999783192165336, 0.9999756067434826, 0.9999728937421137, 0.9999701802122726, 0.9999674661538047, 0.9999647515665556, 0.9999620364503707, 0.9999593208050955, 0.9999566046305752, 0.9999538879266551, 0.9999511706931806, 0.9999484529299966, 0.9999457346369481, 0.9999430158138805, 0.9999402964606384, 0.9999375765770672, 0.9999348561630111, 0.9999321352183154, 0.9999294137428245, 0.9999266917363833, 0.9999239691988363, 0.9999212461300281, 0.9999185225298031, 0.9999157983980057, 0.9999130737344804, 0.9999103485390713, 0.9999076228116229, 0.9999048965519792, 0.9999021697599844, 0.9998994424354825, 0.9998967145783175, 0.9998939861883334, 0.999891257265374, 0.9998885278092831, 0.9998857978199045, 0.999883067297082, 0.9998803362406591, 0.9998776046504793, 0.9998748725263862, 0.9998721398682233, 0.999869406675834, 0.9998666729490615, 0.9998639386877491, 0.99986120389174, 0.9998584685608775, 0.9998557326950045, 0.999852996293964, 0.9998502593575991, 0.9998475218857524, 0.9998447838782671, 0.999842045334986, 0.9998393062557515, 0.9998365666404063, 0.9998338264887932, 0.9998310858007545, 0.9998283445761329, 0.9998256028147706, 0.9998228605165099, 0.9998201176811934, 0.9998173743086629, 0.999814630398761, 0.9998118859513293, 0.9998091409662102, 0.9998063954432456, 0.9998036493822773, 0.9998009027831474, 0.9997981556456972, 0.9997954079697688, 0.9997926597552039, 0.9997899110018439, 0.9997871617095305, 0.9997844118781051, 0.999781661507409, 0.9997789105972836, 0.9997761591475703, 0.9997734071581104, 0.9997706546287448, 0.9997679015593147, 0.9997651479496612, 0.9997623937996252, 0.9997596391090477, 0.9997568838777695, 0.9997541281056315, 0.9997513717924741, 0.9997486149381383, 0.9997458575424647, 0.9997430996052935, 0.9997403411264655, 0.999737582105821, 0.9997348225432003, 0.9997320624384439, 0.9997293017913917, 0.9997265406018842, 0.9997237788697612, 0.9997210165948629, 0.9997182537770293, 0.9997154904161002, 0.9997127265119155, 0.999709962064315, 0.9997071970731383, 0.9997044315382253, 0.9997016654594154, 0.9996988988365482, 0.9996961316694631, 0.9996933639579996, 0.9996905957019971, 0.9996878269012947, 0.9996850575557317, 0.9996822876651472, 0.9996795172293804, 0.9996767462482704, 0.999673974721656, 0.999671202649376, 0.9996684300312694, 0.999665656867175, 0.9996628831569315, 0.9996601089003774, 0.9996573340973514, 0.9996545587476919, 0.9996517828512376, 0.9996490064078268, 0.9996462294172976, 0.9996434518794886, 0.9996406737942377, 0.9996378951613832, 0.9996351159807633, 0.9996323362522157, 0.9996295559755785, 0.9996267751506895, 0.9996239937773866, 0.9996212118555078, 0.9996184293848903, 0.999615646365372, 0.9996128627967905, 0.9996100786789831, 0.9996072940117876, 0.9996045087950408, 0.9996017230285805, 0.9995989367122438, 0.9995961498458676, 0.9995933624292894, 0.9995905744623462, 0.9995877859448747, 0.9995849968767121, 0.9995822072576951, 0.9995794170876606, 0.9995766263664453, 0.9995738350938858, 0.9995710432698186, 0.9995682508940804, 0.9995654579665076, 0.9995626644869368, 0.999559870455204, 0.9995570758711456, 0.9995542807345978, 0.9995514850453969, 0.999548688803379, 0.9995458920083797, 0.9995430946602354, 0.9995402967587816, 0.9995374983038545, 0.9995346992952897, 0.9995318997329228, 0.9995290996165894, 0.9995262989461253, 0.9995234977213657, 0.9995206959421464, 0.9995178936083023, 0.999515090719669, 0.9995122872760817, 0.9995094832773754, 0.9995066787233856, 0.9995038736139469, 0.9995010679488945, 0.9994982617280631, 0.9994954549512879, 0.9994926476184034, 0.9994898397292443, 0.9994870312836454, 0.9994842222814411, 0.999481412722466, 0.9994786026065549, 0.9994757919335414, 0.9994729807032605, 0.9994701689155461, 0.9994673565702326, 0.999464543667154, 0.9994617302061443, 0.9994589161870375, 0.9994561016096677, 0.9994532864738686, 0.9994504707794741, 0.9994476545263178]}, {\"mode\": \"lines\", \"name\": \"IgG/IgM\", \"type\": \"scatter\", \"x\": [0.0001, 0.0002, 0.00030000000000000003, 0.0004, 0.0005, 0.0006000000000000001, 0.0007000000000000001, 0.0008, 0.0009000000000000001, 0.001, 0.0011, 0.0012000000000000001, 0.0013000000000000002, 0.0014000000000000002, 0.0015, 0.0016, 0.0017000000000000001, 0.0018000000000000002, 0.0019000000000000002, 0.002, 0.0021, 0.0022, 0.0023, 0.0024, 0.0025, 0.0026, 0.0027, 0.0028, 0.0029, 0.003, 0.0031, 0.0032, 0.0033, 0.0034, 0.0035, 0.0036, 0.0037, 0.0038, 0.0039, 0.004, 0.0041, 0.004200000000000001, 0.004300000000000001, 0.0044, 0.0045000000000000005, 0.004600000000000001, 0.0047, 0.0048000000000000004, 0.004900000000000001, 0.005, 0.0051, 0.005200000000000001, 0.005300000000000001, 0.0054, 0.0055000000000000005, 0.005600000000000001, 0.0057, 0.0058000000000000005, 0.005900000000000001, 0.006, 0.0061, 0.006200000000000001, 0.006300000000000001, 0.0064, 0.006500000000000001, 0.006600000000000001, 0.0067, 0.0068000000000000005, 0.006900000000000001, 0.007000000000000001, 0.0071, 0.007200000000000001, 0.007300000000000001, 0.0074, 0.007500000000000001, 0.007600000000000001, 0.0077, 0.0078000000000000005, 0.0079, 0.008, 0.0081, 0.008199999999999999, 0.0083, 0.0084, 0.0085, 0.0086, 0.0087, 0.0088, 0.0089, 0.009, 0.0091, 0.0092, 0.0093, 0.0094, 0.0095, 0.0096, 0.0097, 0.0098, 0.009899999999999999, 0.01, 0.0101, 0.0102, 0.0103, 0.0104, 0.0105, 0.0106, 0.0107, 0.0108, 0.0109, 0.011, 0.0111, 0.0112, 0.0113, 0.0114, 0.0115, 0.0116, 0.0117, 0.0118, 0.011899999999999999, 0.012, 0.0121, 0.0122, 0.0123, 0.0124, 0.0125, 0.0126, 0.0127, 0.0128, 0.0129, 0.013, 0.0131, 0.0132, 0.0133, 0.0134, 0.0135, 0.0136, 0.0137, 0.0138, 0.013900000000000001, 0.014, 0.0141, 0.0142, 0.0143, 0.0144, 0.0145, 0.0146, 0.0147, 0.0148, 0.0149, 0.015, 0.0151, 0.0152, 0.0153, 0.0154, 0.0155, 0.0156, 0.015700000000000002, 0.0158, 0.0159, 0.016, 0.0161, 0.0162, 0.0163, 0.0164, 0.0165, 0.0166, 0.0167, 0.0168, 0.016900000000000002, 0.017, 0.0171, 0.0172, 0.0173, 0.0174, 0.0175, 0.0176, 0.0177, 0.0178, 0.0179, 0.018, 0.0181, 0.0182, 0.0183, 0.0184, 0.0185, 0.018600000000000002, 0.0187, 0.0188, 0.0189, 0.019, 0.0191, 0.019200000000000002, 0.0193, 0.0194, 0.0195, 0.0196, 0.0197, 0.0198, 0.0199, 0.02], \"y\": [0.9999971352716052, 0.9999942699865682, 0.999991404144727, 0.9999885377459191, 0.9999856707899822, 0.9999828032767537, 0.9999799352060713, 0.9999770665777724, 0.9999741973916942, 0.9999713276476742, 0.9999684573455494, 0.9999655864851572, 0.9999627150663346, 0.9999598430889187, 0.9999569705527466, 0.999954097457655, 0.9999512238034807, 0.9999483495900607, 0.9999454748172317, 0.9999425994848304, 0.9999397235926932, 0.9999368471406569, 0.9999339701285579, 0.9999310925562324, 0.999928214423517, 0.9999253357302479, 0.9999224564762613, 0.9999195766613933, 0.9999166962854802, 0.9999138153483579, 0.9999109338498622, 0.9999080517898293, 0.999905169168095, 0.9999022859844949, 0.9998994022388648, 0.9998965179310403, 0.9998936330608571, 0.9998907476281506, 0.9998878616327561, 0.9998849750745095, 0.9998820879532456, 0.9998792002687998, 0.9998763120210076, 0.9998734232097038, 0.9998705338347237, 0.9998676438959019, 0.9998647533930738, 0.999861862326074, 0.9998589706947374, 0.9998560784988987, 0.9998531857383928, 0.999850292413054, 0.9998473985227169, 0.9998445040672161, 0.9998416090463862, 0.9998387134600613, 0.9998358173080756, 0.9998329205902635, 0.9998300233064593, 0.9998271254564969, 0.9998242270402102, 0.9998213280574335, 0.9998184285080006, 0.9998155283917451, 0.9998126277085012, 0.9998097264581023, 0.9998068246403822, 0.9998039222551741, 0.9998010193023121, 0.9997981157816292, 0.999795211692959, 0.9997923070361349, 0.9997894018109899, 0.9997864960173574, 0.9997835896550702, 0.9997806827239618, 0.9997777752238649, 0.9997748671546126, 0.9997719585160375, 0.9997690493079727, 0.9997661395302508, 0.9997632291827044, 0.9997603182651662, 0.9997574067774688, 0.9997544947194444, 0.9997515820909256, 0.9997486688917449, 0.9997457551217342, 0.999742840780726, 0.9997399258685521, 0.9997370103850449, 0.9997340943300365, 0.9997311777033584, 0.9997282605048429, 0.9997253427343215, 0.9997224243916262, 0.9997195054765884, 0.99971658598904, 0.9997136659288124, 0.9997107452957371, 0.9997078240896455, 0.999704902310369, 0.9997019799577388, 0.9996990570315861, 0.9996961335317422, 0.9996932094580382, 0.999690284810305, 0.9996873595883733, 0.9996844337920744, 0.9996815074212391, 0.9996785804756977, 0.9996756529552815, 0.9996727248598207, 0.999669796189146, 0.9996668669430877, 0.9996639371214766, 0.9996610067241427, 0.9996580757509165, 0.999655144201628, 0.9996522120761075, 0.9996492793741852, 0.9996463460956909, 0.9996434122404546, 0.9996404778083063, 0.9996375427990758, 0.9996346072125926, 0.9996316710486867, 0.9996287343071876, 0.9996257969879248, 0.9996228590907278, 0.999619920615426, 0.9996169815618489, 0.9996140419298255, 0.9996111017191853, 0.9996081609297575, 0.9996052195613708, 0.9996022776138543, 0.9995993350870372, 0.9995963919807483, 0.9995934482948164, 0.99959050402907, 0.9995875591833382, 0.9995846137574492, 0.9995816677512317, 0.9995787211645143, 0.9995757739971253, 0.999572826248893, 0.9995698779196456, 0.9995669290092115, 0.9995639795174188, 0.9995610294440954, 0.9995580787890694, 0.9995551275521688, 0.9995521757332214, 0.9995492233320549, 0.9995462703484972, 0.9995433167823758, 0.9995403626335185, 0.9995374079017526, 0.9995344525869057, 0.999531496688805, 0.999528540207278, 0.999525583142152, 0.9995226254932541, 0.9995196672604113, 0.9995167084434508, 0.9995137490421995, 0.9995107890564844, 0.9995078284861322, 0.9995048673309697, 0.9995019055908236, 0.9994989432655208, 0.9994959803548874, 0.9994930168587504, 0.9994900527769358, 0.9994870881092702, 0.9994841228555799, 0.999481157015691, 0.9994781905894297, 0.9994752235766221, 0.9994722559770941, 0.9994692877906719, 0.9994663190171813, 0.9994633496564479, 0.9994603797082977, 0.9994574091725563, 0.9994544380490492, 0.999451466337602, 0.9994484940380403, 0.9994455211501893, 0.9994425476738744, 0.9994395736089208, 0.9994365989551538, 0.9994336237123985, 0.9994306478804798, 0.999427671459223, 0.9994246944484527, 0.9994217168479939, 0.9994187386576712, 0.9994157598773096]}, {\"mode\": \"lines\", \"name\": \"IgM\", \"type\": \"scatter\", \"x\": [0.0001, 0.0002, 0.00030000000000000003, 0.0004, 0.0005, 0.0006000000000000001, 0.0007000000000000001, 0.0008, 0.0009000000000000001, 0.001, 0.0011, 0.0012000000000000001, 0.0013000000000000002, 0.0014000000000000002, 0.0015, 0.0016, 0.0017000000000000001, 0.0018000000000000002, 0.0019000000000000002, 0.002, 0.0021, 0.0022, 0.0023, 0.0024, 0.0025, 0.0026, 0.0027, 0.0028, 0.0029, 0.003, 0.0031, 0.0032, 0.0033, 0.0034, 0.0035, 0.0036, 0.0037, 0.0038, 0.0039, 0.004, 0.0041, 0.004200000000000001, 0.004300000000000001, 0.0044, 0.0045000000000000005, 0.004600000000000001, 0.0047, 0.0048000000000000004, 0.004900000000000001, 0.005, 0.0051, 0.005200000000000001, 0.005300000000000001, 0.0054, 0.0055000000000000005, 0.005600000000000001, 0.0057, 0.0058000000000000005, 0.005900000000000001, 0.006, 0.0061, 0.006200000000000001, 0.006300000000000001, 0.0064, 0.006500000000000001, 0.006600000000000001, 0.0067, 0.0068000000000000005, 0.006900000000000001, 0.007000000000000001, 0.0071, 0.007200000000000001, 0.007300000000000001, 0.0074, 0.007500000000000001, 0.007600000000000001, 0.0077, 0.0078000000000000005, 0.0079, 0.008, 0.0081, 0.008199999999999999, 0.0083, 0.0084, 0.0085, 0.0086, 0.0087, 0.0088, 0.0089, 0.009, 0.0091, 0.0092, 0.0093, 0.0094, 0.0095, 0.0096, 0.0097, 0.0098, 0.009899999999999999, 0.01, 0.0101, 0.0102, 0.0103, 0.0104, 0.0105, 0.0106, 0.0107, 0.0108, 0.0109, 0.011, 0.0111, 0.0112, 0.0113, 0.0114, 0.0115, 0.0116, 0.0117, 0.0118, 0.011899999999999999, 0.012, 0.0121, 0.0122, 0.0123, 0.0124, 0.0125, 0.0126, 0.0127, 0.0128, 0.0129, 0.013, 0.0131, 0.0132, 0.0133, 0.0134, 0.0135, 0.0136, 0.0137, 0.0138, 0.013900000000000001, 0.014, 0.0141, 0.0142, 0.0143, 0.0144, 0.0145, 0.0146, 0.0147, 0.0148, 0.0149, 0.015, 0.0151, 0.0152, 0.0153, 0.0154, 0.0155, 0.0156, 0.015700000000000002, 0.0158, 0.0159, 0.016, 0.0161, 0.0162, 0.0163, 0.0164, 0.0165, 0.0166, 0.0167, 0.0168, 0.016900000000000002, 0.017, 0.0171, 0.0172, 0.0173, 0.0174, 0.0175, 0.0176, 0.0177, 0.0178, 0.0179, 0.018, 0.0181, 0.0182, 0.0183, 0.0184, 0.0185, 0.018600000000000002, 0.0187, 0.0188, 0.0189, 0.019, 0.0191, 0.019200000000000002, 0.0193, 0.0194, 0.0195, 0.0196, 0.0197, 0.0198, 0.0199, 0.02], \"y\": [0.9999872988911932, 0.9999745955643856, 0.9999618900189959, 0.9999491822544432, 0.9999364722701459, 0.9999237600655223, 0.9999110456399907, 0.9998983289929686, 0.9998856101238743, 0.999872889032125, 0.9998601657171382, 0.9998474401783307, 0.9998347124151199, 0.9998219824269222, 0.9998092502131541, 0.9997965157732321, 0.999783779106572, 0.99977104021259, 0.9997582990907018, 0.9997455557403226, 0.999732810160868, 0.9997200623517527, 0.9997073123123921, 0.9996945600422005, 0.9996818055405924, 0.9996690488069822, 0.9996562898407837, 0.999643528641411, 0.9996307652082778, 0.9996179995407973, 0.9996052316383829, 0.9995924615004477, 0.9995796891264043, 0.9995669145156654, 0.9995541376676436, 0.9995413585817506, 0.9995285772573991, 0.9995157936940005, 0.9995030078909664, 0.9994902198477083, 0.999477429563637, 0.9994646370381641, 0.9994518422706999, 0.9994390452606553, 0.9994262460074402, 0.9994134445104651, 0.9994006407691398, 0.9993878347828742, 0.9993750265510776, 0.9993622160731593, 0.9993494033485286, 0.9993365883765943, 0.9993237711567653, 0.9993109516884497, 0.9992981299710559, 0.9992853060039923, 0.9992724797866664, 0.999259651318486, 0.9992468205988586, 0.9992339876271912, 0.9992211524028911, 0.999208314925365, 0.9991954751940196, 0.9991826332082613, 0.999169788967496, 0.9991569424711302, 0.9991440937185693, 0.999131242709219, 0.9991183894424847, 0.9991055339177715, 0.9990926761344844, 0.9990798160920281, 0.9990669537898071, 0.9990540892272257, 0.9990412224036881, 0.9990283533185982, 0.9990154819713597, 0.999002608361376, 0.9989897324880503, 0.9989768543507859, 0.9989639739489855, 0.9989510912820517, 0.9989382063493871, 0.9989253191503936, 0.9989124296844736, 0.9988995379510287, 0.9988866439494606, 0.9988737476791704, 0.9988608491395596, 0.998847948330029, 0.9988350452499795, 0.9988221398988113, 0.998809232275925, 0.9987963223807207, 0.9987834102125982, 0.9987704957709572, 0.9987575790551974, 0.9987446600647176, 0.9987317387989174, 0.9987188152571953, 0.9987058894389501, 0.9986929613435801, 0.9986800309704834, 0.9986670983190584, 0.9986541633887026, 0.9986412261788136, 0.9986282866887886, 0.9986153449180251, 0.9986024008659198, 0.9985894545318695, 0.9985765059152708, 0.9985635550155197, 0.9985506018320126, 0.9985376463641452, 0.9985246886113133, 0.9985117285729123, 0.9984987662483371, 0.9984858016369832, 0.9984728347382452, 0.9984598655515178, 0.9984468940761951, 0.9984339203116714, 0.9984209442573408, 0.9984079659125971, 0.9983949852768335, 0.9983820023494434, 0.99836901712982, 0.9983560296173561, 0.9983430398114446, 0.9983300477114776, 0.9983170533168474, 0.9983040566269462, 0.9982910576411658, 0.9982780563588977, 0.9982650527795333, 0.9982520469024635, 0.9982390387270798, 0.9982260282527725, 0.9982130154789323, 0.9982000004049494, 0.9981869830302138, 0.9981739633541156, 0.9981609413760444, 0.9981479170953896, 0.9981348905115403, 0.9981218616238857, 0.9981088304318145, 0.9980957969347153, 0.9980827611319765, 0.9980697230229859, 0.998056682607132, 0.9980436398838021, 0.9980305948523839, 0.9980175475122645, 0.9980044978628309, 0.9979914459034701, 0.9979783916335688, 0.9979653350525134, 0.9979522761596898, 0.9979392149544842, 0.9979261514362824, 0.9979130856044698, 0.9979000174584318, 0.9978869469975533, 0.9978738742212195, 0.997860799128815, 0.997847721719724, 0.997834641993331, 0.9978215599490198, 0.9978084755861744, 0.9977953889041783, 0.9977822999024147, 0.997769208580267, 0.9977561149371178, 0.9977430189723501, 0.9977299206853462, 0.9977168200754885, 0.9977037171421589, 0.9976906118847392, 0.9976775043026113, 0.9976643943951562, 0.9976512821617552, 0.9976381676017894, 0.9976250507146394, 0.9976119314996856, 0.9975988099563086, 0.9975856860838881, 0.997572559881804, 0.9975594313494363, 0.997546300486164, 0.9975331672913664, 0.9975200317644226, 0.997506893904711, 0.9974937537116105, 0.9974806111844994, 0.9974674663227554, 0.9974543191257568, 0.9974411695928808, 0.9974280177235051, 0.9974148635170069]}, {\"mode\": \"lines\", \"name\": \"IgG\", \"type\": \"scatter\", \"x\": [0.0001, 0.0002, 0.00030000000000000003, 0.0004, 0.0005, 0.0006000000000000001, 0.0007000000000000001, 0.0008, 0.0009000000000000001, 0.001, 0.0011, 0.0012000000000000001, 0.0013000000000000002, 0.0014000000000000002, 0.0015, 0.0016, 0.0017000000000000001, 0.0018000000000000002, 0.0019000000000000002, 0.002, 0.0021, 0.0022, 0.0023, 0.0024, 0.0025, 0.0026, 0.0027, 0.0028, 0.0029, 0.003, 0.0031, 0.0032, 0.0033, 0.0034, 0.0035, 0.0036, 0.0037, 0.0038, 0.0039, 0.004, 0.0041, 0.004200000000000001, 0.004300000000000001, 0.0044, 0.0045000000000000005, 0.004600000000000001, 0.0047, 0.0048000000000000004, 0.004900000000000001, 0.005, 0.0051, 0.005200000000000001, 0.005300000000000001, 0.0054, 0.0055000000000000005, 0.005600000000000001, 0.0057, 0.0058000000000000005, 0.005900000000000001, 0.006, 0.0061, 0.006200000000000001, 0.006300000000000001, 0.0064, 0.006500000000000001, 0.006600000000000001, 0.0067, 0.0068000000000000005, 0.006900000000000001, 0.007000000000000001, 0.0071, 0.007200000000000001, 0.007300000000000001, 0.0074, 0.007500000000000001, 0.007600000000000001, 0.0077, 0.0078000000000000005, 0.0079, 0.008, 0.0081, 0.008199999999999999, 0.0083, 0.0084, 0.0085, 0.0086, 0.0087, 0.0088, 0.0089, 0.009, 0.0091, 0.0092, 0.0093, 0.0094, 0.0095, 0.0096, 0.0097, 0.0098, 0.009899999999999999, 0.01, 0.0101, 0.0102, 0.0103, 0.0104, 0.0105, 0.0106, 0.0107, 0.0108, 0.0109, 0.011, 0.0111, 0.0112, 0.0113, 0.0114, 0.0115, 0.0116, 0.0117, 0.0118, 0.011899999999999999, 0.012, 0.0121, 0.0122, 0.0123, 0.0124, 0.0125, 0.0126, 0.0127, 0.0128, 0.0129, 0.013, 0.0131, 0.0132, 0.0133, 0.0134, 0.0135, 0.0136, 0.0137, 0.0138, 0.013900000000000001, 0.014, 0.0141, 0.0142, 0.0143, 0.0144, 0.0145, 0.0146, 0.0147, 0.0148, 0.0149, 0.015, 0.0151, 0.0152, 0.0153, 0.0154, 0.0155, 0.0156, 0.015700000000000002, 0.0158, 0.0159, 0.016, 0.0161, 0.0162, 0.0163, 0.0164, 0.0165, 0.0166, 0.0167, 0.0168, 0.016900000000000002, 0.017, 0.0171, 0.0172, 0.0173, 0.0174, 0.0175, 0.0176, 0.0177, 0.0178, 0.0179, 0.018, 0.0181, 0.0182, 0.0183, 0.0184, 0.0185, 0.018600000000000002, 0.0187, 0.0188, 0.0189, 0.019, 0.0191, 0.019200000000000002, 0.0193, 0.0194, 0.0195, 0.0196, 0.0197, 0.0198, 0.0199, 0.02], \"y\": [0.9999975597619303, 0.9999951190476286, 0.9999926778569551, 0.9999902361897707, 0.9999877940459356, 0.9999853514253104, 0.9999829083277552, 0.9999804647531305, 0.9999780207012966, 0.9999755761721135, 0.9999731311654415, 0.9999706856811406, 0.9999682397190709, 0.9999657932790923, 0.9999633463610648, 0.9999608989648482, 0.9999584510903022, 0.9999560027372869, 0.9999535539056617, 0.9999511045952864, 0.9999486548060204, 0.9999462045377234, 0.9999437537902549, 0.9999413025634741, 0.9999388508572409, 0.9999363986714139, 0.999933946005853, 0.9999314928604169, 0.9999290392349652, 0.9999265851293566, 0.9999241305434503, 0.9999216754771055, 0.9999192199301807, 0.9999167639025353, 0.9999143073940276, 0.9999118504045168, 0.9999093929338613, 0.9999069349819197, 0.999904476548551, 0.9999020176336134, 0.9998995582369655, 0.9998970983584657, 0.9998946379979726, 0.9998921771553441, 0.9998897158304387, 0.9998872540231147, 0.9998847917332302, 0.9998823289606432, 0.9998798657052118, 0.9998774019667941, 0.9998749377452477, 0.9998724730404308, 0.9998700078522013, 0.9998675421804165, 0.9998650760249346, 0.999862609385613, 0.9998601422623093, 0.9998576746548812, 0.9998552065631859, 0.9998527379870812, 0.9998502689264241, 0.9998477993810723, 0.9998453293508828, 0.9998428588357128, 0.9998403878354195, 0.9998379163498602, 0.9998354443788915, 0.9998329719223708, 0.9998304989801547, 0.9998280255521004, 0.9998255516380645, 0.9998230772379038, 0.999820602351475, 0.9998181269786346, 0.9998156511192394, 0.999813174773146, 0.9998106979402106, 0.9998082206202898, 0.9998057428132399, 0.9998032645189173, 0.999800785737178, 0.9997983064678785, 0.9997958267108747, 0.9997933464660229, 0.999790865733179, 0.9997883845121989, 0.9997859028029386, 0.9997834206052538, 0.9997809379190006, 0.9997784547440345, 0.9997759710802112, 0.9997734869273865, 0.9997710022854157, 0.9997685171541546, 0.9997660315334584, 0.9997635454231826, 0.9997610588231826, 0.9997585717333136, 0.9997560841534309, 0.9997535960833895, 0.9997511075230449, 0.9997486184722516, 0.9997461289308649, 0.99974363889874, 0.9997411483757312, 0.999738657361694, 0.9997361658564825, 0.9997336738599519, 0.9997311813719566, 0.9997286883923514, 0.9997261949209906, 0.9997237009577288, 0.9997212065024206, 0.99971871155492, 0.9997162161150815, 0.9997137201827595, 0.9997112237578081, 0.9997087268400812, 0.9997062294294331, 0.9997037315257179, 0.9997012331287893, 0.9996987342385016, 0.9996962348547083, 0.9996937349772634, 0.9996912346060204, 0.9996887337408331, 0.9996862323815554, 0.9996837305280404, 0.9996812281801419, 0.9996787253377132, 0.9996762220006077, 0.9996737181686788, 0.9996712138417797, 0.9996687090197638, 0.9996662037024839, 0.9996636978897935, 0.9996611915815453, 0.9996586847775925, 0.9996561774777879, 0.9996536696819843, 0.9996511613900348, 0.9996486526017919, 0.9996461433171084, 0.9996436335358369, 0.9996411232578299, 0.99963861248294, 0.9996361012110196, 0.9996335894419212, 0.9996310771754969, 0.9996285644115994, 0.9996260511500804, 0.9996235373907926, 0.9996210231335877, 0.9996185083783179, 0.9996159931248352, 0.9996134773729913, 0.9996109611226386, 0.9996084443736284, 0.9996059271258128, 0.9996034093790431, 0.9996008911331713, 0.9995983723880488, 0.9995958531435272, 0.999593333399458, 0.9995908131556924, 0.999588292412082, 0.9995857711684778, 0.9995832494247313, 0.9995807271806935, 0.9995782044362155, 0.9995756811911485, 0.9995731574453433, 0.9995706331986509, 0.9995681084509221, 0.999565583202008, 0.9995630574517589, 0.9995605312000257, 0.9995580044466593, 0.9995554771915098, 0.9995529494344282, 0.9995504211752644, 0.9995478924138693, 0.9995453631500929, 0.9995428333837856, 0.9995403031147978, 0.9995377723429792, 0.9995352410681804, 0.9995327092902511, 0.9995301770090415, 0.9995276442244012, 0.9995251109361803, 0.9995225771442287, 0.9995200428483958, 0.9995175080485317, 0.9995149727444856, 0.9995124369361075, 0.9995099006232464, 0.9995073638057521, 0.9995048264834738, 0.9995022886562609]}, {\"mode\": \"lines\", \"name\": \"IgA/IgG\", \"type\": \"scatter\", \"x\": [0.0001, 0.0002, 0.00030000000000000003, 0.0004, 0.0005, 0.0006000000000000001, 0.0007000000000000001, 0.0008, 0.0009000000000000001, 0.001, 0.0011, 0.0012000000000000001, 0.0013000000000000002, 0.0014000000000000002, 0.0015, 0.0016, 0.0017000000000000001, 0.0018000000000000002, 0.0019000000000000002, 0.002, 0.0021, 0.0022, 0.0023, 0.0024, 0.0025, 0.0026, 0.0027, 0.0028, 0.0029, 0.003, 0.0031, 0.0032, 0.0033, 0.0034, 0.0035, 0.0036, 0.0037, 0.0038, 0.0039, 0.004, 0.0041, 0.004200000000000001, 0.004300000000000001, 0.0044, 0.0045000000000000005, 0.004600000000000001, 0.0047, 0.0048000000000000004, 0.004900000000000001, 0.005, 0.0051, 0.005200000000000001, 0.005300000000000001, 0.0054, 0.0055000000000000005, 0.005600000000000001, 0.0057, 0.0058000000000000005, 0.005900000000000001, 0.006, 0.0061, 0.006200000000000001, 0.006300000000000001, 0.0064, 0.006500000000000001, 0.006600000000000001, 0.0067, 0.0068000000000000005, 0.006900000000000001, 0.007000000000000001, 0.0071, 0.007200000000000001, 0.007300000000000001, 0.0074, 0.007500000000000001, 0.007600000000000001, 0.0077, 0.0078000000000000005, 0.0079, 0.008, 0.0081, 0.008199999999999999, 0.0083, 0.0084, 0.0085, 0.0086, 0.0087, 0.0088, 0.0089, 0.009, 0.0091, 0.0092, 0.0093, 0.0094, 0.0095, 0.0096, 0.0097, 0.0098, 0.009899999999999999, 0.01, 0.0101, 0.0102, 0.0103, 0.0104, 0.0105, 0.0106, 0.0107, 0.0108, 0.0109, 0.011, 0.0111, 0.0112, 0.0113, 0.0114, 0.0115, 0.0116, 0.0117, 0.0118, 0.011899999999999999, 0.012, 0.0121, 0.0122, 0.0123, 0.0124, 0.0125, 0.0126, 0.0127, 0.0128, 0.0129, 0.013, 0.0131, 0.0132, 0.0133, 0.0134, 0.0135, 0.0136, 0.0137, 0.0138, 0.013900000000000001, 0.014, 0.0141, 0.0142, 0.0143, 0.0144, 0.0145, 0.0146, 0.0147, 0.0148, 0.0149, 0.015, 0.0151, 0.0152, 0.0153, 0.0154, 0.0155, 0.0156, 0.015700000000000002, 0.0158, 0.0159, 0.016, 0.0161, 0.0162, 0.0163, 0.0164, 0.0165, 0.0166, 0.0167, 0.0168, 0.016900000000000002, 0.017, 0.0171, 0.0172, 0.0173, 0.0174, 0.0175, 0.0176, 0.0177, 0.0178, 0.0179, 0.018, 0.0181, 0.0182, 0.0183, 0.0184, 0.0185, 0.018600000000000002, 0.0187, 0.0188, 0.0189, 0.019, 0.0191, 0.019200000000000002, 0.0193, 0.0194, 0.0195, 0.0196, 0.0197, 0.0198, 0.0199, 0.02], \"y\": [1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0, 1.0]}],\n",
       "                        {\"template\": {\"data\": {\"bar\": [{\"error_x\": {\"color\": \"#2a3f5f\"}, \"error_y\": {\"color\": \"#2a3f5f\"}, \"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"bar\"}], \"barpolar\": [{\"marker\": {\"line\": {\"color\": \"#E5ECF6\", \"width\": 0.5}}, \"type\": \"barpolar\"}], \"carpet\": [{\"aaxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"baxis\": {\"endlinecolor\": \"#2a3f5f\", \"gridcolor\": \"white\", \"linecolor\": \"white\", \"minorgridcolor\": \"white\", \"startlinecolor\": \"#2a3f5f\"}, \"type\": \"carpet\"}], \"choropleth\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"choropleth\"}], \"contour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"contour\"}], \"contourcarpet\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"contourcarpet\"}], \"heatmap\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmap\"}], \"heatmapgl\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"heatmapgl\"}], \"histogram\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"histogram\"}], \"histogram2d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2d\"}], \"histogram2dcontour\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"histogram2dcontour\"}], \"mesh3d\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"type\": \"mesh3d\"}], \"parcoords\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"parcoords\"}], \"pie\": [{\"automargin\": true, \"type\": \"pie\"}], \"scatter\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter\"}], \"scatter3d\": [{\"line\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatter3d\"}], \"scattercarpet\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattercarpet\"}], \"scattergeo\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergeo\"}], \"scattergl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattergl\"}], \"scattermapbox\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scattermapbox\"}], \"scatterpolar\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolar\"}], \"scatterpolargl\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterpolargl\"}], \"scatterternary\": [{\"marker\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"type\": \"scatterternary\"}], \"surface\": [{\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}, \"colorscale\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"type\": \"surface\"}], \"table\": [{\"cells\": {\"fill\": {\"color\": \"#EBF0F8\"}, \"line\": {\"color\": \"white\"}}, \"header\": {\"fill\": {\"color\": \"#C8D4E3\"}, \"line\": {\"color\": \"white\"}}, \"type\": \"table\"}]}, \"layout\": {\"annotationdefaults\": {\"arrowcolor\": \"#2a3f5f\", \"arrowhead\": 0, \"arrowwidth\": 1}, \"coloraxis\": {\"colorbar\": {\"outlinewidth\": 0, \"ticks\": \"\"}}, \"colorscale\": {\"diverging\": [[0, \"#8e0152\"], [0.1, \"#c51b7d\"], [0.2, \"#de77ae\"], [0.3, \"#f1b6da\"], [0.4, \"#fde0ef\"], [0.5, \"#f7f7f7\"], [0.6, \"#e6f5d0\"], [0.7, \"#b8e186\"], [0.8, \"#7fbc41\"], [0.9, \"#4d9221\"], [1, \"#276419\"]], \"sequential\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]], \"sequentialminus\": [[0.0, \"#0d0887\"], [0.1111111111111111, \"#46039f\"], [0.2222222222222222, \"#7201a8\"], [0.3333333333333333, \"#9c179e\"], [0.4444444444444444, \"#bd3786\"], [0.5555555555555556, \"#d8576b\"], [0.6666666666666666, \"#ed7953\"], [0.7777777777777778, \"#fb9f3a\"], [0.8888888888888888, \"#fdca26\"], [1.0, \"#f0f921\"]]}, \"colorway\": [\"#636efa\", \"#EF553B\", \"#00cc96\", \"#ab63fa\", \"#FFA15A\", \"#19d3f3\", \"#FF6692\", \"#B6E880\", \"#FF97FF\", \"#FECB52\"], \"font\": {\"color\": \"#2a3f5f\"}, \"geo\": {\"bgcolor\": \"white\", \"lakecolor\": \"white\", \"landcolor\": \"#E5ECF6\", \"showlakes\": true, \"showland\": true, \"subunitcolor\": \"white\"}, \"hoverlabel\": {\"align\": \"left\"}, \"hovermode\": \"closest\", \"mapbox\": {\"style\": \"light\"}, \"paper_bgcolor\": \"white\", \"plot_bgcolor\": \"#E5ECF6\", \"polar\": {\"angularaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"radialaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"scene\": {\"xaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"yaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}, \"zaxis\": {\"backgroundcolor\": \"#E5ECF6\", \"gridcolor\": \"white\", \"gridwidth\": 2, \"linecolor\": \"white\", \"showbackground\": true, \"ticks\": \"\", \"zerolinecolor\": \"white\"}}, \"shapedefaults\": {\"line\": {\"color\": \"#2a3f5f\"}}, \"ternary\": {\"aaxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"baxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}, \"bgcolor\": \"#E5ECF6\", \"caxis\": {\"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\"}}, \"title\": {\"x\": 0.05}, \"xaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"title\": {\"standoff\": 15}, \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}, \"yaxis\": {\"automargin\": true, \"gridcolor\": \"white\", \"linecolor\": \"white\", \"ticks\": \"\", \"title\": {\"standoff\": 15}, \"zerolinecolor\": \"white\", \"zerolinewidth\": 2}}}, \"title\": {\"text\": \"Probabilities of being healthy when tested negative\"}, \"xaxis\": {\"title\": {\"text\": \"Probabilities of being sick\"}}},\n",
       "                        {\"responsive\": true}\n",
       "                    ).then(function(){\n",
       "                            \n",
       "var gd = document.getElementById('d5cb8efb-18f0-4e0e-b9c3-61f8c83dc1ee');\n",
       "var x = new MutationObserver(function (mutations, observer) {{\n",
       "        var display = window.getComputedStyle(gd).display;\n",
       "        if (!display || display === 'none') {{\n",
       "            console.log([gd, 'removed!']);\n",
       "            Plotly.purge(gd);\n",
       "            observer.disconnect();\n",
       "        }}\n",
       "}});\n",
       "\n",
       "// Listen for the removal of the full notebook cells\n",
       "var notebookContainer = gd.closest('#notebook-container');\n",
       "if (notebookContainer) {{\n",
       "    x.observe(notebookContainer, {childList: true});\n",
       "}}\n",
       "\n",
       "// Listen for the clearing of the current output cell\n",
       "var outputEl = gd.closest('.output');\n",
       "if (outputEl) {{\n",
       "    x.observe(outputEl, {childList: true});\n",
       "}}\n",
       "\n",
       "                        })\n",
       "                };\n",
       "                });\n",
       "            </script>\n",
       "        </div>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "fig = go.Figure()\n",
    "                       \n",
    "for i, test in enumerate(metrics_summary.index):\n",
    "    metrics = metrics_summary.loc[test]\n",
    "    fig.add_trace(go.Scatter(x= prob_sick,\n",
    "                             y= metrics.Specificity*prob_healthy/(\n",
    "                                 metrics.Specificity*prob_healthy + (1 - metrics.Sensitivity)*prob_sick),\n",
    "                                mode= \"lines\", \n",
    "                                name= test)\n",
    "                  )\n",
    "\n",
    "fig.update_layout(title= \"Probabilities of being healthy when tested negative\", \n",
    "                 xaxis_title= \"Probabilities of being sick\")\n",
    "fig.show()"
   ]
  }
 ],
 "metadata": {
  "hide_input": false,
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.4"
  },
  "toc": {
   "base_numbering": 1,
   "nav_menu": {},
   "number_sections": true,
   "sideBar": true,
   "skip_h1_title": false,
   "title_cell": "Table of Contents",
   "title_sidebar": "Contents",
   "toc_cell": false,
   "toc_position": {},
   "toc_section_display": true,
   "toc_window_display": true
  },
  "varInspector": {
   "cols": {
    "lenName": 16,
    "lenType": 16,
    "lenVar": 40
   },
   "kernels_config": {
    "python": {
     "delete_cmd_postfix": "",
     "delete_cmd_prefix": "del ",
     "library": "var_list.py",
     "varRefreshCmd": "print(var_dic_list())"
    },
    "r": {
     "delete_cmd_postfix": ") ",
     "delete_cmd_prefix": "rm(",
     "library": "var_list.r",
     "varRefreshCmd": "cat(var_dic_list()) "
    }
   },
   "oldHeight": 407.073818,
   "position": {
    "height": "429.063px",
    "left": "1394.28px",
    "right": "20px",
    "top": "120px",
    "width": "455.344px"
   },
   "types_to_exclude": [
    "module",
    "function",
    "builtin_function_or_method",
    "instance",
    "_Feature"
   ],
   "varInspector_section_display": "block",
   "window_display": false
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
